Generated by All in One SEO v5.0.1, this is an llms.txt file, used by LLMs to index the site.

# SwedenBIO

Branschorganisationen för svenska life science företag

## Sitemaps

- [XML Sitemap](https://swedenbio.se/sitemap.xml): Contains all public & indexable URLs for this website.

## Inlägg

- [Aktuellt](https://swedenbio.se/aktuellt/)
- [Medlemsturné 2026: Göteborg ](https://swedenbio.se/medlemsturne-2026-goteborg/) - SwedenBIOs medlemsturné syftar till att komma närmare medlemmarna och lära sig mer om deras behov och utmaningar. Sedan turnéstarten i början av året har vårt team hunnit besöka medlemsföretag i Umeå, Flemingsberg och Göteborg. Life science är en stark och viktig del av Göteborgsregionen med drygt 600 life science-företag, högkvalitativ vård vid Sahlgrenska universitetssjukhuset, och världsledande utbildning och forskning vid Sahlgrenska akademin (Göteborgs universitet) och Chalmers tekniska högskola. Nedan följer en kort presentation av medlemsföretag som teamet hade möjlighet att samtala med på plats i Göteborg. Fluicell - gör vävnadsterapi möjligt Fluicell är ett svenskt life science-bolag som är specialiserat på mikrofluidik och vävnadsteknik (tissue engineering) för utveckling av avancerade forsknings- och terapilösningar. Bolaget fokuserar nu på att bredda kommersialiseringen genom strategiska partnerskap, licensiering och affärsutveckling. Fluicell utvecklar tillsammans med partners en mikrofluidikbaserad plattform för lokal läkemedelsleverans vid hjärncancer, med potential att utvidgas till flera onkologiska indikationer. Inom typ 1-diabetes utvecklar bolaget bioengineerade pankreasöar genom att kombinera sin vävnadsteknologiplattform med stamcellsteknik från Mayo Clinic. Samtidigt har Fluicell förnyat styrelsen med kompetens inom medicinteknik, regenerativ medicin och kommersialisering för att stärka bolagets fortsatta tillväxt. Sahlgrenska Science Park – med uppdraget att stärka konkurrenskraften inom life science-sektorn i Göteborg och Västsverige. Sahlgrenska Science Park är en innovationsmiljö som hjälper life science- och hälsobolag att utvecklas från tidig innovation till kommersiell tillväxt. Genom ett nära samarbete med Sahlgrenska Universitetssjukhuset, akademin och industripartners bidrar Science Park till att accelerera forskning, innovation och kommersialisering. Parken erbjuder dessutom delad laboratorie- och kontorsmiljö, vilket sänker kostnaderna och underlättar utvecklingen för startups och växande företag. Verigraft - möjliggör transplantation och adresserar sjukdomar som hittills varit obotliga Verigraft är ett svenskt biotechbolag som utvecklar personanpassade kärlgraft för kärlkirurgi. Bolagets teknologi bygger på venklaffar från avlidna donatorer där alla celler och allt DNA avlägsnas, varefter transplantatet anpassas med patientens eget blod före implantation, vilket eliminerar behovet av livslång immunhämmande behandling. Verigraft har framgångsrikt genomfört sin första kliniska säkerhetsstudie med positiva resultat och förbereder nu en registreringsgrundande fas 2/3-studie med omkring 80 patienter i Europa och USA. Tidiga kliniska data visar förbättrade patientresultat och ökad livskvalitet. Bolaget har dessutom säkrat cirka 110 miljoner kronor i finansiering från en befintlig investerare och bedömer att ytterligare omkring 300 miljoner kronor behövs för att slutföra den registreringsgrundande studien. Antaros Medical - skräddarsyr bilddiagnostiska lösningar och genomför imagingstudier för att ge avgörande insikter om läkemedel Antaros Medical är ett svenskt CRO-bolag och partner inom läkemedelsutveckling, specialiserat på avancerad medicinsk avbildning, bildanalys, imaging-biomarkörer och precisionsmedicin i kliniska prövningar. Bolaget stödjer läkemedelsföretag med
- [Mindre än en månad kvar till NLSDays](https://swedenbio.se/mindre-an-en-manad-kvar-till-nlsdays/) - Inför årets konferens ger SwedenBIO:s Marjo Puumalainen, executive director för NLSDays en inblick i vad deltagarna kan förvänta sig – från aktuella teman och internationella talare till partnering, delegationer och sociala aktiviteter. Vad står på agendan för årets konferens? – Programmet fokuserar på några av de viktigaste krafterna som formar life science-sektorn i dag, bland annat banbrytande utveckling inom CNS, den växande betydelsen av strategiskt riskkapital, investeringar inom healthtech, Kinas påverkan på det globala affärslandskapet inom biopharma samt framtiden för europeisk innovationsfinansiering, förklarar Marjo. Årets öppningssession kommer att lyfta fram styrkorna och den globala relevansen hos nordisk life science. Därutöver skapar Nordic Star Pitch Competition, innovationsposterutställningen, företagspresentationerna och tusentals partneringmöten möjligheter för deltagarna att hitta nya samarbetspartners. En nyhet i årets program är Spotlight Panels – fokuserade 30-minutersdiskussioner där företag och experter får möjlighet att fördjupa sig i specifika ämnen i ett dynamiskt format. NLSDays välkomnar dessutom rekordmånga 13 internationella delegationer, vilket ger konferensen en ännu starkare global dimension samtidigt som fokus på nordisk life science och innovation bibehålls. Vilka välkända branschprofiler kommer att stå på scen? – Totalt är 48 talare från investerings-, läkemedels-, biotech- och healthtechsektorerna bekräftade. Från investerarsidan välkomnar vi bland andra Maha Radhakrishnan från Sofinnova Investments, Emma Johnson från M Ventures, Victor Decrion från Lauxera Capital Partners och Kevin Dalgaard från Lundbeckfonden BioCapital. Bland representanterna från läkemedelsindustrin finns Toby Richardson från Johnson & Johnson, Malin Jonsson Boezelman från AstraZeneca, Jim Allpress från Eisai och Daniel
- [Hur säkerställer vi fortsatt tillväxt för svenska life science-bolag? ](https://swedenbio.se/hur-sakerstaller-vi-fortsatt-tillvaxt-for-svenska-life-science-bolag/) - Samtalet modererades av Magnus Lejelöv, STUNS, och panelen bestod av David Sikström, statssekreterare vid Klimat- och näringsdepartementet, Sara Frykstrand Ångström, Industrifonden, Aida Birinxhiku, riksdagsledamot (S), Lena Svendsen, IKEM, samt SwedenBIOs vd Jessica Martinsson. Jessica Martinsson inledde med att beskriva en bransch som trots stora utmaningar fortsätter att leverera innovation och tillväxt. Samtidigt menade hon att regelverken allt oftare blir ett hinder snarare
- [Europas säkerhetsagenda ställer nya krav på svensk life science ](https://swedenbio.se/europas-sakerhetsagenda-staller-nya-krav-pa-svensk-life-science/) - Samtalet modererades av Lina Hultqvist, Roche. I panelen deltog Fredrik Ax, Roche, Tomas Stavbom, Stockholms Handelskammare, Luisa Lundin, NorthX Biologics och Alexander Gorgijevski, Totalförsvarets forskningsinstitut (FOI). Ett återkommande budskap under seminariet var att industrin är beredd att ta ett större ansvar för Sveriges försörjningsberedskap – men att staten behöver ta initiativet. Alexander Gorgijevski från FOI beskrev hur dagens produktionssystem är optimerade för effektivitet, inte för kris eller krig. Just-in-time-logistik och högt kapacitetsutnyttjande lämnar liten marginal för störningar. – Ingen kan förvänta sig att företag ska hålla reservkapacitet utan ersättning. Staten behöver definiera vilken beredskap som behövs och teckna långsiktiga avtal med industrin. Beredskap är något som måste köpas i fredstid, inte improviseras när krisen redan är här. Luisa Lundin, NorthX Biologics, betonade att frågan handlar om betydligt mer än investeringar i ny produktion. – Vi behöver ett kontinuerligt kapitalflöde för att hålla avancerade produktionsanläggningar, utrustning och kompetens vid liv. Den kapaciteten går inte att bygga upp när en kris redan har inträffat. Hon pekade också på att säkerhetsfrågorna blivit allt mer komplexa, där biologiska hot, AI och fysisk produktion numera måste hanteras parallellt. Panelen återkom flera gånger till att life science inte kan betraktas som en isolerad sektor. Produktionsanläggningar är beroende av fungerande elförsörjning, vatten, transporter och annan kritisk infrastruktur. Tomas Stavbom från Stockholms Handelskammare menade att diskussionen om beredskap måste breddas. – Om elen försvinner fungerar inte produktionen. Om vattnet försvinner fungerar den inte heller. Utan transporter kommer inte personalen till jobbet. Life science är en del av ett större samhällsekosystem och måste planeras därefter. Han efterlyste också ett högre tempo i det politiska genomförandet. – I Almedalen hör vi i stort sett samma analys överallt. Nu är det dags att gå från ord till handling. Andra länder springer betydligt snabbare än vi gör. En annan central fråga var den nya lagstiftningen om granskning av utländska direktinvesteringar (FDI). Alexander Gorgijevski konstaterade att den stora majoriteten av anmälningarna aldrig leder till någon fördjupad granskning och att själva prövningen därför sällan utgör ett problem. Samtidigt pågår ett arbete inom EU
- [Swedish Pavilion at BIO “A milestone for Swedish life science” ](https://swedenbio.se/swedish-pavilion-at-bio-a-milestone-for-swedish-life-science/) - Swedish life science had a strong presence at the world’s largest biotech event, with a national pavilion organized by Business Sweden, SwedenBIO, Invest in Skåne and Business Region Gothenburg. In total, more than 50 Swedish companies were present in sunny San Diego. “After 10 years, the Swedish Pavilion made a strong return, showcasing the strength, innovation and ambition of Sweden’s
- [Medlemsturné 2026: Flemingsberg ](https://swedenbio.se/medlemsturne-2026-flemingsberg/) - Life science-bolag väljer Flemingsberg för kombinationen av talang, forskning, klinisk närhet, ATMP-kompetens, relevanta nätverk, specialanpassad laboratorieinfrastruktur och möjlighet att växa i ett snabbt expanderande kluster. National Director Joanna Daffy Tiitus och Community Manager Emma Danell hade nöjet att träffa flera av våra medlemmar och nyckelaktörer i det lokala ekosystemet. – “Det blev tydligt att Flemingsberg erbjuder en unik kombination av forskning,
- [SwedenBIO lanserar undersökning för att kartlägga den svenska medtech-sektorn](https://swedenbio.se/swedenbio-lanserar-undersokning-for-att-kartlagga-den-svenska-medtech-sektorn/) - Arbetet med undersökningen leds av Joanna Daffy Tiitus, National Director på SwedenBIO, som själv har en bakgrund inom medtech. Hon ser ett tydligt behov av att kartlägga sektorn: – Sverige har en stark och innovativ medtech-sektor, men dess bredd och potential är inte alltid synliga för omvärlden. Genom den här undersökningen vill vi skapa en omfattande kartläggning av svenska medtechinnovationer och samtidigt lyfta fram de företag som driver utvecklingen framåt. Rapporten ska fungera som ett skyltfönster för svensk medtech och bidra till nya möjligheter för investeringar, partnerskap och internationell tillväxt”, säger Joanna Daffy Tiitus. På vilka sätt kan undersökningen hjälpa sektorn? – Rapporten (The Swedish Medtech Innovation Pipeline Report 2027) kommer att ge värdefulla insikter om den svenska medtech-sektorn och skapa ett starkt och datadrivet underlag för dialog med beslutsfattare, investerare och andra nyckelaktörer. Den blir också ett sätt att lyfta fram svenska innovationer och öka synligheten för våra svenska medtech bolag, både nationellt och internationellt. Är det tänkt att detta ska bli en återkommande undersökning, likt SwedenBIOs Barometer och Pipeline-rapporter? – Ja, likt vår Drug Discovery and Development Pipeline är planen att rapporten ska publiceras vart tredje år. Det gör det möjligt att följa utvecklingen i sektorn över tid och samtidigt fortsätta visa upp bredden och innovationskraften inom svensk medtech. Hur lång tid tar det att svara på enkäten och vilka riktar den sig till? – Den riktar sig till personer i ledande befattningar inom medtechbolag med huvudkontor i Sverige. Bolagen ska ha nya produkter eller innovationer under utveckling i sin pipeline. Även bolag som är i tidig kommersiell fas/marknadsintroduktion är
- [Building bridges between Swedish and Korean ecosystems](https://swedenbio.se/building-bridges-between-swedish-and-korean-ecosystems/) - Why should Sweden and Korea collaborate more within life science? – Sweden and Korea have highly complementary strengths. Sweden brings a research-driven life science ecosystem, strong biotech innovation and companies developing new approaches across areas such as therapeutics, diagnostics, medtech and advanced manufacturing. Korea, meanwhile, has a fast-growing biopharma ecosystem, strong capabilities in clinical development and production, and an ability
- [SwedenBIOs vd får toppuppdrag i global bioteknikorganisation](https://swedenbio.se/swedenbios-vd-far-toppuppdrag-i-global-bioteknikorganisation/) - – Jag ser fram emot att ta plats i ICBA:s styrelse och bidra till utvecklingen av bioteknologi världen över. Det är naturligtvis även bra för svensk life science att vi finns representerade i framträdande internationella organisationer. Det ger oss möjlighet att påverka viktiga frågor, bygga internationella nätverk och stärka Sveriges position som ledande life science-nation säger Jessica Martinsson om utnämningen. International Council of Biotechnology Associations (ICBA) är en sammanslutning av nationella, icke-vinstdrivande branschorganisationer inom bioteknik. Organisationen arbetar för att öka allmänhetens förståelse för bioteknik samt verka för politiska beslut som stödjer tillväxt inom den innovativa bioteknikindustrin. ICBA samlar för närvarande nationella branschföreträdare från 28 länder.
- [Record Nordic delegation to Swiss Biotech Day shows growing collaboration](https://swedenbio.se/record-nordic-delegation-to-swiss-biotech-day-shows-growing-collaboration/) - The 2026 edition of Swiss Biotech Day, held in May in Basel, welcomed more than 3,500 participants from 58 countries, including 31 international delegations. One of the biggest delegations was the Nordic one, co-lead by SwedenBIO together with INNOSIAMO, a Swiss-Nordic consultancy firm, and in collaboration with our Nordic partners Business Finland, Life Science Nord, Medicon Valley Alliance and the Life Science Cluster. SwedenBIOs Nordic Community Manager, Sigrún Elfa Snæbjörnsdóttir, shares her
- [De tar plats i SwedenBIOs styrelse ](https://swedenbio.se/de-tar-plats-i-swedenbios-styrelse-2/) - Minna Lundholm från Sobi, Boubou Hallberg från Sahlgrenska Sjukhuset, Charlie Grafström, från Roche och Kerstin Falck från Hansa Biopharma har valts in till SwedenBIOs styrelse under årrstämman den 7 maj i Stockholm. Presentationen av den nya styrelsen finns här. Oförändrad medlemsavgift och Indexuppräkning Årsmötet beslutade att behålla nuvarande medlemsavgiftsnivåer. För att säkra att föreningens resurser inte urholkas med inflationen godkände årsmötet en indexuppräkning av serviceavgiften för 2026 för samtliga tre medlemskategorier med konsumentprisindex (KPI 1980) per september för uppräkning. Ta del av verksamhetsberättelsen I verksamhetsberättelsen informerar vi om arbetet under föregående år. I den kan du ta del av hur vi arbetat för att våra medlemmar ska kunna stärka sina affärsnätverk, hur vi spridit fakta och kunskap samt hur vi jobbat med att ge branschen en stark röst. Läs verksamhetsberättelsen i sin helhet här.
- [SwedenBIO lanserar 34 reformförslag för starkare svensk life science ](https://swedenbio.se/swedenbio-lanserar-34-reformforslag-for-starkare-svensk-life-science/) - Trots stark export, världsledande forskning och ett växande innovationsklimat riskerar Sverige att tappa mark i den globala konkurrensen. Nu efterlyser SwedenBIO ett mer samlat och offensivt agerande från politiken. – Svensk life science bidrar med stora värden genom, forskning och innovation och är vår näst största exportgren. Men potentialen finns att växa ytterligare . Med rätt förutsättningar kan vi stärka både tillväxt, vårdkvalitet och
- [SwedenBIO en av undertecknarna till MoU mellan Sverige och Korea](https://swedenbio.se/swedenbio-en-av-undertecknarna-till-mou-mellan-sverige-och-korea/) - Avtalet, som undertecknades den 27 april 2026 i Seoul, uttrycker en gemensam avsikt från SwedenBIO, Business Sweden, Korea Innovative Medicines Consortium (KIMCo) och Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) att utforska möjligheter att fördjupa samarbetet inom den life science -sektorn. Detta inkluderar gemensam forskning och utveckling, investeringar och affärsutveckling. – Efter tre års samarbete
- [Seminar Summary: The Road to Successful Corporate-Academic Collaborations](https://swedenbio.se/seminar-summary-the-road-to-successful-corporate-academic-collaborations/) - Organized by SwedenBIOs IP working group, the event focused on intellectual property (IP), legal frameworks, and the practical realities of collaboration. Speakers included Johanna Bergh, AWA, Per Hedman, Cirio advokatbyrå, Henrik Ihre, Cytiva, Sara Mangsbo and Andy Browning from Uppsala University and moderated by Magnus Lejelöv from STUNS. Johanna Bergh opened by emphasizing the centrality
- [Föreningsstämma 2026](https://swedenbio.se/foreningsstamma-2026/) - Högsta beslutande organ är föreningsstämman som också utser organisationens styrelse. Datum: torsdagen den 7 maj 2026Tid: klockan 17.00Plats: Münchenbryggeriet, Söder Mälarstrand 29, 118 25 STOCKHOLM Anmäl dig här. (Du kan välja att anmäla dig till både årsmötet och Executive Dinner eller enbart till årsmötet) Stämmohandlingar Kallelse till ordinarie årsstämma 2026 Revisionsberättelse föreningen SwedenBIO Styrelsens förslag till justering av medlemsavgifter
- [Synlighet, utbyte och insikter i fokus för medlemsturné   ](https://swedenbio.se/synlighet-utbyte-och-insikter-i-fokus-for-medlemsturne/) - Syftet med medlemsturnén är att träffa medlemmarna i deras egna miljöer för att få en djupare förståelse för deras arbete, utmaningar och möjligheter. Det kommer att hjälpa SwedenBIO att bättre förstå hur vi som branschorganisation kan stötta dem i olika skeden. De fördjupade kontakterna som blir ett resultat av träffarna kommer även att hjälpa oss att synliggöra dem för vårt medlemsnätverk. Sist men inte minst vill SwedenBIO genom turnén lyfta och visa på bredden i svensk life science, förklarar Joanna Daffy Tiitus. Under stoppet i Umeå kunde SwedenBIO-teamet träffa Helén Fält på APL (Apotek Produktion & Laboratorier AB), Pernilla Abrahamsson på LIPUM AB, Tor Ny på Omnio AB, Sofia Mayans, på Diamyd Medical, Annica Rönnbäck på QureTech Bio AB samt Andreas Lindberg på Umeå Biotech Incubator. Teamet deltog även i Open Up for Innovation, arrangerat av Umeå Biotech Incubator, vilket gav ytterligare insikter i regionens starka innovationsanda. – Det var både inspirerande och värdefullt att få uppleva Umeås life science-scen på nära håll. Det är tydligt att mycket spännande händer här, med stark samverkan mellan företag, akademi och stödjande organisationer, kommenterar Linn Mattsson, Community Manager. Nedan följer en kort presentation av medlemsföretag som teamet hade möjlighet att samtala med på plats i Umeå. APL – tillverkar individanpassade läkemedel APL är ett statligt ägt bolag och har ett viktigt samhällsuppdrag: att säkerställa tillgången till läkemedel i Sverige både i fredstid och vid kriser.
- [Ny lag försvårar kapitalanskaffning för life science-bolag – garantigivning vid emissioner i fokus](https://swedenbio.se/ny-lag-forsvarar-kapitalanskaffning-for-life-science-bolag-garantigivning-vid-emissioner-i-fokus/) - Bakgrund och syfte Bakgrunden till lagen är att nuvarande sanktionsverktyg – vitesförelägganden och sanktionsavgifter – inte bedömts vara tillräckligt effektiva mot aktörer som bedriver finansiell verksamhet utan tillstånd. Syftet med kriminaliseringen är att öka möjligheterna att upptäcka och motverka penningtvätt, finansiering av terrorism och kringgående av internationella sanktioner. Lagstiftaren valde att ge kriminaliseringen en generell
- [Help make the Swedish pavilion at BIO International a success  ](https://swedenbio.se/help-make-the-swedish-pavilion-at-bio-international-a-success/) - Business Sweden has taken the decision to arrange a Swedish pavilion at the BIO International Convention 2026 in San Diego, 22–25 June. SwedenBIO is helpinga partner in this strategic initiative – It is becoming increasingly important to promote Swedish life science abroad amid the rising international competition. National pavilions at events like BIO are crucial for the visibility of
- [European biotech funding: “We need to be more bullish, bolder, and faster”](https://swedenbio.se/european-biotech-funding-we-need-to-be-more-bullish-bolder-and-faster/) - The discussion, moderated by Jessica Martinsson, CEO of SwedenBIO, the Swedish Biotech Association, brought together perspectives from the investment side and the entrepreneurial front line: Dana Burduja of the European Investment Bank and Raffael Wohlgensinger, founder and CEO of Formo, a German biotech. "Financing alone cannot solve every challenge" The European Investment Bank plays a
- [Debatt om medtech regulation](https://swedenbio.se/debatt-om-medtech-regulation/) - Artikeln, som är undertecknad av Jessica Martinsson, vd SwedenBIO och Hanna Sjöström, ordförande i SwedenBIOs Medtech-arbetsgrupp, belyser en kritisk situation där de ökade kraven och de långa ledtiderna för certifiering slår hårt mot både små och stora företag. Detta hotar inte bara den svenska konkurrenskraften utan begränsar även tillgången till livsviktig teknik inom vården. Huvudpunkter
- [Möt Anna Ax, SwedenBIOs nya Policy Manager](https://swedenbio.se/mot-anna-ax-swedenbios-nya-policy-manager/) - Välkommen till teamet, hur känns det? – Tack, det känns jättebra! Det ska bli spännande att få jobba med mina hjärtefrågor från en ny position. Vad är det som får dig att brinna för just life science-sektorns utveckling? – Det är i life science-sektorn jag har min bas -livsvetenskaperna har alltid fascinerat mig och är orsaken till att jag blev just läkemedelskemist. Att få bidra till människors hälsa och välmående, oavsett om det är från labbet eller genom förbättrade förutsättningar genom policyutveckling känns betydelsefullt. Att sektorn dessutom är Sveriges näst största exportsektor och även på det sättet bistår till samhällsutvecklingen gör det än mer intressant och viktigt. Vad lockade med SwedenBIO? – Det är lätt att prata om att det är viktigt att röra sig "i systemet" mellan stat, region och näringsliv, att det berikar och bidrar till lärande. Nu fick jag möjligheten att faktiskt göra just det och själv förhoppningsvis bidra till att öka kunskapen om hur policyarbete i regeringskansliet går till. Jag ser fram emot att få arbeta närmare bolagen som genom sin forskning utvecklar produkter för samhälls- och patientnytta. SwedenBIO har genom sina medlemmar mycket fakta och sakkunskap och kan på många sätt bistå och bidra till samhällsdebatten, till exempel arbete med av ny lagstiftning. Här ser jag fram emot att hjälpa till med min erfarenhet. Du har arbetat med den nationella life science-strategin. Vilka är de viktigaste lärdomarna från Regeringskansliet som du tar med dig in i rollen på SwedenBIO? – Behovet av samverkan och samarbete. Life science-sektorn är komplex, det är många aktörer som är essentiella för att det ska fungera, lärosäten, hälso- och sjukvård, myndigheter och bolag. En aktör klarar sig inte själv utan systemet och helheten. Och det finns en stark vilja till samarbete. Den nationella strategin hjälper till att samla de enskilda krafterna mot gemensamma målsättningar. Hur hoppas du kunna bidra till SwedenBIOs policy-arbete? – SwedenBIOs medlemmar sitter på mycket kunskap som jag tror att kan komma till ännu bättre nytta i policyarbetet. Det gäller att vi kan komma in "rätt" i processerna både när det gäller nivå och timing. Här tror jag att jag kan bidra utifrån mina tidigare erfarenheter. Vilken policyfråga ser du som den mest akuta att lösa för att de svenska små- och medelstora life science-bolagen ska stå sig i den globala konkurrensen? –
- [Sveriges IP-strategi: "Ingen naturlag att vi kan upprätthålla vår position" ](https://swedenbio.se/sveriges-ip-strategi-ingen-naturlag-att-vi-kan-uppratthalla-var-position/) - Snarare än att vara en nischfråga för enskilda bolag eller branscher är immateriella tillgångar fundamentet för Sverige som kunskapsnation och måste tas på största allvar. Det var huvudbudskapet under ett möte den 19 februari där SwedenBIOs arbetsgrupp för IP och vd Jessica Martinsson diskuterade med PRV:s generaldirektör Anna Jardfelt. Patent- och registreringsverket var tidigt en del av det internationella PCT-systemet
- [Swedish CEOs share what it takes to succeed in the US market](https://swedenbio.se/swedish-ceos-share-what-it-takes-to-succeed-in-the-us-market/) - There are many compelling reasons for Swedish life science companies to enter the US market. It's by far the largest market for pharmaceuticals, with 40-50% of global sales revenues – a figure that rises to 70% for orphan drugs. Perhaps more importantly, drug prices are often 2-3 times higher than in Europe, helping companies achieve
- [Ny cybersäkerhetslag ställer nya krav på life science-bolag](https://swedenbio.se/ny-cybersakerhetslag-staller-nya-krav-pa-life-science-bolag/) - CSL lagen implementerar det så kallade NIS 2 direktivet och innefattar bland annat företag som bedriver läkemedelsutveckling- och forskning, läkemedelstillverkare samt tillverkare av medicintekniska produkter som anses vara kritiska vid hot mot folkhälsan. Även tillverkning av medicintekniska produkter och medicintekniska produkter för in vitro-diagnostik omfattas av CSL men utgör inte en högkritisk sektor men likväl
- [Matchmaking event brought together industry and students](https://swedenbio.se/matchmaking-event-brought-together-industry-and-students/) - The event brought together students, researchers and industry representatives for an after work event at Life City in Stockholm. The program included brief presentations, short pitches from ongoing joint projects, and informal discussions designed to connect academic and industry partners at an early stage. SwedenBIOs International Director, Marjo Puumalainen, explained the need for such initiatives.
- [JP Morgan 2026: Swedish CEOs share their experience](https://swedenbio.se/jp-morgan-2026-swedish-ceos-share-their-experience/) - Each year, SwedenBIO works to help member companies achieve their goals at JP. Morgan and this year was no exception. Our International Director, Marjo Puumalainen and Community Manager Linn Mattsson teamed up with BusinessSweden, the Swedish Consulate in San Francisco and the Swedish-American Chamber of Commerce in San Francisco to offer different types of opportunities designed to maximize the benefits
- [Upcoming delegations and opportunities](https://swedenbio.se/upcoming-delegations-and-opportunities/) - Swedish Pavilion at BIO International Convention 2026 We're excited to invite SwedenBIO members to participate in the Swedish Pavilion at BIO International Convention 2026 in San Diego, 22–25 June! This premier global life science event brings together industry leaders, investors, researchers, and policymakers — offering an unparalleled platform to showcase Swedish innovation, build partnerships, and
- [From Pitch to Partnership: Mastering Pharma-Biotech Collaborations](https://swedenbio.se/from-pitch-to-partnership-mastering-pharma-biotech-collaborations/) - The well-attended seminar, held on 3 February at SwedenBIO member Cirio law firm in Stockholm, saw four experienced industry leaders share practical insights from real-world collaborations. The Pharma Perspective: Strategy and the Funnel For big pharma, external innovation is a necessity, not an option. Simon Regnéll, Associate Director at Novo Nordisk, emphasized that every partnership
- [Nationellt klimatinitiativ inom hälso- och sjukvård och life science](https://swedenbio.se/nationellt-klimatinitiativ-inom-halso-och-sjukvard-och-life-science/) - Initiativet har som mål att genom samverkan minska utsläppen av växthusgaser med ambition att nå netto noll i hela värdekedjan 2045. – Genom detta initiativ visar vi att den svenska life science-industrin och hälso- och sjukvårdssektorn är redo att ta ansvar för klimatet. Tillsammans kan vi skapa en mer hållbar framtid, där innovation och patientsäkerhet går hand
- [From Biotech Winter to the Next Growth Wave](https://swedenbio.se/from-biotech-winter-to-the-next-growth-wave/) - After several years of tight capital markets, compressed valuations, and hesitant public investors, the global life science sector is still feeling the effects of the “biotech winter.” The discussion is shifting however. How can Swedish biotech companies navigate the later stages of the downturn, and position themselves for long-term growth toward 2030? Sebastian Alexanderson, Global
- [What is needed to build and Scale in Sweden?](https://swedenbio.se/panel-summary-how-to-build-and-scale-in-sweden/) - What is needed for Sweden to maintain and strengthen its position as a strong life science nation, and how can more companies grow here? This was the focus of one of the panels at this year's Summit, under the heading: How to Build and Scale in Sweden? The session highlighted Sweden's unique advantages, the challenges
- [Hansa Biopharma Named Winner of the 2025 SwedenBIO Award](https://swedenbio.se/hansa-biopharma-named-winner-of-the-2025-swedenbio-award/) - Hansa Biopharma's CEO, Renée Aguiar-Lucander, received the award in a prize ceremony during SwedenBIO Summit at Grand Hôtel in Stockholm on 21 January. “Absolutely fantastic. What an amazing honour. It has taken some time and a lot of hard work from my colleagues, but here we are! What a lovely surprise, she said upon the announcement.” Hansa Biopharma is a commercial-stage
- [Life Science Barometern 2026 släppt](https://swedenbio.se/life-science-barometern-2026-slappt/) - SwedenBIO, branschorganisationen för Sveriges life science-företag, presenterar i dag, den 21 januari 2025, Life Science Barometern 2026 – en årlig undersökning av utvecklingen inom den svenska life science-industrin. Årets rapport visar att industrin fortsätter sin fleråriga tillväxt och fortsatt bidrar i betydande utsträckning till den svenska ekonomin, med en nettoomsättning på 508 miljarder kronor står branschen för nästan 10 procent av varuexporten, vilket gör den till den näst största exportsektorn. Rapporten visar även att andelen kvinnliga vd:ar har ökat med fem procentenheter sedan den förra mätningen och nu uppgår till 31 procent. – Life Science industrin är avgörande för Sveriges tillväxt. Förutom att vara en viktig exportsektor skapar den arbetstillfällen, driver innovation och utvecklar unik kompetens, säger Joanna Daffy Tiitus, National Director på SwedenBIO. Tillgång till finansiering fortsatt bromskloss Trots den positiva utvecklingen inom flera områden kvarstår orosmoln och utmaningar för industrin, främst kopplat till tillgången på finansiering. Rapporten visar att samtidigt som den globala biopharmafinansieringen återhämtade sig under 2025, med fjärde kvartalet bland de starkaste på över fyra år, upplevde den svenska life science-industrin inte samma momentum. Företagsledare uppmanar därför beslutsfattare att prioritera starkare finansieringsstrukturer, ökat kapital i tidiga skeden samt långsiktig finansiell stabilitet. – För att stärka Sveriges position som en ledande life science-nation behöver vi vara konkurrenskraftiga och skapa goda förutsättningar för internationella investeringar i svenska bolag, säger Daffy Tiitus. Viktiga trender i svensk life science enligt rapporten Den svenska life science-industrin står för nästan 10 procent av varuexporten, vilket gör den till den näst största exportsektorn. Majoriteten av de 3 879 företagen är små och unga, men har en betydande potential i form av immateriella tillgångar. Andelen kvinnliga vd:ar ökade med 5 procentenheter jämfört med förra årets rapport och uppgår nu till 31 procent. Finansiering är fortsatt en av de största utmaningarna enligt företagsledare. Ladda ner rapporten Life
- [Uppdaterade samverkansregler mellan sjukvården och företag](https://swedenbio.se/uppdaterade-samverkansregler-mellan-sjukvarden-och-foretag/) - De uppdaterade samverkansreglerna har antagits av Sveriges Kommuner och Regioner, Lif – de forskande läkemedelsföretagen, Swedish Medtech, SwedenBIO och Swedish Labtech. De träder i kraft den 1 februari 2026. Samverkan mellan hälso- och sjukvård, forskning och företag inom läkemedel, medicinteknik, bioteknik och diagnostik har länge varit viktig för utvecklingen av nya metoder och behandlingar. För
- [Möt de tre finalisterna till SwedenBIO Award](https://swedenbio.se/mot-de-tre-finalisterna-till-swedenbio-award/) - SwedenBIO Award syftar till att ge ökad synlighet för life science-branschen genom att uppmärksamma och belöna framgångsrika och föredömliga medlemsföretag som har utmärkt sig särskilt och bidragit till positiv uppmärksamhet för branschen. Under hösten har rekordmånga bolag nominerats till SwedenBIO Award – branschens eget pris – som delas ut i samarbete med HealthCap. Här är
- [Förbättrad progression i Sveriges läkemedelspipeline sedan 2022](https://swedenbio.se/forbattrad-progression-i-sveriges-lakemedelspipeline-sedan-2022/) - Den senaste upplagan av Swedish Drug Discovery and Development Pipeline visar tydliga framsteg i hur projekt rör sig genom de tidiga utvecklingsfaserna. En jämförelse mellan data från 2022 och 2025 visar högre övergångsfrekvenser från discovery till preklinisk fas och förbättrad framgång i övergången från fas II till fas III. Samtidigt har vissa övergångar – som
- [Sveriges läkemedelspipeline fortsätter att imponera](https://swedenbio.se/sveriges-lakemedelspipeline-fortsatter-att-imponera/) - Den senaste upplagan av SwedenBIO:s pipeline-rapport visar på en dynamisk och snabbt växande svensk läkemedelspipeline. Sedan 2006 har rapporten kartlagt bredden av läkemedelsforskning och -utveckling som bedrivs av företag med huvudkontor i Sverige. År 2025 identifierades totalt 518 projekt från 152 företag, en nivå som matchar global big pharma inom kliniska tillgångar och överträffar den
- [London Life Sciences Week: Strong Networking Without Crossing the Pond ](https://swedenbio.se/london-life-sciences-week-strong-networking-without-crossing-the-pond/) - Taking place in November, during the Jefferies Global Healthcare Conference, the week brings together a multitude of events and partnering opportunities. The 2025 programme featured over 70 satellite events across London’s Covent Garden, Aldwych, and Holborn, supported by a free networking app. Anchored by the Jefferies European Healthcare Conference, which annually attracts around 1,300 life science investors, the week
- [Från mejeri & maskinrum till bioteknik: SwedenBIOs PUT-grupp besöker Alfa Laval](https://swedenbio.se/fran-mejeri-maskinrum-till-bioteknik-swedenbios-put-grupp-besoker-alfa-laval/) - Få förknippar Alfa Laval med life science, men företaget har i själva verket varit en aktiv leverantör till bioproduktionsindustrin i 140 år – med produkter och system designade specifikt för bioteknologi, även om det ursprungliga fokuset var något helt annat. Peter Thorwid, Concept Development Manager på Alfa Laval, välkomnade PUT-gruppen till företagets anläggning i Flemminsberg
- [Framtidens Life Science kräver naturvetare med digital kompetens](https://swedenbio.se/framtidens-life-science-kraver-naturvetare-med-digital-kompetens/) - Sverige står inför ett teknikskifte inom life science, där AI, maskininlärning och avancerad dataanalys förändrar hur biologiska prover tolkas och används. Naturvetare som kombinerar djup biologisk kunskap med programmering och datafärdigheter blir nyckelpersoner i den datadrivna framtiden, visar Naturvetarna i en ny rapport. Efterfrågan på dessa kompetenser har exploderat enligt samma rapprt – de senaste
- [Join the Swedish pavilion at BIO International 2026 ](https://swedenbio.se/join-the-swedish-pavilion-at-bio-international-2026/) - BIO International Convention 2026 will take place from June 22 - 25 in San Diego, USA and will, following several years of absence, have a coordinated Swedish presence in the form of a national pavilion. – "A Swedish booth at BIO International is very positive news. We at SwedenBIO have repeatedly raised the issue to
- [Branschaktörer och myndigheter i samtal om beredskap och prevention ](https://swedenbio.se/branschaktorer-och-myndigheter-i-samtal-om-beredskap-och-prevention/) - Rundabordssamtalet, som ägde rum tisdagen den 11 november, samlade representanter från flera myndigheter med uppdrag inom sjukvård, hälsa och beredskap – tillsammans med företrädare för life science-branschen. För att ett land ska ha en god beredskap i händelse av krig eller pandemi, krävs att många olika aktörer arbetar tillsammans effektivt. Rundabordssamtalet bekräftade att industrin vill
- [SwedenBIO tar plats i rådsgrupp för SweTrial](https://swedenbio.se/swedenbio-tar-plats-i-radsgrupp-for-swetrial/) - SweTrial är ett nationellt partnerskap med uppdrag att stärka Sveriges roll inom kliniska prövningar och life science. Partnerskapet ligger under Läkemedelsverket, som har fått regeringens uppdrag att genomföra den permanenta satsningen på bättre infrastruktur för kliniska prövningar i landet. För att säkerställa ett långsiktigt och framgångsrikt arbete har SweTrial inrättat ett råd med representanter från
- [Nurturing the next generation of life science talents](https://swedenbio.se/nurturing-the-next-generation-of-life-science-talents-2/) - SwedenBIOs Science Director Maja Neiman has given lectures about the Swedish innovation support system and Career skills for scientist for Swedish and European PhD students. She has also acted as an advisor to KTH to define their new master programs combining biotech and data science, as well as to KI for their master program Translational
- [Banar väg för svenskt ledarskap inom datadriven life science](https://swedenbio.se/banar-vag-for-sveriges-globala-ledarskap-inom-datadriven-life-science/) - Vad är DDLS, Data Driven Life Science-programmet? – Det som kallas DDLS heter egentligen SciLifeLab and Wallenberg National Program for Data-Driven Life Science, och är en av Sveriges genom tiderna största forskningssatsningar. 3.1 miljarder SEK (300 million USD) från Knut och Alice Wallenbergs stiftelse avsätts för programmet under 12 år. Programmet omfattar 11 lärosäten över
- [Record funding gives Sweden an edge in data-driven Life Science](https://swedenbio.se/how-record-funding-is-giving-sweden-an-edge-in-data-driven-life-science/) - Backed by 3.7 billion SEK from the Knut and Alice Wallenberg Foundation, one of Europe’s largest private scientific funders, the SciLifeLab and Wallenberg National Program for Data-Driven Life Science, simply referred to as the ”DDLS program”, aims to place Sweden at the forefront of tomorrow’s life science technologies. Announced three years ago, the program provides
- [Record funding gives Sweden an edge in data-driven Life Science](https://swedenbio.se/how-record-funding-is-giving-sweden-an-edge-in-data-driven-life-science/) - Backed by 3.7 billion SEK from the Knut and Alice Wallenberg Foundation, one of Europe’s largest private scientific funders, the SciLifeLab and Wallenberg National Program for Data-Driven Life Science, simply referred to as the ”DDLS program”, aims to place Sweden at the forefront of tomorrow’s life science technologies. Announced three years ago, the program provides
- [Årets Barometerundersökning i life science är igång](https://swedenbio.se/arets-barometerundersokning-i-life-science-ar-igang/) - Enkäten är redan öppen, hur ser intresset ut bland företagen för att svara? – Vi smygöppnade enkäten redan under NLSDays och har faktiskt redan fått in en hel del svar! Jag tror att många företag känner igen Barometern och ser det som ett relativt enkelt sätt att bidra till att påverka life science-industrin i stort.
- [Svensk life science fortsatt stark inom tidig forskning och innovation, visar ny pipeline-rapport](https://swedenbio.se/svensk-life-science-fortsatt-stark-inom-tidig-forskning-och-innovation-visar-ny-pipeline-rapport/) - 518 projekt hos 152 företag – en pipeline i klass med big pharma Den svenska pipeline-rapporten för läkemedelsutveckling, som publiceras vart tredje år, baseras på en enkät till svenska företag och kartlägger framsteg och trender inom landets läkemedelsutvecklingssektor. Den senaste upplagan visar att den svenska läkemedelspipelinen omfattar 518 projekt som drivs av 152 företag med
- [Swedish delegation opens new doors for biotech in Singapore](https://swedenbio.se/swedish-delegation-opens-new-doors-for-biotech-in-singapore/) - In November 2024, Sweden and Singapore signed a MoU in healthcare to advance global health innovation and encourage partnerships and exchanges addressing global health challenges. Since the signing of the MoU, actors in both countries have been exploring the strengths and gaps of their respective ecosystems. One area identified for Swedish-Singaporean cooperation is biotech. – From
- [Swedish delegation opens new doors for biotech in Singapore](https://swedenbio.se/swedish-delegation-opens-new-doors-for-biotech-in-singapore/) - In November 2024, Sweden and Singapore signed a MoU in healthcare to advance global health innovation and encourage partnerships and exchanges addressing global health challenges. Since the signing of the MoU, actors in both countries have been exploring the strengths and gaps of their respective ecosystems. One area identified for Swedish-Singaporean cooperation is biotech. – From
- [Swiss delegation to NLSDays in Gothenburg](https://swedenbio.se/swiss-delegation-to-nlsdays-in-gothenburg/) - Nordic-Swiss exchanges within life science are on the rise. Earlier this year a Nordic life science-delegation participated in the Swiss Biotech Days. Now, a Swiss delegation organized by the Embassy of Switzerland in Sweden is heading to Sweden and Nordic Life Science Days. Gustav Henriksson, Head of Swiss Business Hub Nordics at the Embassy of Switzerland
- [Swiss delegation to NLSDays in Gothenburg](https://swedenbio.se/swiss-delegation-to-nlsdays-in-gothenburg/) - Nordic-Swiss exchanges within life science are on the rise. Earlier this year a Nordic life science-delegation participated in the Swiss Biotech Days. Now, a Swiss delegation organized by the Embassy of Switzerland in Sweden is heading to Sweden and Nordic Life Science Days. Gustav Henriksson, Head of Swiss Business Hub Nordics at the Embassy of Switzerland
- [”Innovationer kommer till liv genom att de tillverkas” ](https://swedenbio.se/innovationer-kommer-till-liv-genom-att-de-tillverkas/) - I Almedalen sa du att vi skulle kunna locka hit fler aktörer om Sveriges förstklassiga infrastruktur marknadsförs bättre. Kan du utveckla ditt resonemang? – Sverige har satsat mycket och utvecklat bra forsknings- och industri-infrastrukturer inom life science men många känner inte till dem. Om vi marknadsför helheten för svenska och internationella innovatörer skulle fler läkemedelsprojekt kunna
- [“At the end of the day, it's all about building relationships”](https://swedenbio.se/at-the-end-of-the-day-its-all-about-building-relationships/) - Life science companies face a unique challenge: communicating complex science and uncertain timelines to investors who need clear information to make decisions. During the seminar “Raising Capital in Life Science: What Investors Really Want to Know”, several expert investors shared their perspectives. Sweeping claims don’t suffice Viktor Drvota, CEO of Karolinska Development, focused on what
- [“At the end of the day, it's all about building relationships”](https://swedenbio.se/at-the-end-of-the-day-its-all-about-building-relationships/) - Life science companies face a unique challenge: communicating complex science and uncertain timelines to investors who need clear information to make decisions. During the seminar “Raising Capital in Life Science: What Investors Really Want to Know”, several expert investors shared their perspectives. Sweeping claims don’t suffice Viktor Drvota, CEO of Karolinska Development, focused on what
- [SwedenBIO’s CEO takes a seat in Europe’s largest industry association for biotechnology](https://swedenbio.se/swedenbios-vd-tar-plats-i-europas-storsta-branschorgan-for-bioteknik/) - “I look forward to contributing with a Swedish perspective and sharing our experiences in the European discussions on biotech and life science. The conditions for our industry are increasingly being shaped at the EU level, and the sector’s future growth will be crucial for Europe’s competitiveness and prosperity,” says Jessica Martinsson about her new role.
- [SwedenBIOs vd tar plats i Europas största branschorgan för bioteknik](https://swedenbio.se/swedenbios-vd-tar-plats-i-europas-storsta-branschorgan-for-bioteknik/) - – Jag ser fram emot att bidra med ett svenskt perspektiv och dela med mig av våra erfarenheter in i de europeiska diskussionerna kring biotech och life science. Villkoren för vår bransch formas i allt högre grad på EU-nivå, och den framtida tillväxten inom sektorn kommer att vara avgörande för Europas konkurrenskraft och välstånd, säger Jessica
- [SwedenBIO welcomes new National Director and Key Account Manager](https://swedenbio.se/swedenbio-welcomes-a-new-national-director-and-a-key-account-manager/) - Joanna Daffy Tiitus – our new National DirectorJoanna Daffy Tiitus has a solid background in business development, marketing, and communications with over 10 years' experience from the life science industry. She has worked with MedTech and biotech companies ranging from early-stage startups to medium-sized enterprises. Joanna holds a BSc in Biomedicine from Uppsala University and an
- [“Vi behöver en konkret IP-strategi med en handlingsplan” ](https://swedenbio.se/vi-behover-en-konkret-ip-strategi-med-en-handlingsplan/) - Vi ser väldigt bra ut på papper, men när vi skrapar på ytan framträder brister som faktiskt behöver åtgärdas SwedenBIOs arbetsgrupp för IP bjöd nyligen in Christina Wainikka, policyexpert för immaterialrätt hos Svenskt Näringsliv, för att berätta om sitt arbete för att stärka Sveriges position inom immateriella tillgångar. Christina Wainikka har arbetat med IP-frågor sedan
- [SwedenBIO welcomes new National Director and Key Account Manager](https://swedenbio.se/swedenbio-welcomes-a-new-national-director-and-a-key-account-manager/) - Joanna Daffy Tiitus – our new National DirectorJoanna Daffy Tiitus has a solid background in business development, marketing, and communications with over 10 years' experience from the life science industry. She has worked with MedTech and biotech companies ranging from early-stage startups to medium-sized enterprises. Joanna holds a BSc in Biomedicine from Uppsala University and an
- [”Om inget görs riskerar fler att dö av resistenta bakterier än cancer om 25 år”](https://swedenbio.se/om-inget-gors-riskerar-fler-att-do-av-resistenta-bakterier-an-cancer-om-25-ar/) - Vad är den senaste utvecklingen inom pandemic preparedness? – Ett historiskt pandemiavtal antogs i maj av WHO:s medlemsländer för att förbättra beredskap, samordning, och rättvis tillgång till medicinska resurser. – WHO lyfter också fram vaccination som en nyckelstrategi i arbetet mot antimikrobiell resistens (AMR). Genom att minska infektioner och antibiotikaanvändning kan utvecklingen av resistenta bakterier bromsas och
- [Swedish delegation to Singapore](https://swedenbio.se/swedish-delegation-to-singapore/) - In November last year, Sweden and Singapore signed a memorandum of understanding (MoU) on cooperation in health innovation. Now, a delegation organized by Swecare, BusinessSweden, SwedenBIO and Vinnova and consisting of Swedish biotech and medtech companies is heading to Singapore. The delegation will be in Sinapore from September 8–10, 2025 to strengthen ties with Singapore's
- [Svenska bolag internationellt uppkopplade – Atrogi får koreansk storinvestering](https://swedenbio.se/svenska-bolag-internationellt-uppkopplade-atrogi-far-k-oreansk-storinvestering/) - Ett exempel på sådan är SwedenBIO-medlemmen Atrogi som precisgenomfört en nyemission om 90 miljoner kronor. Bland ankarinvesterarna finns Koreas största riskkapitalbolag, Korea Investment Partners. Vad betyder investeringen för er? Och var kommer denta er? –Att en så etablerad aktör som Korea Investment Partners satsar på oss ser vi som ett starkt bevis på vår forskning
- [Swedish delegation to Singapore](https://swedenbio.se/swedish-delegation-to-singapore/) - In November last year, Sweden and Singapore signed a memorandum of understanding (MoU) on cooperation in health innovation. Now, a delegation organized by Swecare, BusinessSweden, SwedenBIO and Vinnova and consisting of Swedish biotech and medtech companies is heading to Singapore. The delegation will be in Sinapore from September 8–10, 2025 to strengthen ties with Singapore's
- [Opportunities abound  for Swedish life science in Japan](https://swedenbio.se/in-japan-opportunities-abound-for-swedish-life-science/) - Japan has the third largest pharmaceuticals market and is home to countless pharma companies. With more than 123 millon inhabitants, the island country offers many opportunities for Swedish life science companies. But entering a new market and finding the right partners is always challenging and Japan is considered one of the toughest countries to do
- [Opportunities abound  for Swedish life science in Japan](https://swedenbio.se/in-japan-opportunities-abound-for-swedish-life-science/) - Japan has the third largest pharmaceuticals market and is home to countless pharma companies. With more than 123 millon inhabitants, the island country offers many opportunities for Swedish life science companies. But entering a new market and finding the right partners is always challenging and Japan is considered one of the toughest countries to do
- [Debattartikel: Sverige är bäst i världen – men bakterierna tar flyget](https://swedenbio.se/debattartikel-sverige-ar-bast-i-varlden-men-bakterierna-tar-flyget/) - Vad krävs för att möjliggöra detta? Läs vår debattartikel på it-hälsa.se
- [SweTrial i sikte – så ska Sverige stärka sin roll inom kliniska prövningar](https://swedenbio.se/swetrial-i-sikte-sa-ska-sverige-starka-sin-roll-inom-kliniska-provningar/) - Peter Asplund och Gunilla Andrew-Nielsen, båda från Läkemedelsverket, Adam Szulkin från Roche, Anders Ahlsson från Region stockholm och Karin Eriksson från Cancerfonden var på plats för att delge sina tankar med Björn Arvidsson från Region Uppsala som moderator. Peter Asplund inledde med att berätta om de olika delarna i förslaget från utredningen och förklarade att Läkemedelsverket nu väntar
- [Välkommet beslut om SweTrial ](https://swedenbio.se/valkommet-beslut-om-swetrial/) - Det var ett väntat regeringsbeslut som kom mitt under sommarsemestern och som utgör startskottet för implementering efter år av utredningar och beredning i syfte att stärka Sveriges kapacitet för kliniska prövningar. Swetrial ska fungera som en samlande nationell funktion där hälso- och sjukvård, akademi, näringsliv och myndigheter samarbetar. Läkemedelsverket får i uppdrag att ta fram
- [Jessica Martinsson blir ny vd på SwedenBIO](https://swedenbio.se/jessica-martinsson-blir-ny-vd-pa-swedenbio/) - Jessica Martinsson kommer närmast från Sprint Bioscience där hon är medgrundare och där hon förutom rollen som operativ chef även varit vd. Hon är entreprenör och läkemedelsutvecklare med erfarenhet som spänner över både små och stora bolag, såsom Pharmacia & Upjohn och Biovitrum, och som styrelseledamot i Lipigon Pharmaceuticals. Till SwedenBIO för hon med sig
- [From Lab to Global Market: The Swedish Research Behind an Export Triumph](https://swedenbio.se/from-lab-to-global-market-the-swedish-research-behind-an-export-triumph/) - “The whole world thought it was impossible, but I was determined to give it a try" Professor Mathias Uhlén, a pioneer in Swedish life science, and professor Sophia Hober, a global expert in protein binders, are behind one of Sweden’s most exported products: an antibody purification column utilizing an engineered bacterial protein. So, what is
- ["It’s not enough to be good, we must aim to be the best"](https://swedenbio.se/its-not-enough-to-be-good-we-must-aim-to-be-the-best/) - How do you perceive the issue of clinical trials has developed over the past 2–3 years, and are we now on the right track after all the discussions? – It has developed very positively! There is a strong political will to improve the situation, which has resulted in the Medical Products Agency being tasked with creating
- [Ny EU-parlamentsgrupp för bioteknik och life science](https://swedenbio.se/ny-eu-parlamentsgrupp-for-bioteknik-och-life-science/) - Precis innan semestersäsongen i år lanserades EU Biotech and Life Sciences Alliance, ett nytt forum i Europaparlamentet där ledamöter (MEP) engagerade i bioteknik och life science samlas över partigränser för stärkt samverkan. Initiativet syftar till att positionera EU som global ledare inom bioteknik och livsvetenskaper, genom att samordna kommande strategier och lagstiftning – särskilt den
- [Gearing up for Stronger Nordic Life Science Cooperation](https://swedenbio.se/gearing-up-for-stronger-nordic-life-science-cooperation/) - Beginning in January this year, SwedenBIO’s Nordic Community Manager, Sigrun Elfa Snæbjörnsdóttir, packed her bags and set out on a mission to connect with key stakeholders in the life science sector across all Nordic countries. Here's what she had to say about the impact of the tour. Which places did you visit and whom did
- [Gearing up for Stronger Nordic Life Science Cooperation](https://swedenbio.se/gearing-up-for-stronger-nordic-life-science-cooperation/) - Beginning in January this year, SwedenBIO’s Nordic Community Manager, Sigrun Elfa Snæbjörnsdóttir, packed her bags and set out on a mission to connect with key stakeholders in the life science sector across all Nordic countries. Here's what she had to say about the impact of the tour. Which places did you visit and whom did
- [Ny handlingsplan från SwedenBIO, LIF och Swedish Medtech](https://swedenbio.se/handlingsplan2018/) - Handlingsplanen lyfter tre viktiga områden som måste stärkas för att företagen ska kunna verka och utvecklas i Sverige. Det handlar om: forskning och utveckling introduktion av innovativa behandlingsmetoder och att Sverige väljs som förstahandsval vid investeringar och etableringar Under dessa rubriker finns 19 föreslagna åtgärder. En tydlig satsning på life science kräver engagemang från flera
- [”Sweden’s ecosystem for medtechs is impressive”](https://swedenbio.se/swedens-ecosystem-for-medtechs-is-impressive/) - Sweden has long been regarded as a leading engineering nation, but how do we stand today in the development of new medical technologies? What works, and what barriers do you see to innovations reaching the patients?– Sweden has a long tradition of interdisciplinary collaboration between technology and medicine, which has led to groundbreaking innovations such
- [Building Bridges Between Swedish and Swiss Life Science ](https://swedenbio.se/building-bridges-between-swedish-and-swiss-life-science/) - SwedenBIO has a long history of engaging with actors in Switzerland to help companies from both countries meet and do business. The exchanges and contacts have evolved over the years and matured to the extent that SwedenBIO arranged a Nordic delegation to Swiss Biotech Day in 2025. Seven companies joined the delegation that promoted Sweden
- ["Mycket av det vi planterat är nu redo att skördas"](https://swedenbio.se/det-ar-kul-att-flyga/) - Grattis till nya jobbet! Hur känns det? – Det är blandade känslor. Det känns otroligt spännande och roligt, men också såklart tråkigt att lämna SwedenBIO. Hur svårt, eller lätt var det att ta beslutet och varför? – Det var egentligen ett lätt beslut. Jag är en mycket värdedriven person, och arbetet som Unga Forskare driver
- [Nationellt partnerskap för kliniska prövningar – från strategi till samhandling](https://swedenbio.se/nationellt-partnerskap-for-kliniska-provningar-fran-strategi-till-samhandling/) - På plats i SwedenBIOs trädgård för att diskutera vad rapporten innebär och vad den kan bidra till framåt fanns Maja Neiman, Science Director, SwedenBIO, Frida Lundmark, Sakkunnig policy, Lif, Björn Arvidsson, moderator, Region Uppsala, Jenny Almkvist, Samordnare life science, Region Västra Götaland, Andreas Muranyi Scheutz, Forsknings- och innovationsdirektör, Region Stockholm och Jesper Petersson, Forskningschef, Region Skåne. Projektets bakgrund:
- [Strategin finns, men var är verkstaden?](https://swedenbio.se/strategin-finns-men-var-ar-verkstaden/) - Jessica Martinsson, vd SwedenBIO, Janet Hoogstraate, CEO NorthX Biologics, Micael Györei, CEO Invest in Skåne och Sara Modig, statsråd intog SwedenBIO-huset under ledning av Magnus Lejelöf, STUNS Life Science som samtalsledare. Diskussionen präglades av samsyn, men också frustration över uteblivet politiskt genomslag, bristande struktur och svag marknadsföring. Sverige saknas på den globala scenenJessica Martinsson öppnade
- [Raising the Swedish flag in Boston  ](https://swedenbio.se/raising-the-swedish-flag-in-boston/) - Represented by CEO Jessica Martinsson, International Director Marjo Puumalainen, and Nordic Manager Sigrun Elfa Snæbjörnsdóttir, the SwedenBIO team arrived with clear objectives for the busy days ahead. In this Q&A, Marjo Puumalainen shares her insights and takeaways from Boston. What was the SwedenBIO team able to accomplish during the days in Boston? – We kicked
- [Här är alla Almedalen-aktiviteter i SwedenBIO-huset](https://swedenbio.se/har-ar-alla-almedalen-aktiviteter-i-swedenbio-huset/) - SwedenBIO-huset kommer att husera en rad arrangemang – allt från allvarsamma politikersamtal och engagerande paneler till avslappnade sommarmingel. Vi anordnar tre egna panelsamtal, ett med fokus på hur vi stärker life science-branschen och de två andra på det momentum som nu byggs upp kring arbetet för fler kliniska prövningar. Vårt populära sommarmingel är redan fullsatt
- [Ny rapport visar hur Sverige stärker sin konkurrenskraft inom kliniska prövningar](https://swedenbio.se/ny-rapport-visar-hur-sverige-starker-sin-konkurrenskraft-inom-kliniska-provningar/) - – Rapporten utgör ett viktigt bidrag till Sveriges satsning på kliniska prövningar. Genom att kartlägga både utmaningar, möjligheter och föreslå metoder framåt har vi förhoppningsvis lagt grunden för starkare framtida konkreta samarbeten, inte bara samverkan, säger Maja Neiman, Science Director på SwedenBIO, som representerat organisationen i projektet. Förstudien har utforskat centrala delar och processer nödvändiga
- [New Pipeline report published](https://swedenbio.se/pipeline2025/) - Draft page
- [Grow Your Nordic Life Science Business in the United States](https://swedenbio.se/grow-your-nordic-life-science-business-in-the-united-states/) - In the lead-up to the annual SelectUSA Investment Summit, this virtual seminar and networking session offers targeted insights for life science companies planning their next step toward the American market. Held on April 13, 2021, the session will provide in-depth guidance on key aspects of doing business in the U.S., including working with the U.S.
- [Back to Business: Expanding to the U.S.](https://swedenbio.se/back-to-business-expanding-to-the-u-s/) - The Swedish-American Chamber of Commerce New England (SACC-NE) invites Swedish life science companies to a focused webinar on expanding to the United States. As international borders reopen and business accelerates, now is the time to sharpen your U.S. market strategy. The event, Back to Business: Expanding to the U.S., takes place on Wednesday, October 27,
- [”Både Sverige och EU måste vakna upp”](https://swedenbio.se/bade-sverige-och-eu-maste-vakna-upp/) - Hur påverkas Sveriges konkurrenskraft av EU:s nya läkemedelsförordning? – Det var den centrala frågeställningen under en av SwedenBIOs öppna debatter i Almedalen den 26 juni i år. I panelen, som hölls under gassande sol, fanns Helena Anderin från Novo Nordisk, Matti Sällberg från Karolinska Institutet, Joachim Alexandersson från Merck och statssekreteraren Sara Modig från regeringskansliet.
- [Välkommen till SwedenBIOs seminarium i Almedalen](https://swedenbio.se/almedalen2016/) - Fabrikernas återkomst – så vinner Sverige slaget om framtidens läkemedelstillverkning Onsdag 6 juli klockan 10 – 11 Atrium, Volters gränd 8, Visby Det senaste året har globala life science-företag gjort flera stora investeringar i fabriker i Sverige. Investeringarna visar på ett nyväckt intresse för Sverige. Redan idag är läkemedel, bioteknik och medicinteknik landets största exportprodukter efter
- [Möt oss i Almedalen](https://swedenbio.se/mot-oss-almedalen/) - Hör av dig till Jonas Ekstrand, VD SwedenBIO, på 070–302 08 96 eller jonas.ekstrand(a)swedenbio.se.
- [Träffa SwedenBIO i Almedalen](https://swedenbio.se/traffa-swedenbio-almedalen/) - SwedenBIO arrangerar seminarium med LIF och Swedish Medtech Sverige är ett starkt life science-land. Men vi kan bli än bättre. Sedan flera år tillbaka har politiska beslutsfattare pekat på life science-sektorn som en framtidsbransch. Vi vill ha mer forskning, fler kliniska prövningar, mer tillverkning och mer samarbete mellan universitet, företag och sjukvård. Medverkande: Jenni Nordborg, chef, Sveriges
- [SwedenBIOs program i Almedalen – nu öppnar bokning av SwedenBIO-huset!](https://swedenbio.se/swedenbios-program-almedalen-nu-oppnar-bokning-av-swedenbio-huset/) - Från måndag 1/7 till och med torsdag är SwedenBIO-huset öppet för mötesbokningar exklusivt för medlemmar som vill ta tillfället i akt för ett rundabordssamtal (upp till 10 personer) eller mindre möten kring något som berör branschen. Medlemmarnas möten varvas med SwedenBIOs egen ”precision lobbying”, d.v.s. högnivåmöten med särskilt fokus på de beslutsfattare som närvarar i
- [Träffa SwedenBIO i Almedalen!](https://swedenbio.se/traffa-swedenbio-almedalen-2019/) - Almedalen: möjlighet att låna SwedenBIO-huset för möten Från måndag 1/7 till torsdag är SwedenBIO-huset öppet för mötesbokningar exklusivt för medlemmar som vill ta tillfället i akt för ett rundabordssamtal eller mindre möten kring något som berör branschen. Medlemmarnas möten varvas med SwedenBIOs egen ”precision lobbying”, d.v.s. högnivåmöten med särskilt fokus på de beslutsfattare som närvarar
- [SwedenBIO i Almedalen: panelsamtal om konkurrenskraft och EU-påverkan](https://swedenbio.se/swedenbios-paneldiskussioner-i-almedalen/) - Den svenska life science-branschen fortsätter att uppvisa styrka. Nytt exportrekord av läkemedel och positiva siffror i den mest omfattande branschkartläggningen tyder på en god utveckling, och geopolitiska och makroekonomiska omständigheter i omvärlden tycks inte ha påverkat branschen i den utsträckning som befarats. Samtidigt kan vi skönja nya orosmoln och utmaningar. En fråga som har konkretiserats
- [Vi söker en National Director](https://swedenbio.se/vi-soker-en-national-director/) - Varmt välkommen till SwedenBIO, en branschorganisation med ambitionen att samla hela Life Science Sveriges bolag. Vi är ett litet hängivet team med ambitionen att göra stor skillnad. Vi representerar fler än 330 medlemsbolag verksamma inom bioteknik, läkemedel, diagnostik, medicinteknik samt tjänstebolag och samarbetsorganisationer. Gemensamt för alla dessa bolag är strävan att förbättra människors hälsa, i Sverige och
- [IP Term Sheet launched to strengthen corporate–academic collaborations](https://swedenbio.se/ip-term-sheet-launched-to-strengthen-corporate-academic-collaborations/) - SwedenBIO unveiled a new term sheet on 29 April during its seminar “Unlocking Innovation: Best Practices for Corporate–Academic Partnerships.” Designed to steer companies and academic institutions clear of common pitfalls, the tool lays out the key topics both sides should agree on before drafting a binding contract. Collaborations between universities and industry fuel much of
- [Join the Swedish delegation to BIO International](https://swedenbio.se/join-the-swedish-delegation-to-bio-international/) - BIO International is a significant gathering in the biotechnology sector, attracting over 20,000 industry leaders worldwide. The convention offers a platform for professionals across various sectors, including pharmaceuticals, biotech startups, academia, non-profits, and government agencies to establish valuable connections. SwedenBIO is welcoming member companies to join our Swedish delegation to Boston where we will offer
- [“SweTrial kan träffa marken springande tack vare förstudien” ](https://swedenbio.se/swetrial-kan-traffa-marken-springande-tack-vare-forstudien/) - Efter 15 månaders arbete var det äntligen dags att presentera resultatet av den Swelife-finansierade förstudien. Projektet har genomförts i samverkan mellan Region Skåne, Region Stockholm och Västra Götalandsregionen, tillsammans med branschorganisationerna Lif och SwedenBIO. Syftet har varit att utreda bärande delar av ett presumtivt nationellt partnerskap för kliniska prövningar. Specifikt har projektet syftat till att
- [Swiss–Nordic collaboration to drive life science innovation  ](https://swedenbio.se/swiss-nordic-collaboration-to-drive-life-science-innovation/) - Switzerland and the Nordics consistently rank among the world’s top innovation leaders, with both regions boasting world-class research institutions and cutting-edge biotech ventures, providing excessive collaboration opportunities between the two. The Nordic delegation, arranged by SwedenBIO with the support of The Life Science Cluster, and Medicon Valley Alliance, consisted of 7 Swedish companies. The companies enjoyed
- [De tar plats i SwedenBIOs styrelse](https://swedenbio.se/de-tar-plats-i-swedenbios-styrelse/) - Jesper Ericsson från Symcel, Hanna Sjöström från Neola Medical och Tobias Lundin Gerdås från Roche valdes enhälligt på förslag från valberedningen under föreningens årsmöte den 6 maj. Sara Corin valdes till vice ordförande. Presentationen av den nya styrelsen finns här. Oförändrad medlemsavgift och Indexuppräkning Årsmötet beslutade att behålla nuvarande medlemsavgiftsnivåer. För att säkra att föreningens
- [SwedenBIO uppdaterar branschstandard för kapitalanskaffning](https://swedenbio.se/swedenbio-uppdaterar-branschstandard-for-kapitalanskaffning/) - En första version av branschstandarden introducerades i december 2020. I den uppdaterade version som lanseras idag finns en tydligare uppdelning mellan läkemedelsutvecklande bolag och medicinteknikföretag - två delar av branschen som har mycket gemensam men också vissa specifika förutsättningar som påverkar vad som är viktigt att kommunicera till investerare. – Förhoppningen är att branschstandarden nu
- [Ingrid Heath – Huvudkursledare på kursen Strategi- och affärsutveckling för life science-ledare](https://swedenbio.se/ingrid-heath-huvudkursledare-pa-kursen-strategi-och-affarsutveckling-for-life-science-ledare/) - Med bakgrund som vice vd och policychef på SwedenBIO och chefredaktör för Läkemedelsvärlden samt Life Science Sweden, har Ingrid även bred erfarenhet från media och påverkansarbete inom life science. Allt detta delar hon med sig av på kursen Strategi och affärsutveckling för life science-ledare.I år är det tredje gången som kursen genomförs och Ingrid ger
- [IP task force elevated to full working group](https://swedenbio.se/ip-task-force-elevated-to-full-working-group/) - This move reflects SwedenBIO’s continued efforts to strengthen its expert network, which now spans nine key areas of life science. Previously operating under the Research and Development working group, the Intellectual Property task force is now established as an independent working group. Led by Johanna Bergh, Business Area Manager at AWA, the group brings together
- [2023 Swedish Drug Discovery and Development Pipeline Report](https://swedenbio.se/2023-swedish-drug-discovery-and-development-pipeline-report/) - The Swedish Drug Discovery and Development Pipeline Report 2023 contains a mapping of the pharmaceutical pipeline run by companies headquartered in Sweden. The target group for the report includes international investors, the life science industry in Sweden and of course decision makers within politics, business and academia. The aim of the report is to be
- [2023 Swedish Drug Discovery and Development Pipeline Report](https://swedenbio.se/2023-swedish-drug-discovery-and-development-pipeline-report/) - The Swedish Drug Discovery and Development Pipeline Report 2023 contains a mapping of the pharmaceutical pipeline run by companies headquartered in Sweden. The target group for the report includes international investors, the life science industry in Sweden and of course decision makers within politics, business and academia. The aim of the report is to be
- [New IP rules will stifle medical innovation in Europe,  life science leaders conclude](https://swedenbio.se/new-ip-rules-will-stifle-medical-innovation-in-europe-swedish-life-science-leaders-conclude-during-seminar/) - The newly proposed EU pharmaceutical legislation puts European innovation at risk due to proposed changes in IP rights for new drugs, industry experts and leaders concluded during a seminar in Stockholm this summer. Leaders from the Swedish life science industry gathered on 27th June in Stockholm during a seminar to highlight the importance of IP-protection
- [New IP rules will stifle medical innovation in Europe,  life science leaders conclude](https://swedenbio.se/new-ip-rules-will-stifle-medical-innovation-in-europe-swedish-life-science-leaders-conclude-during-seminar/) - The newly proposed EU pharmaceutical legislation puts European innovation at risk due to proposed changes in IP rights for new drugs, industry experts and leaders concluded during a seminar in Stockholm this summer. Leaders from the Swedish life science industry gathered on 27th June in Stockholm during a seminar to highlight the importance of IP-protection
- [SwedenBIO Present at Swiss Biotech Day 2024](https://swedenbio.se/swedenbio-present-at-swiss-biotech-day-2024/) - The event brought together more than 1,800 life science professionals from around the world for two days of partnering, expert insights, and international collaboration. Representing SwedenBIO, Marjo Puumalainen took part in the event, engaging with global stakeholders to strengthen Sweden’s international life science ties and explore new opportunities for collaboration and investment.– Switzerland continues to
- [SwedenBIO at Swiss Nordic Bio 2025 – Connecting Nordic Innovation with Swiss Investment](https://swedenbio.se/swedenbio-at-swiss-nordic-bio-2025-connecting-nordic-innovation-with-swiss-investment/) - SwedenBIO was proud to represent the Swedish life science industry at Swiss Nordic Bio 2025, held on March 13 in Zürich. The event brought together Nordic biotech and medtech companies with Swiss investors and strategic partners for a full day of targeted partnering meetings and expert panels. Organized by Business Sweden in collaboration with partners
- [Nordic delegation to attend Swiss Biotech Day 2025 for the first time](https://swedenbio.se/nordic-delegation-to-attend-swiss-biotech-day-2025-for-the-first-time/) - The initiative brings together innovative companies from across the Nordic region to showcase the strength and diversity of the Nordic life science ecosystem on an international stage. The participating companies include: Cellectricon – Specializing in neurobiology drug discovery with groundbreaking in vitro concepts. Cytel – Supporting life sciences companies with advanced analytics and strategies. Invest
- [Föreningsstämma 2025](https://swedenbio.se/foreningsstamma-2025/) - SwedenBIO är en icke vinstdrivande medlemsorganisation. Högsta beslutande organ är föreningsstämman som också utser organisationens styrelse. Datum: tisdagen den 6 maj 2025Tid: klockan 17.30Plats: Münchenbryggeriet, Söder Mälarstrand 29, 118 25 STOCKHOLM Anmäl dig här. (Du kan välja att anmäla dig till både årsmötet och Executive Dinner eller enbart till årsmötet) Stämmohandlingar Kallelse Ordinarie Föreningssammanträde Föreningen SwedenBIO 2025 Revisionsberättelse 2024
- [DNB//Back Bay becomes a SwedenBIO Patron ](https://swedenbio.se/dnb-back-bay-becomes-a-swedenbio-patron/) - DNB//Back Bay and SwedenBIO have finalized a Silver Patron agreement to intensify and expand their cooperation, focusing on international activities. – We are very happy to welcome DNB//Back Bay as a patron. US markets and investors are priority for many Swedish life science companies. This long-term strategic partnership will enable SwedenBIO’s members to leverage DNB//Back Bay’s knowledge and
- [Here are the finalists for the SwedenBIO Award for 2023](https://swedenbio.se/here-are-the-finalists-for-the-swedenbio-2023-award/) - The SwedenBIO Award is the industry's own award and aims to provide increased visibility for life science actors by recognizing and rewarding successful and exemplary member companies that have distinguished themselves and contributed to positive attention for Swedish life science. The award has been handed out since 2007 to put the spotlight on successful and
- [Life Science Barometer 2023 survey now open for submissions](https://swedenbio.se/life-science-barometer-2023-survey-now-open-for-submissions/) - The Life Science Barometer is a yearly survey of the Swedish life science-industry that generates an up-to-date overview of Swedish life science and highlights needs and trends in the industry. It aims to uncover needs and trends within the sector, empowering informed decision-making and fostering a stronger industry. The survey is open for submissions Oct
- [We're hiring an Event Sales Manager (Application closed)](https://swedenbio.se/were-hiring-an-event-sales-manager/) - SwedenBIO is the Swedish life science industry organization with over 340 member companies. We aim to improve the business environment for the life science ecosystem by building networks, increasing knowledge transfer, and influencing policies. SwedenBIO organizes the largest life science partnering event in the Nordics – Nordic Life Science Days (NLSDays) – an annual conference
- [Swedish life science united during the presidency and beyond ](https://swedenbio.se/swedish-life-science-united-during-the-presidency-and-beyond/) - The Swedish government welcomes key decision makers to a life science conference at Aula Medica, Karolinska Institutet, 26-27 June. Following the conference, we open up for everyone interested in the Swedish and European life science industry to join us in a reflecting seminar at the Royal Academy of Engineering Sciences, IVA, in Stockholm, June 27th
- [Launch of The Swedish Drug Discovery & Development Pipeline 2023](https://swedenbio.se/launch-of-the-swedish-drug-discovery-development-pipeline-2023/) - The Swedish Drug Discovery and Development Pipeline Report 2023 contains a mapping of the pharmaceutical pipeline run by companies headquartered in Sweden. The target group for the report includes international investors, the life science industry in Sweden and of course decision makers within politics, business and academia. The aim of the report is to provide
- [From Realheart to Miniheart - how one Swedish company is aiming for gender equality in cardiac devices](https://swedenbio.se/from-realheart-to-miniheart-how-one-swedish-company-is-aiming-for-gender-equality-in-cardiac-devices/) - Ina Laura Perkins, CEO Scandinavian RealHeart Scandinavian Realheart is a medtech company based in Västerås, Sweden which is developing a n artificial heart (the Realheart® TAH) that has the potential to help millions of people suffering from severe heart failure. While artificial hearts have been in use for decades, with more than 2,000 patients around the
- [Highlights from JPM’s 2023 Healthcare Week](https://swedenbio.se/highlights-from-jpms-annual-healthcare-week/) - The international life sciences year started off with J.P. Morgan's Annual Healthcare week, which drew thousands of life science experts to San Francisco earlier this month. Out of the many partnering meetings and vibrant panel discussions on current trends and challenges in the field, Marjo Puumalainen, Program Director of NLSDays and International Director at SwedenBIO,
- [Why attending JP Morgan should be a priority for Swedish companies](https://swedenbio.se/why-attending-jp-morgan-should-be-a-priority-for-swedish-companies/) - J.P Morgan Healthcare week in January of each year jump-starts the business year for the life science industry. Thousands of investors and life science executives from all over the world gather in San Francisco. SwedenBIO coordinates a Swedish delegation each year and supports members in different ways to make the most out of the hectic
- [Why attending JP Morgan should be a priority for Swedish companies](https://swedenbio.se/why-attending-jp-morgan-should-be-a-priority-for-swedish-companies/) - J.P Morgan Healthcare week in January of each year jump-starts the business year for the life science industry. Thousands of investors and life science executives from all over the world gather in San Francisco. SwedenBIO coordinates a Swedish delegation each year and supports members in different ways to make the most out of the hectic
- [Antaros Medical wins SwedenBIO Award for their innovative imaging technology](https://swedenbio.se/antaros-medical-wins-swedenbio-award-for-their-innovative-imaging-technology/) - Carl Sjöberg, manager of software development, Carina Schmidt, member of the board, and CEO and co-founder Johannes Hulthe from Antaros Medical receives SwedenBIO Award from Lotta Ljungkvist, chair of SwedenBIO's board, on Dec 6, 2022. Antaros Medical’s CEO and co-founder Johannes Hulthe received the SwedenBIO Award on December 6, in a prize ceremony held in
- [Sneak peek of the Life Science Barometer 2022](https://swedenbio.se/sneak-peek-of-the-life-science-barometer-2022/) - The Barometer is a annual survey from SwedenBIO. The core of the survey is SwedenBIOs members – more than 330 companies that span the entire range of life science companies, and represent roughly 10% of the entire life science company population in Sweden. Additionally, this year’s survey was also directed to companies within drug discovery
- [Three finalists selected for SwedenBIO’s annual life science award](https://swedenbio.se/three-finalists-selected-for-swedenbios-annual-life-science-award/) - SwedenBIO Award finalists 2022 The SwedenBIO Award is bestowed upon a company that has made a noteworthy contribution to the life science ecosystem in the past year, and – through its contributions to society – has demonstrated the importance of a thriving life science industry in Sweden. SwedenBIO Award is the industry’s own prize and
- [SwedenBIO Summit 2022](https://swedenbio.se/swedenbio-summit-2022/) - At this year’s SwedenBIO Summit we focus on the foundations necessary for building strong and resilient companies. We take inspiration from the pillars introduced by the international Worldview Ranking of health biotech sectors and translate them to intimate business stories. You will hear tales of success, and tales of hurdles and obstacles. You will also get a
- [Nordic Life Science Days attracts record number of international delegates](https://swedenbio.se/nordic-life-science-days-attracts-record-number-of-international-delegates/) - NLSDays' Managing Director Olivier Duchamp-Giudicelli at NLSDays 2019. Photo: Camille Sonally Held in Malmo from September 28-29th, Nordic Life Science Days (NLSDays) is the largest partnering conference for life sciences in the Nordic region. Through its partnering system, stage programme, and extensive list of exhibitors, it is a unique event showcasing the entire spectrum of life sciences
- [We're hiring a part-time programmer](https://swedenbio.se/were-hiring-a-part-time-programmer/) - SwedenBIO is the Swedish life science industry organization with over 300 member companies in biotech, pharma and medtech. An important activity for SwedenBIO is to provide up-to-date statistics and overviews of the life science sector. We do this through questionnaires and surveys, as well as through other available data sets. We now plan to increase
- [SwedenBIO is hiring an International Program Director](https://swedenbio.se/swedenbio-is-hiring-an-international-program-director/) - SwedenBIO, the Swedish life science industry organization with over 300 member companies in biotech, pharma and medtech, is looking for a new team member to be responsible for the program development within our international platforms, primarily but not exclusively Nordic Life Science Days. Nordic Life Science Days is our flagship event and has grown into
- [Getting ready for the bio revolution](https://swedenbio.se/getting-ready-for-the-bio-revolution/) - Personalized medicine is the future of healthcare, offering the promise to deploy cell and gene therapy platforms to once and for all cure diseases – some of which stand without a cure today or which require life-long treatment regimens. “We’re looking at taking medicines just in the beginning of a treatment, instead of taking it
- [Over 100 Nordic companies present at BIO2022 as US–Nordics collaborations increase](https://swedenbio.se/over-100-nordic-companies-present-at-bio2022-as-us-nordics-collaborations-increase/) - This week, over 100 Nordic companies have made it to BIO International Convention 2022 in San Diego on June 13-16 for the world’s premier life sciences event. The companies represent the region’s traditional strengths in cancer immunotherapy, CNS, genomics and protein science, along with new areas such as cell and gene therapy, microbiomics and precision
- [Dare to share](https://swedenbio.se/dare-to-share/) - Arbetsgruppen för HR & Kompetens: Björn Henriksson (Nordic Interim), Hanna Sandvall (Randstad Sweden), Frida Lawenius (SwedenBIO), Ann Fredriksson (Vironova AB) & Petra Duprez (Biotage). Ej på bild: Hani Aoun (MSD) Den totala tillgången till kompetens är begränsad och gör att vi idag konkurrerar med varandra om talangerna inom life science. En särskild utmaning för de
- [SwedenBIO and BIO offer members discount for BIO International Convention 2022](https://swedenbio.se/swedenbio-and-bio-offer-members-discount-for-bio-international-convention-2022/) - Register as soon as possible to enjoy one of these discounted rates: Until March 30, a discount of 400$ is available to our members (200$ off the early-bird rate)From March 31, SwedenBIO members are offered an extended early-bird discount ($200 off the general access rate) This exclusive offer is only available to delegates from SwedenBIO’s
- [Grand finale av MDR-Podden](https://swedenbio.se/grand-finale-av-mdr-podden/) - I MDR-poddens sista avsnitt rundar Frida och Sofia av och diskuterar resan som varit. Hur ser det ut idag? Har MDR hunnit sätta sig ännu? Hur har podden fyllt sin funktion och vilka är Sofias highlights? Lyssna även för att höra när ljudteknikern Sebastian sätts på kunskapsprov. Klicka här för att lyssna i Spotify. MDR-Podden finns också
- [SwedenBIO Star Award nominees contribute to competence development](https://swedenbio.se/swedenbio-star-award-nominees-contribute-to-competence-development/) - The SwedenBIO Star Award was created to highlight extraordinary efforts by individuals or organizations to address common challenges within life sciences. This year's prize is focused to the skills shortage the industry is facing, which hampers the growth of companies. The winner of the SwedenBIO Star Award 2022 will be announced at the industry organisation’s
- [Coordination across the EU needed to manage AMR](https://swedenbio.se/coordination-across-the-eu-needed-to-manage-amr/) - Johanna Assadi Rissanen, SwedenBIO's representative in Taskforce AMR. Earlier this month, SwedenBIO submitted its comment on the European Commission’s call for evidence on AMR, which aims to set concrete objectives and activities that can strengthen national action against AMR among member states. At SwedenBIO, we increased our focus on the highly relevant and urgent topic
- [BICO brings home the life-science prize SwedenBIO Award](https://swedenbio.se/bico-brings-home-the-life-science-prize-swedenbio-award/) - CTO Héctor Martínez and CEO Erik Gatenholm, both co-founders of BICO BICO’s CEO and co-founder Erik Gatenholm received the SwedenBIO Award on December 8, in a prize ceremony at Grand Hôtel in Stockholm that capped off this year’s SwedenBIO Summit. In the five years since its conception, BICO has grown from being the bioink and
- [SwedenBIO welcomes new director of communications and digital communications officer](https://swedenbio.se/swedenbio-welcomes-new-director-of-communications-and-digital-communications-officer/) - “In Alexandra, we get an experienced director of communications to the team, whose background in life science combined with an international career as a journalist will be valuable for how we continue to develop SwedenBIO. We have previously worked with Sebastian to digitalize and renew the communications offering towards the members, for example by setting
- [SwedenBIO hits 300 members!](https://swedenbio.se/swedenbio-hits-300-members/) - Photo: Johan Stillman, TTV Media Your company’s slogan is ’Value Through Innovation’. What is your expectation on the value that a membership in SwedenBIO could bring to Boehringer Ingelheim? I made a commitment to our team that I would bring in several opportunities to inspire them with innovation every year. The Nordics and especially Sweden is
- [Swedish government and industry boosting cell therapy and RNA manufacturing](https://swedenbio.se/swedish-government-and-industry-boosting-cell-therapy-and-rna-manufacturing/) - Thomas Eldered, President Flerie Invest, Helena Strigård, CEO SwedenBIO and Ted Fjällman, CEO NorthX Biologics The new entity, NorthX Biologics AB, will take over and expand the facility equipped to provide GMP-grade plasmid DNA and technical protein manufacture at commercial scale. The Swedish Minister for Business, Industry and Innovation, Ibrahim Baylan, revealed in a press conference that the
- [Four prominent life science ambassadors awarded for outstanding contributions](https://swedenbio.se/four-prominent-life-science-ambassadors-awarded-for-outstanding-contributions/) - Prof. Johan Rockberg wins the “Sharing is Caring Award” A fundamental pillar in a successful ecosystem surrounding life sciences is the ability to share. Share knowledge, share technologies and data, share human resources or even functionalities. It takes boldness and an open mindset to be in the first line of sharing. “Johan Rockberg, professor in
- [Awards for outstanding life science contributions](https://swedenbio.se/awards-for-outstanding-life-science-contributions/) - The winners will be announced at Executive Dinner on September 14th. Award category: “Sharing is caring” A fundamental pillar in a successful ecosystem surrounding life sciences is the ability to share. Share knowledge, share technologies and data, share human resources or even functionalities. It takes boldness and an open mindset to be in the first
- [SwedenBIO CEO enters SACC San Francisco Advisory board](https://swedenbio.se/swedenbio-ceo-enters-sacc-san-francisco-advisory-board/) - – I am thrilled to be able to build the connections between Swedish and Californian life sciences even stronger and honored to join this group of driven individuals, says Helena about the appointment. The links between Swedish and Californian life sciences have grown stronger over the past year, as demonstrated through the increased collaboration between
- [NLSDays 2022: Registration is open!](https://swedenbio.se/nlsdays-2022-registration-is-open/) - Registration includes All registrations are personal/individual, including access to all super sessions, fireside chats, exhibition, company presentations, One-on-One partnering including submission of up to 150 requests per company for onsite face-to-face meetings, coffee-breaks, lunches and receptions.SwedenBIO members receive 30% discount on their registration. Contact info@swedenbio.se for your discount code. Like a Nordic Saga, five small countries in
- [White paper on the impact of MDR on medical device software](https://swedenbio.se/white-paper-on-the-impact-of-mdr-on-medical-device-software/) - Read our latest white paper to get an overview of the impact of MDR on medical device software. In the summer there’ll be a follow-up white paper digging into the details of clinical evidence for medical device software. This white paper is published by Clarvin AB, Morris Law, Kickfile, Devicia and us. Kickfile and Devicia are new
- [Voices from NLSDays 2021](https://swedenbio.se/hello-anita-patel-jusnes-chief-commercial-officer-at-genetic-analysis/) - Hello Anita Patel Jusnes, Chief Commercial Officer at Genetic Analysis During NLSDays you had over twenty partnering meetings with pharma and investors, and several that are quickly proceeding forward. What do you bring back home? – Genetic Analysis got a lot of traction this year and we think this is mainly due to the hot
- [Highlights from NLSDays Digital, 21st April 2021](https://swedenbio.se/highlights-from-nlsdays-digital-21st-april-2021/) - The day’s first Super Session was all about intelligent investment and, continuing from the inaugural and highly successful NLSInvest on Monday, it challenged the more traditional views of investors and processes. The Keynote from the European Investment Bank (Head of the Life Science division) considered the mental shifts that investors – and investees – need
- [Highlights from NLSDays Digital, 20th April 2021](https://swedenbio.se/highlights-from-nlsdays-digital-20th-april-2021/) - The opening session focused on the great achievements delivered during the current pandemic, through the industry’s huge and collaborative efforts to find and approve coronavirus vaccines. One of the main themes that emerged from the speakers was how the great trust and willingness among Nordic companies to work together has led to the region becoming
- [Apoglyx, Respinor and RetinaRisk Announced as NLSInvest Rising Star Award Winners](https://swedenbio.se/apoglyx-respinor-and-retinarisk-announced-as-nlsinvest-rising-star-award-winners/) - From the 80 Rising Stars, one company from each track was selected as the category winner. The three winners will be awarded a package prize of 15,000 DKK, two registrations to NLSDays 2022, and one company presentation at the 2022 conference. This year, the NLSInvest Rising Star Award Winners are: Biotech / Pharma: ApoGlyx (Sweden) is developing
- [NLSDays starting on April 20 – here is the program](https://swedenbio.se/nlsdays-starting-on-april-20-here-is-the-program/) - Although this year is completely digital, the partnering possibilities and the program are just as excellent as in the previous years. Check out #NLSDays 2021's full program here.
- [Meeting scheduling ongoing now!](https://swedenbio.se/meeting-scheduling-ongoing-now/) - The meeting scheduling is ongoing now, so get into the partnering platform to find your next business partner. The meetings will be scheduled in 30-minute intervals from April 20 to 23, at any preferred time zone. SwedenBIO members receive 30% discount on their registration. Contact info@swedenbio.se for your discount code. Register here to get access to partnering.
- [Bridging the Gap (April 7–8)](https://swedenbio.se/bridging-the-gap-april-7-8/) - Bridging the Gap is Life Science Bridge's first ever event, and it has the purpose to promote trade across borders and build bridges between different regions. This unique life science event will be held 7-8th of April on Zoom. The topics will be focused on The life science ecosystem in the U.S., Swedish life science
- [#NLSDays' partnering portal is now open – start sending your personal meeting requests!](https://swedenbio.se/nlsdays-2021s-partnering-portal-is-now-open-start-sending-your-personal-meeting-requests/) - The countdown for Nordic Life Science Days 2021 has truly begun. Check out the latest newsletter and get to know some of the 100+ investors, and get hyped about the 80 Rising Stars that you'll get to meet through the partnering platform.
- [SwedenBIO to partner with SciLifelab, ESS and MAX IV to maximize benefits of research infrastructures](https://swedenbio.se/swedenbio-to-partner-with-scilifelab-ess-and-max-iv-to-maximize-benefits-of-research-infrastructures/) - SciLifeLab is a national infrastructure for molecular bioscience research, MAX IV Laboratory currently houses the brightest X-ray source in the world and the ESS will soon house the world’s most powerful neutron source. – Together, we will engage the broad life science community in academia, industry, and health care, and jointly develop new technology-, data- and
- [An all-time high of interest from investors in Nordic life sciences!](https://swedenbio.se/an-all-time-high-of-interest-from-investors-in-nordic-life-sciences/) - As the region's largest business partnering meeting in this field, it is a sign of strength of how the sector is evolving that more international investors than ever before are signing up to the event. The booming interest for innovations stemming from the region will also be captured in a pre-event to NLSDays as we
- [New member benefits through international collaboration](https://swedenbio.se/new-member-benefits-through-international-collaboration/) - The MoU has a clear focus on the member company benefits that this US-Swedish collaboration platform will provide, giving both SACC and SwedenBIO members a possibility to tap into the strengths and hands-on tools of the respective organizations. – At the Swedish American Chamber of Commerce in San Diego, we provide strategic advice to our
- [Looking for a trainee from an American University?](https://swedenbio.se/looking-for-a-trainee-from-an-american-university/) - SACC is designated by the Sweden’s Ministry of Foreign Affairs as well as the US Department of State to facilitate transatlantic exchange through the Talent Mobility Program. It aims to enable companies to find the skillsets that they need from students or graduates from top universities, as well as to develop their employer brand, internationalization
- [Two SwedenBIO members unite when LINK Medical acquires IRW](https://swedenbio.se/two-swedenbio-members-unite-when-link-medical-buys-irw-we-asked-links-ceo-ola-gudmundsen-to-share-his-thoughts-on-this-exciting-acquisition/) - What does this mean for you and what do you look forward to by joining forces? – Adding IRW to our team means strengthening our company in many ways. Not only do we get a team of very competent and experienced colleagues that are well recognized in the industry, but we add an important office
- [SwedenBIO and Swedish American Chamber of Commerce San Diego to become formal partners through a MoU](https://swedenbio.se/swedenbio-and-swedish-american-chamber-of-commerce-san-diego-to-become-formal-partners-through-a-mou/) - With California and Sweden excelling in the same fields within life sciences, notably immuno-oncology, rare diseases and cell and gene therapy, many fruitful business-to-business relationships have a potential to come out of the partnership, according to The Chamber´s president Ted Stübner and Helena Strigård, CEO SwedenBIO. The MoU has a clear focus on the member
- [Free Digital Partnering for Members](https://swedenbio.se/free-digital-partnering-members/) - The three day conference will be from May 18th to 20th and is free for all member companies. Registration and more information can be found here: https://partnering.biotechgate.com SwedenBIO members get a free up-grade to premium partnering. Contact info@swedenbio.se for your promotion code.
- [Three days of free virtual partnering meetings](https://swedenbio.se/three-days-free-virtual-partnering-meetings/) - From April 20th to May 6th, a consortium of Biotech clusters, Inova and Evaluate, are hosting a free Covid-19 virtual partnering event to bring together the key leaders and decision makers in the global pharma industry to connect and help bring forward solutions. This includes the development, trials and manufacture of patient solutions such as diagnostics, drug treatment and,
- [The COVID-19 crisis puts a spotlight on IP protection vs. public health interests](https://swedenbio.se/covid-19-crisis-puts-spotlight-ip-protection-vs-public-health-interests/) - One aspect that has gained notoriety in the current global headlines is the protection for IP-rights and other proprietary information bestowed upon the life sciences focused companies and organizations, research institutes etc. In the past weeks we have seen numerous headlines in various media claiming that the industry “must change” and that there is a
- [Welcome to SwedenBIO Summit 2019!](https://swedenbio.se/welcome-swedenbio-summit-2019/) - When? December 4th. The program starts at 13.00 with registration and coffee from 12.30. The first hour will be in Swedish and, upon request from our members, the rest of the day will be in English, welcoming our non-Swedish speaking members. Where? Grand Hôtel, Södra Blaiseholmshamnen 8, Stockholm The event is member exclusive and free of
- [Success for Nordic presence at BIO Convention!](https://swedenbio.se/success-nordic-presence-bio-convention/) - For this year´s conference, the Nordic countries were for the first time jointly branded as The Nordics – Global Hub for Life Science Innovation, with our value proposition to international companies and investors packaged in one set of messages, building upon common denominators. – By joining forces with our neighboring countries, we believe that we
- [The Nordics getting ready to showcase joint strengths](https://swedenbio.se/nordics-getting-ready-showcase-joint-strengths/) - Together, all Nordic countries have worked in a consortium to set up a joint pavilion in the conference exhibition hall, as well as hosting a reception – the Nordic Mixer – aiming to bring together the American executive community and anyone interested in building collaboration in our region of the world. – By joining forces
- [Registration for NLSDays 2019 is now open!](https://swedenbio.se/registration-nlsdays-2019-now-open/) - SwedenBIO members enjoy a 30% discount on registration rates as well as on company presentations. To benefit from membership discount, make sure to enter your personal promotion code at the end of the registration process, clearly displayed on the registration summary before payment. Are you missing your promotion code? Contact info@swedenbio.se. Visit our new NLSDays website for
- [Saga Diagnostics wins Startup Challenge @NLSDays 2017 for best pitch](https://swedenbio.se/saga-diagnostics-wins-startup-challenge-nlsdays-2017-best-pitch/) - The Startup Challenge @NLSDays 2017 gave the audience a taste of different research and development projects within therapeutics, medical technology and platform solutions. The contestants were given only three minutes to pitch, after which they were challenged by a seasoned jury: three life science experts and an investor. – It is great to see high
- [Sweden - the top candidate for EMA](https://swedenbio.se/sweden-top-candidate-ema/) - The application has been submitted and Sweden has a great offer! Today, on the 1st of August the Swedish Government published the offer to host the European Medical Agency, EMA when it's moving out from London in connection with the UK’s withdrawal from the EU next year. - The highly integrated Swedish life science ecosystem leave nothing to
- [Registration opens today for NLSDays](https://swedenbio.se/registration-opens-today-for-nlsdays-2017/) - SwedenBIO members enjoy a 30% discount on registration rates as well as on company presentations and posters. To benefit from membership discount, make sure to enter the your personal promotion code at the end of the registration process, clearly displayed on the registration summary before payment. Are you missing your promotion code? Contact info@swedenbio.se. Discounts are
- [Strong link forming between life science hot spots of California and Sweden](https://swedenbio.se/strong-link-forming-between-life-science-hot-spots-of-california-and-sweden/) - The collaboration has taken off with a networking event bringing together some 70+ selected companies, investors and academic actors from Sweden and California to brainstorm about how to overcome obstacles standing in the way of innovations in these fields. But the initiative is just as much about connecting on a social level, making it easy
- [SwedenBIOs annual report 2023](https://swedenbio.se/swedenbios-annual-report-2023/) - In 2023, SwedenBIO experienced a notably eventful and productive year, marked by an increase in membership, headcount, and various other positive developments outlined in the annual report. From highly successful and well-attended member events to forging international partnerships and collaborations, the SwedenBIO team effectively accomplished numerous objectives over the past year. The pinnacle of these
- [Citeline signs Gold Patron agreement with SwedenBIO](https://swedenbio.se/citeline-signs-gold-patron-agreement-with-swedenbio/) - UK based pharma intelligence company Citeline has concluded a Gold Patron agreement with SwedenBIO. Becoming a Patron means joining a select group dedicated to advancing the mission of SwedenBIO. Patrons are chosen based on their expertise and capacity to make significant contributions to SwedenBIOs goals. A Patron supports the work of SwedenBIO in an exclusive
- [Regional Insights from the 2024 Barometer Paint a Detailed Picture of the Industry](https://swedenbio.se/en/regional-insights-from-the-2024-barometer-paint-a-detailed-picture-of-the-industry/) - The Life Science Barometer is more than an annual report. It’s a full concept designed to enrich the discussions about the Swedish life science industry with proper facts, statistics and outlooks. This knowledge is now being put to use to gain a more granular overview of the different Swedish region’s life science scenes. The Uppsala
- [Registration opens today for NLSDays](https://swedenbio.se/registration-opens-today-for-nlsdays-2017/) - SwedenBIO members enjoy a 30% discount on registration rates as well as on company presentations and posters. To benefit from membership discount, make sure to enter the your personal promotion code at the end of the registration process, clearly displayed on the registration summary before payment. Are you missing your promotion code? Contact info@swedenbio.se. Discounts are
- [Sweden - the top candidate for EMA](https://swedenbio.se/sweden-top-candidate-ema/) - The application has been submitted and Sweden has a great offer! Today, on the 1st of August the Swedish Government published the offer to host the European Medical Agency, EMA when it's moving out from London in connection with the UK’s withdrawal from the EU next year. - The highly integrated Swedish life science ecosystem leave nothing to
- [Saga Diagnostics wins Startup Challenge @NLSDays 2017 for best pitch](https://swedenbio.se/saga-diagnostics-wins-startup-challenge-nlsdays-2017-best-pitch/) - The Startup Challenge @NLSDays 2017 gave the audience a taste of different research and development projects within therapeutics, medical technology and platform solutions. The contestants were given only three minutes to pitch, after which they were challenged by a seasoned jury: three life science experts and an investor. – It is great to see high
- [Registration for NLSDays 2019 is now open!](https://swedenbio.se/registration-nlsdays-2019-now-open/) - SwedenBIO members enjoy a 30% discount on registration rates as well as on company presentations. To benefit from membership discount, make sure to enter your personal promotion code at the end of the registration process, clearly displayed on the registration summary before payment. Are you missing your promotion code? Contact info@swedenbio.se. Visit our new NLSDays website for
- [The Nordics getting ready to showcase joint strengths](https://swedenbio.se/nordics-getting-ready-showcase-joint-strengths/) - Together, all Nordic countries have worked in a consortium to set up a joint pavilion in the conference exhibition hall, as well as hosting a reception – the Nordic Mixer – aiming to bring together the American executive community and anyone interested in building collaboration in our region of the world. – By joining forces
- [Success for Nordic presence at BIO Convention!](https://swedenbio.se/success-nordic-presence-bio-convention/) - For this year´s conference, the Nordic countries were for the first time jointly branded as The Nordics – Global Hub for Life Science Innovation, with our value proposition to international companies and investors packaged in one set of messages, building upon common denominators. – By joining forces with our neighboring countries, we believe that we
- [Welcome to SwedenBIO Summit 2019!](https://swedenbio.se/welcome-swedenbio-summit-2019/) - When? December 4th. The program starts at 13.00 with registration and coffee from 12.30. The first hour will be in Swedish and, upon request from our members, the rest of the day will be in English, welcoming our non-Swedish speaking members. Where? Grand Hôtel, Södra Blaiseholmshamnen 8, Stockholm The event is member exclusive and free of
- [The COVID-19 crisis puts a spotlight on IP protection vs. public health interests](https://swedenbio.se/covid-19-crisis-puts-spotlight-ip-protection-vs-public-health-interests/) - One aspect that has gained notoriety in the current global headlines is the protection for IP-rights and other proprietary information bestowed upon the life sciences focused companies and organizations, research institutes etc. In the past weeks we have seen numerous headlines in various media claiming that the industry “must change” and that there is a
- [Three days of free virtual partnering meetings](https://swedenbio.se/three-days-free-virtual-partnering-meetings/) - From April 20th to May 6th, a consortium of Biotech clusters, Inova and Evaluate, are hosting a free Covid-19 virtual partnering event to bring together the key leaders and decision makers in the global pharma industry to connect and help bring forward solutions. This includes the development, trials and manufacture of patient solutions such as diagnostics, drug treatment and,
- [Free Digital Partnering for Members](https://swedenbio.se/free-digital-partnering-members/) - The three day conference will be from May 18th to 20th and is free for all member companies. Registration and more information can be found here: https://partnering.biotechgate.com SwedenBIO members get a free up-grade to premium partnering. Contact info@swedenbio.se for your promotion code.
- [Strong link forming between life science hot spots of California and Sweden](https://swedenbio.se/strong-link-forming-between-life-science-hot-spots-of-california-and-sweden/) - The collaboration has taken off with a networking event bringing together some 70+ selected companies, investors and academic actors from Sweden and California to brainstorm about how to overcome obstacles standing in the way of innovations in these fields. But the initiative is just as much about connecting on a social level, making it easy
- [SwedenBIO and Swedish American Chamber of Commerce San Diego to become formal partners through a MoU](https://swedenbio.se/swedenbio-and-swedish-american-chamber-of-commerce-san-diego-to-become-formal-partners-through-a-mou/) - With California and Sweden excelling in the same fields within life sciences, notably immuno-oncology, rare diseases and cell and gene therapy, many fruitful business-to-business relationships have a potential to come out of the partnership, according to The Chamber´s president Ted Stübner and Helena Strigård, CEO SwedenBIO. The MoU has a clear focus on the member
- [Two SwedenBIO members unite when LINK Medical acquires IRW](https://swedenbio.se/two-swedenbio-members-unite-when-link-medical-buys-irw-we-asked-links-ceo-ola-gudmundsen-to-share-his-thoughts-on-this-exciting-acquisition/) - What does this mean for you and what do you look forward to by joining forces? – Adding IRW to our team means strengthening our company in many ways. Not only do we get a team of very competent and experienced colleagues that are well recognized in the industry, but we add an important office
- [Looking for a trainee from an American University?](https://swedenbio.se/looking-for-a-trainee-from-an-american-university/) - SACC is designated by the Sweden’s Ministry of Foreign Affairs as well as the US Department of State to facilitate transatlantic exchange through the Talent Mobility Program. It aims to enable companies to find the skillsets that they need from students or graduates from top universities, as well as to develop their employer brand, internationalization
- [New member benefits through international collaboration](https://swedenbio.se/new-member-benefits-through-international-collaboration/) - The MoU has a clear focus on the member company benefits that this US-Swedish collaboration platform will provide, giving both SACC and SwedenBIO members a possibility to tap into the strengths and hands-on tools of the respective organizations. – At the Swedish American Chamber of Commerce in San Diego, we provide strategic advice to our
- [An all-time high of interest from investors in Nordic life sciences!](https://swedenbio.se/an-all-time-high-of-interest-from-investors-in-nordic-life-sciences/) - As the region's largest business partnering meeting in this field, it is a sign of strength of how the sector is evolving that more international investors than ever before are signing up to the event. The booming interest for innovations stemming from the region will also be captured in a pre-event to NLSDays as we
- [SwedenBIO to partner with SciLifelab, ESS and MAX IV to maximize benefits of research infrastructures](https://swedenbio.se/swedenbio-to-partner-with-scilifelab-ess-and-max-iv-to-maximize-benefits-of-research-infrastructures/) - SciLifeLab is a national infrastructure for molecular bioscience research, MAX IV Laboratory currently houses the brightest X-ray source in the world and the ESS will soon house the world’s most powerful neutron source. – Together, we will engage the broad life science community in academia, industry, and health care, and jointly develop new technology-, data- and
- [#NLSDays' partnering portal is now open – start sending your personal meeting requests!](https://swedenbio.se/nlsdays-2021s-partnering-portal-is-now-open-start-sending-your-personal-meeting-requests/) - The countdown for Nordic Life Science Days 2021 has truly begun. Check out the latest newsletter and get to know some of the 100+ investors, and get hyped about the 80 Rising Stars that you'll get to meet through the partnering platform.
- [Bridging the Gap (April 7–8)](https://swedenbio.se/bridging-the-gap-april-7-8/) - Bridging the Gap is Life Science Bridge's first ever event, and it has the purpose to promote trade across borders and build bridges between different regions. This unique life science event will be held 7-8th of April on Zoom. The topics will be focused on The life science ecosystem in the U.S., Swedish life science
- [Meeting scheduling ongoing now!](https://swedenbio.se/meeting-scheduling-ongoing-now/) - The meeting scheduling is ongoing now, so get into the partnering platform to find your next business partner. The meetings will be scheduled in 30-minute intervals from April 20 to 23, at any preferred time zone. SwedenBIO members receive 30% discount on their registration. Contact info@swedenbio.se for your discount code. Register here to get access to partnering.
- [NLSDays starting on April 20 – here is the program](https://swedenbio.se/nlsdays-starting-on-april-20-here-is-the-program/) - Although this year is completely digital, the partnering possibilities and the program are just as excellent as in the previous years. Check out #NLSDays 2021's full program here.
- [Apoglyx, Respinor and RetinaRisk Announced as NLSInvest Rising Star Award Winners](https://swedenbio.se/apoglyx-respinor-and-retinarisk-announced-as-nlsinvest-rising-star-award-winners/) - From the 80 Rising Stars, one company from each track was selected as the category winner. The three winners will be awarded a package prize of 15,000 DKK, two registrations to NLSDays 2022, and one company presentation at the 2022 conference. This year, the NLSInvest Rising Star Award Winners are: Biotech / Pharma: ApoGlyx (Sweden) is developing
- [Highlights from NLSDays Digital, 20th April 2021](https://swedenbio.se/highlights-from-nlsdays-digital-20th-april-2021/) - The opening session focused on the great achievements delivered during the current pandemic, through the industry’s huge and collaborative efforts to find and approve coronavirus vaccines. One of the main themes that emerged from the speakers was how the great trust and willingness among Nordic companies to work together has led to the region becoming
- [Highlights from NLSDays Digital, 21st April 2021](https://swedenbio.se/highlights-from-nlsdays-digital-21st-april-2021/) - The day’s first Super Session was all about intelligent investment and, continuing from the inaugural and highly successful NLSInvest on Monday, it challenged the more traditional views of investors and processes. The Keynote from the European Investment Bank (Head of the Life Science division) considered the mental shifts that investors – and investees – need
- [Voices from NLSDays 2021](https://swedenbio.se/hello-anita-patel-jusnes-chief-commercial-officer-at-genetic-analysis/) - Hello Anita Patel Jusnes, Chief Commercial Officer at Genetic Analysis During NLSDays you had over twenty partnering meetings with pharma and investors, and several that are quickly proceeding forward. What do you bring back home? – Genetic Analysis got a lot of traction this year and we think this is mainly due to the hot
- [White paper on the impact of MDR on medical device software](https://swedenbio.se/white-paper-on-the-impact-of-mdr-on-medical-device-software/) - Read our latest white paper to get an overview of the impact of MDR on medical device software. In the summer there’ll be a follow-up white paper digging into the details of clinical evidence for medical device software. This white paper is published by Clarvin AB, Morris Law, Kickfile, Devicia and us. Kickfile and Devicia are new
- [NLSDays 2022: Registration is open!](https://swedenbio.se/nlsdays-2022-registration-is-open/) - Registration includes All registrations are personal/individual, including access to all super sessions, fireside chats, exhibition, company presentations, One-on-One partnering including submission of up to 150 requests per company for onsite face-to-face meetings, coffee-breaks, lunches and receptions.SwedenBIO members receive 30% discount on their registration. Contact info@swedenbio.se for your discount code. Like a Nordic Saga, five small countries in
- [SwedenBIO CEO enters SACC San Francisco Advisory board](https://swedenbio.se/swedenbio-ceo-enters-sacc-san-francisco-advisory-board/) - – I am thrilled to be able to build the connections between Swedish and Californian life sciences even stronger and honored to join this group of driven individuals, says Helena about the appointment. The links between Swedish and Californian life sciences have grown stronger over the past year, as demonstrated through the increased collaboration between
- [Awards for outstanding life science contributions](https://swedenbio.se/awards-for-outstanding-life-science-contributions/) - The winners will be announced at Executive Dinner on September 14th. Award category: “Sharing is caring” A fundamental pillar in a successful ecosystem surrounding life sciences is the ability to share. Share knowledge, share technologies and data, share human resources or even functionalities. It takes boldness and an open mindset to be in the first
- [Four prominent life science ambassadors awarded for outstanding contributions](https://swedenbio.se/four-prominent-life-science-ambassadors-awarded-for-outstanding-contributions/) - Prof. Johan Rockberg wins the “Sharing is Caring Award” A fundamental pillar in a successful ecosystem surrounding life sciences is the ability to share. Share knowledge, share technologies and data, share human resources or even functionalities. It takes boldness and an open mindset to be in the first line of sharing. “Johan Rockberg, professor in
- [Swedish government and industry boosting cell therapy and RNA manufacturing](https://swedenbio.se/swedish-government-and-industry-boosting-cell-therapy-and-rna-manufacturing/) - Thomas Eldered, President Flerie Invest, Helena Strigård, CEO SwedenBIO and Ted Fjällman, CEO NorthX Biologics The new entity, NorthX Biologics AB, will take over and expand the facility equipped to provide GMP-grade plasmid DNA and technical protein manufacture at commercial scale. The Swedish Minister for Business, Industry and Innovation, Ibrahim Baylan, revealed in a press conference that the
- [SwedenBIO hits 300 members!](https://swedenbio.se/swedenbio-hits-300-members/) - Photo: Johan Stillman, TTV Media Your company’s slogan is ’Value Through Innovation’. What is your expectation on the value that a membership in SwedenBIO could bring to Boehringer Ingelheim? I made a commitment to our team that I would bring in several opportunities to inspire them with innovation every year. The Nordics and especially Sweden is
- [SwedenBIO welcomes new director of communications and digital communications officer](https://swedenbio.se/swedenbio-welcomes-new-director-of-communications-and-digital-communications-officer/) - “In Alexandra, we get an experienced director of communications to the team, whose background in life science combined with an international career as a journalist will be valuable for how we continue to develop SwedenBIO. We have previously worked with Sebastian to digitalize and renew the communications offering towards the members, for example by setting
- [BICO brings home the life-science prize SwedenBIO Award](https://swedenbio.se/bico-brings-home-the-life-science-prize-swedenbio-award/) - CTO Héctor Martínez and CEO Erik Gatenholm, both co-founders of BICO BICO’s CEO and co-founder Erik Gatenholm received the SwedenBIO Award on December 8, in a prize ceremony at Grand Hôtel in Stockholm that capped off this year’s SwedenBIO Summit. In the five years since its conception, BICO has grown from being the bioink and
- [SwedenBIO and BIO offer members discount for BIO International Convention 2022](https://swedenbio.se/swedenbio-and-bio-offer-members-discount-for-bio-international-convention-2022/) - Register as soon as possible to enjoy one of these discounted rates: Until March 30, a discount of 400$ is available to our members (200$ off the early-bird rate)From March 31, SwedenBIO members are offered an extended early-bird discount ($200 off the general access rate) This exclusive offer is only available to delegates from SwedenBIO’s
- [Grand finale av MDR-Podden](https://swedenbio.se/grand-finale-av-mdr-podden/) - I MDR-poddens sista avsnitt rundar Frida och Sofia av och diskuterar resan som varit. Hur ser det ut idag? Har MDR hunnit sätta sig ännu? Hur har podden fyllt sin funktion och vilka är Sofias highlights? Lyssna även för att höra när ljudteknikern Sebastian sätts på kunskapsprov. Klicka här för att lyssna i Spotify. MDR-Podden finns också
- [Coordination across the EU needed to manage AMR](https://swedenbio.se/coordination-across-the-eu-needed-to-manage-amr/) - Johanna Assadi Rissanen, SwedenBIO's representative in Taskforce AMR. Earlier this month, SwedenBIO submitted its comment on the European Commission’s call for evidence on AMR, which aims to set concrete objectives and activities that can strengthen national action against AMR among member states. At SwedenBIO, we increased our focus on the highly relevant and urgent topic
- [SwedenBIO Star Award nominees contribute to competence development](https://swedenbio.se/swedenbio-star-award-nominees-contribute-to-competence-development/) - The SwedenBIO Star Award was created to highlight extraordinary efforts by individuals or organizations to address common challenges within life sciences. This year's prize is focused to the skills shortage the industry is facing, which hampers the growth of companies. The winner of the SwedenBIO Star Award 2022 will be announced at the industry organisation’s
- [Dare to share](https://swedenbio.se/dare-to-share/) - Arbetsgruppen för HR & Kompetens: Björn Henriksson (Nordic Interim), Hanna Sandvall (Randstad Sweden), Frida Lawenius (SwedenBIO), Ann Fredriksson (Vironova AB) & Petra Duprez (Biotage). Ej på bild: Hani Aoun (MSD) Den totala tillgången till kompetens är begränsad och gör att vi idag konkurrerar med varandra om talangerna inom life science. En särskild utmaning för de
- [Over 100 Nordic companies present at BIO2022 as US–Nordics collaborations increase](https://swedenbio.se/over-100-nordic-companies-present-at-bio2022-as-us-nordics-collaborations-increase/) - This week, over 100 Nordic companies have made it to BIO International Convention 2022 in San Diego on June 13-16 for the world’s premier life sciences event. The companies represent the region’s traditional strengths in cancer immunotherapy, CNS, genomics and protein science, along with new areas such as cell and gene therapy, microbiomics and precision
- [Getting ready for the bio revolution](https://swedenbio.se/getting-ready-for-the-bio-revolution/) - Personalized medicine is the future of healthcare, offering the promise to deploy cell and gene therapy platforms to once and for all cure diseases – some of which stand without a cure today or which require life-long treatment regimens. “We’re looking at taking medicines just in the beginning of a treatment, instead of taking it
- [SwedenBIO is hiring an International Program Director](https://swedenbio.se/swedenbio-is-hiring-an-international-program-director/) - SwedenBIO, the Swedish life science industry organization with over 300 member companies in biotech, pharma and medtech, is looking for a new team member to be responsible for the program development within our international platforms, primarily but not exclusively Nordic Life Science Days. Nordic Life Science Days is our flagship event and has grown into
- [We're hiring a part-time programmer](https://swedenbio.se/were-hiring-a-part-time-programmer/) - SwedenBIO is the Swedish life science industry organization with over 300 member companies in biotech, pharma and medtech. An important activity for SwedenBIO is to provide up-to-date statistics and overviews of the life science sector. We do this through questionnaires and surveys, as well as through other available data sets. We now plan to increase
- [Nordic Life Science Days attracts record number of international delegates](https://swedenbio.se/nordic-life-science-days-attracts-record-number-of-international-delegates/) - NLSDays' Managing Director Olivier Duchamp-Giudicelli at NLSDays 2019. Photo: Camille Sonally Held in Malmo from September 28-29th, Nordic Life Science Days (NLSDays) is the largest partnering conference for life sciences in the Nordic region. Through its partnering system, stage programme, and extensive list of exhibitors, it is a unique event showcasing the entire spectrum of life sciences
- [SwedenBIO Summit 2022](https://swedenbio.se/swedenbio-summit-2022/) - At this year’s SwedenBIO Summit we focus on the foundations necessary for building strong and resilient companies. We take inspiration from the pillars introduced by the international Worldview Ranking of health biotech sectors and translate them to intimate business stories. You will hear tales of success, and tales of hurdles and obstacles. You will also get a
- [Three finalists selected for SwedenBIO’s annual life science award](https://swedenbio.se/three-finalists-selected-for-swedenbios-annual-life-science-award/) - SwedenBIO Award finalists 2022 The SwedenBIO Award is bestowed upon a company that has made a noteworthy contribution to the life science ecosystem in the past year, and – through its contributions to society – has demonstrated the importance of a thriving life science industry in Sweden. SwedenBIO Award is the industry’s own prize and
- [Sneak peek of the Life Science Barometer 2022](https://swedenbio.se/sneak-peek-of-the-life-science-barometer-2022/) - The Barometer is a annual survey from SwedenBIO. The core of the survey is SwedenBIOs members – more than 330 companies that span the entire range of life science companies, and represent roughly 10% of the entire life science company population in Sweden. Additionally, this year’s survey was also directed to companies within drug discovery
- [Antaros Medical wins SwedenBIO Award for their innovative imaging technology](https://swedenbio.se/antaros-medical-wins-swedenbio-award-for-their-innovative-imaging-technology/) - Carl Sjöberg, manager of software development, Carina Schmidt, member of the board, and CEO and co-founder Johannes Hulthe from Antaros Medical receives SwedenBIO Award from Lotta Ljungkvist, chair of SwedenBIO's board, on Dec 6, 2022. Antaros Medical’s CEO and co-founder Johannes Hulthe received the SwedenBIO Award on December 6, in a prize ceremony held in
- [Highlights from JPM’s 2023 Healthcare Week](https://swedenbio.se/highlights-from-jpms-annual-healthcare-week/) - The international life sciences year started off with J.P. Morgan's Annual Healthcare week, which drew thousands of life science experts to San Francisco earlier this month. Out of the many partnering meetings and vibrant panel discussions on current trends and challenges in the field, Marjo Puumalainen, Program Director of NLSDays and International Director at SwedenBIO,
- [From Realheart to Miniheart - how one Swedish company is aiming for gender equality in cardiac devices](https://swedenbio.se/from-realheart-to-miniheart-how-one-swedish-company-is-aiming-for-gender-equality-in-cardiac-devices/) - Ina Laura Perkins, CEO Scandinavian RealHeart Scandinavian Realheart is a medtech company based in Västerås, Sweden which is developing a n artificial heart (the Realheart® TAH) that has the potential to help millions of people suffering from severe heart failure. While artificial hearts have been in use for decades, with more than 2,000 patients around the
- [Launch of The Swedish Drug Discovery & Development Pipeline 2023](https://swedenbio.se/launch-of-the-swedish-drug-discovery-development-pipeline-2023/) - The Swedish Drug Discovery and Development Pipeline Report 2023 contains a mapping of the pharmaceutical pipeline run by companies headquartered in Sweden. The target group for the report includes international investors, the life science industry in Sweden and of course decision makers within politics, business and academia. The aim of the report is to provide
- [Why attending JP Morgan should be a priority for Swedish companies](https://swedenbio.se/why-attending-jp-morgan-should-be-a-priority-for-swedish-companies/) - J.P Morgan Healthcare week in January of each year jump-starts the business year for the life science industry. Thousands of investors and life science executives from all over the world gather in San Francisco. SwedenBIO coordinates a Swedish delegation each year and supports members in different ways to make the most out of the hectic
- [Swedish life science united during the presidency and beyond ](https://swedenbio.se/swedish-life-science-united-during-the-presidency-and-beyond/) - The Swedish government welcomes key decision makers to a life science conference at Aula Medica, Karolinska Institutet, 26-27 June. Following the conference, we open up for everyone interested in the Swedish and European life science industry to join us in a reflecting seminar at the Royal Academy of Engineering Sciences, IVA, in Stockholm, June 27th
- [We're hiring an Event Sales Manager (Application closed)](https://swedenbio.se/were-hiring-an-event-sales-manager/) - SwedenBIO is the Swedish life science industry organization with over 340 member companies. We aim to improve the business environment for the life science ecosystem by building networks, increasing knowledge transfer, and influencing policies. SwedenBIO organizes the largest life science partnering event in the Nordics – Nordic Life Science Days (NLSDays) – an annual conference
- [Life Science Barometer 2023 survey now open for submissions](https://swedenbio.se/life-science-barometer-2023-survey-now-open-for-submissions/) - The Life Science Barometer is a yearly survey of the Swedish life science-industry that generates an up-to-date overview of Swedish life science and highlights needs and trends in the industry. It aims to uncover needs and trends within the sector, empowering informed decision-making and fostering a stronger industry. The survey is open for submissions Oct
- [Here are the finalists for the SwedenBIO Award for 2023](https://swedenbio.se/here-are-the-finalists-for-the-swedenbio-2023-award/) - The SwedenBIO Award is the industry's own award and aims to provide increased visibility for life science actors by recognizing and rewarding successful and exemplary member companies that have distinguished themselves and contributed to positive attention for Swedish life science. The award has been handed out since 2007 to put the spotlight on successful and
- [SwedenBIOs annual report 2023](https://swedenbio.se/swedenbios-annual-report-2023/) - In 2023, SwedenBIO experienced a notably eventful and productive year, marked by an increase in membership, headcount, and various other positive developments outlined in the annual report. From highly successful and well-attended member events to forging international partnerships and collaborations, the SwedenBIO team effectively accomplished numerous objectives over the past year. The pinnacle of these
- [SwedenBIO annual report 2023](https://swedenbio.se/swedenbio-annual-report-2023/)
- [Citeline signs Gold Patron agreement with SwedenBIO](https://swedenbio.se/citeline-signs-gold-patron-agreement-with-swedenbio/) - UK based pharma intelligence company Citeline has concluded a Gold Patron agreement with SwedenBIO. Becoming a Patron means joining a select group dedicated to advancing the mission of SwedenBIO. Patrons are chosen based on their expertise and capacity to make significant contributions to SwedenBIOs goals. A Patron supports the work of SwedenBIO in an exclusive
- [Regional Insights from the 2024 Barometer Paint a Detailed Picture of the Industry](https://swedenbio.se/regional-insights-from-the-2024-barometer-paint-a-detailed-picture-of-the-industry/) - The Life Science Barometer is more than an annual report. It’s a full concept designed to enrich the discussions about the Swedish life science industry with proper facts, statistics and outlooks. This knowledge is now being put to use to gain a more granular overview of the different Swedish region’s life science scenes. The Uppsala
- ["We need to build on our country's proven ability to deliver both scientific and technical excellence"](https://swedenbio.se/we-need-to-build-on-our-countrys-proven-ability-to-deliver-both-scientific-and-technical-excellence/) - What has been the biggest insight so far in this new role? – It has become even clearer to me that there is so much potential in our sector! Great opportunities both for the companies and Sweden AB, based on the ongoing development, and for the patients who can benefit from the innovative treatments. But
- [20 Nordic companies to compete for Life Science awards at NLSDays 2024](https://swedenbio.se/20-nordic-companies-to-compete-for-life-science-awards-at-nlsdays-2024/) - SwedenBIO is thrilled to announce that twenty promising life science companies from the Nordic region have been shortlisted to compete in the prestigious Nordic Stars pitch competition at Nordic Life Science Days (NLSDays) 2024. This event will take place in Malmö on September 18-19 and will showcase cutting-edge innovations to an audience of investors, industry
- [To increase female representation, focus on board composition](https://swedenbio.se/to-increase-female-representation-focus-on-board-composition/) - One year ago, the Vilda network for women leaders in the life science sector was initiated in response to the slow progress to reach gender balance in top management and boards within the industry. Among its founders is Cecilia Bröms-Thell, Senior Business Developer at Uppsala Innovation Centre. The below is a short interview with her
- ["Sweden can be better at marketing itself"](https://swedenbio.se/sweden-can-be-better-at-marketing-itself/) - What is Business Sweden’s focus for 2024? – Our main focus is “business as usual”, i.e. to help Swedish companies grow internationally and to attract foreign investment to Sweden. Through our 45 offices abroad and our government mission, we can support Swedish companies on the ground and help them expand internationally. For small and medium-sized
- [Swedish and Danish Life Science sectors experiencing substantial growth ](https://swedenbio.se/swedish-and-danish-life-science-sectors-experiencing-substantial-growth/) - The Nordics have long been recognized as a hub of research and innovation, so it's little surprise that the life sciences—one of the most research-intensive sectors—are seeing substantial growth in this region. Pharmaceuticals now account for nearly ten percent of Sweden's total exports, with an impressive 180 percent growth over the past decade (1). In
- [SwedenBIO Summit 2024](https://swedenbio.se/swedenbio-summit-2024/) - The SwedenBIO summit is a member exclusive event, free of charge, wrapping up the year in a festive yet informal setting. ​This years theme centers around the Nobel prizes.​ Life science is a field which has relevance to all Nobel prize categories and we will show how these areas relate to the constantly innovative and
- [SwedenBIO ready to welcome global life science community to BIO-Europe in Stockholm ](https://swedenbio.se/swedenbio-ready-to-welcome-global-life-science-community-to-bio-europe-in-stockholm/) - Taking place in the Swedish capital Stockholm, this pan-European flagship event is expected to gather several thousand experts who will have a chance to get a closer glance of Swedish life science. SwedenBIO will contribute to putting Sweden's vibrant life science ecosystem in the spotlight, reinforcing its global position as a hub for cutting-edge research,
- [Takeaways from BIO-Europe in Stockholm ](https://swedenbio.se/takeaways-from-bio-europe-in-stockholm/) - BIO-Europe, the continent's premier life science event, celebrated its 30th anniversary in Stockholm from November 4-6, 2024. Hosting Europe’s biggest life science industry event offered a rare opportunity for global visibility. As the main industry association for Swedish life science companies, SwedenBIO seized this chance to showcase the dynamic Swedish life science ecosystem and to
- [Sahlgrenska Global Health Hackathon aims to bring new solutions](https://swedenbio.se/sahlgrenska-global-health-hackathon-aims-to-bring-new-solutions/) - SwedenBIO is a partner to the Sahlgrenska Global Health Hackathon, held throughout 2025 in six countries on three continents and nine locations with the slogan “Co-action Addressing Global Health Challenges”. The world tour will take the innovation marathon to Gothenburg, Malmö and Stockholm, Boston and Miami, London, Göttingen (Germany), Barcelona and Singapore before returning to Gothenburg in
- [Three finalists compete for the SwedenBIO Award 2024](https://swedenbio.se/three-finalists-compete-for-the-swedenbio-award-2024/) - The annual gathering of the Swedish life science community, Summit, serves as an arena to celebrate the very best of the industry. The SwedenBIO Award, handed out since 2007, is the industry’s premier recognition, designed to spotlight and celebrate outstanding member companies within Swedish life science. By honoring exemplary achievements, the award aims to increase
- [Join SwedenBIO at JPM in San Francisco](https://swedenbio.se/join-swedenbio-at-jpm-in-san-fransisco/) - SwedenBIO is once again attending JP Morgan week in January and we have curated a range of benefits and events for our members who are also going. Our International Director Marjo Puumalainen and our Community Manager Linn Mattsson look forward to meeting SwedenBIOs members in San Francisco and help them make the most of what
- [Vicore Pharma takes home 2024 SwedenBIO Award](https://swedenbio.se/vicore-pharma-takes-home-2024-swedenbio-award/) - Vicore Pharma was founded in the early 2000s based on the design and synthesis of buloxibutid (C21) by Professor Anders Hallberg’s group at Uppsala University. The company is unlocking the potential of a new class of drugs – Angiotensin II Type 2 Receptor Agonists (ATRAGs) – stopping disease progression and restoring function. As a result
- [SwedenBIO and Biocom Californa sign MOU](https://swedenbio.se/swedenbio-and-biocom-californa-sign-mou/) - Biocom California is the leading advocate for Californias life science sector with clusters across the US and Japan. Both organisations share a mutually beneficial cooperation going back to 2020. The collaboration took off with a networking event in November 2020 bringing together more than 70 selected companies, investors and academic actors from Sweden and California
- [Svenska aktörers förslag till EU:s nya life science-strategi](https://swedenbio.se/svenska-aktorers-forslag-till-eus-nya-life-science-strategi/) - Organisationerna efterlyser en kraftfull europeisk strategi för att stärka konkurrenskraften, säkra innovationen och rusta Europas försörjningsberedskap inom läkemedel och medicinteknik. – Sverige har mycket att bidra med i en life science strategi för EU med vår modell med samarbete över tre departement. För att kunna accelerera life science-industrin behövs korta beslutsvägar och en helhetssyn som
- [Svenska aktörers förslag till EU:s nya life science-strategi](https://swedenbio.se/svenska-aktorers-forslag-till-eus-nya-life-science-strategi/) - Organisationerna efterlyser en kraftfull europeisk strategi för att stärka konkurrenskraften, säkra innovationen och rusta Europas försörjningsberedskap inom läkemedel och medicinteknik. – Sverige har mycket att bidra med i en life science strategi för EU med vår modell med samarbete över tre departement. För att kunna accelerera life science-industrin behövs korta beslutsvägar och en helhetssyn som
- [Vi söker en Key Account Manager](https://swedenbio.se/swedenbio-soker-en-key-account-manager/) - Varmt välkommen till SwedenBIO, en branschorganisation med ambitionen att samla hela Life Science Sveriges bolag. Vi är ett litet hängivet team med ambitionen att göra stor skillnad. Vi representerar fler än 330 medlemsbolag verksamma inom bioteknik, läkemedel, diagnostik, medicinteknik samt tjänstebolag och samarbetsorganisationer. Gemensamt för alla dessa bolag är strävan att förbättra människors hälsa, i Sverige och
- [SwedenBIO i samtal med regeringen om eventuella amerikanska tullar](https://swedenbio.se/swedenbio-i-samtal-med-regeringen-om-eventuella-amerikanska-tullar/) - Med anledning av de hotande amerikanska tullarna så bjöd Bistånds- och utrikeshandelsminister Benjamin Dousa in representanter från två av Sveriges starkaste exportindustrier, life science och fordon, för en diskussion om hur Sverige bäst bör möta tullhoten. SwedenBIO representerades av CEO Jessica Martinsson.– En bra och viktig diskussion om hur våra försörjningskedjor ser ut och vilka
- [Eléonore Maguin on NLSDays and NLSInvest](https://swedenbio.se/eleonore-maguin-on-nlsdays-and-nlsinvest/) - This is your first time coming to Nordic Life Science Days and our pre-event NLS Invest. What attracts you to the Nordics? – IPF Partners is the leading growth debt provider exclusively dedicated to the healthcare sector and mainly focusing on Europe. Our team identifies the Nordic region as a fast growing environment for life
- [SwedenBIO:s rekommendation för informationsgivning avseende bolag i utvecklingsfas](https://swedenbio.se/swedenbios-rekommendation-for-informationsgivning-avseende-bolag-i-utvecklingsfas/) - Framtagen av SwedenBIO:s Arbetsgrupp för Affärsutveckling och Finansiering.Fastställd av SwedenBIO:s styrelse 2020 12 11 Ladda ner branschstandarden här: SwedenBIO:s rekommendation för informationsgivning avseende life science-bolag i utvecklingsfas (pdf) Dokumentet har till syfte att uppmuntra bolag i utvecklingsfas att i prospekt och annan dokumentation som upprättas i samband med ägarspridningar och kapitalanskaffningar som underlag för investerares bedömning
- [Brännpunkt Life Science - del 2](https://swedenbio.se/brannpunkt-life-science-del-2/) - I andra delen analyserar Helena Strigård, vd för SwedenBIO, läget i branschen och tittar närmare på hur året har sett ut för SwedenBIO och medlemmarna. Vill du fördjupa dig? Missa inte konferensen SwedenBIO Summit den 9 december. Läs mer eller anmäl dig här.
- [Inspel – internationell lyskraft](https://swedenbio.se/inspel-internationell-lyskraft/) - Uppslutningen och engagemanget bakom inspelet talar sitt tydliga språk – det brådskar att ta sig an uppgiften. Ekosystemet är redo att hugga i, nu behöver regeringen möta upp med resurser och tydliga signaler i den nationella life science-strategin. Vårt inspel har samlat en bredd av aktörer, från akademi, inkubatorer och science parks, forskningsinfrastrukturer, branschorganisationer, offentliga
- [Det ska vara lätt att göra rätt](https://swedenbio.se/det-ska-vara-latt-att-gora-ratt/) - Små och medelstora life science-företag möter många utmaningar på sin utvecklingsresa, där samverkan med myndigheter inte borde bidra till utmaningarna, utan tvärtom skapa möjligheter. Life science är en hårt reglerad bransch. Det är inte längre bara läkemedel som behöver framhäva starka evidens för sin nytta, utan även medicinsk teknik och diagnostik blir mer reglerat. Vi
- [Life Science-strategin – implementering via temagrupper](https://swedenbio.se/life-science-strategin-implementering-via-temagrupper/) - Covid-19 och resiliens i samhället temagruppen leds av SwedenBIOs vice ordförande Lotta Ljungqvist, vd för Testa center. SwedenBIO representeras av Janet Hoogstraate, Valneva. Precisionsmedicin och ATMP SwedenBIO representeras av Johan Hyllner, Head of Cell Therapy Department på AstraZeneca Hälsodata SwedenBIO representeras av Björn Arvidsson, verksamhetsledare STUNS Life science och ordförande för SwedenBIOs interna arbetsgrupp för
- [Föreningsstämma 2022](https://swedenbio.se/foreningsstamma-2022/) - Bilagor Kallelse ordinarie föreningsstämma 2022 Årsredovisning föreningen SwedenBIO 2021 Revisionsberättelse föreningen SwedenBIO 2021 Årsredovisning SwedenBIO Service AB 2021 Valberedningens protokoll Fastställande föreningsavgift
- [Föreningsstämma 2024](https://swedenbio.se/foreningsstamma-2024/) - Datum: tisdagen den 14 maj 2024Tid: klockan 17.30Plats: Münchenbryggeriet, Torkel Knutssonsgatan 2, StockholmAnmäl dig här. (Du kan välja att anmäla dig till både årsmötet och Executive Dinner eller enbart till årsmötet) Stämmohandlingar Kallelse Ordinarie Föreningssammanträde Föreningen SwedenBIO 2024 Revisionsberättelse 2023 Styrelsens förslag Indexuppräkning Valberedningens förslag Verksamhetsberättelse 2023 Årsredovisning föreningen SwedenBIO 2023
- [Den Tysta Pandemin](https://swedenbio.se/den-tysta-pandemin/) - Sverige är bra på att minska förskrivningen av antibiotika, men det räcker inte långt. De resistenta bakterierna stannar inte vid gränskontrollen, utan följer med in i våra hem och på våra sjukhus i takt med att våra resmönster blir alltmer världsomspännande. För att komma åt problemen behöver flera olika insatser göras samtidigt. Läs vår debattartikel
- [Kampanj: kliniska prövningar](https://swedenbio.se/kampanj-kliniska-provningar-2/) - Fler företagsinitierade kliniska prövningar! I Sverige och övriga Norden finns, i flera fall unika, förutsättningar för kliniska prövningar. Vi har framstående medicinsk forskning och sjukvård, innovativa företag, register och biobanker men också en befolkning med hög tilltro till myndigheter, forskning och till innovationer. Delarna finns, men det väloljade maskineriet saknas. När aktörer går in med
- [Läkemedelsverkets tips till dig som ska genomföra klinisk prövning](https://swedenbio.se/lakemedelsverkets-tips-till-dig-som-ska-genomfora-klinisk-provning/) - När man planerar för sin kliniska prövning kan man med fördel tänka på vad det är vi granskar vid en inkommen ansökan. Huvudsyftet med vår granskning är att bedöma produkten och dess kvalitet och tillverkning samt prövningen ur ett säkerhetsperspektiv med patienten i fokus. Vi bedömer också hur studien har utformats vetenskapligt och förutsättningarna att
- [SwedenBIOs förslag på åtgärder för fler kliniska prövningar i Sverige](https://swedenbio.se/swedenbios-forslag-pa-atgarder-for-fler-kliniska-provningar-i-sverige/) - Korta ledtiderna fram till studiestart! Processen fram till studiestart behöver slimmas i alla led. För det behövs samordning av nationella och regionala aktörer i ett gemensamt gränssnitt för en användarvänlig, överskådligt och attraktiv process. Tydligt politiskt ledarskap! Det behövs ett politiskt ledarskap för hälso- och sjukvården som efterfrågar forskning och prövning, med ett tydligt FoU-uppdrag
- [Nationell samordning och satsning](https://swedenbio.se/nationell-samordning-och-satsning/) - Det är komplicerat och fragmentiserat att genomföra studieförfrågningar i Sverige. Våra grannländer erbjuder kostnadsfria och smidiga processer som lockar företagen att förlägga sina studier där istället. Sverige behöver samordning på nationell nivå, med en samlad ingång för företag som vill undersöka möjligheterna att genomföra kliniska prövningar. Inom ramen för den danska satsningen ”Trial nation” erbjuds
- [Myndigheterna kan bli en snabbfotad partner till företagen](https://swedenbio.se/myndigheterna-kan-bli-en-snabbfotad-partner-till-foretagen/) - Att genomföra kliniska studier kräver planeringshorisont och är förenat med höga kostnader. Planering av studierna förutsätter tydlighet i tidsramar och smidig hantering i förhållande till myndigheter och utförare av prövningarna. Oförutsägbarhet i tidsramar och långa ledtider skapar förseningar som leder till stora extra kostnader. Faktorer som får företagen att vända sig utomlands för sina studier.
- [Samarbetet med sjukhusen är den största utmaningen](https://swedenbio.se/samarbetet-med-sjukhusen-ar-den-storsta-utmaningen/) - Inom sjukvårdsorganisationen måste incitamenten för kliniska prövningar öka. Sjukvårdens styrsystem behöver förändras så att det bli attraktivt att medverka i kliniska prövningar. Intresse och förutsättningar att möta upp studieförfrågningar behöver skapas. Idag finns också ett stort underutnyttjande av resurser och utrustning. Flexibilitet behövs i synen på tillgängliggörande av tillgångarna så att CRO-bolag och andra studieutförare
- [Hyvla trösklarna – undanröj onödiga administrativa hinder](https://swedenbio.se/hyvla-trosklarna-undanroj-onodiga-administrativa-hinder/) - “Coronapandemin är den första att på några månader sprida sig över hela världen. Under 2020 har vi sett vikten av samarbete och vad vi kan åstadkomma tillsammans, ansträngningar mellan företag, akademin, sjukvården, myndigheter och individer. Det gör mig hoppfull att vi sätter en ny standard för samarbete för att driva forskning framåt. Det som gjorde
- [Den ena handen måste veta vad den andra gör](https://swedenbio.se/den-ena-handen-maste-veta-vad-den-andra-gor/) - Det krävs ett systemperspektiv där delarna är kommunicerande kärl oavsett om de är statligt, regionalt eller privat organiserade och finansierade. Det handlar om myndigheter, akademi, hälso- och sjukvård, kliniska forskningsutförare samt läkemedels- samt medicinteknikproducerande företag.”Administrativa konstruktioner har en förmåga att motverka de politiska ambitioner de är till för att hantera. Det är en uttalad ambition
- [Forsknings- och innovationspropositionen 2020](https://swedenbio.se/forsknings-och-innovationspropositionen-2020/) - 1. Tillgängliggör forskningsinfrastrukturen SwedenBIOs inspel till den forskningspolitiska propositionen Förslag 1 av 7.SwedenBIO:s bedömning: Sveriges forskningsinfrastruktur, både den nationella och vid enskilda lärosäten bidrar till att flytta fram forskningsfronten för akademi, men tar idag inte tillvara samma möjlighet att bidra till företagens utveckling, trots att detta var regeringens avsikt. Regelverken är otydliga och incitamentsstrukturer saknas, vilket
- [För medlemsföretag angående covid](https://swedenbio.se/for-medlemsforetag-angaende-covid/) - Hur kan vi som biotechföretag bidra med vår forskning och vilka pengar finns att söka? 16 mars 2020 Genom EU-initiativet IMI finansieras innovationsprojekt utifrån forskning kring covid-19-utbrottet, det så kallade coronaviruset. Projekten kan handla om antivirala medel, diagnostik eller verktyg för att hantera nuvarande och framtida utbrott av covid-19. Syftet är att lyfta medicinska innovationer för
- [Nu behövs alla delar av ekosystemet!](https://swedenbio.se/nu-behovs-alla-delar-av-ekosystemet/) - Ett läge där regulatoriska myndigheter, akademi, hälso- och sjukvård och näringsliv behöver lyssna på varandra och jobba ihop för att nå gemensamma mål som ytterst handlar om att rädda och förlänga liv. Just nu är denna livsviktiga växelverkan mer tydlig än någonsin. SwedenBIO, som den nationella branschorganisationen för life science, samlar en betydande del av den
- [Överenskommelse kliniska prövningar](https://swedenbio.se/overenskommelse-kliniska-provningar/) - SKR och life science-branschen har tecknat två överenskommelser för att utveckla arbetet med kliniska prövningar och kvalitetsregister. I Sverige förekommer sedan länge en värdefull samverkan mellan akademi, hälso- och sjukvård och industri, det finns i dag ett nära samarbete. För att underlätta och tydliggöra arbetet har SKR och life science-industrin tecknat två överenskommelser, en om
- [Sverige bör lyfta sin nationella life science-strategi som modell för EU](https://swedenbio.se/sverige-bor-lyfta-sin-nationella-life-science-strategi-som-modell-for-eu/) - EU-kommissionen har aviserat en ny life science-strategi för EU. Arbetet för att ta fram den nya strategin väntas påbörjas under första halvan av detta år och Sverige bör söka påverka utformningen av strategin, uppmanar SwedenBIO, Lif och Swedish Medtech i ett gemensamt uttalande och i ett formellt inspel som alla tre har undertecknat. "Sverige har
- [Lars Bäckman ny ledamot i SwedenBIOs styrelse](https://swedenbio.se/lars-backman-ny-ledamot-i-swedenbios-styrelse/) - Biotage engagerar sig starkt i SwedenBIO och branschen, varför gör ni det? ”För oss är det en självklarhet att vara med och påverka och driva utvecklingen framåt. SwedenBIO gör ett viktigt jobb i detta sammanhang och där vill vi bidra så mycket vi kan. Sverige har en rik historia av framgångsrika företag inom branschen och
- [Anders Persson om nya uppdraget](https://swedenbio.se/anders-persson-om-nya-uppdraget/) - Det pratas om branschglidning och ”sector convergence”. Vad är det du ser händer från din horisont? ”Innovation bygger i stor utsträckning på att applicera upp idéer från en annan kontext plus att behov är kreativitetens moder vilket vi inte minst har påmints om under pandemin. Ett exempel är att före pandemin hade det under ganska
- [Nominera till SwedenBIO Award 2021](https://swedenbio.se/nominera-till-swedenbio-award-2021/) - SwedenBIO Award är branschens eget pris och består, utöver äran, av ett vandringspris och två delegatplatser till Nordic Life Science Days. Vinnaren av SwedenBIO Award 2021 kommer att presenteras på SwedenBIO Summit den 8 december i Stockholm. Priset ska stärka visionen av Sverige som en ledande life science-nation samt bidra positivt till bilden och erkännandet av life science-branschen bland beslutsfattare och allmänhet i Sverige.
- [LINK Medical ökar sin nordiska närvaro](https://swedenbio.se/link-medical-okar-sin-nordiska-narvaro/) - På bilden från vänster: Tom Ivar Horvei, COO, Ola Gudmundsen CEO, Marianne Holst, EVP of Regulatory och Laila Agerholm Executive Vice President QA & Compliance ”Det har varit en lång och spännande resa. Redan från början tänkte vi skandinaviskt och etablerade tidigt kontor i både Norge, Sverige och Danmark. Idag när vi är så många fler så
- [Branschen hjälps åt. På olika bolag, men under samma tak.](https://swedenbio.se/branschens-basta-hjalps-at-pa-olika-bolag-men-under-samma-tak/) - ”Det ger oss en möjlighet att behålla fantastisk kompetens och samtidigt skapa en stabilare och mer sammanhållen struktur än ett samarbetsnätverk. Vi vill behålla det unika som funkar bra och bevara den kultur som är etablerad på respektive enskilt bolag och tycker att det här var ett utmärkt sätt att erbjuda kunderna en bredare expertis.”,
- [Premiär för SwedenBIOs utbildning i Strategi- och affärsutveckling](https://swedenbio.se/premiar-for-swedenbio-s-utbildning-i-strategi-och-affarsutveckling/) - Karoline Akerjordet, Johan Ungerstedt och Christina Östberg Lloyd var några av deltagarna på kursen, här tillsammans med kursledare Ingrid Heath Kursen samlade 19 ledare inom life science, tillsammans med prominenta företrädare för life science från både när och fjärran, som föreläsare och vägledare kring den egna strategiska utvecklingsplanen. Kursen lotsades fram under ledning av Ingrid Heath, partner
- [Trendspaning med Torkel Gren](https://swedenbio.se/trendspaning-med-torkel-gren/) - Välkommen in i styrelsen Torkel. Om du i ett ord skulle sammanfatta vad som kommer att vara vägledande för branschen mot framtiden, vad skulle det då vara?Mognad! Jag menar att branschen håller på att växa upp och närmar sig sina bästa år. Det jag tänkte på är att vi har allt fler bolag med bärkraft både i sina
- [Agrisera hjälper oss sätta fokus på marknaden vid SwedenBIO Summit 2021](https://swedenbio.se/agrisera-hjalper-oss-satta-fokus-pa-marknaden-vid-swedenbio-summit-2021/) - I takt med att fler och fler svenska life science bolag börjar se ljuset i tunneln, dvs marknaden, behöver nya frågor adresseras. Val av distributionskanaler, säljorganisation och varumärkesbyggande är förstås sådant bör ha funnits med under resans gång men blir mer trängande närmre målet. Erika, ni är ett anrikt biotechbolag med mer än tusen produkter på
- [Intervju med Klara Kämpfer, Communications Business Partner på Sanofi](https://swedenbio.se/intervju-med-klara-kampfer-communications-business-partner-pa-sanofi/) - Sanofi är ett globalt läkemedelsbolag med över 100 000 anställda i fler än 100 länder. Varför var det självklart för er att ta ansvar för de globala hälso- och hållbarhetsmålen? Jag tror att de flesta branscher börjar inse att socialt ansvarstagande inte längre är ett ’nice to have’ som kan stärka varumärket, utan en nödvändighet
- [Årets finalister visar på stor bredd i branschen](https://swedenbio.se/arets-finalister-visar-pa-stor-bredd-i-branschen/) - SwedenBIO delar årligen ut pris till ett life science-företag som utmärkt sig speciellt under året och bidragit till samhällelig nytta som understryker betydelsen av en framgångsrik life science-industri i Sverige. Årets nomineringar till SwedenBIO Award visar den fantastiska mångfald som finns inom svensk life science. Svenska life science-företag tar mark, inte bara genom banbrytande forskning och
- [Nytt avsnitt av MDR-Podden!](https://swedenbio.se/nytt-avsnitt-av-mdr-podden-2/) - Många säger att #MDR bidrar till att det blir dyrare att sätta produkter på EU-marknaden. I detta avsnitt gästas Sofia Nordgren av Magdalena Johansson och Johan Norinder från Almi Halland, en aktör som arbetar just med att hjälpa våra svenska bolag och som titulerar sig Sveriges mest aktiva företagsutvecklare. Klicka här för att lyssna i Spotify. MDR-Podden finns också på Apple Podcasts, och
- [Växla upp på dina tillgångar – ett panelsamtal på SwedenBIO Summit](https://swedenbio.se/vaxla-upp-pa-dina-tillgangar-ett-panelsamtal-pa-swedenbio-summit/) - Några av samtalspunkterna var: Hur hanterar man motgångar som biotechbolag?Vad krävs för att fånga intresset hos investerare?Och hur kan investerare bidra med mer än pengar? Ifall du missade Summit eller vill se panelsamtalet igen har vi kokat ner det till en film som du kan se här:
- [God jul och gott nytt år!](https://swedenbio.se/god-jul-och-gott-nytt-ar/) - Nu sitter jag här igen och konstaterar att alla år under en överskådlig tid kommer att bli exceptionella för oss. Det vi åstadkommit ihop med medlemsskaran 2021 förtjänar folkets jubel på Sergels torg. Men i vår bransch harvar vi ofta i skymundan. Det är inte lätt för politiker och allmänhet att fullt ut förstå den
- [Anpassad rekryteringstjänst för dedikerade styrelser och seniora rådgivare](https://swedenbio.se/anpassad-rekryteringstjanst-for-dedikerade-styrelser-och-seniora-radgivare/) - K2 Search Life Science erbjuder medlemmar i SwedenBIO hjälp att komplettera eller komponera en ny styrelse eller advisory board. Vi identifierar och attraherar personer med kunskap och erfarenhet från styrelse- eller ledande befattningar inom ert specifika verksamhetsområde. Personer som kan gå in i er styrelse eller advisory board och kan dessutom bidra med sina utvecklade
- [Årsmöte och Executive Dinner – SwedenBIO 20 år!](https://swedenbio.se/arsmote-och-executive-dinner-swedenbio-20-ar/) - Välkommen att delta på SwedenBIO:s årsmöte med påföljande jubileumsmiddag.I guldglimrande inramning vill vi fira 20-årsjubileumet tillsammans med er.Som sig bör blir det en storslagen afton i gott sällskap och underhållning i världsklass! Var: Berns SalongerNär: 18/5 16:30 Mer info kommer inom kort.
- [Kasta inte ut barnet med badvattnet i strävan efter hållbarhet i offentlig upphandling (Remissvar)](https://swedenbio.se/kasta-inte-ut-barnet-med-badvattnet-i-stravan-efter-hallbarhet-i-offentlig-upphandling-remissvar/) - Som representant för ett stort antal små och medelstora företag vill SwedenBIO belysa dessa bolags särskilda förutsättningar att å ena sidan bidra med innovativa, hållbara alternativ till sjuk- och hälsovården, och å andra sidan att äska fram de administrativa resurser som krävs för att leva upp till regeringens förslag om att myndigheter och enheter ska
- [Datahantering och GDPR i senaste avsnittet av MDR-Podden](https://swedenbio.se/datahantering-och-gdpr-i-senaste-avsnittet-av-mdr-podden/) - MDR har bidragit till ökade krav på kliniska data. Vår värd Sofia Nordgren gästas i detta avsnitt av David Schreiber, advokat och partner på advokatbyrån dNovo. Tillsammans reder de ut vad man ska tänka på när man samlar in olika typer av data och vad GDPR egentligen innebär. Klicka här för att lyssna i Spotify. MDR-Podden finns
- [Idé till patient-Podden är här!](https://swedenbio.se/ide-till-patient-podden-ar-har/) - Podd-säsongen Idé till patient är en gemensam produktion mellan CTR-gruppen och SwedenBIO. Säsongen innehåller sex avsnitt där inbjudna gäster från läkemedelsindustrin kommer att prata om fallgropar och höjdpunkter i tidig läkemedelsutveckling. Avsnitt två och fyra kommer att spegla vägen till kliniska prövningar och avsnitt fem kommer att omfatta diskussioner om första prövningen på människan. I
- [Nytt avsnitt av Idé till patient-Podden!](https://swedenbio.se/nytt-avsnitt-av-ide-till-patient-podden/) - I det andra avsnittet av podden Idé till patient diskuteras vikten av att tidigt ha en Target Product Profile (TPP). Behövs en TPP om man ändå ska sälja av sitt projekt? Jenny Högblad sitter som värd och gästas av Marie Gårdmark, RegSmart Life science och Sven Undeland, FHC Undeland, de kommer att guida oss från starten av
- [Idé till patient-Podden: Tänk toxikologi tidigt!](https://swedenbio.se/ide-till-patient-podden-tank-toxikologi-tidigt/) - I det tredje avsnittet av podden Idé till patient får vår värd Jenny Högblad, Clinical Trial Consultants (CTC) besök av Suzanne Iverson Hemberg, Toxicology Knowledge Team och Bengt Danielsson, BeDa Consulting. De tar upp en stor och viktig del av läkemedelsutvecklingen nämligen den toxikologiska strategin. De pratar kring design och utvärdering av säkerhetsfarmakologiska och toxikologiska studier
- [Nu finns senaste avsnittet av podden "Idé till patient" ute!](https://swedenbio.se/nu-finns-senaste-avsnittet-av-podden-ide-till-patient-ute/) - Jenny Högblad, CTR, Agneta Larhed, Regsmart Life Science och Fredrik Lehmann, Oncopeptides, diskuterar även kring varför det ibland pratas om “smutsiga” batcher och vilken formulering som är bäst att använda i sin första kliniska studie. Idé till patient-podden finns på Spotify och Apple Podcasts, och vill du lyssna direkt i webbläsaren klickar du här. Säsong 2,
- [SwedenBIOs verksamhetsberättelse 2021](https://swedenbio.se/swedenbios-verksamhetsberattelse-2021/) - I verksamhetsberättelsen informerar vi om hur vi arbetat under föregående år för att uppfylla våra mål. Vi berättar om hur vi arbetat för att våra medlemmar ska kunna stärka sina affärsnätverk, hur vi spridit fakta och kunskap samt hur vi jobbat med att ge branschen en stark röst. Life science-branschens betydelse för samhällets krisberedskap hamnade
- [SwedenBIOs 20 års jubileums-film](https://swedenbio.se/swedenbios-20-ars-jubileums-film/) - Året är 2022 och SwedenBIO firar 20 år. Efter en tillbakablick på vad som skett i branschen sedan 2002 kan vi konstatera att vi hunnit med en hel del de senaste två decennierna.Idag anställer den svenska life science industrin ungefär 60 000 personer i över 3 000 bolag. Exportvärdet av läkemedelsprodukter ligger runt 100 miljarder
- [Samarbete mellan CRO:er och mjukvaruleverantör ger bättre system](https://swedenbio.se/samarbete-mellan-croer-och-mjukvaruleverantor-ger-battre-system/) - Vänster: Kajsa Wiklund, VivoLogica. Höger: Maryam Mostajeran, Per-Ola Önnervik och Charlott Brunmark från Truly Labs, med Nina Woodworth och Pontus Kjellman från Redoxis. På pappret borde Redoxis och Truly Labs, två CRO-bolag som sitter grannar i Medicon Village i Lund, vara konkurrenter med varandra. I verkligheten är de inkörda i ett samförstånd sedan länge och
- [Sista avsnittet av Idé till patient-Podden!](https://swedenbio.se/sista-avsnittet-av-ide-till-patient-podden/) - I avsnittet ges tillbakablickar, summering av podd-serien och tips till lyssnaren. Det diskuteras även varför investerare ska lyssna på podden, vikten av den strategiska planen och hur vi säkrar kompetens kring den translationella fasen, men också det kommande utredningsuppdraget kring kliniska prövningar. Idé till patient-podden finns på Spotify och Apple Podcasts, och vill du lyssna
- [Nominera till SwedenBIO Award!](https://swedenbio.se/nominera-till-swedenbio-award-2/) - Vem tycker du förtjänar priset i år? Passa på att skicka in din nominering! Vinnaren presenteras på SwedenBIO Summit den 6 december på Grand Hôtel i Stockholm. De nominerade företagen kommer att bedömas enligt följande kriterier: Ha ett gott renommé i branschen generellt Ha uppvisat extraordinära prestationer vad gäller egen FoU, affärsutveckling, tillväxt eller liknande Ha bidragit
- [Frida Lawenius blir ny VD på SwedenBIO](https://swedenbio.se/frida-lawenius-blir-ny-vd-pa-swedenbio/) - ”I Frida får vi en erfaren ledare som är väl inkörd både i life science-branschens behov och i den dagliga driften av SwedenBIOs kansli, och som har upparbetade och välfungerande relationer med nyckelpersoner inom och utanför SwedenBIOs medlemskrets. I vår dynamiska bransch behövs ett flexibelt SwedenBIO som kan möta existerande och nya utmaningar som bolagen
- [Brev från VD: Frida Lawenius pratar om hösten för SwedenBIO och branschen i stort](https://swedenbio.se/brev-fran-vd-frida-lawenius-pratar-om-hosten-for-swedenbio-och-branschen-i-stort/) - "Tack, ja, det känns fantastiskt kul att få förtroendet att leda denna dynamiska organisation, för ett tag i alla fall." Den frasen har jag sagt så många gånger under de senaste veckorna att den börjar kännas innött, och det positiva bemötande ni har gett mig värmer i höstkylan. Det är en ära att få leda
- [VD till SwedenBIO (Ansökningsdatumet har passerat)](https://swedenbio.se/vd-till-swedenbio/) - Notera att vi inte längre tar emot ansökningar för den här tjänsten då sista ansökningsdatumet var 28:e oktober. SwedenBIO är en icke vinstdrivande medlemsorganisation, högsta beslutande organ är föreningsstämman som också utser organisationens styrelse. Den dagliga verksamheten drivs av ett kansli som är lokaliserat i centrala Stockholm och som leds av VD. SwedenBIOs vision är att driva frågor som gör
- [Kommunikatör sökes till SwedenBIO (ansökning stängd)](https://swedenbio.se/kommunikator-sokes-till-swedenbio/) - Ansökningstiden för den här tjänsten har passerat. Som branschorganisationen för life science-industrin har SwedenBIO ett viktigt uppdrag att representera branschen gentemot politiska beslutsfattare och att skapa goda förutsättningar för bolagen på marknaden. I detta arbete är kommunikatörens roll kritisk och vi söker nu en kollega som kan stärka upp det operativa kommunikations- och marknadsföringsarbetet. Vi
- [Läkemedelstillverkning för ett konkurrenskraftigt och friskare Sverige](https://swedenbio.se/lakemedelstillverkning-for-ett-konkurrenskraftigt-och-friskare-sverige/) - SwedenBIO arrangerar i samarbete med AstraZeneca, Pfizer, Novavax, Recipharm, APL, Valneva, NorthX Biologics, Phase2Phase Biopharma och Mpya Sci & Tech en halvdagskonferens på temat "Läkemedelstillverkning för ett konkurrenskraftigt och friskare Sverige" onsdagen den 8/2, kl. 13:00-17:00 på LifeCity i Solna. Vi vill med detta seminarium diskutera läkemedelstillverkningens förutsättningar i Sverige. Är det viktigt, i en
- [<strong>Läkemedelstillverkning för ett konkurrenskraftigt och friskare Sverige</strong>](https://swedenbio.se/lakemedelstillverkning-for-ett-konkurrenskraftigt-och-friskare-sverige-2/) - Den 8 februari 2023 hölls en halvdagskonferens i SwedenBIO:s regi på temat läkemedelstillverkning i Sverige. I tre block diskuterade inbjudna experter viken av läkemedelstillverkning för Sverige, varför Sverige är ett attraktivt land att förlägga tillverkning i och hur branschen kan säkra upp kompetens. Eventet gavs inför publik på Life City i Stockholm och sändes också
- [Frida Lawenius lämnar SwedenBIO](https://swedenbio.se/frida-lawenius-lamnar-swedenbio/) - I årets första VD-brev delar Frida några ord om vad som komma skall under 2023, och tackar för den tid som varit på SwedenBIO. Den 16 januari påbörjade hon en ny tjänst som tillförordnad förbundsdirektör för Naturvetarna. . God fortsättning på det nya året! SwedenBIOs kansli står riggade för att företräda er medlemmar under ännu
- [Tre snabba frågor till Sciety](https://swedenbio.se/tre-snabba-fragor-till-sciety/) - Sciety och SwedenBIO anordnar ett lunchseminarium med fokus på kapitalanskaffning för onoterade bolag. Varför ska man gå på det, tycker du? Andreas: Om du som bolag planerar att resa kapital och vill ha konkreta tips på hur man attraherar investerare så är det här ett gyllene tillfälle att lära sig mer. Vi kommer dessutom ha
- [Mårten Winge ny styrelseledamot i SwedenBIO](https://swedenbio.se/marten-winge-ny-styrelseledamot-i-swedenbio/) - Mårten Winge, chief operating officer på Strike Pharma har valts till styrelseledamot i SwedenBIO under årsmötet som hölls den 10 maj på Färgfabriken. Mårten ersätter Lars Bäckman från Biotage. Resten av styrelsen med Lotta Ljungqvist som ordförande valdes om för en ny mandatperiod. Utöver förändringen i styrelsen valdes Johan Kördel från Sound Bioventures till att
- [SwedenBIO öppnar nytt kontor i Göteborg](https://swedenbio.se/swedenbio-oppnar-nytt-kontor-i-goteborg/) - GoCo Health Innovation City växer just nu fram som det främsta innovationsklustret i Göteborg för bolag, forskare och start-ups inom life science. Satsningen lockar både nationella och internationella aktörer och talanger. SwedenBIO verkar nationellt men har hittills enbart haft kontor i Stockholm och invigningen på GoCo är organisationens första fysiska etablering utanför huvudstaden. Syftet är
- [Ta del av handlingarna till föreningsstämman 2024](https://swedenbio.se/foreningsstamman-2024/) - Här hittar du alla handlingar till SwedenBIOs föreningsstämma den 14 maj.
- [AstraZenecas Anders Persson ny styrelseordförande för SwedenBIO](https://swedenbio.se/anders-persson-ny-styrelseordforande-for-swedenbio/) - Anders Persson har varit ordinarie styrelseledamot i SwedenBIO sedan 2021 och valdes till ordförandeposten under årsstämman som hölls i Stockholm den 14 maj. Han efterträder Lotta Ljungqvist som har haft rollen sedan 2021.– Det känns oerhört spännande och stimulerande att få axla rollen som ordförande för SwedenBIO. Jag ser verkligen fram emot att tillsammans med
- [SwedenBIO söker en Community Manager](https://swedenbio.se/swedenbio-soker-en-community-manager/) - Varmt välkommen till SwedenBIO, en branschorganisation med ambitionen att samla hela Life Science Sveriges bolag. Vi är ett litet hängivet team med ambitionen att göra stor skillnad. Vi representerar mer är 330 medlemsbolag verksamma inom bioteknik, läkemedel, diagnostik, medicinteknik samt tjänstebolag och samarbetsorganisationer. Gemensamt för alla dessa bolag är strävan att förbättra människors hälsa, i
- [Möt Anders Persson, SwedenBIOs nya styrelseordförande](https://swedenbio.se/mot-anders-persson-swedenbios-nya-styrelseordforande/) - Du har meddelat att du vill fokusera på att ge SwedenBIO en ännu starkare röst i life science-frågor. Hur vill du att organisationen ska nå det målet? – Vår största styrka är våra medlemmar, och all den kunskap och erfarenhet som finns hos medlemmarna. Den hjärntrusten ska vi använda, och med det självförtroendet som bas
- [Efterfrågar miljardsatsning för att behålla Sveriges konkurrenskraft inom life science](https://swedenbio.se/efterfragar-miljardsatsning-for-att-behalla-sveriges-konkurrenskraft-inom-life-science/) - 18 representanter för Sveriges life science-sektor har uttryckt oro över att Sverige tappar mark inom den globala konkurrensen för life science. Gruppen har därför presenterat ett förslag för regeringen om ett nytt program och ett programkontor för avancerad life science. Förslaget, som överlämnades till statssekreterare på utbildningsdepartementet samt klimat- och näringslivsdepartementet den 14 juni, innebär
- [SwedenBIO skapar nytt nav för att nordisk life science ska kunna satsa internationellt](https://swedenbio.se/swedenbio-skapar-nytt-nav-att-nordisk-life-science-ska-kunna-satsa-internationellt/) - – Det här är ett naturligt nästa steg för oss, säger Jonas Ekstrand, VD på SwedenBIO. Life science är en global kunskapsbaserad industri och vi behöver en formaliserad plattform för att få full kraft i våra internationella ambitioner. Bakgrunden är insikten om att det internationella arbetet måste ha både bredd, spets och dedikerade eldsjälar som
- [Nordisk innovation i fokus under NLSDays 18-19 september i Malmö](https://swedenbio.se/innovation-i-fokus-under-nlsdays-18-19-september-i-malmo/) - I år är Nordic Life Science Days tillbaka i trevliga Malmö och den 18-19 september hyser Malmömässan återigen den största konferensen dedikerad för nordisk life science. Den elfte upplagan av eventet kommer att bygga på tidigare års framgångsrika koncept och kvalité men även bjuda på en del nya inslag. Nordisk healthtech, utökning av innovation posters
- [Strategi, resurser och politisk stöd – nycklar till att säkra Sveriges life science framtid](https://swedenbio.se/strategi-resurser-och-politisk-stod-nycklar-till-att-sakra-sveriges-life-science-framtid/) - En av SwedenBIOs två paneler under årets Almedalsvecka hade rubriken ”Svensk life science är unikt innovativ – hur ska vi säkra att det består”. En panel bestående av Britta Stensson från Business Sweden, Tine Hylleberg från Danska ambassaden, Tobias Lundin Gerdås från Roche, Katarina Beech från Bristol Myers Squibb och Jeanette Edblad från regeringskansliets life
- [Välkommet regeringsbesked om kliniska prövningar ](https://swedenbio.se/valkommet-regeringsbesked-om-kliniska-provningar/) - Regeringensbeskedet innebär att Läkemedelsverket får i uppdrag att föreslå åtgärder för att förbättra förutsättningarna och stärka kapaciteten för kliniska prövningar i Sverige. Detta ska göras genom att ta avstamp i den tidigare publicerade utredningen Förslag på åtgärder för att skapa bättre förutsättningar för kliniska prövningar (Ds 2023:8) där förslaget att inrätta ett nationellt partnerskap, SweTrial presenterades. SwedenBIO
- [Möt Linn Mattsson, SwedenBIOs nya Community Manager](https://swedenbio.se/mot-linn-mattsson-swedenbios-nya-community-manager/) - Hur känns det att börja på SwedenBIO och vad är dina intryck så här långt? – Det känns verkligen spännande och roligt! Jag har fått ett varmt välkomnande från hela teamet och känner mig redan som en del av "familjen". Jag ser fram emot att lära känna alla medlemsbolag och partners närmare, och se vad
- [Möt Sigrún Elfa Snæbjörnsdóttir, SwedenBIOs nya Nordic Community Manager](https://swedenbio.se/mot-sigrun-elfa-snaebjornsdottir-swedenbios-nya-nordic-community-manager/) - Hur känns det att börja på SwedenBIO och vad är dina intryck så här långt? – Det känns verkligen spännande och jag är imponerad av teamets engagemang och hur mycket man får gjort! Jag har blivit varmt välkomnad och första intrycken är mycket positiva. Jag ser fram emot att dyka djupare i vårt arbete och
- [Calliditas VD om konkurrenskraft, talangförsörjning och att behålla stora bolag i Sverige](https://swedenbio.se/calliditas-vd-om-konkurrenskraft-talangforsorjning-och-att-behalla-stora-bolag-i-sverige/) - "Om vi vill behålla framgångsrika biotechbolag i Sverige så måste vi titta på själva ekosystemet och investeringsviljan över en lång period" Du har varit vd för Calliditas i cirka sju år. Hur har det varit att leda ett svenskt life science-bolag under denna tid, och vad skulle du säga har varit din största utmaning? –
- [Så påverkas life science-branschen av 2025 års budgetproposition](https://swedenbio.se/sa-paverkas-life-science-branschen-av-2025-ars-budgetproposition/) - Ökade forskningsanslag Forskningspropositionen bekräftade tidigare uttalanden från dåvarande utbildningsminister Mats Persson om kraftigt ökade forskningsanslag. I budgeten står att "Regeringens kommande forsknings- och innovationsproposition har den största ökningen av resurser till forskning och innovation någonsin och kommer att fokusera på excellens, internationalisering och innovation." Även om life science inte nämns uttryckligen, finns det goda förhoppningar
- [SwedenBIO om forskningsproppen](https://swedenbio.se/swedenbio-om-forskningsproppen/) - Vad är ditt samlade intryck av propositionen och de satsningar och ambitioner som den ger uttryck för? Regeringens höga ambitionsnivå är väl i linje med det inspel som SwedenBIO lämnade in till arbetet med propositionen. Det framgår tydligt hur avgörande forskning och innovation (FoI) är för svensk konkurrenskraft och i förlängningen för svensk ekonomi. För
- [Bristande investeringar i marknadsföringen av svensk life science](https://swedenbio.se/bristande-investeringar-riskerar-svensk-life-science/) - I artikeln, som publicerades den 30 januari i Dagens Industri, framhåller SwedenBIOs vd Jessica Martinsson och Micael Györei, Director Investment Promotion, Invest in Skåne, att investeringarna i marknadsföringen av svensk life science inte motsvarar dess enorma bidrag till samhällsekonomin. Medan länder som USA, Kina och flera EU-länder satsar kraftigt på att marknadsföra sig, bland annat
- [Ny kartläggning av svensk läkemedelsutveckling](https://swedenbio.se/ny-kartlaggning-av-svensk-lakemedelsutveckling/) - SwedenBIOs Science Director, Maja Neiman (fotot), förklarar syftet med kartläggningen och varför det är viktigt att företagen medverkar. Vad är syftet med Pipeline-rapporten? – Att kartlägga svensk läkemedelsutveckling för att synliggöra den för internationella investerare och beslutsfattare inom politik, näringsliv och akademi. Den syftar framförallt till att främja Sveriges globala position inom läkemedelsutveckling, men också
- [Stärkt samverkan för utveckling av vården](https://swedenbio.se/starkt-samverkan-utveckling-av-varden/) - I Sverige förekommer sedan länge en värdefull samverkan mellan akademi, hälso- och sjukvård och industri, det finns i dag ett nära samarbete. För att underlätta och tydliggöra arbetet har SKR och life science-industrin tecknat två överenskommelser, en om samverkan inom kliniska prövningar samt en om kvalitetsregister. Syftet med överenskommelserna är att ge vägledning om etiska,
- [Kampanj: kliniska prövningar](https://swedenbio.se/kampanj-kliniska-provningar/) - Till kampanjsidan.
- [Sverige ledande inom ATMP](https://swedenbio.se/sverige-ledande-inom-atmp/) - Detta för att Sverige ska kunna möta ambitionen att vara ledande inom ATMP till 2030, men även för att Sveriges FoU-investeringar inom området fullt ut ska skapa värden i form av industriell konkurrenskraft, tillväxt och nytta för sjukvård och patienter. Avancerade läkemedel för gen-, cell- och vävnadsterapier står inför ett globalt genombrott som innebär stora
- [Kampanj: AMR](https://swedenbio.se/kampanj-amr/) - I samband med årets #WAAW kampanjar SwedenBIO och vår AMR Task Force för att uppmärksamma den eskalerande antimikrobiella resistensen – med ett lösningsorienterat fokus. Mellan den 18-24 november kommer vi dagligen uppdatera aktuellt med content kring WAAW, och allting kommer samlas på vår kampanjsida. Vi kickstartar med vår kampanjfilm som tar upp problematiken med AMR och
- [Överenskommelse kring användning av hälsodata](https://swedenbio.se/overenskommelse-kring-anvandning-av-halsodata-med-region-stockholm-och-centrum-for-halsodata/) - Region Stockholm har omfattande databaser och ansökningar om datauttag samordnas av Centrum för hälsodata. Syftet med överenskommelsen är att skapa bättre förutsättningar för användning och utlämnande av hälsodata i samverkan med Life Science-industrin, där företagens ges tydliga förutsättningar samtidigt som integritetsskyddet för patienterna och invånarna säkras. Överenskommelsen har tecknats mellan Läkemedelsindustriföreningen (Lif), Swedish Medtech, SwedenBIO
- [SwedenBIO:s ståndpunkt gentemot EU-läkemedelslagstiftningen (Remissvar)](https://swedenbio.se/swedenbios-standpunkt-gentemot-eu-lakemedelslagstiftningen-remissvar/) - I veckan lämnade vi in vårt svar på Socialdepartementets remiss EU-läkemedelslagstiftning: Kommissionens förslag på förordning och direktiv om humanläkemedel (S2023/01768 ). Lagförslaget eftersträvar att stärka innovation genom regulatoriska förändringar samt säkerställa tillgång till läkemedel för alla unionens medlemmar. SwedenBIO stödjer båda dessa ambitioner men är starkt kritiska till delar i den föreslagna reformen som riskerar
- [Nytt samarbete mellan SwedenBIO och Thermo Fisher Scientific](https://swedenbio.se/nytt-samarbete-mellan-swedenbio-och-thermo-fisher-scientific-ger-attraktiva-rabatter/) - En viktig del av SwedenBIOs medlemserbjudande omfattar rabatter som hjälper medlemmarna att driva utvecklingen framåt för life science-industrin i Sverige. Genom ett nytt samarbete erbjuder Fisher Scientific, en del av Thermo Fisher Scientific, SwedenBIO:s medlemmar rabatt på en komplett portfölj av laboratorieutrustning, kemikalier, förnödenheter och tjänster med exceptionella valmöjligheter och bekvämlighet. ”Vi är glada över
- [Attitydförändring till betydelsen av näringslivets forskning](https://swedenbio.se/attitydforandring-till-betydelsen-av-naringslivets-forskning/) - ”Sverige ska vara det naturliga valet för internationella investeringar inom området” konstaterade näringsminister Ibrahim Baylan vid torsdagens presskonferens, med passning till vår bransch. – Det hör inte till vanligheterna att värdet av internationella investeringar inom life science för samhällsnyttan eller betydelsen av små och medelstora forskningsintensiva företag kommer fram så tydligt i ett sammanhang som handlar om forskning och innovation, men det är helt rätt tänkt, menar vice vd
- [Marknadsplatser och analytiker sluter upp bakom branschstandard](https://swedenbio.se/marknadsplatser-och-analytiker-sluter-upp-bakom-branschstandard/) - Det gånga året har varit exceptionellt på många vis och finansmarknaden har också påverkats. En frenetisk aktivitet av börsintroduktioner och nyemissioner har skett parallellt med att världens fokus har riktats mot life science-företagen. I samband med att investeringsviljan i branschen ökar vill SwedenBIO ta ett ansvar för att underlätta värderingen av bolagen baserat på relevant
- [Ny undersökning visar stark framtidstro i life science-branschen – 80% vill rekrytera](https://swedenbio.se/ny-undersokning-visar-stark-framtidstro-i-life-science-branschen-80-vill-rekrytera/) - Undersökningen, som riktar sig till svenska bolag inom läkemedelsutveckling, visar att hela 80% av bolagen planerar att expandera genom att rekrytera fler medarbetare/konsulter det närmaste året. Jämfört med läget för ett år sedan har framtidstron ökat, 62% av bolagen har en mer positiv syn på sina framtidsutsikter nu än vad de hade innan covid slog
- [Investerarna flyger norrut](https://swedenbio.se/investerarna-flyger-norrut/) - Årets upplaga av Nordic Life Science days kommer att slå alla tidigare rekord vad gäller antal deltagare och jag vill hävda att det är precis rätt människor som kommer. Så självklart förväntar vi oss att mötet ska ge vår bransch en rejäl injektion i form av nya investeringar och fruktbara samarbeten. Att kvaliteten på svenska
- [Nytt avsnitt av Idé till patient-Podden!](https://swedenbio.se/nytt-avsnitt-av-ide-till-patient-podden-2/) - I det femte avsnittet av podden Idé till patient får vår värd Jenny Högblad, Clinical Trial Consultants besök av Erik Rein-Hedi, Clinical Trial Consultants och Charlotte Edenius, Gesynta Pharma. De pratar om hur viktigt det är att säkerheten styr den kliniska planen och hur man som litet till medelstort bolag ska tänka inför sin första
- [Missa inte Life Science-Barometern 2022](https://swedenbio.se/missa-inte-life-science-barometern-2022/) - Så här roligt är arbetet med SwedenBIOs nya undersökning Life Science-Barometern 2022 Vi erbjuder er marknadens mest uppdaterade och relevanta statistik, och ni möjliggör det här viktiga arbetet genom att svara på enkäten. Hjälp oss att ge er bästa möjliga data genom att svara på frågorna – och uppmana gärna fler bolag att svara! Vi
- [Life Science Barometern 2024 släppt](https://swedenbio.se/life-science-barometern-2024-slappt/) - The Life Science Barometer - a snapshot of the Swedish Life Science industry, är en årlig undersökning med syfte att ta temperaturen på life science branschen. Rekordmånga bolag har deltagit i undersökningen för årets upplaga, vilket gör rapporten till SwedenBIOs mest omfattande hittills. Undersökningen bekräftar vikten av att Sverige har hela värdekedjan i utveckling av
- [Årets Barometerenkät nu öppen](https://swedenbio.se/arets-barometer-enkat-nu-oppen/) - Förra årets Barometer byggde på svar från 200 företag, hur många räknar du med ska delta i enkäten i år? – Min förhoppning är såklart att deltagandet ökar rejält när Barometern blir mer och mer etablerad. En förhoppning är att nå upp till 400 bolag, vilket skulle motsvara ca 10% av den svenska bolagspopulationen. Att
- [Svensk life science-framgång synliggjord i ny rapport](https://swedenbio.se/svensk-life-science-framgang-synliggjord-i-ny-rapport/) - Intresset var stort inom life science-communityt när Vinnova den 23 oktober presenterade sin årliga rapport; Statistik över svenska life science-företag, under ett livesänt seminarium med SwedenBIO. Detta är den andra rapporten sedan regeringen 2021 gav Vinnova uppdraget att årligen följa branschens utveckling. I presentationen deltog Anders Brinne, Strategic Area Lead, Sustainable Precision Health, Vinnova, Jessica
- [Life Science Barometern 2025 – Svensk life science-export i nivå med skogsindustrin](https://swedenbio.se/life-science-barometern-2025-fortsatt-optimism-trots-finansiella-utmaningar/) - SwedenBIO har släppt en ny upplaga av sin årliga undersökning av life science-branschen där personer i ledande ställning har besvarat på en rad frågor. Den tredje upplagan av rapporten erbjuder en kombination av färsk branschstatistik, nyckeltal samt örat-mot-marken känslor och framåtblickande prognoser. I årets rapport ägnas extra mycket uppmärksamhet åt begreppet värdeskapande. Vilka typer av
- [Hyllner och Gidlund rapporterar från ATMP-gruppen](https://swedenbio.se/hyllner-och-gidlund-rapporterar-fran-atmp-gruppen/) - ATMP har ju blivit väldigt hett inom Sverige de senaste åren, varför? – Sverige är ett innovations- och forskningsdrivet land som just nu också har som strategiskt mål att bli ”ledande inom avancerade terapier innan 2030”. Dessa terapier som inte bara kan lindra och behandla svår sjukdom utan, i vissa fall, till och med bota
- [#WAAW – Pharmiva](https://swedenbio.se/waaw-pharmiva/) - Inom svensk life science finns många bolag med lösningar på den ökande antibiotikaresistensen. Ett av dessa är Pharmiva som i filmen nedan berättar hur just dem tar kampen mot AMR: Mellan den 18-24 november kommer vi dagligen uppdatera aktuellt med content kring WAAW, och allting samlas på vår kampanjsida. #AntimicrobialResistance #AMR #HandleWithCare #lifescience
- [#WAAW – Bactiguard](https://swedenbio.se/waaw-bactiguard/) - Inom svensk life science ryms en mängd lösningar på den ökande antibiotikaresistensen. Ett av bolagen som tar kampen mot #AMR är Bactiguard som i filmen nedan berättar hur just de jobbar för att tackla problemet. Mellan den 18-24 november kommer vi dagligen uppdatera aktuellt med content kring WAAW, och allting samlas på vår kampanjsida. #AntimicrobialResistance #AMR #HandleWithCare
- [#WAAW – BioGaia](https://swedenbio.se/waaw-biogaia/) - Den svenska life science-sektorn rymmer en mängd lösningar på den eskalerande antibiotikaresistensen, och BioGaia AB är ett av bolagen som tar kampen mot #AMR Se filmen för att se hur de jobbar för att motverka problemet. Mellan den 18-24 november kommer vi dagligen uppdatera aktuellt med content kring WAAW, och allting samlas på vår kampanjsida.#WAAW #AntimicrobialResistance
- [#WAAW – QureTechBio](https://swedenbio.se/waaw-quretechbio/) - Inom svensk life science finns många lösningar på den ökande antibiotikaresistensen. QureTechBio är ett av bolagen som tar kampen mot #AMR. Se filmen för att lära dig mer om deras viktiga arbete: Mellan den 18-24 november kommer vi dagligen uppdatera aktuellt med content kring WAAW, och allting samlas på vår kampanjsida. #AntimicrobialResistance #AMR #HandleWithCare #lifescience
- [Sverige har lösningar i kampen mot AMR](https://swedenbio.se/sverige-har-losningar-i-kampen-mot-amr/) - Varför är det så viktigt att ta kampen mot #AMR? Vilka konsekvenser kan den eskalerande antibiotikaresistensen få ifall den inte motverkas? Och vilken roll spelar Sverige i lösningen på problemet. Se filmen för att få svar!Mellan den 18-24 november kommer vi dagligen uppdatera aktuellt med content kring WAAW, och allting samlas på vår kampanjsida. #AntimicrobialResistance #AMR #HandleWithCare
- [SwedenBIO vill ändra attityder](https://swedenbio.se/swedenbio-uppmarksammar-produktionssatsningar/) - Nu pågår något av ett paradigmskifte inom den tillverkande industrin – från mekaniserat pillertrillande till smarta fabriker som förser hela världen med det som kallas ATMP, Advanced Therapy Medicinal Products. Stora investeringar görs, utbyggnader planeras och behovet av nyanställningar aktualiserar problemet med kompetensförsörjning. SwedenBIO menar att utvecklingen möjliggör stora fördelar för Sverige genom att unik
- [Vaccin mot nya coronaviruset utvecklas av Novavax med verksamhet i Sverige och USA](https://swedenbio.se/vaccin-mot-nya-coronaviruset-utvecklas-av-novavax-med-verksamhet-sverige-och-usa/) - Det nya vaccinet mot coronaviruset, eller sars-CoV-2 som det heter, behöver inte utvecklas helt från början, det är därför det förhållandevis snart kan vara färdigt. Novavax, med verksamhet i Sverige och USA, har använt sina befintliga teknologiplattformar och har därför ett försprång. Den nya vaccinkandidaten liknar tidigare framtagna kandidater mot sars, mers och ebola som
- [Vaccinproduktion och forskningspropositionen i fokus vid samverkansgruppsmöte](https://swedenbio.se/fokus-pa-vaccin-och-forskningsproporsionen-vid-samverkansgruppsmote/) - Vaccinproduktion vid pandemier Den pågående Covid-19 pandemin belyser tydligt behovet av att nya effektiva vacciner snabbt kan utvecklas och sedan produceras i stor skala. Vid pandemier finns risk för att bristsituationer, konkurrens mellan länder och transportproblem kan uppstå. I dessa lägen kan det vara en fördel att ha inhemsk kapacitet för utveckling och produktion av
- [Rapport om Sveriges kapacitet att producera vaccin](https://swedenbio.se/rapport-om-sveriges-kapacitet-att-producera-vaccin/) - Janet Hoogstraate & Frida Lawenius – Sverige borde ta ledning och vara drivande i ett nordiskt eller europeiskt vaccininitiativ för att åstadkomma en flexibel produktionskapacitet, tycker Janet Hoogstraate, ordförande för SwedenBIOs arbetsgrupp för processutveckling och tillverkning. Sverige har under många år stått för hög kompetens och prestanda både inom avancerad tillverkningsindustri generellt och specifikt inom
- [Replik i Aftonbladet till en nordisk ministerdialog kring produktionskapacitet av vaccin](https://swedenbio.se/replik-i-aftonbladet-till-en-nordisk-ministerdialog-kring-produktionskapacitet-av-vaccin/) - Swedenbio har länge lyft betydelsen av Norden som arena inom life science, som värd för the Nordic Life Science Days, men också genom att samla till gemensam positionering i internationella sammanhang under samlingsnamnet ”the Nordics”. De nordiska länderna har life science gemensamt, men med olika styrkor som gemensamt kan göra Norden till en av de
- [Cytiva satsar i Sverige](https://swedenbio.se/cytiva-satsar-i-sverige/) - Cytiva är en global koncern med 8000 anställda globalt. I Uppsala är Cytiva med sina 1600 personer den största privata arbetsgivaren. Och nu nyanställer de på löpande band och innan årets slut räknar de med att ha rekryterat cirka 200 personer till anläggningen i Uppsala. ”Vi har fått en enormt stor efterfrågan på alla våra
- [Sju förslag till forsknings- och innovationspropositionen](https://swedenbio.se/sju-forslag-till-forsknings-och-innovationspropositionen/) - Förslagen går på djupet med vad och hur som behöver förändras och har valts ut baserat på att de lämpar sig att implementera i en forskningspolitisk proposition. I tillägg skickar SwedenBIO återigen sitt inspel ”Sveriges internationella attraktionskraft och lyskraft som life science-nation” som togs fram inför nationella life science strategin, eftersom det från regeringens sida
- [Regeringens stödinsatser bommar life science-branschen](https://swedenbio.se/regeringens-stodinsatser-bommar-life-science-branschen/) - I fredags kom regeringen med ett nytt stödpaket innehållande bl.a. ett kapitaltillskott på tre miljarder kronor till Almi Företagspartner för att öka sin utlåning till små och medelstora företag och låneramen för statliga Svensk Exportkredits höjdes. Även tidigare åtgärder har fokuserat på lån. Samtidigt vet vi att enbart 2% av finansieringshändelserna inom life science-branschen 2007-2018
- [Starkt gensvar på life science-branschens behov i budgetpropositionen](https://swedenbio.se/starkt-gensvar-pa-life-science-branschens-behov-budgetpropositionen/) - – Flera av de förslag som SwedenBIO, och många med oss, har dragit i långbänk ett tag har nu realiserats. Självklart är vi rejält nöjda med detta, konstaterar SwedenBIOs vice vd Frida Lawenius. Det handlar t.ex. om ökade medel till investeringsfrämjandet, om utökad tidsgräns för expertskatten från tre till fem år, ett utökat FoU-avdrag från
- [Nya medlemmar med fokus på forskning – Baxter och BioGaia tar plats i FoU-gruppen](https://swedenbio.se/nya-medlemmar-med-fokus-pa-forskning-baxter-och-biogaia-tar-plats-fou-gruppen/) - Kristine Koppelhus är Scientific Affairs Manager på BioGaia – ett globalt företag med ett starkt forskningsnätverk över hela världen, både inom pre-klinik och klinik. BioGaia vill bidra till att sprida kunskap om probiotika och erbjuda kliniskt testade och konsumentvänliga probiotiska produkter. – Vår förhoppning är att få insikt i hur andra företag arbetar med medicinsk
- [Almi Invests miljonsatsning under pandemin – hur har det gått?](https://swedenbio.se/almi-invests-miljonsatsning-under-pandemin-hur-har-det-gatt/) - Life science var en av branscherna som regeringen pekade ut som särskilt prioriterade då Almi Invest tillfördes 400 miljoner tidigare i vår. Hur har det gått? – Vi har utökat investeringsmandaten för alla team genom att nyttja de 400 MSEK som ett komplement till de regionala fonderna. Det ska gå till alla branscher men vi
- [SwedenBIO kommenterar innovationsutredningen: ”Alltför snävt perspektiv!”](https://swedenbio.se/swedenbio-kommenterar-innovationsutredningen-alltfor-snavt-perspektiv/) - Frida Lawenius, vice vd på SwedenBIO anser att utredningen har varit alltför snäv. – Det finns stora vinster att göra i ett väloljat innovationssystem, men tyvärr har utredningen enbart analyserat och lämnat åtgärder till stöd för de innovation som kommer från idéer hos lärosätenas egen verksamhet och som tar vägen via lärosätenas innovationskontor och holdingbolag.
- [SwedenBIO kommenterar utredningen kring forskningsinfrastruktur](https://swedenbio.se/swedenbio-kommenterar-utredningen-kring-forskningsinfrastruktur/) - – Många av förslagen, som vi måste analysera mer, pekar ut en bra riktning. Men kanske att just komplexiteten tappats bort. Det är i dagsläget svårt för till exempel Scilifelab att agera för ökat nyttiggörande. Bara att teckna avtal blir svårt. Vi från branschen vill se ett förenklat och tydligt mandat som gör det enkelt att
- [Remissvar: Forskningsinfrastrukturerna är inte bara en akademisk angelägenhet](https://swedenbio.se/remissvar-forskningsinfrastrukturerna-ar-inte-bara-en-akademisk-angelagenhet/) - Foto: Håkan Lindgren/KTH Forskningsinfrastrukturerna är en investering för hela samhället och bidrar till att skapa innovativa lösningar på våra samhällsutmaningar i samverkan med både offentlig sektor och näringslivet. Det är avgörande att infrastrukturerna betraktas ur detta breda perspektiv och inte enbart ses som en akademisk angelägenhet. Trots att SwedenBIOs medlemsföretag ser en fantastisk potential i
- [Inspel till forskningsproppen försvarar forskningens grundförutsättningar](https://swedenbio.se/inspel-till-forskningsproppen-forsvarar-forskningens-grundforutsattningar/) - SwedenBIOs inspel till regeringens kommande forskningsproposition, där instruktionen pekade ut ledorden excellens, internationalisering och innovation som viktiga komponenter, har fokuserat på förslag som syftar till att stärka dessa tre delar inom svensk forskning. Våra tre huvudpunkter är: Öka de totala anslagen till forskning och innovationFör att främja en konkurrenskraftig life science-industri måste särskilt andelen av
- [Få life science-företag i tidig fas syntes i internationell branschmedia](https://swedenbio.se/fa-life-science-foretag-i-tidig-fas-syntes-i-internationell-branschmedia/) - – In-licensieringsteam och beslutsfattare på de större pharmabolagen ser branschmedia som en viktig informationskälla och de betalar stora prenumerationsavgifter för att få tillgång till information och faktum är att de förväntar sig att även bli uppdaterade om företag i tidiga faser, säger Ola Björkman. – Om man som litet svenskt bolag lyckas komma in där,
- [Expertnätverkets stormöte diskuterade vägar för effektivare policy-arbete](https://swedenbio.se/expertnatverkets-stormote-diskuterade-vagar-for-effektivare-policy-arbete/) - SwedenBIOs expertnätverk består av arbetsgrupper och task forces för en rad fokusfrågor inom life science vilka SwedenBIO i egenskap av branschorganisation driver. Experterna i nätverket är alla verksamma i företag som är medlemmar i SwedenBIO. Till halvdagsworkshopen som hölls i Stockholm den 26 september var alla representanter i expertnätverket inbjudna för att utmana och finslipa
- [SwedenBIO pådrivande i opinionen för svensk life science och innovation](https://swedenbio.se/swedenbio-padrivande-i-opinionen/) - Med flera pågående regulatoriska processer med potential att påverka villkoren för life science-branschen satsar SwedenBIO på att växla upp sitt opinionsbildande arbete. Under inledningen av året har vi medverkat i debatten och synts i media för att uppmärksamma frågor som är viktiga för våra medlemmar och för att synliggöra svensk life science framgångar. Opinionsartikel i
- [Börsen växer i betydelse](https://swedenbio.se/borsen-vaxer-betydelse/) - – Den kraft som bolagen lägger på att söka kapital går i allt större grad till andra finansieringskällor än private equity. Främst handlar det om börsnoteringar, men det finns också ett ökat intresse för EU-pengar och vi ser även att bolagen i större omfattning vänder sig till statliga myndigheter som Vinnova, säger Sten Westerberg till
- [Faktablad: Skapa hållbar handel på börsen – tips till små bolag](https://swedenbio.se/faktablad-skapa-hallbar-handel-pa-borsen-tips-till-sma-bolag/) - – Handeln föds kanske inte på samma sätt för små bolag som för de stora och vi vill med faktabladet tipsa om vad man ska tänka på för att se värdeutveckling över tid. Det gäller att man har en tydlig plan för att särskiljas i mängden, skriver Niclas Stenberg, Nordic Manager på Recall Capital som
- [Life science-bolag breddar sina möjligheter till finansiering](https://swedenbio.se/life-science-bolag-breddar-sina-mojligheter-till-finansiering/) - – I en industrisektor där tillgång till riskkapital är en hörnpelare för att bygga framgång och tillväxt är det mycket glädjande att se den starka kapitalförsörjningen till bolagen, kommenterar Jonas Ekstrand, VD i branschorganisationen SwedenBIO. Enkäten har samlat in data på 361 finansieringshändelser sedan grundandet i fyrtiosex bolag under perioden 2007-18 och visar att svenska
- [SwedenBIO välkomnar ny life science fond – Eir Ventures reser 76 milj. euro](https://swedenbio.se/swedenbio-valkomnar-ny-life-science-fond-eir-venturesreser-76-miljoner-euro/) - – Planen är att investera i 2-3 företag redan i år och på lång sikt tänker vi ha 12-15 i portföljen. Vi kommer att göra investeringar i både nystartade och etablerade företag och fokusera särskilt på innovationer från Nordens ledande universitet och inkubatorer, säger Stephan Christgau, Founding Partner på Eir Ventures Han ser investeringsmöjligheter i den obalans av bolag och antalet specialiserade life science-investerare som finns i regionen. Även om internationella
- [Hur ser framtiden ut för dual listings i USA? När är det rätt tillfälle? Det är frågor Adam Kostyal ägnar sig åt att besvara i senaste avsnittet av Brännpunkt Life Science.](https://swedenbio.se/hur-ser-framtiden-ut-for-dual-listings-i-usa-nar-ar-det-ratt-tillfalle-det-ar-fragor-adam-kostyal-agnar-sig-at-att-besvara-i-senaste-avsnittet-av-brannpunkt-life-science/) - Den 9 december talar Adam på SwedenBIO Summit 2020 på temat Money Talks.Anmäl dig här.
- [Tips inför USA-notering – nytt faktablad från Nasdaq och Baker McKenzie](https://swedenbio.se/tips-infor-usa-notering-nytt-faktablad-fran-nasdaq-och-baker-mckenzie/) - Faktabladet hittar du här
- [Skatteförändringar ger nya möjligheter för life science-branschen](https://swedenbio.se/skatteforandringar-ger-nya-mojligheter-for-life-science-branschen/) - Nu under 2021 träder både expertskattens mer generösa regelverk i kraft liksom det utökade FoU-avdraget. Båda förslagen har länge lyfts av SwedenBIO. Därtill har regeringens förslag om utökade regler för personaloptioner just remitterats. Ett förslag som adresserar flera av de tillkortakommanden som råder med det nuvarande regelverket, som att styrelseledamöter hittills inte inkluderas. Förslaget fångar upp deras strategiska
- [Tips på väg mot marknad](https://swedenbio.se/mot-phrostpharma/) - Vi har frågat FrostPharmas vd Cecilia Bröms-Thell om några handfasta tips på hur du bör tänka för att lyckas med allt detta. Vad är det viktigaste att tänka på vid en marknadsintroduktion? – Det enkla svaret är fundera på om jag har kompetens och resurser att sälja produkten och om det finns en mottagare för det du
- [Så blir life science-bolag ännu mer attraktiva för investerare](https://swedenbio.se/sa-blir-life-science-bolag-annu-mer-attraktiva-for-investerare/) - Life science-sektorn är unik och inte jämförbar med andra sektorer. Inte minst påverkas risknivån av osäkerheten kring bolagens kliniska utvecklingsprogram. För att underlätta investerarnas beslut och värderingen av bolagen har SwedenBIO tillsammans med marknadsplatserna Nasdaq och Spotlight nyligen arbetat fram en enhetlig standard för informationsgivning. Kommer trenden med den ökade investeringsviljan i life science att
- [Alternativa vägar behövs för att säkra upp seriöst utländskt kapital (remissvar)](https://swedenbio.se/alternativa-vagar-behovs-for-att-sakra-upp-seriost-utlandskt-kapital-remissvar/) - Foto: Iris Öhrn, investment advisor life science, Business Region Göteborg Regeringens betänkande om Granskning av utländska direktinvesteringar (SOU 2021:87) var ute på remiss i februari, för att ta fram förslag på hur ett svenskt system för detta kan utformas inom skyddsvärda områden. Syftet med regelverket är att kontrollera uppköp och strategiska förvärv av bolag med säte i Sverige
- [Ingrid Heath ny ordförande för arbetsgruppen för finansiering](https://swedenbio.se/ingrid-heath-ny-ordforande-for-arbetsgruppen-for-finansiering/) - "När det blåser motvind blir det betydligt viktigare att kunna svara på hur man ska nå den där potentialen" Vad ser du att arbetsgruppen för finansiering kan bidra med?– Eftersom gruppens medlemmar är väl förankrade i det finansieringslandskap som omger ett life science-bolag kan vi tillsammans skapa en bild av vilka frågeställningar som just nu
- [Nytt projekt ska undersöka genomförbarheten i ett svenskt partnerskap för kliniska prövningar](https://swedenbio.se/nytt-projekt-ska-undersoka-genomforbarheten-i-ett-svenskt-partnerskap-for-kliniska-provningar/) - Projektet söktes genom och med stöd av det strategiska innovationsprogrammet Swelife. Förstudien syftar till att undersöka och konkretisera några av partnerskapets bärande delar och vad som skulle krävas för att realisera dem. Fem parter bestående av storstadsregionerna Region Skåne, Region Stockholm och Västra Götalandsregionen, samt branschföreningarna Läkemedelsindustriföreningen och SwedenBIO deltar i projektet. Kliniska prövningar innebär
- [Covid-19 och dina pågående eller planerade kliniska prövningar](https://swedenbio.se/covid-19-och-dina-pagaende-eller-planerade-kliniska-provningar/) - Sverre Bengtsson – medgrundare och senior vice president på det svenska företaget Viedoc Technologies AB som tillhandahåller Viedoc, en mjukvara för kliniska studier – ger en nulägesbild av situationen och tips till dig som driver en pågående eller planerar för en ny klinisk studie. Hur går det för de kliniska prövningarna i dagsläget? – Vi ser att studieaktiviteter
- [SwedenBIOs remissvar: Nej till avgiftshöjning av kliniska prövningar](https://swedenbio.se/swedenbios-remissvar-nej-till-avgiftshojning-av-kliniska-provningar/) - Läs SwedenBIOs remissvar till Socialdepartementet här.
- [SwedenBIO kritisk till förslag om avgiftshöjning för kliniska prövningar](https://swedenbio.se/swedenbio-kritisk-till-forslag-om-avgiftshojning-for-kliniska-provningar/) - SwedenBIOs medlemsföretag vill i Läkemedelsverket se en snabbfotad partner med smidiga processer, korta ledtider och hög kapacitet. De indirekta kostnader som uppstår som effekt av ineffektiva processer är betydligt mer omfattande är tillståndsavgifterna. Även om den främsta konkurrensfördelen ligger i snabba och smidiga processer, medför nivåerna i den förslagna avgiftsstrukturen att Sverige riskerar att tappa
- [Handlingsplan krävs för att säkra klinisk forskning trots vårdskulden](https://swedenbio.se/handlingsplan-kravs-for-att-sakra-klinisk-forskning-trots-vardskulden/) - Direkt från Cancerfondens rapport: Försenade forskningsstudierStopp för rekrytering av patienter till nya kliniska cancerstudier. Samtliga universitetssjukhus i Sverige beslutade att stoppa rekryteringen av nya patienter till kliniska cancerstudier under våren 2020Omfördelning av personal från forskning till vården. Intervjuade forskare uppger att cirka 25–50 procent av personalen från deras kliniska studier har omfördelats till att hjälpa till
- [Clinical Trials Day 20 maj: Precisionsmedicin – framtidens kliniska prövningar är redan här](https://swedenbio.se/clinical-trials-day-20-maj-precisionsmedicin-framtidens-kliniska-provningar-ar-redan-har/) - - Det finns en stor samsyn kring precisionsmedicin, det märks inte minst i den nationella life science-strategin. Men mer behöver ske för att man ska kunna nå den fulla potential som finns, bland annat måste det bli möjligt att dela patientdata mellan regioner, säger Jan-Olov Sandberg, medicinsk chef på Roche. - Vi har en relativt hög mognadsgrad
- [Prislappen för ansökan om klinisk prövning blir 55 000 istället för 150 000 kronor](https://swedenbio.se/prislappen-for-ansokan-om-klinisk-provning-blir-55-000-istallet-for-150-000-kronor/) - Enligt Läkemedelsverkets beräkningar skulle avgiften ha landat på 150 000 kronor för att uppnå kravet på full kostnadstäckning, men regeringen förbinder sig att stå för mellanskillnaden. – De kliniska prövningarna av läkemedel är viktiga för forskningen i Sverige, och regeringen har i life science-strategin uttalat målet att vi ska få fler läkemedelsprövningar hit. Genom att subventionera
- [SwedenBIO och Läkemedelsverket lanserar dialogforum om kliniska prövningar](https://swedenbio.se/swedenbio-och-lakemedelsverket-lanserar-dialogforum-om-kliniska-provningar/) - De mindre forsknings- och utvecklingsbolagens förutsättningar och behov kring kliniska prövningar skiljer sig i flera avseenden från de större aktörernas. Medan de stora bolagen i branschen redan har upparbetade kontaktytor med Läkemedelsverket har det hittills saknats en arena för dialog och kunskapsöverföring mellan myndigheten och de mindre bolagen inom läkemedelsutveckling och medicinteknik. Syftet med dialogforumet
- [SME-bolagens behov kring kliniska prövningar i fokus vid lansering av LV och SwedenBIOs dialogforum](https://swedenbio.se/sme-bolagens-behov-kring-kliniska-provningar-i-fokus-vid-lansering-av-lv-och-swedenbios-dialogforum/) - Vid invigningen talade Björn Eriksson, generaldirektör på Läkemedelsverket, live från studion om vikten av att möjliggöra för små och medelstora bolag (SME-bolag) att genomföra kliniska prövningar i Sverige. ”Vi är väldigt stolta idag när vi kan från Läkemedelsverkets sida tillsammans med SwedenBIO få bjuda på lite kunskaper kring det vi tycker är viktigast av allt,
- [Samtal om framtiden för kliniska prövningar i Sverige](https://swedenbio.se/poddsamtal-om-framtiden-for-kliniska-provningar-i-sverige/) - Hur påverkar de senaste förändringarna i regelverk möjligheterna för kliniska prövningar och vilka konsekvenser kan det få för life science-sektorn och patienter i Sverige? SwedenBIOs VD Jessica Martinsson gästade nyligen Sjukvårdspodden tillsammans med Peter Asplund, regeringens tidigare utredare om kliniska prövningar och Adam Szulkin, ekosystem partner på Roche för att diskutera frågan. "Det är i genomförandet som problemet ligger, att få sjukhus och
- [Seminarium belyste Sveriges utmaningar inom kliniska prövningar ](https://swedenbio.se/seminarium-belyste-sveriges-vag-mot-att-uppna-varldsklass-inom-kliniska-provningar/) - Seminariet, arrangerat av SwedenBIOs arbetsgrupper för public affairs och kliniska prövningar, hölls i samarbete med Paues Åberg Communications, som också stod värd för samtalet. Inbjudna talare var Maja Neiman, Science Director på SwedenBIO, Adam Szulkin, ansvarig för kliniska prövningar hos Roche i Sverige och ordförande för SwedenBIOs arbetsgrupp för kliniska prövningar, Kristina Kannisto, strateg inom
- [Rapport från svensk delegation i San Francisco](https://swedenbio.se/rapport-fran-svensk-delegation-i-san-francisco/) - Helena Strigård, Frida Eriksson, Inger Gustafsson, Viveka Rydell Andersson, Jonas Ekstrand, Charlotte af Klercker and Iris Öhrn at a visit to Nordic Innovation House in Palo Alto. San Francisco med Palo Alto/Silicon Valley runt hörnet är en dynamisk life science hot spot året runt och de möten vi fick till genererade samarbeten till gagn för
- [Knyt kontakter i Boston](https://swedenbio.se/knyt-kontakter-i-boston/) - Svensk-amerikanska handelskammaren ordnar den 13-15 oktober Life Tech Forum. Under tre dagar erbjuds svenska entreprenörer ett program som går igenom finansiering, regelverk, affärsplaner och samarbetsmöjligheter i Bostonområdet. Programmet är framtaget för att accelerera svenska life science-företags etablering i USA. Deltagarna kommer under dagarna få möjlighet att validera sina idéer, nätverka och träffa investerare. Ur programmet:
- [NLSDays 2016 på tre minuter](https://swedenbio.se/nlsdays-2016-pa-tre-minuter/) - USA:s ambassadör i Sverige öppnade NLSDays 2016 USA:s ambassadör i Sverige, Azita Raji, öppnade mötet med ett tal om relationer, om affärsmöjligheter och om utmaningar. Stor vikt lades vid att bygga samarbeten, och att främja tillväxt och handel för såväl små som stora företag. - Vi behöver plattformar för gränsöverskridande samarbeten mellan många aktörer inom life science, menade
- [SwedenBIO and Biocom Californa sign MOU](https://swedenbio.se/swedenbio-and-biocom-californa-sign-mou/) - Biocom California is the leading advocate for Californias life science sector with clusters across the US and Japan. Both organisations share a mutually beneficial cooperation going back to 2020. The collaboration took off with a networking event in November 2020 bringing together more than 70 selected companies, investors and academic actors from Sweden and California
- [Vicore Pharma takes home 2024 SwedenBIO Award](https://swedenbio.se/vicore-pharma-takes-home-2024-swedenbio-award/) - Vicore Pharma was founded in the early 2000s based on the design and synthesis of buloxibutid (C21) by Professor Anders Hallberg’s group at Uppsala University. The company is unlocking the potential of a new class of drugs – Angiotensin II Type 2 Receptor Agonists (ATRAGs) – stopping disease progression and restoring function. As a result
- [Join SwedenBIO at JPM in San Francisco](https://swedenbio.se/join-swedenbio-at-jpm-in-san-fransisco/) - SwedenBIO is once again attending JP Morgan week in January and we have curated a range of benefits and events for our members who are also going. Our International Director Marjo Puumalainen and our Community Manager Linn Mattsson look forward to meeting SwedenBIOs members in San Francisco and help them make the most of what
- [Three finalists compete for the SwedenBIO Award 2024](https://swedenbio.se/three-finalists-compete-for-the-swedenbio-award-2024/) - The annual gathering of the Swedish life science community, Summit, serves as an arena to celebrate the very best of the industry. The SwedenBIO Award, handed out since 2007, is the industry’s premier recognition, designed to spotlight and celebrate outstanding member companies within Swedish life science. By honoring exemplary achievements, the award aims to increase
- [Sahlgrenska Global Health Hackathon aims to bring new solutions](https://swedenbio.se/sahlgrenska-global-health-hackathon-aims-to-bring-new-solutions/) - SwedenBIO is a partner to the Sahlgrenska Global Health Hackathon, held throughout 2025 in six countries on three continents and nine locations with the slogan “Co-action Addressing Global Health Challenges”. The world tour will take the innovation marathon to Gothenburg, Malmö and Stockholm, Boston and Miami, London, Göttingen (Germany), Barcelona and Singapore before returning to Gothenburg in
- [Takeaways from BIO-Europe in Stockholm ](https://swedenbio.se/takeaways-from-bio-europe-in-stockholm/) - BIO-Europe, the continent's premier life science event, celebrated its 30th anniversary in Stockholm from November 4-6, 2024. Hosting Europe’s biggest life science industry event offered a rare opportunity for global visibility. As the main industry association for Swedish life science companies, SwedenBIO seized this chance to showcase the dynamic Swedish life science ecosystem and to
- [SwedenBIO ready to welcome global life science community to BIO-Europe in Stockholm ](https://swedenbio.se/swedenbio-ready-to-welcome-global-life-science-community-to-bio-europe-in-stockholm/) - Taking place in the Swedish capital Stockholm, this pan-European flagship event is expected to gather several thousand experts who will have a chance to get a closer glance of Swedish life science. SwedenBIO will contribute to putting Sweden's vibrant life science ecosystem in the spotlight, reinforcing its global position as a hub for cutting-edge research,
- [SwedenBIO Summit 2024](https://swedenbio.se/swedenbio-summit-2024/) - The SwedenBIO summit is a member exclusive event, free of charge, wrapping up the year in a festive yet informal setting. ​This years theme centers around the Nobel prizes.​ Life science is a field which has relevance to all Nobel prize categories and we will show how these areas relate to the constantly innovative and
- [Swedish and Danish Life Science sectors experiencing substantial growth ](https://swedenbio.se/swedish-and-danish-life-science-sectors-experiencing-substantial-growth/) - The Nordics have long been recognized as a hub of research and innovation, so it's little surprise that the life sciences—one of the most research-intensive sectors—are seeing substantial growth in this region. Pharmaceuticals now account for nearly ten percent of Sweden's total exports, with an impressive 180 percent growth over the past decade (1). In
- ["Sweden can be better at marketing itself"](https://swedenbio.se/sweden-can-be-better-at-marketing-itself/) - What is Business Sweden’s focus for 2024? – Our main focus is “business as usual”, i.e. to help Swedish companies grow internationally and to attract foreign investment to Sweden. Through our 45 offices abroad and our government mission, we can support Swedish companies on the ground and help them expand internationally. For small and medium-sized
- ["We need to build on our country's proven ability to deliver both scientific and technical excellence"](https://swedenbio.se/we-need-to-build-on-our-countrys-proven-ability-to-deliver-both-scientific-and-technical-excellence/) - What has been the biggest insight so far in this new role? – It has become even clearer to me that there is so much potential in our sector! Great opportunities both for the companies and Sweden AB, based on the ongoing development, and for the patients who can benefit from the innovative treatments. But
- [To increase female representation, focus on board composition](https://swedenbio.se/to-increase-female-representation-focus-on-board-composition/) - One year ago, the Vilda network for women leaders in the life science sector was initiated in response to the slow progress to reach gender balance in top management and boards within the industry. Among its founders is Cecilia Bröms-Thell, Senior Business Developer at Uppsala Innovation Centre. The below is a short interview with her
- [20 Nordic companies to compete for Life Science awards at NLSDays 2024](https://swedenbio.se/20-nordic-companies-to-compete-for-life-science-awards-at-nlsdays-2024/) - SwedenBIO is thrilled to announce that twenty promising life science companies from the Nordic region have been shortlisted to compete in the prestigious Nordic Stars pitch competition at Nordic Life Science Days (NLSDays) 2024. This event will take place in Malmö on September 18-19 and will showcase cutting-edge innovations to an audience of investors, industry
- [SwedenBIO annual report 2023](https://swedenbio.se/swedenbio-annual-report-2023/)
- [Nurturing the next generation of life science talents](https://swedenbio.se/nurturing-the-next-generation-of-life-science-talents/)
- [Genovis tog hem SwedenBIO award](https://swedenbio.se/genovis-tog-hem-swedenbio-award/) - Genovis VD, Fredrik Olsson, tog emot priset vid en prisceremoni under SwedenBIO Summit på Grand Hôtel i Stockholm den 30 januari. Genovis grundades 1999 och har sedan dess vuxit kraftigt. Bolaget utvecklar och levererar innovativa enzym- och antikroppslösningar som möjliggör högre effektivitet vid utveckling och karakterisering av biopharma- och ATMP-produkter. Med kunden i fokus har
- [Nordens största life science-event fyller tio år](https://swedenbio.se/nordens-storsta-life-science-event-fyller-tio-ar/) - Nordic Life Science Days är den största nordiska partneringkonferensen för life science-industrin. Sedan starten 2013 har evenemanget skapat en gemenskap av människor från life science-världen och en unik plats att göra affärer på. NLSDays lockar ledande beslutsfattare från bioteknik, läkemedel och medicinteknik samt finans, forskning, politik och tillsynsmyndigheter. Deltagarna uppskattar den informella atmosfären i kombination
- [Tre snabba frågor till Sciety](https://swedenbio.se/tre-snabba-fragor-till-sciety-2/) - Sciety och SwedenBIO anordnar ett seminarium med fokus på kapitalanskaffning för onoterade bolag. Varför ska man gå på det, tycker du? Andreas: Om du som bolag planerar att resa kapital och vill ha konkreta tips på hur man attraherar investerare så är det här ett gyllene tillfälle att lära sig mer. Vi kommer dessutom ha
- [Ny rapport: Högtryck i svensk läkemedelspipeline](https://swedenbio.se/ny-rapport-hogtryck-svensk-lakemedelspipeline/) - Sedan kartläggningen 2016 har antalet projekt ökat från 369 till 420 stycken. Det har också skett en tillväxt av antalet företag, framför allt med projekt i klinik. – Fler företag har nått till fas III eller är på väg mot godkännande av nya produkter. Glädjande är att antalet anställda i bolagen har ökat, framförallt i de
- [Octoberfest at EY – with seminars on tax incentives and sustainability](https://swedenbio.se/ey-talks-about-rd-tax-incentives/) - On October 27, EY has invited SwedenBIO's member base to a vibrant after work mingle inspired by the German tradition Octoberfest! In connection with the drinks mingle, they are also treating us to a seminar about grants and tax incentives, another about human-focused sustainability, and a tour around their hyper-modern office building for anyone interested.
- [Anmäl dig till Executive Dinner och årsmöte den 18:e maj](https://swedenbio.se/anmal-dig-till-executive-dinner-och-arsmote-den-18e-maj/) - Takin’ Care of Business är temat för årets VD-middag, och det är precis vad SwedenBIO strävat mot de senaste 20 åren. Ja, ni läste rätt – i år firar vi 20 år och den 18:e maj slår vi upp dörrarna till Berns i Stockholm för att fira jubileet tillsammans med er! I guldglittrande inramning och
- [Strategi- och affärsutvecklingskurs för life science-ledare](https://swedenbio.se/strategi-och-affarsutvecklingskurs-for-life-science-ledare/) - Även om varje resa är unik finns det många utmaningar som är gemensamma för alla life science-bolag. Genom att tidigt skaffa dig en överblick över kommande strategiska beslut blir du bättre på att prioritera och använda dina resurser smart. Kursen hålls under fyra dagar den 19-21 oktober samt 24 november på Läkemedelsakademin i Stockholm. Begränsat
- [TLV efterlyser nya medicintekniska produkter för digital bilddiagnostik](https://swedenbio.se/tlv-efterlyser-nya-medicintekniska-produkter-for-digital-bilddiagnostik/) - Vad är syftet med temaundersökningen? – Att fånga upp intressanta medicintekniska produkter inom automatiserad digital bilddiagnostik. Det kan till exempel handla om en programvara som indikerar områden med tumörceller i patologiska preparat eller markerar förändringar på lungröntgen. Tanken med sådana produkter är att de ska kunna stödja klinikern i sin bedömning. TLV:s temaspaningar går ut på att få en
- [Nytt avsnitt av MDR-Podden!](https://swedenbio.se/nytt-avsnitt-av-mdr-podden/) - I detta uppföljande avsnitt med Helena Dzojic, enhetschef för medicinteknik på Läkemedelsverket, behandlas ämnen så som designering av anmälda organ, EUDAMED samt hur Brexit och avsaknaden av mutual recognition agreement (ömsesidigt erkännande) med Schweiz påverkar våra medicintekniska företag. Länk till Spotify:https://open.spotify.com/episode/30WPyuJxUZF4v6tYk6Vjxb?si=DOsk7tlmQNSSl7XlzKMDLg&dl_branch=1 Direkt i webbläsaren:https://www.buzzsprout.com/1802420/9127491
- [Äntligen dags för Executive Dinner](https://swedenbio.se/antligen-dags-for-executive-dinner/) - Den 14:e september rullar vi ut röda mattan för branschens egna stjärnor vid GuldBIO-galan, en filmfestival kantad av glitter & glamour ✨ 🎥Årets Executive Dinner är efterlängtad och efterfrågad av våra medlemsbolag. Då vi samlar ett stort antal människor till en sammankomst har vi förstås tänkt till kring hur eventet ska kunna genomföras i enlighet
- [Sol, vind och saltvatten](https://swedenbio.se/sol-vind-och-saltvatten/) - Man kommer ganska långt med pannben, det vet alla de som försökt sig på att driva ett life science-företag framåt. Ungefär vart tionde projekt når marknaden. Och det är ju dit vi ska, förstås. Poängen med det arbete som sker inom svensk life science är att sätta nya redskap, läkemedel och andra typer av behandlingar
- [Remissvar om Läkemedelsverkets avgiftsstruktur: ”Nationell satsning krävs”](https://swedenbio.se/remissvar-om-lakemedelsverkets-avgiftsstruktur-nationell-satsning-kravs/) - I sitt svar menar SwedenBIO att regeringen bör finansiera system- och strukturförändringar förknippade med övergången till den nya EU-förordningen som träder i kraft efter årsskiftet. Subventioner av kostnaderna för handläggning av ansökningar är också motiverade för att möjliggöra konkurrenskraftiga handläggningsprocesser till en rimlig kostnad. Det bidrar till att göra Sverige till ett attraktivt land för
- [Helena Strigård lägesrapporterar i  Läkemedelsmarknaden](https://swedenbio.se/helena-strigard-lagesrapporterar-i-lakemedelsmarknaden/) - Du hittar intervjun här.
- [SwedenBIO söker Communications Manager](https://swedenbio.se/swedenbio-soker-communications-manager/) - Vårt kommunikationsarbete är centralt för att få hjulen att snurra i den virtuella organisation som SwedenBIO utgör, med fem anställda medarbetare, men över 100 representanter från medlemsbolagen i olika roller. Med hjälp av dessa fångar och utvecklar du organisationens behov och synlighet via medlemmarna. Som Communications Manager kommer du exempelvis att ansvara för arbetsgruppen Public
- [MDR – strategisk fördel eller nödvändigt ont?](https://swedenbio.se/mdr-strategisk-fordel-eller-nodvandigt-ont/) - Hur kan medicintekniska tillverkare göra MDR till en konkurrensfördel? Vilka trender kan vi se i och med implementeringen av MDR? Detta och mycket mer diskuteras i senaste avsnittet av MDR-podden, där programledaren Sofia Nordgren gästas av Per Hedman, partner på Cirio Advokatbyrå.Lyssna på Spotify eller direkt i webbläsaren. MDR-podden finns även på Apple Podcasts.
- [Företagsforskarskolan vid Umeå universitet – Forskning och innovation i samverkan](https://swedenbio.se/foretagsforskarskolan-vid-umea-universitet-forskning-och-innovation-i-samverkan/) - Forskarskolan är öppen för alla forskningsområden och doktoranden har sin anställning vid Umeå universitet. Tillsammans med företag eller organisation arbetar doktoranderna under fyra år med att utforska en frågeställning. Både universitetets forskare och potentiell extern part har möjlighet att initiera ett doktorand-projekt. Projekten har hög vetenskaplig kvalitet och samhällsrelevans, vilket skapar förutsättningar för konkurrenskraft och
- [Shut up, Siri!](https://swedenbio.se/shut-up-siri/) - Visst, Siri och hennes AI-vänner vill oss väl. Men nog har vi väl alla blivit arga på henne? Du hittar webb-versionen av Naturvetaren här och en hög igenkänningsfaktor i Helenas krönika på sid 39.
- [#2 Nationell implementering](https://swedenbio.se/2-nationell-implementering/) - I det andra avsnittet gästas MDR-podden och programledaren Sofia Nordgren av Helena Dzojic, enhetschef för medicinteknik på Läkemedelsverket. Tillsammans pratar de om myndighetens roll, nationell lagstiftning, och vad som kan hända om man inte följer regelverket 🔎Avsnittet på SpotifyI webbläsarenMDR-podden finns även på Apple Podcasts.
- [Hallå där Lotta!](https://swedenbio.se/halla-dar-lotta/) - Du är ingenjör från KTH i botten, med en lång karriär därefter. Vad tar du med dig in i din nya roll? – Jag ser fram emot att fortsätt jobba med att stödja life science-branschen i Sverige. Jag har haft olika roller genom åren men nu jobbar jag med Testa center, en testbädd som Cytiva
- [Helena Strigård i DI om svensk life science](https://swedenbio.se/helena-strigard-i-di-om-svensk-life-science/) - Du hittar artikeln här.
- [Nu lanseras ny webbsida och videopodd från life science-kontoret](https://swedenbio.se/nu-lanseras-ny-webbsida-och-videopodd-fran-life-science-kontoret/) - Du hittar informationen här: www.regeringen.se/lifescience I samband med lanseringen av webbsidan släpps också videopodden ”Tillsammans för en ledande life science-nation”. Podden sätter fokus på prioriterade områden i den nationella life science-strategin med gäster som kan göra skillnad för arbetet framåt. Värd är Jenni Nordborg, nationell samordnare och chef för life science-kontoret. Samtalen faciliteras av Björn Arvidsson,
- [Hej Lars!](https://swedenbio.se/hej-lars/) - Vad ska du göra nu? – Jag kommer att få lite mer tid till att fortsätta växa Adlersson Heath där vi hjälper life science-företag att kommunicera med kapitalmarknaden, men också ger strategiska råd till beslutsfattare inom helt andra samhällssektorer. Dessutom sitter jag i styrelsen för Irlab Therapeutics, ett bolag som utvecklar nya läkemedel mot Parkinsons
- [MDR-podden är här!](https://swedenbio.se/mdr-podden-ar-har/) - MDR-podden är ett samarbete mellan SwedenBIO, Kickfile och Devicia. Programledare och din vän i etern är Sofia Nordgren, vd för Kickfile. I pilotavsnittet berättar hon för SwedenBIOs Frida Lawenius vad podden kommer ta upp i kommande avsnitt. Klicka här för att lyssna på Spotify. Vill du lyssna direkt i webbläsaren klickar du här. I dagarna
- [FDA-godkännande skapar möjligheter för svenska life science-bolag](https://swedenbio.se/fda-godkannande-skapar-mojligheter-for-svenska-life-science-bolag/) - Vad är det egentligen FDA nu har godkänt och varför är det en stor grej? FDA har godkänt aducanumab för att behandla patienter med Alzheimers sjukdom. Det är verkligen en stor händelse då det är den första sjukdomsmodifierande behandlingen som godkänns för behandling av Alzheimers. Det är en uppmuntrande nyhet för alla hundratusentals patienter i Sverige och
- [Kallelse till SwedenBIOs ordinarie föreningsstämma](https://swedenbio.se/kallelse-till-swedenbios-ordinarie-foreningsstamma/) - Då stämman hålls digitalt genom Teams bjuder vi i år endast in en person per röstberättigat medlemsbolag. Föranmälan krävs och anmälan är personlig. Sista anmälningsdag är den 24:e maj. (publicerad 5/5 – uppdaterad 26/5) Bilagor Kallelse Ordinarie Föreningssammanträde Föreningen SwedenBIO 2021Ladda ner Årsredovisning föreningen SwedenBIO 2020Ladda ner Revisionsberättelse föreningen SwedenBIO 2020Ladda ner Valberedningens protokollLadda ner
- [Coming soon: MDR-podden!](https://swedenbio.se/coming-soon-mdr-podden/) - Varför behövs denna podd, Sofia? – Dagligen träffar jag bolag, både svenska och internationella, som har svårt att navigera i alla de krav som ställs på medicintekniska produkter, inte minst i och med den nya medicintekniska förordningen. I podden hoppas jag, tillsammans med inbjudna gäster, kunna räta ut några frågetecken och ge exempel på hur
- [Intervju med Genagon Therapeutics vd Moa Fransson](https://swedenbio.se/intervju-med-genagon-therapeutics-vd-moa-fransson/)
- [Ny task force om hållbarhet](https://swedenbio.se/ny-task-force-om-hallbarhet/) - Du är med i SwedenBIOs arbetsgrupp för public affairs och kommunikation. En del av arbetsgruppens uppgifter berör hållbarhet. Vill du berätta lite kort om hur ni jobbar med frågor kring hållbar utveckling? – Arbetet med hållbarhet inom gruppen är nytt för i år. Vi är just nu i processen att lägga grunden till ett forum
- [Guide för användning av kvalitetsregister](https://swedenbio.se/guide-for-anvandning-av-kvalitetsregister/) - – Kvalitetsregistren utgör en hörnpelare i forskning och utveckling för att få fram bättre, säkrare och effektivare behandlingar. Ambitionen är att öka och förenkla tillgängligheten såväl för forskare som företagare och samtidigt bidraga till att utveckla kvalitetsregistren. Guiden ska vara ett "levande" ramverk för alla parter i det fortsatta utvecklingsarbetet, berättar Maria Anvret, seniorrådgivare som lett
- [Dags för ny life science aktör att ta ledartröjan för EU SME Support](https://swedenbio.se/dags-for-ny-life-science-aktor-att-ta-ledartrojan-for-eu-sme-support/) - Nu, ett och ett halvt decennium senare kan vi blicka tillbaka med stolthet på vår gärning som värdorganisation för en mycket viktig funktion i finansieringslandskapet inom life science. När den innevarande programperioden löper ut i slutet av juni så väljer SwedenBIO att inte delta i Vinnovas utlysning för nästa programperiod. Det handlar om att organisationen
- [#vinterbadaförvaccinet](https://swedenbio.se/vinterbadaforvaccinet/)
- [Rådslag om strategier och prioriteringar i förverkligande av Vision e-hälsa 2025](https://swedenbio.se/radslag-om-strategier-och-prioriteringar-i-forverkligande-av-vision-e-halsa-2025/) - Berätta om rådslaget för Vision e-hälsa 2025, vad är det? Visionen är ett initiativ från regeringen tillsammans med Sveriges kommuner och regioner, med mål att Sverige ska vara världsledande inom området e-hälsa år 2025. Tillsammans med aktörerna i styr- och samverkansorganisationen för initiativet bjöd de in till rådslag med fokus att diskutera hur de aktuella
- [Nyttja hälsodatan!](https://swedenbio.se/nyttja-halsodatan/)
- [Course in drug development (May 18–20)](https://swedenbio.se/course-in-drug-development-may-18-20/)
- [SwedenBIO stärker teamet med klinisk kompetens](https://swedenbio.se/swedenbio-starker-teamet-med-klinisk-kompetens/) - – SwedenBIO känns för mig som den perfekta platsen att kombinera mina erfarenheter, mitt intresse för life science och min vilja att utvecklas inom projektledning. Jag har fått ett otroligt varmt välkomnande och ser fram emot att få jobba tillsammans med ett så kompetent team. Av över 200 sökande valde vi tillslut Johanna, som vi
- [SwedenBIO i Healthcare Direkt om behovet av internationell kompetens inom life science](https://swedenbio.se/swedenbio-i-healthcare-direkt-om-behovet-av-internationell-kompetens-inom-life-science/) - Avsnittet hittar du här.
- [Helena Strigård i Womengineer Magazine 2021](https://swedenbio.se/helena-strigard-i-womengineer-magazine-2021/) - Idag, på internationella kvinnodagen, släpper Womengineer årets "Womengineer Magazine" som är fullt av inspiration och tips till tekniknyfikna tjejer med ingenjörsdrömmar. En av de som intervjuas är vår egen Helena Strigård som berättar om sin väg från studier i bioteknik på Uppsala Universitet till att bli VD på SwedenBIO. Läs mer om Womengineers fantastiska arbete
- [Sebastian Blomstrand växlar upp SwedenBIOs digitala kanaler](https://swedenbio.se/sebastian-blomstrand-vaxlar-upp-swedenbios-digitala-kanaler/) - – Som communications intern kommer jag att lyfta life science-branschens framgångar och medlemmarnas behov i olika forum, bland annat genom att fylla webbsidan och sociala kanaler med aktuell och relevant content. Först ut är en kampanj för att öka antalet kliniska prövningar i Sverige, berättar Sebastian Blomstrand. Praktikarbetet innebär också marknadsföring av SwedenBIOs nätverksträffar såsom
- [Dr Gianfranco Grompone about NLSDays’ Microbiome Super Session](https://swedenbio.se/dr-gianfranco-grompone-about-nlsdays-microbiome-super-session/) - You have a very exciting title on your talk: “From Michelangelo to Leonardo – Translational Challenges for Probiotics in the Microbiome Era”. What insights will you be sharing during the session? – Leonardo Da Vinci, Michelangelo (and Raphael) are considered the most representative geniuses of the 15th century Florentine Renaissance Art. The idea behind the
- [Hej Jenni Nordborg!](https://swedenbio.se/vad-hander-i-arbetet-med-life-science-strategin-just-nu-och-vad-ser-ni-framat/) - – Regeringen har publicerat artikeln Ett år med life science-strategin – vad har hänt? , en sammanställning av de 53 insatser som tagits under första året med strategin för att möta de 30 målsättningar som bedöms vara särskilt angelägna att uppnå. Framåt kommer vi att arbeta vidare med de prioriteringsområden och målsättningar som strategin pekar ut och
- [Vi pratar 2021 med Vaccinfabriken](https://swedenbio.se/vi-pratar-2021-med-vaccinfabriken/) - Vad händer i ert bolag under 2021? – Vi siktar på att avsluta de pre-kliniska studierna och vara redo att gå in i klinisk fas med vårt huvudprojekt med ett terapeutiskt botande vaccin mot hepatit B och D. I samband med detta kommer vi även att ta in externt kapital för att accelerera utvecklingen. Det
- [Ny arbetsgrupp för HR och kompetens](https://swedenbio.se/ny-arbetsgrupp-for-hr-och-kompetens/) - – Jag tror att den här arbetsgruppen ligger helt rätt i tiden, säger Frida Lawenius som håller i gruppen från SwedenBIOs kansli. Det var stor energi i det digitala mötesrummet under uppstartsmötet och det finns en uppsjö av utmaningar att angripa, från internationell rekrytering till att skapa känsla av tillhörighet för nya medarbetare när alla
- [Fyra frågor till Mpya Sci & Tech](https://swedenbio.se/fyra-fragor-till-mpya-sci-tech/) - År 2020 var ett speciellt år för branschen men också för er. Ni hjälper bolag inom life science att rekrytera. Hjälp oss ta tempen på rekryteringstrycket, hur ser det ut? I våras upplevde vi under ett par månader att mycket stannade upp och sattes på hold. Det vi nu ser är att Life Science branschen
- [Intervju med Moa Fransson – VD för Genagon Therapeutics](https://swedenbio.se/intervju-med-moa-fransson-vd-for-genagon-therapeutics/) - Vad händer i ert bolag under 2021? – Under 2021 förbereder vi vårt terapeutiska program inom bröstcancer för kliniska prövningar. Vi har lovande antikroppskandidater som vi kommer att utvärdera i olika effektmodeller relevanta för sjukdomen. Vi har tillsammans med våra samarbetspartners planerat ett fullt prekliniskt program som innehåller alla relevanta delar. Vi växer som bolag och
- [Motionera till Årsmötet!](https://swedenbio.se/motionera-till-arsmotet/) - Maila dessa till VD Helena Strigård (helena.strigard@swedenbio.se) senast den 26 mars 2021. Ange ”Motion Årsmötet 2021” i mailets ämnesrad.
- [Tips! Life science-konferens den 18 januari](https://swedenbio.se/tips-life-science-konferens-den-18-januari/) - – Vi kommer summera var vi står nu i strategiarbetet och diskutera vad som krävs för att ta nästa kliv. Jag hoppas på en bred uppslutning från alla delar av landet och alla aktörer som bidrar till life science-sektorns utveckling, säger Jenni Nordborg, regeringens nationella life science-samordnare. Programmet kommer att beröra forsknings- och innovationspropositionen, internationellt
- [Fem snabba med Malin Parkler, vd på Pfizer Sverige](https://swedenbio.se/fem-snabba-med-malin-parkler-vd-pa-pfizer-sverige/) - – Utan en lösningsinriktad och prestigelös inställning från alla dessa aktörer så hade det inte gått. Ur ett historiskt perspektiv, hur stort är detta? Det bör utan tvekan räknas som den viktigaste insatsen inom medicinsk forskning de senaste 50 åren, menar Helena Strigård, vd för branschorganisationen SwedenBIO. Beskedet kommer nästan på dagen ett år efter
- [Vi söker en junior projektkoordinator / executive assistant](https://swedenbio.se/vi-soker-en-junior-projektkoordinator-executive-assistant-2/) - Rollen Som executive assistant kommer du att vara en viktig nod för kansliets verksamhet och ha en kontinuerlig gränsyta mot våra medlemmar, t.ex. våra arbetsgrupper. Life science-branschen växer och vi med den. Vår medlemsskara har ökat kraftigt under det gångna året och du kommer in i ett spännande skede där vi ser över och utvecklar
- [SwedenBIO Summit 2020 – se klippen i efterhand](https://swedenbio.se/swedenbio-summit-2020-se-klippen-i-efterhand/) - SwedenBIO Summit: vd Strigård om 2020 och framtiden Hur ska life science-företaget finansieras? Marknadsplatsernas betydelse för lifescience Pharmivas väg till börsen Så investerar Almi Invest i life science Björn Henriksson, vd, Nordic Interim, Annika Muskantor, Interim CFO, Frideborg Consulting samtalar med Frida Lawenius, vice vd, SwedenBIO om att kompetensförsörja på nya och innovativa vis under
- [SwedenBIO Summit 9 december](https://swedenbio.se/swedenbio-summit-9-december/) - Programmet kommer sändas live ifrån Grand Hôtel, via Youtube länk. Sändningen, som börjar kl 13:00 kommer ni åt här: https://youtu.be/nqmxpvP875M Har du frågor eller behöver hjälp med access till mingelplattformen för SwedenBIOs medlemmar, kontakta Björn Ursing på 070 – 811 12 68 eller Nicole Hanzon på 0706 96 36 33. Välkommen!
- [Calliditas Therapeutics vinnare av SwedenBIO Award 2020](https://swedenbio.se/calliditas-therapeutics-vinnare-av-swedenbio-award-2020/) - Calliditas Therapeutics har i egen regi målmedvetet utvecklat sin läkemedelskandidat Nefecon mot kronisk njurinflammation (IgA-nefropati) och presenterade nyligen positiva resultat från en registreringsgrundande fas 3-studie. – Årets vinnare har visat en imponerande professionalism och uthållighet i utvecklingen av en helt ny behandling för patienter med kroniska njurinflammationer som idag saknar effektiv terapi. Med positiva fas
- [Fem finalister till SwedenBIO Award 2020](https://swedenbio.se/fem-finalister-till-swedenbio-award-2020/) - Kampen mot sars-cov-2 sätter ljuset på life science-industrins ansträngningar för att ta fram effektiva vacciner, bättre diagnostik och behandlingar av virusets följdverkningar. Samtidigt pågår ett intensivt arbete för att bekämpa helt andra sjukdomar – cancer, stroke, diabetes, reumatism m.fl. – för att bidra till bättre hälsa och ekonomisk tillväxt. Under hösten har rekordmånga bolag nominerats
- [Tillväxtanalys föreslår ny metod för insamling av branschdata](https://swedenbio.se/tillvaxtanalys-foreslar-ny-metod-for-insamling-av-branschdata/) - Nu har Tillväxtanalys på regeringens uppdrag föreslagit en metod för hur företag inom life science ska identifieras och branschens utveckling mätas. Med förslaget vill Tillväxtanalys skapa en långsiktigt hållbar metod, som ger goda möjligheter att ta fram data med hög kvalitet, men också nationell samsyn och samverkan kring strategiskt viktiga analyser. Läs mer här.
- [Regeringens nationella life science-strategi presenteras nu på engelska](https://swedenbio.se/regeringens-nationella-life-science-strategi-presenteras-nu-pa-engelska/) - Varför är det viktigt att kommunicera strategin på engelska? – Det internationella intresset för Sverige är mycket stort inom life science. Det är många aktörer som kan ha nytta av att sprida strategins ramverk och målsättningar. Vem vill ni nå med den engelska versionen? – Vi vill stärka långsiktiga relationer och samarbeten. Vi vill nå
- [Från big pharma till start up, med börsen i sikte](https://swedenbio.se/fran-big-pharma-till-start-up-med-borsen-i-sikte/) - Pharmiva har fokus på kvinnohälsa med mecialinriktning på vaginal hälsa där det första steget handlar om en antibiotikafri behandling mot bakteriell vaginos. Pharmiva har utvecklat en patenterad produkt som i steg ska lanseras på den nationella och internationella marknaden, efter en planerad börsintroduktion under 2021. Vad är annorlunda i din nya roll? Hur är livet
- [Vilket företag förtjänar utmärkelsen SwedenBIO Award 2020?](https://swedenbio.se/vilket-foretag-fortjanar-utmarkelsen-swedenbio-award-2020/) - SwedenBIO Award är branschens eget pris och består, utöver äran, av ett vandringspris och två delegatplatser till Nordic Life Science Days. Vinnaren av SwedenBIO Award 2020 kommer att presenteras på SwedenBIO Summit. Priset ska stärka visionen av Sverige som en ledande life science-nation samt bidra positivt till bilden och erkännandet av life science-branschen bland beslutsfattare och allmänhet
- [SwedenBIO-kurs i läkemedelsutveckling – fokus på biologiska läkemedel](https://swedenbio.se/swedenbio-kurs-lakemedelsutveckling-fokus-pa-biologiska-lakemedel/) - Kursen riktar sig främst till dig som arbetar i ett SME och vill få insikt i hur man arbetar i olika utvecklingsstadier, vad man ska tänka på och vilka fallgropar som finns på vägen.Kursen arrangeras som ett samarbete mellan Läkemedelsakademin och SwedenBIO och medlemmar har givetvis rabatt – bara att klicka i vid anmälan. För
- [Vägledning framtagen med SKR om frivillig bemanning av vården](https://swedenbio.se/vagledning-framtagen-med-skr-om-frivillig-bemanning-av-varden/) - SwedenBIO har därför tillsammans med Swedish Medtech, Swedish Labtech och LIF tagit fram en gemensam vägledning med Sveriges Kommuner och Regioner för de verksamheter som är intresserade av att ge medarbetare möjlighet att rycka in i vården. Företag som har förutsättningar att avvara kompetens och har medarbetare som är intresserade av att stötta upp hälso-
- [Dags att nominera till SwedenBIO Award!](https://swedenbio.se/dags-att-nominera-till-swedenbio-award-2015/)
- [SwedenBIOs förslag till förändringar av det statliga riskkapitalet](https://swedenbio.se/swedenbios-forslag-for-att-starka-life-science-genom-forandringar-av-det-statliga-riskkapitalet/) - Riksrevisionens analys av det statliga riskkapitalet 2014 visade på flera utmaningar. Bland annat visade den att det statliga riskkapitalet inte var särskilt riskvilligt och att för mycket kapital är inaktivt. När regeringen nu ser över det statliga riskkapitalet bör man också fullt ut genomföra de förändringar som krävs för att på ett kraftfullt och framsynt
- [Förslag om det statliga riskkapitalet har potential för life science](https://swedenbio.se/forslag-om-det-statliga-riskkapitalet-har-potential-for-life-science/) - Life science-sektorn har en stark tradition i Sverige och har goda möjligheter att hävda sig i den globala konkurrensen. För att vi ska stå fortsatt starka krävs dock kraftfulla satsningar och regeringen har visat en tydlig ambition att stärka life science i Sverige. Ett mer effektivt utnyttjande av det statliga riskkapitalet är en viktig pusselbit
- [Regeringens expertgrupp för life science utsedd](https://swedenbio.se/regeringens-expertgrupp-for-life-science-utsedd/) - Ska bidra med underlag till regeringen Den 1 april utsåg regeringen Anders Lönnberg till nationell samordnare för life science. Anders Lönnberg ska bidra med underlag till regeringens arbete med att stärka Sveriges position inom life science. Till sin hjälp har Anders Lönnberg en expertgrupp som utsetts av regeringen. Expertgruppen ska förmedla kunskaper och ge en
- [Här är de nominerade till SwedenBIO Award 2015](https://swedenbio.se/har-ar-de-nominerade-till-swedenbio-award-2015/) - De nominerade till SwedenBIO Award 2015 är: Moberg Pharma, OnTarget Chemistry, Xvivo Perfusion AB, Scandinavian Biopharma, Immunicum AB, Recipharm och Bioarctic Neuroscience. Vinnaren koras på KATALYS 2015 - SwedenBIOs framtidsdag den 4 juni, läs mer här. Priset är branschens eget pris och består, utöver äran, av ett vandringspris och två delegatplatser på Nordic Life Science Days 9-10
- [Välbesökt seminarium om det statliga riskkapitalet](https://swedenbio.se/valbesokt-seminarium-om-det-statliga-riskkapitalet/) - Referat Under våren 2015 genomför regeringen en översyn av det statliga riskkapitalet då Riksrevisionens rapport från 2014 har visat på en tydlig ineffektivitet i det nuvarande systemet. Life science lyfts fram som ett av de områden som kräver ett aktivt statligt riskkapital och det finns många funderingar kring hur man på bästa sätt kan använda
- [SwedenBIO del av nytt EU-supportkontor för små och medelstora företag](https://swedenbio.se/swedenbio-del-av-nytt-eu-supportkontor-for-sma-och-medelstora-foretag/) - VINNOVA och Tillväxtverket finansierar tillsammans ett nytt ”Supportkontor för små och medelstora företag till Horisont 2020”. Syftet med supportkontoret är att öka den svenska medverkan i projekt som finansieras av EU:s forskningsprogram Horisont 2020. Supportkontoret ska ge kostnadsfri rådgivning till företag som önskar ansöka och delta i en EU-utlysning. Det har även tidigare funnits supportkontor,
- [25 åtgärder för att stärka life science i Sverige](https://swedenbio.se/handlingsplan/) - Life science i Sverige är satt under press. De senaste åren har det gjorts flera större satsningar för att stärka sektorn och många av dessa är bra och kommer att ge resultat på lite längre sikt. Samtidigt ser vi att det fortfarande saknas en sammanhållen strategi som inkluderar alla viktiga delar. Det finns därför risk
- [Pengar till samverkansprogam för life science i vårbudgeten](https://swedenbio.se/pengar-till-samverkansprogam-for-life-science-i-varbudgeten/) - Statsminister Stefan Löfven och närings- och innovationsminister Mikael Damberg presenterade på måndagen den 13 april vårbudgetens näringspolitiska satsningar. Totalt lägger 226 miljoner kronor på näringspolitik under 2015, bland annat på exportfrämjande åtgärder. Men det blir också ytterligare satsningar på innovationsklimatet. Innovationsrådet och de samverkansprogram som ska drivas i anslutning får 50 miljoner kronor 2015 och
- [Nominera till Athenapriset 2015!](https://swedenbio.se/nominera-till-athenapriset-2015/) - Klinisk forskning och innovationer är avgörande för den medicinska utvecklingen i sjukvården. De är också viktiga för att stärka Sveriges konkurrenskraft. Athenapriset har instiftats för att lyfta fram behovet av klinisk forskning av hög vetenskaplig kvalitet som sker i samverkan mellan hälso- och sjukvården, akademin och näringslivet. Vinnaren får ett forskningsstipendium på 150 000 kronor. Dags att
- [Athenapriset går till forskning om cancervacciner](https://swedenbio.se/athenapriset-gar-till-forskning-om-cancervacciner/) - Priset, som består av ett forskningsstipendium på 150 000 kronor, utdelas torsdagen den 4 december i samband med Svenska Läkaresällskapets Medicinska riksstämma. Prisutdelare är Daniel Forslund, nyvald till Sveriges första innovationslandstingsråd. Om pristagaren Alex Karlsson-Parra har tillsammans med sina medarbetare ägnat 15 års forskningsarbete åt utveckling av ett terapeutiskt cancervaccin som bygger på att främmande
- [Early bird och 25% rabatt för medlemmar på NLSDays!](https://swedenbio.se/unikt-tillfalle-early-bird-och-25-rabatt-for-medlemmar-pa-nlsdays/) - Med runt 1000 delegater från 30 länder är mötet en unik möjlighet att träffa internationella investerare och samarbetspartners på hemmaplan. Det internationella intresset är redan mycket stort för Nordic Life Science Days 2015. Nytt för 2015 är att medlemmar i SwedenBIO har 25 procents rabatt på deltagaravgiften! Tillsammans med Early bird-erbjudandet innebär det att medlemmar
- [Innovationsrådet på plats – nu måste arbetet börja](https://swedenbio.se/innovationsradet-pa-plats-nu-maste-arbetet-borja/) - Innovationsrådet är ett rådgivande organ som genom dialog och samverkan mellan politik, näringsliv, akademi och fackföreningsrörelse ska ta fram förslag och idéer som ska stärka Sveriges innovationsförmåga och konkurrenskraft. SwedenBIO ser fram emot att det riktade arbetet för life science-branschen som tidigare annonserats ska ske i anslutning till innovationsrådet nu kan börja. SwedenBIO uppskattar även att
- [SwedenBIO kommenterar rapport om life science i Sverige](https://swedenbio.se/swedenbio-kommenterar-rapport-om-life-science-i-sverige/) - I rapporten ”Ett konkurrenskraftigt ekosystem för life science” går regeringens samordnare igenom resultatet av möten med 80 organisationer och företag inom life science-sektorn i Sverige. Rapporten beskriver väl sektorns utmaningar och presenterar flera förslag på åtgärder. - Det är bra att Susanne Ås Sivborg har med alla viktiga delar i sin rapport. Ska Sverige stärka
- [SwedenBIO kommenterar regeringsförklaringen](https://swedenbio.se/swedenbio-kommenterar-regeringsforklaringen/) - I regeringsförklaringen som presenterades den 3 oktober återkom statsminister Stefan Löfven till sina planer på ett innovationsråd och en nyindustrialisering av Sverige. Life science är sedan tidigare ett uttalat prioriterat område i det arbetet och där ser vi fram emot en bra dialog så att den utformas på bästa möjligaste vis. Ambitionen att koordinera de
- [SwedenBIO kommenterar partiernas satsningar på life science](https://swedenbio.se/swedenbio-kommenterar-partiernas-satsningar-pa-life-science/) - Överlag är det politiska engagemanget för life science stort vilket är mycket positivt. Det har gjorts satsningar på life science och medicinsk forskning de senaste åren som lagt en bra grund. Men det saknas fortfarande en tydlig och koordinerad plan som innefattar alla de politikområden som berör life science. SwedenBIO vill bland annat se politiska
- [Välkommen till Bubbel & Debatt i Göteborg 23 september](https://swedenbio.se/goteborg2015/) - Det satsas mycket pengar på nationella miljöer för life science i Sverige i syfte att stärk landet som helhet i den globala konkurrensen. Hur ska dessa nationella center agera för att akademi och företag i hela landet ska kunna utnyttja den kompetens som finns? Debattörer: Tomas Lundqvist, Life Sciences Director, MAX-IV Laboratory Håkan Billig, ordförande
- [Nordic Life Science Days](https://swedenbio.se/nordic-life-science-days/) - Nordic Life Science Days grundades av SwedenBIO 2013 och har växt år för år och är nu etablerad som Nordens största partneringkonferens inom life science. Bland investerare och stora företag som deltar på NLSDays 2015 kan nämnas AbbVie, Alexion, Almi Invest, Astellas, AstraZeneca, Bayer HealthCare, BoehringerIngelheim, Bristol-Myers Squibb, CadilaPharma, GE Healthcare Life Science, HealthCap, Industrifonden, Johnson
- [Remissvar på utredning om det statliga riskkapitalet](https://swedenbio.se/remissvar-pa-utredning-om-det-statliga-riskkapitalet/) - SwedenBIO och dess arbetsgrupp för affärsutveckling och finanisering har analyserat den statliga utredningen "En fondstruktur för innovation och tillväxt". I vårt remissvar fokuserar vi på att kommentera de delar av utredningen som kan få betydelse för life science-sektorn. Vi lämnar också rekommendationer för hur ramvillkoren för en life science-fond bör se ut. Sammanfattat anser SwedenBIO att: Den föreslagna
- [NLSDays 2015 på tre minuter](https://swedenbio.se/nlsdays-2015-pa-tre-minuter/) - Ministern öppnade mötet Ministern för högre utbildning och forskning, Helene Hellmark Knutsson, öppnade mötet med ett tal om styrkorna i nordisk och svensk life science. Hon sa bland annat: "The Nordic countries have a long tradition of medical research of world class, successful large and small pharmaceutical companies, and a well-developed and well organized health care.
- [Bidra till Pipelinerapporten 2015](https://swedenbio.se/swedish-drug-development-pipeline-2015/) - Länk till enkäten: Drug Development Pipeline Survey 2015 Vem ska svara? Enkäten vänder sig till samtliga biotech- och läkemedelsföretag med huvudkontor och FoU-verksamhet i Sverige som har projekt i preklin till fas III. Enkäten innehåller även frågor om produkter som fått marknadsgodkännande under året som gått. (Projekt som har sin regulatoriska tillhörighet som medicinteknisk produkt efterfrågas inte
- [Välkommen till Bubbel & Debatt i Umeå den 17 november](https://swedenbio.se/valkommen-till-bubbel-debatt-i-umea-den-17-november/) - Det satsas mycket pengar på nationella miljöer för life science i Sverige i syfte att stärk landet som helhet i den globala konkurrensen. Hur ska dessa nationella center agera för att akademi och företag i hela landet ska kunna utnyttja den kompetens som finns? Debattörer: Tomas Lundqvist, Life Sciences Director, MAX-IV Laboratory Håkan Billig, ordförande
- [SwedenBIOs inspel till forskningspropositionen 2016](https://swedenbio.se/forskning2016/) - Hösten 2016 ska regeringen presentera nästa forskningsproposition. SwedenBIO har bjudits in att komma med underlag inför framtagandet av propositionen. SwedenBIO uppskattar de ökade satsningar som gjorts på biomedicin och teknik i tidigare forskningspropositioner. Nu krävs fokuserade satsningar för att få full utväxling på de insatser som redan gjorts. I vårt inspel pekar vi ut sex områden
- [Athenapriset till forskning som gör fynd i nationella kvalitetsregister](https://swedenbio.se/athenapriset-till-forskning-som-gor-fynd-i-nationella-kvalitetsregister/) - Priset, som består av ett forskningsstipendium på 150 000 kronor, utdelas torsdagen den 3 december i samband med Svenska Läkaresällskapets Medicinska riksstämma. Prisutdelare är Anders Lönnberg, regeringens nationella samordnare för life science. Athenaprisjuryns motivering till valet av pristagare lyder: "Ett banbrytande koncept som nyttiggör de nationella kvalitetsregistren och banar väg för intressanta samarbeten mellan akademi, sjukvård
- [Akbar Seddigh i ljust minne](https://swedenbio.se/akbar-seddigh-i-ljust-minne/) - Med sin fantastiska energi och aldrig sinande entusiasm har Akbar under decennier varit en mycket omtyckt och betydelsefull person inom life science-sektorn. Bland mycket annat grundade han medicinteknikföretaget Ortivus och har varit styrelseordförande i Elekta, A+ Science och Innovationsbron. Akbar Seddigh lämnade rollen som styrelseordförande för SwedenBIO i förtid 2013 på grund av den sjukdom som
- [Ny kurs för småföretag som utvecklar läkemedel](https://swedenbio.se/kurs/) - Syftet med kursen är att öka kunskapen hos dessa företag för att både vara en påläst kravställare och kunna ta en produkt från idé till marknad. - Vi har under senare tid noterat en hög efterfrågan på en ny form av utbildning som är anpassad efter de förutsättningar de mindre life science-bolagen har idag och i
- [Fler projekt i klinisk utveckling](https://swedenbio.se/pipeline2015/) - I Sverige finns runt 1500 life science-företag och av dessa är 800 aktiva i olika forsknings- och utvecklingsprogram. I rapporten The Swedish Drug Development Pipeline analyseras vilka svenska bolag som driver egna projekt inom läkemedelsutveckling. Årets analys visar bland annat: Det finns 123 företag med svenskt huvudkontor som utvecklar läkemedel. Av dessa 123 företag har
- [Registreringen till Nordic Life Science Days 14-15 september är öppen](https://swedenbio.se/nlsdays-2016-registreringen-har-oppnat/) - Förra året samlandes drygt tusen delegater från 30 länder, under nordens största partneringkonferens för life science-industrin. Missa inte chansen att träffa investerare och framtida affärspartners från hela världen. Konferensen äger rum den 14-15 september på Stockholm Waterfront, och erbjuder one-to-one meetings, super sessions på stora scenen, workshops och mingel. Anmäl dig här: www.nlsdays.com Är du
- [300 euro rabatt på BIO Europe Spring](https://swedenbio.se/300-euro-rabatt-pa-bio-europe-spring/) - Läs mer om BIO Europe Spring 2016 här.
- [Välkommen till frukostseminarium: Halvtid med Anders Lönnberg](https://swedenbio.se/frukostseminarium-halvtid-med-anders-lonnberg/) - I snart ett år har Anders Lönnberg haft regeringens uppdrag att samla life science-branschen och föreslå åtgärder för att få den att lyfta. Till sin hjälp har han en referensgrupp med representanter från industrin, akademin och hälso- och sjukvården. Under en intensiv timme känner Läkemedelsvärlden Anders Lönnberg på pulsen om vad som faktiskt har åstadkommits.
- [Ola Björkman programdirektör för NLSDays 2016](https://swedenbio.se/ola-bjorkman-programdirektor-for-nlsdays-2016/) - Drygt 1000 delegater från 30 länder möts varje september i Stockholm för Nordens största partneringmöte inom life science. Parallellt med tusentals affärsmöten fylls NLSDays av ett program på scen där talare från hela världen ger sina trendspaningar kring utvecklingen inom den globala life science-industrin. Programmet tas fram av SwedenBIO tillsammans med samarbetsorganisationer. Inför NLSDays 2016
- [Bubbel & Debatt 9 mars i Stockholm](https://swedenbio.se/bubbeldebattstockholm2016/) - Sverige satsar nationellt på life science. Vad görs i Stockholmsregionen? I panelen: Fredrik Piehl, överläkare Karolinska Institutet, Jakob Hellman, tillträdande innovationschef, Stockholms Läns Landsting, Maria Englund, verksamhetschef Karolinska Trial Alliance, Bengt Gustavsson, apotekare och doktor i patologi, norsk medicinsk chef, Celgene. Moderator: Ingrid Helander, chefredaktör Läkemedelsvärlden. När? 9 mars. Debatten startar klockan 17.00. Bubbel och snack
- [Halvtid med Anders Lönnberg - här kan du se seminariet i efterhand](https://swedenbio.se/halvtid-med-anders-lonnberg/) - I snart ett år har Anders Lönnberg haft regeringens uppdrag att samla life science-branschen och föreslå åtgärder för att få den att lyfta. Till sin hjälp har han en referensgrupp med representanter från industrin, akademin och hälso- och sjukvården. Under en intensiv timme kände Ingrid Helander, chefredaktör Läkemedelsvärlden Anders Lönnberg på pulsen om vad som
- [Ny webbsida för EUSMESupport2020](https://swedenbio.se/ny-webb-for-eusmesupport2020/) - Har ditt företag behov av bidrag för att driva ett innovativt utvecklingsprojekt, eller behöver ni medel för att utveckla era produkter och tjänster? EUSMESupport2020 reder ut begreppen och går igenom dina möjligheter till bidrag från EUs forsknings- och innovationsprogram Horizon 2020 och Eurostars. Besök nya webbsidan www.eusme.se EUSMESupport2020 är en nationell stödfunktion, vars syfte är att öka
- [Nominera framträdande bolag till SwedenBIO Award 2016](https://swedenbio.se/nominera-framtradande-bolag-till-swedenbio-award-2016/) - Det nominerade bolaget ska: - ha visat prestationer och framgångar utöver det normala inom life science-industrin under det gångna året. - ha bidragit till ett ökat intresse för branschen. - vara ett life science-bolag som är medlem i SwedenBIO. Tidigare vinnare är: 2015 Recipharm, 2014 Orexo, 2013 Affibody, 2012 Vitrolife, 2011 Aerocrine, 2010 BioInvent, 2009 Cellavision, 2008 Medivir, 2007 Gyros. Juryn består av SwedenBIOs
- [Lunchseminarium: När ska jag säga vad till vem?](https://swedenbio.se/nar-ska-jag-saga-vad-till-vem-att-overleva-som-life-science-bolag-pa-borsen/) - Små bolag inom life science-branschen har alla en gemensam utmaning - finansiering. En väg som ånga väljer är att göra företaget publikt genom en börsnotering. Detta innebär att kommunikation blir en huvudfråga för företagets strategi. Välkommen till ett seminarium där en erfaren expertpanel reder ut begreppen! I panelen Rein Piir. VP Investor relations på Camurus
- [Välkommen förändring av det statliga riskkapitalet](https://swedenbio.se/valkommen-forandring-av-det-statliga-riskkapitalet/) - Näringsminister Mikael Damberg presenterade på måndagen propositionen Staten och kapitalet med förslag på en ny struktur för det statliga riskkapitalet. Propositionen behandlar enbart hur det statliga riskkapitalet ska organiseras och går inte in på vilken inriktning de nya fonderna ska ha. Beslut om inriktning ska tas efter att den nya strukturen är på plats. Enligt näringsminister Mikael
- [Ny ordförande för arbetsgruppen för processutveckling och tillverkning](https://swedenbio.se/torkel-gren-recipharm-ny-ordforande-for-swedenbios-arbetsgrupp-for-processutveckling-och-tillverkning/) - Nominering av Torkel Gren, Senior Sales Director, Recipharm, till ordförande i Arbetsgruppen Processutveckling och Tillverkning: Torkel Gren har en gedigen och relevant bakgrund inom life science. Efter sin apotekarexamen 1988 började Torkel en industrikarriär på ACO/KABI/Pharmacia & Upjohn samtidigt som han doktorerade i farmaceutisk vetenskap i Uppsala. Han har sedan haft ett flertal ledande roller inom industrin och behärskar
- [Ny krönika: Låt oss slippa fler påtvingade grupparbeten](https://swedenbio.se/ny-kronika-lat-oss-slippa-fler-patvingade-grupparbeten/) - Läs hela krönikan här.
- [Frukostmöte 25 maj: Elementärt min käre Watson](https://swedenbio.se/elementart-min-kare-watson/) - ...genom att analysera stora mängder data som medicinsk litteratur, patientjournaler, kliniska prövningar och egengenererad data för att tillhandahålla ett beslutsstöd som ger kliniskt värdefulla insikter och rekommendationer för personliga och evidensbaserade behandlingar. Hur förändrar det relationen patient-vårdpersonal och upplevelsen under patientresan? Föreläser gör Torbjörn Hägglöf, Consultant, Cognitive Business Solutions IBM Global Business Services. Torbjörn har
- [Här är de nominerade till SwedenBIO Award 2016!](https://swedenbio.se/har-ar-de-nominerade-till-swedenbio-award-2016/) - För att vinna SwedenBIO Award ska bolaget ha visat prestationer och framgångar utöver det normala inom life science-industrin under det gångna året, ha bidragit till ett ökat intresse för branschen och vara ett life science-bolag som är medlem i SwedenBIO. I år delas SwedenBIO Award ut för tionde gången och följande sex bolag är nominerade:
- [Grattis Alligator Bioscience till SwedenBIO Award 2016!](https://swedenbio.se/grattis-alligator-bioscience-till-swedenbio-award-2016/) - Motiveringen lyder: Alligator Bioscience har gjort en sann pionjärinsats och tidigt identifierat möjligheterna att med nya terapeutiska koncept ta fram unika antikroppar som har potential att förlänga livet för patienter med spridd cancer. Kombinationen av högkvalitativ forskning och ett väl utvecklat affärssinne har resulterat i ett samarbetsavtal av sällan skådad dignitet med ett av världens
- [Nominera till Athenapriset 2016](https://swedenbio.se/nominera-till-athenapriset/) - Athenapriset, Sveriges största pris för klinisk forskning har instiftats för att lyfta fram behovet av klinisk forskning av hög vetenskaplig kvalitet som sker i samverkan mellan hälso- och sjukvården, akademin och näringslivet. För att vinna har forskning och utveckling skett i nära samverkan mellan vård, akademi och näringsliv. Det behöver inte vara ett stort etablerat
- [Sara Gunnerås ny kontaktperson på SwedenBIOs EU supportkontor](https://swedenbio.se/sara-gunneras-ny-kontaktperson-pa-swedenbios-eu-supportkontor/) - De senaste åren har Tuulikki Lindmark hjälpt bolag med ansökningar till EU-programmen. Från och med juni finns Tuulikki på Uppsalabolaget Disruptive Materials, och Sara Gunnerås, tidigare analyschef på SwedenBIO blir ny kontakt på supportkontoret. SwedenBIOs EU supportkontor är en del av EU SME Support 2020 - ett branschöverskridande supportkontor för små och medelstora bolag. EU SME
- [Referat: Fabrikernas återkomst – så vinner Sverige slaget om läkemedelstillverkningen](https://swedenbio.se/referat-fabrikernas-aterkomst-sa-vinner-sverige-slaget-om-lakemedelstillverkningen/) - Aktuella satsningar ger hopp – men mycket jobb återstår Under Almedalsveckan anordnade SwedenBIO ett seminarium om läkemedelsproduktion (läs mer om talarna och se inbjudan här). Deltagare på scenen var Oscar Stenström, statssekreterare hos handelsminister Ann Linde samt representanter från AstraZeneca, Cobra Biologics, GE Healthcare, Pfizer och Sobi. Bakgrunden var det senaste årets stora investeringar i tillverkning
- [Hitta en europeisk partner till Eurostars under NLSDays 14-15 september](https://swedenbio.se/hitta-europeisk-partner-till-eurostars/)
- [Inger Näsman blir vikarierande policychef på SwedenBIO](https://swedenbio.se/inger-nasman-blir-vikarierande-policychef-pa-swedenbio/) - Hon har jobbat på apotek i olika positioner både i monopolet på olika typer av apotek samt på huvudkontoret och efter omregleringen som kvalitetschef på Kronans apotek. Inger har haft flera olika tjänster på Läkemedelsverket och har bland annat arbetat med naturmedel, inspektion samt i ledningskansliet hos Thomas Lönngren. Inger kommer närmast från LIF där
- [Remissvar om avgifter till Läkemedelsverket](https://swedenbio.se/swedenbios-remissvar-om-avgifter-till-lakemedelsverket/) - Ladda ner SwedenBIOs remissvar här.
- [Remissvar om beskattning av incitamentsprogram](https://swedenbio.se/remissvar-om-beskattning-av-incitamentsprogram/) - ... och bör därför modifieras för att kunna ge avsedda effekter i en bransch som är internationellt konkurrensutsatt och som karaktäriseras av kunskapsintensiva tillväxtföretag med stort behov av att kunna engagera global toppkompetens i såväl verksamhet som ledning. Det land som med en genomtänkt proaktiv strategi, med en hög beredskap att möta förändringar och som över
- [Björn Ursing blir programdirektör på SwedenBIO](https://swedenbio.se/bjorn-ursing-blir-programdirektor-pa-swedenbio/) - ...samt som egen som egen konsult. En viktig uppgift i sin nya roll som programdirektör blir att vara programansvarig för NLSDays 2017. Björn kommer senast från N2MO A/S i Köpenhamn där han kommer att fortsätta en mindre del av sin tid.
- [Pressinbjudan till Nordic Life Science Days 2016](https://swedenbio.se/pressinbjudan-nordic-life-science-days-2016/) - – Vi hoppas och tror att årets konferens, precis som de tidigare, ska leda till nya affärsrelationer, investeringar och samarbeten med nordiska bolag, säger Jonas Ekstrand, VD för SwedenBIO som arrangerar NLSDays, Nordens största partneringkonferens inom life science. I år är över 650 företag anmälda och 80 företag kommer att presentera sina idéer på framtida innovationer
- [Nytt sökverktyg för svenska företag](https://swedenbio.se/sokverktyg-med-matchmaking-funktion/) - Nylanserade SwedishLifeSciences.com ska serva bolag, entreprenörer och forskare som behöver komplettera ett utvecklingsarbete av en ny produkt eller tjänst för hälso- och sjukvården med rätt expertis. En annan målgrupp är investerare och industri på jakt efter intressanta partners. Nationell expertis – Många tidiga bolag och entreprenörer har hög akademisk kompetens inom sitt område men har luckor inom annat
- [Årets vinnare av Nordic Stars Award](https://swedenbio.se/arets-vinnare-nordic-stars-award/) - Nordic Stars Award infördes 2013 och priset i år uppmärksammar nordiska bolag som aktivt arbetar med några av byggstenarna för en hållbar hälso- och sjukvård, med patient-inflytande, digitala lösningar, prevention, precision, och genom nya former av samarbeten. – På SwedenBIO vi är stolta över att presentera vinnarna av Nordic Stars Award 2016, som var och en brinner för att
- [Få global synlighet för ditt företag genom The Swedish Drug Development Pipeline](https://swedenbio.se/bidra-till-pipeline-rapporten-2016/) - Genom att fylla i frågeformuläret försäkrar du dig om att korrekt information om ditt bolag presenteras i rapporten. Länk till undersökningen: The Swedish Drug Development Pipeline 2016 Syfte med rapporten? Rapporten är ett viktigt verktyg för att marknadsföra svensk life science globalt och specifikt lyfta svenska företag aktiva inom läkemedelsforskning och utveckling. Att vara med i
- [SwedenBIO medverkar i Läkemedelskongressen](https://swedenbio.se/swedenbio-medverkar-i-lakemedelskongressen/) - Läkemedelskongressen erbjuder dig: Kompetensutveckling och aktuell kunskap Debatt och diskussion inom angelägna ämnen En mötesplats för professionellt nätverksbyggande Oavsett om du är verksam inom apotek, läkemedelsindustri, myndighet, sjukvård eller akademin så erbjuder den årligen återkommande Läkemedelskongressen kompetensutveckling och ny kunskap för dig! Ur programmet På eftermiddagen den 9 november SwedenBIOs VD Jonas Ekstrand med i
- [Välkommen till Bubbel & Debatt i Umeå](https://swedenbio.se/valkommen-till-bubbel-debatt-i-umea/) - Sverige satsar nationellt på life science. Vad görs i Region Västerbotten? När? torsdag 24 november. Debatten börjar 16.30, minglet börjar 17.30. Var? Triple Helix i Samverkanshuset, Universitetstorget 4, Umeå Universitet Bubbel & Debatt Umeå arrangeras årligen av Apotekarsocieteten, Kemivärlden Biotech, Naturvetarna, SwedenBIO, Sveriges Farmaceuter tillsammans med Biotech Umeå och Umeå Biotech Incubator. ANMÄL DIG TILL BUBBEL & DEBATT I UMEÅ HÄR:
- [Välkommen till SwedenBIO Summit 2016](https://swedenbio.se/valkommen-till-swedenbio-summit-2016/) - När? Onsdagen den 7 december 2016. Seminarieprogrammet börjar klockan 13.00, följt av mingel från 17.00. Var? Grand Hotel, Södra Blasieholmshamnen 8, Stockholm LÄS MER OCH ANMÄL DIG HÄR.
- [SwedenBIO välkomnar långsiktighet – men fler kraftfulla insatser behövs](https://swedenbio.se/swedenbio-valkomnar-langsiktighet-men-fler-kraftfulla-insatser-behovs/) - SwedenBIO ställer sig positivt till den allmänna inriktningen med långsiktigt politiskt engagemang för att stärka Sveriges konkurrenskraft, men påpekar att mer behöver göras för att stimulera ett världsledande innovationsklimat. – Om Sverige ska behålla och stärka sin position som ledande forskningsnation måste företagen få förutsättningar att spela den viktiga roll de faktiskt kan göra, säger Jonas
- [Svensk läkemedelsutveckling går för högtryck](https://swedenbio.se/svensk-lakemedelsutveckling-gar-for-hogtryck/) - – Det är en kraftig ökning av projekt i år. Utvecklingen är både glädjande och hoppingivande, säger Sara Gunnerås, ansvarig för branschorganisationen SwedenBIO:s pipeline-rapport. I rapporten The Swedish Drug Discovery and Development Pipeline presenteras svenska företag som driver egen forskning och utveckling av läkemedel och företagens pågående projekt. Rapporten görs årligen och i år identifierades 144 bolag
- [Medicon Village firar fem år - SwedenBIO önskar fortsatt framgång](https://swedenbio.se/medicon-village-firar-fem-ar-swedenbio-onskar-fortsatt-framgang/) - Fem år har gått sedan Medicon Village slog upp portarna. Intresset för att en plats på anläggningen är fortfarande stor. – En av höjdpunkterna efter övertagandet från AstraZeneca är att lokalerna fyllts med forskare och entreprenörer. Det är en sant internationell miljö, här jobbar nu fler än 55 olika nationaliteter. Den kanske viktigaste platsen är
- [Anmäl dig till NLSDays redan idag!](https://swedenbio.se/anmal-dig-till-nlsdays-redan-idag/) - SwedenBIO-medlemmar får 30% rabatt på delegatavgiften samt företagspresentationer och posterpresentationer. Glöm inte att ange din personliga rabattkod vid anmälan. Saknar du din kampanjkod? Kontakta info@swedenbio.se. Rabatter finns även för småföretag och forskare. Registrera idag och dra nytta av early bird priser! Besök vår nya NLSDays webbsida för kontinuerligt uppdaterad information. REGISTRERA DIG IDAG!
- [SwedenBIOs styrelseledamot ny VD i P.U.L.S. AB](https://swedenbio.se/swedenbios-styrelseledamot-ny-vd-i-p-u-l-s-ab/) - Ur pressmeddelande från P.U.L.S. AB: Sarah Fredriksson har en civilingenjörsexamen inom bioteknik och är för närvarande VD på bioteknikbolaget Edvince AB, Lund. Hon har en doktorsexamen från Lunds universitet och efter sin examen grundade Sarah bioteknikbolaget Genovis AB, som senare börsnoterades. Sarah ledde verksamheten som VD fram till 2015. Sarah är även engagerad i branschen
- [SwedenBIO kräver permanent kansli för life science](https://swedenbio.se/anders-lonnberg-delrapport/) - Under 2017 ligger ett starkt fokus på att stödja regeringen i arbetet med den svenska ansökan om en lokalisering av EMA till Sverige samt uppdraget att främja investeringar här hemma. SwedenBIO, som medverkar i arbetet i referensgruppen, gläds åt framstegen och vill understryka vikten av att detta drivs som ett långsiktigt arbete för att ytterligare stärka Sveriges position inom life science. Ett kansli för
- [Kallelse till föreningsstämma](https://swedenbio.se/kallelse-till-foreningsstamma/) - Datum: måndagen den 3 april 2017 Tid: klockan 17.30 – 18.00 Plats: Sjöfartshuset, Skeppsbron 10, Stockholm. Anmäl dig här. Det finns tre sorters medlemskap i SwedenBIO: life science-företag, tjänsteföretag och samarbetsorganisationer. Enbart life science-företag har rösträtt på föreningsstämman. Tjänsteföretag och samarbetsorganisationer har rätt att närvara på stämman om stämman beviljar dem rätten att närvara. Läs mer om årsmötet och stadgar här.
- [Nominera ett framstående bolag till SwedenBIO Award 2017](https://swedenbio.se/nominera-ett-framstaende-bolag-till-swedenbio-award-2017/) - SwedenBIO Award är branschens eget pris och består, utöver äran, av ett vandringspris och två delegatplatser till Nordic Life Science Days. Priset delas ut till ett bolag som visat prestationer och framgångar utöver det normala inom life science-industrin under det gångna året och som bidragit till ett ökat intresse för branschen. Vinnaren av SwedenBIO Award presenteras på
- [Rekordhögt intresse för nordiska life science-bolag när 37 internationella investerare möts på Nasdaq](https://swedenbio.se/rekordhogt-intresse-nordiska-life-science-bolag-nar-37-internationella-investerare-mots-pa-nasdaq/) - För första gången någonsin bjöds det på ”speed-dejting” för investerare, när branschorganisationen SwedenBIO lanserade mötesplatsen ”vc2vc”. Tanken är att underlätta samarbeten mellan olika riskkapitalbolag och etablera en smidigare väg med lägre trösklar till den nordiska affärskulturen. Det handlar om investeringar i privata eller börsnoterade life science-bolag. – Att utländska investerare får prata ihop sig exklusivt med
- [Så ska regeringen få EMA till Sverige](https://swedenbio.se/sa-ska-regeringen-fa-ema-till-sverige/) - Ladda ner broschyren här: EMA - From London to the Stockholm-Uppsala Region
- [”Riv barriärer som hindrar nordiskt forskningssamarbete”](https://swedenbio.se/riv-barriarer-som-hindrar-nordiskt-forskningssamarbete/) - I rapporten lyfts flera olika typer av hinder, från juridiska till tekniska, som försvårar samarbetet över landsgränserna. – Rapporten pekar på värdet av register och biobanker som en grundläggande infrastruktur för forskningen, men den här guldgruvan används inte på ett optimalt sätt, säger Inger Näsman, policychef på SwedenBIO. Det finns för många legala, etiska, organisatoriska
- [Erbjudande från SwedenBIO: Kommunicera med medlemsrabatt](https://swedenbio.se/erbjudande-fran-swedenbio-kommunicera-med-medlemsrabatt/) - SwedenBIO har förhandlat fram förmånliga avtal som ger våra medlemmar rabatt och skräddarsydd service på Mynewsdesk och Cision. Alla nyheter som distribueras via dessa kanaler publiceras också automatiskt på startsidan på SwedenBIO:s webbplats. Läs mer om erbjudandet här.
- [Välkommen till SwedenBIOs försommarmingel den 17 maj!](https://swedenbio.se/valkommen-till-swedenbios-forsommarmingel-den-17-maj/) - Läs mer och anmäl dig här.
- [Vi söker en policychef till SwedenBIO!](https://swedenbio.se/vi-soker-en-policychef-till-swedenbio/) - Vi arbetar för en konkurrenskraftig life science-bransch i Sverige. Vi skapar effektiva nätverk och mötesplatser med breda kontaktytor, bygger och sprider kunskap samt driver opinion för att ge branschen en stark röst. Till ett av Sveriges mest spännande och utmanande jobb inom life science söker vi nu en Policychef som ska fortsätta vårt outtröttliga arbete
- [Cobra Biologics investerar 165 miljoner i tillverkning av genterapiprodukter](https://swedenbio.se/cobra-biologics-investerar-165-miljoner-sek-utokad-tillverkning-av-genterapiprodukter/) - Cobra investerar under de kommande två åren upp till 15 miljoner GBP (165 miljoner SEK) i en expansionsplan i flera faser, med syftet att stödja företagets kapacitet inom forskning och utveckling när det gäller att utveckla snabba och kostnadseffektiva produktionsplattformar för virala vektorer och plasmid-DNA. I den första fasen, som är förlagd till Storbritannien, utökar
- [Carl-Johan Spak ny styrelsemedlem i SwedenBIO](https://swedenbio.se/carl-johan-spak-ny-styrelsemedlem-swedenbio/) - Varför engagerar du dig i SwedenBIO? Jag anser att SwedenBIO fyller en mycket viktig funktion som en samlingsplats för den svenska life science-industrin. SwedenBIO är unik som organisation med en stor mängd utvecklingsbolag inom både pharma och medtech, större läkemedelsföretag, investerare och service providers bland sina medlemmar. Det är en stor ära att få medverka
- [Oncopeptides vinnare av SwedenBIO Award 2017](https://swedenbio.se/oncopeptides-vinnare-av-swedenbio-award-2017/) - Motiveringen lyder: Efter ett mångårigt professionellt utvecklingsarbete kunde Oncopeptides under 2016 presentera positiva fas II-resultat för läkemedelskandidaten Ygalo i patienter med multipelt myelom, en allvarlig form av blodcancer. Baserat på dessa kliniska resultat slutförde bolaget arbetet med att definiera ett komplett registreringsprogram, vilket godkändes i sin helhet av läkemedelsmyndigheterna både i USA och EU. Framgångarna
- [Lotta Ljungqvist till SwedenBIO:s styrelse: Fler bolag ska växa](https://swedenbio.se/lotta-ljungqvist-till-swedenbios-styrelse-fler-bolag-ska-vaxa/) - – Det är viktigt att vi ger idéer, forskning och innovation möjlighet att utvecklas och slipas i en miljö där man exponeras mot den globala industrin. Det är då vi kan möjliggöra en värdeförädling i vårt land så att fler små bolag kan växa till medelstora företag, säger Lotta Ljungqvist. Hon anser att SwedenBIO har
- [NLSDays: Ulrica Sehlstedt leder session om finansiering av projekt i sen fas](https://swedenbio.se/nlsdays-2017-ulrica-sehlstedt-leder-session-om-finansiering-av-projekt-sen-fas/) - En möjlig lösning är att paketera återstående prövningar och driva dem som samarbetsprojekt med investerare, CRO:er och andra partners med extern finansiering. Hur kan den här typen av biopharma-projekt finansieras? Och hur påverkas life science-ekosystemet av ett överskott av projekt i klinisk fas? Bland annat dessa frågor diskuteras vid 2017 års NLSDays under rubriken A
- [Ebba Fåhraeus och Ulf G Andersson leder Startup Challenge @ NLSDays](https://swedenbio.se/ebba-fahraeus-och-ulf-g-andersson-leder-startup-challenge-nlsdays/) - Startup Challenge går ut på att ett antal bolag, utsedda av de nordiska inkubatorerna, på en begränsad tid får presentera sina företag och innovationer för en krävande jury – allt under ledning av kvällens värdar, inkubatordirektörerna Ebba Fåhraeus på SmiLe Incubator och Ulf G Andersson, Medeon. Startup Challenge anordnas kl. 18.30–20.00 på öppningsdagen av NLSDays, den 12
- [Så ska Sverige bli ledande inom biologiska läkemedel](https://swedenbio.se/sa-ska-sverige-bli-ledande-inom-biologiska-lakemedel/) - Målet är att Sverige ska bli en ledande nation på området och satsningen ingår i ett större forskningsprogram på 320 miljoner och är en del i regeringens strategiska samverkansprogram inom life science. Inom respektive centrum ska flera av våra största läkemedelsbolag arbeta tillsammans med universitet, högskolor och andra aktörer inom hälso- och sjukvården, forskning, utveckling
- [NLSDays: Sista chansen på fredag till förmånligt pris + 30% medlemsrabatt!](https://swedenbio.se/nlsdays-sista-chansen-pa-fredag-till-formanligt-pris-30-medlemsrabatt/) - Planera redan nu för 12–14 september i Malmö-Köpenhamn-regionen. Anställda i SwedenBIO:s medlemsföretag får 30 procents rabatt på registreringsavgiften. Kontakta info(a)swedenbio.se för din medlemskod. Anmäl dig på www.nlsdays.com
- [Partneringportalen är öppen! Sök efter deltagare och skicka mötesförfrågningar!](https://swedenbio.se/partneringportalen-ar-oppen-sok-efter-deltagare-och-borja-skicka-motesforfragningar/) - Konferensen hålls den 12–14 september i Malmö-Köpenhamn-regionen. Anställda i SwedenBIO:s medlemsföretag får 30 procents rabatt på registreringsavgiften. Kontakta info(a)swedenbio.se för din medlemskod. Anmäl dig på www.nlsdays.com och logga in i portalen för att boka dina möten här.
- [Sverige stark kandidat vid EMA-flytt](https://swedenbio.se/ema-till-sverige/) - SwedenBIO:s VD Jonas Ekstrand menar att Sverige har goda chanser, trots att konkurrensen är stenhård. – En fördel för Sverige är att vårt läkemedelsverk är Europas kanske mest respekterade nationella läkemedelsmyndighet. Det märks inte minst på det stora antal kvalificerade uppdrag som EMA årligen lägger ut på Sverige, säger han. Här finns expertkunnande, erfarenhet och tyngd.
- [NLSDays: Hög tid att skicka dina mötesförfrågningar!](https://swedenbio.se/hog-tid-att-skicka-dina-motesforfragningar/) - Just nu pågår mötesbokningarna för fullt! Logga in på partneringportalen och sök bland företag och delegater. Redan nu finns 427 licensingsmöjligheter inlagda. Vi räknar med minst lika många deltagare som förra året, dvs. över 1200 delegater från 680 företag och 36 länder. Senast den 31 augusti bör du ha skickat ut (samt accepterat dina inkommande)
- [SwedenBIO i satsning för enad röst om svenska styrkor inom life science](https://swedenbio.se/swedenbio-satsning-enad-rost-om-svenska-styrkor-inom-life-science/) - Sverige ligger idag bra till när det gäller andelen beviljade anslag från EU, men det kan bli ännu bättre. Det är mot denna bakgrund som påverkansplattformen ska bidra till att synliggöra det bästa av svensk life science på EU-nivå inför det kommande ramprogrammet som än så länge går under arbetsnamnet FP9, Framework Programme 9. –
- [Missa inte Personalized Medicine and Biomarkers i Köpenhamn](https://swedenbio.se/missa-inte-personalized-medicine-biomarkers-kopenhamn/) - - Mötet, som hålls i anslutning till NLSDays, är ett utmärkt tillfälle för den som vill informera sig om kommande arbetspaket inom hälsa och även initiera kontakter för framtida samarbeten, säger Sara Gunnerås, director för EU Support på SwedenBIO och en av talarna på mötet. Bland talarna i övrigt märks bland andra Malin Eklund från
- [Missa inte: Möten med medlemsrabatt](https://swedenbio.se/missa-inte-moten-med-medlemsrabatt/) - Den 20–21 september är det dags för MYiHealth, en konferens tillägnad digital teknik med patienten i fokus. Dag ett hålls i Aula Medica på Karolinska Institutet och dag två i Aula Magna, Stockholms Universitet. Medlemmar i SwedenBIO erhåller 30 procents rabatt på avgiften. Den tionde upplagan av partneringkonferensen Biopharm America arrangeras i Boston den 26–27
- [NLSDays: Första rundan för mötesförfrågningar stänger på torsdag!](https://swedenbio.se/forsta-rundan-motesforfragningar-stanger-pa-torsdag/) - Just nu pågår mötesbokningarna för fullt! Logga in på partneringportalen och sök bland företag och delegater. Redan nu finns 507 licensingsmöjligheter inlagda. Vi räknar med minst lika många deltagare som förra året, dvs. över 1200 delegater från 680 företag och 36 länder. Senast den 31 augusti bör du ha skickat ut (samt accepterat dina inkommande)
- [Femårsjubilerande NLSDays slår rekord](https://swedenbio.se/femarsjubilerande-nlsdays-slar-rekord/) - SwedenBIO har sedan tidigare noterat ett ökande intresse från internationella investerare och globala life science-företag för att satsa på projekt i allt tidigare skede i utvecklingen. NLSDays har vuxit för varje år och nu räknar arrangörerna med att över 2 500 möten mellan företag och investerare kommer att äga rum. Inledningstalar gör Mikael Odenberg, ordförande
- [Helena Strigård ny vice vd på SwedenBIO](https://swedenbio.se/helena-strigard-ny-vice-vd-pa-swedenbio/) - Life science är en av Sveriges mest framgångsrika och betydande näringsgrenar. Fortsatta framgångar kräver en dynamisk och genomtänkt politik. Branschorganisationen SwedenBIO stöder sina 235 medlemsföretag genom att analysera och beskriva verkligheten som dessa befinner sig i. Genom att bidra till ökade kunskaper och en aktiv samhällsdebatt kring life science, kommer SwedenBIO fortsatt att underlätta för
- [Herantis Pharma, Pelago Bioscience and Targovax receive Nordic Stars Award 2017 at NLSDays in Malmö](https://swedenbio.se/herantis-pharma-pelago-bioscience-targovax-receive-nordic-stars-award-2017-nlsdays-malmo/) - Nordic Stars Award was introduced in 2013 in special recognition of life science companies in the Nordic region demonstrating outstanding innovation and entrepreneurial skills. Björn Ursing, Chairman of the Nordic Stars Award: - At SwedenBIO we are proud to present the three winners of the Nordic Stars Award 2017. Each of them has demonstrated impressive entrepreneurial spirit,
- [SwedenBIO i ny podd om integrerad kapitalanskaffning](https://swedenbio.se/swedenbio-ny-podd-om-integrerad-kapitalanskaffning/) - Genom podden vill Hedvig Andersén framför allt vända sig till innovativa företag som vill växa internationellt och så effektivt som möjligt nå sin fulla potential. – Den röda tråden i podden är hur man kan spara både tid och pengar genom att arbeta utifrån en helhetsbild, förklarar Hedvig Andersén. Hon kommer att dela med sig
- [Utvärderingen av EMA-kandidaterna offentlig](https://swedenbio.se/utvarderingen-av-ema-kandidaterna-offentlig/) - Vid rådets möte i oktober väntas en politisk diskussion och det slutgiltiga beslutet fattas vid rådsmötet den 20 november. Läs mer: http://www.lakemedelsvarlden.se/sa-bedoms-stockholm-som-ema-kandidat/ Bedömning i korthet av de 19 anbuden. Läs EU-kommissionens kommentar.
- [Bubbel & Debatt – vad händer på andra sidan bron?](https://swedenbio.se/bubbel-debatt-vad-hander-pa-andra-sidan-bron/) - Moderator är Frida Lawenius, samhällspolitisk direktör på Naturvetarna, och panelen ser ut så här: Mats Persson, CEO, Hamlet Pharma AB Ursula Hultkvist Bengtsson, CEO and founder, Multihelix AB Anna C Hanson, COO, Senzagen AB Bubbel & Debatt arrangeras av Apotekarsocieteten, Kemivärlden Biotech, Naturvetarna, SwedenBIO, och Sveriges Farmaceuter i samarbete med Medicon Village. Anmäl dig till Bubbel
- [Späckad kunskapshöst!](https://swedenbio.se/spackad-kunskapshost/) - Läs vårt senaste nyhetsbrev här.
- [Nya utbildningen: Kom och träffa framtidens kollegor!](https://swedenbio.se/nya-utbildningen-kom-och-traffa-framtidens-kollegor/) - Det är ett outtröttligt arbete lett av Christer Johansson i SwedenBIOs arbetsgrupp för utbildning processutveckling och tillverkning, som ligger bakom tillkomsten av den nya utbildningen. Studenterna tar examen till julen 2018 och är nu på jakt efter praktikplatser, sommarjobb och framtida karriärmöjligheter. Under dagen finns också möjligheter för företag att presentera sin verksamhet. Kontakta utbildningsledare
- [Senior rådgivare förstärker SwedenBIO](https://swedenbio.se/senior-radgivare-forstarker-swedenbio/) - Susanne Baltzer, specialist inom proteinkemi och bioteknik, har en gedigen bakgrund i life science-branschen med erfarenhet från företag med olika inriktning. Hon kommer närmast från Läkemedelsverket där hon var med och byggde upp myndighetens innovationskontor som hade till uppgift att informera om de regler som omger läkemedel och medicintekniska produkter på ett mer begripligt vis.
- [”Granska EU-ansökningar  ger unik inblick”](https://swedenbio.se/granska-eu-ansokningar-ger-unik-inblick/) - – Det ger en unik möjlighet att hålla sig uppdaterad om marknadsutvecklingen, få nya insikter från framgångsrika småföretag och utnyttja nätverksmöjligheter med investerare och andra relevanta aktörer, säger Iris Öhrn. Dessutom kan vi med vår expertis bidra till att bygga vårt innovationslandskap genom att dela kunskap med våra företag och samarbetspartners i Sverige och Norden.
- [EMA-striden: Kartläggning från SwedenBIO visar att Sverige hyllas av redan hitflyttade](https://swedenbio.se/ema-striden-kartlaggning-fran-swedenbio-visar-att-sverige-hyllas-av-redan-hitflyttade/) - Det visar SwedenBIOs kartläggning av redan hitflyttade life science-experter som nu presenteras och sprids i sociala medier inför slutstriden om vilket land som ska ta över värdskapet för den europeiska läkemedelsmyndigheten EMA. Bakgrunden till initiativet är en tidigare undersökning som visat att det finns frågetecken hos delar av dagens EMA-anställda att flytta med till Stockholm
- [Notering – varför och vad innebär det?](https://swedenbio.se/exklusivt-medlemmar-notering-varfor-och-vad-innebar-det/) - Praktisk information När: Torsdagen den 23 november 2017, kl 09:00-16:00, frukost och lunch ingår. Var: Stockholm Waterfront Hotel, Nils Ericsons Plan 4 i Stockholm Frukost och lunch ingår – meddela gärna eventuella allergier. En slutlig agenda kommer att distribueras senare. Anmäl dig här! Läs mer på www.swedenbio.se/notering
- [Välkommen till årets stora inspirations- och nätverksträff!](https://swedenbio.se/swedenbio-summit/) - Fyll på med nya krafter genom att lyssna till inspirerande tips från styrelseexperter. Styrelsen har en viktig funktion men intar inte alltid den roll som hade behövts för att maximera bolagets utfall, och när bolagen utvecklas ställs nya krav på styrelsen. Under SwedenBIO Summit 2017 går vi igenom olika aspekter av styrelsens roll i företaget
- [Nasdaq välkomnar SwedenBIOs initiativ för ny branschstandard avseende informationsgivning](https://swedenbio.se/nasdaq-valkomnar-swedenbios-initiativ-ny-branschstandard-avseende-informationsgivning/) - – Vi vill långsiktigt säkra att life science-bolag kan få tillgång till riskvilligt kapital. Då är det viktigt med hög kvalitet och relevans i informationsgivningen, säger Jonas Ekstrand, VD på SwedenBIO. Och initiativet välkomnas av Nasdaq där life science och biotech är stora och viktiga sektorer. – Det är oerhört värdefullt för investerare att få
- [SwedenBIO lyckönskar Amsterdam - ny värdstad för den europeiska läkemedelsmyndigheten, EMA](https://swedenbio.se/swedenbio-lyckonskar-amsterdam-ny-vardstad-den-europeiska-lakemedelsmyndigheten-ema/) - Sverige hade hoppats på att bli värdland för European Medicines Agency, EMA när myndigheten på grund av Brexit flyttar från London i mars 2019. Av de 19 länder som tävlade om myndigheten är Sverige det land som, efter England, får flest uppdrag av EU-myndigheten. – Självklart är vi mycket besvikna över att EMA inte omlokaliserades
- [Krönika: "Det är något som ännu gnisslar i relationen mellan industrin och universiteten"](https://swedenbio.se/kronika-det-ar-nagot-som-annu-gnisslar-relationen-mellan-industrin-och-universiteten/) - Jonas Ekstrand menar att vi bör titta på hur andra länder löst detta och lyfter bland annat fram Kanada och USA där seniora industriforskare kan göra sabbaticals i akademiska laboratorier. Han skriver: Vi skulle kunna stimulera till ökad rörlighet genom fler utlysningar för delade forskartjänster och inrätta ett system med sabbaticals och öka det akademiska
- [Nytt avsnitt av Hedvigpodden: SwedenBIO om den nya branschstandarden för life science-bolag](https://swedenbio.se/nytt-avsnitt-av-hedvigpodden-6-swedenbio-om-den-nya-branschstandarden-life-science-bolag/) - Hedvig Andersén, initiativtagare till podden, har i närmare 20 år arbetat med riskkapitalinvesteringar och genom podden vill hon på ett lättsamt sätt väcka intresse för mer komplexa frågor. – När jag arbetade som investerare insåg jag hur mycket tid och pengar företagen kunde spara genom att arbeta mer integrerat och se till att kapitalanskaffningen gick
- [Invitation to participate in the Swedish Precision Medicine survey](https://swedenbio.se/invitation-participate-swedish-precision-medicine-survey/) - Who may participate? You have a B2B company registered in Sweden and conduct the majority of your R & D in Sweden. You develop innovative products such as biomarkers, diagnostic or prognostic assays, technologies, services, screening tools, platforms, software, etc. with application in Precision Medicine, especially within: • Diagnostics (e.g. Biomarkers, Companion Diagnostics, Imaging, -Omics)
- [”Statlig life science-satsning – viktigt steg i rätt riktning”](https://swedenbio.se/statlig-life-science-satsning-viktigt-steg-ratt-riktning/) - ”Statlig life science-satsning – viktigt steg i rätt riktning” Statens nya riskkapitalbolag har fattat beslut om sin första investering: 160 miljoner kronor satsas i en life science-specialiserad fond som ska investera i svenska företag.– Det här är en bra början som kan underlätta riskkapitalanskaffning för life science-bolag samtidigt som det är ett kvitto på att
- [Riskkapital i fokus i årets sista poddavsnitt](https://swedenbio.se/riskkapital-fokus-arets-sista-poddavsnitt/) - Kanske av särskilt intresse för SwedenBIOs medlemmar torde vara den del av diskussionen som belyser i vilket skede life science-bolag är mogna för en börsnotering. Avslutningsvis delar de rutinerade poddgästerna med sig av några goda råd till företag som söker riskkapital. Som alltid finns Hedvigpodden både på webbenoch på iTunes.
- [Hedvig summerar i 2018 års första poddavsnitt](https://swedenbio.se/hedvig-summerar-2018-ars-forsta-poddavsnitt/) - Som alltid finns Hedvigpodden både på webbenoch på iTunes.
- [Vad gör egentligen en policychef?](https://swedenbio.se/vad-gor-egentligen-en-policychef/) - En rad frukostmöten och event har också ordnats, till vårt EU Support Office har många företag kommit för att få information och stöd med sin Horizon 2020-ansökan och det är tydligt att vi blir lyssnade på i den beslutsfattande sfären. Signaler från branschen visar att fler och fler fått upp ögonen för att denna näringsgren
- [Kontor för life science viktig signal för branschen](https://swedenbio.se/kontor-life-science-viktig-signal-branschen/) - Näring- och innovationsministern Mikael Damberg, ministern för högre utbildning och forskning Helene Hellmark Knutsson samt socialminister Annika Strandhäll skriver gemensamt i Dagens Medicin idag om det nya kontoret. Inrättandet beskrivs som ett nästa steg, efter expertrådet för life science tillblivande och samverkansprogrammen. – Exakt hur det nya kontoret kommer att utformas eller vad som händer
- [Södertälje skapar större konkurrenskraft inom hållbar produktion](https://swedenbio.se/sodertalje-skapar-storre-konkurrenskraft-inom-hallbar-produktion/) - Ambitionen är att bli en innovativ utvecklingsarena och kunskapsnod för hållbara produktionsflöden. Bakom samarbetet står Södertälje kommun, KTH, Scania, AstraZeneca och Acturum. Södertälje Science Park och nya KTH Södertälje erbjuder gemensamt 1 200 nya utbildningsplatser och forskartjänster i en helt nyuppförd anläggning signerad Acturum. Invigningen förrättades gemensamt av Helene Hellmark Knutsson, minister för högre utbildning
- [Brexit kan ge fler svenska AstraZeneca-jobb](https://swedenbio.se/brexit-kan-ge-fler-svenska-astrazeneca-jobb/) - Samma dag uppger Pam Cheng, produktionschef på AstraZeneca, i en intervju med Dagens Nyheteratt de merkostnader som följer på brexit kommer att leda till fler anställningar i Sverige. Företaget har redan beslutat att duplicera kvalitetstestandet av läkemedel i Sverige, och Pam Cheng utesluter inte att fler arbetstillfällen kan tillkomma. – Brexit är ett exempel bland
- [Ny politikerprao sätter fokus på life science](https://swedenbio.se/ny-politikerprao-satter-fokus-pa-life-science/) - För Lars Hjälmered var dagen ett sätt att få handfasta besked om vad som utgör hinder och förutsättningar för branschen, både nationellt och lokalt för Göteborg – Tillgången på expertkompetens var en sak vi diskuterade. Bostadsbrist, visumregler och tillgång till internationella förskolor och skolor är sådant som spelar in. Där måste vi göra mer både i
- [Kallelse till föreningsstämma 2018](https://swedenbio.se/foreningsstamma-2018/) - Datum: måndagen den 19 mars 2018 Tid: klockan 18.00 – 18.30 Plats: Vasamuseet, Galärvarvsvägen 14, Stockholm PDF: Kallelse Ordinarie Föreningssammanträde Föreningen SwedenBIO 2018 PDF: Protokoll Valberedning SwedenBIO Välkommen!
- [Ny rapport kartlägger det svenska industrilandskapet inom precision medicine](https://swedenbio.se/ny-rapport-kartlagger-det-svenska-industrilandskapet-inom-precision-medicine/) - – Vår ambition med rapporten är att skapa en överblick över detta spännande life science-segment, samt att exponera svenska företag inom området för globala aktörer. Vi vill stimulera till fler samarbeten och investeringar i Sverige, säger Sara Gunnerås, redaktör och analyschef, SwedenBIO. Med en lång tradition inom proteinvetenskap och avancerad bildteknik som matchas av en
- [Tyck till om Processindustriell IT och Automation (PiiA)](https://swedenbio.se/piia-enkat/) - Men hur väl mappar programmet mot branschens behov? Hur behöver programmet utformas för att ge goda förutsättningar för mindre bolag att delta i projekten? SwedenBIOs arbetsgrupp för processutveckling och tillverkning har tagit fram en enkät till medlemmarna med syfte att få svar på det. En sammanställning av synpunkterna kommer att förmedlas till PiiA. Länk till enkäten: https://www.surveymonkey.com/r/PiiA
- [SwedenBIO lanserar faktablad](https://swedenbio.se/swedenbio-lanserar-faktablad/) - Det här är en produkt för medlemmar, av medlemmar. Det finns väldigt mycket kunskap bland SwedenBIO-företagen och faktabladen är ett sätt att dra nytta av den gemensamt. Tanken är att ge praktisk information och handfasta råd i ett för medlemmarna relevant område. Under året kommer SwedenBIO att bygga upp ett litet bibliotek av faktablad på olika teman. PDF:
- [Seminarium: "Pathway for Drug Development"](https://swedenbio.se/seminarium-pathway-drug-development/) - Att fråga rätt frågor är viktigt för företag som närmar sig klinisk fas. Vi har samlat experter inom läkemedelsutveckling för en halvdagsutbildning och kommer att belysa grunderna inom klinisk forskning och hur man tar sig över olika hinder. Mötet vänder sig främst mot mindre bioteknikbolag som vill veta mer om övergången mellan preklinisk forskning till
- [Välkommen till SwedenBIO Opinion](https://swedenbio.se/swedenbio-opinion/) - På scen moderaternas näringspolitiske talesperson Lars Hjälmered samt näringsutskottets ordförande Jennie Nilsson (S), följt av en panel av life science-företagare. Handlingsplanen för life science som SwedenBIO, LIF och Swedish Medtech åter tar fram gemensamt kommer att presenteras för första gången, med åtgärdsförslag för att stärka Sveriges konkurrenskraft. När? Onsdagen den 16 maj. Politikerdebatt och företagspanel kl
- [Nominera till SwedenBIO Award](https://swedenbio.se/nominera-till-swedenbio-award-2018/) - För att komma till nomineringsformuläret >>> klicka här. SwedenBIO Award är branschens eget pris och består, utöver äran, av ett vandringspris och två delegatplatser till Nordic Life Science Days. Vinnaren av SwedenBIO Award 2018 presenteras på SwedenBIO Opinion den 16 maj. Priset ska stärka visionen av Sverige som en ledande life science-nation samt bidra positivt till bilden
- [B2B ger tillväxtmöjligheter inom life science](https://swedenbio.se/b2b-ger-tillvaxtmojligheter-inom-life-science/) - För Getinge är life science ett framtidsområde där det finns stora fördelar att producera i Sverige. Komplexa produkter och kunder inom biomedicinsk forskning, läkemedels-produktion och produktion av medicinteknisk utrustning innebär en B2B-logik där Sverige som produktionsland har många styrkor att hävda sig med. Men för att företagen ska kunna växla upp krävs tillgång till kompetens.
- [Dags att söka till Startup Challenge @NLSDays](https://swedenbio.se/dags-att-soka-till-startup-challenge-nlsdays/) - Hur känns det att Umeå Biotech Incubator fick äran att anordna årets Startup Challenge? – Jätteroligt! Vi hoppas att det ska bli ett bra koncept och jobbar hårt för att bolag från alla de nordiska länderna anmäler sig, säger Jennie Ekbeck, VD Umeå Biotech Incubator. Hur går planeringen? – Det går bra och enligt plan. Just
- [Nå ut till hela Europa med EURES!](https://swedenbio.se/na-ut-till-hela-europa-med-eures/) - Genom detta nätverk av arbetsförmedlingar kan du som arbetsgivare nå ut i hela EU med kravspecifikationer på en kompetensprofil. Du kan få hjälp med annonsering, med ansökan om ekonomiskt stöd vid omlokalisering och med introduktion för nyanställda. En annan möjlighet är att tillsammans med EURES delta på mässor runt om i Europa. – Företag är
- [Nytt faktablad om hur du navigerar i patentlandskapet](https://swedenbio.se/nytt-faktablad-om-hur-du-navigerar-patentlandskapet/) - – Inom life science är medvetenheten om patent generellt sett hög; de flesta företag har bra koll på sina egna patent. Men det är din skyldighet att alltid respektera andras patent, och där ser vi oftare brister i den interna hanteringen. Därför märker vi en ökad efterfrågan kring att informera om och arbeta strategiskt med
- [Sobi tar plats i SwedenBIOs styrelse](https://swedenbio.se/sobi-tar-plats-swedenbios-styrelse/) - ... med integrerad kompetens som omfattar hela värdekedjan, från forskning till preklinisk och klinisk utveckling, biologisk läkemedelstillverkning, distribution och tillgängligörande av läkemedel för patienterna. – Det är mycket värdefullt för oss att få in Kirsti i vår styrelse, säger Jonas Ekstrand, VD SwedenBIO. Hon har gedigen erfarenhet från branschen och Sobi är med sin storlek
- [Krönika: The Nordic USP](https://swedenbio.se/kronika-nordic-usp/) - Så inleder Helena Strigård, policychef SwedenBIO, sin krönika "The Nordic USP" i det senaste numret av Nordic Life Science News. Läs krönikan här: Thank you Denmark! Seriously, on behalf of the Swedish life science industry organization, I mean it. Thank you for continuously keeping us on our toes, showing us and our politicians that international
- [BioArctic vinnare av årets SwedenBIO Award](https://swedenbio.se/bioarctic-vinnare-av-arets-swedenbio-award/) - Starka samarbeten med både akademin och globala läkemedelsbolag samt en hög vetenskaplig ambition har gett årets vinnare av priset en portfölj av innovativa projekt för behandling av sjukdomar i centrala nervsystemet. Ett område där de medicinska och samhälleliga behoven är växande. Det internationellt uppmärksammade bolaget har sedan starten 2003 byggts upp och skickligt finansierats av
- [Life science-branschen i Sverige växer!](https://swedenbio.se/life-science-branschen-sverige-vaxer/) - Från enmansbolag inom bio- och medicinteknik till globala life science-jättar och kliniska prövningsföretag, från patent- och juristbyråer till science parks och finansiärer. – Det är precis den här bredden vi eftersträvar, berättar Jonas Ekstrand, VD SwedenBIO. Helheten har blivit vår nisch. Det talas ofta om ekosystemet som life science i Sverige utgörs av, där samspelet
- [Nytt faktablad: Regulatoriska myndigheter bidrar till framgångsrik läkemedelsutveckling](https://swedenbio.se/nytt-faktablad-regulatoriska-myndigheter-bidrar-till-framgangsrik-lakemedelsutveckling/) - – Oavsett om företaget har för avsikt att avyttra ett projekt efter en viss utvecklingsfas eller planerar att själva marknadsföra sin produkt, ger en tydlig strategi ett ökat intresse hos en potentiell partner, menar Eva Lilienberg, Service Area Lead, på enheten för global utveckling. – Det sparar företaget både tid och pengar och säkerställer att
- [Inbjudan att delta i ny undersökning om finansieringslandskapet](https://swedenbio.se/inbjudan-att-delta-ny-undersokning-om-finansieringslandskapet/) - Enkäten ska ligga till grund för en rapport över finansieringsstrategier hos tidiga forskningsbolag där vi tittar på hur valet av finansieringsform, alltifrån olika mjuka medel till aktiekapital, kan påverka bolagens chanser att ta sig vidare i värdekedjan. Vi vänder oss till ett brett urval av life science-bolag i olika utvecklingsskeden med ett krav på att
- [Seminarium i affärsutveckling 16 okt](https://swedenbio.se/seminarium-i-affarsutveckling/) - Kursen är fullbokad.
- [Vi söker en junior projektkoordinator / executive assistant](https://swedenbio.se/vi-soker-en-junior-projektkoordinator-executive-assistant/) - Rollen Som executive assistant kommer du att vara en viktig nod både för kansliet och för våra medlemsföretag. Life science-branschen växer och vi med den. Vår medlemsskara ökar stadigt och du kommer in i ett spännande skede där vi ser över och utvecklar vår verksamhet. Du kommer att handha en bredd av utmanande och stimulerande
- [Tyck till om Processindustriell IT och Automation (PiiA)](https://swedenbio.se/tyck-till-om-processindustriell-och-automation-piia/) - Men hur väl mappar programmet mot branschens behov? Hur behöver programmet utformas för att ge goda förutsättningar för mindre bolag att delta i projekten? SwedenBIOs arbetsgrupp för processutveckling och tillverkning har tagit fram en enkät till medlemmarna med syfte att få svar på det. En sammanställning av synpunkterna kommer att förmedlas till PiiA. Länk till enkäten: https://www.surveymonkey.com/r/PiiA
- [Inspel till life science-strategin](https://swedenbio.se/inspel-till-life-science-strategin/) - – SwedenBIOs arbete sker på flera plan. Dels handlar det om att bidra med fakta, konsekvensanalyser och förslag i de arbetsgrupper m.m. under Life science-kontoret där SwedenBIO ingår, men också att gå bredare än så. Vi har identifierat frågor som är prioriterade för SwedenBIOs medlemmar och som inte fångats upp i ”Färdplan Life Science” som
- [Ilya Pharma först ut på Testa Center – industrialiserar sin teknologi för accelererad sårläkning](https://swedenbio.se/ilya-pharma-forst-ut-pa-testa-center-industrialiserar-sin-teknologi-accelererad-sarlakning/) - – Vi har utvecklat modifierade mjölksyrabakterier som fungerar som små bioreaktorer av terapeutiska kroppsegna proteiner direkt i sår på huden och i mag-tarmkanalen och det snabbar på läkningsprocessen, berättar Evelina Vågesjö, VD på Ilya Pharma. Under våren genomfördes de sista säkerhets-studierna i större djur och GMP-tillverkningen inleds snart. Parallellt får bolaget chansen att ytterligare verifiera
- [Hedvigpodden – now launched in English!](https://swedenbio.se/hedvigpodden-now-launched-english/) - Hedvig Andersén, an experienced consultant who has worked as an investor with venture capital investments in life science for almost 20 years, started the podcast together with SwedenBIO to share her and other experts’ experiences and make complex questions easily accessible. – When I worked as an investor, I realized how time and money can
- [Nytt samarbete med mediekanalen Nordic Life Science](https://swedenbio.se/nytt-samarbete-med-mediekanalen-nordic-life-science/) - Genom nyhetstjänsten Nordic Life Science News, affärsmagasinet Nordic Life Science och nyhetsportalen www.nordiclifescience.org får över 40 000 läsare över hela världen ta del av de senaste nyheterna, affärerna, marknadstrenderna, forskningen och utvecklingen inom läkemedel, medicinteknik, bioteknik och diagnostik. Läs mer om erbjudandet här (kom ihåg din rabattkod: SWEDENBIO): https://nordiclifescience.org/swedenbio-subscription/ Det är också möjligt att testa
- [Inspel till nationella life science-strategin](https://swedenbio.se/infor-framtagandet-av-den-nationella-life-science-strategin/) - En tydlig satsning på life science kräver engagemang från flera håll Regeringen tillsatte 2015 en life science-samordnare som arbetat med att lyfta flera viktiga områden. I februari tillsatte regeringen även ett life science-kontor som under året ska komma med en agenda och strategi. Det är dock först när beslut och satsningar blir till handling som
- [Ji Vichitong ny medarbetare på SwedenBIO](https://swedenbio.se/ji-vichitong-ny-medarbetare-pa-swedenbio/) - Med en roll som executive assitant/koordinator kommer det vara naturligt med mycket medlemskontakt och en roll som ”spindeln-i-nätet”. Ji kommer närmast från en projektledarroll på Office Development, har en bakgrund som egenföretagare inom läderdesign och tävlar i padel på fritiden.
- [Nu är registreringen till NLSDays 2019 öppen!](https://swedenbio.se/registreringen-nlsdays-2019/) - SwedenBIO-medlemmar får 30% rabatt på registreringsavgiften samt företagspresentationer. Rabatten gäller medlemsföretagens anställda i Sverige och förbokning av företagspresentationen görs i samband med anmälan. Glöm inte att ange din personliga rabattkod vid anmälan. Registrera idag och dra nytta av early bird priser! Saknar du din kampanjkod? Kontakta info@swedenbio.se. Besök vår NLSDays webbsida för kontinuerligt uppdaterad information. Registrera
- [Kansliet önskar god helg!](https://swedenbio.se/kansliet-onskar-god-helg/)
- [Nytt avsnitt av Hedvigpodden ute](https://swedenbio.se/nytt-avsnitt-av-hedvigpodden-ute/) - Börja med slutet och gör en exitanalys! Detta ger dig en överblick om hur allt hänger ihop som kommunicerande kärl och hur ett beslut inom ett område kan få oanade konsekvenser inom ett helt annat område i framtiden. Hedvig delar också med sig av några andra tankar som hon hoppas kan vara till nytta. Du hittar Hedvigpodden här eller
- [Light on the horizon for Swedish biopharma](https://swedenbio.se/light-horizon-swedish-biopharma/) - Läs hela artikeln: SwedishBiopharma Nov-Dec 2018 MedNous.
- [Nytt år och nya möjligheter att söka finansiering från EU!](https://swedenbio.se/nytt-ar-och-nya-mojligheter-att-soka-finansiering-fran-eu/) - Under hösten träffade supportkontoret Matteo Fedeli, Programme Management Call and Evaluation Coordinator på Eurostars projektkontor i Bryssel. Under en dag diskuterade vi Eurostarsprogrammet och gjorde bl.a. textgranskningar av redan granskade ansökningar för att jämföra supportens kunskaper med ett par verkliga case vilket gav nya insikter i utvärderingsförfarandet. Ta ta del av våra nyvunna kunskaper genom
- [Medlemsförmåner – planera in för årets möten!](https://swedenbio.se/medlemsformaner-planera-arets-moten/) - Passa redan nu på att kombinera 30% medlemsrabatt med early bird-priser till NLSDays den 10-12 sep i Malmö. Kontakta info@swedenbio.se för dina personliga rabattkoder. BIO-Europe Spring, 25-27 mars, Wien ChinaBio Partnering Forum, 8-9 maj, Shanghai Knowledge for Growth, 8-9 maj, Ghent BIO International Convention, 3-6 juni, Philadelphia Nordic Life Science Days, 10-12 sep, Malmö BioPharm
- [Årets kalendarium ute nu!](https://swedenbio.se/arets-kalendarium-ute-nu/) - Lär med och ladda. hem pdf:en här: SwedenBIO- Detta händer 2019
- [Inspel till regeringen om stärkt internationell attraktionskraft och lyskraft](https://swedenbio.se/ekosystemet-samlar-sig-bakom-uppgiften-att-starka-sveriges-attraktions-och-lyskraft-som-life-science-nation/) - Uppslutningen och engagemanget bakom inspelet talar sitt tydliga språk – det brådskar att ta sig an uppgiften. Ekosystemet är redo att hugga i, nu behöver regeringen möta upp med resurser och tydliga signaler i den nationella life science-strategin. Vårt inspel har samlat en bredd av aktörer, från akademi, inkubatorer och science parks, forskningsinfrastrukturer, branschorganisationer, offentliga
- [Ny temadag! Optimera din affärsutveckling för medicintekniska produkter](https://swedenbio.se/ny-temadag-optimera-din-affarsutveckling-medicintekniska-produkter/)
- [Nytt faktablad: Missa inte möjligheten att förlänga din ensamrätt på marknaden](https://swedenbio.se/nytt-faktablad-missa-inte-mojligheten-att-forlanga-din-ensamratt-pa-marknaden/) - Varför behöver life science-företag känna till SPC-förordningen? – För life science-bolag tar det ofta lång tid att få produkterna på marknaden vilket gör den effektiva patenttiden kort. SPC är ett sätt att maximera skyddstiden och därmed intäkterna, berättar Joanna Applequist, European Patent Attorney på Valea. Varför är tilläggsskyddet aktuellt just nu? – SPC:er är ett ständigt aktuellt
- [AI Innovation of Sweden invigd](https://swedenbio.se/ai-innovation-sweden-invigd/) - – Genom att använda AI kan vi bättre analysera den stora mängd data som vi får genom vår forskning och utveckling. Vi hoppas och tror att detta samarbete kommer leda till insikter från andra branscher kring hur man strukturerar och analyserar olika datakällor och det kommer ge goda effekter för life science-branschen, säger Anders Holmén,
- [NLSDays: Sista chansen med early bird!](https://swedenbio.se/nlsdays-sista-chansen-med-early-bird/) - Passa på att anmäla dig före februari månads slut för att ta del av både early bird och 30% medlemsrabatt (gäller inte investerare som har egen förmånlig priskategori). Små företag och akademiska forskare får ytterligare rabatt. Kontakta info@swedenbio.se för din unika medlemskod. Anmäl dig här: www.nlsdays.com
- [Episode #21: Optimise design to minimise elements of failure](https://swedenbio.se/episode-21-optimise-design-minimise-elements-failure/) - We will also talk about the long-term risks associated with poor design of clinical trials and underline some of the typical reasons why a study fails. Finally, Rupert will give his view on what it takes to design a good trial and how this can best be achieved. So, go in and listen! http://www.torsen.se/podcast/
- [Medlemsrabatt: BIO Europe Spring](https://swedenbio.se/medlemsrabatt-bio-europe-spring/) - Till registreringen: https://ebdgroup.knect365.com/bioeurope-spring/
- [Ny rapport om svenska läkemedelsprojekt riktade mot sällsynta sjukdomar](https://swedenbio.se/ny-rapport-om-svenska-lakemedelsprojekt-riktade-mot-sallsynta-sjukdomar/) - nga svenska forskningsintensiva företag som utvecklar behandlingar mot sällsynta sjukdomar och som har stor potential att göra skillnad för patienter som idag kan stå mer eller mindre utan adekvat behandling. Sedan år 2000 har 107 orphan drug designations blivit beviljade svenska företag av den amerikanska resp. europeiska läkemedelsmyndigheten. – Investerare, särskilt från USA, efterfrågar rare disease-projekt och därför
- [Rotation på ordförandeposter i SwedenBIOs arbetsgrupper](https://swedenbio.se/rotation-pa-ordforandeposter-swedenbios-arbetsgrupper/) - Enligt Janet är produktionsgruppen är en viktig träffpunkt för de tillverkande bolagen och ett forum att ta sig an utmaningar för branschen. Det handlar till exempel om att nå ut till unga med vad jobb i modern, avancerad life science-produktion faktiskt innebär och uppmärksamma att Sverige är i frontlinjen som produktionsland. – Flera bolag väljer just nu
- [Letar du nytt jobb eller kandidater?](https://swedenbio.se/letar-du-nytt-jobb-eller-kandidater/) - Magasinet utgör ett forum för erfarenhetsutbyte, debatt och eftertanke som tar det vida perspektivet på läkemedelsindustrin. Artiklarna spänner över hela spektrat från ledarskap till politiska förändringar som påverkar branschen. Meddela redaktionen@pharma-industry.se om ert företag är intresserad av en kostnadsfri prenumeration. Vill du hellre prenumerera på den digitala upplagan, anmäl dig här. Anmäl dig till nyhetsbrevet från Pharmajobb.se här.
- [NLSDays: partnering öppnar 1 juli](https://swedenbio.se/nlsdays-partnering-oppnar-1-juli/) - För dig om inte hunnit anmäla dig, kontakta info@swedenbio.se för din unika medlemskod. Alla anställda i SwedenBIOs medlemsföretag i Sverige har 30% medlemsrabatt. Små företag och akademiska forskare får ytterligare rabatt. Medlemsrabatten gäller inte investerare som har egen priskategori. www.nlsdays.com
- [Nästa cut-off för SME Instrumentet fas ett 5 september](https://swedenbio.se/nasta-cut-off-sme-instrumentet-fas-ett-5-september/) - Näst på tur är sista möjligheten att söka SME Instrumentet fas 1 där cut-off är 5 september. Man kan där få 50.000 euro för att undersöka den tekniska genomförbarheten och den kommersiella potentialen i sitt projekt. Vi kan vara med och se hur väl ditt projekt passar för finansiering från EU eller Eureka. När ni
- [Helena Strigård ny vd på SwedenBIO](https://swedenbio.se/helena-strigard-ny-vd-pa-swedenbio/) - – Jag är mycket glad att Helena Strigård har tackat ja till uppgiften att leda Sveriges största branschförening för life science. Som vice vd på SwedenBIO har hon starkt bidragit till organisationens positiva utveckling och jag är övertygad om att hon kommer att kunna vidareutveckla verksamheten som nu befinner sig i kraftig expansion, säger SwedenBIOs
- [Vill se tjänsteföretagen expandera internationellt](https://swedenbio.se/vill-se-tjansteforetagen-expandera-internationellt/) - Därför har SwedenBIO inlett ett samarbete med Business Sweden, som ska underlätta för tjänstebolag att expandera internationellt. I ett första steg har två workshops ägt rum, ett i Lund och ett i Stockholm, för att få en uppfattning av behov och önskade aktiviteter. – Vi har nu en bra utgångspunkt för att ta fram ett
- [Save the date: SwedenBIO Summit](https://swedenbio.se/save-date-swedenbio-summit-2019/)
- [Gehör för utökat FoU-avdrag – en av SwedenBIOs hjärtefrågor](https://swedenbio.se/gehor-utokat-fou-avdrag-en-av-swedenbios-hjartefragor/) - Policyarbete påminner ibland om forskning. Det är tålamodskrävande och gäller att nöta på, ibland år efter år. Vårt arbete med frågan har lyfts i handlingsplan för life science och i den arbetsgrupp under life science-kontoret som SwedenBIO ledde tidigare i år (Inspel attraktionskraft lyskraft). Tack L och regeringen för att ni lyssnat! Se artikel i
- [Senior medarbetare till SwedenBIO](https://swedenbio.se/senior-medarbetare-till-swedenbio/) - Du kommer att få engagera dig i policyfrågor där du tillsammans med vd formar strategier, insatser och verkställer dem. Policyarbete för oss är inte bara påverkansarbete utan en del av ett holistiskt arbetssätt där vi som organisation aktivt bidrar till den förändring vi önskar få beslutsfattare att agera för. I vår portfölj av handfasta åtgärder
- [Ett effektivare investeringsfrämjande](https://swedenbio.se/ett-effektivare-investeringsframjande/) - Nyligen löpte remisstiden ut för den statliga utredningen för ett effektivare investeringsfrämjande, där SwedenBIO bidragit genom intervjuer under arbetets gång. I vårt remissvar uppmanar vi regeringen att resurssätta detta politikområde som varit kraftigt eftersatt under många år, vilket drabbat vår internationella synlighet som life science-nation. Vi berättar vilka initiativ som tagits av aktörer som SwedenBIO
- [Små och medelstora tjänstebolag välkomnas på studieresa till Berlin i februari](https://swedenbio.se/sma-och-medelstora-tjanstebolag-valkomnas-pa-studieresa-till-berlin-februari/) - SwedenBIO arbetar aktivt med att lyfta tjänstebolagens betydelse för life science. Som vi tidigare uppmärksammat i nyhetsbrevet (”Vill se tjänsteföretagen expandera internationellt”) pågår en dialog med Business Sweden och ett antal medlemmar kring detta. Nu är du som företrädare för ett mindre tjänstebolag inom life science (CDMO/CRO) varmt välkommen att delta på studieresa! Resan går
- [Där gick startskottet för regeringen – life science-strategin är här!](https://swedenbio.se/dar-gick-startskottet-regeringen-life-science-strategin-ar-har/) - Strategin är mycket efterlängtad av hela sektorn, näringsliv, akademi och hälso- och sjukvård har alla av bidragit med förslag och många aktörer, inte minst SwedenBIO, är redan igång med att göra sitt för att implementera vad vi kan av de förslag som spelats in. Nu väntar vi oss att regeringen gör detsamma, konstaterar Helena Strigård,
- [Dags att fylla i pipeline-enkäten!](https://swedenbio.se/pipeline2020/) - Klicka på länken för att delta: https://www.surveymonkey.com/r/pipeline2020 Varför en rapport? Rapporten är ett verktyg för SwedenBIO och våra partners för att marknadsföra svensk life science globalt och mer specifikt lyfta svenska företag aktiva inom läkemedelsforskning och utveckling. Rapporten tas även fram för att få en nationell överblick av branschen och dess behov för att kunna påverka
- [Frida Lawenius ny vice vd på SwedenBIO](https://swedenbio.se/frida-lawenius-ny-vice-vd-pa-swedenbio/) - SwedenBIO är med sina över 260 medlemmar från hela ekosystemet för life science i Sverige en organisation som växer kraftigt och får allt större synlighet och betydelse. Vår styrka ligger i att vi har örat mot marken och jobbar – inte bara nära – utan tillsammans med våra medlemmar. Genom att kombinera ihop policyarbete där vi
- [Boka in årets möten!](https://swedenbio.se/boka-arets-moten/) - Ladda ner årshjulet här: SwedenBIO: Det här händer 2020
- [Föreningsstämma 2020](https://swedenbio.se/foreningsstamma-2020/) - Datum: tisdagen den 10 mars 2020 Tid: klockan 17.30 Plats: Fjärilshuset i Hagaparken, 16970 Solna PDF: Kallelse Ordinarie Föreningssammanträde Föreningen SwedenBIO 2020 PDF: Valberedningens protokoll PDF: Förslag till stämmobeslut PDF: Årsredovisning föreningen SwedenBIO 2019
- [Nu behövs alla delar av ekosystemet!](https://swedenbio.se/fraga/) - Ett läge där regulatoriska myndigheter, akademi, hälso- och sjukvård och näringsliv behöver lyssna på varandra och jobba ihop för att nå gemensamma mål som ytterst handlar om att rädda och förlänga liv. Just nu är denna livsviktiga växelverkan mer tydlig än någonsin. SwedenBIO, som den nationella branschorganisationen för life science, samlar en betydande del av
- [Ställ en fråga](https://swedenbio.se/stall-en-fraga/) - Vad sker inom den svenska life science-branschen för att möta Corona-utmaningen? Hur kan vi som biotechföretag bidra med vår forskning och vilka pengar finns att söka? Vad innebär regeringens stödpaket? Svaret på frågorna hittar du här: https://swedenbio.se/covid-19/ Om SwedenBIO Branschorganisationen SwedenBIOs drygt 260 medlemsföretag har totalt 20 000 anställda som på olika sätt bidrar till utvecklingen av
- [Snabbutlysning för Covid-19](https://swedenbio.se/snabbutlysning-covid-19/) - Hur kan vi som biotechföretag bidra med vår forskning och vilka pengar finns att söka? a) EU har genom EIC Accelerator öppnat en snabbutlysning för finansiering till små innovativa företag som kan bidra till lösningar. Ansökan stänger redan 18 mars. Läs mer här. Kontakta gärna SwedenBIOs EU SME Support vid frågor. b) Genom EU-initiativet IMI finansieras
- [Medlemsintervju: Svenska virusbekämpare är redo](https://swedenbio.se/svenska-virusbekampare-ar-redo/) - Det här är några av soldaterna vid fronten i kriget mot viruset. Läkemedelsutvecklarna som hoppas kunna hitta en substans som botar eller lindrar de allvarliga symtom som olika virus kan ge. Hur nära en substans som verkar mot coronaviruset, är ni? -- Den substans vi utvecklar är effektiv främst mot enterovirus, en annan grupp
- [VD-brev med anledning av Covid-19](https://swedenbio.se/vd-brev-med-anledning-av-covid-19/) - ...för att höra hur börsoro, direktiv om att jobba hemifrån och tvärstopp i kliniska prövningar och mycket annat har påverkat er. Och vad ni behöver. Fortsätt gärna höra av er! Det som händer med er input är att vi omvandlar den till två ting. Dels åtgärder som ligger inom vår makt och kapacitet att genomföra.
- [I gott sällskap eller vad hände med smekmånaden?](https://swedenbio.se/gott-sallskap-eller-vad-hande-med-smekmanaden/) - Så fort man tror att man ridit ut en storm dyker det upp en ny. Ett orosmoln som hägrar är om vi lyckas upprätthålla en tillräcklig produktion av läkemedel för att täcka de medicinska behoven. Bolagen kämpar med att hålla igång produktionen i ett läge där vi även kan behöva skala upp och ställa om
- [Reducerad medlemsavgift för startup-bolag knutna till inkubatorer](https://swedenbio.se/reducerad-medlemsavgift-startup-bolag-knutna-till-inkubatorer/) - För bolagen som kvalificerar för den här möjligheten gäller medlemskapet i två år. Med denna kraftigt reducerade avgift vill vi bidra till att startup-bolagen ska kunna ta del av den styrka som kommer av att ingå i en community med erfarenhetsutbyten bolag emellan och vårt fulla utbud av medlemsförmåner. Genom att få tillgång till våra
- [Vad händer med mina patent om resultaten blir försenade?](https://swedenbio.se/vad-hander-med-mina-patent-och-patentansokningar-om-resultaten-blir-forsenade/) - Situation 1: Första patentansökan (prioritetsgrundande ansökan) Eftersom det inte är möjligt att lägga till nya uppgifter i en patentansökan efter ingivningsdagen, kan det vara klokt att överväga att skjuta på inlämningen av ansökan tills resultat har genererats. Detta förutsätter att uppfinningen kan hemlighållas tills inlämning av ansökan har skett, annars går uppfinningens nyhet ändå förlorad
- [Vad gör regulatoriska myndigheterna med anledning av Covid-19?](https://swedenbio.se/vad-gor-regulatoriska-myndigheterna-med-anledning-av-covid-19/) - Vad gör regulatoriska myndigheterna med anledning av COVID-19 pandemin? Även om klinisk prövning är en nationell fråga så samverkar Läkemedelsverket med systermyndigheter inom EU för att i möjligaste mån ha samsyn om hur kliniska prövningar ska hanteras under rådande omständigheter. Myndigheterna har förståelse för att pandemin får stora konsekvenser för kliniska prövningar och har publicerat
- ["Effekterna på vår verksamhet ligger en bit framåt i tiden"](https://swedenbio.se/effekterna-pa-var-verksamhet-ligger-en-bit-framat-tiden/) - Hur ser läget ut för kliniska prövningar internationellt och hur påverkas ni? Vi har ett brett nätverk av kunder i USA och Europa och vår bild är att branschen påverkas rejält men lite olika beroende på storlek på bolag, i vilken utvecklingsfas bolagens projekt ligger samt om man tittar på kort eller längre sikt. Vi
- [Covid-19 lär inte minska efterfrågan på innovativa life science-produkter](https://swedenbio.se/covid-19-lar-inte-minska-efterfragan-pa-innovativa-life-science-produkter/) - Nu kraftsamlar SwedenBIO och våra medlemmar för att hantera den globala pandemin. I det akuta skedet som vi befinner oss i nu arbetas det hårt för att säkra produktionen av livsnödvändiga läkemedel och medicintekniska produkter. Samtidigt görs allt för att hålla tempot uppe i alla de innovativa projekt som kan förbättra vår hälsa i det
- [Intervju med Swelifes nya ordförande](https://swedenbio.se/intervju-med-swelifes-nya-ordforande/) - Swelife är ett strategiskt innovationsprogram, med koppling till Vinnova, med fokus på ett stärkt life science i Sverige och startade 2014 utifrån flera olika initiativ. Strategiska innovationsprogram är aktörsdrivna satsningar som ska skapa förutsättningar för hållbara lösningar på globala samhällsutmaningar och en ökad internationell konkurrenskraft. De flesta känner nog tlll Swelife, men kan du
- [Var med och frigör expansionskraften inom life science!](https://swedenbio.se/var-med-och-frigor-expansionskraften-inom-life-science/) - Vi bjuder därför in till ett ”hackathon”, en konstruktiv problemlösning under begränsad tid i små hackgrupper med olika intressenter. Syftet är att undanröja upplevda störningar och hinder inom kliniska prövningar, tillgången till forskningsinfrastrukturer och förutsättningar för forskning i samverkan. Ta tillfället i akt och gör en insats. Tillsammans kan vi frigöra expansionskraften och accelerera värdeskapandet!
- [KI Innovations först med SwedenBIO-erbjudande till start-ups](https://swedenbio.se/ki-innovations-forst-med-swedenbio-erbjudande-till-start-ups/) - Hur kom det sig att ni nappade på detta Lillian Wikström, vd för KI Innovations? – Vi vill på bästa möjliga sätt stötta våra startup-bolag som ofta inte har de finansiella möjligheterna att delta i kostsamma event, seminarier och kurser som ordnas. Som medlemmar så får de gratis tillgång till en palett av värdeskapande aktiviteter
- [Aktuella anslag för forskningsprojekt kring covid-19](https://swedenbio.se/aktuella-anslag-forskningsprojekt-kring-covid-19/) - För frågor, kontakta Heather Marshall-Heyman, Project manager, Swelife International på heather.marshall-heyman@swelife.se Listan finns här: Covid-19/SARS-COV-2 – International funding and access to resources
- [Påverkan på kort och lång sikt](https://swedenbio.se/paverkan-pa-kort-och-lang-sikt/) - SwedenBIO lämnade nyligen in sitt remissvar på Vinnovas föreslagna teknikparksfunktion för ESS och MaxIV, vilket framjobbats i arbetsgruppen för FoU och ger både ris och ros och konkretisering av de förslag som lämnas. Ökat tillgängliggörande av forskningsinfrastruktur är en viktig del i att stärka Sveriges attraktionskraft för forskningsinvesteringar och att stötta de forskande produktbolagen, men
- [Rapportsläpp: Livestreama idag kl. 14-16](https://swedenbio.se/final-swedenbio-hack-och-rapportslapp/) - Du följer seminariet via https://youtu.be/Ia59Rga04G8 Sändningen startar idag kl. 14.00. Det kommer att finnas möjlighet till interaktivt deltagande via menti. För programtider, se inbjudan nedan.
- [Två stolta vinnarbidrag i SwedenBIOs hackfinal](https://swedenbio.se/tva-stolta-vinnarbidrag-swedenbios-hackfinal/) - Ett av de teman som ingick i SwedenBIO Hack var lösningar för att få en smidig och förutsägbar tillståndsprövning kring kliniska prövningar. Temat baseras på erfarenheter från SwedenBIOs pipeline-undersökning som visar att svenska företag förlägger sina prövningar utomlands då de svenska tillståndsmyndigheterna har långa ledtider och oförutsägbarhet och skapar höga kostnader för företagen. Vinnarhacket menade
- [SwedenBIO önskar glad sommar](https://swedenbio.se/swedenbio-onskar-glad-sommar/)
- [Workshop 17 juni för dig som söker EU-finansiering](https://swedenbio.se/workshop-17-juni-dig-som-soker-eu-finansiering/) - Vi går igenom de olika programmen och ger tips om hur ni ska skriva en framgångsrik ansökan. Onsdagen 17:e juni kl 10.00-14.30 fokuserar vi på Eurostars. För information och registrering se eventen i kalendariet på www.eusme.se/kalendarium
- [Ny facebookgrupp för labbmaterial – köp och sälj](https://swedenbio.se/ny-facebookgrupp-labbmaterial-kop-och-salj/) - ”Umeå universitet, landstinget och ett antal livsmedelsföretag i Umeå behöver ofta ett laboratorium, men ny utrustning är dyr och kräver mycket kunskap för att driva. Denna nya Facebook-grupp gör det möjligt för Umeå-företag att stödja varandra på ett hållbart sätt”, säger Jennie Ekbeck, VD för SwedenBIO-medlemmen Umeå Biotech Inkubator i ett pressmeddelande. Den nya gruppen
- [Debatt: "Låt de trösklar som filats ned under covid-19 förbli sänkta"](https://swedenbio.se/debatt-lat-de-trosklar-som-filats-ned-covid-19-forbli-sankta/) - Ur kriser föds ofta drivkrafter till förändring. Den pandemi som världen befinner sig i just nu är inget undantag. Från life science-sektorn i Sverige har vi kunnat se hur universiteten, hälso- och sjukvården och life science-företagen tagit tag i problem ihop och därmed löst sådant som tidigare inte gått att lösa. Byråkratiska, kulturella och resursmässiga

## Sidor

- [Front page](https://swedenbio.se/)
- [Discount codes - FOR SWEDENBIO MEMBERS ONLY](https://swedenbio.se/discount-codes-for-swedenbio-members-only/) - Biotech Showcase 2026 When & where: January 12-14, 2026, San Francisco, CA Discount rates: $200 discount for SwedenBIO members Discount details and codes 19th Annual European Life Sciences CEO Forum When & where: March 4-5, 2026, Zurich, Switzerland Discount rates: 10% discount for SwedenBIO members Discount details and codes Bio-Europe Spring 2026 When & where: March
- [Life Science Barometer survey](https://swedenbio.se/barometer/) - The Life Science Barometer is an annual survey highlighting key trends and needs of the industry. It takes 10 minutes to complete. Participate for a chance to win a ticket to NLSDays 2027! We will raffle off one ticket, and for every 100 survey responses, we’ll add one extra ticket to the draw. The more
- [Remissvar](https://swedenbio.se/vi-ger-branschen-en-stark-rost/remissvar-2/) - 2026 Omvärldsspaning 2026 - Inspel till Nationell läkemedelsstrategi SwedenBIOs synpunkter på Naturvårdsverkets föreslag till författningsändringar till följd av EU:s reviderade avloppsvattendirektiv Input on EPO Guidelines G‑II, 6.2 – Inventive step of antibodies Remissvar FI206/00105: Skatteincitament för forskning och utveckling Remissvar S2026/00162: Europeiska kommissionens förslag på förslag till översyn av det medicintekniska regelverket Remissvar S2026/00180: Europeiska
- [Arbetsgruppen för processutveckling och produktion](https://swedenbio.se/om-swedenbio/swedenbios-arbetsgrupper-fran-ord-till-handling/arbetsgruppen-for-processutveckling-och-produktion/) - För en ökad och mer diversifierad produktionskapacitet Sverige är redan idag ett framstående land inom läkemedelsproduktion med en bred kapacitet. Produktionen är dock långt ifrån heltäckande vilket leder till ett importberoende. En stor andel av de svensktillverkade läkemedlen styrs av internationella avtal, och går på export. En kartläggning av Läkemedelsverket från 2024 visar att det
- [Arbetsgruppen för Medtech](https://swedenbio.se/om-swedenbio/swedenbios-arbetsgrupper-fran-ord-till-handling/arbetsgruppen-for-medtech/) - Medlemmar Stödjer utvecklingen av en växande sektor Medtech är en dynamisk och snabbt växande sektor inom life science. Medicintekniska produkter och lösningar är avgörande för att diagnosticera, behandla och lindra en rad olika sjukdomstillstånd. Framsteg inom AI och datahantering banar väg för nya behandlingar och system som tidigare varit oåtkomliga, vilket öppnar dörrar för innovation
- [Arbetsgruppen för kliniska prövningar](https://swedenbio.se/om-swedenbio/swedenbios-arbetsgrupper-fran-ord-till-handling/arbetsgruppen-for-kliniska-provningar/) - En nyckel för nya behandlingar och satsningar Kliniska prövningar utgör en central del av life science-ekosystemet. Genom att underlätta för företag att genomföra prövningar i Sverige stärker vi attraktiviteten för nya investeringar. Prövningar är avgörande för utvecklingen av innovativa produkter och behandlingar baserade på den senaste forskningen. Dessutom bidrar fler prövningar till att utveckla hälso-
- [Swedish Medtech Innovation Pipeline survey](https://swedenbio.se/medtech-innovation-pipeline-survey/) - Join the Swedish Medtech Innovation Pipeline Survey The Swedish Medtech Innovation Pipeline Survey will deliver a comprehensive overview of Sweden's medtech innovation landscape. The resulting report will highlight key trends, showcase innovative companies and technologies, as well as identify investment, partnership and growth opportunities. The survey only takes 5–10 minutes to complete. ”This survey will, for the first time ever, help us map the Swedish medtech pipeline and I hope that everyone in the sector will see
- [Kontakt](https://swedenbio.se/kontakt/) - Jessica Martinsson CEO & Director General Talk to me about the Swedish life science industry and policy work of SwedenBIO. + 46 (0) 72 984 97 03jessica.martinsson@swedenbio.se Marjo Puumalainen International Director Talk to me about international collaborations and NLSDays. +46 (0) 760 72 20 88marjo.puumalainen@swedenbio.se Joanna Daffy Tiitus National Director Talk to me about our national
- [Kontakt](https://swedenbio.se/kontakt/) - Jessica Martinsson CEO & Director General Talk to me about the Swedish life science industry and policy work of SwedenBIO. + 46 (0) 72 984 97 03jessica.martinsson@swedenbio.se Marjo Puumalainen International Director Talk to me about international collaborations and NLSDays. +46 (0) 760 72 20 88marjo.puumalainen@swedenbio.se Joanna Daffy Tiitus National Director Talk to me about our national
- [Rabatter till medlemmar](https://swedenbio.se/rabatter-till-medlemmar/) - Konferenser Rabatter till internationella konferenser SwedenBIO samarbetar med en lång rad arrangörer av internationella life science-konferenser och partnering-events. Genom våra samarbeten har vi möjlighet att erbjuda våra medlemmar betydande rabatter till många konferenser varje år. Detaljer Bland återkommande konferenser som vi erbjuder rabatter till finns Biotech Showcase, BIO International Convention, BIO Europe, Swiss Biotech med
- [Arbetsgruppen för forskning och utveckling](https://swedenbio.se/om-swedenbio/swedenbios-arbetsgrupper-fran-ord-till-handling/arbetsgruppen-for-forskning-och-utveckling-2/) - Samarbete för ökad forskningsnytta Sverige har en lång och stolt tradition av framstående forskning och rankas konsekvent bland de mest innovativa länderna i världen. I FN-organet WIPOs årliga ranking över innovation hamnar Sverige återkommande på en topplacering på listan. För att forskning ska komma till verklig nytta behöver den omsättas i konkreta idéer och lösningar
- [Din guide till europeisk life science](https://swedenbio.se/din-guide-till-schweizisk-life-science/) - Aktuellt Vårt fokus på Schweiz SwedenBIO har många års utbyten med viktiga aktörer i Schweiz och besöker årligen konferenser som Swiss Biotech Day, ibland i form av skräddarsydda företagsdelegationer för maximal nytta. Samarbetspartners för ökat utbyte SwedenBIO har väletablerade samarbeten med viktiga Schweiziska aktöreri syfte att öka utbytet mellan svensk och schweizisk life science. Högspecialiserad
- [Arbetsgruppen för Intellectual Property](https://swedenbio.se/om-swedenbio/swedenbios-arbetsgrupper-fran-ord-till-handling/arbetsgruppen-for-intellectual-property/) - För ökad kunskap om immaterialrätt Immaterialrätt (IP) spelar en allt viktigare roll – inte minst för svensk life science, där många små och innovativa bolag verkar. Att skydda sina uppfinningar på rätt sätt är avgörande, men kan vara både komplext och resurskrävande. Arbetsgruppen fungerar som ett stöd genom att stärka IP som strategisk resurs, utveckla
- [Arbetsgruppen för public affairs och kommunikation](https://swedenbio.se/om-swedenbio/swedenbios-arbetsgrupper-fran-ord-till-handling/arbetsgruppen-for-public-affairs-och-kommunikation/) - Vill öka intresset för branschen Sverige är ett framgångsrikt land inom life science. Samtidigt är den globala konkurrensen om investeringskapital, talanger och de globala företagens etableringar tuff. För att fortsatta stärka svensk life science behövs ett allmänt intresse för branschen, ökad kunskap och förståelse för branschens villkor hos beslutsfattare och att vi blir bättre på
- [BIO International 2026](https://swedenbio.se/bio-international-2026/)
- [Styrelse & Valberedning](https://swedenbio.se/om-swedenbio/styrelse/) - Anders Persson Ordförande SwedenBIO Head of Ecosystem Strategy & Projects, BioVenture Innovation Unit, AstraZeneca Sara Corin Vice ordförande SwedenBIOGeneral Manager for Downstream Hardware and Consumables, Cytiva Charlie Grafström Market access and Tender Director, Roche Boubou Hallberg Direktör, Sahlgrenska Sjukhuset Kerstin Falck VP Corporate Affairs, Hansa Biopharma Mårten Winge Board Member, Pelago Bioscience Minna Lundholm Head of Technical
- [The 2025 Drug Discovery and Development Pipeline – presenting Swedish pharma innovation to the world ](https://swedenbio.se/the-swedish-drug-discovery-and-development-pipeline/) - A triennial mapping of Swedish drug development Every third year, the Pipeline report provides a uniquely detailed mapping of the drug developing pharma and biotech industry in Sweden. It includes industry statistics, a deep-dive into the combined domestic pipeline and detailed company and project lists. It is produced by SwedenBIO with support from Business Sweden,
- [Arbetsgruppen för business strategi](https://swedenbio.se/om-swedenbio/swedenbios-arbetsgrupper-fran-ord-till-handling/arbetsgruppen-for-business-strategi/) - Medlemmar Ett stöd på den komplexa kommersialiseringsresan Majoriteten av Sveriges life science-företag är små eller medelstora, och deras tillväxt är beroende av flera olika faktorer. En av de mest avgörande är valet av affärsstrategi. Kommersialiseringsresan inom life science-branschen är komplex och ställer höga krav på både expertis och strategiskt tänkande. Arbetsgruppen för business strategi arbetar
- [Stadgar och dokument](https://swedenbio.se/om-swedenbio/stadgar-och-dokument/) - SwedenBIO är en icke vinstdrivande medlemsorganisation. Högsta beslutande organ är föreningsstämman som också utser organisationens styrelse. Föreningsstämman Föreningsstämman hålls innan maj månads utgång varje år, normalt sett i månadsskiftet mars/april. Kallelse till föreningsstämman skall ske per e-post till medlemmarna senast tio dagar före stämman samt anslås på föreningens webbsida. Motioner Om en medlem vill att ett
- [Kraftsamling för life science: vår policyplattform](https://swedenbio.se/vi-ger-branschen-en-stark-rost/fokusfragor/) - Policyplattform: Kraftsamling för life science 34 konkreta förslag för en starkare och mer motståndskraftig life science-bransch. Vår policyplattform i korthet SwedenBIOs aktuella policyplattform innehåller 34 konkreta policyförslag för en starkare life science-bransch. Plattformen har tagits fram under 2026 tillsammans med aktiva medlemmar i vårt breda expertnätverk. Kraftsamling Sverige har en life science-industri i världsklass men
- [Join us at Swiss Biotech Day](https://swedenbio.se/swedenbio-at-swiss-biotech-day/) - Why join the Nordic delegation to Swiss Biotech Day 2026? Increase your visibility and build connections with Swiss actors including pharma, biotech and investor representatives​. SwedenBIO increases the visibility of Swedish life science and enables its members to make the most out of the Swiss Biotech Day conference 2026 by joining the Nordic delegation. The
- [Arbetsgruppen för finansiering](https://swedenbio.se/om-swedenbio/swedenbios-arbetsgrupper-fran-ord-till-handling/arbetsgruppen-for-finansiering/) - Arbetar för högre kompetens kring finansieringsstrategi Sverige beskrivs ibland som ett land med fler innovationer och startups än kapital. Finansiering är mycket riktigt en av de främsta utmaningarna för majoriteten av nystartade och små företag inom life science. Företagen behöver kunna navigera rätt i finansieringslandskapet och ha rätt finansieringsstrategi för att ta sin idé hela
- [Vi ger branschen en stark röst](https://swedenbio.se/vi-ger-branschen-en-stark-rost/) - Helheten är vår nisch Som enda aktör samlar vi helheten inom svensk life science, från de små enmansbolagen till stora internationella företag, hela tiden med entreprenören i centrum och med fokus på bolag verksamma i Sverige med forskning, utveckling och/eller produktion. Det vi driver på för att politiker och andra beslutsfattare ska förändra, det arbetar
- [Life science-industrin och den akademiska världen](https://swedenbio.se/life-science-industrin-och-den-akademiska-varlden/) - Synliggör och kopplar samman SwedenBIO har hållit föreläsningar om det svenska innovationsstödsystemet och om karriärfärdigheter för forskare för svenska och europeiska doktorander. SwedenBIO har även fungerat som rådgivare till KTH i arbetet med att definiera deras nya masterprogram som kombinerar bioteknik och datavetenskap, samt till KI för deras masterprogram i translationell fysiologi och farmakologi. Praktikplatser
- [SwedenBIOs expertnätverk – från ord till handling](https://swedenbio.se/om-swedenbio/swedenbios-arbetsgrupper-fran-ord-till-handling/) - SwedenBIOs expertnätverk består av arbetsgrupper och task forces. Dessa utgör motorn i SwedenBIOs särskilda sätt att arbeta – att med hjälp av medlemmarna identifiera, analysera och lösa de utmaningar som branschen står inför. Det vi driver på för att beslutsfattare ska förändra, det har vi också egna insatser inom. När politiska processer tar tid är vi
- [Medlemserbjudandet](https://swedenbio.se/medlemscommunity/medlemserbjudandet/) - Utöka ditt nätverk SwedenBIO arrangerar årligen flera event och mötesplatser. På majoriteten av dessa är det kostnadsfritt att delta för alla anställda på våra medlemsföretag. Nationella events för att utöka ditt affärsnätverk Executive Dinner. Exklusiv middag och framtidsdiskussioner för ledarna i våra medlemsföretag. Följer på SwedenBIOs formella årsmöte i maj. SwedenBIO Summit. Vi avrundar året med
- [](https://swedenbio.se/en/swiss-biotech-day-participation/)
- [Bio-Europe Spring 2026](https://swedenbio.se/bio-europe-spring-2026/)
- [SwedenBIO patrons](https://swedenbio.se/swedenbio-patrons/) - Get to know our patrons Citeline Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health science professionals to accelerate the connection of treatments to patients and patients to treatments. As a Gold Patron, Citeline contributes to and helps strengthen SwedenBIO’s business intelligence capabilities. Visit Citeline's website to
- [Medlemsansökan](https://swedenbio.se/medlemsansokan/) - Medlemskapet i föreningen SwedenBIO är 300 svenska kronor per år (ej momspliktig). Dessutom tillkommer en serviceavgift (momspliktig) som varierar beroende på medlemskategori. Förenings- och serviceavgift beslutas av föreningsstämman. Vi har följande tre medlemskategorier: Life science-företag Företag med verksamhet i Sverige som bedriver forskning och utveckling, tillverkning, försäljning eller erbjuder tjänster inom life science-området. Ni verkar
- [SwedenBIO Award](https://swedenbio.se/medlemscommunity/nominera-till-swedenbio-award/) - En hyllning till svensk life science SwedenBIO Award är branschens eget pris och består, utöver äran, av ett vandringspris och två delegatplatser till Nordic Life Science Days. Priset ska stärka visionen av Sverige som en ledande life science-nation samt bidra positivt till bilden och erkännandet av life science-branschen bland beslutsfattare och allmänhet i Sverige. Vinnaren av SwedenBIO award presenteras på SwedenBIO Summit, ett event där
- [Life Science Barometer Reports](https://swedenbio.se/life-science-barometer-reports/) - Life Science Barometer 2026 The Life Science Barometer 2026 provides a snapshot of the Swedish life science industry. Life Science Barometer 2025 The Life Science Barometer 2025 provides a snapshot of the Swedish life science industry. Life Science Barometer 2024 The Life Science Barometer 2024 provides a snapshot of the Swedish life science industry.
- [Rapporter och faktablad](https://swedenbio.se/vi-bygger-kunskap/rapporter-och-faktablad/) - SwedenBIO undersöker regelbundet hur industrilandskapet inom life science ser ut. Vi mäter årligen branschens status i vår Life Science Barometer. Vart tredje år kartlägger vi de svenska läkemedelsprojekten i Pipelinerapporten. Vi ger även ut särskilda rapporter om utvalda områden som exempelvis finansiering, precisionsmedicin med mera. Swedish Drug Discovery and Development Pipeline Reports Pipeline-rapporten, som publicerar vart tredje år, ger en detaljerad
- [Front page](https://swedenbio.se/)
- [Membership application](https://swedenbio.se/en/medlemsansokan/membership-application/) - Membership in the association SwedenBIO is 300 SEK per year (not subject to VAT). In addition, there is a service fee (subject to VAT) that varies depending on the membership category. Association and service fees are decided by the general meeting. We have the following three membership categories: Life science companies Companies with operations in
- [Om SwedenBIO](https://swedenbio.se/om-swedenbio/) - Vi samlar hela ekosystemet SwedenBIO är den nationella branschorganisationen för life science i Sverige. Våra medlemsföretag utvecklar bioteknik, diagnostik, läkemedel och medicinteknik eller är experter inom bland annat affärsutveckling, IP och juridik. Vi samlar även finansiärer, inkubatorer, science parks, regionala investeringsfrämjande aktörer och många fler. Gemensamt för våra medlemmar är att de är instrumentella för utvecklandet av medicinska innovationer
- [SwedenBIO at JPM](https://swedenbio.se/swedenbio-at-jpm/) - Discount to Biotech Showcase™ 2026 Annual International Partnering Conference January 12–14, 2025 | San Francisco, CAJanuary 20–21, 2025 | Virtual SwedenBIO members benefits from a discount. Swedish Breakfast BusinessSweden, the Swedish Consulate in SanFrancisco, SwedenBIO and the Swedish-American Chambers of Commerce-SF invitesyou to kick-off the JPM week with Swedishfellows over a networking breakfast. Date &
- [Internationella nätverk](https://swedenbio.se/natverk/vart-internationella-arbete/) - Vi synliggör svensk life science på den internationella arenan Vårt internationella arbete sker i nära samarbete med organisationer inom den privata och offentliga sektorn i starka life science-nav som Schweiz, Sydkorea, Japan, Kalifornien och USA:s östkust. Som medlem i SwedenBIO kan du delta i svenska delegationer, få insikter och rabatter till internationella konferenser samt öka
- [Vi utökar ditt affärsnätverk](https://swedenbio.se/natverk/) - Uppskattade nationella event för nätverkande och inspiration Executive Dinner och Summit är våra två årliga nationella event som är mycket uppskattade av communityt. Dessa evenemang syftar till att stärka våra medlemmar genom att erbjuda förstklassiga möjligheter till nätverkande och kunskapsutbyte. NLSDays - mötesplatsen för nordisk life science Träffa din nästa samarbetspartner på Nordic Life Science
- [Swedish Drug Discovery and Development Pipeline reports](https://swedenbio.se/pipeline-reports/) - Swedish Drug Discovery and Development Pipeline report 2026 The latest Pipeline report provides a detailed mapping of assets in the Swedish drug developing pharma and biotech industry. Swedish Drug Discovery and Development Pipeline report 2023 The 2023 Pipeline report provides a detailed mapping of the drug developing pharma and biotech industry in Sweden. Previous pipeline
- [Arbetsgruppen för pandemic preparedness](https://swedenbio.se/om-swedenbio/swedenbios-arbetsgrupper-fran-ord-till-handling/arbetsgruppen-for-pandemic-preparedness/) - Stärker industrins roll för en säkrare framtid Covid-19-pandemin blev en allvarlig påminnelse om hur sårbart samhället är inför globala hälsokriser. För att effektivt möta framtida kriser och utmaningar, såsom mikrobiella hot och läkemedelsbrist, krävs ett starkt, samordnat och långsiktigt arbete. Här spelar industrin en central roll – inte bara genom att utveckla nya läkemedel och vacciner, utan även genom att säkerställa robusta produktionskedjor,
- [Din guide till Asiens life science-industri](https://swedenbio.se/din-guide-till-asiens-life-science-industri/) - Aktuellt Vårt fokus på Asien SwedenBIO satsar på Asiens växande life science-industrier som spås bli en strategiskt viktig marknad för att diversifiera satsningar, investeringar och samarbeten för att minska beroendet av USA. Genom SwedenBIO får ni tillgång till ibland i form av skräddarsydda företagsdelegationer för maximal nytta. Samarbetspartners SwedenBIO har väletablerade samarbeten med viktiga asiatiska
- [SwedenBIO i Almedalen](https://swedenbio.se/swedenbio-i-almedalen/) - Aktiviteter i SwedenBIO-huset Tisdag 11-13 Rundabordssamtal med politiker Anordnas av SwedenBIO För inbjudna. Tisdag 13-14 Vi ställer om för miljön - när ställer samhället om för hållbart utbyte av läkemedel?” Panelsamtal av Chiesi Pharma Läs mer Beskrivning Forskande läkemedelsföretag med ett starkt samhällsengagemang arbetar nu intensivt och gör stora investeringar för att skapa framtidens läkemedelsbehandlingar med
- [Membership offer](https://swedenbio.se/medlemscommunity/medlemserbjudandet/) - Expand your network SwedenBIO organizes several events and networking opportunities each year. At the majority of these, participation is free of charge for all employees of our member companies. National events for expanding your business network Executive DinnerAn exclusive dinner and forward-looking discussions for leaders of our member companies. Held in connection with SwedenBIO’s formal
- [SwedenBIO at BIO International 2025](https://swedenbio.se/swedenbio-at-bio-international-2025/) - Planned activities in Boston The list of activities is updated continuously. Contact marjo.puumalainen@swedenbio.se for questions on joining and our planned activities. Nordic Kickoff Breakfast Organized by SwedenBIO and Nordic partners in collaboration with DNB // Back bay.Start your BIO International experience by connecting with key Nordic and US stakeholders in the life sciences sector. Monday,
- [We give the industry a strong voice](https://swedenbio.se/vi-ger-branschen-en-stark-rost/) - The whole has become our niche As the only player, we bring together the whole of Swedish life science, from small one-man companies to large international companies, always with the entrepreneur at the center and with a focus on companies operating in Sweden with research, development and/or production. What we push for politicians and other
- [About SwedenBIO](https://swedenbio.se/om-swedenbio/) - Bringing the whole ecosystem together SwedenBIO is the national trade organization for life sciences in Sweden. Our member companies develop biotechnology, diagnostics, pharmaceuticals and medical devices or are experts in business development, IP and law, among others. We also bring together financiers, incubators, science parks, regional investment promoters and many more. What our members have
- [We build knowledge](https://swedenbio.se/vi-bygger-kunskap/) - Reports and factsheets SwedenBIO annually surveys how the industry is doing. This could be for pharmaceutical projects or capital issues. The reports are used by members, export and investment promotion organizations as well as foreign actors to learn more about the industry and find cooperation projects. They also serve as a knowledge base in dialog
- [We expand your business network](https://swedenbio.se/natverk/) - Valued national events for networking and inspiration The Executive Dinner and Summit are our two annual national events that are highly appreciated by the community. These events aim to empower our members by providing first-class networking and knowledge-sharing opportunities. NLSDays - the meeting place for Nordic life science Meet your next partner at Nordic Life
- [Calendar](https://swedenbio.se/natverk/kalendarium/)
- [User](https://swedenbio.se/user/) - Post on the bulletin boardEdit postsLog out
- [Reset your password](https://swedenbio.se/password-reset/)
- [Register a new account](https://swedenbio.se/register/)
- [Logout](https://swedenbio.se/logout/)
- [Log in / Register account](https://swedenbio.se/login/)
- [Latest news](https://swedenbio.se/aktuellt/)
- [About SwedenBIO in English](https://swedenbio.se/information-in-english/) - We represent the leading life science companies in Sweden Our member companies develop biotechnology, diagnostics, pharmaceuticals, and medical technology or are experts in areas such as business development, intellectual property, and legal affairs. We also bring together investors, incubators, science parks, regional investment promotion organizations, and many others. What our members have in common is
- [Vi bygger kunskap](https://swedenbio.se/vi-bygger-kunskap/) - Rapporter och faktablad SwedenBIO kartlägger årligen hur det går för branschen. Det kan handla om läkemedelsprojekt eller kapitalfrågor. Rapporterna används både av medlemmar, export- och investeringsfrämjande organisationer samt utländska aktörer för att lära sig mer om branschen och hitta samarbetsprojekt. De fungerar också som kunskapsunderlag i dialog med beslutsfattare om vad branschen behöver. Kurser I
- [Webbinarier och poddar](https://swedenbio.se/vi-bygger-kunskap/webbinarier/) - Sjukvårdspodden: kliniska prövningar Ett samtal från oktober 2024 om samordningens roll i att stärka Sveriges position inom kliniska prövningar. Under de senaste tio åren har antalet ansökningar om kliniska läkemedelsprövningar i Sverige minskat. Vilken roll skulle en nationell samordning kunna spela för att vända trenden, och vad kan vi lära oss från andra länder som Danmark
- [Executive Dinner och Summit](https://swedenbio.se/natverk/executive-dinner-och-summit/) - Exklusivt för SwedenBIOs medlemmar SwedenBIOs nationella evenemang är bland av våra mest värdefulla medlemsförmåner. Som medlem får du tillgång till exklusiva mötesplatser som samlar hela landets life science-bransch. Dessa evenemang erbjuder unika möjligheter att nätverka, dela kunskap och stärka samarbeten inom sektorn. Det unika med dessa event för den svenska life science-branschen är den imponerande
- [Nordic Life Science Days](https://swedenbio.se/natverk/nordic-life-science-days/) - Fler än 3000 partneringmöten Skicka enkelt dina mötesförfrågningar genom att logga in på den internationellt etablerade plattformen. I portalen kan du ladda upp en företagsprofil som gör dig synlig för möjliga samarbetspartners och investerare. Du kan också söka bland anmälda delegater och företag. Ungefär en vecka före konferensen får du ett personligt schema med dina accepterade
- [Kurser och utbildningar](https://swedenbio.se/kurser-och-utbildningar/) - Fullmatad kurs i läkemedelsutveckling Att få en överblick över alla steg som är ett måste från ax till limpa är det som gjort denna utbildning så populär. Många av deltagarna är erfarna, men kurser vänder sig till såväl juniora som seniora medarbetare som vill få en ”crash course” inom hela processen kring läkemedelsutveckling. Läkemedelsutvecklingsprojekt inleds
- [Vår representation i nationella och internationella organ & arbetsgrupper](https://swedenbio.se/vi-ger-branschen-en-stark-rost/var-rost-i-nationella-och-internationella-organ/) - Nationella Svenskt Näringsliv Svenskt Näringsliv samlar 60 000 företag och 48 bransch- och arbetsgivarorganisationer. Nordiska Medicon Valley AllianceMedicon Valley är det binationella life science-klustret som omfattar ön Själland i östra Danmark och Skåne-regionen i södra Sverige och samlar mer än 200 läkemedelsföretagsamt cirka 170 företag inom medicinteknik Internationella EuropaBIOEuropaBio representerar företag inom olika sektorer, samt nationella och regionala bioteknikorganisationer
- [Din guide till den amerikanska life science-branschen](https://swedenbio.se/guide-till-den-amerikanska-life-science-branschen/) - Aktuellt Ett robust nätverk till ditt förfogande SwedenBIO har byggt upp ett nätverk bland amerikanska aktörer och besöker årligen konferenser som JP Morgan. Genom åren har vi även välkomnat amerikanska företagsdelegationer till Sverige för att introducera svensk life science. Samarbetspartners för ökat utbyte SwedenBIO har väletablerade samarbeten med viktiga amerikanska aktörer i syfte att öka
- [Kalendarium](https://swedenbio.se/natverk/kalendarium/)
- [User](https://swedenbio.se/user/) - Skriv inlägg på anslagstavlanRedigera inläggLogga ut
- [SwedenBIOs integritetspolicy](https://swedenbio.se/om-swedenbio/swedenbios-integritetspolicy/) - SwedenBIO värnar om din personliga integritet och att du ska känna dig trygg när du lämnar personuppgifter till oss. Vi respekterar och skyddar därför dina personuppgifter i enlighet med gällande lagstiftning, interna riktlinjer och rutiner. Personuppgiftsansvarig SwedenBIO ansvarar för att dina personuppgifter behandlas i enlighet med gällande lagstiftning. Personuppgiftsansvarig är SwedenBIO Service AB, org. nr 556644-6398, Wallingatan 24, 111 24 Stockholm.
- [Erbjudanden från medlemmar](https://swedenbio.se/medlemscommunity/erbjudanden-fran-andra-medlemmar/) - Har du ett erbjudande till våra medlemmar?
- [Logout](https://swedenbio.se/logout/)
- [Logga in / Registrera konto](https://swedenbio.se/login/)
- [Registrera nytt konto](https://swedenbio.se/register/)
- [SKRIV INLÄGG PÅ ANSLAGSTAVLAN](https://swedenbio.se/medlemscommunity/skriv-inlagg-pa-anslagstavlan/)
- [Våra medlemmar](https://swedenbio.se/medlemscommunity/vara-medlemmar/)
- [Återställ ditt lösenord](https://swedenbio.se/password-reset/)
- [Ditt konto](https://swedenbio.se/account/)

## Kalendarium

- [Biotech Showcase 2027](https://swedenbio.se/kalendarium/biotech-showcase-2027/) - Biotech Showcase isn't just another event in San Francisco—it is THE event where innovative life science companies access capital, present and forge meaningful partnerships. For 19 years, Biotech Showcase has been the premier event where industry leaders kick off the new year, making it "the place to be to start the year." Seamlessly integrated with
- [Seminarium: Life Sciences - licensering och prissättning](https://swedenbio.se/kalendarium/the-view-life-sciences-licensering-och-prissattning/) - Datum: Tisdagen den 29 september 2026 Tid: Frukost serveras från kl. 08.30. Seminariet börjar kl. 08.45. Plats: Hammarskiöld, Jakobsgatan 6, Stockholm Under förmiddagen diskuterar vi: Licensiering som strategiVilken roll kan licensiering spela i utvecklingen av Life Sciences-bolag? Medverkande: Aneesh Khokar (Carnegie), Martin Jönsson (AlzeCure Pharma) och Niklas Mattsson (BioArctic). MFN-regleringens påverkan på den svenska marknadenHur kan regleringen påverka
- [London Life Sciences Week](https://swedenbio.se/kalendarium/london-life-sciences-week/) - Launched by the UK BioIndustry Association, MedCity and London & Partners, London Life Sciences Week is apremier gathering of global investors and leaders from pharma and UK biotech companies, offering a dynamicweek of networking and dealmaking.London Life Sciences Week brings together investors, founders, policymakers, business leaders and innovators from around the world to connect, collaborate
- [Hesa-Fredrik AW at Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-at-haymarket-7/) - Every quarter when Hesa ​​Fredrik calls*, we want you to turn off the computer, end the experiment and sign that deviation report. Because then it’s time to head towards Life Science Stockholm’s new watering hole. There you get the opportunity to make new contacts, brainstorm ideas and untie knots. We at SwedenBIO, in collaboration with
- [BIO-Europe 2026](https://swedenbio.se/kalendarium/bio-europe-2026/) - Don’t miss the opportunity to join BIO-Europe, one of Europe’s premier partnering events for the life science and biotech industry. Bringing together leading biotech companies, pharma, investors, academics and solution providers from across the globe, the conference is a unique platform for networking, collaboration and business development. With thousands of one-to-one partnering meetings, insightful panel
- [LSX Congress USA](https://swedenbio.se/kalendarium/lsx-congress-usa/) - LSX Congress USA brings together biotech leaders, pharma BD teams and active investors from across North America and beyond, creating a focused environment for strategic conversations, investment discussions and partnership development. For life science companies, the Congress offers a valuable opportunity to build visibility with the US and global market, connect with investors, and engage with
- [LSX Investival Showcase Europe 2026](https://swedenbio.se/kalendarium/lsx-investival-showcase-europe-2026/) - The LSX Investival Showcase is your gateway to biopharma and medtech investment and partnering.Taking place on the first day of London Life Science Week, it's growing in size and scale. It's the first and biggest public event of the week, open to the wider life science community, and offers full partnering facilities to all attendees.Join
- [1st Annual European Healthcare Impact Summit](https://swedenbio.se/kalendarium/1st-annual-european-healthcare-impact-summit/) - The event brings together a global audience of senior pharma, biotech, HealthTech, MedTech and digital health executives, alongside bankers, consultants, financial and corporate investors, along with a select number of service providers. The EHIS will focus on the broader healthcare ecosystem, bringing together KOLs, leading healthcare organisations, hospitals, scientists, and life sciences and HealthTech executives.
- [26th Annual Biotech in Europe Forum](https://swedenbio.se/kalendarium/26th-annual-biotech-in-europe-forum/) - Returning for its 26th Annual Edition, this established global bio-pharma industry event will address the key challenges and investment trends for 2026, with a strong focus on partnering, alliance management, and future prospects. Leading industry figures will contribute their insights through a series of panel discussions covering the broader market outlook, as well as innovation across different therapeutic sectors.SwedenBIO members receive a discount.
- [Swiss Nordic Bio](https://swedenbio.se/kalendarium/swiss-nordic-bio-5/) - Swiss Nordic Bio 2026 is a premier Nordic–Swiss life science partnering and investor conference in Zurich, bringing together biotech, pharma, medtech, diagnostics companies, investors, and industry leaders for networking, company pitches, and one-to-one partnering meetings to accelerate innovation, investment, and cross-border collaboration.SwedenBIO members receive a discount. Contact us on info@swedenbio.se if you don’t know where
- [Medica 2026](https://swedenbio.se/kalendarium/medica-2026/) - Medica is the leading international platform of the healthcare industry and the central meeting point for the global medical sector. As a hotspot for trends, innovations, and markets, it covers the entire value chain of medical technology together with COMPAMED. Through its unique combination of a high-level trade fair, practice-oriented forums, and inspiring networking opportunities,
- [BIO International Convention 2026](https://swedenbio.se/kalendarium/bio-international-convention-2026/) - The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from around the world.Whether you work at a public pharmaceutical company, biotech startup, academia, non-profit organization, or government agency; or you work as a researcher, business development professional or investor, BIO is where you'll
- [Almedalen Garden Mingle](https://swedenbio.se/kalendarium/almedalen-garden-mingle/) - On Tuesday, June 23, from 5:00 PM to 8:00 PM, we will gather to enjoy a summer evening during the Almedalen Week. It will be an opportunity to meet colleagues, industry representatives, and policymakers, make new connections, and discuss current issues in a relaxed setting. We will be serving drinks, grilled sausages, cake, and, above
- [Hesa-Fredrik AW at Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-at-haymarket-5/) - Every quarter when Hesa ​​Fredrik calls*, we want you to turn off the computer, end the experiment and sign that deviation report. Because then it's time to head towards Life Science Stockholm's new watering hole. There you get the opportunity to make new contacts, brainstorm ideas and untie knots. We at SwedenBIO, in collaboration with
- [Office Hours - From Trial Design to Execution, What Gets in the Way?](https://swedenbio.se/kalendarium/office-hours-from-trial-design-to-execution-what-gets-in-the-way/) - Cytel invites you to an interactive Office Hours session with Angela Vinken, Jürgen Hummel, and Flaminia Chiesa, moderated by Nelia Padilla. Even the strongest trial designs can face challenges once execution begins. Assumptions made early on do not always hold in practice, and disconnects between involved partners on the design and delivery can affect timelines,
- [Breakfast conversation: How do we get the best return on innovation investments?](https://swedenbio.se/kalendarium/breakfast-conversation-how-do-we-get-the-best-return-on-innovation-investments/) - How can we maximize the return on investments in life science? Which initiatives have an impact? How can access to capital be improved? What role do innovation districts play? How do different national initiatives affect and what is missing in the system? Sweden has world-class innovation environments. A large part of our economy is built
- [Vitalis Conference 2026](https://swedenbio.se/kalendarium/vitalis-conference-2026/) - Vitalis is the premier Nordic conference on the future of healthcare rooted in one of the world’s most advanced digital health landscapes. Drawing on the maturity and momentum of the Nordic model, the conference brings together pioneers, experts and decision-makers from across the healthcare ecosystem, and from across the world, to explore how technology, innovation
- [SwedenBIO in Almedalen](https://swedenbio.se/kalendarium/swedenbio-i-almedalen-4/) - Join us in the SwedenBIO Garden during Almedalen week, where we will gather for inspiring exchanges, new connections, and shared perspectives from across the life science community.𝗢𝗻 𝟮𝟯–𝟮𝟱 𝗝𝘂𝗻𝗲, 𝘄𝗲 𝗮𝗻𝗱 𝗼𝘂𝗿 𝗺𝗲𝗺𝗯𝗲𝗿𝘀 𝘄𝗶𝗹𝗹 𝗵𝗼𝘀𝘁 𝗮𝗻 𝗲𝗻𝗴𝗮𝗴𝗶𝗻𝗴 𝗽𝗿𝗼𝗴𝗿𝗮𝗺 filled with conversations and insights from across the life science sector. We will also have our much-loved
- [Nordic Health Summit Japan & South Korea](https://swedenbio.se/kalendarium/nordic-health-summit-japan-south-korea/) - Join this partnering and business development conference that connects Nordic healthcare innovators with Japanese and Korean industry and investors through matchmaking. Business Sweden invites Nordic life science companies, scaleups, investors, and ecosystem partners to take part in a delegation to Asia’s most dynamic healthcare markets. The initiative is carried out in partnership with SwedenBIO, Invest
- [BioFit 2026](https://swedenbio.se/kalendarium/biofit-2026/) - With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies,
- [Asia Bio Partnering Forum 2026](https://swedenbio.se/kalendarium/asia-bio-partnering-forum-2026/) - Discover new partnership opportunities at the Asia Bio Partnering Forum – a premier life science event connecting global biotech, pharma, and investors with Asia-Pacific innovation. Taking place in Singapore, the forum brings together 650+ leaders for high-impact networking, one-to-one meetings, and insights into emerging trends, dealmaking, and market expansion.SwedenBIO members receive a discount. Contact us
- [Swetrial Breakfast Seminar](https://swedenbio.se/kalendarium/swetrial-breakfast-seminar/) - Welcome to a breakfast seminar organized by Läkemedelsverket that will present the strategic direction for Swetrials’ 2026 calls—an important step in strengthening Sweden’s position in clinical trials. The seminar will also be streamed live for those unable to attend in person. A link will be sent upon registration. REGISTRATIONSign up by sending an email to
- [The Road to Successful Corporate–Academic Collaborations](https://swedenbio.se/kalendarium/the-road-to-successfulcorporate-academic-collaborations/) - Collaborations between companies and academic institutions can unlock groundbreaking innovation—but they also raise important questions. Who owns what? What can be published, and when? How do you protect sensitive information while still enabling open research dialogue? During this session, we will explore: Essential IP knowledge needed to secure your company’s rights in collaborations with academic institutions.
- [The EU Biotech Act Unpacked: A Power Hour of Insights, Impacts & Discussions](https://swedenbio.se/kalendarium/the-eu-biotech-act-unpacked-a-power-hour-of-insights-impacts-discussions/) - As momentum builds around the EU Biotech Act, this invitation-only 60 minute session will provide a focused presentation and discussion on its strategic importance for the biotech industry. The session will cover the progress of Part I and the ambitions for Part II, with a strong emphasis on how the Act will shape company strategy
- [Executive Dinner & Annual meeting](https://swedenbio.se/kalendarium/executive-dinner-and-annual-meeting-4/) - An informal thematic evening where senior management from our member companies gather to gain inspiration, discuss and network. Warmly welcome to our 2026 annual gathering for life science industry executives. During the formal annual general meeting the fiscal year is briefly summarized. Exclusively for SwedenBIO members. For any questions, please contact info@swedenbio.se. Find more info and register
- [SwedenBIO Summit 2026](https://swedenbio.se/kalendarium/swedenbio-summit-2026/) - Make sure to mark your calendar for the upcoming SwedenBIO Summit at Grand Hotel. The purpose of SwedenBIO Summit is to provide a forum to share intimate business stories. You will also get a sneak peek of the most up-to-date statistics of the industry from the Life Science Barometer 2026 and we will wrap up
- [Empowering Women's week: Inspirational Voices](https://swedenbio.se/kalendarium/empowering-womens-week-inspirational-voices/) - During this special gathering organized by GoCo Health Innovation City, three women will generously share their personal journeys – the experiences, choices, challenges, and turning points that have shaped the paths that brought them to where they are today. No road is ever straight. It is marked by learnings, highs and lows, moments of encouragement,
- [AngloNordic Life Science Conference 2026](https://swedenbio.se/kalendarium/anglonordic-life-science-conference-2026/) - Over 350 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, will get together in London on 23 April, 2026 for the 22nd Annual Anglonordic Life Science Conference. The conference Programme features on-point panel discussions around European investment and technologies,
- [Hesa-Fredrik AW på Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-pa-haymarket-10/) - Every quarter when Hesa ​​Fredrik calls*, we want you to turn off the computer, end the experiment and sign that deviation report. Because then it's time to head towards Life Science Stockholm's new watering hole. There you get the opportunity to make new contacts, brainstorm ideas and untie knots. We at SwedenBIO, in collaboration with
- [BioEquity 2026](https://swedenbio.se/kalendarium/bioequity-2026/) - BioEquity Europe returns in 2026 as the continent’s leading biotech-investment and partnering event. Hosted for the first time in Prague, the conference brings together investors, pharma executives, and emerging biotechs for presentations, strategic discussions, and one-on-one partnering. A key opportunity to connect with Europe’s biotech-innovation community and explore new collaborations.SwedenBIO members receive a discount. Contact
- [ChinaBio Partnering Forum](https://swedenbio.se/kalendarium/chinabio-partnering-forum-2/) - The ChinaBio Partnering Forum is a premier life science partnering event that connects global biotech, pharma, investors, and innovators with China’s dynamic life science ecosystem. Over the course of the forum, attendees engage in curated one-to-one partnering meetings, expert panel discussions, networking sessions, and company presentations designed to accelerate cross-border collaborations, explore investment opportunities, and
- [LSX World Congress Europe](https://swedenbio.se/kalendarium/lsx-world-congress-europe/) - LSX Europe is the continent's premier life sciences fundraising and investment event, where innovation meets opportunity through strategic 1:1 meetings and targeted networking. Early-stage biotechnology, medical devices, diagnostics, and digital health companies, including university spin-outs, are attending seeking investment and collaboration opportunities. Active life science investors attend, looking for new investments and syndication. Together through
- [Webinar: Navigating Biotech SME Funding - What’s available, How it works, What’s next for Europe](https://swedenbio.se/kalendarium/webinar-navigating-biotech-sme-funding-whats-available-how-it-works-whats-next-for-europe/) - Europe’s biotech sector continues to face significant financing challenges, especially during growth and scale‑up. As the EU moves forward with the landmark Biotech Act, this webinar explores the funding tools available today, how companies can access them, and what changes are needed to expand investment in European biotech. The session will provide an overview of current
- [Swiss Biotech Day 2026](https://swedenbio.se/kalendarium/swiss-biotech-day-2026/) - Since 2021, the Swiss Biotech Day has seen remarkable growth every year and has become a premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships. In 2025 it attracted more than 3,000 participants from 49 countries, including 25 international delegations. It was by far the biggest and most international edition
- [BioTrinity 2026](https://swedenbio.se/kalendarium/biotrinity-2026/) - BioTrinity is attended by an ever-evolving international audience of c.850 delegates, comprising a mix of academic entrepreneurs, early stage and emerging life sciences R&D companies, funders & investors, big pharma teams, charities & research bodies, government, regulatory bodies, along with professional services and expert supporters to the industry. What's New for 2026? -A focus on unlocking access
- [Industry and academy matchmaking for joint DDLS projects 2026 - Industry](https://swedenbio.se/kalendarium/industry-and-academy-matchmaking-for-joint-ddls-projects-2026-industry/) - To further support networking and the formation of collaborative projects within the SciLifeLab & Wallenberg National Program for Data-Driven Life Science (DDLS), a matchmaking event between industry and academia is organized by SwedenBIO and DDLS Research School at Life City, Hagastaden (Stockholm) 15:30-17:30 on Thursday 12 February. This “after work”-style event will contain information about
- [NLSDays 2026](https://swedenbio.se/kalendarium/nlsdays-2026/) - The fastest growing life science event in the Nordic region, attracting a highly relevant audience. ✓ Startups and early phase clinical projects can find new investors. ✓ Established businesses can find partners for expansion. ✓ Global pharmaceutical and biotech companies can evaluate new and promising investment opportunities in the Nordic region.SwedenBIO members receive a discount.
- [ISCT 2026 Conference](https://swedenbio.se/kalendarium/isct-202/) - ISCT 2026 is a global conference on cell and gene therapy — bringing together scientists, clinicians, industry experts and regulators from around the world. The four-day program features translational science, clinical and preclinical research, regulatory and manufacturing insights, and broad networking opportunities. Attendees can expect: Cutting-edge presentations and latest advances shaping the future of cell
- [German Biotech Days 2026](https://swedenbio.se/kalendarium/german-biotech-days-2026/) - The German Biotech Days are the central forum for the German biotechnology sector, bringing together entrepreneurs with experts from science, politics, investment, funding institutions, and public administration to exchange ideas and build collaborations. The two-day conference program highlights the diverse application areas and the full potential of biotechnology – from health research to the bioeconomy.
- [Innovation for Health 2026](https://swedenbio.se/kalendarium/innovation-for-health-2026/) - Join on 26 March, 2026, in Utrecht for the 13th edition of Innovation for Health, the leading event in Health & Life Sciences. This year’s theme, Bridging the Gap, will bring together 800+ innovators, entrepreneurs, scientists, investors, and policymakers to accelerate the development of healthcare solutions that will shape the future. Why attend? Innovation for
- [APAC Healthcare & Life Sciences Opportunities Webinar](https://swedenbio.se/kalendarium/apac-healthcare-life-sciences-opportunities-webinar/) - To kick-start the year, Team Sweden – Swecare, Business Sweden and SwedenBIO – is pleased to invite you to a webinar on healthcare and life sciences opportunities in Asia Pacific. The webinar will provide: A high-level overview of key healthcare and life science trends and opportunities across Asia Pacific An overview of planned 2026 activities and platforms
- [Nordic-American Healthcare Conference](https://swedenbio.se/kalendarium/nordic-american-healthcare-conference/) - Hosted by the DNB Carnegie, Inc. and Back Bay Life Science Advisors - DNB Carnegie //Back Bay - the NAHC unites large and mid-cap public and private IPO-ready US and Nordic life science companies with US institutional investors. Participating companies present their equity story and showcase leading products that offer substantial advancements in patient care, making
- [SwedenBIO Summit](https://swedenbio.se/kalendarium/swedenbio-summit-2025/) - Make sure to mark your calendar for the upcoming SwedenBIO Summit at Grand Hotel. The purpose of SwedenBIO Summit is to provide a forum to share intimate business stories. You will also get a sneak peek of the most up-to-date statistics of the industry from the Life Science Barometer 2026 and we will wrap up the
- [BioProcess International Europe 2026](https://swedenbio.se/kalendarium/bioprocessing-summit-europe-2026/) - BioProcess International Europe (BPI Europe) in Vienna is the industry’s premier event for advancing biopharmaceutical development and production. Go beyond theory to master the future of bioprocessing: from cell line development, upstream, downstream, ATMPs to AI-driven factories and more. This is where innovation meets implementation. Join industry leaders, renowned scientists, and innovative technology providers to
- [Bio-Europe Spring 2026](https://swedenbio.se/kalendarium/bio-europe-spring-2026/) - This event is a spring-time partnering conference for the biopharma and life-sciences industry in Europe, designed to bring together companies, academic institutions, investors and industry leaders to foster strategic collaborations.Attendees can expect a mix of one-to-one partnering meetings, workshops, company presentations, panels, and an exhibition — providing ample opportunities for networking and exploring new business
- [19th Annual European Life Sciences CEO Forum](https://swedenbio.se/kalendarium/19th-annual-european-life-sciences-ceo-forum/) - The success and longevity of the forum is built on the goodwill and repeat attendance of major corporate and financial investors, and pharma licensing executives and advisors, who are seeking to network with biotechs. The programme and presentations allow all to keep up with the latest industry developments and strategies for 2026. The physical programme will
- [Biotech Showcase 2026](https://swedenbio.se/kalendarium/biotech-showcase-2026/) - Leading investor conference that connects private and micro-mid-cap biotech companies with investors and biopharma executives, providing a platform to showcase their innovations and facilitate one-on-one meetings. For 18 years, Biotech Showcase has been the premier event where industry leaders kick off the new year, making it "the place to be to start the year." Seamlessly
- [Drug development 3-day Course](https://swedenbio.se/kalendarium/drug-development-3-day-course-5/) - Drug development projects are often initiated by identifying treatment for a disease. The project usually contains a deep knowledge of the disease and the biological mechanism. However, in order to develop a drug for the disease, a broad knowledge of many different areas is required. This three-day course provides insights into all the parts that
- [From Pitch to Partnership: Mastering Pharma-Biotech Collaborations​](https://swedenbio.se/kalendarium/from-pitch-to-partnershipmastering-pharma-biotech-collaborations/) - Partnering with pharmaceutical companies is a critical pathway for emerging biotechs looking to advance their assets and accelerate development. In this seminar, experienced industry speakers will share practical insights from real-world collaborations—offering a behind-the-scenes perspective on how to capture big pharma’s attention, navigate the evaluation and due-diligence process, and select the most appropriate collaboration model.
- [Park Annual #20 2025](https://swedenbio.se/kalendarium/park-annual-20-2025/) - Now in its 20th year, Park Annual is a leading life science event that brings together entrepreneurs, innovators, researchers, clinicians, investors and students to inspire, share, challenge, dream, and collaborate around life science and health innovation.This year’s theme: Next Generation - Precision Medicine Highlights include:Showcasing cutting-edge technologies within Next Generation - Precision Medicine.PRECISEU: Defining the
- [MVA Annual Summit 2025](https://swedenbio.se/kalendarium/mva-annual-summit-2025/) - The EU Competitiveness Compass Points to Medicon Valley The EU-Commission´s Draghi report explicitly highlights the bi-national Medicon Valley life science cluster as a potential life science innovation hub in a future European strategy for increasing European competitiveness within life science. What are our strongholds and unique selling points? How do we compare it with other
- [Conference Focus Clinical Trials](https://swedenbio.se/kalendarium/conference-focus-clinical-trials/) - Swetrial opens the doors to this year's conference with a focus on clinical trials. Preliminary program Day 1 9:00 AMCoffee servedWelcome to Focus Clinical TrialsMingel lunchThe world around usAfternoon coffeeSwetrialHow is Swetrial realized in regional policy? 5:00 PMMingel dinner Day 2 9:00 AMInspirational lecture"Organizing cross-border collaboration – dilemmas, pitfalls and good advice"Morning coffeeClinical trial networksInternationalizationMingel
- [AWA Seminar: Navigate In-Licensing, DD and M&A from an IP perspective](https://swedenbio.se/kalendarium/awa-seminar-navigate-in-licensing-dd-and-ma-from-an-ip-perspective/) - Building on the insights from the previous seminar on licensing within the pharmaceutical industry, we delve deeper into the critical processes and vital intellectual property (IP) aspects of in-licensing, due diligence (DD) and mergers & acquisitions (M&A).• Discover how thorough DD can safeguard your investments• Learn the intricacies of in-licensing to expand your portfolio• Explore
- [Healthcare Meetup](https://swedenbio.se/kalendarium/healthcare-meetup/) - SwedenBio, Vitalis and Område Digital Hälsa, Sahlgrenska University Hospital invites you to an afterwork on the occasion of Kvalitetsmässan – a relaxed event where industry players meet across borders. We know that the future of healthcare is best shaped when we connect with each other. That is why we are creating a meeting place where healthcare providers,
- [IP That Matters: Behind Orexo’s Milestone Patent Win at the US Court](https://swedenbio.se/kalendarium/ip-that-matters-behind-orexos-milestone-patent-win-at-the-us-court/) - Following the announcement of the NLSDays 2025 panel and the fantastic response it received, Potter Clarkson is bringing the conversation back to Stockholm on 15 October 2025. If you’re unable to attend NLSDays but still want to hear from this panel, this is a great opportunity to join the discussion. The panel discussion will unpack Orexo’s
- [ASIA BIO Partnering Forum](https://swedenbio.se/kalendarium/asia-bio-partnering-forum-2/) - This Life science partnering event is organized by EBD/Informa and brings together emerging biotech, pharma, investors, and service providers from across the Asia‑Pacific and global markets. Whether you're a startup seeking growth capital or a pharma executive scouting partnerships, this Forum provides a uniquely effective mix of content, connections, and curated engagement to accelerate your
- [25th Annual Biotech in Europe Forum](https://swedenbio.se/kalendarium/25th-annual-biotech-in-europe-forum/) - Join this premier biotech partnering and investment forum—offering 50+ company showcases, 15+ hours of panels and keynotes, targeted one-to-one meetings (in person and virtual), and curated networking receptions. Expect 650+ participants across pharma, finance, and biotech innovation sectors. The event will be part of the Sachs Autumn Life Sciences Week.A discount is available for SwedenBIO members,
- [12th Annual HealtTech Investment Forum](https://swedenbio.se/kalendarium/12th-annual-healthtech-investment-forum/) - The 12th Annual HealthTech Investment Forum (HTIF), hosted by Sachs Associates, is a leading one-day event focused on Digital Health, MedTech, and Medical Devices. Held during Sachs Autumn Life Sciences Week, HTIF offers a high-impact platform for startups, industry leaders, and investors to engage in dialogue, deal-making, and discovery.A discount is available for SwedenBIO members,
- [Navigating the Quantum Landscape: Applications in Health and Life Sciences](https://swedenbio.se/kalendarium/navigating-the-quantum-landscape-applications-in-health-and-life-sciences/) - Sweden is a key player in quantum technology, with strong research initiatives from institutions like KI, Chalmers and KTH, government support for innovation, industry collaborations, active participation in European quantum programs, and a focus on developing a skilled workforce in the field.What do you need to do to become Quantum ready?Imagine harnessing the power of
- [Raising Capital in Life Science: What Investors Really Want to Know](https://swedenbio.se/kalendarium/capital-raise-in-life-science-what-investors-really-want-to-know/) - Life science companies face a unique challenge: communicating complex science and uncertain timelines to investors who need clear information to make decisions. SwedenBIO's updated Industry standard for information disclosure in life science capital raising helps simplify this process. This session explores how better disclosure creates stronger investor relationships and a more robust capital market.During an
- [Investival Showcase Europe 2025](https://swedenbio.se/kalendarium/investival-showcase-europe-2025/) - 10 Years of Life Science Partnering at the Investival Showcase Europe The LSX Investival Showcase is your gateway to biopharma and medtech investment and partnering. Taking place on the first day of London Life Science Week, it's growing in size and scale. It's the first and biggest public event of the week, open to the
- [BIO-Europe 2025](https://swedenbio.se/kalendarium/bio-europe/) - BIO-Europe is the largest, longest-running biopharma partnering conference in Europe. It has evolved with the biotech industry to deliver an efficient way for biotech and pharma companies to identify and build partnerships. Organized by EBD Group and supported by partneringONE, the conference is a forum for connection: though one-to-one meetings, and through the program, exhibit
- [LSX USA Congress 2025](https://swedenbio.se/kalendarium/lsx-usa-congress-2025/) - LSX USA Congress gathers leaders from the US biotech, medtech, and pharmatech sectors to network, showcase innovations, and explore partnership opportunities. It offers a unique platform for CEOs, investors, and pharma executives to engage in meaningful discussions and collaborative sessions, shaping the future of healthcare technology. SwedenBIO members receive 15% discount. Contact marjo.puumalainen@swedenbio.se if you don’t know where to find our discounts. More
- [Welcome to the Summer Edition of Hesa Fredrik AW!](https://swedenbio.se/kalendarium/hesa-fredrik-aw-pa-haymarket-8/) - Join us for the quarterly Hesa Fredrik After Work on June 2nd – this time hosted at EY's office on Hamngatan 26. The AW kicks off at 16:45, right after our "Growing Your Business in the US" seminar. Choose between attending both the seminar and the AW or either. Please register in advance to help
- [SwedenBIO i Almedalen](https://swedenbio.se/kalendarium/swedenbio-i-almedalen-3/) - Välkommen att besöka oss i SwedenBIO-huset under Almedalsveckan. Vi håller till på Visborgsgatan 5 i Visby med egna och medlemmars aktiviteter i vår mysiga trädgård. Almedalsveckan är fullspäckad med life science-evenemang arrangerade av oss och våra medlemsföretag. Här är de evenemang vi själva anordnar i vår trädgård: Tisdag, 24 juni, kl: 17:00-21:00SwedenBIOs trädgårdsmingelOnsdag, 25 juni,
- [Executive Dinner and annual meeting](https://swedenbio.se/kalendarium/executive-dinner-and-annual-meeting-2/) - An informal thematic evening where senior management from our member companies gather to gain inspiration, discuss and network. Warmly welcome to our 2025 annual gathering for life science industry executives. During the formal annual general meeting the fiscal year is briefly summarized. Exclusively for SwedenBIO members. For any questions, please contact info@swedenbio.se. Find more info and register
- [Growing your business in the US](https://swedenbio.se/kalendarium/growing-your-business-in-the-us/) - The US offers unparalleled opportunities for life science companies whether looking for investments or sales. But how to attract US investors or enter the US market? Join us for an insightful seminar where life science industry experts will share their stories and tips how to expand your business to the United States.Register here
- [Unlocking Innovation: Best Practises for Corporate-Academic Partnerships](https://swedenbio.se/kalendarium/seminar-unlocking-innovation-best-practises-for-corporate-academic-partnerships/) - SwedenBIO's IP Task force is inviting you to an engaging seminar on how to level up your academic collaborations. We will present our Term Sheet Checklist, a tool designed to simplify and secure successful agreements between industry and academia in the Life Science sector. You'll also get an exclusive look at the Data Driven Life
- [Strengthened Swedish competitiveness for clinical trials](https://swedenbio.se/kalendarium/webinar-strengthened-swedish-competitiveness-for-clinical-trials/) - The project "Strengthening Swedish competitiveness for clinical trials" is a feasibility study funded by Swelife with the aim of investigating and analyzing a number of key elements in a competitive Swedish partnership for clinical trials. Welcome to a webinar about the project's results and lessons learned.More info and registeration here: lif.se/event
- [Swiss Biotech Day 2025](https://swedenbio.se/kalendarium/swiss-biotech-day-2025/) - Experience the Swiss Biotech Day, a premier biotechnology conference, and join us in 2025 for an unparalleled gathering of more than 2,500 professionals from the global life sciences community. Explore the latest advancements in R&D, manufacturing, data management, artificial intelligence, and innovative financing.More info and registration here. SwedenBIO, together with MVA and Health Catalyst, are
- [NLSDays 2025](https://swedenbio.se/kalendarium/nlsdays-2025/) - This will be a unique opportunity to partner and network with the best of Nordic and International leaders in life sciences. Learn more and register as a delegate, exhibitor, investor, sponsor or company on nldays.com Members in SwedenBIO receive a discount. Contact marjo.puumalainen@swedenbio.se
- [Biologics drug development 3-day course](https://swedenbio.se/kalendarium/biologics-drug-development-3-day-course-3/) - Drug development of various types of biologic products is a complex and multidisciplinary process. The development integrates knowledge of the underlying disease, target identification, principles on biologics safety, planning strategy for toxicology and clinical studies incorporating the key aspects of manufacturing and controls. This three-day course provides insights into all parts that should be addressed
- [German Biotech Days](https://swedenbio.se/kalendarium/german-biotech-days/) - The event is the national forum for the German and international biotechnology industry. The German Biotech Days – in German abbreviated DBT – bring together entrepreneurs with scientists and partners from politics, investors, funding institutions and administration. The DBT 2025 will offer a great mix of presentations, panel discussions and breakout sessions, the largest and
- [AngloNordic Life Science Conference 2025](https://swedenbio.se/kalendarium/anglonordic-life-science-conference-4/) - The AngloNordic Conference is specifically for European investors and R&D companies from the Nordic and the UK to connect with each other. With an established format of panel discussions, parallel technology, biotech, investment rooms and 1:1 meetings, this conference provides exceptional value.Find more info hereSwedenBIO members receive a discount. Contact marjo.puumalainen@swedenbio.se if you do not
- [ALIS Venture Days](https://swedenbio.se/kalendarium/alis-venture-days/) - ALIS Venture Days is a digital event designed to bring together Swedish life science companies and investors for impactful one-on-one meetings. The event brings the chance to establish new investor relations and uncover exciting investment opportunities. Easily screen, book, and participate in one-to-one video meetings from the comfort of your location.More information here
- [BioTrinity 2025](https://swedenbio.se/kalendarium/biotrinity-2025/) - BioTrinity, now in its 19th year, is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The two-day conference programme for 2025 features a dual track of showcase presentations from R&D companies at around the Series A stage, across 14 different therapy areas, a packed business & investment track, sponsors exhibition,
- [SwedenBIO Summit 2023](https://swedenbio.se/kalendarium/swedenbio-summit-2023/) - Make sure to mark your calendar for the upcoming SwedenBIO Summit on the 30th January 2024 at Grand hotel. The purpose of SwedenBIO Summit is to provide a forum to share intimate business stories. This year's themes are: Excellence, Internationalisation and Innovation. You will also get a sneak peek of the most up-to-date statistics of
- [SwedenBIO Summit 2024](https://swedenbio.se/kalendarium/swedenbio-summit-2024/) - Make sure to mark your calendar for the upcoming SwedenBIO Summit at Grand Hotel. The purpose of SwedenBIO Summit is to provide a forum to share intimate business stories. You will also get a sneak peek of the most up-to-date statistics of the industry from the Life Science Barometer 2025 and we will wrap up
- [LSX World Congress 2025](https://swedenbio.se/kalendarium/lsx-world-congress-2025-2/) - For over a decade, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science strategy, investment, partnering and deal-making. LSX World Congress gathers the founders and CEOs of innovative start-ups through to public healthcare giants, and everyone in between. It represents the breadth and depth
- [J.P. Morgan Healthcare Conference](https://swedenbio.se/kalendarium/j-p-morgan-healthcare-conference-2/) - The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. Read more. SwedenBIO has put together a wide range of activities, discounts and other possibilities to help Swedish companies make the
- [Hesa-Fredrik AW på Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-pa-haymarket-6/) - Varje kvartal när Hesa Fredrik kallar* vill vi att du stänger av datorn, avslutar experimentet och signerar den där avvikelserapporten. För det är då dags att bege sig mot Life Science Stockholms nya vattenhål. Där får du möjlighet att knyta nya kontakter, bolla idéer och lösa knutar. Vi på SwedenBIO, i samarbete med våra medlemmar,
- [Hesa-Fredrik AW på Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-pa-haymarket-9/) - Every quarter when Hesa ​​Fredrik calls*, we want you to turn off the computer, end the experiment and sign that deviation report. Because then it's time to head towards Life Science Stockholm's new watering hole. There you get the opportunity to make new contacts, brainstorm ideas and untie knots. We at SwedenBIO, in collaboration with
- [Hesa-Fredrik AW på Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-pa-haymarket-7/) - Every quarter when Hesa ​​Fredrik calls*, we want you to turn off the computer, end the experiment and sign that deviation report. Because then it's time to head towards Life Science Stockholm's new watering hole. There you get the opportunity to make new contacts, brainstorm ideas and untie knots. We at SwedenBIO, in collaboration with
- [Vitalis 2025](https://swedenbio.se/kalendarium/vitalis-2025/) - Take part in the Nordics' leading meeting place for the health, care and care of the future - get skills development, network with colleagues and participate in important discussions about the future of care and care and how visions become reality. More information here
- [BIO KOREA 2025](https://swedenbio.se/kalendarium/bio-korea-2025/) - The 20th BIO KOREA International Convention Since 2006, BIO KOREA has been holding the International Convention every year for invigorating and growing the global bio-health industry. This year also, we are pleased to announce the 20th BIO KOREA will be held on May 7-9, 2025 at COEX, Seoul. Through various programs of BIO KOREA 2024
- [BIO-Europe Spring® 2025](https://swedenbio.se/kalendarium/bio-europe-spring-2025/) - Access the new wave of innovation at BIO-Europe Spring—the event connecting companies from the top innovation centers around Europe with the global life science community to cultivate strategic partnerships. The ninetieth annual BIO-Europe Spring® premier springtime partnering conference will be taking place March 17-19, 2025, in Milan, Italy. Building and nurturing relationships is an essential
- [Swiss Nordic Bio](https://swedenbio.se/kalendarium/swiss-nordic-bio-4/) - Swiss Nordic Bio is a high-level partnering and investor conference aimed at connecting healthcare innovations, investor and industry. The conference is the number one platform that gathers life science professionals from Switzerland and the Nordic countries under one roof. The conference is organised by the Nordic countries in cooperation with Swiss partners. Register here
- [Biotech Showcase™ 2025](https://swedenbio.se/kalendarium/biotech-showcase-2025/) - 17th Annual International Partnering Conference Biotech Showcase is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering them a unique opportunity to showcase their innovations and engage one-to-one with investors and biopharmaceutical executives. Register here.
- [SwedenBIO Summit 2023](https://swedenbio.se/kalendarium/swedenbio-summit-2024/) - Make sure to mark your calendar for the upcoming SwedenBIO Summit on the 30th January 2024 at Grand hotel. The purpose of SwedenBIO Summit is to provide a forum to share intimate business stories. This year's themes are: Excellence, Internationalization and Innovation. You will also get a sneak peek of the most up-to-date statistics of
- [Data Lake Event](https://swedenbio.se/kalendarium/data-lake-event/) - Region Skåne and SmiLe Venture Hub is collaborating in the Data Lake, a project to create a secure health data repository. The goal is to build tools to collect and analyze large amounts of data from the population of Skåne to explore complex disease correlations. This, in turn, will help develop better treatments and healthcare, as
- [KI Science Park Day Warm-Up: Finansieringsklimatet inom life science](https://swedenbio.se/kalendarium/ki-science-park-day-warm-up-finansieringsklimatet-inom-life-science/) - Osäkerheter i världsekonomin, hög inflation och högre räntelägen har minskat investerares riskaptit de senaste åren vilket har påverkat finansieringsklimatet för företag i alla branscher. Hur har förändringarna påverkat forskande life science företag? Vad kan vi förvänta oss av utvecklingen de kommande åren? Vad krävs av företagen som söker investeringar idag? Vilka affärsmodeller och strategier inom
- [Frukostseminarium: Ett år med FDI: Nyheter, utmaningar och praktiska tips](https://swedenbio.se/kalendarium/frukostseminarium-ett-ar-med-fdi-nyheter-utmaningar-och-praktiska-tips/) - FDI-lagens omfattande tillämpningsområde har resulterat i ett stort antal anmälningar till Inspektionen för strategiska produkter (ISP), per den 4 oktober hade fler än 900 anmälningar inkommit. Endast i 21 fall har ISP valt att inleda en granskning och inga fall har ännu förbjudits. Under detta frukostseminarium kommer vi att diskutera vår erfarenhet efter ett första
- [BIO International 2025](https://swedenbio.se/kalendarium/bio-international-2025/) - Whether you work at a public pharmaceutical company, biotech startup, academia, non-profits, and government or are a researcher, business development professional or investor, BIO is where you'll make valuable connections and build relationships. Our proprietary BIO One-on-One Partnering™ match-making platform—included in the Premier Access registration package—allows you to find potential partners, schedule and accept meetings. See
- [KI Science Park DAY 2024](https://swedenbio.se/kalendarium/ki-science-park-day-2024/) - The KI Science Park DAY is a unique opportunity to connect, learn, and inspire. We welcome you to the 2024 edition of KI Science Park DAY on November 13th! Program at Biomedicum: 13:00-17:00. After-event-mingle at Innomedium, A Working Lab cafe: 17:00-19:00 Moderator: Johan Christenson, Partner at HealthCap What to expect at this event? Award lecture
- [BIO-Europe 2024](https://swedenbio.se/kalendarium/bio-europe-2024/) - BIO-Europe is a must-attend event for executives from the global biotechnology industry who will gain direct access to service and manufacturing partners, innovative assets, and ideas from biotech companies ranging from very early stage to large, established companies. The event will cater to the needs of the entire value chain, start-up and innovator educational programmes,
- [Drug Development – 3 day course](https://swedenbio.se/kalendarium/drug-development-3-day-course-4/) - The course is aimed for those involved in drug development (eg in small and medium-sized companies), and needs a comprehensive picture of the complex development chain. During the course you will get insight into how to work in the different stages of development, what to think about and what pitfalls there are on the road.
- [Park Annual 2024](https://swedenbio.se/kalendarium/park-annual-2024/) - Inspirational speakers and co-action cases Matthew Rappaport (UC-Berkeley Deep Tech Innovation Lab) Miden Melle-Hannah (Surgeon & entrepreneur, Multi4 Medical) Petter Björquist (CEO, VERIGRAFT & Itedale Namro (CSO, CELLINK) Craig Anderson (Director, Information Management, Pfizer) Jan Smith (Founder, Circius Pharma) Håkan Sandahl (Regional Director, Region Västra Götaland) Siri Bergnéhr (UX designer & founder of AFRY’s FemTech
- [Hur går det för Sveriges 4000 life science-företag?](https://swedenbio.se/kalendarium/hur-gar-det-for-sveriges-4000-life-science-foretag/) - SwedenBIO och Vinnova bjuder in till en presentation av och diskussion om Vinnovas senaste statistik från regeringsuppdraget att följa den svenska life science-sektorn. Till årets rapport hör även en fördjupning om Deep tech. I årets rapport görs en fördjupning inom deeptech. Vad är ett deeptech-företag och hur ser deeptech ut inom life science-sektorn? Registrera här
- [Cyber Security Attacks in MedTech Companies are Increasing- Are You Prepared?](https://swedenbio.se/kalendarium/cyber-security-attacks-in-medtech-companies-are-increasing-are-you-prepared/) - Data breaches and ransomware pose significant threats to the industry. Internet-connected medical devices are particularly vulnerable to cyberattacks. Regulatory authorities are increasing security standards. In today’s digital age, medical devices are under constant threat from cyber-attacks. We will highlighting the prevalence of daily attacks and the specific dangers posed by ransomware and explore case studies
- [Frukostseminarium: Kliniska prövningar i Sverige – hur långt har vi kommit?](https://swedenbio.se/kalendarium/frukostseminarium-kliniska-provningar-i-sverige-hur-langt-har-vi-kommit/) - Sverige står inför utmaningen att öka antalet kliniska prövningar. Vi bjuder in dig till ett frukostseminarium för en aktuell statusuppdatering om utvecklingen, där vi bland annat får höra från Maja Neiman, Science Director på SwedenBIO, tillsammans med andra insatta inom området.Vi får också en uppdatering från projektet ”Stärkt konkurrenskraft för kliniska prövningar”, finansierat av Swelife,
- [Make the Most Out of BIO-Europe 2024](https://swedenbio.se/kalendarium/make-the-most-out-of-bio-europe-2024/) - Maximize your participation with SwedenBIOs Business Strategy Working Group SwedenBIO’s Business Strategy group—comprising experts in various aspects of business development—will share valuable insights on securing meetings with the right contacts, making the most of a 25-minute meeting, and effective follow-up strategies. Join the webinar to maximize your impact at BIO-Europe! Register here
- [The Advanced Business Development Course](https://swedenbio.se/kalendarium/the-industrys-premier-advanced-business-development-course/) - Brought to you by EBD Academy, the Advanced Business Development (ABD) is a long-running course instructed by Joe Dillon, Lesley Stolz, Kenneth Krisko, and Patrick Duxbury, that focuses on all key aspects of transactions in the biopharma industry. Advanced Business Development incorporates lectures from experienced dealmakers, reviews of example models, dissections of actual deals, interaction
- [The Biotech and Pharmaceutical Mini MBA](https://swedenbio.se/kalendarium/the-biotech-and-pharmaceutical-mini-mba/) - Brought to you by EBD Academy, the Biotech and Pharmaceutical Mini MBA discusses relevant challenges and strategies used to drive success of life science companies and provides vital knowledge about the typical lifecycle of activities in a pharmaceutical company. Delivered over five days, each module is based on key areas of activity which include: Strategic
- [NLSDays 2024](https://swedenbio.se/kalendarium/nlsdays-2024/) - This will be a unique opportunity to partner and network with the best of Nordic and International leaders in life sciences. Learn more and register as a delegate, exhibitor, investor, sponsor or company on nldays.com Members in SwedenBIO receive a discount. Contact marjo.puumalainen@swedenbio.se
- [Life Science Collaborations Based on Intellectual Property (IP) - Must Smaller Player Be the Weaker Party?](https://swedenbio.se/kalendarium/life-science-collaborations-based-on-intellectual-property-ip-must-smaller-player-be-the-weaker-party/) - Come and listen to Annika Kilander, Managing Partner at Brann, for a session of providing insight and useful tips when it comes to approaching and dealing with a party larger than yourself in a collaboration involving IP. Join us in a conversation around business drivers and motives, hidden agendas and the reason behind. Food and
- [På väg till börsen – hur förbereder man sig i dagens klimat?](https://swedenbio.se/kalendarium/pa-vag-till-borsen-hur-forbereder-man-sig-i-dagens-klimat/) - För att reda ut hur man som börskandidat bäst förbereder sig inför en notering och att sedan verka i en noterad miljö bjuder vi in till ett frukostseminarium den 3 september där Rasmus Karlgren, manager på Paues Åberg Communications, inledningsvis kommer att redovisa en aktuell spaning kring förutsättningarna att notera bolag på svenska marknadsplatser och vad
- [Nordic Healthcare Horizons](https://swedenbio.se/kalendarium/nordic-healthcare-horizons/) - The Nordic healthcare landscape faces identical structural challenges that can be addressed through enhanced cross-regional collaboration and strategic public-private partnerships. The report highlights the potential for smarter, more sustainable healthcare solutions and uncovers strategies and national initiatives to strengthen resilience and public private partnerships that can help innovating the health care eco system. Register here.
- [Hesa-Fredrik AW på Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-pa-haymarket-5/) - Varje kvartal när Hesa Fredrik kallar* vill vi att du stänger av datorn, avslutar experimentet och signerar den där avvikelserapporten. För det är då dags att bege sig mot Life Science Stockholms nya vattenhål. Där får du möjlighet att knyta nya kontakter, bolla idéer och lösa knutar. Vi på SwedenBIO, i samarbete med våra medlemmar,
- [Life Science Mixer](https://swedenbio.se/kalendarium/life-science-mixer/) - More details June 4th, 6.30 pm The Westgate Hotel, 1055 Second Ave, San Diego, CA 92101 More info and registration
- [Life Science Mixer](https://swedenbio.se/kalendarium/life-science-mixer/) - Details June 4th, 6.30 pm The Westgate Hotel, 1055 Second Ave, San Diego, CA 92101 More info and registration
- [Från förslag till beslut och implementering av nya läkemedelslagstiftningen och HTA-förordningen](https://swedenbio.se/kalendarium/fran-forslag-till-beslut-och-implementering-av-nya-lakemedelslagstiftningen-och-hta-forordningen/) - Vad innebär den nya läkemedelslagstiftningen och hur kommer den påverka framtida innovativa läkemedel? Vad innebär HTA-förordningen och hur fortskrider dess implementering hos TLV? Välkommen till föreläsning med paneldiskussion hos PharmaRelations. Mer info och registrering.
- [From proposal to decision and implementation of new pharmaceutical legislation and the HTA Regulation](https://swedenbio.se/kalendarium/from-proposal-to-decision-and-implementation-of-new-pharmaceutical-legislation-and-the-hta-regulation/) - What does the new pharmaceutical legislation mean and how will it affect future innovative medicines? What does the HTA Regulation mean and how is its implementation progressing at TLV? Welcome to a lecture and panel discussion at PharmaRelations. More info and registration.
- [SwedenBIO in Almedalen](https://swedenbio.se/kalendarium/swedenbio-in-almedalen-2/) - Welcome to the SwedenBIO house in central Visby during the Almedalen week. As a member, you are welcome to hold your meetings in our centrally located cottage. Please contact us well in advance for available premises. Everyone is welcome to our garden mingle and our two panel discussions. 25 JuneSwedenBIO's traditional garden mingle at 17:00Register
- [SwedenBIO i Almedalen](https://swedenbio.se/kalendarium/swedenbio-i-almedalen-2/) - Välkommen till SwedenBIO-huset i centrala Visby under Almedalsveckan. Som medlem är du välkommen att hålla dina möten i vår centralt belägna stuga. Kontakta oss gärna i god tid för lediga lokaler. Alla är välkomna till vårt trädgårdsmingel och våra två panelsamtal. 25 juniSwedenBIOs traditionella trädgårdsmingel kl 17:00Anmäl dig här. 26 juni13:00 - 14:00 panelsamtalSvensk innovation
- [Data Driven Business Growth](https://swedenbio.se/kalendarium/data-driven-business-growth/) - Data, expertise and insight are critical enablers of driving growth across all areas of the pharmaceutical product lifecycle; from clinical and portfolio strategy, prioritizing indications for lead assets, commercialization and scouting for new licensing, investment or partnering opportunities. This seminar will focus on how Citeline can help pharma/biotech companies with what comes next, including how
- [Data Driven Business Growth](https://swedenbio.se/kalendarium/data-driven-business-growth/) - Data, expertise and insight are critical enablers of driving growth across all areas of the pharmaceutical product lifecycle; from clinical and portfolio strategy, prioritizing indications for lead assets, commercialization and scouting for new licensing, investment or partnering opportunities. This seminar will focus on how Citeline can help pharma/biotech companies with what comes next, including how
- [Eastern IP Stories: Pharma IP enforcement and Litigation in Asia](https://swedenbio.se/kalendarium/eastern-ip-stories-pharma-ip-enforcement-and-litigation-in-asia/) - On 8 May at 10am (CET), Rouse together with SwedenBIO, the national industry organization for life sciences in Sweden, are pleased to invite you to a webinar discussing pharma patent enforcement and litigation in Asia. Joining us we have Nick Redfearn, Global Head of Enforcement at Rouse and Terry Lu, Associate in the Litigation team
- [Eastern IP Stories: Pharma IP enforcement and Litigation in Asia](https://swedenbio.se/kalendarium/eastern-ip-stories-pharma-ip-enforcement-and-litigation-in-asia/) - On 8 May at 10am (CET), Rouse together with SwedenBIO, the national industry organization for life sciences in Sweden, are pleased to invite you to a webinar discussing pharma patent enforcement and litigation in Asia. Joining us we have Nick Redfearn, Global Head of Enforcement at Rouse and Terry Lu, Associate in the Litigation team
- [Navigating the current funding environment and other key challenges in drug development for 2024 and beyond](https://swedenbio.se/kalendarium/navigating-the-current-funding-environment-and-other-key-challenges-in-drug-development-for-2024-and-beyond/) - The breakfast seminar, taking place on May 23 in Stockholm, gives an overview of the recent dynamic environmental, economic, regulatory and payer developments which are creating complex and interwoven challenges the global current healthcare has to overcome in order to be successful in the future. After the program, speakers and organizers are available for 1:1
- [Webinar: Bridging the Gap 2024](https://swedenbio.se/kalendarium/webinar-bridging-the-gap-2024/) - On April 25th, the Life Science Bridge initiative will host its annual Bridging the Gap webinar, focusing on "Healthcare Empowered by AI". During the webinar, participants will have the opportunity to listen to presentations by five esteemed speakers from the life science industry, followed by a dynamic panel discussion to conclude the event. More info
- [Webinar: Bridging the Gap 2024](https://swedenbio.se/kalendarium/webinar-bridging-the-gap-2024/) - On April 25th, the Life Science Bridge initiative will host its annual Bridging the Gap webinar, focusing on "Healthcare Empowered by AI". During the webinar, participants will have the opportunity to listen to presentations by five esteemed speakers from the life science industry, followed by a dynamic panel discussion to conclude the event. More info
- [Ticket to ride Nordics](https://swedenbio.se/kalendarium/ticket-to-ride-nordics/) - This will be the third stop on a series of seminars exploring how to succeed with talent attraction and building strong teams for a growth journey that will ultimately take you and your company to an international market. Join Medicon Valley Alliance, SwedenBIO, Novo Nordisk, aera, Eir Ventures and many more to discuss this over
- [Ticket to ride Nordics](https://swedenbio.se/kalendarium/ticket-to-ride-nordics/) - This will be the third stop on a series of seminars exploring how to succeed with talent attraction and building strong teams for a growth journey that will ultimately take you and your company to an international market. Join Medicon Valley Alliance, SwedenBIO, Novo Nordisk, aera, Eir Ventures and many more to discuss this over a
- [NLSDays 2024](https://swedenbio.se/kalendarium/nlsdays-2024/) - This will be a unique opportunity to partner and network with the best of Nordic and International leaders in life sciences. Learn more and register as a delegate, exhibitor, investor, sponsor or company on nldays.com Members in SwedenBIO receive a discount. Contact marjo.puumalainen@swedenbio.se
- [David against Goliath: how Orexo managed to successfully defend their patents against big pharma in the US](https://swedenbio.se/kalendarium/david-against-goliath-how-orexo-managed-to-successfully-defend-their-patents-against-big-pharma-in-the-us/) - Robert Rönn, SVP and Head of R&D at Orexo will tell about how they successfully litigated their patents against Big Pharma in the US. Join Brann for an after work with drinks and food and listen to Orexo's exciting story. RSVP: event@brann.se before 2nd April. Länk till seminariet
- [David against Goliath: how Orexo managed to successfully defend their patents against big pharma in the US](https://swedenbio.se/kalendarium/david-against-goliath-how-orexo-managed-to-successfully-defend-their-patents-against-big-pharma-in-the-us/) - Robert Rönn, SVP and Head of R&D at Orexo will tell about how they successfully litigated their patents against Big Pharma in the US. Join Brann for an after work with drinks and food and listen to Orexo's exciting story. RSVP: event@brann.se before 2nd April. Link to the seminar
- [New ways of conducting clinical trials](https://swedenbio.se/kalendarium/new-ways-of-conducting-clinical-trials/) - Join the webinar by Link Medical to listen to the new way of conducting clinical trials. Three experts share their experience from different angles of decentralized trials and have tips for modern tools to use. This is the future, are you prepared? More info and registration
- [New ways of conducting clinical trials](https://swedenbio.se/kalendarium/new-ways-of-conducting-clinical-trials/) - Join the webinar by Link Medical to listen to the new way of conducting clinical trials. Three experts share their experience from different angles of decentralized trials and have tips for modern tools to use. This is the future, are you prepared? More info and registration
- [UPC - what will its impact be on the life science sector?](https://swedenbio.se/kalendarium/upc-what-will-its-impact-be-on-the-life-science-sector/) - The long awaited UPC patent court system finally opened for business on 1 June 2023. There was a lot of speculation about how the new system would impact patent strategies for companies and whether some sectors would be more affected than others. Join this breakfast event where patent firm EIP will give you a guide
- [UPC – what will its impact be on the life science sector?](https://swedenbio.se/kalendarium/upc-what-will-its-impact-be-on-the-life-science-sector/) - The long awaited UPC patent court system finally opened for business on 1 June 2023. There was a lot of speculation about how the new system would impact patent strategies for companies and whether some sectors would be more affected than others. Join this breakfast event where patent firm EIP will give you a guide
- [Asia Bio Partnering Forum](https://swedenbio.se/kalendarium/asia-bio-partnering-forum/) - Asia Bio Partnering Forum will continue to build on its strong start and will gather biotech and pharma leaders from around the world with hundreds of emerging innovators across Asia Pacific to advance dealmaking in Asia. SwedenBIO members receive a discount. Contact marjo.puumalainen@swedenbio.se More info and registration.
- [Asia Bio Partnering Forum](https://swedenbio.se/kalendarium/asia-bio-partnering-forum/) - Asia Bio Partnering Forum will continue to build on its strong start and will gather biotech and pharma leaders from around the world with hundreds of emerging innovators across Asia Pacific to advance dealmaking in Asia. SwedenBIO members receive a discount. Contact marjo.puumalainen@swedenbio.se More info and registration.
- [Executive Dinner and annual meeting](https://swedenbio.se/kalendarium/executive-dinner-and-annual-meeting/) - An informal thematic evening where senior management from our member companies gather to gain inspiration, discuss and network. Warmly welcome to our 2024 annual gathering for life science industry executives. This year we are happy to welcome Caroline Farberger to share her story on the topic Drive value creation through inclusion. During the formal annual general
- [Executive Dinner and annual meeting](https://swedenbio.se/kalendarium/executive-dinner-and-annual-meeting/) - An informal thematic evening where senior management from our member companies gather to gain inspiration, discuss and network. Warmly welcome to our 2024 annual gathering for life science industry executives. This year we are happy to welcome Caroline Farberger to share her story on the topic Drive value creation through inclusion. During the formal annual
- [Swiss Nordic Bio](https://swedenbio.se/kalendarium/swiss-nordic-bio-3/) - Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech and healthtech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 17 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organized by the Nordic countries in cooperation with Swiss partners. When: 7 March 2024Where: Zürich
- [Swiss Nordic Bio](https://swedenbio.se/kalendarium/swiss-nordic-bio-3/) - Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech and healthtech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 17 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners. When: 7 March 2024Where: Zürich Airport, Radisson
- [BIO-Europe Spring® 2024](https://swedenbio.se/kalendarium/bio-europe-spring-2024/) - BIO-Europe Spring, the premier springtime partnering event, brings together over 3,700 attendees from 2,000+ companies to engage in 20,000 one-to-one meetings. THE SPRINGTIME PARTNERING EVENTMarch 18-20, 2024 | Barcelona, Spain,March 26-27, 2024 | Digital Partnering Members in SwedenBIO receive a discount. Contact marjo.puumalainen@swedenbio.se Event website: https://informaconnect.com/bioeurope-spring/
- [BIO-Europe Spring® 2024](https://swedenbio.se/kalendarium/bio-europe-spring-2024/) - BIO-Europe Spring, the premier springtime partnering event, brings together over 3,700 attendees from 2,000+ companies to engage in 20,000 one-to-one meetings. THE SPRINGTIME PARTNERING EVENTMarch 18–20, 2024 | Barcelona, Spain,March 26–27, 2024 | Digital Partnering Members in SwedenBIO receive a discount. Contact marjo.puumalainen@swedenbio.se Event website: https://informaconnect.com/bioeurope-spring/
- [LSX World Congress 2024](https://swedenbio.se/kalendarium/lsx-world-congress-2024/) - The event brings together the CEOs and senior decision makers from the world's most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments - all geared at putting capital and ideas to work to help create the world's future
- [LSX World Congress 2024](https://swedenbio.se/kalendarium/lsx-world-congress-2024/) - The event brings together the CEOs and senior decision makers from the world's most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments - all geared at putting capital and ideas to work to help create the world's future
- [Anglonordic Life Science Conference](https://swedenbio.se/kalendarium/anglonordic-life-science-conference-2/) - Join over 350 delegates from leading and upcoming drug discovery and technology companies from the UK and Nordic regions, and investment firms throughout Europe, for a full day of talks and panel discussions along with pitch presentations from investor-chosen startups. Members in SwedenBIO receive a discount. Contact marjo.puumalainen@swedenbio.se for discount code. More info: https://www.anglonordiclifescience.com/
- [Anglonordic Life Science Conference](https://swedenbio.se/kalendarium/anglonordic-life-science-conference-2/) - Join over 350 delegates from leading and upcoming drug discovery and technology companies from the UK and Nordic regions, and investment firms throughout Europe, for a full day of talks and panel discussions along with pitch presentations from investor-chosen startups. Members in SwedenBIO receive a discount. Contact marjo.puumalainen@swedenbio.se for discount code. More info: https://www.anglonordiclifescience.com/
- [Swedish Life Science Investor Meeting](https://swedenbio.se/kalendarium/swedish-life-science-investor-meeting/) - This match-making event brings together Swedish life science companies from all growth phases and investors. The ambition is to offer an arena for Swedish life science companies to establish new investor relations and to find investment opportunities. Arranged by Umeå Biotech Incubator More info & registration
- [Swedish Life Science Investor Meeting](https://swedenbio.se/kalendarium/swedish-life-science-investor-meeting/) - This match-making event brings together Swedish life science companies from all growth phases and investors. The ambition is to offer an arena for Swedish life science companies to establish new investor relations and to find investment opportunities. Arranged by Umeå Biotech Incubator More info & registration
- [Breakfast seminar - Three months of FDI](https://swedenbio.se/kalendarium/breakfast-seminar-three-months-of-fdi/) - On December 1, 2023, a new law entered into force regarding the screening of foreign direct investments to protect Swedish security interests (the "FDI Act"). It is a security policy legislation that allows for the control of both direct and indirect investments in companies engaged in so-called 'high-value activities'. Read more and register
- [Frukostseminarium - Tre månader med FDI](https://swedenbio.se/kalendarium/frukostseminarium-tre-manader-med-fdi/) - Den 1 december 2023 trädde en ny lag i kraft gällande granskning av utländska direktinvesteringar till skydd för svenska säkerhetsintressen (”FDI-lagen”). Det är en säkerhetspolitisk lagstiftning som möjliggör kontroll av såväl direkta som indirekta investeringar i bolag som bedriver så kallad skyddsvärd verksamhet. Läs mer och registrera dig
- [Nordic Health Summit Japan](https://swedenbio.se/kalendarium/nordic-health-summit-japan-2/) - The Nordic Health Summit Japan 2024 kicks off with an onsite seminar which can be also followed online. For online participation, registration will open closer the date. Seminar program for 2024 is being confirmed. More info and registration
- [Nordic Health Summit Japan](https://swedenbio.se/kalendarium/nordic-health-summit-japan-2/) - The Nordic Health Summit Japan 2024 kicks off with an onsite seminar which can be also followed online. For online participation, registration will open closer the date. Seminar program for 2024 is being confirmed. More info and registration
- [AseBio Investor Day](https://swedenbio.se/kalendarium/asebio-investor-day/) - Since its first edition (Barcelona, 2017), the event has attracted national and international investors, contributing to give visibility to the national biotechnology industry. AseBio Investor Day also fosters networking between investors from Spain and the rest of the world. AseBio Investor Day includes a program of round tables where relevant topics on investment and finance
- [AseBio Investor Day](https://swedenbio.se/kalendarium/asebio-investor-day/) - Since its first edition (Barcelona, 2017), the event has attracted national and international investors, contributing to give visibility to the national biotechnology industry. AseBio Investor Day also fosters networking between investors from Spain and the rest of the world. AseBio Investor Day includes a program of round tables where relevant topics on investment and finance
- [Open up for Innovation](https://swedenbio.se/kalendarium/open-up-for-innovation/) - Welcome to a discussion about joining forces between researchers in Academia and the Life Science Industry to ignite more collaboration for innovative research and translation of this research into impact for better health.Organized by: Umeå Biotech Incubator, Coalition Umeå for Life, Innovation Office Umeå University. Speakers:Mikael Elofsson, Dean Faculty of Science and Technology, Umeå UniversityJessica
- [Open up for Innovation](https://swedenbio.se/kalendarium/open-up-for-innovation/) - Welcome to a discussion about joining forces between researchers in Academia and the Life Science Industry to ignite more collaboration for innovative research and translation of this research into impact for better health.Organized by: Umeå Biotech Incubator, Coalition Umeå for Life, Innovation Office Umeå University. Speakers:Mikael Elofsson, Dean Faculty of Science and Technology, Umeå UniversityJessica Martinsson, CEO
- [BIO KOREA](https://swedenbio.se/kalendarium/bio-korea/) - Since 2006, BIO KOREA has been holding the International Convention every year for invigorating and growing the global bio-health industry. This year the 19th BIO KOREA will be held on May 8-10, 2024 at COEX, Seoul. Through various programs of BIO KOREA 2024 including Business Partnering, Exhibition, Conference, and Invest Fair, exchange the newest bio-health
- [BIO KOREA](https://swedenbio.se/kalendarium/bio-korea/) - Since 2006, BIO KOREA has been holding the International Convention every year for invigorating and growing the global bio-health industry. This year the 19th BIO KOREA will be held on May 8-10, 2024 at COEX, Seoul. Through various programs of BIO KOREA 2024 including Business Partnering, Exhibition, Conference, and Invest Fair, exchange the newest bio-health
- [Swiss Biotech Days 2024](https://swedenbio.se/kalendarium/swiss-biotech-days-2024/) - The Swiss Biotech Day is a premier biotechnology conference in Europe, attracting professionals from the global life sciences community. In 2024, it will once again provide a platform for networking, engaging discussions, and the exploration of advancements in R&D, manufacturing, data management, artificial intelligence, and innovative financing. SwedenBIO members receive discount. Contact marjo.puumalainen@swedenbio.se for more
- [Swiss Biotech Days 2024](https://swedenbio.se/kalendarium/swiss-biotech-days-2024/) - The Swiss Biotech Day is a premier biotechnology conference in Europe, attracting professionals from the global life sciences community. In 2024, it will once again provide a platform for networking, engaging discussions, and the exploration of advancements in R&D, manufacturing, data management, artificial intelligence, and innovative financing. SwedenBIO members receive discount. Contact marjo.puumalainen@swedenbio.se for more
- [Drug Development - 3 day course](https://swedenbio.se/kalendarium/drug-development-3-day-course-4/) - The course is aimed for those involved in drug development (eg in small and medium-sized companies), and needs a comprehensive picture of the complex development chain. During the course you will get insight into how to work in the different stages of development, what to think about and what pitfalls there are on the road.
- [Drug Development - 3 day course](https://swedenbio.se/kalendarium/drug-development-3-day-course-4/) - The course is aimed for those involved in drug development (eg in small and medium-sized companies), and needs a comprehensive picture of the complex development chain. During the course you will get insight into how to work in the different stages of development, what to think about and what pitfalls there are on the road.
- [Brain & Breakfast](https://swedenbio.se/kalendarium/brain-breakfast/) - The new Joint Clinical Assessment (JCA) promises big change in how products go to market. Are you ready for it? An upcoming live panel discussion — hosted by SwedenBio and PharmaLex (Cencora) — will share what you need to know about this new regulation. If you are launching a product into Europe and Sweden, this
- [Brain & Breakfast](https://swedenbio.se/kalendarium/brain-breakfast/) - The new Joint Clinical Assessment (JCA) promises big change in how products go to market. Are you ready for it? An upcoming live panel discussion - hosted by SwedenBio and PharmaLex (Cencora) - will share what you need to know about this new regulation. If you are launching a product into Europe and Sweden, this
- [Ticket To Ride Nordics - Connecting life science hot spots for a joint labor market!](https://swedenbio.se/kalendarium/connecting-life-science-hot-spots-for-a-joint-labor-market/) - Ton Berkien will share an inspirational talk about his own journey as a Dutch entrepreneur, living in Sweden and working for Norwegian based Ultimovacs. This talk will be followed by an open discussion moderated by Helena Strigård, CEO Haeger & Carlsson Executive Search and Interim, on how the connection between the life science hotspots of
- [Ticket To Ride Nordics - Connecting life science hot spots for a joint labor market!](https://swedenbio.se/kalendarium/connecting-life-science-hot-spots-for-a-joint-labor-market/) - Ton Berkien will share an inspirational talk about his own journey as a Dutch entrepreneur, living in Sweden and working for Norwegian based Ultimovacs. This talk will be followed by an open discussion moderated by Helena Strigård, CEO Haeger & Carlsson Executive Search and Interim, on how the connection between the life science hotspots of
- [Experience vs. potential - How can we ensure innovation and growth?](https://swedenbio.se/kalendarium/skills-potential-how-can-we-ensure-innovation-and-growth-if-we-only-look-backwards/) - In the form of a relaxed "sofa talk", industry representatives discuss how Swedish industry can succeed in being innovative and continue to grow, despite a finite national candidate market. In addition to wise thoughts, drinks and snacks will be served. Welcome to an afterwork on skills supply, a key factor for the continued success of
- [Erfarenhet vs. potential - Hur kan vi säkerställa innovation och tillväxt?](https://swedenbio.se/kalendarium/kompetens-potential-hur-kan-vi-sakerstalla-innovation-och-tillvaxt-om-vi-bara-tittar-bakat/) - Under formerna av ett avslappnat ”sofa talk” samtalar representanter från industrin kring hur vi som svensk industri ska lyckas vara innovativa och fortsätta växa, trots en finit nationell kandidatmarknad. Utöver kloka tankar serveras även dryck och tilltugg. Välkommen till en afterwork kring kompetensförsörjning, en nyckelfaktor för vår industris fortsatta framgång.Talare: Linus Norrbom, Division Manager, Life
- [BioEquity Europe 2024](https://swedenbio.se/kalendarium/bioequity-europe-2/) - Join BioCentury, EBD Group, and Regional Host Committee Chair Ysios Capital, May 12-14, 2024, in one of the culinary capitals of the world. Don't wait to book your ticket to San Sebastian. Last year, Bio€quity sold out. Members in SwedenBIO receive a discount. Contact marjo.puumalainen@swedenbio.se Event website: https://conferences.biocentury.com/bioequity-europe
- [BioEquity Europe 2024](https://swedenbio.se/kalendarium/bioequity-europe-2/) - Join BioCentury, EBD Group, and Regional Host Committee Chair Ysios Capital, May 12-14, 2024, in one of the culinary capitals of the world. Don’t wait to book your ticket to San Sebastian. Last year, Bio€quity sold out. Members in SwedenBIO receive a discount. Contact marjo.puumalainen@swedenbio.se Event website: https://conferences.biocentury.com/bioequity-europe
- [BIO-Europe 2024](https://swedenbio.se/kalendarium/bio-europe-2024/) - BIO-Europe is a must-attend event for executives from the global biotechnology industry who will gain direct access to service and manufacturing partners, innovative assets, and ideas from biotech companies ranging from very early stage to large, established companies. The event will cater to the needs of the entire value chain, start-up and innovator educational programs,
- [Ethics Day 2023: Breakthrough for genome therapies - is society ready?](https://swedenbio.se/kalendarium/ethics-day-2023-breakthrough-for-genome-therapies-is-society-ready/) - The seminar will start with some examples of genome therapies recently introduced or currently in clinical trials. It then describes some of the legal, health economic, ethical and other challenges posed by these developments. The seminar will end with a panel discussion with policy makers. For more information and registration, click here.
- [Etikdagen 2023: Genombrott för genomterapier – är samhället redo?](https://swedenbio.se/kalendarium/etikdagen-2023-genombrott-for-genomterapier-ar-samhallet-redo/) - Seminariet inleds med några exempel på genomterapier som nyligen introducerats eller som för närvarande prövas kliniskt. Därefter beskrivs några av de juridiska, hälsoekonomiska, etiska och andra utmaningar som utvecklingen medför. Seminariet avslutas med ett panelsamtal med beslutsfattare. För mer info och anmälan, klicka här.
- [SEMINAR: HOW TO COMBAT AMR NOW AND IN THE FUTURE?](https://swedenbio.se/kalendarium/how-to-counteract-amr-now-and-in-the-future/) - What is going on in Sweden and the world to counteract antimicrobial resistance, what is the state of research, the development of new medicines and not least - how to raise awareness of AMR among the public and patients? Listen to:Malin Grape, Sweden's AMR ambassadorUlrika Knutsson, Founder, SepsisfondenJörgen Johansson, Prof. Umeå University, founder of QuretechKristina
- [SEMINAR: HOW TO COMBAT AMR NOW AND IN THE FUTURE?](https://swedenbio.se/kalendarium/how-to-counteract-amr-now-and-in-the-future/) - What is going on in Sweden and the world to counteract antimicrobial resistance, what is the state of research, the development of new medicines and not least - how to raise awareness of AMR among the public and patients? Listen to:Malin Grape, Sweden's AMR ambassadorUlrika Knutsson, Founder, SepsisfondenJörgen Johansson, Prof. Umeå University, founder of QuretechKristina
- [SEMINARIUM: HUR MOTVERKA AMR NU OCH I FRAMTIDEN?](https://swedenbio.se/kalendarium/hur-motverka-amr-nu-och-i-framtiden/) - Vad pågår i Sverige och världen för att motverka antimikrobiell resistens, hur ser forskningen ut, utvecklingen av nya läkemedel och inte minst – hur medvetandegöra allmänhet och patienter om AMR? Lyssna till:Malin Grape, Sveriges AMR-ambassadörUlrika Knutsson, Grundare, SepsisfondenJörgen Johansson, Prof. Umeå Universitet, grundare QuretechKristina Björkqvist, Representant Sepsisföreningen Jonas Ålebring, Medical Director, PfizerJessica Martinsson, VD SwedenBioPernilla
- [Seminar: Sweden - best in the world at innovation, but how good are we at implementation?](https://swedenbio.se/kalendarium/seminar-sweden-best-in-the-world-at-innovation-but-how-good-are-we-at-implementation/) - Sweden is repeatedly ranked as one of the most innovative countries in the world but lags behind when it comes to actually implementing innovations in healthcare. The panel discussion will highlight the panelists' perspectives on: why implementation is important, its challenges, bottlenecks and success factors! The panel discussion will be moderated by Shadi Abbas, Managing
- [Seminarium: Sverige – världsbäst på innovation, men hur bra är vi på implementering?](https://swedenbio.se/kalendarium/seminarium-sverige-varldsbast-pa-innovation-men-hur-bra-ar-vi-pa-implementering/) - Sverige blir gång på gång topprankade som en av världens mest innovativa länder men halkar efter när det gäller att faktiskt implementera innovationer i vården. Paneldiskussionen kommer att lyfta paneldeltagarnas perspektiv inom; varför implementering är viktigt, dess utmaningar, flaskhalsar och framgångsfaktorer! Paneldebatten kommer att modereras av Shadi Abbas, Managing Director på Sirona. Panelen kommer bestå av: Anna
- [Roundtable discussion: What do you need to be fundable in 2024?](https://swedenbio.se/kalendarium/roundtable-discussion-what-do-you-need-to-be-fundable-in-2024/) - With the evolving landscape and investor outlook and the challenges of developing new technologies and assets in the current biotech environment, this is an insightful and in-depth roundtable discussion with Syneos Health® and one of their strategic partners, TreeHill Partners, focusing on the key areas which should be considered by biotech companies to ensure they
- [SwedenBIO in Gothenburg/GoCo](https://swedenbio.se/kalendarium/swedenbio-in-gothenburg-goco/) - We welcome members and interested companies for some Friday bubbly and something sweet at Vigor & Joy's at GoCo between 13-14. Come by and say hello!
- [Biotech Showcase™ 2024](https://swedenbio.se/kalendarium/biotech-showcase-2024/) - Biotech Showcase™ is an investor and networking conference devoted to providing private and micro-mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives. The event will be back in San Francisco, January 8-10, 2024, to continue to fulfil its mission of providing a forum for investors and biopharma innovators to
- [Vinnova seminar: Competence supply in the life science sector](https://swedenbio.se/kalendarium/vinnova-seminar-competence-supply-in-the-life-science-sector/) - Life sciences is a fast-growing sector in Sweden, but the return of skills points in a different direction. This is according to Vinnova's first statistical report on Swedish life science companies. Welcome to a webcast seminar where Vinnova, together with guests from the industry, explores the challenges and how we can best ensure the supply
- [Major meeting for elected representatives in SwedenBIO](https://swedenbio.se/kalendarium/major-meeting-for-elected-representatives-in-swedenbio/) - The meeting aims to identify gaps, overlaps and synergies between groups and to challenge and refine SwedenBIO's focus questions. More information will come closer to the meeting, but feel free to contact our Science Director Maja Neiman if you have any questions! We hope to see you there! SwedenBIO Office
- [Hesa-Fredrik AW at Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-at-haymarket/) - Every quarter when Hesa Fredrik calls*, we want you to turn off your computer, finish the experiment and sign that deviation report. Because it's time to head to Life Science Stockholm's new watering hole. You will have the opportunity to make new contacts, exchange ideas and untie knots. We at SwedenBIO, in cooperation with our
- [Hesa-Fredrik AW at Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-at-haymarket-2/) - Every quarter when Hesa Fredrik calls*, we want you to turn off your computer, finish the experiment and sign that deviation report. Because it's time to head to Life Science Stockholm's new watering hole. You will have the opportunity to make new contacts, exchange ideas and untie knots. We at SwedenBIO, in cooperation with our
- [Hesa-Fredrik AW at Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-at-haymarket-3/) - Every quarter when Hesa Fredrik calls*, we want you to turn off your computer, finish the experiment and sign that deviation report. Because it's time to head to Life Science Stockholm's new watering hole. You will have the opportunity to make new contacts, exchange ideas and untie knots. We at SwedenBIO, in cooperation with our
- [Hesa-Fredrik AW at Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-at-haymarket-4/) - Every quarter when Hesa Fredrik calls*, we want you to turn off your computer, finish the experiment and sign that deviation report. Because it's time to head to Life Science Stockholm's new watering hole. You will have the opportunity to make new contacts, exchange ideas and untie knots. We at SwedenBIO, in cooperation with our
- [Almedalen - Panel discussion: Swedish life science in a competitive environment](https://swedenbio.se/kalendarium/almedalen-panel-discussion-swedish-life-science-in-a-competitive-environment/) - In a global market where many industries in many countries are struggling to maintain their foothold, Sweden's life science industry is doing well. Our innovation capacity in drug development exceeds the comparatively modest level of investment in the industry, we have a good track record of turning academic discoveries into commercial products that benefit patients,
- [Nordic Mixer at BIO](https://swedenbio.se/kalendarium/nordic-mixer-at-bio/) - To increase visibility of Swedish life science community and promote networking, SwedenBIO is organizing activities in Boston during BIO. Please save-the-dates - more information to come before the event. To ensure receiving all information, please let us know that you're attending BIO, if you haven't yet been in touch with Frida or Marjo. Location and
- [Science for Breakfast with SwedenBIO](https://swedenbio.se/kalendarium/science-for-breakfast-with-swedenbio/) - SwedenBIO presents new CEO and pipeline-data over breakfast! Come enjoy breakfast while SwedenBIO's new CEO, Jessica Martinsson, presents highlights from the life science community and the 2023 pipeline report. On March 8, SwedenBIO launched the 2023 edition of the Swedish Drug Discovery and Development Pipeline Report, containing a mapping of the pharmaceutical pipeline run by
- [BioStock Life Science Summit](https://swedenbio.se/kalendarium/biostock-life-science-summit/) - BioStock Life Science Spring Summit is one of the Nordic region's most important platforms for private and listed innovation companies to present their projects to Swedish and international investors, industry colleagues and potential partners. This digital event showcases the breadth and depth of innovation in the Nordic life science sector during two full days of
- [Biologics Drug Development-3 day course](https://swedenbio.se/kalendarium/biologics-drug-development-3-day-course/) - Drug development of various types of biologic products is a complex and multidisciplinary process. The development integrates knowledge of the underlying disease, target identification, principles on biologics safety, planning strategy for toxicology and clinical studies incorporating the key aspects of manufacturing and controls. This three-day course provides insights into all parts that should be addressed
- [Workshop on RNA-LNP and non-viral vectors](https://swedenbio.se/kalendarium/workshop-on-rna-lnp-and-non-viral-vectors/) - More systematic characterization efforts and open exchange of knowledge in the field are needed to accelerate an effective and rational approach to LNP development. During this workshop, prominent researchers in the field will share their experiences and engage in discussions with the broader community on the characterization and development of LNP vectors for nucleic acid
- [<strong><sup>BIO-Europe®</sup> 2023</strong>](https://swedenbio.se/kalendarium/bio-europe-2023/) - Access the global biopharma community all under one roof at BIO-Europe®. After being delivered virtually for two years, the event returned face-to-face in 2022 breaking all records-becoming the biopharma reunion of the year. In 2023, BIO-Europe will continue to raise the bar with another record-breaking year. The 29th annual BIO-Europe will take place November 6-8,
- [Breakfast seminar: Capital, contacts and communication: How successful life science companies take the next step in their development journey.](https://swedenbio.se/kalendarium/breakfast-seminar-capital-contacts-and-communication-how-successful-life-science-companies-take-the-next-step-in-their-development-journey/) - According to SwedenBIO's recent pipeline report, many life science companies are currently experiencing major challenges. These include difficulties in recruiting staff with the right skills, attracting growth capital and creating good conditions for successful commercialization. In order to share valuable insights on how life science companies can best handle the challenges they face, we have
- [Nordic Health Summit Japan](https://swedenbio.se/kalendarium/nordic-health-summit-japan/) - Nordic Health Summit Japan 2023 is a partnering and investor conference that connects Nordic healthcare innovations and Japanese investors and industry. We invite innovative Nordic health tech and life science companies to meet with Japanese stakeholders, including pharmaceutical companies, investors and medical device companies, who are eager to connect with the Nordics. This is a
- [Friends with benefits: How your life science company can benefit from MAX IV and ESS - Seminar](https://swedenbio.se/kalendarium/friends-with-benefits-how-your-life-science-company-can-benefit-from-max-iv-and-ess-seminar/) - Join us for a seminar on May 9th, 09:00-11:00, where Esko Oksanen (Instrument Scientist at ESS) and Marc Obiols-Rabasa (Industrial Relations Officer at MAX IV) will introduce you to the facilities and the possibilities they provide for researchers at life science companies. Per Brunmark from SmiLe Incubator will tell you more about how they guide
- [Seminar - how to succeed in raising capital as an unlisted life science company](https://swedenbio.se/kalendarium/seminar-how-to-succeed-in-raising-capital-as-an-unlisted-life-science-company/) - Sciety is passionate about innovation, research and company building in life sciences and digital health. That's why we invite researchers and entrepreneurs to a seminar where we share our best tips on how to raise capital. We will talk about everything from how to communicate properly to what to consider when negotiating contracts and conditions.
- [Biostock Investor Meeting 2023](https://swedenbio.se/kalendarium/biostock-investor-meeting-2023/) - BioStock Investor Meeting will be broadcasted online on this page and on our YouTube channel PROGRAM 10.00 Abliva10.20 Xbrane Biopharma10.40 Xintela11.00 Chordate Medical11.20 Aqilion - Expert insights11.40 QuiaPEG Pharmaceuticals12.00 WntResearch12.20 Arcede Pharma12.40 Closing remarks Additional companies may be added. EVENT DETAILS Where? The event will be broadcasted online on this page and on our YouTube
- [Bio€quity Europe 2023](https://swedenbio.se/kalendarium/bioequity-europe-2023/) - Join the discussion in Dublin or attend from home via a digital pass. Plus take advantage of two bonus days of digital one-to-one meetings. Now in our 23rd year, Bio€quity heads to Dublin, Ireland*, May 14-16, 2023, with a program focused on how to create a new playbook for biotech success in Europe. BioCentury and
- [Knowledge for Growth](https://swedenbio.se/kalendarium/knowledge-for-growth-4/) - The cream of the European life sciences community will be attending this business conference, attracting decision makers from biotech, pharma and MedTech as well as investors, universities, top-notch research institutes, policymakers, and competence providers. Join us and hundreds of life sciences professionals from about 500+ companies & organizations. The conference features an exciting program, providing
- [Swiss Biotech Day 2023](https://swedenbio.se/kalendarium/swiss-biotech-day-2023/) - In 2022, the conference demonstrated the impressive growth of the Swiss biotech industry and presented an exciting program with ideal networking opportunities for over 1,100 participants across the globe. In 2023, the Swiss Biotech Day will again offer high-level experts from the life science industry the space to network, discuss and discover trends in R&D,
- [Anglo Nordic Life Science Conference 2023](https://swedenbio.se/kalendarium/anglo-nordic-life-science-conference-2023/) - 20th April 2023, the reception 19th April 2023 London, UK This year we are pleased to announce that the Swedish Ambassador to the UK, H.E. Ms Mikaela Kumlin Granit, invites registered Anglonordic Life Science Conference attendees to take part in drinks, canapes and networking at the Swedish Ambassador's Residence. Date & time: 19 April, 2023
- [Swiss Nordic Bio](https://swedenbio.se/kalendarium/swiss-nordic-bio-2/) - Swiss Nordic Bio carries 16 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organized by the Nordic countries in cooperation with Swiss partners The conference has a broad focus within biotech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as
- [Reflection seminar and final party on the EU presidency](https://swedenbio.se/kalendarium/reflection-seminar-and-final-party-on-the-eu-presidency/) - Immediately after the official conference, the Kungl. Academy of Engineering Sciences IVA and SwedenBIO invite you to a reflection seminar on the life science conference and the EU presidency. This will be followed by a life science closing party in Hagastaden for all those involved in the life science ecosystem, together with many other stakeholders.
- [Nordic Life Science Days 2023](https://swedenbio.se/kalendarium/nordic-life-science-days-2023/) - This will be a unique opportunity to partner and network with the best of Nordic and International leaders in life sciences and celebrate together our 10th anniversary. Learn more and register as a delegate, exhibitor, investor, sponsor or company on nldays.com.
- [Almedalen - SwedenBIO's gardening mingle](https://swedenbio.se/kalendarium/almedalen-swedenbios-gardening-mingle/) - SwedenBIO will be at Almedalen again this year and invites you to the usual garden mingle in our house on Visborgsgatan. On Wednesday June 28 at 17:00 we look forward to meeting in the summer heat during the busiest political week of the year to socialize and exchange ideas on current issues at our garden
- [SwedenBIO Annual Meeting and Executive Dinner 2023](https://swedenbio.se/kalendarium/swedenbio-annual-meeting-and-executive-dinner-2023/) - Together with our main sponsor Erik Penser Bank, we're happy to invite you to this years's Executive Dinner! Welcome to an evening full of networking with friends and colleagues from the industry - after feedback from the previous year food and drinks will be served in a nice mingle format. When: 10th of May at
- [Report launch: The Swedish Drug Discovery and Development Pipeline 2023](https://swedenbio.se/kalendarium/report-launch-the-swedish-drug-discovery-and-development-pipeline-2023/) - Tune in for key findings in the Swedish Drug Discovery and Development Pipeline Report 2023. We mark the release of the report by a live broadcast, Wednesday March 8th at 14.00, from the studio of our member and launch partner, DNB. You are welcome to submit questions during the broadcast. The report can be found
- [The Importance of Regulatory CMC Strategy During Early Development](https://swedenbio.se/kalendarium/the-importance-of-regulatory-cmc-strategy-during-early-development/) - Having the right Chemistry, Manufacturing, and Controls (CMC) documentation throughout drug development is essential for avoiding pitfalls, ensuring an efficient regulatory review process, and achieving the goals for your product. The key is an early development regulatory strategy that includes CMC. Join LINK Medical Research regulatory CMC webinar to strengthen your knowledge of how regulatory
- [Pharmaceutical manufacturing for a competitive and healthier Sweden](https://swedenbio.se/kalendarium/pharmaceutical-manufacturing-for-a-competitive-and-healthier-sweden/) - SwedenBIO, in collaboration with AstraZeneca, Pfizer, Novavax, Recipharm, APL, Valneva, NorthX Biologics, Phase2Phase Biopharma and Mpya Sci & Tech , is organizing a half-day conference with pharmaceutical manufacturing in focus. This is a meeting aimed at policy makers and a way for the industry to reach out for deeper collaboration, new perspectives and increased knowledge.
- [Swedish Life Science Reception](https://swedenbio.se/kalendarium/swedish-life-science-reception/) - Have a drink and seize the opportunity to network and build stronger bonds within our booming business communities. Warmly welcome to Business Sweden's office downtown, just two blocks from Union Square, on January 10th, from 5:30pm. Read more and register here.
- [BIO International Convention in Boston 2023](https://swedenbio.se/kalendarium/bio-international-convention-in-boston-2023/) - BIO International Convention in Boston 2023 offers: One-on-One Partnering:The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Engaging ProgrammingInnovative programming around the current and future state of biotech. Including areas like therapeutic frontiers, the business of biotech, regulatory and policy outlooks,
- [RESI Boston](https://swedenbio.se/kalendarium/resi-boston/) - More information about this RESI Conferences will come soon. As a SwedenBIO member you are offered a discount at RESI Boston. To receive the discount code please contact Frida Eriksson on frida.eriksson@swedenbio.se
- [RESI JPM San Francisco](https://swedenbio.se/kalendarium/resi-jpm-san-francisco/) - RESI San Francisco is an in-person conference with two days of dedicated to virtual-only partnering. Virtual attendees may attend for this option. The one day of in-person partnering also features expert panels, educational workshops, and the Innovator's Pitch Challenge. Read more and register here. As a SwedenBIO member you are offered a 50% discount at
- [Drug Development: 3 day course](https://swedenbio.se/kalendarium/drug-development-3-day-course/) - Drug development projects are often initiated by identifying treatment for a disease. The project usually contains a deep knowledge of the disease and the biological mechanism. However, in order to develop a drug for the disease, a broad knowledge of many different areas is required. This three-day course provides insights into all the parts that
- [Park Annual 2022 by Sahlgrenska Science Park](https://swedenbio.se/kalendarium/park-annual-2022-by-sahlgrenska-science-park/) - A physical event where there are thought-provoking presentations and discussions, several startups that pitch their ideas and the Arvid Carlsson Award by Sahlgrenska Science Park, which is awarded for the 6th year in a row. Read more and register here.
- [Nordic American Life Science Conference 2022](https://swedenbio.se/kalendarium/nordic-american-life-science-conference-2022/) - Welcome to the most comprehensive gathering of Nordic life science innovation in the US, covering key company developments and trends from Norway, Sweden, Denmark, Finland and Iceland. The only event of its kind in the US, providing the largest US-Nordic forum in the US for life sciences, while at the same time being an intimate
- [BioStock Life Science Summit 2022](https://swedenbio.se/kalendarium/biostock-life-science-summit-2022/) - This year, we will meet in person, as more than 30 listed and private companies from a wide range of therapeutic areas present their innovations and business cases to invited investors. The program also includes insights from professional investors and sector experts. Take the opportunity to listen to, mingle with and maybe even pitch to
- [Meet your regulator](https://swedenbio.se/kalendarium/meet-your-regulator-2/) - Let us know in advance which area(s) you have questions about. For example, we answer questions about Clinical trial protocolManufacturing of medicines under developmentPreclinical developmentChoice of procedure to obtain a marketing authorization in Sweden or in the EU. There are a limited number of places and a maximum of two are accepted per company. It
- [Meet your regulator](https://swedenbio.se/kalendarium/meet-your-regulator/) - Let us know in advance which area(s) you have questions about. For example, we answer questions about Clinical trial protocolManufacturing of medicines under developmentPreclinical developmentChoice of procedure to obtain a marketing authorization in Sweden or in the EU. There are a limited number of places and a maximum of two are accepted per company. It
- [Digital Health and AI: Benefits and Costs of Data Sharing in the EU](https://swedenbio.se/kalendarium/digital-health-and-ai-benefits-and-costs-of-data-sharing-in-the-eu/) - The debate with expert policymakers, academics, industry and civil society representatives will provide the opportunity to exchange opinions on the impact and challenges of using new digital health technologies, and to identify areas of consensus and/or disagreement among experts. The event will also feature lessons learned from the COVID-19 pandemic and the need for better
- [Regulatory processes for performance studies (IVDR)](https://swedenbio.se/kalendarium/regulatory-processes-for-performance-studies-ivdr/) - Presentation of the regulatory framework that regulates performance studies of medical devices for in vitro diagnostics and what is current in Sweden. The regulatory framework (horizontal)Mission and role of the authoritiesNotification and application to the MPA when several regulations need to be applied simultaneously (e.g. CTR and IVDR). Lecturer: Anna Skott, Regulatory Investigator Medical Devices,
- [Clinical trials for advanced therapy medicinal products (ATMP)](https://swedenbio.se/kalendarium/clinical-trials-for-advanced-therapy-medicinal-products-atmp/) - Theme: Regulatory framework and support for development What is the regulatory framework, what does it cover?What is important to consider when developing ATMPs?Clinical trial application for ATMP.Support and access to advice. Lecturer: Miriam Idar, Regulatory Investigator Advanced Therapies, Medical Products Agency The format is a 45-minute lecture followed by a 15-minute question and answer session.
- [Registers in clinical research - a valuable resource](https://swedenbio.se/kalendarium/registers-in-clinical-research-a-valuable-resource/) - Content: Review of available national registers, how they can and may be used, different possible project arrangements with different partners. The course also includes exercises with practical hands-on advice for planning a register study. National quality registersSCB's registerRegister of the National Board of Health and WelfareMetadata tools for planning registry researchLegal possibilities for register researchQuality
- [Welcome to Oktoberfest at EY!](https://swedenbio.se/kalendarium/welcome-to-oktoberfest-at-ey/) - As well as traditional food, mingling with new and old contacts, we've asked the experts at EY to share a few current topics: Grants and research allowances. Boost your company's innovation profile and make sure you apply for what you are eligible for and what many companies miss out on.Human-centred sustainability. How can we as
- [Webinar: National pilot for repurposing](https://swedenbio.se/kalendarium/webinar-national-pilot-for-repurposing/) - The objective is to develop a method to provide scientific and regulatory support to academic researchers to establish new indications for older medicines outside patent protection. You are welcome to hear more about the progress of the project and have an opportunity to ask questions to the Medical Products Agency. The national repurposing pilot project
- [Stockholm Life Science Conference](https://swedenbio.se/kalendarium/stockholm-life-science-conference/) - The COVID-19 pandemic is still not over. Yet now is the time to harness the momentum of the successes and the lessons learned. The collaborative effort leading to the rapid development of new vaccines and treatments is a true success story. But we have also seen what needs to be done better next time crisis
- [How to develop and communicate a strategic research and innovation agenda](https://swedenbio.se/kalendarium/how-to-develop-and-communicate-a-strategic-research-and-innovation-agenda/) - Over the past decade, strategic innovation programs have played a central role in financing research and development in Sweden. As the responsible authorities prepare the next generation of innovation programs, Impact Innovation, there is an opportunity for different industries to review their strategic work. A strategic innovation program is based on a strategic research and
- [BIO-Europe spring 2023](https://swedenbio.se/kalendarium/bio-europe-spring-2023/) - BIO-Europe Spring attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts. Don't miss out! Read more here. As a SwedenBIO member you are offered a discount at BIO-Europe spring 2023. To receive the discount code please
- [Biotech Showcase 2023](https://swedenbio.se/kalendarium/biotech-showcase-2023/) - The conference offers 3 days in-person, 2 days virtually. Biotech Showcase™ is an investor and partnering conference devoted to providing private and small and mid-cap biotechnology companies an opportunity to present and meet investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attract investors and biopharmaceuticals executives from
- [FOKUS Patient Event 2022](https://swedenbio.se/kalendarium/fokus-patient-event-2022/) - Days and themes: 3/10 Patient safety in Sweden, Europe and the world - A full day on patient safety that concerns all patient groups, health care, life science companies and public organizations on how patient safety can look like and be worked with in different ways and from different perspectives both in Sweden and in
- [J.P. Morgan Healthcare Conference](https://swedenbio.se/kalendarium/j-p-morgan-healthcare-conference/) - The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. Read more and register here.
- [BIO-Europe 2022](https://swedenbio.se/kalendarium/bio-europe-2022/) - BIO-Europe is finally back for life sciences partnering in person! This will be the first in-person BIO-Europe since its 2019 edition in Hamburg, Germany. It's time to build real bridges with real people again. There's no better place to do that than in lovely Leipzig, the city with more bridges than Venice, at BIO-Europe, the
- [Data Driven Collaboration: Blueprint for a Successful Life Science Nation](https://swedenbio.se/kalendarium/data-driven-collaboration-blueprint-for-a-successful-life-science-nation/) - Real world evidence (RWE) is fundamentally transforming the future of the life science sector in Sweden, at European level and globally. Unlike traditional research, RWE provides insights of what happens in the everyday clinical practice. This can deepen the understanding of how the individual patient and a heterogeneous patient population will respond to a treatment,
- [The future of drug development](https://swedenbio.se/kalendarium/the-future-of-drug-development/) - From the program Jenni Nordborg, Life Science Coordinator, Government Offices of Sweden. Two blocks with subsequent panel discussions following presentations from a wide range of companies and authorities related to the future of medicines. Read more and register here.
- [Health data and its potential for the future of Life Science](https://swedenbio.se/kalendarium/health-data-and-its-potential-for-the-future-of-life-science/) - The session contains two parts: Panel talk 15.30 - 16.30 The session will invite to a themed data panel talk presented by Devicia. The session will be held in English and the names of the panel partcipants will be released in August. After-Work 16.30 - 18.00Afterward, we round up an after-work and the opportunity to
- [<strong>Health data and its potential</strong><br><strong>for the future of Life Science</strong>](https://swedenbio.se/kalendarium/health-data-and-its-potentialfor-the-future-of-life-science/) - Invitation August 30 at 15:30 -16:30 We need to collaborate to find new creative ways to accelerate Health Innovation. Together with GoCo, dNovo, Kickfile and Devicia we invite you to an afternoon session at GoCo Arena to meet in a new context to talk about challenges and opportunities with Health Data and its potential for
- [Karolinska Institutet Science Park DAY 2022](https://swedenbio.se/kalendarium/karolinska-institutet-science-park-day-2022/) - Welcome to KI Science Park DAY 2022. The primary target group is life science companies, but also researchers and clinics are welcomed so the meeting breathes "triple helix". Focus on innovation and collaboration. Read more and register here.
- [BioStock Life Science Spring Summit](https://swedenbio.se/kalendarium/biostock-life-science-spring-summit/) - BioStock Life Science Spring Summit offers an important platform for Nordic innovation companies, who get the chance to pitch their projects to Swedish and international investors, industry colleagues and potential partners. BioStock Life Science Spring Summit offers a broad line-up of Nordic innovation companies, that despite a relatively small local market, manage to attract industrial
- [Get to know SwedenBIO over breakfast or drinks in Lund!](https://swedenbio.se/kalendarium/get-to-know-swedenbio-over-breakfast-or-drinks-in-lund/) - We want to show you how important the life science industry is for Sweden, how important Skåne is for the life science community, and what SwedenBIO does to support the community. Most of all, we want to get to know you! Sign up and tell a friend! Everyone is welcome but remember to register. Breakfast:
- [Next generation commercialization for Life Science](https://swedenbio.se/kalendarium/next-generation-commercialization-for-life-science/) - EVERSANA welcome you to a breakfast program that examines best practices to expand into the U.S. market. The pharmaceutical pipeline is gaining momentum, led by many first-time launchers. But the reality is companies spend more than $200 million over three years leading up to launch, and 66% of drugs still don't meet launch expectations. Session:
- [JIM Symposium](https://swedenbio.se/kalendarium/jim-symposium/) - This symposium focuses on how precision medicine will change and improve diagnostics, treatment and prevention, as well as the potential for research and innovation within the precision medicine framework. Focus areas for the conference are cancer, rare diseases and complex diseases. Practice examples showcasing how precision medicine has been implemented in Europe will be presented
- [Clinical trials of medicines containing genetically modified organisms](https://swedenbio.se/kalendarium/clinical-trials-of-medicines-containing-genetically-modified-organisms/) - The purpose of the webinar is to clarify the requirements for clinical trials of medicinal products containing or consisting of genetically modified (micro-) organisms with a focus on: Regulatory framework and boundaries between authorities' responsibilitiesApplication for deliberate release and notification/application for contained use - and what to submit to the authorities. The webinar is aimed
- [Dialogue forum part 4](https://swedenbio.se/kalendarium/dialogue-forum-part-4/) - Regulatory processes part 4 - Clinical trials of medical devices. The aim is to provide an overview of regulatory frameworks governing clinical trials of medical devices. The seminar will cover Mission and role of the authoritiesThe regulatory framework (horizontal)Tips and advice. Speaker: Elin Karlberg, Head of the Regulatory Group in Clinical Trials, Medical Products Agency.
- [Dialogue forum part 3](https://swedenbio.se/kalendarium/dialogue-forum-part-3/) - Regulatory processes part 3 - Regulatory framework for human clinical trials. The aim is to provide an overview of the regulatory framework governing clinical trials. The seminar will cover Mission and role of the authoritiesThe regulatory framework (horizontal)Tips and advice. Speaker: Gunilla Andrew-Nielsen, Head of Unit for Clinical Trials and Licenses, Medical Products Agency. The
- [Dialogue forum part 2](https://swedenbio.se/kalendarium/dialogue-forum-part-2/) - Regulatory processes part 2 - Strategic and practical aspects of drug approval. The aim is to provide an overview of the regulatory aspects of bringing a medicine to the market. The seminar will cover How is an application structuredChoice of authorization procedure - strategic challengesWhat help is available? Regulatory and scientific advice (national/central). The format
- [Dialogue forum part 1](https://swedenbio.se/kalendarium/dialogue-forum-part-1/) - On May 24, the theme is Regulatory Processes Part 1 - Regulatory Framework for Drug Author ization. The aim is to provide an overview of the regulatory framework governing the authorization of medicines (Marketing Authorization). The seminar will cover Dialogue Forum (Medical Products Agency DG Björn Eriksson, Vice President SwedenBIO Frida Lawenius)Mission and role of
- [Opening the Ivory Tower Wide](https://swedenbio.se/kalendarium/opening-the-ivory-tower-wide/) - Sessions:I. Path from Scientific Research to Impact and Industry II. Freedom vs Impact? Role of Universities and FundersIII. Life Science Research for the Benefit of Patients and SocietyIV. Science Communication and Policy Advice The symposium is organized by the Swedish Collegium for Advanced Study (scas) and is an event of its Natural Sciences Programme (Measurable
- [ChinaBio Partnering Forum 2022](https://swedenbio.se/kalendarium/chinabio-partnering-forum-2022/) - ChinaBio Partnering Forum returns to Beijing! 2 days in-person, 2 days virtually. This year's hybrid event enables you to identify, meet and network with leaders across the life science value chain. Read more and register here. As a SwedenBIO member you are offered a special discount at ChinaBio Partnering Forum 2022. To receive the discount
- [Tips to adapt to today's auditing environment, an auditor's perspective](https://swedenbio.se/kalendarium/tips-to-adapt-to-todays-auditing-environment-an-auditors-perspective/) - ProPharma Group offers a live webinar, free of charge, focusing on: Understand how we have adapted to hybrid auditingUnderstand how to overcome auditing challengesUnderstand how you can manage global vendor audit programs Click here for more info and registration.
- [Quality registers for research 5 May 2022](https://swedenbio.se/kalendarium/quality-registers-for-research-5-may-2022/) - Reduced fee until 31 March! This year the conference will be live-streamed from the Piperska Muren in Stockholm, you choose whether you participate in Stockholm or online. Learn about current issues in quality register research and have the opportunity to discuss methods across disciplines and professions. The program includes national examples of how quality registers
- [Seminar on fundraising](https://swedenbio.se/kalendarium/seminar-on-fundraising/) - How to successfully raise capital as an unlisted life science company Many people running life science companies can experience challenges around funding. It is often time-consuming and raises many questions: Which investment players are available and which one is best suited to our company? What is important to consider in terms of conditions and contracts?
- [Biocom California's Global Life Science Partnering Conference](https://swedenbio.se/kalendarium/biocom-californias-global-life-science-partnering-conference/) - The partnering conference and the relationships you build promise to be fruitful for your business ventures this year and for many years to come. We are excited by the prospect of continuing an annual bio-pharma partnering conference that brings together leading deal makers and emerging biotechs from around the world, while providing a local San
- [Swiss Biotech Day 2022](https://swedenbio.se/kalendarium/swiss-biotech-day-2022/) - What to expect: Meet 850+ senior experts from the life science industry50+ exhibition from across EuropeDelegations from various regionsGeneral Assembly of the Swiss Biotech AssociationSwiss Biotech Success Stories AwardsInnovative biotech start-ups and medium-sized biotech companiesThematically focused panel discussionsPre-scheduled one-to-one partnering meetingsRead more and register here.
- [BIO-Europe Spring 2022](https://swedenbio.se/kalendarium/bio-europe-spring-2022/) - BIO-EUROPE SPRING 2022 SHIFTS TO DIGITAL FORMAT Given recent renewals of corporate travel restrictions and the temporary suspension of large-scale events by the Kanton of Basel Stadt due to the spiking Omicron variant, we have regretfully decided to make BIO-Europe Spring a 100% digital event. Roche and Novartis will continue to fully endorse the digital
- [ATMP Sweden 2022](https://swedenbio.se/kalendarium/atmp-sweden-2022/) - Currently the 2022 conference is planned for Stockholm. The event is expected to be held at Aula, Solna campus Karolinska Institutet. The event is planned to coincide with the International Round Table on Nucleosides, Nucleotides and Nucleic acids, will be held august 28-31, 2022 in Stockholm, Sweden. IS3NA Society | IRT 2022 (irt2021.se) Registration and
- [Virtual early development workshop](https://swedenbio.se/kalendarium/virtual-early-development-workshop-2/) - Advancing your drug or vaccine candidate from late-stage discovery into the clinic is one of the most critical steps in development. This is the phase when you make key decisions that will have long-term scientific and business impact, frequently under extreme time and cost pressure. Our protein design and optimization services help identify and mitigate
- [SwedenBIO Summit 2022](https://swedenbio.se/kalendarium/swedenbio-summit-2022/) - This year we focus on the foundations necessary for building strong and resilient companies. We take inspiration from the pillars introduced by the international Worldview Ranking of health biotech sectors and translate them to intimate business stories. You will hear tales of success, and tales of hurdles and obstacles. You will also see a sneak
- [AI-Powered Medical Information Contact Centers](https://swedenbio.se/kalendarium/ai-powered-medical-information-contact-centers/) - AI can enable MI Contact Centers to transform the customer experience using digital avenues, thus helping create a truly scalable and global Medical Information capability. Participants will gain a better understanding of: Understand how to navigate the ever-changing MI landscape and scale-up MI servicesUnderstand how to create an AI-powered global MI capability to support HCPs,
- [SwedenBIO in Almedalen](https://swedenbio.se/kalendarium/swedenbio-in-almedalen/) - Welcome to visit us in the SwedenBIO house during the Almedalen week. We are located at Visborgsgatan 5 in Visby during Monday to Wednesday, with our own and members' activities in our cozy garden. Almedalen week is packed with life science events organized by us and our member companies! We have put together the full
- [Introducing the Innovative Health Initiative: Europe's new partnership for health](https://swedenbio.se/kalendarium/introducing-the-innovative-health-initiative-europes-new-partnership-for-health/) - In the first session, IHI Executive Director Dr. Pierre Meulien will present IHI and explain why we are launching a new European partnership for health. He will also describe what's new compared to the Innovative Medicines Initiative (IMI), and what will stay the same. IHI staff will then present opportunities for stakeholders to get involved
- [Advanced Therapy Showcase in Tokyo#2 (ATST#2)](https://swedenbio.se/kalendarium/advanced-therapy-showcase-in-tokyo2-atst2/) - Now they are pleased to announce that the second edition of the series, the ATST#2, is going to be held on Friday, January 28, 2022. The ATST#2 features live-streaming company presentations and pre-arranged 1-on-1 business partnering meetings. The event will be fully virtual. Any entities or individuals engaged in the field of advanced therapy including
- [Strategy and business development for life science leaders](https://swedenbio.se/kalendarium/strategy-and-business-development-for-life-science-leaders/) - Evaluation of previous course 100% of participants would recommend the course to a professional colleague.Quotes from course participants: "Provides breadth and depth at the same time and the opportunity for interaction and exchange from course participants." Course content In this course, experienced and senior life science experts give you an in-depth understanding of the most
- [Annual meeting and Executive Dinner (SwedenBIO 20 years!)](https://swedenbio.se/kalendarium/annual-meeting-and-executive-dinner-swedenbio-20-years/) - You are welcome to attend SwedenBIO's annual meeting followed by an anniversary dinner. We want to celebrate the 20th anniversary with you in a golden setting. As usual, it will be a great evening of good company and world-class entertainment!Please note that the deadline for submitting motions for the annual meeting is 19/3. Take the
- [Biotech Showcase™ Digital 2022](https://swedenbio.se/kalendarium/biotech-showcase-digital-2022/) - What to expect: The event dates will remain the same, January 10-12, 2022 and January 17-19, 2022One-to-one meetings for January 10-12, 2022 will now be held virtually and expanded to a 24-hr timeframe to accommodate and facilitate meetings with delegates from around the world.All event content, company presentations and program sessions will now be hosted
- [Biocompatibility Matters 2022](https://swedenbio.se/kalendarium/biocompatibility-matters-2022/) - Program Advisor Committee Sherry Parker Senior Director of Regulatory Toxicology at WuXi AppTec Medical Device Testing - St. Paul, MN, USTed Heise Vice President, Regulatory and Clinical Services at MED Institute, USRon Brown Toxicologist at Risk Science Consortium, USArthur Brandwood Medtech Regulatory Expert with International Perspective, AustraliaLars-Magnus Bjursten Senior Professor Bioimplant Research. Convener ISO 18562
- [Glögg Mingle - Digital Clinical Trials - Possibilities and Challenges](https://swedenbio.se/kalendarium/glogg-mingle-digital-clinical-trials-possibilities-and-challenges/) - Digital clinical trials are attracting a lot of attention right now. The pandemic has further raised questions and concerns on how we traditionally conduct clinical trials. There are many steps when conducting a clinical trial ranging from feasibility, identification of potential subjects, eligibility assessment, efficacy assessment, safety assessment and subject retention to IMP handling, monitoring
- [Making Clinical Trial Safety and Pharmacovigilance easy and affordable with HALOPV](https://swedenbio.se/kalendarium/making-clinical-trial-safety-and-pharmacovigilance-easy-and-affordable-with-halopv/) - Modules are available to cover all data and processes. You can start with the safety database modules and slowly add to your suite of modules, until you have a full pharmacovigilance system. You will hear from Martin Holm-Petersen CEO of Insife and also from the Safety Director Tina Elberling and Ewa Lyzell, Safety Group Manager
- [Swiss Nordic Bio 2022](https://swedenbio.se/kalendarium/swiss-nordic-bio-2022/) - TIME AND PLACE When: 23 March 2022Where: Zürich Airport, Radisson Blu Hotel FOCUS The conference has a broad focus within biotech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as well as global, commercial corporations.The conference is open for biotech and pharma
- [How to successfully navigate the transition to the IVDR](https://swedenbio.se/kalendarium/how-to-successfully-navigate-the-transition-to-the-ivdr/) - Join us for breakfast Cirio law firm, Devicia, and Kickfile invite you to a complimentary breakfast seminar on 23 November 2021 in central Gothenburg. Join us in a conversation about the regulatory and legal aspects of an IVDR transition and take the opportunity to network with industry experts. Transition to the IVDR is required for
- [Partnering/licensing in the pharmaceutical industry - how does it work in practice?](https://swedenbio.se/kalendarium/partnering-licensing-in-the-pharmaceutical-industry-how-does-it-work-in-practice/) - Seminar organized by Cirio Advokatbyrå together with Sprint Bioscience. Link to registration.
- [Back to Business: Expanding to the U.S.](https://swedenbio.se/kalendarium/back-to-business-expanding-to-the-u-s/) - The Swedish-American Chamber of Commerce New England is excited to announce our event Back to Business: Expanding to the U.S, which will take place on the 27 of October at 9 AM on Zoom. Join this webinar to make sure that your company is ready to get back to business as restrictions are easing and
- [Pop Up Talk - Optimize the Future of Pre-Clinical Studies With VivoLogica](https://swedenbio.se/kalendarium/pop-up-talk-optimize-the-future-of-pre-clinical-studies-with-vivologica/) - Advancements in scientific fields are moving at the speed of light, putting increasing pressure on developing new systems to log, analyze and ensure the integrity of data. Despite great scientific advancement, paper, pen and Excel are still the most frequently utilized tools to document critical pre-clinical studies. At VivoLogica we empower research through technology to
- [Biologics Drug Development: 3 day course](https://swedenbio.se/kalendarium/biologics-drug-development-3-day-course-2/) - Read more and register here.
- [New updates in Drug Formulation & Bioavailability](https://swedenbio.se/kalendarium/new-updates-in-drug-formulation-bioavailability-4/) - Moderator: Korbinian Löbmann,Associate Professor University of Copenhagen This event is a platform based on the concept of synergies between "science" and "business". Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about this exciting topic. The presented content and topics will focus on advancements in formulations and cutting edge technologies that
- [The Future of Swedish & Danish Life Science](https://swedenbio.se/kalendarium/the-future-of-swedish-danish-life-science-4/) - Hybrid event - Both physical and digitalThis year, The Future of Swedish & Danish Life Science is arranged as a hybrid event, i.e. event type that at the same time delivers the same experience and content to both a live and online audience. This years themes are: Reflections on the past decade, and looking to
- [BIO 2022 San Diego (BIO International Convention)](https://swedenbio.se/kalendarium/bio-2022-san-diego-bio-international-convention/) - BIO is thrilled to be back in person for the 2022 International Convention happening in San Diego, CA June 13-16. The Convention theme 'LIMITLESS' is our commitment to unlocking possibilities for our members and attendees while paving the path to the future of our industry. The BIO International Convention attracts 15,000+ biotechnology and pharma leaders
- [BioPharm America 2021](https://swedenbio.se/kalendarium/biopharm-america-2021/) - Learn more and register here.
- [Bio-Europe Digital](https://swedenbio.se/kalendarium/bio-europe-digital/) - Learn more and register here.
- [NLSDays 2022](https://swedenbio.se/kalendarium/nlsdays-2022/) - Registration includes All registrations are personal/individual, including access to all super sessions, fireside chats, exhibition, company presentations, One-on-One partnering including submission of up to 150 requests per company for onsite face-to-face meetings, coffee-breaks, lunches and receptions.SwedenBIO members receive 30% discount on their registration. Contact us info@swedenbio.se for your discount code. Like a Nordic Saga ,
- [SwedenBIO Summit 2021](https://swedenbio.se/kalendarium/swedenbio-summit-2021/) - At this year's SwedenBIO Summit, we want to help write success stories. Stories that begin with hard work, heroism, community and health challenges and now pay off; in market penetration and finally reaching the user. Optimizing the company's resources is one way to ensure success. In life science ecosystems, experiences, contacts, investments and other assets
- [Webinar - Implementation of the Clinical Trials Regulation EU 536/2014](https://swedenbio.se/kalendarium/webinar-implementation-of-the-clinical-trials-regulation-eu-536-2014/) - The webinar is titled "Implementation of the Clinical Trials Regulation EU 536/2014" and is an informative session on the implementation and plans for further work. The event will be held as a Teams Live event. This means an unlimited number of participants and no registration is required to participate. However, with this technical solution, there
- [Park Annual 2021](https://swedenbio.se/kalendarium/park-annual-2021/) - Excited to meet you all on the Park Annual interactive platform allowing chat, one-to-one meetings and an inspiring exhibition in close connection to our live studio.Stay tuned for more info! Park Annual is free of charge.
- [FDA Inspection Readiness: A Guide to Preparing for Success and Overcoming Remediation](https://swedenbio.se/kalendarium/fda-inspection-readiness-a-guide-to-preparing-for-success-and-overcoming-remediation/) - Interested in learning more? Register today and join us for a live webinar! Learning objectives of this Complimentary Live Webinar: - Help you manage inspections efficiently and effectively. - Best practices on how to avoid 483s and increased enforcement action(s). - The FDA's approach to inspections, focus areas, and what documents they will be asking
- [Where Medical Device Regulation is Headed - Taking the Mystery out of Changes in the EU and US](https://swedenbio.se/kalendarium/where-medical-device-regulation-is-headed-taking-the-mystery-out-of-changes-in-the-eu-and-us/) - Interested in learning more? Register today and join us for a live webinar! Learning objectives of this Complimentary Live Webinar: - What will the new requirements look like in the EU and how should Sponsors adapt their regulatory strategy appropriately to obtain marketing approval for their device? - Explain the recent changes to FDA's 510(k)
- [HealthTech Innovation Days](https://swedenbio.se/kalendarium/healthtech-innovation-days/) - This event organized by HealthTech For Care, an endowment fund launched by France Biotech, and co-organised with EIT Health, and in collaboration with BIO Deutschland, BioWin , CEBR, Flanders.bio, LifeSci , SwissBiotech & Sweden Bio will accelerate patient access to healthcare solutions and contribute to building a stronger ecosystem. This event is open to many
- [Probiotics as invisible allies to promote our health and prevent diseases (BioGaia)](https://swedenbio.se/kalendarium/probiotics-as-invisible-allies-to-promote-our-health-and-prevent-diseases-biogaia/) - Do you know that antimicrobial resistance has been declared as one of the 10th public health threat for the coming years by WHO? Would you take care of your health before becoming ill? We will bring some answers to these questions and discuss the role of probiotics as health promoters in our day-to-day life.Click here
- [Brilliant Minds Studio Webinar - Gianfranco Grompone and guests (BioGaia)](https://swedenbio.se/kalendarium/brilliant-minds-studio-webinar-gianfranco-grompone-and-guests-biogaia/) - HOST Gianfranco Grompone, PhD Chief Scientific Officer, BioGaia GUEST Pedro Gutiérrez-Castrellón, MD, MSc, DSc Center for Translational Research on Mother-Child Health & Center for Research on Microbiota, Pre/Probiotics, Hospital General Dr Manuel Gea González, Ministry of Health, MexicoClick here to register.
- [Nordic AMPlify 2021 Launch Webinar: Accelerated U.S. Market Entry](https://swedenbio.se/kalendarium/nordic-amplify-2021-launch-webinar-accelerated-u-s-market-entry/) - WHY AMPLIFY? This initial workshop will give Nordic digital and MedTech companies a solid understanding of both the program and the potential of the US market with US investors and healthcare leaders presenting an insider's perspectives on current opportunities and essential knowledge on market entry. The webinar will cover: ✓ Introduction to Nordic AMPlify and
- [How to make life science companies even more attractive to investors](https://swedenbio.se/kalendarium/how-to-make-life-science-companies-even-more-attractive-to-investors/) - The life sciences sector is unique and not comparable to other sectors. In particular, the risk level is affected by the uncertainty surrounding the companies' clinical development programs. To facilitate investors' decisions and the valuation of companies, SwedenBIO, together with the marketplaces Nasdaq and Spotlight, has recently developed a uniform standard for disclosure. Will the
- [Webinar - Advanced therapies](https://swedenbio.se/kalendarium/webinar-advanced-therapies/) - The Medical Products Agency invites you to a half-day event on the topic of advanced therapies (ATMP). The webinar is held on Teams, the maximum number of participants is 300. If more than 300 people register, places will be prioritized for the intended target group. Target group People active in the development, manufacture and clinical
- [Life Science: Introduction to the UK and the NHS](https://swedenbio.se/kalendarium/life-science-introduction-to-the-uk-and-the-nhs/) - In partnership with Department for International Trade (DIT) Sweden and Embassy of Sweden, London, UK, the Swedish Chamber of Commerce for the UK invites Swedish Life Science, Medtech and Digital Health companies to learn about the opportunities and challenges businesses currently face entering the UK. Participants will have the chance to gain valuable insights into
- [Surviving early biotech pitfalls - Overcoming challenges when moving from non-clinical to clinical](https://swedenbio.se/kalendarium/surviving-early-biotech-pitfalls-overcoming-challenges-when-moving-from-non-clinical-to-clinical/) - This event is designed to help biotech companies in early development however, the content will also be helpful for the full life cycle of a product. View the agenda below to learn more. Learn more and register here.
- [Medical devices - basic course](https://swedenbio.se/kalendarium/medical-devices-basic-course/) - Training objectives At the end of the course you should have An overview of CE marking and the current regulatory framework for medical devices in the EU, MDR.Knowledge of quality systems and technical documentationKnowledge of the actors and authorities involvedKnowledge of risk management systems.Knowledge of applicable regulations, standards and guidelines Course content and structure Background
- [IVDR - a basic course](https://swedenbio.se/kalendarium/ivdr-a-basic-course/) - The new legislation means big changes for most of the industry, with much stricter requirements for both the business and its products. With a new risk-based classification, the majority of companies are expected to need a Notified Body for conformity assessment and CE marking of products. Another major change is the increased demand for clinical
- [Building an Effective Cybersecurity Culture](https://swedenbio.se/kalendarium/building-an-effective-cybersecurity-culture/) - After registering, the link to attend this program will be sent before April 13, 2021.Click here for more information and registration.
- [Mpya Sci & Tech and Linus Jonkman - Digital breakfast lecture](https://swedenbio.se/kalendarium/mpya-sci-tech-and-linus-jonkman-digital-breakfast-lecture/)
- [Insider Talks - COVID-19 Vaccines & Treatments](https://swedenbio.se/kalendarium/insider-talks-covid-19-vaccines-treatments/) - Learning objectives of this Complimentary Live Webinar:Our panel of experts will discuss how to bring life-saving vaccines and treatments to market faster while ensuring patient health and safety - based on experience. Our team will share insights on: A strategic project management approach that ensures teams move quickly and adaptively to bring vaccines and treatments
- [Theme day - Medical Writing](https://swedenbio.se/kalendarium/theme-day-medical-writing/) - Target group The workshop is aimed at those who write or review regulatory documents or are involved in documentation issues, such as service commissioners, statisticians or medical experts. Learning objectives After the day, you as a participant: Be aware of key regulations and guidelines that are relevant - how to find them, basic knowledge of
- [Life Science Bridge - Bridging the Gap](https://swedenbio.se/kalendarium/life-science-bridge-bridging-the-gap/) - With Sweden and the U.S. being at the top of the life science industry, we aim to build bridges between these nations to promote a healthy and innovative world. Bridging the Gap will be held 7-8th of April on Zoom. Day 1 is free of charge and the topics will be focused on The life
- [Grow Your Nordic Life Science Business in the United States](https://swedenbio.se/kalendarium/grow-your-nordic-life-science-business-in-the-united-states/) - In lead-up to the SelectUSA Summit, The U.S. Department of Commerce and SelectUSA invite Nordic Life Science startups currently exploring business development opportunities in the United States, to an in-depth virtual seminar and networking session. Join us on April 13, 2021 to gain greater insight into working with the U.S. Food and Drug Administration, Investment
- [EU funding Café](https://swedenbio.se/kalendarium/eu-funding-cafe/) - For the EU-funding Café, there is no need to register in advance. However, it can be useful to go in and add your photo and link your LinkedIn profile to your user.Click here for more information.
- [Background checks - when, how and why?](https://swedenbio.se/kalendarium/background-checks-when-how-and-why/)
- [New Horizons in Biologics & Bioprocessing](https://swedenbio.se/kalendarium/new-horizons-in-biologics-bioprocessing-3/) - The international target audience will consist of Biotech companies - all - start up, small-medium sized, largeResearchers from the academia and the industryLarge Pharma with interest in biotechContract manufacturing organizationsEngineering houses and consultantsQA Managers - Process developersProcess engineersManufacturing and production managersProcurement groupsInvestment managers Book meetings with participants The meeting will include pre-bookable one-on-one meetings and
- [Bioscience Research through Innovative Technologies](https://swedenbio.se/kalendarium/bioscience-research-through-innovative-technologies/) - Welcome to the 9th edition of our event Bioscience Research through Innovative Technologies. Some of the topics that will be highlighted: The latest in cell biologyprecision medicinegene editing/genomicsAIproteomics and fighting SARS-CoV 2 and antimocrobials resistanceare The latest research findings made by scientists at Umeå University shows that some severe cancers can be predicted by biomarkers
- [Pharma Outsourcing - Find the right partner](https://swedenbio.se/kalendarium/pharma-outsourcing-find-the-right-partner-2/) - Choosing the right service provider is an extremely important decision and is often decisive on what the company's future will look like. Many Swedish innovative research projects/enterprises have succeeded in their preclinical work, they are now recruiting patients for clinical trials, and hope to make money from products within a couple of years in order
- [Immunology Virtual Partnering](https://swedenbio.se/kalendarium/immunology-virtual-partnering/) - #VirtualPartnering 2020 edition brought together thousands of pioneers working on treatments and therapies across the life sciences: early-stage biotechs, pharma, investors, academia, medtech, digital health and more. From 9-12 March, make targeted connections and discover new #partneringopportunities in #immunology and, if you're a SwedenBIO-member, you can benefit from a 15% discount (reach out to us
- [Oncology Virtual Partnering](https://swedenbio.se/kalendarium/oncology-virtual-partnering/) - #VirtualPartnering 2020 edition brought together thousands of pioneers working on treatments and therapies: early-stage biotechs, pharma, investors, academia, medtech, digital health and more. From 2-5 March, make targeted connections and discover new #partneringopportunities in #oncology and, if you're a SwedenBIO-member, you can benefit from a 15% discount (reach out to us directly). Read more and
- [Funding opportunities for SMEs under the new EU framework program](https://swedenbio.se/kalendarium/funding-opportunities-for-smes-under-the-new-eu-framework-program/) - The seminar includes information about the new program and calls from Vinnova, and gives you the opportunity to meet and ask questions to representatives from EU SME Support and EEN (Enterprise Europe Network). They explain how the support for SMEs to apply for EU funds works. In addition, you will have a unique opportunity to
- [Virtual early development workshop](https://swedenbio.se/kalendarium/virtual-early-development-workshop/) - Advancing your drug or vaccine candidate from late-stage discovery into the clinic is one of the most critical steps in development. This is the phase when you make key decisions that will have long-term scientific and business impact, frequently under extreme time and cost pressure. Our protein design and optimization services help identify and mitigate
- [Stockholm Life Science Conference 2021: Reframing Life Science Post-Pandemic](https://swedenbio.se/kalendarium/stockholm-life-science-conference-2021-reframing-life-science-post-pandemic/) - During this conference we will reexamine the current and potential role of the sector and explore an expanded vision for Life Science that includes prevention, implementation, accountability, and "a universal preparedness for health". During expert panels and workshops we will discuss: How can we accelerate implementation of the national and regional life science strategies to
- [Information webinar on the Sustainability Program](https://swedenbio.se/kalendarium/information-webinar-on-the-sustainability-program/) - You are hereby invited to an information webinar on the Sustainability Programme, organized in collaboration with PURE ACT, and offered to life science companies in East Central Sweden.If you and your company choose to take part in the Sustainability Programme, which is now scheduled to start, you will be guided through various steps to understand
- [Strategy and business development course](https://swedenbio.se/kalendarium/strategy-and-business-development-course/) - While each journey is unique, there are many challenges common to all life science companies. By gaining an early overview of upcoming strategic decisions, you will be better able to prioritize and make smart use of your resources. The course will be held over four days on October 20-22 and November 25 at the Medical
- [Drug Development Course](https://swedenbio.se/kalendarium/drug-development-course/) - Drug development projects are often initiated by identifying treatment for a disease. The project usually contains a deep knowledge of the disease and the biological mechanism. However, in order to develop a drug for the disease, a broad knowledge of many different areas is required. This three-day course provides insights into all the parts that
- [Executive dinner](https://swedenbio.se/kalendarium/executive-dinner/) - On September 14, we roll out the red carpet for the industry's own stars at the GuldBIO gala, a film festival full of glitz and glamor ✨ 🎥.This year's Executive Dinner is highly anticipated and requested by our member companies. As we are gathering a large number of people for a gathering, we have of
- [This is the future: Advanced Manufacturing and Life Science in the Stockholm-Uppsala region](https://swedenbio.se/kalendarium/this-is-the-future-advanced-manufacturing-and-life-science-in-the-stockholm-uppsala-region/) - Opinion leaders Johan Rockberg, KTH and Catarina Flyborg, Cytiva, will give us their expert perspectives on the thriving cluster, and we are also very much looking forward to presenting success stories from AstraZeneca, Cambrex and Valneva. For more information and registration click here.
- [Five Tips to Maximize the Value of Your Cell and Gene Therapy / ATMP](https://swedenbio.se/kalendarium/five-tips-to-maximize-the-value-of-your-cell-and-gene-therapy-atmp/) - For more information and registration click here.
- [Mpya Sci & Tech and Fredrik Reinfeldt - Digital breakfast lecture.](https://swedenbio.se/kalendarium/mpya-sci-tech-and-fredrik-reinfeldt-digital-breakfast-lecture/) - For more information and registration click here.
- [EU Funding Café - EIC Accelerator](https://swedenbio.se/kalendarium/eu-funding-cafe-eic-accelerator/) - More information will be available soon.
- [Funding opportunities in life sciences after the pandemic](https://swedenbio.se/kalendarium/funding-opportunities-in-life-sciences-after-the-pandemic/) - Welcome to a webinar on the growth and financing opportunities for the life science industry in the wake of the pandemic. During the webinar, Martina Banyay and Åsa Angel Voss from One in 200 will share the results of a survey that interviewed 25 business leaders in the life sciences sector. We will hear how
- [Webinar on the new EU Medical Device Regulation](https://swedenbio.se/kalendarium/webinar-on-the-new-eu-medical-device-regulation/) - For more information and registration click here.
- [Advanced Therapy Showcase in Tokyo](https://swedenbio.se/kalendarium/advanced-therapy-showcase-in-tokyo/) - SwedenBIO members receive 25% discount on their registration. Contact info@swedenbio.se for your discount code. For more information and registration click here.
- [Future opportunities with biologics in health care](https://swedenbio.se/kalendarium/future-opportunities-with-biologics-in-health-care/) - For more information and registration click here. The deadline for registration is 8/3.
- [Sweden's success factors in the development of biological medicines](https://swedenbio.se/kalendarium/swedens-success-factors-in-the-development-of-biological-medicines/) - For more information and registration click here. The deadline for registration is 8/3.
- [Life sciences conference 2021](https://swedenbio.se/kalendarium/life-sciences-conference-2021/) - Read more and register here.
- [ChinaBio® Partnering Forum 2021](https://swedenbio.se/kalendarium/chinabio-partnering-forum-2021/) - 2 days in-person, 3 days virtually. This year's hybrid event enables you to identify, meet and network with leaders across the life science value chain. SwedenBIO members get a discount on registration. Contact info@swedenbio.se for your promotion code. For registration and more information click here.
- [BIO-Europe Spring 2021](https://swedenbio.se/kalendarium/bio-europe-spring-2021/) - BIO-Europe Spring Digital 2021 is expected to bring together over 2,500 executives from biotechnology, pharmaceutical and finance companies from around the world, who will engage in more than 15,000 partnering meetings. SwedenBIO members get a discount on registration. Contact info@swedenbio.se for your promotion code. For registration and more information click here.
- [Biotech Showcase™ Digital 2021](https://swedenbio.se/kalendarium/biotech-showcase-digital-2021/) - SwedenBIO members get a discount on registration. Contact info@swedenbio.se for your promotion code. For registration and more information click here.
- [Launch of Horizon Europe](https://swedenbio.se/kalendarium/launch-of-horizon-europe/) - Register here.
- [Brilliant Minds Studio Webinar](https://swedenbio.se/kalendarium/brilliant-minds-studio-webinar/) - HOSTGianfranco Grompone, PhDChief Scientific Officer, BioGaia SPEAKERSProf. Dr. Ulrich SchlagenhaufDept. Of Periodontology, University of Wuerzburg, GermanyProf. Dr. Wim Teughels Department of Oral Health Sciences, Periodontology & Oral Microbiology KU Leuven. Department of Oral Health Sciences, University Hospitals Leuven, Belgium Sign up to the webinar here.
- [Prevention of antibiotic resistance](https://swedenbio.se/kalendarium/prevention-of-antibiotic-resistance/) - The seminar will include presentations by leading researchers in the field who have received funding from PAR Foundation as well as details about the upcoming grant call. To the program and registration.
- [Drug treatment in COVID-19 - what have we learned and where do we stand now?](https://swedenbio.se/kalendarium/drug-treatment-in-covid-19-what-have-we-learned-and-where-do-we-stand-now/) - Presentation Now that cases are increasing again, the health sector is better equipped with knowledge and treatment options. But how much better? What drugs are in the arsenal? How good are they? What other measures have the greatest impact on patients? And what is in the pipeline? In a digital breakfast seminar, senior physician Jan
- [Accelerating the process from basic drug discovery to clinical trial for Covid-19](https://swedenbio.se/kalendarium/accelerating-the-process-from-basic-drug-discovery-to-clinical-trial-for-covid-19/) - This Covid19-focused symposium, hosted by SciLifeLab, will bring together scientists pushing the boundaries of drug discovery to find remedies for ongoing Covid-19 pandemic and future epidemics. We will hear about how basic research in drug discovery has been taken to clinical practice, get examples of ongoing clinical trials and increase our understanding of suitable animal
- [Individual and organizational sustainability - In a rapid digital transformation](https://swedenbio.se/kalendarium/individual-and-organizational-sustainability-in-a-rapid-digital-transformation/) - For many of us, the pandemic has contributed to an ultra-fast change and a digital everyday life at home is now the norm for many. The transition affects our behaviors, structures and what it means to manage yourself and your staff sustainably. Many managers describe difficulties in keeping track of how employees are doing around
- [Focus on Cancer Collaboration](https://swedenbio.se/kalendarium/focus-on-cancer-collaboration-2/) - You're invited to interact around research and innovation in the oncology area. How can new ideas be created working cross borders? How can industry, academia and healthcare sector work together? We are proud to have professor Douglas Hanahan onboarded as keynote speaker (with some reservation for changes caused by pandemic and travel restrictions). The full
- [SwedenBIO's Annual General Meeting](https://swedenbio.se/kalendarium/swedenbios-annual-general-meeting/) - As the meeting is held digitally through Teams, this year we only invite one person per voting member company. Pre-registration is required and registration is personal. The deadline for registration is May 24. Annexes Notice of Ordinary Meeting of the SwedenBIO 2021 Association Annual report of the SwedenBIO association 2020 Audit report of the SwedenBIO
- [Swedish-US Networking Event (closed)](https://swedenbio.se/kalendarium/swedish-us-networking-event-closed/) - In an exclusive networking event, we are bringing together a selection of Swedish and Californian companies active in this field, ranging from small highly innovative companies to big pharma and biotech´s. Organisors include US Embassy in Sweden, Swedish Embassy to the US, AmCham, SACC & BIOCOM. Check out the program HERE.
- [BIO International Convention 2021](https://swedenbio.se/kalendarium/bio-international-convention-2021/)
- [JLABS webinar - Meet with BioGeneration Ventures](https://swedenbio.se/kalendarium/jlabs-webinar-meet-with-biogeneration-ventures/) - Partnering with a Venture Capitalist (VC) may fast forward your innovation, because they could bring much more to the table than just funding. Virtually join JLABS, where Edward van Wezel, Managing Partner BioGeneration Ventures, will elaborate on their aim to build new companies around either single assets or technology platforms with the goal of creating
- [The US Election and Outlook for Transatlantic Trade and Business](https://swedenbio.se/kalendarium/the-us-election-and-outlook-for-transatlantic-trade-and-business/) - Want to get a more thorough understanding on the upcoming US election? Or are you concerned with how it might impact our business? Then join in! On October 27 at 18:00, Björn Arvidsson, Head of Trade and Economic Affairs, Embassy of Sweden in Washington DC, will host a webinar together with SACC-NE, where he will
- [Opportunities in the UK for clinical research and med-tech](https://swedenbio.se/kalendarium/opportunities-in-the-uk-for-clinical-research-and-med-tech/) - The event will include presentations and a Q&A session. Focus areas will be: - The UK offer in clinical research; - The UK offer in medtech; - Accessing the NHS market and its procurement channels; - Investor benefits. UK Life Sciences Investment Opportunities, DIT Sweden webinar Nov. 3 (Flyer)
- [Korea-EU Biopharma Open Innovation Forum](https://swedenbio.se/kalendarium/korea-eu-biopharma-open-innovation-forum/)
- [Unleashing the potential - Life Science from Norway](https://swedenbio.se/kalendarium/unleashing-the-potential-life-science-from-norway/) - As we continue to grow, we are looking at ways to strengthen the cluster, our members, and the industry further. Join us for this seminar, where we explore how to unleash the potential of the life science industry in Norway.
- [BeHEALTH - Online International Event in Healthcare](https://swedenbio.se/kalendarium/behealth-online-international-event-in-healthcare/) - The3rd edition of this unique event will bring together companies, organizations, universities and public entities, being the perfect environment for international partnerships, resulting in increased health related economic competitiveness. The BeHEALTH agenda includes, beside the brokerage event, also a start-up contest and eight panels for discussions covering the cluster expertise. Our aim is to create
- [Complimentary webinar - Successfully navigating MDR transition](https://swedenbio.se/kalendarium/complimentary-webinar-successfully-navigating-mdr-transition/) - Rather than being a formal MDR training session, the webinar - hosted by AstraZeneca's BioVentureHub - will provide you with insights, examples and experiences on how big pharma, global medtech and SMEs are planning and navigating their MDR journeys depending on product profiles and market strategies. For registration and more information please click here.
- [US Dual Listing Webinar for Nordic Life Sciences Companies 2020](https://swedenbio.se/kalendarium/us-dual-listing-webinar-for-nordic-life-sciences-companies-2020/) - This webinar, co-hosted by Nasdaq Nordics and Advokatfirman Vinge, is designed to address and shed light on some of these key items to enable decision makers to more clearly assess whether a dual listing in the US is an option that should be considered. C-suite executives and board members of Nordic life sciences companies will
- [How are media and influencers faring in the coronavirus crisis?](https://swedenbio.se/kalendarium/how-are-media-and-influencers-faring-in-the-coronavirus-crisis/) - Alexander Mason, commercial director at Cision and Åsa Melin Mandre, partner at Greenhill Relations meet Yasmine Winberg, reporter and editor at Resumé and Linnéa Kihlström, reporter and editor at Dagens Media. How are media and influencers doing in the corona crisis and what can we expect the media landscape to look like post corona? For
- [Webinar: Brand portfolio optimization - reducing costs and increasing value](https://swedenbio.se/kalendarium/webinar-brand-portfolio-optimization-reducing-costs-and-increasing-value-2/) - Portfolio optimization is a structured service that can be found in our service description; our Workflow. We often offer this type of advice to our clients and have a structured approach to our implementation. This often involves screening clients' trademark portfolios to clear out duplicate registrations and rights that are no longer in use, and
- [Life Sciences PLM Innovation Forum Virtual Experience 2020](https://swedenbio.se/kalendarium/life-sciences-plm-innovation-forum-virtual-experience-2020/) - Bringing together inspirational customer speakers, industry leading experts and attendees from around the globe, the event promises to promote digitalization for the future of sustainable healthcare. The agenda covers multiple time zones with live panel discussions for all audiences to join. Presentation and demo content will be presented live and hosted on-demand, meaning you can
- [Biotechgate Digital Partnering](https://swedenbio.se/kalendarium/biotechgate-digital-partnering/) - We want to support the business development of start-up and early stage companies, specifically members of our Biotechgate partners and Biotechgate companies. As such, we are now offering online partnering through our Biotechgate Digital Partnering platform. Members of SwedenBIO may contact info@swedenbio.se for a promotion code. For more information and registration click here.
- [Marketing Material - A Nordic Approach](https://swedenbio.se/kalendarium/marketing-material-a-nordic-approach/) - In addition, the webinar will focus on guidance regarding collaboration with healthcare during the corona pandemic. There will be an opportunity to discuss uncertainties that compliance professionals come across in the Nordic region, interacting with healthcare professionals in the current situation. Which type of meetings can still take place in physical form and what are
- [Oncology Virtual Partnering Event](https://swedenbio.se/kalendarium/oncology-virtual-partnering-event/) - At Inova, our aim is to accelerate partnering by facilitating the bridge between science and business. From 22 to 24 September, Inova in collaboration with BIO, are organizing a 3-day virtual partnering event oncology, where researchers, biotech companies and business development executives from biopharmaceutical companies will be able to network in a virtual space. SwedenBIO
- [Digital briefing on the Sweden Canada Innovation Initiative](https://swedenbio.se/kalendarium/digital-briefing-on-the-sweden-canada-innovation-initiative/) - In today's challenging world situation, it is even more important to continue our global cooperation with key innovation countries, such as Canada. Vinnova invites you to a digital meeting on cooperation opportunities with Canadian actors. During the meeting we will present our major initiative Sweden Innovation Days and future funding opportunities. For registration and more
- [Webinar: Brand portfolio optimization - reducing costs and increasing value](https://swedenbio.se/kalendarium/webinar-brand-portfolio-optimization-reducing-costs-and-increasing-value/) - This webinar will explain in a hands-on way how portfolio optimization works and what to consider. The focus will be on the following - Preliminary work such as the holder search. - Questions to ask to know what to keep and what can be removed. - Other efficiency measures. - Supplementary applications. - Cases in
- [HealthTech event @TechConnect Europe](https://swedenbio.se/kalendarium/healthtech-event-techconnect-europe/) - In order to seize this opportunity, Medicon Valley Alliance (MVA) and Invest in Skåne have joined forces for this Healthtech event and offer you two opportunities to be involved: as a participant, or as a pitching company in one of the 'HealthTech Challenges' on the programme. In both cases, as a member of MVA, you
- [Artificial Intelligence in Pharma Summit](https://swedenbio.se/kalendarium/artificial-intelligence-in-pharma-summit/) - Given the increasingly decisive role of AI and machine learning in Pharma industry, it becomes progressively crucial to learn, adopt and integrate latest technologies to keep your business competitive. Discover latest AI trends and developments within Pharma and network with professionals across both industry and academia. For more information click here.
- [2nd Gene and Cell Therapy Summit](https://swedenbio.se/kalendarium/2nd-gene-and-cell-therapy-summit/) - This is a place to take part in exciting presentations while networking with attending speakers and delegates. Together you can address the key burning issues and innovative approaches. Learn more about the delivery of cost and quality efficient process development, manufacturing and commercialization of cell and gene therapies, and much more. For more information click
- [Introduction to Regulatory Affairs in Drug Development](https://swedenbio.se/kalendarium/introduction-to-regulatory-affairs-in-drug-development/) - This course targets an up-to-date overview of current regulation and how to ensure sufficient regulatory documentation in all phases of a drug's development, with focus on the early phase. The course is primarily aimed at you who work at a small to medium sized research based pharmaceutical company and need an overall knowledge of Regulatory
- [COVID-19: Risk Based Quality Management & Monitoring Webinar with Gunnar Danielsson](https://swedenbio.se/kalendarium/covid-19-risk-based-quality-management-monitoring-webinar-with-gunnar-danielsson/) - This requirement is an enhanced concept and requires a change in the mindset for the implementation of updated and new processes when conducting clinical studies. The responsibility for these processes always lies with the sponsor, irrespective if the task itself is delegated to an outside vendor. Therefore, we encourage all of our current and prospective
- [When Decisions are Worth Billions, You Must Deal with Uncertainty](https://swedenbio.se/kalendarium/when-decisions-are-worth-billions-you-must-deal-with-uncertainty/) - For this Webinar, we have invited one of our Life Science Members- Captario. Specialized in helping Drug Development project teams and portfolio leads, the Swedish high-tech company Captario will show their advanced modeling & simulation tool and argue that decision making must shift from guesswork to well-informed data driven decisions. The complexities in the development
- [Breakfast club](https://swedenbio.se/kalendarium/breakfast-club/) - In this webinar, you will hear the experts' advice on financial communication in times of crisis and what to consider to communicate clearly and confidently in an economic downturn. Participating are Jonas Rodny, director at Paues Åberg, Carolin Wiken, partner at Paues Åberg and Malin Johansson, manager at Paues Åberg as moderator. Register here.
- [Webinar: Trademark holders - how to optimize your domain names?](https://swedenbio.se/kalendarium/webinar-trademark-holders-how-to-optimize-your-domain-names/) - Domain names should be seen as a digital extension of your brands. Therefore, it is appropriate that these two types of registrations are handled uniformly. All too often, we see domain names handled by the IT department and trademarks by the legal or marketing department. This can lead to inefficient management and increased costs, and
- [Free Digital Partnering for Members](https://swedenbio.se/kalendarium/free-digital-partnering-for-members/) - The three day conference will be from May 18th to 20th and is free for all member companies. Registration and more information can be found here SwedenBIO members get a free up-grade to premium partnering. Contact info@swedenbio.se for your promotion code.
- [Webinar: How is COVID-19 accelerating Digital Healthcare?](https://swedenbio.se/kalendarium/webinar-how-is-covid-19-accelerating-digital-healthcare/) - The topics for the webinar involves the future for digital healthcare solutions. The global pandemic has changed the way healthcare services and workers are operating. In order to protect staff and patients the healthcare systems needs to work remotely. Telemedicine and Life Science companies are developing new efficient solutions faster than ever before, in order
- [Dissolution Testing in Quality Control and Drug Development - from USP Vessels to Artificial Intelligence](https://swedenbio.se/kalendarium/dissolution-testing-in-quality-control-and-drug-development-from-usp-vessels-to-artificial-intelligence/) - The meeting is of interest to anyone working with pharmaceutical production, development, research or quality control. Lectures connected to different areas e.g. formulation design, analytical methods and correlation to biopharmaceutical behavior will be presented. The lectures will be given in English. For more information and registration click here.
- [Park Annual by Sahlgrenska Science Park](https://swedenbio.se/kalendarium/park-annual-by-sahlgrenska-science-park/) - Since 2017, Sahlgrenska Science Park awards the Arvid Carlsson Award every year in connection with Park Annual. The aim is to pay tribute to innovation, knowledge and competence in conjunction with good entrepreneurship through an award in Nobel Prize winner Arvid Carlsson's name. For more information and registration click here.
- [BIO LATIN AMERICA CONFERENCE 2020](https://swedenbio.se/kalendarium/bio-latin-america-conference-2020/) - BIO and Biominas Brasil invite you to the BIO Latin America Conference, the industry's must attend conference for innovation and collaboration on biotech and life sciences in Latin America. More information will soon be available. For SwedenBIO members please contact info@swedenbio.se for more information about your discount code. For more information and registration click
- [Knowledge for Growth](https://swedenbio.se/kalendarium/knowledge-for-growth-3/) - The cream of the Belgian life sciences community will attend the 16th edition of flanders.bio's annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech, agricultural and chemical industry as well as investors, universities, research institutes, policymakers and competence providers. For SwedenBIO members please contact info@swedenbio.se for more information about your
- [BioPharm America](https://swedenbio.se/kalendarium/biopharm-america/) - BioPharm America attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts. For SwedenBIO members please contact info@swedenbio.se for more information about your discount code. For more information and registration click here.
- [BIO Europe Spring](https://swedenbio.se/kalendarium/bio-europe-spring/) - Between endless partnering opportunities using EBD Group's gold-standard partneringONE® meeting platform, incisive panels and workshops by top industry executives and the opportunity to present your company as well as attend presentations.For SwedenBIO members please contact info@swedenbio.se for more information about your discount code. For more information and registration click here.
- [NLSDays 2021](https://swedenbio.se/kalendarium/nlsdays-2021/) - Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business. Most attendees express their delight in the informal atmosphere, combined with an organized approach to meeting highly relevant people. Return visitors come back because they feel they belong to our growing community.
- [MDR training with TUV SUD](https://swedenbio.se/kalendarium/mdr-training-with-tuv-sud/) - Acquiring an overview of MDR requirements and the latest news and interpretations as well as insights to develop appropriate strategies. Läkemedelsakademin in collaboration with SwedenBIO and members of course have a discount - just click here. notification.
- [SWISS NORDIC BIO 2020](https://swedenbio.se/kalendarium/swiss-nordic-bio-2020/) - Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 13 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organized by the Nordic countries in cooperation with Swiss partners. DeadlinesTasks31JanEnd of registration31 JanEnd of booking of
- [Business development for medical devices 2020](https://swedenbio.se/kalendarium/business-development-for-medical-devices-2020/) - Business development as well as sales strategy needs to be adapted to meet the new medical device landscape. What regulatory strategic decisions need to be made, what are the practicalities of evaluation and testing, what are the different investment routes? In short, what are the important things I need to know to make the right
- [Quality Risk Management in practice](https://swedenbio.se/kalendarium/quality-risk-management-in-practice/) - The regulations require you to actively manage risks in the manufacture and handling of medicines/medical devices. During an inspection, you need to show how and argue that decisions have been made based on risk-based thinking. We give you the tools to understand both what a risk-based approach can mean in practice and how to carry
- [15th Park Annual 2020](https://swedenbio.se/kalendarium/15th-park-annual-2020/)
- [New Horizons in Biologics & Bioprocessing](https://swedenbio.se/kalendarium/new-horizons-in-biologics-bioprocessing-2/) - This international educational forum will have an emphasis on change, developments, improvements, new directions, management, R&D of biologics and bio-processing with focus on technical rather than commercial achievements. Areas will include analytical techniques, cell culturing and upstream processing, downstream processing, single-use systems, gene-therepy and regulatory issues etc. More information: http://www.bioprocessing.se/
- [Pharma Outsourcing - Find The Right Partner](https://swedenbio.se/kalendarium/pharma-outsourcing-find-the-right-partner/) - The international annual partnering meeting is targeted at R&D and CMC professionals, service providers and Investment Managers, and provides an opportunity to meet, network and discuss best practices related to outsourcing in drug development. Organized for the 6th time, the event will cover all stages from preclinical research to late clinical phases, preclinical and clinical
- [Bioscience - Research Through Innovative Technologies](https://swedenbio.se/kalendarium/bioscience-research-through-innovative-technologies-2/) - The latest in cell biology, synthetic biology, precision medicine, gene-edtiting/genomics, proteomics and the latest of "omics" - metabolomics are some of the topics that will be highlighted at the 7th edition of our scientific international partnering event Bioscience - Research through Innovative Technologies taking place in Stockholm at Karolinska Institutet in beautiful Aula Medica.
- [The Future of Swedish & Danish Life Science](https://swedenbio.se/kalendarium/the-future-of-swedish-danish-life-science-3/) - The international partnering-event The Future of Swedish & Danish Life Science started in 2012 and includes a combination of partnering (pre-bookable one-on-one meetings), presentations, exhibition and informal networking.These four core elements of the day run in parallel and ensure that the event is a lively, energetic day designed to impart new knowledge and build new
- [New Updates in Drug Formulation & Bioavailability](https://swedenbio.se/kalendarium/new-updates-in-drug-formulation-bioavailability-3/) - Pharmaceutical formulation can have a huge impact on the bioavailability of a given drug and is one of the key factors in the successful development of drug delivery systems. However, many of the drugs in the development pipelines often possess poor physico-chemical properties, which make them difficult to formulate using classic approaches and hence require
- [IVDR training with TUV SUD](https://swedenbio.se/kalendarium/ivdr-training-with-tuv-sud/) - IVDR training day from Andreas Strange, TÜV SÜD. An opportunity to learn of requirements, challenges and useful insights directly from one of Europe's largest and leading notified body for Medical Devices Läkemedelsakademin in collaboration with SwedenBIO and members of course have a discount - just click here. notification.
- [Regulatory Affairs - an overview](https://swedenbio.se/kalendarium/regulatory-affairs-an-overview/) - The RA plays a key role in drug development and during the product life cycle. The training day will give you an overview of the role of Regulatory Affairs, familiarize you with the terminology in the field and give you an overview of all stages of drug development and the product life cycle. For example,
- [Business development for medical devices](https://swedenbio.se/kalendarium/business-development-for-medical-devices/) - Business development as well as sales strategy needs to be adapted to meet the new medical device landscape. What regulatory strategic decisions need to be made, what are the practicalities of evaluation and testing, and what are the different investment routes? In short, what are the important things I need to know to make the
- [Usability Engineering in Medical Devices](https://swedenbio.se/kalendarium/usability-engineering-in-medical-devices/) - In the US, it has been important for many years to apply usability aspects during product development. In Europe, this is now more in focus with the new medical device regulations (MDR/IVDR). Läkemedelsakademin in collaboration with SwedenBIO and members of course have a discount - just click here. notification.
- [Drug development course (completed)](https://swedenbio.se/kalendarium/drug-development-course-completed/) - The course is mainly aimed at those who work in an SME and want to gain insight into how to work in different stages of development, what to consider and what pitfalls there are along the way. The course is organized by Läkemedelsakademin in cooperation with SwedenBIO and members have of course a discount -
- [BIO International Convention](https://swedenbio.se/kalendarium/bio-international-convention-2/) - From an enhanced partnering experience, to expanded registration benefits, insightful sessions, and unforgettable networking opportunities, BIO 2020 helps you dream big and tackle daunting industry challenges.
- [German Biotech Day 2020](https://swedenbio.se/kalendarium/german-biotech-day-2020/) - The DBT are a meeting place for more than 850 representatives from the worlds of business, science and government, including partners from funding institutions and public administration. Through a series of talks, panel discussions and breakfast sessions, the conference discusses the conditions for innovation in biotechnology and the wide range of biotech applications. All employees
- [BIO Europe 2020](https://swedenbio.se/kalendarium/bio-europe-2020/) - All employees in Sweden, in a SwedenBIO member company have a personal discount. Please contact info@swedenbio.se for you discount code.
- [ChinaBio Partnering Forum](https://swedenbio.se/kalendarium/chinabio-partnering-forum/) - Forge cross-border partnerships with leaders from global pharma and biotech companies to innovative startups and researchers from leading universities and institutes, as well as VCs and other investors. ChinaBio® Partnership Forum is a leading biopharmaceutical partnering conference, where you will gain valuable exposure to the fastest growing healthcare market in the world. All employees in
- [Biotech Showcase](https://swedenbio.se/kalendarium/biotech-showcase/) - Biotech Showcase™ is an investor and partnering conference devoted to providing private and small and mid-cap biotechnology companies an opportunity to present and meet investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attract investors and biopharmaceuticals executives from around the world. All employees in Sweden, in a
- [NLS Invest 2021](https://swedenbio.se/kalendarium/nls-invest-2021/) - A by-invitation-only event through which 60+ selected companies (Rising Stars) within the Nordic life science industry will be invited to pitch before a range of national and international investors, including pharmaceutical venture arms. Read more and apply here.
- [SwedenBIO Hack + report release (closed)](https://swedenbio.se/kalendarium/swedenbio-hack-report-release-closed/) - You can follow the seminar via https://youtu.be/Ia59Rga04G8 The broadcast starts at 14.00. There will be an opportunity for interactive participation via menti. For program times, see the invitation below.
- [SwedenBIO Executive Dinner and Annual Meeting](https://swedenbio.se/kalendarium/swedenbio-executive-dinner-and-annual-meeting/) - An informal thematic evening where senior management from our member companies gather to gain inspiration, discuss and network. By invitation. During the formal annual general meeting the fiscal year is briefly summarized. For any questions, please contact info@swedenbio.se for questions.
- [BIO-Europe Spring 2020](https://swedenbio.se/kalendarium/bio-europe-spring-2020/) - The fourteenth annual BIO-Europe Spring conference is the premier springtime partnering conference for the biotechnology industry. For its 2020 edition, BIO-Europe Spring returns to Paris, France on March 23-25, 2020. Theconference annually attracts the international "who's who" from biotech, pharma and finance for three days of high caliber networking. BIO-Europe Spring's world-class workshops, panels and
- [Heading towards a more automated and augmented world, how do we cope with that?](https://swedenbio.se/kalendarium/heading-towards-a-more-automated-and-augmented-world-how-do-we-cope-with-that/) - But that's not all. We have also invited Conny Svensson, head of Digital Transformation and AI at CGI Sverige. Conny will talk about The world as we know it is about to change, big time! AI is driving automation and augmentation while delivering new sensations. Join this presentation in following the story of the human
- [Matchmaking at Medica](https://swedenbio.se/kalendarium/matchmaking-at-medica/) - Uminova Innovation as a partner in Enterprise Europe Network (EEN) offers enterprises, SME:s and Start-Ups to participate in a matchmaking event 18-20 November, the "Healthcare Brokerage event MEDICA 2019". The matchmaking will offer healthcare executives and key opinion leaders as well as disruptive and promising companies the possibility to meet bilaterally in pre-arranged 30 minutes
- [How to implement foundations of success in the biotech development from the beginning](https://swedenbio.se/kalendarium/how-to-implement-foundations-of-success-in-the-biotech-development-from-the-beginning/) - The Biotech & MedTech industry are increasingly complex from a commercial, regulatory, and clinical perspective. Join us to learn about essential development steps to take and get inspiration about how to integrate these requirements into your lifecycle planning for increased success and sustainable growth. Quotes from previous workshops with Charlotte Piester: "I feel the talk
- [Innovation conference](https://swedenbio.se/kalendarium/innovation-conference/) - Welcome to a conference on medical technology innovation that meets tomorrow's patient and healthcare needs. During the day you will hear about 5G as oxygen for AI and the emerging digital landscape. But innovation is not just new technology. A willingness to change is just as crucial if we are to embrace the transformative technologies
- [Eurostars Workshop](https://swedenbio.se/kalendarium/eurostars-workshop/) - Eurostars supports international innovative projects led by research and development- performing small- and medium-sized enterprises. With its bottom-up approach, Eurostars is an ideal first step in international cooperation, enabling small businesses to combine and share expertise and benefit from working beyond national borders. The role of SMEs for the economy has never been so important.
- [Lab & Diagnostics of the Future](https://swedenbio.se/kalendarium/lab-diagnostics-of-the-future/) - The seminar will highlight the latest innovations in labtech and diagnostics, experiences and future visions from the industry's decision makers and the users of lab technology equipment. The seminar is amied at lab managers, biomedicine analysts, purchasers, investors and leading decision makers in health- care and pharma. More information
- [Boost Seminar - How Chr. Hansen transformed their labeling to meet the industry 4.0 challenge](https://swedenbio.se/kalendarium/boost-seminar-how-chr-hansen-transformed-their-labeling-to-meet-the-industry-4-0-challenge/) - For the highly-regulated life sciences and food & beverage industries, Industry 4.0 represents a unique challenge. There is no doubt that the future of all manufacturing is digital. Yet, how do we get there? What is the best approach and how can companies ensure that they follow an efficient, future-proof path to digitization, one that
- [Drug Development - 3 day course](https://swedenbio.se/kalendarium/drug-development-3-day-course-2/) - This three-day course provides insights into all the parts that should be addressed to effectively target a drug project. This course is available as a traditional and as an online course. Traditional participant also have the opportunity to add lectures online. Who should attend? The course is aimed for those involved in drug development (eg
- [Drug Development - 3 day course](https://swedenbio.se/kalendarium/drug-development-3-day-course-3/) - Who should attend? The course is aimed for those involved in drug development (eg in small and medium-sized companies), and needs a comprehensive picture of the complex development chain. During the course you will get insight into how to work in the different stages of development, what to think about and what pitfalls there are
- [The life science industry's own tennis paddle tournament](https://swedenbio.se/kalendarium/the-life-science-industrys-own-tennis-paddle-tournament/)
- [Roche breakfast in Almedalen](https://swedenbio.se/kalendarium/roche-breakfast-in-almedalen/) - What should we talk about in Almedalen this year? What are the big issues that we need to rally around, what stories will we agree on and which ones will reach above the noise? We aim for high interactivity and the opportunity to listen to the experiences and insights of all participants - both on
- [Cake party in the SwedenBIO house](https://swedenbio.se/kalendarium/cake-party-in-the-swedenbio-house/) - Cake party in the SwedenBIO house We summarize the week from a life science perspective with Björn Arvidsson, Head of Policy at Roche and Chairman of SwedenBIO's Public Affairs Group, and Jonny Sågänger, journalist at Läkemedelsmarknaden, both of whom have a keen eye on everything that is said in the Almedalen panels! What was the
- [A Swedish life science strategy - how will it meet health challenges and strengthen our competitiveness?](https://swedenbio.se/kalendarium/a-swedish-life-science-strategy-how-will-it-meet-health-challenges-and-strengthen-our-competitiveness/) - Life science is one of Sweden's most important industries and exports and a strong research area. In order for Sweden to maintain its prominent position, the government is now developing a new life science strategy with a focus on the utilization of health data, personalized medicines, and the future of healthcare and effective implementation of
- [Back to the future - is there vitality in Swedish life science?](https://swedenbio.se/kalendarium/back-to-the-future-is-there-vitality-in-swedish-life-science/) - The life science industry has historically been good for Sweden, and Sweden has been good for the industry. With internationally renowned research, cutting-edge technology and talented employees, companies large and small have contributed to Sweden's prosperity and medical progress. How do we ensure that this cooperation continues? What are the challenges facing the country, industry
- [Early Clinical Development - Challenges & Opportunities](https://swedenbio.se/kalendarium/early-clinical-development-challenges-opportunities/) - The seminar will cover different aspects of early development with special focus on the translation phase. A range of speakers will cover different aspects of early development with special focus on the translation phase, design of phase I studies and pharmacokinetic studies. Other topics are dose selection for early trials, regulatory aspects and bioequivalence trials.
- [The right focus in board work SME](https://swedenbio.se/kalendarium/the-right-focus-in-board-work-sme/) - Time of the event: The training is divided into 2 sessions, Monday 10/06/2019 8:30 - 17:00 hrs Monday 2019-06-17 8:30 - 17:00 pm Information: We want you to increase your knowledge of corporate governance and board work. To make them both broader and deeper. We want to equip you to become a more competent member
- [BIOSCIENCE 2019](https://swedenbio.se/kalendarium/bioscience-2019-2/) - A world without any diseases - science fiction or a reality? One thing is certain - we are getting closer and it starts in the lab by using the latest cutting edge technologies. In 1900, the average life expectancy in Sweden was around 53. Today some claim that we shortly live to be 150. Researchers
- [How can Swedish life sciences live up to these ambitions?](https://swedenbio.se/kalendarium/how-can-swedish-life-sciences-live-up-to-these-ambitions/) - Moderator: Ylva Williams, CEO, Stockholm Science City Ole Petter Ottersen, President, Karolinska Institutet Helena Strigård, Vice President, SwedenBIO Eugen Steiner, Partner, HealthCap Lotta Ljungqvist, CEO, GE Nordic Göran Stiernstedt, government investigator "Governance for a more equal care" Ella Bohlin (KD), Regional Health Development Council, Region Stockholm The seminar is organized by Karolinska Institutet.
- [Optimizing Value - Regulatory and Market Access Considerations](https://swedenbio.se/kalendarium/optimizing-value-regulatory-and-market-access-considerations/) - NDA would like to invite you to join Professor Steffen Thirstrup and Professor Mira Pavlovich-Ganascia share their experiences and provide their insights and considerations to optimize the value of your development program. The market access environment is getting increasingly challenging. The ability to develop plans and strategies for access, for today as well as tomorrow,
- [MVA ANNUAL MEETING 2019](https://swedenbio.se/kalendarium/mva-annual-meeting-2019/) - To discuss how to ensure the competitiveness of our region in a globalized world, Medicon Valley Alliance has the pleasure of inviting you to an afternoon with inspirational regional, national and international speakers. The topics of this years Annual Meeting will be: How do we make the most of our unique position as the leading
- [GOOD MORNING MEETING - BIOMARKERS ANALYSIS CHALLENGES IN CLINICAL TRIALS](https://swedenbio.se/kalendarium/good-morning-meeting-biomarkers-analysis-challenges-in-clinical-trials/) - Welcome to MVA's Good Morning Meeting on "Biomarkers analysis challenges in Clinical Trials" with HalioDx. One of the biggest challenges in immunotherapy area is to find accurately which patients will benefit from a therapy or a combination of therapies. To help drug developers getting this information, the assessment of biomarkers through clinical research studies represent
- [Strengthen your procurement skills and increase the number of contracts you win.](https://swedenbio.se/kalendarium/strengthen-your-procurement-skills-and-increase-the-number-of-contracts-you-win-2/) - Join our half-day event with EU lawyer Ohad Graber-Soudry(www.xofficio.eu), an expert in public procurement. Ohad has a background as Head of Legal Division at ESS and developed and implemented ESS procurement rules. The training is in English and free of charge. More information
- [Strengthen your procurement skills and increase the number of contracts you win.](https://swedenbio.se/kalendarium/strengthen-your-procurement-skills-and-increase-the-number-of-contracts-you-win/) - Join our half-day event with EU lawyer Ohad Graber-Soudry(www.xofficio.eu), an expert in public procurement. Ohad has a background as Head of Legal Division at ESS and developed and implemented ESS procurement rules. The training is in English and free of charge. More information
- [BIO Latin America 2019](https://swedenbio.se/kalendarium/bio-latin-america-2019/) - This year's conference theme will be "Innovation and Business Partnering as Drivers of the Bioeconomy in Latin America". Throughout two full-days, discussion panels and sessions will focus on solutions for challenges faced by the Latin American biotech and life sciences sector. The conference will feature private, pre-arranged meetings between senior-level executives, using BIO's state-of-the-art software,
- [Partnering opportunity between UK and Sweden](https://swedenbio.se/kalendarium/partnering-opportunity-between-uk-and-sweden/) - In January this year a first partnering event hosted by The Swedish Research Council, Vinnova, Enterprise Europe Network and Innovate UK took place focusing on fostering and facilitating R&D projects between UK and Swedish organizations in regenerative medicine. We are now pleased to inform you that there will be a follow up meeting in the
- [B2B Health Innovation Market - Portugal 2019](https://swedenbio.se/kalendarium/b2b-health-innovation-market-portugal-2019/) - The event will bring together around 100 participants from highly specialized medical and health companies from Portugal, Spain, Israel and other countries. The Micro & Nano sector groups members are expected to bring at least one company or organization per member.
- [EU❤VC- What happens in the funding flow for life science companies?](https://swedenbio.se/kalendarium/eu❤vc-what-happens-in-the-funding-flow-for-life-science-companies/) - Orient yourself to the funding landscape and how the upcoming EU programs for SMEs will be matched with venture capital. You will learn about a recent study on the financing history of Swedish life science companies and the Swedish stock market miracle. Welcome on May 24 at 13.00 - 14.00, wishes Medicon Village, SwedenBIO, EU
- [Optimize your business development for medical devices](https://swedenbio.se/kalendarium/optimize-your-business-development-for-medical-devices/) - The medical device market is governed by a regulatory framework that is more diverse than many other markets. Successful development and sales require the entrepreneur, business developer and investor to be aware of the regulatory challenges and their costs. Business development as well as sales strategy needs to be adapted to meet the regulatory requirements,
- [Digital health products and MDR](https://swedenbio.se/kalendarium/digital-health-products-and-mdr/) - Digital health and care have the potential to innovate and improve access to care, quality of care, and to increase the overall efficiency of the health sector. In this breakfast seminar we will look at some key regulatory and other legal issues relevant for existing and new digital health products intended for the EU market.
- [Life Science Hotlist Summit](https://swedenbio.se/kalendarium/life-science-hotlist-summit/) - Growing a life science company requires considerable financial muscle. In one afternoon, we will explore the pros and cons of different financing solutions, from angel to stock exchange. Listen to investors and learn from the experiences of other entrepreneurs. More information
- [Artificial Intelligence for Life Sciences](https://swedenbio.se/kalendarium/artificial-intelligence-for-life-sciences/) - AI has many facets: it may be algorithmic as in game playing programs or take a control theoretic approach as in autonomous vehicles. It may also manifest itself as linguistic ability, creativity, spatial reasoning, learning, and many others. We are now recognizing that AI has begun to make huge inroads to Life Sciences, be it
- [Interactions with the Agencies During Drug Development](https://swedenbio.se/kalendarium/interactions-with-the-agencies-during-drug-development/) - There are many opportunities for bringing your message across to regulators, by interacting with the right EU Agencies at the right time, dependent on the type of product, applicant, procedure and stage of development. Find out whether you're making the most of all these opportunities to facilitate your drug development program. More information
- [Swiss Biotech Day 2019](https://swedenbio.se/kalendarium/swiss-biotech-day-2019/) - The SBD is not just the place to be for members of the Swiss Biotech Association, who traditionally meet there for the association's Annual General Assembly. As always, the event targets entrepreneurs, investors, researchers, analysts, BD&L, political decision makers, industry stakeholders and media. For more information and registration please visit swissbiotechday. Remember, as a SwedenBIO
- [Cancer Immunotherapy](https://swedenbio.se/kalendarium/cancer-immunotherapy/) - In December 2018, two immunologists-American James Allison and Japan's Tasuku Honjo-were awarded the Nobel Prize in medicine for pioneering a way to re-program a person's immune system to attack cancer cells. In this seminar Klas Kärre (professor at KI and member of the Nobel Committee) will explain Allison's and Hoino's research as well as previous
- [European Biotechnology Congress](https://swedenbio.se/kalendarium/european-biotechnology-congress/) - More information
- [IACCT 2019](https://swedenbio.se/kalendarium/iacct-2019/) - More information
- [Introduction to Regulatory Affairs in R&D - 1 day course](https://swedenbio.se/kalendarium/introduction-to-regulatory-affairs-in-rd-1-day-course/) - This course is for you who work at a small to medium sized research based pharmaceutical company and need overall knowledge of Regulatory Affairs. You might work as project manager, project team member, innovator and entrepreneur, academic researcher, drug developer or as business manager who work in a pharmaceutical R&D company. The course is also
- [The 3rd Annual Nordic Precision Medicine Forum](https://swedenbio.se/kalendarium/the-3rd-annual-nordic-precision-medicine-forum/) - Expanding upon the agenda from previous years, in 2019 there will even greater opportunities for learning, sharing ideas and networking through our industry workshops, roundtables, networking breaks and plenary sessions. There will be a technology showcase, providing start-ups, university spin-outs, global leading tech providers and more to provide quick fire insights as to how new
- [Fundraising Boot Camp](https://swedenbio.se/kalendarium/fundraising-boot-camp/) - Download the invitation here: 6 February Stockholm-Fundraising and Valuation Boot Camp Register here: https://events.r20.constantcontact.com/register/eventReg?oeidk=a07eg2a5cuoe04b776c&oseq=&c=&ch=
- [BIO 2019, Philadelphia](https://swedenbio.se/kalendarium/bio-2019-philadelphia/) - For more information please visit: BIO 2019 Members get discount please contact info@swedenbio.se for your personal code.
- [New horizons in biologics & bioprocessing](https://swedenbio.se/kalendarium/new-horizons-in-biologics-bioprocessing/) - Areas will include analytical techniques, culturing and upstream processing, downstream processing, regulatory issues and single-use systems etc. The event will feature about 130 delegates and 15 exhibitors.Pre-bookable on-on-one meetings will be offered.
- [Bioscience 2019](https://swedenbio.se/kalendarium/bioscience-2019/) - The event will feature about 300 delegates and 25 exhibitors and includes a series of interesting lectures focusing on new technologies and applications as well as the latest results in research. Providing a platform for meetings and networking, the event is aimed at parties in both industry and academia. The seminar part comprises a series
- [Pharma Outsourcing](https://swedenbio.se/kalendarium/pharma-outsourcing/) - The day will feature 30 exhibitors, and is expected to attract around 160 delegates. Pharma Outsourcing will cover contract research and manufacturing in both small molecule and biological APIs, and the event will be covered by the media.
- [Bio Japan 2019](https://swedenbio.se/kalendarium/bio-japan-2019/) - BioJapan has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating new business opportunities for almost two decades. Top business development, licensing, and alliance management professionals, R&D personnel, and biotech company executives from around the world will gather in Yokohama in October 2019 for the 21st iteration of BioJapan. SwedenBIO
- [InnoHealth 2019](https://swedenbio.se/kalendarium/innohealth-2019/) - SwedenBIO members receive discount on the registration fee. Contact info@swedenbio.se for your personal promotion code. More information
- [Knowledge for Growth](https://swedenbio.se/kalendarium/knowledge-for-growth-2/) - The cream of the Belgian life sciences community will be attending the 15th edition of flanders.bio's annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech, agricultural and chemical industry as well as investors, universities, topnotch research institutes, policymakers and competence providers. SwedenBIO members receive discount on the registration fee. Contact
- [BioFIT](https://swedenbio.se/kalendarium/biofit/) - Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences. SwedenBIO members receive discount on the registration fee. Contact info@swedenbio.se for your personal promotion code. More information
- [3 day course in Biologics Drug Development](https://swedenbio.se/kalendarium/3-day-course-in-biologics-drug-development-2/) - During the course on May 14-16th you will get insight on how to work in the different stages of development, what to think about and what pitfalls there are on the road. Also available online with access to all streamed lectures for a month. The course is co-organized by the Swedish Academy of Pharmaceutical Sciences
- [Therapeutic proteins - focus on analysis and formulations](https://swedenbio.se/kalendarium/therapeutic-proteins-focus-on-analysis-and-formulations/) - SwedenBIO members have 20% discount, contact info@swedenbio.se for your personal code. More information
- [The Future of Swedish & Danish Life Science 2019](https://swedenbio.se/kalendarium/the-future-of-swedish-danish-life-science-2019/) - These four core elements of the day run in parallel and ensure that the event is a lively, energetic day designed to impart new knowledge and build new networks. The event attracts 400-500 leading decision makers every year from all over the world from pharma, biotech and medtech as well as research, the healtchcare sector,
- [New Updates in Drug Formulation & Bioavailability](https://swedenbio.se/kalendarium/new-updates-in-drug-formulation-bioavailability-2/) - Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about this exciting topic at this meeting featuring about 100 delegates and 10 exhibitors. New updates in Drug Formulation & Bioavailability is a platform that based on the concept of synergies between "science" and "business". The presented content and topics will focus
- [SWISS NORDIC BIO 2019](https://swedenbio.se/kalendarium/swiss-nordic-bio-2019/) - As part of the Swedish Innovation Initiative (SWII) program, Business Sweden is hosting the Swiss Nordic Bio 2019 conference on February 7, 2019 in Zurich. Vinnova offers travel grants for small and medium-sized enterprises in life sciences. The conference brings together Nordic and Swiss life science companies. Take the opportunity to present your company at
- [SwedenBIO Summit 2019](https://swedenbio.se/kalendarium/swedenbio-summit-2019/) - The program starts at 13.00 with registration and coffee from 12.30. The first hour will be in Swedish and, upon request from our members, the rest of the day will be in English, welcoming our non-Swedish speaking members. Secure your ticket today! The event is member exclusive and free of charge. No show fee of
- [Executive Dinner 2019](https://swedenbio.se/kalendarium/executive-dinner-2019/) - Program 17.00 Welcome 17.30 SwedenBIO Annual General Meeting (AGM) 18.00 Tonight's inspirational speakers 18.30 Mingle 19.00 We sit down at the table We continue in the lounge with entertainment Registration Personal invitation. Are you missing the invitation? Contact info@swedenbio.se Please note that we charge an envelope fee of 600 incl. VAT. VAT for the company
- [Regenerative medicine - partnering meeting at Vinnova](https://swedenbio.se/kalendarium/regenerative-medicine-partnering-meeting-at-vinnova/) - Partnering event- hosted by the UK and Sweden The Swedish Research Council, Vinnova, Enterprise Europe Network, Innovate UK, and the Knowledge Transfer Network are pleased to announce a partnering event focused on fostering and facilitating R&D project consortia for Horizon 2020 funded projects for topic BHC-07-2019 - Regenerative medicine: from new insights to new applicationsProjects
- [Medicon Valley Alliance R&D Network - Enhancing collaboration](https://swedenbio.se/kalendarium/medicon-valley-alliance-rd-network-enhancing-collaboration/) - Medicon Valley Alliance, together with one of our members - Medicon Village Science Park - now welcomes you to MVA R&D Network and our 2nd meeting where we discuss the opportunities and challenges with the preclinical-clinical transition in a Swedish and Danish perspective.
- [Lunch & Learn: The role of the board in start-ups](https://swedenbio.se/kalendarium/lunch-learn-the-role-of-the-board-in-start-ups/) - It is important for you as a management representative in the start-up company that the composition of the board reflects the current needs and that you can use its expertise in a way that creates value in the company. This and more will be discussed by Karin Wingstrand and Artur Aira from ISEA. Karin and
- [14th Park Annual 2019](https://swedenbio.se/kalendarium/14th-park-annual-2019/)
- [Engineering Health](https://swedenbio.se/kalendarium/engineering-health/) - What will the future of healthcare bring? How do we take advantage of the endless possibilities of new technology? And what skills will be desired? This conference aims to inspire new research collaborations and new career tracks of the future of healthcare. For whom? This is a conference mainly for those who are studying or
- [Export Credit Board support for small and medium-sized exporting companies](https://swedenbio.se/kalendarium/export-credit-board-support-for-small-and-medium-sized-exporting-companies/) - Meet Åsa Larsson from the Swedish Export Credit Agency (EKN) who will present how the Export Credit Agency can help your company secure export business and facilitate financing. There will be an opportunity to ask questions and book a meeting to discuss how EKN can help your company in its internationalization journey.
- [Ningbo-Gothenburg Industrial Cooperation Conference](https://swedenbio.se/kalendarium/ningbo-gothenburg-industrial-cooperation-conference/) - The conference includes a seminar session where the focus is on business and collaboration opportunities in Ningbo and Gothenburg. There will also be multiple opportunities for networking. Speakers include Pan Yingming, Division Chief of Ningbo Municipal Commission of Commerce, the Lord Mayor of Gothenburg, the Consul General of China, as well as representatives from Lindholmen
- [The future of health and social care - who does what for whom?](https://swedenbio.se/kalendarium/the-future-of-health-and-social-care-who-does-what-for-whom/) - Taking a look at the state of our health system with its 200-year-old roots, Hans Winberg looks ahead to what the transformation of the coming years might entail. And talks about how all of us working in the system need to understand and reinvent ourselves. Hans Winberg is an organizational researcher and has worked on
- [Feasibility - approach to study requests](https://swedenbio.se/kalendarium/feasibility-approach-to-study-requests/) - A number of proposals for measures in VGR and Norra Halland are presented. The work has been carried out within the framework of Clinical Studies Sweden with the aim of streamlining the request and response process for study requests. Speakers: Per-Anders Jansson, Gothia Forum This meeting is part of Gothia Forum's seminar series on clinical
- [Investment evening for life tech companies](https://swedenbio.se/kalendarium/investment-evening-for-life-tech-companies/) - An event for inspiration and the opportunity to meet a handful of exciting life science companies seeking capital and expertise, with associated mingling and discussion between investors and early-stage entrepreneurs. The opening inspirational speaker this time is Devdatt Dubashi who is Professor at the Data Science division, Department of Computer Science and Engineering at Chalmers
- [Clinical trials now and in the future](https://swedenbio.se/kalendarium/clinical-trials-now-and-in-the-future/) - This evening is a great opportunity to hear the latest regulatory news on the new EU Clinical Trials Regulation, the requirements for publishing clinical data and how to find information on ongoing and completed studies. You will also have the opportunity to meet colleagues in a relaxed and friendly environment.
- [Does Region Västra Götaland want to be the locomotive? What is the vision?](https://swedenbio.se/kalendarium/does-region-vastra-gotaland-want-to-be-the-locomotive-what-is-the-vision/) - A lot is going on in the region today with investments in the Innovation Fund and the Innovation Platform, AI both at Lindholmen and Chalmers, MedTech West with their investments in medical technology research and Sahlgrenska Life. Investors are now finding their way to the life science industry in western Sweden.
- [Identification of biomarkers from large-scale biological data](https://swedenbio.se/kalendarium/identification-of-biomarkers-from-large-scale-biological-data/) - Recently, there has been an explosion of technological development in the field of life sciences, which means that large amounts of biological data can be generated in a short period of time. There is currently a great deal of interest and high expectations regarding the possibility of discovering new biomarkers that can be used for
- [Nordic-Canada Health Solutions Initiative 2018-2019](https://swedenbio.se/kalendarium/nordic-canada-health-solutions-initiative-2018-2019/) - This program is targeted to established Nordic Companies with solutions applicable to healthy ageing, rehabilitation and digital health. Nordic Innovation is supporting this collaboration project to assist Nordic healthcare companies with accelerated entry to the Canadian market.
- [Seminar to launch the report on antimicrobial resistance](https://swedenbio.se/kalendarium/seminar-to-launch-the-report-on-antimicrobial-resistance/) - In connection with the launch, PRV is organizing a breakfast seminar. Welcome to listen to experts together with policy makers, research funders and academia. Take part in a discussion and debate on how we can make better use of the 37 research billions, how we utilize the assets that come from Swedish research and get
- [The Seminar on Medical Device Reimbursement](https://swedenbio.se/kalendarium/the-seminar-on-medical-device-reimbursement/)
- [The future of health - challenging and enabling technologies](https://swedenbio.se/kalendarium/the-future-of-health-challenging-and-enabling-technologies-2/)
- [International conference on physical activity and health](https://swedenbio.se/kalendarium/international-conference-on-physical-activity-and-health/)
- [The future of health - challenging and enabling technologies](https://swedenbio.se/kalendarium/the-future-of-health-challenging-and-enabling-technologies-3/)
- [MEDICA 2018](https://swedenbio.se/kalendarium/medica-2018/)
- [Breakfast club Paues Åberg](https://swedenbio.se/kalendarium/breakfast-club-paues-aberg/) - Theodor Paues, partner at Paues Åberg, explains how to lobby public inquiries and what to avoid. Martin Persson, a manager at Paues Åberg with many years of experience in the Government Offices and as a secretary for investigations, explains how investigations work in practice and how to get an investigation's attention. Read more and register
- [After Work - "The successful defense of Zubsolv®"](https://swedenbio.se/kalendarium/after-work-the-successful-defense-of-zubsolv/) - SwedenBIO and Orexo invites members of SwedenBIO and investors and analysts as well as media to an educating After Work seminar in collaboration with Vinge where you will have the opportunity to share the insights from Orexo's management and legal counsel from the extensive litigation. In addition to get a brief company update on
- [Nordic Life Science Days 2019](https://swedenbio.se/kalendarium/nordic-life-science-days-2019/) - The meeting covers all aspects of the life science industry in the Nordic countries. In parallel, NLSDays offers Supersessions covering new trends and hot topics, Workshops with in depth discussion in specific areas, company presentations, face-to-face partnering and an exhibition. For more information and registration please visit nlsdays.com. Remember, as a SwedenBIO member you have
- [Industry day with the City of Stockholm](https://swedenbio.se/kalendarium/industry-day-with-the-city-of-stockholm/)
- [Pharmacogenetics and Stratified Medicine Network Annual Open Meeting](https://swedenbio.se/kalendarium/pharmacogenetics-and-stratified-medicine-network-annual-open-meeting/)
- [To Do Right - The European Commission explains](https://swedenbio.se/kalendarium/to-do-right-the-european-commission-explains/)
- [Financial issues in Horizon 2020 - basic course](https://swedenbio.se/kalendarium/financial-issues-in-horizon-2020-basic-course/)
- [Breakfast at Nobel Museum](https://swedenbio.se/kalendarium/breakfast-at-nobel-museum/) - We will explore this topic with Lisa Lindström, CEO of Doberman, Elcim "Superturken" Yilmaz, communicator and PR agent, and Suzan Hourieh, Head of Diversity Management at M/Volvo Car Mobility and Founder of The Social Few. The discussion will be led by Tobias Degsell, CEO of Combiner and former curator at the Nobel Museum. During the
- [Lunch Seminar: AI and digital promotions in health and medicine](https://swedenbio.se/kalendarium/lunch-seminar-ai-and-digital-promotions-in-health-and-medicine/)
- [Breakfast Seminar with Läkemedelsvärlden & Apotekarsocieteten](https://swedenbio.se/kalendarium/breakfast-seminar-with-lakemedelsvarlden-apotekarsocieteten/) - Antibiotics is classified as one of the world's largest health threats by the WHO World Health Organization. The problem is not just due to the overuse of antibiotics. In the entire chain, from manufacture to use, there are things to do to prevent an increase in resistance development. This includes reducing the impact on our
- [Vinnova Announcement for cooperation Sweden-Germany](https://swedenbio.se/kalendarium/vinnova-announcement-for-cooperation-sweden-germany/) - At the meeting, the background, content and application procedure of the announcement will be presented to both Swedish and German project partners. A representative from AiF Projekt GmbH will also attend the meeting and will tell you more about how the application and financing process looks like in Germany. There will also be time to
- [NARVA Lunch seminar](https://swedenbio.se/kalendarium/narva-lunch-seminar/) - During the lunch seminar, we will present results and conclusions from the survey with Swedish and international examples of smart and innovative annual and sustainability reports. Read more and register here!
- [The 3rd World Congress on Clinical Trails in Diabetes](https://swedenbio.se/kalendarium/the-3rd-world-congress-on-clinical-trails-in-diabetes/)
- [NanoForum 2018](https://swedenbio.se/kalendarium/nanoforum-2018-2/) - At NanoForum we create meaningful encounters around the most important topics for our future. With a highly relevant audience, including policy makers, investors, world class scientists and entrepreneurs, NanoForum is the most important meeting for the Scandinavian Nano community. Read more and register here!
- [National conference on clinical trials](https://swedenbio.se/kalendarium/national-conference-on-clinical-trials/) - National Conference on Clinical Studies is a meeting place for knowledge sharing and networking. The conference is aimed at you who work with clinical studies in healthcare, dental care, academy and industry as well as for patients. The conference is also addressed to you as a manager, employee or politician responsible for healthcare or research
- [BioProduction Congress](https://swedenbio.se/kalendarium/bioproduction-congress/)
- [Biologics World Nordic 2019](https://swedenbio.se/kalendarium/biologics-world-nordic-2019/) - Read more here.
- [The International Congress on Precision Medicine Beyond Cancer](https://swedenbio.se/kalendarium/the-international-congress-on-precision-medicine-beyond-cancer/)
- [The European Biopolymer Summit 2019](https://swedenbio.se/kalendarium/the-european-biopolymer-summit-2019/) - The two day event will give you an insight into the latest updates on the environmental projects, the feedstock's landscape, and the role of biopolymers in the circular economy, application, new technologies, and many more. Read more and register here!
- [What does it take to be successful in the MedTech and BioTech industry?](https://swedenbio.se/kalendarium/what-does-it-take-to-be-successful-in-the-medtech-and-biotech-industry/)
- [The International Congress on Presicion Medicine Beyond Cancer](https://swedenbio.se/kalendarium/the-international-congress-on-presicion-medicine-beyond-cancer/)
- [Lunchtime seminar NARVA](https://swedenbio.se/kalendarium/lunchtime-seminar-narva/) - Together with its client, the Children's Cancer Foundation, Narva invites you to a seminar where we highlight trends in opinion formation and present the successful (and award-winning) advocacy campaigns "If I were Minister of Social Affairs" and "The Promise of the Minister of Social Affairs".
- [Breakfast Seminar with Stockholm Science City Foundation](https://swedenbio.se/kalendarium/breakfast-seminar-with-stockholm-science-city-foundation/) - On September 6th, Stockholm Science City together with Business Sweden will arrange a breakfast seminar on market access and FDA approval in the U.S.. The U.S. represents the single largest market opportunity for life science, medtech and digital health companies, and its also known for its fierce competition. Having the right strategy and roadmap is
- [SwedenBIO: Business Development Course](https://swedenbio.se/kalendarium/swedenbio-business-development-course/) - Business developers! Get inspiration and hear companies share their experience of the business development process with "Big Pharma", as well as how to think about financing and business intelligence to be properly equipped for successful partnering. The course is fully booked! When: Tuesday 16/10 Where: Tändstickspalatset, Västra Trädgårdsgatan 15, Stockholm. Registration to: goeran@bulbintelligence.com The course
- [BioStock](https://swedenbio.se/kalendarium/biostock/)
- [New Horizons in Biologics & Bioprocessing 2018](https://swedenbio.se/kalendarium/new-horizons-in-biologics-bioprocessing-2018/)
- [Pharma Outsourcing](https://swedenbio.se/kalendarium/pharma-outsourcing-2/)
- [Bioscience 2018](https://swedenbio.se/kalendarium/bioscience-2018/)
- [Lunch seminar with Narva](https://swedenbio.se/kalendarium/lunch-seminar-with-narva/) - Together with its client, the Children's Cancer Foundation, Narva invites you to a seminar where we highlight trends in opinion formation and present the successful (and award-winning) advocacy campaigns "If I were Minister of Social Affairs" and "The Promise of the Minister of Social Affairs".
- [NanoForum 2018](https://swedenbio.se/kalendarium/nanoforum-2018/) - At NanoForum we create meaningful encounters around the most important topics for our future. With a highly relevant audience, including policy makers, investors, world class scientists and entrepreneurs, NanoForum is the most important meeting for the Scandinavian Nano community. Prepare yourself for a mind-blowing journey in the smallest of worlds. Read more and register here!
- [Southern Sweden Going Global Final Conference](https://swedenbio.se/kalendarium/southern-sweden-going-global-final-conference/) - The partially EU-financed project Southern Sweden Going Global aims to increase the competitiveness and global visibility of Skåne's young life science businesses through activities that increase competence, and participation in international delegation trips and business fairs. Read more and register here!
- [SwedenBIO: 3 day course in Drug Development with Läkemedelsakademin](https://swedenbio.se/kalendarium/swedenbio-3-day-course-in-drug-development-with-lakemedelsakademin/) - Drug development projects are often initiated by identifying treatment for a disease. The project usually contains a deep knowledge of the disease and the biological mechanism. However, in order to develop a drug for the disease, a broad knowledge of many different areas is required. This three-day course provides insights into all the parts that
- [Minisymposium on Protein Formulation and Characterization](https://swedenbio.se/kalendarium/minisymposium-on-protein-formulation-and-characterization/) - Date and Time: Wednesday, August 29th 2018, 10:00-14:30 Location: Karolinska Institutet Science Park, Solna, Sweden Registration fee: €80 (€40 for SwedenBIO members and academia) Agenda 09:30 Coffee and Registration 10:00 Roger Scherrers, PhD, Wyatt Technology Europe GmbH Wyatt's toolkit for Protein Characterization 10:45 Sergei Kuprin, PhD, Swedish Orphan Biovitrum Application of Light Scattering Methods for
- [European Biotech Week](https://swedenbio.se/kalendarium/european-biotech-week/) - The European Biotech Week celebrates biotechnology, an innovative and vibrant sector launched by the discovery of the DNA molecule back in 1953. The first European Biotech Week that took place in 2013 marked the 60th anniversary of this pivotal moment in history.
- [Orphan Drugs - A Wider Perspective](https://swedenbio.se/kalendarium/orphan-drugs-a-wider-perspective/) - Reserve the date. A full day seminar organized by SDS and Sweden Bio at World Trade Center, Stockholm. Top speakers of international class from a range of disciplines ranging from development, regulatory considerations and also the commercial perspective. To pre-register your interest, please send a mail to event@scanddev.se. The seminar will be advertised from August/September.
- [Increasing access to national research infrastructures in life sciences](https://swedenbio.se/kalendarium/increasing-access-to-national-research-infrastructures-in-life-sciences/) - The Government's research bill 2016/17:50 emphasizes the importance of increased accessibility to academic research infrastructures for all research organizations in Sweden, including industry and healthcare. However, there are currently no clear guidelines on how to ensure this accessibility in practice. Do we have the organizational forms and flexibility required for our research infrastructures to provide
- [If there is a shortage of candidates today, what about tomorrow?](https://swedenbio.se/kalendarium/if-there-is-a-shortage-of-candidates-today-what-about-tomorrow/) - As competition increases both nationally and globally, the availability of skills is the single most important success factor. Many are experiencing a major shortage of candidates and are seeing clear consequences of this today. What can we do to turn today's threat of skills shortages into tomorrow's opportunity to recruit the right managers and employees?
- [How do we strengthen Sweden as a life science nation?](https://swedenbio.se/kalendarium/how-do-we-strengthen-sweden-as-a-life-science-nation/) - The previous government initiated Clinical Studies Sweden and a comprehensive research and innovation bill. The current government appointed a life science coordinator in 2015 and decided at the beginning of the year to establish a permanent life science office within the Ministry of Enterprise and Innovation. A growing number of European countries are now seeking
- [Business Development of Photonics Companies for Healthcare](https://swedenbio.se/kalendarium/business-development-of-photonics-companies-for-healthcare/) - This workshop (free of charge) will gather representatives from photonics companies, med-tech companies, end-users and researchers interested in commercialisation and a number of experts, to discuss and network around issues related to the business development of photonics companies addressing the global healthcare market. Researchers will learn that starting a company developing photonics technology for healthcare
- [Life Science Fair Lund 2018](https://swedenbio.se/kalendarium/life-science-fair-lund-2018/) - Arbetsförmedlingen Lundaregionen, Medicon Village and Crossborder Öresund are organizing a recruitment fair with a focus on work in Life Science! The fair covers the entire breadth of biology, medicine, chemistry and the interdisciplinary fields. Read more and register here.
- [Brokerage for health](https://swedenbio.se/kalendarium/brokerage-for-health/) - Why participate Get all information needed on the upcoming Horizon 2020 calls in the "Health, Demographic change and Wellbeing" work program Present your innovative project idea, or your competence, to an international audience and discover other participants' solutions and technologies Meet potential partners from Europe and beyond and start building your consortium Read more and
- [MVA Annual Meeting 2018](https://swedenbio.se/kalendarium/mva-annual-meeting-2018/) - To sustain and develop the Great Copenhagen region's momentum, we need to effectively remove barriers to the scale-up of innovative life science companies, strengthen collaboration, and brand the region internationally. To discuss how to get from start-up to scale-up and beyond, Medicon Valley Alliance has the pleasure of inviting a list of inspirational regional, national
- [Medicine Valley Alliance Summer Reception 2018](https://swedenbio.se/kalendarium/medicine-valley-alliance-summer-reception-2018/) - Medicon Valley Alliance hopes to see existing and future MVA members, decision makers and everybody else with an interest in the future of Medicon Valley at the MVA Summer Reception. Read more and register here!
- [2018 China Sweden Business Council Health Forum](https://swedenbio.se/kalendarium/2018-china-sweden-business-council-health-forum/) - The forum is organized by Chian-Sweden Business Council and Sweden-China Association of Quality of Life. The mission of Health Forum 2018 is to build up different levels of communication in medical research, medical devices and caring services, experts, governors and entrepreneurs would be invited from both China and Sweden to discuss popular topics and potential
- [Clinical evidence for CE marking of medical devices and IVD devices according to new MDR and IVDR](https://swedenbio.se/kalendarium/clinical-evidence-for-ce-marking-of-medical-devices-and-ivd-devices-according-to-new-mdr-and-ivdr/) - The seminar will outline the new Medical Device Regulations (MDR 2017/745) and in-vitro Diagnostic Regulations (IVDR 2017/746) that will come in effect over the next two to four years. PCG and QAdvis will present strategies and opportunities to navigate through these new requirements. The seminar will explore clinical evaluation and clinical performance evaluation regulations as
- [Lunch seminar on public offerings](https://swedenbio.se/kalendarium/lunch-seminar-on-public-offerings/) - Program: 11.30 Registration and lunch 12.30 SwedenBIO's Disclosure Recommendations for Development Stage Companies Björn Ursing, Program Director, SwedenBIO 12.40 It is all about the Money: How to prepare a successful IM Ozgur Tuncer, VP Consulting, Strategy Life Science, IQVIA 13.00 Prospectuses - regulatory framework, info requirements and practical experiences Dain Hård Nevonen, Lawyer/Partner, Vinge 13.20
- [Immunogenicity for investigational biopharmaceutical products](https://swedenbio.se/kalendarium/immunogenicity-for-investigational-biopharmaceutical-products/) - Understanding and controlling immunogenicity-related risks are attainable objectives, and approvability should not be compromised if these risks are suitably evaluated from the earliest stages of development. Learning aspects: How to apply immunogenicity risk assessment at the lead candidate selection stage Minimizing incremental risks associated with manufacturing Understanding what and how to evaluate, at different stages
- [Dare to be social with your medicine!](https://swedenbio.se/kalendarium/dare-to-be-social-with-your-medicine/) - Welcome to a breakfast seminar where we will explain how to interpret and manage the regulatory framework and clarify any questions. We also discuss how to plan your social media campaign to make it successful. To register, please send an e-mail to jenny.battistich@narva.se, 08-599 211 00. Read more here!
- [IACCT 2018 Europe](https://swedenbio.se/kalendarium/iacct-2018-europe/) - IACCT 2018 Europe is a great opportunity to meet colleagues from the clinical trials community from academia, clinical research entities, pharmaceutical, biomedical and medical device industries. At this Congress you will have the opportunity to not only expand your network but also to be privy to presentations that incorporate a wide variety of topics ranging
- [Seminar on ownership diversification and new issuance models](https://swedenbio.se/kalendarium/seminar-on-ownership-diversification-and-new-issuance-models/) - The capital market is facing major changes with new creative solutions to provide companies with access to capital. We understand that you have a good knowledge of the basic principles of both rights issues and private placements. But how familiar are you with the new emission models available? And what can shareholders expect from the
- [LSX Nordic Congress 2018](https://swedenbio.se/kalendarium/lsx-nordic-congress-2018/) - The Nordic region has long produced world-leading science and innovation and Nasdaq Nordic is one of the leading hubs for biotech companies in Europe, strengthened further by a hugely active IPO market over the last two years. However, growth and venture funding is lacking compared with other hubs and listed Nordic companies face a number
- [County councils in value-creating innovation partnerships](https://swedenbio.se/kalendarium/county-councils-in-value-creating-innovation-partnerships/) - Robert Winroth, Innovation County Councilor in Västerbotten, talks about the successful work of implementing "innovation in partnership" to streamline healthcare and create measurable values for all parties. Together with VLL Innovation AB and the Leading Health Care Foundation, it presents both obstacles and possible solutions in such processes. Can Västerbotten's way of working with value-creating
- [After working with the law firm Lindahl, are you ready for GDPR?](https://swedenbio.se/kalendarium/after-working-with-the-law-firm-lindahl-are-you-ready-for-gdpr/) - Join us for an afternoon at Conextion to learn the most pressing issues regarding GDPR in your organization and the opportunity to ask the specialists all your questions! The Lindahl team are experts in GDPR and throughout their presentation they will give you hands-on suggestions and examples that you can follow and implement in your
- [Sofus Talks about Tech Transfers](https://swedenbio.se/kalendarium/sofus-talks-about-tech-transfers/) - Due to business or compliance reasons technology transfer of pharmaceuticals can sometimes be inevitable. A profound understanding in CMC and GMP is needed for transfer projects to succeed in terms of secure supply and product quality. Also available via live streaming (in English). Read more and register here!
- [Expanding your research with MAX IV and ESS](https://swedenbio.se/kalendarium/expanding-your-research-with-max-iv-and-ess/) - During this breakfast seminar, Tomas Lundqvist, Life Science Director of MAX IV will explore the opportunities for academic and industrial use of the brightest X-ray source in the world and what that means for researchers in Stockholm. Esko Oksanen who leads the NMX instrument at ESS will also present an array of different instruments that
- [SwedenBio and PCG Clinical Services Seminar on the pathway to drug development](https://swedenbio.se/kalendarium/swedenbio-and-pcg-clinical-services-seminar-on-the-pathway-to-drug-development/) - We are bringing together our experts in clinical drug development for a half day of learning. If you are a small biotech company and would like to learn more about how to navigate the transition from pre-clinical to clinical research & development, please register below. Reducing time and cost to market and increasing the chances
- [Science Summit 2018](https://swedenbio.se/kalendarium/science-summit-2018/) - The advent of new automatizing and genome editing technologies is revolutionizing screening efforts from the academia. In this context, for this year, we will bring together an excellent group of scientists actively involved in chemical and genetic screenings from various independent angles. We will favor interactions with the speakers and among attendants, to facilitate the
- [New Updates in Drug Formulation and Bioavailability](https://swedenbio.se/kalendarium/new-updates-in-drug-formulation-and-bioavailability/) - Formulation and bioavailability are critical steps in the development process of new effective drugs. One reason for failure in clinical trials might be explained by poor formulation and bioavailability properties of the drug. Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about these topics at this meeting featuring about 125
- [BIO Investor Forum](https://swedenbio.se/kalendarium/bio-investor-forum/) - The BIO Investor Forum is an international biotech investor conference focused on investment trends and opportunities in life sciences, with unbiased emphasis on venture-stage growth and emerging public companies as well as those poised to join the growth "watch list" in 2018. The BIO Investor Forum delivers a rich program that features corporate presentations and
- [BIO World Congress on Industrial Biotechnology](https://swedenbio.se/kalendarium/bio-world-congress-on-industrial-biotechnology/) - It is the only conference highlighting advances in the science, policy and business of renewable chemicals, biobased materials, and advanced biofuels. Breakout sessions will include tracks focused on growing global biobased markets; advanced biofuels and biorefineries; synthetic biology and gene editing; and renewable chemicals and biobased products. Read more and register here!
- [BIO International Convention](https://swedenbio.se/kalendarium/bio-international-convention/) - The key benefits of attending the 2018 BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering, exposure to industry though-leaders with over 1,500 education sessions at your fingertips, and unparalleled networking opportunities with 16,000+ attendees from 74 countries. ** SwedenBIO members can receive $200 off the non-member Convention Access/
- [BIO Asia International Conference](https://swedenbio.se/kalendarium/bio-asia-international-conference/) - The 15th Annual BIO Asia International Conference is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies interested in research collaborations and licensing agreements. Read more and register here!
- [BIO CEO & Investor Conference](https://swedenbio.se/kalendarium/bio-ceo-investor-conference/) - Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives can shape the future investment landscape of the biotechnology industry. The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.
- [The future of health - challenging and enabling technologies](https://swedenbio.se/kalendarium/the-future-of-health-challenging-and-enabling-technologies/) - We will take a closer look at how technologies such as Virtual Reality, Augmented Reality and Chatbots can be used to lower thresholds, reduce burdens and create new forms of treatment. We will also discuss what this requires in terms of cooperation between public and private actors and what it can lead to in terms
- [Artificial intelligence - a survey](https://swedenbio.se/kalendarium/artificial-intelligence-a-survey/) - AI is currently a very hot area - both here in Sweden and internationally. Ideas for applications are popping up all the time and companies, individuals, researchers and institutions are discussing what time, cost and efficiency gains they can make in their respective businesses using AI. The future is already here! Read more and register
- [Anglonordic Life Science Conference](https://swedenbio.se/kalendarium/anglonordic-life-science-conference/) - Anglonordic is the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other. This 1-day London conference provides exceptional value MEET decision makers at leading and upcoming drug discovery and technology companies from the UK and Nordic regions,
- [Park Annual 18](https://swedenbio.se/kalendarium/park-annual-18/) - A full day event with seminars, one-to-one meetings, exhibition and lots of networking opportunities. With innovation, Digital Health and implementation in focus you'll get to see several short presentations from startup-companies as well as more recognized life science organizations. Read more and register here!
- [Vitalis - the largest ehealth event in Scandinavia](https://swedenbio.se/kalendarium/vitalis-the-largest-ehealth-event-in-scandinavia-2/) - Vitalis offers a vibrant conference and exhibition that covers every aspect of business development in health, care and welfare where IT solutions provide support and assistance. Vitalis is a meeting point for everyone working strategically or operatively with business development and eHealth issues within healthcare and welfare. Read more and register here!
- [Financing for small and medium-sized enterprises](https://swedenbio.se/kalendarium/financing-for-small-and-medium-sized-enterprises/) - The state, region and EU offer various checks, loans and other funding for the development and innovation of SMEs. During an intensive morning, you will learn about innovation grants, loans and other public - and now also private - money that can be applied for by SMEs to co-finance product and business development. Read more
- [Wallenberg Center for Molecular and Translational Medicine yearly event](https://swedenbio.se/kalendarium/wallenberg-center-for-molecular-and-translational-medicine-yearly-event/) - Wallenberg Centre for Molecular and Translational Medicine would like to invite you to an inspiring afternoon where the WCMTM´s researchers present their research projects and invited speakers from the University of Gothenburg, Region Västra Götaland, Chalmers University of Technology and Astra Zeneca give their view on good examples of collaboration between academia, health care sector
- [Infoseminar on Horizon2020 - the next EU program in health - Dare to take the leap!](https://swedenbio.se/kalendarium/infoseminar-on-horizon2020-the-next-eu-program-in-health-dare-to-take-the-leap/) - Together with Umeå University and Västerbotten County Council, we invite stakeholders from industry, the public sector and academia to a meeting focused on raising awareness of the opportunities for to learn about the EU's various health initiatives and get concrete tips on how to apply for funding. Welcome to an inspiring morning of dialogue and
- [Life Science Relays](https://swedenbio.se/kalendarium/life-science-relays/) - On February 21, 2018, the Life Science Relay continues. This time in Umeå in cooperation with Västerbotten County Council. Since 2014, the Life Science Relay has aimed to build relationships and collaboration through meetings to exchange knowledge in areas related to Life Science. In February 2018, the focus will be on antibiotics and antibiotic resistance.
- [9th Biotech Umeå Investment Day](https://swedenbio.se/kalendarium/9th-biotech-umea-investment-day/) - The event is organized by Biotech Umeå and Umeå Biotech Incubator and offers a unique opportunity for potential investors and industrial partners to meet 15 well-prepared life science companies and pipeline prospects from the Swedish Västerbotten region under familiar conditions in gilt-edged surroundings. Read more here!
- [Lessons in Herding Cats: Business Development Basics for Life Science Companies](https://swedenbio.se/kalendarium/lessons-in-herding-cats-business-development-basics-for-life-science-companies/) - In this workshop, you'll learn fundamental business development skills to help you successfully evaluate and manage strategic alliances and other potential growth opportunities. Topics will include: Strategic alliance process management Concepts in valuation Importance of IP and IP diligence Communication and negotiation skills Basic components of a contract Read more and register here!
- [Health calls in the EU's Horizon 2020 framework program](https://swedenbio.se/kalendarium/health-calls-in-the-eus-horizon-2020-framework-program/) - The strategic innovation programs Medtech4Health and Swelife, together with Lund University and Medicon Village, invite stakeholders from industry and academia to a meeting focusing on increasing knowledge about the EU's upcoming calls in the field of health. Participants also receive concrete advice on how to apply and what support is available in the application process.
- [SEB: Nordic outlook](https://swedenbio.se/kalendarium/seb-nordic-outlook/) - On February 7, you will have the opportunity to listen and take part of SEB's reputable business intelligence at a breakfast meeting at Medicon Village in Lund. Read more and register here!
- [Information session on Brexit](https://swedenbio.se/kalendarium/information-session-on-brexit/) - On the afternoon of February 5, 2018, the Swedish Medical Products Agency will hold an information session on how Brexit will affect drug approvals. The aim is to provide a status update and practical information; there will also be an opportunity to ask questions. Read more and register here!
- [The innovation pavilion by Sweden](https://swedenbio.se/kalendarium/the-innovation-pavilion-by-sweden/) - Showcasing Sweden's world-class range of skills and innovation in the health care and Life Science sector, this unique B2B networking concept has been conceptualized for companies wanting to enter the MENA region and partner with consultants who understand what it takes to do business in this environment. Read more and register here!
- [Recipharm Pathway to Clinic](https://swedenbio.se/kalendarium/recipharm-pathway-to-clinic/) - Learn more about what Recipharma and their partner CTC Clinical Trial Consultants do and how they can help you succeed in pharmaceutical development and subsequent clinical trials. For a lucky few, there will be 15min slots available to book with Recipharm and/or CTC Clinical Trial Consultants! For some one-on-one time to discuss your project with
- [3 day course in biologics drug development](https://swedenbio.se/kalendarium/3-day-course-in-biologics-drug-development/) - During the course you will get insight on how to work in the different stages of development, what to think about and what pitfalls there are on the road. To get the most exchange of the course, it is an advantage to have a natural science background. The course is organized in cooperation with SwedenBIO.
- [BioFIT 2018](https://swedenbio.se/kalendarium/biofit-2018/) - BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. BioFIT is also the marketplace for pre-seed, seed and Series A investment in Life Sciences. Read more and register here!
- [BioSpain 2018](https://swedenbio.se/kalendarium/biospain-2018/) - BioSpain 2018 is the 9th international meeting on biotechnology, and it has become one of the leading events in Europe. One-to-one business meetings rose to 3000, making BioSpain one of the largest business and technology transfer partnering events in Europe, ranked third in the year 2016 by the number of one-to-one meetings. Read more and
- [Viral Safety and Raw Materials 2018](https://swedenbio.se/kalendarium/viral-safety-and-raw-materials-2018/) - With 900+ attendees, 275+ companies and over 70 sessions showcasing new data and technologies, including new focused sessions on Continuous Processing, Viral Safety for ATMPs, NGS, Novel Clearance, Inactivation with Novel Detergents and much more, this year in one not to be missed! Read more and register here!
- [BioProcess International European Summit 2018](https://swedenbio.se/kalendarium/bioprocess-international-european-summit-2018/) - Bringing together attendees from all major departments in bioprocessing: Cell Culture, Downstream, Vaccines, Viral Safety and Cell Line Development this April in Amsterdam, Europe's largest bioprocessing event, BPI Europe 2018 will provide you with the latest advice on how to optimize the bioprocessing through connecting science, technology and business, and with partneringONE to maximize your
- [Healthcare research day - Precision medicine from research to patients](https://swedenbio.se/kalendarium/healthcare-research-day-precision-medicine-from-research-to-patients/) - The development of precision medicine is a typical example of how research, healthcare and related structures need to interact and adapt in order for new technologies to reach patients. Based on the opportunities and challenges of precision medicine, the 2018 Healthcare Research Day will discuss Sweden's ambitions in clinical and medical research. From the program:
- [BioJapan 2018](https://swedenbio.se/kalendarium/biojapan-2018/) - BioJapan has played an important role in facilitating interaction between Japanese and global companies / organizations and stimulating new business opportunities for almost two decades. Top business development, licensing, and alliance management professionals, R & D personnel, and biotech company executives from around the world will gather in Yokohama in October 2018 for the 20th
- [Election year and Almedalen - what is the recipe for success?](https://swedenbio.se/kalendarium/election-year-and-almedalen-what-is-the-recipe-for-success/) - On January 30, Göran Hägglund, senior advisor at Narva, former party leader and Minister of Social Affairs, and Anna-Karin Hatt, CEO of Almega, former Minister of IT and Energy, will discuss how companies and organizations should plan and act to get the most out of the political week in Almedalen. Bring your questions and suggestions
- [International conference on perspectives in precision medicine](https://swedenbio.se/kalendarium/international-conference-on-perspectives-in-precision-medicine/) - This International Conference on Perspectives in Precision Medicine will focus on opportunities and challenges in the cross field between pharmaceutical development, user involvement and Information and Communications Technology (ICT). The conference focuses especially on SMEs, researchers and anyone else who are looking into new insights and knowledge on personalized medicine, to discover new business and
- [Focus on: Cancer Collaboration](https://swedenbio.se/kalendarium/focus-on-cancer-collaboration-3/) - Organizers for the meeting are Lund University Cancer Center (LUCC), LU Innovation, Medicon Village, SmiLe incubator, BBMRI.se and Medicon Valley Alliance. Read more and register here!
- [The future of Swedish & Danish life science](https://swedenbio.se/kalendarium/the-future-of-swedish-danish-life-science-2/) - In the past 10 years personalized medicine, now precision medicine, has been a highly attractive concept to many stakeholders in the industry. The Danish Government and Danish Regions have developed a National Strategy for Personalized Medicine 2017-2020 and in Sweden, the new initiative for precision medicine. But looking past the hype, when will the promised
- [First Nordic conference on personalized medicine](https://swedenbio.se/kalendarium/first-nordic-conference-on-personalized-medicine/) - This 3-day conference will focus on both basic and clinical aspects of research regarding personalized medicine. The program will consist of talks and workshops within pharmacogenetics, drug interactions, epigenetics and other factors that may cause variation in drug response among individuals. Furthermore, there will be focus on methods available across the participating researchers. Read more
- [Nordic Precision Medicine Forum](https://swedenbio.se/kalendarium/nordic-precision-medicine-forum/) - On the first day we will hold a series of discussions, enabling you to drill down into what is really required, the challenges facing us and how we can better work together to solve the intricacies of providing more personalized healthcare. On day two, we will have just one track, enabling more people to share
- [CHaSE 2018: Careers in health and science exhibition](https://swedenbio.se/kalendarium/chase-2018-careers-in-health-and-science-exhibition/) - During the event you can chose to present your company at a stand, give a presentation in Aula Medica's main lecture hall, or organize a workshop for closer interaction with our large pool of talented, ambitious and young students who are interested in pursuing a career in the health sector outside academia. Read more and
- [Breakfast seminar: Clinical trials - The direct to patient model](https://swedenbio.se/kalendarium/breakfast-seminar-clinical-trials-the-direct-to-patient-model/) - During the seminar you will meet Christina Vinum from Klifo A/S, Chris Elston from the Medical Research Network, and Gunilla Andrew-Nielsen from the Medical Products Agency who will participate in the panel discussion after the presentations. Welcome to a great opportunity to learn more and ask questions about a patient-centered approach to clinical trials. Read
- [BioAsia 2018](https://swedenbio.se/kalendarium/bioasia-2018/) - Technology Conferences of BioAsia is a Science-Business bridge, that aims to bring together a trans-disciplinary environment for driving innovation in the life sciences industry. The tech conferences have been carefully structured in order to leverage technology trends for business relationships and help you put technology in the development relay across the world through co-development opportunities.
- [Connect2Capital](https://swedenbio.se/kalendarium/connect2capital/) - The forum is featuring emerging technology companies across various streams such as ICT, Industry, Life Sciences Technology and more. During two days we facilitate growth by providing matchmaking and pre-booked meetings.The program contains a wide range of keynotes discussing current trends and success stories. Read more and register here !
- [Swedish National ATMP Conference](https://swedenbio.se/kalendarium/swedish-national-atmp-conference/) - Centre for Advanced Medical Products (CAMP), Swelife and Medicon Village cordially invites you to the first Swedish national conference on Advanced Therapy Medicinal Products (ATMP). This conference will provide insights into ongoing academic research, clinical applications and industrial activities in the field. Take the chance to meet potential collaborators and learn more about national initiatives
- [Biologics World Nordic 2018](https://swedenbio.se/kalendarium/biologics-world-nordic-2018/) - Biologics World Nordic will be the only focused biologic drug and vaccines conference in the Nordic region. We will bring together the complete network of the Nordic biologics industry including region's smaller Biopharmas, Big Pharmas, International Biopharmas, CMOs, CROs, Technocrats & Solution Providers. Read more and register here !
- [eHealth Match 2018](https://swedenbio.se/kalendarium/ehealth-match-2018/) - Enterprise Europe Network in collaboration with Business Region Göteborg, Scanbalt and HealthTech Nordic invites you to join a high-profile B2B matchmaking event(complimentary with a Vitalis or MIE2018 conference registration or if you are an exhibitor at Vitalis or MIE2018). The matchmaking will offer digital health technology executives and key opinion leaders as well as disruptive
- [Stockholm Corporate Finance Life Science seminar](https://swedenbio.se/kalendarium/stockholm-corporate-finance-life-science-seminar/) - Stockholm Corporate Finance will organize the tenth Life Science seminar at Operaterassen in Stockholm in collaboration with Financialhearings. Read more and register here!
- [MEDXPERIENCE](https://swedenbio.se/kalendarium/medxperience/) - MedXperience is the first open innovation healthtech event. This international event brings together the Paris Region's major healthcare players and their partners from around the globe. You can Gain insights from the MedXperience event, organized around 4 strategic fields: Diagnosis, Imaging, Advanced Therapies and eHealth Be inspired by the Talent Factory and the European MedX
- [Precision Medicine in Cancer (E1)](https://swedenbio.se/kalendarium/precision-medicine-in-cancer-e1/) - The conference will encompass the rapidly evolving field of disease monitoring by ultra-sensitive sequencing of tumor-specific mutations, as well as introduce novel approaches and other omics technologies and functional studies that will aid future efforts in precision medicine. Finally, successful examples of how genomic findings have spurred development of targeted therapies will be presented. In
- [17th Human Proteome Organization World Congress](https://swedenbio.se/kalendarium/17th-human-proteome-organization-world-congress/) - HUPO 2018 will have 4 topics which will be explored in 30 parallel sessions. The topics are technical sessions, biology-focused sessions, clinical sessions and HPP sessions. Each parallel session will feature two invited talks followed by five talks selected from submitted abstracts. In addition to main program parallel sessions there will be HPP committee and
- [IP strategy - why do I need it?](https://swedenbio.se/kalendarium/ip-strategy-why-do-i-need-it/) - Join us when HØIBERG Patent Attorneys, Pernille Winding Gojkovic and Jens Viktor Nørgaard, elaborate on why you need a patent strategy that is aligned with your business plan. They will encourage you to get value for money and maximize your ROI. Read more and register here !
- [IP strategy - why do I need it?](https://swedenbio.se/kalendarium/ip-strategy-why-do-i-need-it-2/) - Join us when HØIBERG Patent Attorneys, Pernille Winding Gojkovic and Jens Viktor Nørgaard, elaborate on why you need a patent strategy that is aligned with your business plan. They will encourage you to get value for money and maximize your ROI. Read more and register here!
- [What's next in digital customer engagement?](https://swedenbio.se/kalendarium/whats-next-in-digital-customer-engagement/) - Key take-aways - Get inspired on how to challenge and re-think the customer experience that you provide. - Learn how virtual customer engagements can make your campaigns more impactful. - Explore new ways and new tools that will make your customer-facing teams more successful Read more and register here !
- [Towards a national meeting place and agenda for ESS and MAX IV](https://swedenbio.se/kalendarium/towards-a-national-meeting-place-and-agenda-for-ess-and-max-iv/) - SWEbeams aims to achieve three key results: The actual collection of stakeholders with an explicit or potential interest in ESS, MAX IV and the related research and innovation arena. Proposals on how to ensure coherent dialogue and cooperation between stakeholders. Compilation of the actors' strategies, plans, needs and conditions for using and developing ESS and
- [Biotech and Money](https://swedenbio.se/kalendarium/biotech-and-money/) - The biotech and money themes in the 2018 congress include a number of formats designed to provide education, peer-to-peer discussion and meaningful interaction between all attendees. The congress delivers thought provoking panels, inspiring four-page chats and intimate roundtables. Read more and register here!
- [MYiHealth](https://swedenbio.se/kalendarium/myihealth-2/) - MYiHealth will address a number of the largest challenges facing today's healthcare community by taking the patient as its vantage point and focusing on outcomes that really matter to the patient. MYiHealth will feature: - World-class speakers - Seminars on digitizing the human body, treatment decision support, data integrity, VR tech for patients and other
- [BioTrinity 2018](https://swedenbio.se/kalendarium/biotrinity-2018/) - Our theme for BioTrinity 2018 is 'Next Generation Healthcare' which we will explore via a range of insightful keynote and panel discussions including 'AI and Drug Discovery', 'An insight into Nanotechnology','Next Generation Chemistry' and'Fintech and the Future of the Investment Industry' - keep an eye on the conference program. Read more and register here!
- [Swedish drug discovery, development and competency](https://swedenbio.se/kalendarium/swedish-drug-discovery-development-and-competency/) - Hays Specialist Recruitment would like to welcome you to an evening seminar at our Stockholm office with SwedenBio to discuss the booming Swedish drug development and how we can cater to its needs. Sara Gunnerås, Director, EU Support at SwedenBio, will present their findings on drug discovery and development pipeline report. Meanwhile, the Hays Global
- [Almedalen](https://swedenbio.se/kalendarium/almedalen/)
- [Biotech Showcase™ 2018](https://swedenbio.se/kalendarium/biotech-showcase-2018/) - The 2017 event showed a significant increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. Now in its tenth year, Biotech Showcase 2018 is expected to feature presentations by close to 400 public and private companies and attract more than 3,000 attendees. The event
- [BIO€QUITY EUROPE](https://swedenbio.se/kalendarium/bioequity-europe/) - https://www.biocentury.com/conferences/bio€quity-europe-2018
- [SwedenBIO Summit](https://swedenbio.se/kalendarium/swedenbio-summit/)
- [SwedenBIO Opinion](https://swedenbio.se/kalendarium/swedenbio-opinion/) - On stage, Lars Hjälmered, spokesperson for the Moderate Party's industrial policy, and Jennie Nilsson (S), chair of the Committee on Industry, External Trade and Energy, followed by a panel of life science entrepreneurs. The action plan for life science that SwedenBIO, LIF and Swedish Medtech are developing together again will be presented for the first
- [SwedenBIO Annual Meeting and Executive Dinner](https://swedenbio.se/kalendarium/swedenbio-annual-meeting-and-executive-dinner/) - We are delighted to once again invite the leaders of our member companies to an evening of good company. Join us for an exciting journey into the unknown and a nice dinner with industry colleagues. A link to the notification has been sent separately to the CEOs of our member companies. Tonight's program 17.30 Tour
- [Nordic Life Science Days 2018](https://swedenbio.se/kalendarium/nordic-life-science-days-2018/) - Nordic Life Science Days is the premier Nordic annual life science partnering meeting. The meeting covers all aspects of the life science industry in the Nordic countries. In parallel, NLSDays offers Supersessions covering new trends and hot topics, Workshops with in depth discussion in specific areas, company presentations, face-to-face partnering and an exhibition. This first
- [BIO-Europe 2018](https://swedenbio.se/kalendarium/bio-europe-2018/) - This "must-attend" event is Europe's largest life science partnering conference. BIO Europe's world-class workshops, panels and active exhibitions along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. ** SwedenBIO members can receive 300EUR registration discount, please contact us through
- [ChinaBio Partnering Forum 2018](https://swedenbio.se/kalendarium/chinabio-partnering-forum-2018/) - Forge cross-border partnerships with leaders from global pharma and biotech companies to innovative startups and researchers from leading universities and institutes, as well as VCs and other investors. ChinaBio® Partnership Forum is a leading biopharmaceutical partnering conference, where you will gain valuable exposure to the fastest growing healthcare market in the world. ** SwedenBIO members
- [BIO-Europe Spring 2018](https://swedenbio.se/kalendarium/bio-europe-spring-2018/) - With a focus on European innovation and global collaboration, BIO-Europe Spring is the premier springtime partnering conference bringing together a "whoʼs who" from biotech, pharma and finance in the most innovative biopharma clusters in Europe. **SwedenBIOmembers receive 300 EUR registration discount, please contact us through info@swedenbio.se to get promotion code.
- [Swiss Nordic Bio](https://swedenbio.se/kalendarium/swiss-nordic-bio/) - Swiss Nordic Bio is the number one platform that gathers life science professionals from Switzerland and the Nordic countries. Running for the 12th consecutive year, this high-level partnering and investor conference is organized by the Nordic countries in cooperation with Swiss partners. By connecting healthcare innovations, investors and industry, Swiss Nordic Bio is the perfect
- [How can your company benefit from CETA?](https://swedenbio.se/kalendarium/how-can-your-company-benefit-from-ceta/) - This seminar will focus on the benefits of CETA for the Swedish Life Science Industry The Embassy of Canada invites you to a seminar and reception. Space is limited - register early!
- [SwedenBIO and QuintilesIMS jointly invites to Breakfast Meeting on Rare Disease](https://swedenbio.se/kalendarium/swedenbio-and-quintilesims-jointly-invites-to-breakfast-meeting-on-rare-disease/) - In addition, an update of the drivers of the Swedish drug budget, including to what extent orphan drugs impact the overall budget, will be given by Per Troein, VP Supplier & Assoc Relations, responsible for the underlying analysis completed for Socialstyrelsen's autumn update to the Government. Agenda: 8.00 - 8.30 Breakfast is served 8.30 -
- [SwedenBIO: Listing - why and what does it mean?](https://swedenbio.se/kalendarium/swedenbio-listing-why-and-what-does-it-mean/) - Provisional agenda 09.00 Registration 09.15 Introduction 09.30 Nasdaq: "The stock market and life science companies" Nasdaq, Inc. is the world's largest exchange company, providing trading, exchange technology and services to over 3,500 issuers on six continents. 10.00 HealthCap: "The stock market from a shareholder perspective" With more than €1 billion in total capital since its
- [Workshop: Sharpening your application to the SME Instrument!](https://swedenbio.se/kalendarium/workshop-sharpening-your-application-to-the-sme-instrument/) - The focus of the writing workshop, held at Argongatan 30 in Mölndal, is on putting the innovation idea in context and making sure you communicate your entire idea in the best possible way. We go through the entire application process, from idea to final application, because a good and well-written application increases the chance of
- [SwedenBIO's drug development course](https://swedenbio.se/kalendarium/swedenbios-drug-development-course/) - The popular course is already fully booked for this fall, but it is possible to participate online.
- [Information day on the final calls of Horizon 2020](https://swedenbio.se/kalendarium/information-day-on-the-final-calls-of-horizon-2020/) - The information day is aimed at those who are interested in applying for funds in Horizon 2020 or working with support on funding opportunities. It is particularly aimed at those who are already familiar with Horizon 2020. The information day is held in Swedish with presentation material in English. National Contact Persons (NCPs) and invited
- [Artificial Intelligence in health - a data-driven revolution](https://swedenbio.se/kalendarium/artificial-intelligence-in-health-a-data-driven-revolution/) - The fourth and final seminar in the series will be held on 16 November. We will then try to look into the future together with a number of people with a good understanding of AI in health. How can AI be used in the analysis of genetic data and medical image information, what business opportunities
- [MIND THE GAP - conditions for Swedish entrepreneurship in 2017](https://swedenbio.se/kalendarium/mind-the-gap-conditions-for-swedish-entrepreneurship-in-2017/) - The report will be presented by Annie Lööf, Member of Parliament, Chairman of the Centre Party and former Minister of Economic Affairs, and Pontus Braunerhjelm, Professor of Economics at the Department of Industrial Economics and Organization at KTH Royal Institute of Technology. They give their views on the Swedish business climate in 2017 - the
- [Regulatory challenges with manufacturing and clinical development of biologics](https://swedenbio.se/kalendarium/regulatory-challenges-with-manufacturing-and-clinical-development-of-biologics/) - Axel Ståhlbom and Gustav Ahlin, consultants at Sofus and with extensive experience as assessors at the Swedish Medical Products Agency, will give an introduction to biologics and their equivalent to generics, biosimilars. In addition, Axel and Gustav will discuss scientific and regulatory challenges with the manufacturing and clinical development of biologics and biosimilars. Download the
- [Industrial Pharmaceutical Meeting 2017](https://swedenbio.se/kalendarium/industrial-pharmaceutical-meeting-2017/) - Program: 09:00 Coffee with sandwiches 09:30 Introduction 09:45 Counterfeit medicines - what weapons does the pharmaceutical industry have? Richard Bergström, External Pharma Lead, SICPA SA 10:45 Biological medicines - development and manufacturing Jonas Fransson, Director, Swedish Orphan Biovitrum AB 11:30 Pharmacy and prescription training - what is happening in Uppsala? Ingrid Nylander, Associate Dean, Professor
- [Mini-symposium on tumor microenvironment](https://swedenbio.se/kalendarium/mini-symposium-on-tumor-microenvironment/) - PROGRAM & SPEAKERS: Chaired by Katja Pokrovskaja Tamm and Angelo De Milito 09:00 - 09:10 Dan Grandér, Chair Dep. Oncology-Pathology, Karolinska Institutet Jessica Martinsson, Sprint Bioscience Welcome 09:10 - 09:30 Anders Lönnberg, Swedish Government National Coordinator for Life Science. 09:30 - 10:00 Ravi Amaravadi, University of Pennsylvania, PhiladelphiaTargeting the lysosome in the tumor microenvironment 10:00
- [Workshop on Photonics for Life Science and Regional Innovation Strategies](https://swedenbio.se/kalendarium/workshop-on-photonics-for-life-science-and-regional-innovation-strategies/) - The main themes of this workshop will be: How do Swedish companies active in the field of photonics manage to enter Life Science markets: Medical, Pharma, Agriculture and Food? How do regional innovation strategies support these companies and benefit from their growth? Preliminary program 10:00 Welcome and Introduction 10:10 The EU Project ÉPRISE (Pierre-Yves Fonjallaz,
- [Welcome to PCG Clinical Services Small Biotech Event](https://swedenbio.se/kalendarium/welcome-to-pcg-clinical-services-small-biotech-event/) - Join us for our free lunch & educational seminar where we are bringing together our experts in clinical drug development for a half day of learning. If you would like to learn more about how to navigate the transition from pre-clinical to clinical research & development, please register below. Reducing time to market and increasing
- [Medical Technology Days 2017](https://swedenbio.se/kalendarium/medical-technology-days-2017/) - Region Västmanland in collaboration with Mälardalen University has for the second time had the honor of hosting in Västerås. The 2017 MTD edition has the theme: the Multidisciplinary Conference. Over two days, the program will inspire you by offering interesting lectures, panel discussions, vendor and research presentations on medical technologies involving the multidisciplinary healthcare system
- [Symposium on Plasma Profiling](https://swedenbio.se/kalendarium/symposium-on-plasma-profiling/) - During the morning session, the different state-of-the-art capabilities of SciLifeLab facilities will be introduced. The afternoon session then provides examples of how these assays and different technologies have employed to advance research projects in plasma and across different disease areas. The symposium is intended for researchers with interest in plasma (body fluid) analysis, including clinical
- [Medicon Valley Alliance Annual Meeting 2017](https://swedenbio.se/kalendarium/medicon-valley-alliance-annual-meeting-2017/) - This year we focus on the parallel processes where Denmark and Sweden are developing their national life science strategies, and where we hope to see the unique bi-national Danish-Swedish perspective reflected in both national strategies. A perspective that will also be addressed in the presentation of "State of Medicon valley 2017 - an analysis of
- [French-Swedish Life Science Day 2017](https://swedenbio.se/kalendarium/french-swedish-life-science-day-2017/) - The conference will gather early stage and highly innovative medtech and biotech companies from Sweden, French and Swedish life science investors as well as executives from pharmaceutical companies. The goal of the conference is to create an arena for French and Swedish players to establish new contacts and to identify business opportunities. In order to
- [Medicon Valley Alliance Microbiome Summit 2014](https://swedenbio.se/kalendarium/medicon-valley-alliance-microbiome-summit-2014/) - It is the explicit ambition of Medicon Valley Alliance (MVA) to contribute to the realization and positioning of Medicon Valley as the most competitive and vital life science cluster in northern Europe. In line with this commitment, MVA, together with partners, are proud to invite you to Medicon Valley Alliance Microbiome Summit 2017! Here we
- [Biomarkers AGORA 2017](https://swedenbio.se/kalendarium/biomarkers-agora-2017/) - The common denominator is an interest in and activities within health care and life sciences with a focus on biomarkers, personalized medicine, drug development, information-communication-technology (ICT) and user involvement. The objective is to share knowledge, get inspired and potentially establish new relationships and collaborations between and with exhibitors and visitors. Please join and enjoy up
- [NOME Annual meeting](https://swedenbio.se/kalendarium/nome-annual-meeting/) - The concept is simple: We link the very best Biotech, Medtech and E-Health start-ups in the Nordics with some of the most successful and experienced investors, serial entrepreneurs and high profile life science executives to assist the next generation of innovators to flourish and succeed. Join the competition and get access to NOME Is your
- [Workshop on process development and production for ATMP](https://swedenbio.se/kalendarium/workshop-on-process-development-and-production-for-atmp/)
- [BioJapan](https://swedenbio.se/kalendarium/biojapan/) - Top business development, licensing, and alliance management professionals, R&D personnel, and biotech company executives from around the world will gather in Yokohama in October 2017 for the 19th iteration of BioJapan. Over 900 organizations from around 30 countries are expected to participate in the event, to hold an anticipated 8,000 business meetings over the course
- [Knowledge for growth](https://swedenbio.se/kalendarium/knowledge-for-growth/) - The conference features an exciting programme providing vital insight into the global life sciences' landscape, B2B Partneringpoweredby EBD Group's partneringLITE, a trade fair with 100 exhibitors and a scientific poster area.
- [The Nordic-American Life Science Conference](https://swedenbio.se/kalendarium/the-nordic-american-life-science-conference-2/) - The conference connects promising, innovative healthcare technology companies and Nordic Life Science organizations with investors, external innovation scouts and business developers in the U.S.. The Nordic-American Life Science Conference, organized by Business Sweden, DNB, NASDAQ and partners took place for the first time on November 30th - December1st in New York. The conference gathered Nordic
- [Translational Medicine 2017](https://swedenbio.se/kalendarium/translational-medicine-2017/) - The theme of this third edition will be "Enhancing Predictivity in Medicines Development" and will focus on bringing together the latest approaches to increase chances of success in drug development, from novel in vitro systems to new biomarkers or clinical trial methodology for patient selection and stratification. The conference will start on Sunday, September 24
- [Bacteria - Foe & Friend, KTH Life Science Technology Day 2017](https://swedenbio.se/kalendarium/bacteria-foe-friend-kth-life-science-technology-day-2017/) - The theme includes e.g. technologies for meeting challenges associated with antibiotic resistance, ranging from societal level to treatment of infections, as well as technologies for using bacteria for the benefit of mankind. The preliminary program has Christopher Voigt from MIT who will talk about his research on synthetic biology that combines engineering disciplines with life
- [Novel solutions in chronic wound healing](https://swedenbio.se/kalendarium/novel-solutions-in-chronic-wound-healing/) - The symposium is held in connection with Nordic Life Science Days 2017. We welcome participants to propose suggestions for the pitch session. If you wish to pitch an idea, indicate this when registering for the symposium.
- [Personalized medicine and biomarkers](https://swedenbio.se/kalendarium/personalized-medicine-and-biomarkers/) - Monday, September 11th, 9 am - 5 pm Morning Plenary sessions: Presentation of Eurostars and Eureka programs, as well as the H2020 Societal Challenge 1 Health, Demographic Change and Wellbeing, and Innovative Medicines Initiative (IMI) ; Presentation of French, Danish and Swedish clusters (MEDICEN, Biopeople and SwedenBIO). Pitch deck sessions. Networking lunch Afternoon Face-to-face discussions:
- [MYiHealth](https://swedenbio.se/kalendarium/myihealth/) - MYiHealth will address a number of the largest challenges facing today's healthcare community by taking the patient as its vantage point and focusing on outcomes that really matter to the patient. We will present and discuss the latest on how patient-centered ICT solutions can improve care and help organizations and industry to evolve. Day one
- [Bubble & Debate in Lund](https://swedenbio.se/kalendarium/bubble-debate-in-lund/) - What happens on the other side of the bridge? What can we learn from Danish leadership in life sciences? Come and mingle with life science professionals and listen to an intense debate: Moderator: Frida Lawenius Social Policy Director at Naturvetarna, Mats Persson, CEO, Hamlet Pharma AB, Ursula Hultkvist Bengtsson, CEO and founder, Multihelix AB and
- [Sofus Talks about eSubmission](https://swedenbio.se/kalendarium/sofus-talks-about-esubmission/) - In the coming years, there will be major changes in eSubmission that will affect practical regulatory work. Welcome to hear Sevim Hasözbek and Rolf Eriksson from Sofus Head Office Regulatory Affairs present news in the field. Among the issues addressed are: What are EMA and ICH doing in eSubmissions? When will the eCTD be mandatory
- [Exit strategies for pharmaceutical projects](https://swedenbio.se/kalendarium/exit-strategies-for-pharmaceutical-projects/) - What factors are important from a taker's perspective? The seminar is aimed at people in decision-making positions at all levels of the small pharmaceutical company. The focus is on CMC, preclinical, clinical, regulatory strategies and IP. The aim is to shed light on the issue from several angles. Organizer: Scandinavian Development Services
- [Statistics in clinical trials - Design and decision support](https://swedenbio.se/kalendarium/statistics-in-clinical-trials-design-and-decision-support/) - The target audience is medical advisors, clinical trial managers, statisticians and those responsible for regulatory affairs. Some sessions will be of a more technical nature, targeting statisticians, but the main points will be summarized also for non-statisticians. Keynote speaker: Kevin J Carroll. Organizer: Scandinavian Development Services
- [Park Annual](https://swedenbio.se/kalendarium/park-annual-2/) - For the 12th year in a row Sahlgrenska Science Park proudly present the innovation event of the year - accelerating Life Science Business. Park Annual gathers 500 entrepreneurs, scientists, innovators, companies and investors in the heart of Gothenburg. Join a full day event with seminars, one-to-one meetings, exhibition and lots of networking opportunities. With an
- [Theme day in environmental chemistry](https://swedenbio.se/kalendarium/theme-day-in-environmental-chemistry/) - There is no doubt that medicines are important for health and well-being in our daily lives, but can residues of the medicines we consume cause damage to the environment? What do we know about the problem today? What are the developments? What new solutions are available? Theme Day in Environmental Chemistry is an annual event
- [SciLifeLab Science Summit 2017](https://swedenbio.se/kalendarium/scilifelab-science-summit-2017/) - Focusing broadly on bioimaging, including super-resolution microscopy as well as cryo-electron microscopy and how these technologies are used for example to study neurobiology on a molecular level, plant differentiation processes or bacterial biofilm formation. This one-day conference offers oral presentations as well as opportunities for interaction and conversation. In addition, we will repeat the successful
- [Information days on new medical device legislation](https://swedenbio.se/kalendarium/information-days-on-new-medical-device-legislation/) - Due to two new regulations for medical devices that are expected to enter into force in the second quarter of 2017, two information days for economic operators are planned: On 31 May , an information day on the "Medical Devices Regulation" (MDR) is organized for manufacturers, authorized representatives, importers and distributors of medical devices. The
- [Information days on new medical device legislation](https://swedenbio.se/kalendarium/information-days-on-new-medical-device-legislation-2/) - Due to two new regulations for medical devices that are expected to enter into force in the second quarter of 2017, two information days for economic operators are planned: On 31 May , an information day on the "Medical Devices Regulation" (MDR) is organized for manufacturers, authorized representatives, importers and distributors of medical devices. On
- [Big&Small Life Science MeetUp](https://swedenbio.se/kalendarium/bigsmall-life-science-meetup/) - Everyone is welcome; from high-potential start-ups to the great established actors that form the Uppsala life-science cluster of today. Join for the first MeetUp on the evening of May4th at the new tech start-up & entrepreneur co-working center Base10. During this evening, you will be presented several "Show-and-Tell's" to inspire and update you on what
- [Digital Health World Congress 2017](https://swedenbio.se/kalendarium/digital-health-world-congress-2017/) - Digital Health World Congress 2017 covers all aspects of medical and mobile technology including ehealth, mhealth, telehealth, telemedicine, genomics and healthcare IT. This years keynotes and speakers include IBM, NHS, ARM, Roche, Orange, Accenture and many more.
- [Webinar on clinical trials for Horizon 2020 projects](https://swedenbio.se/kalendarium/webinar-on-clinical-trials-for-horizon-2020-projects/) - This webinar is targeted in particular to SMEs and research institutes interested in submitting proposals that include clinical trials and who precisely want to follow the directions of Horizon 2020 on this critical issue. Dr. Birte Kretschmer from EURICE will give an overview on the aspects to be considered during proposal planning (e.g. consortium composition,
- [International Training: Exploitation of EU Project Results with a Focus on IP in the Field of Health and Biotechnology](https://swedenbio.se/kalendarium/international-training-exploitation-of-eu-project-results-with-a-focus-on-ip-in-the-field-of-health-and-biotechnology/) - The strategic use and management of Intellectual Property (IP) - in business as well as in international research initiatives - is essential for strengthening the European scientific and technological base, boosting innovation and ensuring growth in the EU. In this context the current EU Framework Programme for Research and Innovation, Horizon 2020, places even more
- [REGMED EUROPE - Paris 2017](https://swedenbio.se/kalendarium/regmed-europe-paris-2017/) - Following the dynamics of BIOREGATE 2016 in Nantes, Medicen Paris Region organizes together with its partners a dedicated one day matchmaking event in the field of regenerative medicine. Why participate? Get information about the ongoing regenerative medicine challenges and topics Learn about the major European ecosystems Get the chance to present your innovative projects Meet
- [World Vaccine Congress Europe](https://swedenbio.se/kalendarium/world-vaccine-congress-europe/) - The 18th annual World Vaccine Congress is the place where the global vaccine industry meet to discuss commercial and scientific issues around regulation, strategy, manufacturing and clinical trials, as well as respiratory, immunotherapy, and emerging diseases. The conference will also be co-located with the 3rd World Veterinary Vaccines Congress and 2nd Immune Profiling World Congress
- [Advances in Cell Based Screening 2017](https://swedenbio.se/kalendarium/advances-in-cell-based-screening-2017/) - The program for this ELRIG meeting has been developed to expand scientific horizons in key topic areas such as advanced cell models, applied omics, assays/methods exploring mode of action, phenotypic screening, target deconvolution, and much more. Speakers from leading laboratories, both academic and industrial, will present and discuss the latest updates and advances in cellular
- [World CDx Europe 2017](https://swedenbio.se/kalendarium/world-cdx-europe-2017/) - World CDx Europe, now in its 7th year, is the comprehensive, end-to-end event for next generation biomarker discovery, targeted drug and diagnostic development. World CDx Europe is dedicated to laying the roadmap to help you rapidly progress from exploratory biomarker to safe, effective and commercially successful precision medicine-CDx combinations To do this they bring together
- [Sciety's and Nordnet's investment evening in e-health and medicine](https://swedenbio.se/kalendarium/scietys-and-nordnets-investment-evening-in-e-health-and-medicine/) - Listen to the companies shaping the future of healthcare and medicine! - Multi-award winning 1928 Diagnostics is revolutionizing the treatment of infections and fighting the global threat of resistant bacteria. Their solution is used in three hospitals in Sweden and agreements have been signed with, among others, a major public health authority in Europe. -
- [How many Swedes create innovations?](https://swedenbio.se/kalendarium/how-many-swedes-create-innovations/) - As part of this international research network, Professor Lars Bengtsson, Lund University of Technology, has studied the frequency of user innovation and its impact on the Swedish economy. Lars will give examples of some of these innovations and explain the challenges for society to make the most of these innovation activities. Vinnova has invited Dr.
- [Nordic Precision Medicine Forum 2017](https://swedenbio.se/kalendarium/nordic-precision-medicine-forum-2017/) - The Nordic Countries represent a unique opportunity when it comes to healthcare; boasting a wealth of data, some of the most advanced HealthTech, and being host to world leading biotech and pharma companies and universities. As such it is little surprise that the precision medicine revolution is creating such a buzz; disruptive technology, a strong
- [Webinar 90: Space Industry Business Opportunities in Japan](https://swedenbio.se/kalendarium/webinar-90-space-industry-business-opportunities-in-japan/) - This project was conducted as part of the MINERVA research fellowship, and the final report provides a comprehensive overview of the Japan Space policy and industry, with a focus on Earth Observation (EO), including a SWOT analysis of the Japanese EO industry. It's the first report of its kind dedicated to the commercial EO data
- [Introduction to Regulatory Affairs in drug development - for life science researchers](https://swedenbio.se/kalendarium/introduction-to-regulatory-affairs-in-drug-development-for-life-science-researchers/) - When developing new medicines, the key to success is to ensure compliance with the regulatory and official requirements at all stages of the research and development process. Getting it right from the start saves time and money and is often the difference between success and failure. Target audience: The training day is primarily aimed at
- [The search for a cure for Alzheimer's disease](https://swedenbio.se/kalendarium/the-search-for-a-cure-for-alzheimers-disease/) - More than 100 000 people in Sweden are living with a diagnosis of Alzheimer's disease. There are currently no drugs that can slow down the progression of the disease. However, a lot of research is ongoing and despite major challenges and setbacks, the hope is that we are getting closer to a more effective treatment.
- [AstraZeneca Exchange 2017](https://swedenbio.se/kalendarium/astrazeneca-exchange-2017/) - AstraZeneca Exchange Gothenburg is a full day event bringing together senior representatives from across the Life Science sector in the Nordic region, covering industry, biotech, academia, Government and the public sector. It will be a day focused on knowledge sharing and networking to nurture the growing Nordic Life Science ecosystem. Building on the successful AstraZeneca
- [Half-day meeting: The new health care market](https://swedenbio.se/kalendarium/half-day-meeting-the-new-health-care-market/) - On the agenda: Henrik Ahlén, Catalyst for Digital Business Development - The new healthcare, is it becoming personal, digital and global? Tove Lindahl Greve, Ambassador of the Young Cancer Patient Association - What new solutions do the patients of the future expect? Thomas Hagbard, idea pilot for increased innovation capacity - How do you go
- [Pharmaceutical Congress 2017](https://swedenbio.se/kalendarium/pharmaceutical-congress-2017/) - The Pharmaceutical Congress is for those who work in pharmacy, the pharmaceutical industry, government, healthcare or academia and offers you..: Skills development and up-to-date knowledge Debate and discussion on key topics A meeting place for professional networking Whether you work in pharmacy, the pharmaceutical industry, government, healthcare or academia, the annual Pharmaceutical Congress offers skills
- [SwedenBIO Summit 2017](https://swedenbio.se/kalendarium/swedenbio-summit-2017/) - Recharge your batteries by listening to inspiring tips from governance experts. The board has an important function but does not always play the role needed to maximize company performance, and as companies evolve, new demands are placed on the board. At the SwedenBIO Summit 2017, we will explore different aspects of the role of the
- [vc2vc](https://swedenbio.se/kalendarium/vc2vc/) - A meeting, which we call vc2vc will connect Nordic VC with foreign VC in the area of Life Science. In this meeting there will be no biotech companies present, only VCs. The meeting will contain partnering and a few presentations. It will run from lunch to lunch in March 8-9, 2017 in Stockholm. The goal
- [SwedenBIO's early summer dinner](https://swedenbio.se/kalendarium/swedenbios-early-summer-dinner/) - Read more and register here.
- [Karolinska Institutet node in Hong Kong, a springboard to Asia](https://swedenbio.se/kalendarium/karolinska-institutet-node-in-hong-kong-a-springboard-to-asia/) - Join our seminar to learn about the exciting opportunities to grow and scale a profitable business in Asia leveraging on Karolinska Institutet's Ming Wai Lau Centre for Reparative Medicine in Hong Kong. The successful set up of the centre at the Hong Kong Science Park (HKSP) is a strong commitment, and demonstration of Sweden's determination
- [Drug Targeting - Pharmacokinetic, pharmacodynamic and safety aspects](https://swedenbio.se/kalendarium/drug-targeting-pharmacokinetic-pharmacodynamic-and-safety-aspects/) - Drug Targeting is a collation of methods to actively increase concentration of drug to cells and tissues of interest. Drug targeting can be achieved using various approaches, such as drug formulations or conjugating the active drug to a targeting ligand. These approaches can improve the therapeutic window for drugs by decreasing drug exposure to nontarget
- [New Updates in Drug Formulation and Bioavaibility](https://swedenbio.se/kalendarium/new-updates-in-drug-formulation-and-bioavaibility/) - Pharmaceutical formulation can have a huge impact on the bioavailability of a given drug and is one of the key factors in the successful development of drug delivery systems. However, many of the drugs in the development pipelines often possess poor physico-chemical properties, which make them difficult to formulate using classic approaches and hence require
- [ADME After Work: CYP inhibition with human hepatocytes](https://swedenbio.se/kalendarium/adme-after-work-cyp-inhibition-with-human-hepatocytes/) - Admescope will organise scientific evening presentation at Finnish Embassy of Stockholm on February 16th 2017. Dr Aki Heikkinen, Senior Scientist Drug-Drug Interactions and PBPK, will give a presentation "CYP inhibition with human hepatocytes". What: At the event you will learn the latest research on CYP inhibition - how to improve in vivo relevance of in
- [Information days on new medical device legislation](https://swedenbio.se/kalendarium/information-days-on-new-medical-device-legislation-3/) - Due to two new regulations for medical devices that are expected to enter into force in the second quarter of 2017, two information days for economic operators are planned: On 31 May , an information day on the "Medical Devices Regulation" (MDR) is organized for manufacturers, authorized representatives, importers and distributors of medical devices. The
- [Information days on new medical device legislation](https://swedenbio.se/kalendarium/information-days-on-new-medical-device-legislation-4/) - Due to two new regulations for medical devices that are expected to enter into force in the second quarter of 2017, two information days for economic operators are planned: On 31 May , an information day on the "Medical Devices Regulation" (MDR) is organized for manufacturers, authorized representatives, importers and distributors of medical devices. The
- [Nordic Conference on Pragmatic Clinical Studies](https://swedenbio.se/kalendarium/nordic-conference-on-pragmatic-clinical-studies/) - Too many decisions about health and healthcare are still not supported by high quality evidence. Prospectively designed registries, cohort studies and randomized clinical trials conducted in the context of clinical practice - pragmatic clinical trials - may be highly valuable as source of knowledge in the future. The purpose of this conference is to evaluate
- [Breakfast seminar on Integrated Fundraising.](https://swedenbio.se/kalendarium/breakfast-seminar-on-integrated-fundraising/) - Most young companies are often short of both money and staff and are often forced to work reactively rather than strategically and proactively. This is not entirely reversible but there are a number of things you can do to improve the situation and prevent it from happening in the first place. Hedvig Andersén will hold
- [Drug development course](https://swedenbio.se/kalendarium/drug-development-course-2/) - The course is organized by SwedenBIO and Läkemedelsakademin, part of Apotekarsocieteten. Target audience: The course is aimed at those who work in drug development (e.g. in small and medium-sized enterprises), and feel that they want a comprehensive view of the complex development chain. During the course you will gain insight into how to work in
- [The World Congress on Regulatory Affairs for Medical Devices (RAMD2017)](https://swedenbio.se/kalendarium/the-world-congress-on-regulatory-affairs-for-medical-devices-ramd2017/) - Participants of the congress will have the opportunity to schedule personal One on One meetings with the faculty and gain first-hand knowledge from key opinion leaders. Target audience: Personal R&D CEOs Regulatory Affairs Managers Medical Device Specialists CROs CRAs Staff QA Business Development Managers The official language of the Congress is English.
- [Seminar on Intellectual Property, Innovation and Growth](https://swedenbio.se/kalendarium/seminar-on-intellectual-property-innovation-and-growth/) - Together with Vinnova, PRV is supporting, within the framework of a government assignment, research projects that investigate the links between intellectual property and company competitiveness. The research projects are funded through Vinnova's call "The link between intangible assets and competitiveness - business strategies in the age of digitalization". The seminar presents the funded research projects
- [Vinnova Innovation Day](https://swedenbio.se/kalendarium/vinnova-innovation-day/) - Last year, the government launched five strategic collaboration programs to meet societal challenges and strengthen Sweden's competitiveness. Vinnova's Innovation Day will discuss what the programs may mean in practice. Participants include State Secretary Niklas Johansson, the government's national coordinator for life science Anders Lönnberg, Professor of Environmental Science Johan Rockström, Ericsson's Head of Research Sara
- [BioTrinity 2017](https://swedenbio.se/kalendarium/biotrinity-2017/) - Now in it's 11th year, the aim of BioTrinity is simple - create an ideal networking and partnering platform for life science companies across the world to meet all under one roof and catalyse business in the industry, to ultimately help shape our healthcare future. BioTrinity offers unique access to global life science investors, big
- [BioFIT 2017](https://swedenbio.se/kalendarium/biofit-2017/) - With the highest attending rate of academics, TTOs and research institutes, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with
- [National Conference on Clinical Studies](https://swedenbio.se/kalendarium/national-conference-on-clinical-studies/) - This year's theme is "The future of clinical studies" and the program will be filled with interesting speakers from academia, healthcare and industry who will present and discuss the theme from different perspectives, such as: - Clinical researchers of the future - The research patient of the future - Future research methods - Future therapeutic
- [EUSME Support Office Writing workshop](https://swedenbio.se/kalendarium/eusme-support-office-writing-workshop/) - Through the SME Instrument, small and medium-sized enterprises can receive innovation support from the EU. On 31 January, the EUSME Support Office is organizing a half-day free writing workshop for those who are familiar with SME Instruments and have decided to apply for the spring SME Instruments calls. The writing workshop is aimed at SMEs
- [Pharmaceutical Industry Day 2017](https://swedenbio.se/kalendarium/pharmaceutical-industry-day-2017/) - Läkemedelsriksdagen is an annual event since 2007 on the initiative of the Swedish Agency for Health and Social Evaluation (SBU), the Swedish Medical Products Agency, the National Board of Health and Welfare and the Dental and Pharmaceutical Benefits Agency (TLV). The authorities have created a forum for discussion and debate with key stakeholders in the
- [MEDINISRAEL](https://swedenbio.se/kalendarium/medinisrael/) - MedinIsrael 2017 is the 4th Medical Devices and Hit International Conference and Exhibition. The event is expecting to have 2000 attendees with over 300 Israeli companies and 800 international business partners. During the event, there will be 120 Start-ups exhibition, 40 speakers and over 1600 business meetings. On March 6 (18:00-21:30), there will be a
- [The Future of Swedish & Danish Life Science](https://swedenbio.se/kalendarium/the-future-of-swedish-danish-life-science-5/) - In the past 10-15 years, Medicon Valley has grown to be the strongest Nordic life science cluster due to a thriving life science industry and strong collaboration between Sweden and Denmark. There have been many success stories that have put Medicon Valley on the international map with four big pharmaceutical companies Novo Nordisk, H. Lundbeck,
- [Breakfast seminar: Nanomedicine](https://swedenbio.se/kalendarium/breakfast-seminar-nanomedicine/) - The seminar will start with a key note presentation on Future potential of nanomedicine in the Life Science sector. It will continue with presentations on European initiatives to help accelerate translation of nanomedicine from research to market. Then there will be a PITCH session where nanomedicine project presentation will take place. The seminar will end
- [Swiss Nordic Bio 2017](https://swedenbio.se/kalendarium/swiss-nordic-bio-2017/) - Swiss Nordic Bio carries the tradition of 10 years of Swiss Scandinavian Bio-Business Seminar (SSBBS). The event will host high ratio of investors and pharma to biotech companies. More than 20 investors and more than 10 scouting/business development executives from pharma/diagnostics companies are expected. This will be an exclusive event with maximum 200 participant in
- [Increase your chances of funding through the SME Instrument](https://swedenbio.se/kalendarium/increase-your-chances-of-funding-through-the-sme-instrument/) - Increased chances of funding The focus of the writing workshop is on putting your innovation idea in context and ensuring that you communicate your entire idea as optimally as possible. We will describe the entire application process, from idea to final application, as a good and well-written application increases the chance of funding. At the
- [Pharmaceutical Sciences World Congress (PSWC)](https://swedenbio.se/kalendarium/pharmaceutical-sciences-world-congress-pswc/) - This will revolutionize medicines research, leading to the intro- duction of novel therapeutic interventions which modify and, it is hoped, cure the disease, rather than providing symptom relief. At the same time, health systems around the globe are exploring new ways to deliver innovative treatment solutions to patients in a sustainable manner. PSWC 2017 will
- [Welcome to the announcement of The Scheele Award 2017 January 19](https://swedenbio.se/kalendarium/welcome-to-the-announcement-of-the-scheele-award-2017-january-19/) - - The Scheele Prize is unique in that it is awarded to many different disciplines, with medicine being the common denominator. Previous laureates range from those involved in pure basic research to those working on antibiotic resistance and societal aspects of drug use. It also reflects Apotekarsocietens focus on working for a favorable development and
- [3rd conference of the International Rare Diseases Research Consortium (IRDiRC)](https://swedenbio.se/kalendarium/3rd-conference-of-the-international-rare-diseases-research-consortium-irdirc/) - Five years have passed since the initial launch of IRDiRC in 2011 and considerable advances have been made in rare diseases research. IRDiRC 2017 conference presents a unique opportunity to reflect upon this progress, confront barriers, and together, form new collaborations to take on challenges posed by rare diseases. Past conferences were held in Dublin,
- [BioLatam 2017](https://swedenbio.se/kalendarium/biolatam-2017/)
- [BIO-Europe 2017](https://swedenbio.se/kalendarium/bio-europe-2017/) - BIO-Europe offers powerful opportunities to network with the right partners and bring together hundreds of the world's most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled partnering meetings, strategic panel discussions and more. The event will be organized by EBD Group. **SwedenBIOmembers will have a €200 discount on this event! Please contact
- [BioPharm America 2017](https://swedenbio.se/kalendarium/biopharm-america-2017/) - BioPharm America offers powerful opportunities to network with the right partners and bring together hundreds of the world's most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled partnering meetings, strategic panel discussions and more. The event will be organized by EBD Group. **SwedenBIOmembers will have a $200 discount on this event! Please
- [ChinaBio® Partnering Forum 2017](https://swedenbio.se/kalendarium/chinabio-partnering-forum-2017/) - This 9th annual international partnering conference is co-produced by EBD Group and ChinaBio®. It is expected to have above 900 attendees of which 69% from China; and above 460 companies to attend. The event provides the environment to engage with global life science partners via one-to-one meetings, company presentations, workshops and panels by bio-tech &
- [BIO-Europe Spring® 2017](https://swedenbio.se/kalendarium/bio-europe-spring-2017/) - The 11th annual BIOEurope Spring® conference is the premier springtime partnering conference for the biotechnology industry. For its 2017 edition, BIOEurope Spring comes to Barcelona, Spain on March 2017. BIOEurope Spring ® is the springtime counterpart to EBD Group's flagship conference, BIOEurope ® , and continues the tradition of providing life science companies with high
- [The right focus in board work SME](https://swedenbio.se/kalendarium/the-right-focus-in-board-work-sme-8/) - Time of the event The training is divided into 2 sessions, Friday June 2, 2017 at 8:30 - 17:00 Friday June 9, 2017 at 8:30 - 17:00 Information We want you to increase your knowledge of corporate governance and board work. To make them both broader and deeper. We want to equip you to become
- [The right focus in board work SME - INTERNAT](https://swedenbio.se/kalendarium/the-right-focus-in-board-work-sme-internat-2/) - Time of the event The training is divided into 2 sessions, Sunday May 21, 2017 10:00 - 18:00 Monday May 22, 2017 8:00 - 17:00 Information We want you to increase your knowledge of corporate governance and board work. To make them both broader and deeper. We want to equip you to become a more
- [The right focus in board work SME](https://swedenbio.se/kalendarium/the-right-focus-in-board-work-sme-6/) - Time of the event The training is divided into 4 sessions, Monday 22 May 2017 at 8:00 - 12:00 Monday 29 May 2017 at 8:00 - 12:00 Monday 5 June 2017 at 8:00 - 12:00 Monday 12 June 2017 at 8:00 - 12:00 Information We want you to increase your knowledge of corporate governance and
- [The right focus in board work for municipally owned companies](https://swedenbio.se/kalendarium/the-right-focus-in-board-work-for-municipally-owned-companies/) - Time of the event The training is divided into 2 sessions, Monday 8 May 2017 at 08:30 - 17:00 Monday 15 May 2017 at 08:30 - 17:00 Information Good governance makes a difference Never before has there been more interest in governance issues than now. We believe it is a matter of increased awareness that
- [The right focus in board work SME](https://swedenbio.se/kalendarium/the-right-focus-in-board-work-sme-2/) - Time of the event The training is divided into 4 sessions, Friday 28 April 2017 at 8:00 - 12:00 Friday 5 May 2017 at 8:00 - 12:00 Friday 12 May 2017 at 8:00 - 12:00 Friday 19 May 2017 at 8:00 - 12:00 Information We want you to increase your knowledge of corporate governance and
- [The right focus in board work for listed companies](https://swedenbio.se/kalendarium/the-right-focus-in-board-work-for-listed-companies/) - Time of the event The training is divided into 3 sessions, Thursday, April 6, 2017 at 10:00 am. 8:30 - 17:00 Friday, April 7, 2017 at 8:30 am. 8:30 - 17:00 Friday, April 21, 2016 at 8:30 am. 8:30 - 17:00 Information In addition to the four parts of the Right Focus in Board Work
- [The right focus in board work SME - INTERNAT](https://swedenbio.se/kalendarium/the-right-focus-in-board-work-sme-internat/) - Time of the event The training is divided into 2 sessions, Sunday 19 March 2017 at 10:00 - 18:00 Monday 20 March 2017 at 8:00 - 17:00 Information We want you to increase your knowledge of corporate governance and board work. To make them both broader and deeper. We want to equip you to become
- [The right focus in board work SME](https://swedenbio.se/kalendarium/the-right-focus-in-board-work-sme-5/) - Time of the event The training is divided into 2 sessions, Monday 20 March 2017 at 8:30 - 17:00 Monday 27 March 2017 at 8:30 - 17:00 Information We want you to increase your knowledge of corporate governance and board work. To make them both broader and deeper. We want to equip you to become
- [The right focus in board work SME](https://swedenbio.se/kalendarium/the-right-focus-in-board-work-sme-4/) - Time of the event The training is divided into 4 sessions, Friday March 10, 2017 at 8:00 - 12:00 Friday March 17, 2017 at 8:00 - 12:00 Friday March 24, 2017 at 8:00 - 12:00 Friday March 31, 2017 at 8:00 - 12:00 Information We want you to increase your knowledge of corporate governance and
- [The right focus in board work SME](https://swedenbio.se/kalendarium/the-right-focus-in-board-work-sme-7/) - Time of the event The training is divided into 2 sessions, Friday, January 27, 2017 at 8:30 - 17:00 Friday, February 3, 2017 at 8:30 - 17:00. Information We want you to increase your knowledge of corporate governance and board work. To make them both broader and deeper. We want to equip you to become
- [Biotech Showcase™ 2017](https://swedenbio.se/kalendarium/biotech-showcase-2017/) - Biotech Showcase™ is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world. The 2016 event showed
- [The right focus in board work SME](https://swedenbio.se/kalendarium/the-right-focus-in-board-work-sme-3/) - Time of the event The training is divided into 4 sessions, Monday, January 16, 2017 at 8:00 - 12:00 Monday, January 23, 2017 at 8:00 - 12:00 Monday, January 30, 2017 at 8:00 - 12:00 Monday, February 6, 2017 at 8:00 - 12:00. 8:00 - 12:00 Information We want you to increase your knowledge of
- [What role does the NKS project play for future research breakthroughs and the development of Swedish life science?](https://swedenbio.se/kalendarium/what-role-does-the-nks-project-play-for-future-research-breakthroughs-and-the-development-of-swedish-life-science-2/) - Agenda items and contributors: Increased collaboration between academia, healthcare and industry. Peter Carpelan, Research Councilor, Stockholm County Council. The vision for the county, research, education and life science throughout Stockholm County. Jan Andersson, Director of Research and Innovation, Stockholm County Council. Theimportance of New Karolinska Solna in a vibrant life science cluster. Ylva Williams, CEO,
- [Taking life science to the stock market. - The if, The why, The how.](https://swedenbio.se/kalendarium/taking-life-science-to-the-stock-market-the-if-the-why-the-how/) - This is part one of a two-part collaboration hosted by Nasdaq, AstraZeneca BioVentureHub and Sahlgrenska Science Park. Part two will take place at Sahlgrenska Science Park later in the spring 2017. Who should attend? This event is intended for anyone interested in biotech and life science company funding. An open session featuring presentations and a
- [PERMIDES EU Workshop](https://swedenbio.se/kalendarium/permides-eu-workshop/) - The workshop starts with an introduction to PERMIDES, the innovation challenges to be addressed with this project and short presentations to inspire the subsequent workshop part. Why join? You can benefit from innovation vouchers of up to EUR 60.000 to develop and implement novel IT based solutions for biopharmaceutical R&D challenges. By sharing your
- [What role does the NKS project play for future research breakthroughs and the development of Swedish life science?](https://swedenbio.se/kalendarium/what-role-does-the-nks-project-play-for-future-research-breakthroughs-and-the-development-of-swedish-life-science/) - The New Karolinska Solna project results in Karolinska University Hospital getting completely new buildings in Solna. The newly built university hospital will be located in the middle of a unique life science cluster where innovation is flourishing. How important is the New Karolinska Solna project for future research breakthroughs and innovations? And for the development
- [Food Venture and Partnering Days](https://swedenbio.se/kalendarium/food-venture-and-partnering-days/) - We invite start-ups, industry, retail and relevant investors to network for business and collaboration opportunities. Participants of the day will access: - Collaboration and development partners - Investment and business opportunities - One2One meetings with specific entrepreneurs, industry and investors - The innovation elite of the food sector to shape the future of the industry
- [Welcome to the meeting on the Innovative Medicines Initiative (IMI)](https://swedenbio.se/kalendarium/welcome-to-the-meeting-on-the-innovative-medicines-initiative-imi/) - IMI is a partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The aim is to support the discovery and development of new, better medicines for patients and to increase Europe's competitiveness in pharmaceutical research and development. It is a unique opportunity to learn more about IMI, one of
- [Connect2capital](https://swedenbio.se/kalendarium/connect2capital-2/) - Connect2Capital is one of Sweden and the Nordics fastest growing events where investors and entrepreneurs go to meet, network, get inspired and do business. Located right in the middle of entrepreneurial hubs Oslo and Copenhagen, Gothenburg is the perfect spot to converge upon for two eventful days filled of great opportunities. Connect2Capital is at its
- [After Work: How the SME can work strategically with recruitment issues](https://swedenbio.se/kalendarium/after-work-how-the-sme-can-work-strategically-with-recruitment-issues/) - Adecco Life Science, the recruitment and staffing company, and XPE, a staffing company niched towards recruitment in life science and pharma, present international trends in skills provision and recruitment strategies. Starting next year, Adecco Life Science will employ a new recruitment model with a more international focus already in use in Belgium (the home of
- [After Work: Life Science and supply of competence - present situation and future perspectives.](https://swedenbio.se/kalendarium/after-work-life-science-and-supply-of-competence-present-situation-and-future-perspectives/) - This after work will offer new and exciting information as well as an opportunity to discuss both during the seminar and the following mingle. Mercuri Urval, established in Sweden in 1967, is a leading HR Consultancy with 800 employees in 24 countries worldwide. Mercuri Urval is working with over 3000 clients in more than 50
- [H2020 European Health Brokerage Event](https://swedenbio.se/kalendarium/h2020-european-health-brokerage-event/) - Get involved in the next H2020 Health proposals! This international brokerage event will help you to build up your proposal for final calls of the 2016 -2017 Health work program, which will still be open in 2017. Why participate? Get all information needed on the upcoming Horizon 2020 calls " Health, " Health, Demographic change
- [Writing workshop on SME instruments funding from Horizon 2020](https://swedenbio.se/kalendarium/writing-workshop-on-sme-instruments-funding-from-horizon-2020/) - On 29 November, the EU SME Support Office (in collaboration with Swerea and SwedenBIO) is organizing a half-day free workshop aimed at SMEs that are in the process of moving from idea to application. - The focus of the writing workshop is on putting the innovation idea in context and making sure you communicate your
- [Arab Health 2017](https://swedenbio.se/kalendarium/arab-health-2017/) - The Arab Health Exhibition & Congress is the largest healthcare exhibition & medical congress in the Middle East. Second largest in the world. It will host 4,400 of the world's leading healthcare companies coming in from 70 countries. During the event participants will have the chance to discover the latest healthcare products and services from
- ['Knowledge for Growth' Conference](https://swedenbio.se/kalendarium/knowledge-for-growth-conference/) - Knowledgefor Growth' will provide a vital insight into the global life sciences' landscape. The conference is expecting more than 1,200 high-level life sciences actors from over 470 companies and organizations. Program will include five high-level plenary talks - focusing on the impact of large data generation on R&D and business in life sciences- , 30+
- [More vitality for life sciences](https://swedenbio.se/kalendarium/more-vitality-for-life-sciences/) - You will also meet some of the most exciting life science companies in Sweden and the world. Do they have the answer to how we can better use Sweden's good conditions with cost-effective and medically advanced healthcare, a strong ecosystem of databases, registers and biobanks and a good tradition of collaboration? Which health challenges will
- [MedTech and innovation - creating value](https://swedenbio.se/kalendarium/medtech-and-innovation-creating-value/) - The MedTech sector is the technology area with the highest number of patent applications filed at the European Patent Office. Therefore, PRV and VINNOVA want to raise a number of issues, including: How does MedTech differ from other sectors? What business models exist? What should be considered? Joining us at the seminar on November 11
- [Seminar - Presentation of the SBU NLS mission](https://swedenbio.se/kalendarium/seminar-presentation-of-the-sbu-nls-mission/) - In 2016, SBU carried out the activity Evaluation of treatment effect in everyday clinical practice within the national pharmaceutical strategy (NLS). The aim of the project is to improve the transferability of data from randomized clinical trials (RCTs) to the monitoring of drug treatment effects in everyday clinical practice and will contribute to better assessments
- [Bubble & Debate in Umeå](https://swedenbio.se/kalendarium/bubble-debate-in-umea-2/) - Sweden is investing nationally in life sciences. What is being done in Region Västerbotten? When? Thursday 24 November. The debate starts at 16.30, the mingle starts at 17.30. Where? Triple Helix in Samverkanshuset, Universitetstorget 4, Umeå University. Bubbel & Debatt Umeå is organized annually by Apotekarsocieteten, Kemivärlden Biotech, Naturvetarna, SwedenBIO, Sveriges Farmaceuter together with Biotech
- [Vitalis 2017](https://swedenbio.se/kalendarium/vitalis-2017/) - The Vitalis conference offers training and insight into the field of eHealth. The seminars range from general government information to in-depth discussions and examples of implementations. The seminars also provide tools that are important for those working on eHealth issues, whether you work with patients or are a decision-maker or politician.
- [Invitation to Seminar on Effective Care](https://swedenbio.se/kalendarium/invitation-to-seminar-on-effective-care/) - For many years, Swedish healthcare has performed well in international comparisons, particularly in terms of the quality of medical care. Recent OECD studies give the Swedish healthcare system high marks for e.g. survival in cancer, but also in terms of surgical complications. However, there are quality deficiencies in other respects, such as long waiting times
- [Prepare your exports - practical guidance A full-day training course with Business Sweden](https://swedenbio.se/kalendarium/prepare-your-exports-practical-guidance-a-full-day-training-course-with-business-sweden/) - In order to succeed in an export deal, it is important to understand the technicalities of exporting in advance. Throughout the supply chain, from preparing the offer to securing final payment, questions arise about financing options, product customization, export and import procedures, document management and delivery conditions. Target group: The course is aimed at
- [Seminar on Gothenburg's entrepreneurial ecosystem](https://swedenbio.se/kalendarium/seminar-on-gothenburgs-entrepreneurial-ecosystem/) - Maureen McKelvey and Olof Zaring, both at the Institute for Innovation and Entrepreneurship (IIE), School of Business, Economics and Law at the University of Gothenburg, will present their new book Sweden's Entrepreneurial Ecosystem. This will be followed by presentations and discussions on Gothenburg's entrepreneurial ecosystem. The focus is on questions about Gothenburg as a geographical
- [What is going on? Customer-smart innovation ideas based on needs - here's how it works](https://swedenbio.se/kalendarium/what-is-going-on-customer-smart-innovation-ideas-based-on-needs-heres-how-it-works/) - When a life science company wants to enter the healthcare sector to demonstrate or test a new product or service, the requirement is that the solution meets a real customer need. The requirement of matching to needs applies in the same way in innovation procurement. In Catalyser, Sahlgrenska Science Park has identified competence in verifying
- [Breakfast meeting - Sustainable recruitment](https://swedenbio.se/kalendarium/breakfast-meeting-sustainable-recruitment/) - RECRUIT SUSTAINABLY! It is easy to take shortcuts when recruiting managers. You take someone who appears in your vicinity, you rush to fill a gap quickly, you overlook cultural differences and the team you have to lead. This morning, we will look at how to think correctly in your recruitment process and how to take
- [Plastic medical devices - a guided tour from idea to product launch](https://swedenbio.se/kalendarium/plastic-medical-devices-a-guided-tour-from-idea-to-product-launch/) - This seminar aims to give you advice on how to create a successful project, based on the speakers' extensive experience in practical projects. There is also an opportunity for discussion and questions afterwards.
- [Regulatory Networking and MPA update](https://swedenbio.se/kalendarium/regulatory-networking-and-mpa-update/) - The meeting provides the perfect opportunity to network with colleagues in Sweden from the regulatory environment in a relaxed and sociable setting. The meeting is open to all working with and interested in regulatory affairs of pharmaceuticals, medical devices and combinations.
- [Take the step to internationalization](https://swedenbio.se/kalendarium/take-the-step-to-internationalization/) - This is a follow-up to the inspirational seminar "We have taken the step" ( Umeå & Lycksele ). - Import - The Chamber of Commerce provides you with competence-enhancing facts and you get to work in a workshop format with the self-analysis you filled in for the activity (emailed to you when you register
- [Biotech Umeå Investment Day 2017](https://swedenbio.se/kalendarium/biotech-umea-investment-day-2017/) - Mark your calendar for the 8th Biotech Umeå Investment Day, a very appreciated and successful partnering event at Grand Hôtel, Stockholm, Sweden.
- [AdvaMed 2016](https://swedenbio.se/kalendarium/advamed-2016/) - An event rich in international flavor and featuring a deep, diverse attendee list that includes influential policy-makers, business executives and media, AdvaMed 2016 seeks to advance industry discussion from key perspectives through detailed panel sessions, executive forums and more. It is a "must-attend" event for any medtech company. Whatever your goals may be, you are
- [Collective creativity as an innovation engine - How Swedish big companies do it](https://swedenbio.se/kalendarium/collective-creativity-as-an-innovation-engine-how-swedish-big-companies-do-it/) - Several major Swedish companies are at the forefront of this development. They have introduced new tools and ways of working that support and simplify the creation, development and implementation of ideas. The idea is that employees can contribute to the profitability and long-term survival of companies by jointly creating and developing ideas that lead to
- [Swedish - American Life Tech Forum](https://swedenbio.se/kalendarium/swedish-american-life-tech-forum/) - The Swedish-American Life Tech Forum is a unique event due not only to SACC NE's intimate connections within the Boston and Cambridge Life Science communities, but also our strong desire to fuel growth, innovation, and accelerate trade. The Forum will offer exposure, networking opportunities, and provide unique expert insights and guidance on topics such as:
- [Breakfast seminar: Getting ready for the first clinical trial?](https://swedenbio.se/kalendarium/breakfast-seminar-getting-ready-for-the-first-clinical-trial/) - During this breakfast meeting you will get the opportunity to hear about the major cost drivers of clinical trials. It will be discussed how clinical trials can be set-up and managed to reach the ultimate goal of delivering quality data on time, at the lowest possible cost. Selecting the right partners, developing an appropriate quality
- [Lunch seminar for core facilities: EATRIS](https://swedenbio.se/kalendarium/lunch-seminar-for-core-facilities-eatris/) - Since fall 2015, a Swedish node within EATRIS (European Advanced Translational Research InfraStructure) is being established in Sweden. The Swedish Research Council supports Sweden's participation and is responsible for Sweden's membership in EATRIS, which enables the universities' researchers to join EATRIS free of charge and the assignments obtained then provide full cost coverage for the
- [Life Science Fair Lund 2016](https://swedenbio.se/kalendarium/life-science-fair-lund-2016/) - Arbetsförmedlingen Lundaregionen, Crossborder Öresund and Science Skills are organizing a recruitment fair focusing on work in Life Science! The fair covers the full range of biology, medicine, chemistry and the interdisciplinary fields. Participation is free of charge and the only requirement is that you have recruitment needs (at the time of the event or shortly
- [The Triple Helix in Biobanking Intertwining Stakeholders](https://swedenbio.se/kalendarium/the-triple-helix-in-biobanking-intertwining-stakeholders/) - This year the topic will be "The Triple Helix in Biobanking: Intertwining Stakeholders" The event will take place in Lund at Medicon Village (Scheelevägen 2. Lund) on 15th and 16th November. Although there's not fee applicable, registration is compulsory for organizational reasons due to the Networking Dinner on November 15th.
- [Drug metabolism - role in drug discovery and development](https://swedenbio.se/kalendarium/drug-metabolism-role-in-drug-discovery-and-development/) - The aim of the course is to increase the participant's understanding of the significance and impact of the metabolism of small molecules in the discovery and development process of drugs. A brief introduction to enzymology will continue into an overview of in silico, in vitro and in vivo approaches. The different in vitro test systems,
- [Regulatory Aspects of Clinical Pharmacology](https://swedenbio.se/kalendarium/regulatory-aspects-of-clinical-pharmacology/) - The aim of the course is to increase the participants' knowledge and understanding of the EMA regulatory demands and guidelines concerning the clinical pharmacology and pharmacokinetic aspects of the drug development process. A brief introduction to the recommended standard clinical pharmacology and pharmacokinetics study package will continue into an overview of in silico, in vitro
- [Analytical Characterization of Therapeutic Proteins](https://swedenbio.se/kalendarium/analytical-characterization-of-therapeutic-proteins/) - Therapeutic proteins, especially monoclonal antibodies, are in the present time developing fast and dominate globally regarding clinical trials and registrations of new pharmaceutical drugs. Large investments for research and development are planned in many countries. In Sweden the Government, the Wallenberg Foundation, AstraZeneca and GE Healthcare are making large investments. Therapeutic proteins are primarily developed
- [Swedish Proteomics Society symposium](https://swedenbio.se/kalendarium/swedish-proteomics-society-symposium/) - We are happy to welcome you to Gothenburg and the 1st joint SPS and SMSS symposium. Here we will bring together students, world-leading scientists and experts with industrial partners to bridge the broad fields of biological mass spectrometry and proteomics. With the ambition to highlight cutting edge achievements in mass spectrometry-based biomarker discovery, the scientific
- [Workshop on the digitalization of industry](https://swedenbio.se/kalendarium/workshop-on-the-digitalization-of-industry/) - The Digital Transformation Masterclass is a highly collaborative workshop with many concrete examples. The goal is to provide you with new methods that are truly useful for your company's continued digitalization. You will have access to all materials afterwards to implement what you have learned during the day. Participation in the Digital Transformation Masterclass is
- [In the head of a Horizon 2020 evaluator](https://swedenbio.se/kalendarium/in-the-head-of-a-horizon-2020-evaluator/) - The aim of the seminar is to give an understanding of the evaluation process for EU research/innovation actions in Horizon 2020 and the approach taken by evaluators in scoring proposals. Monica Schofield will reflect on what is required to score well on the evaluation criteria, what features highly ranked proposals have in common as well
- [Medical Technology Days 2016](https://swedenbio.se/kalendarium/medical-technology-days-2016/) - One of the themes of this year's conference is health economics and clinical benefit, which includes highlights the concept of usability. In addition, the program offers several interesting invited lectures on cutting-edge medical technology research. Medicinteknikdagarna (MTD) is one of Sweden's most important meeting places for medical technology. The aim is to bring together all
- [Medical technology in Skåne with the opening of Medicon Bridge](https://swedenbio.se/kalendarium/medical-technology-in-skane-with-the-opening-of-medicon-bridge/) - The conference is aimed at stakeholders in academia, healthcare and business. The conference also aims to increase understanding of the issues faced by these different actors and to exchange ideas. The organizers of Medical Technology in Skåne are the Medical Technology Portal LABIB, Lund University and Region Skåne. The conference will be organized in the
- [Being an innovator and entrepreneur in medical technology 2016](https://swedenbio.se/kalendarium/being-an-innovator-and-entrepreneur-in-medical-technology-2016/) - The course is provided by Medtech4Health and aims to increase knowledge of the innovation and entrepreneurship process to facilitate collaboration and provide better conditions for more innovation projects to succeed. The course includes the entire process from identifying a problem area in healthcare that can potentially be solved through a technically based innovative idea which
- [Conference on IP Dispute Resolution in Life Sciences](https://swedenbio.se/kalendarium/conference-on-ip-dispute-resolution-in-life-sciences/) - Such disputes require a carefully integrated dispute resolution strategy to control costs and to protect the value of technologies and associated IP rights. Dispute resolution strategies may include out-of-court dispute resolution mechanisms, such as WIPO Mediation or Arbitration. The Conference will provide an overview of the contractual framework of collaborations in life sciences, relevant IP
- [French-Swedish Life Science Day 2016](https://swedenbio.se/kalendarium/french-swedish-life-science-day-2016/) - The conference will gather early stage and highly innovative medtech and biotech companies from Sweden, French and Swedish life science investors as well as executives from pharmaceutical companies. Partnering and investment focus The goal of the conference is to create an arena for French and Swedish players to establish new contacts and to identify business
- [BioJapan](https://swedenbio.se/kalendarium/biojapan-2/) - With over 8,000 meetings expected to take place, this year's Partnering is set to be our largest and most successful ever! The Partnering system is entirely shared between BioJapan and Regenerative Medicine Japan, so participants can now reach an even wider range of potential partners than ever before.
- [Bioscience - Research through innovative Technologies](https://swedenbio.se/kalendarium/bioscience-research-through-innovative-technologies-3/) - The seminar program comprises a series of brief, interesting presentations intended to stimulate curiosity and a continued dialogue among delegates on the exhibition floor. Important target groups are mainly researchers, PI's and professors but also lab technicians, biomedical analysts, lab equipment procurement officers and pharmaceutical industry staff. Some 300 visitors and 35 exhibitors are expected
- [Medicon Valley Alliance - Annual Meeting 2016](https://swedenbio.se/kalendarium/medicon-valley-alliance-annual-meeting-2016/) - The theme for this year´s Annual Meeting will be "How to fund life science innovation?". Initiated by a "State of the region analysis" conducted and presented by MVA and Øresundsinstituttet, we will highlight and discuss structural as well as specific challenges and solutions to the current problems of attracting sufficient capital and ensure continuous growth
- [National eHealth Day 2016](https://swedenbio.se/kalendarium/national-ehealth-day-2016/) - The National eHealth Day starts on the big stage in the Aula Medica at Karolinska Institutet. At 11am, you will be able to choose to either follow the program on the main stage or immerse yourself in good examples and solutions linked to one of the eHealth vision's focus areas - legal, standards or semantics.
- [Nordic Life Science Days September 12-14](https://swedenbio.se/kalendarium/nordic-life-science-days-september-12-14/) - The Nordic region is proud to host some of the world's most innovative biotech, medtech and pharma companies. It also has the 12th strongest economy, making it the perfect place to invest. Set in the heart of Medicon Valley, the conference offers conference sessions, panel discussions, company presentations, exhibition, face-to-face meetings and unique receptions, providing
- [The Nordic-American Life Science Conference (Pre-conference workshop)](https://swedenbio.se/kalendarium/the-nordic-american-life-science-conference-pre-conference-workshop/) - The Pre-Conference Workshop Day on November 30 will consist of interactive workshops and presentations and is only open for the Nordic companies. The workshops and presentations will include thematic experts in order to provide you with insights on topics relevant to life science companies that want to raise capital, enter partnering and licensing deals and
- [Breakfast meeting - theme of antibiotic resistance](https://swedenbio.se/kalendarium/breakfast-meeting-theme-of-antibiotic-resistance/) - MSF has released the report "LIVES ON THE EDGE - TIME TO ALIGN MEDICAL RESEARCH WITH PEOPLE'S HEALTH NEEDS" where we address the changes needed in research and development to overcome the challenges we face. Here is a link to the report http://www.msfaccess.org/content/rd-report-lives-edge In the morning, Helle Aagaard, EU policy advisor at the Access Campaign,
- [Meet experts from the European Patent Office](https://swedenbio.se/kalendarium/meet-experts-from-the-european-patent-office-2/) - On the agenda: Food and Biotech Topics, Early Certainty, PCT Direct, European Patent Solutions and Unitary Patent Court. The meeting is free admission. Coffe and treats will be offered free of charge. Members from the EPO that will participate are: Maria Fotaki, Director Biotec, Munich François Leprètre, Senior Expert, Haag Francesca Fiorenza, Examiner, The Hague
- [East African Chamber of Commerce: Business and Investment Forum 2016](https://swedenbio.se/kalendarium/east-african-chamber-of-commerce-business-and-investment-forum-2016/) - Together with SWEACC members and new business friends you will have the possibility to learn more about ongoing activities and plans for the future in the East African Community. We will listen to and meet all the five EAC Ambassadors from Burundi, Kenya, Rwanda, Tanzania and Uganda. This forum will focus on ICT based solutions
- [Focus on Assistive Technology](https://swedenbio.se/kalendarium/focus-on-assistive-technology/) - If you work in the sector or have a disability, you can meet suppliers, innovators and manufacturers. The purpose of this forum is to be a meeting place for the entire industry, presenting new products and addressing current topics through lectures, thereby increasing the conditions for quality and accessible healthcare and a society with the
- [The Nordic-American Life Science Conference](https://swedenbio.se/kalendarium/the-nordic-american-life-science-conference/) - The conference connects promising, innovative healthcare technology companies and Nordic Life Science organizations with investors, external innovation scouts and business developers in the U.S.. The target audience includes Pharma/Biotech, Diagnostics, Medtech and Digital Health. The conference offers: Company pitches to investors & industry executives One-on-one meetings A company profile visible to all participants Investor and
- [Bubbel & Debatt 2016 in Lund](https://swedenbio.se/kalendarium/bubbel-debatt-2016-in-lund/) - Sweden is investing nationally in life sciences. What is being done in Region Skåne? When? October 5. The debate starts at 16:00, the mingle starts at 17:00. Where? Medicon Village, Scheelevägen 2, Lund, Sweden In the panel: Ulf Malmqvist, Head of Operations, Clinical Trials Skåne, Gavyn Edmunds, Research and Innovation Strategist, Region Skåne, Magnus Hansson,
- [The next Swedish growth era India and China](https://swedenbio.se/kalendarium/the-next-swedish-growth-era-india-and-china/) - The seminar will focus on the economic situation in China and India. Industrial sectors deemed particularly interesting will be highlighted, such as ICT, medical technology, industrial equipment and environmental technology. Similarities and differences between the countries will be highlighted regarding the economic situation, interesting industrial sectors and specific success factors for your business. The seminar
- [Lunch & Learn: Skills supply and demand in the life science industry](https://swedenbio.se/kalendarium/lunch-learn-skills-supply-and-demand-in-the-life-science-industry/) - In the fall of 2015, the Science Skills board commissioned Mercuri Urval to conduct a study that could provide a current and future analysis of the supply of skills and needs in the Life Science industry with a focus on the Öresund region, the Stockholm region (including Uppsala) and the Gothenburg region. The aim of
- [PiiA Summit](https://swedenbio.se/kalendarium/piia-summit/) - Sweden will be a world leader in process industry management and automation. This requires strong investment in research, development and innovation, while developing collaboration between companies, industries, sectors and academia. You can expect from the PiiA Summit: - Interesting results and experiences from PiiA's various research, development and innovation projects. - Meet new partners and
- [Conference on IP Dispute Resolution in Life Sciences](https://swedenbio.se/kalendarium/conference-on-ip-dispute-resolution-in-life-sciences-2/) - Such disputes require a carefully integrated dispute resolution strategy to control costs and to protect the value of technologies and associated IP rights. Dispute resolution strategies may include out-of-court dispute resolution mechanisms, such as WIPO Mediation or Arbitration. The Conference will provide an overview of the contractual framework of collaborations in life sciences, relevant IP
- [SwedenBIO Summit 2016](https://swedenbio.se/kalendarium/swedenbio-summit-2016/) - APPLY HERE.
- [JMP for Life Sciences: Modern Clinical Monitoring and Quality by Design](https://swedenbio.se/kalendarium/jmp-for-life-sciences-modern-clinical-monitoring-and-quality-by-design/) - The JMP family of products provide many capabilities that help you to leverage data better, and this seminar focuses on two distinct but related areas of application. Andrew Lawton, CEO of Risk Based Approach Ltd, will examine and interpret forthcoming regulations and guidance changes and the use of big data and analytics. Geoffrey Mann, JMP
- [Illegal and spurious medicines - a danger to public and personal health](https://swedenbio.se/kalendarium/illegal-and-spurious-medicines-a-danger-to-public-and-personal-health/) - Preliminary program Introduction and welcome Kjell Asplund, Chairman of Smer The epidemiology and impact of poor quality medicines on global Health Paul Newton, Researcher Prel. title: Substandard, Spurious, Falsely labeled, Falsified and Counterfeit (SSFFC) Medical Products Pernette Bourdillon Esteve, WHO Pharmaceutical crime from a national to an international point of view Cecilia Fant, Interpol Panel
- [IHE Forum 2016 - Disruptive Innovations](https://swedenbio.se/kalendarium/ihe-forum-2016-disruptive-innovations/) - This year's IHE Forum will discuss disruptive innovations in more detail and highlight current examples. We will look at how they affect patients as well as county councils and hospitals through their clinical, economic and organizational consequences. The challenges of the health system are growing exponentially while its resources are limited. Could disruptive innovation be
- [The return of factories - how Sweden is winning the battle for the future of pharmaceutical production](https://swedenbio.se/kalendarium/the-return-of-factories-how-sweden-is-winning-the-battle-for-the-future-of-pharmaceutical-production/) - Already today, pharmaceuticals, biotechnology and medical technology are the country's largest export products after paper, and if this trend continues, we can look forward to even greater exports and more skilled jobs. But international competition is fierce. What does it take for Sweden to get the follow-up investments and become a long-term manufacturing country for
- [Antibiotic Forum - National Collaboration Function](https://swedenbio.se/kalendarium/antibiotic-forum-national-collaboration-function/) - The National Antibiotic Forum is held in conjunction with the European Antibiotic Awareness Day on November 18, which is also the date when the Public Health Agency of Sweden submits an annual report to the government on the national coordination function.
- [The future of health - healthcare, medical device industry and research in innovative partnerships](https://swedenbio.se/kalendarium/the-future-of-health-healthcare-medical-device-industry-and-research-in-innovative-partnerships/) - PROGRAM Medtech Week - collaboration and innovation for the future of medical technology Anna Lefevre Skjöldebrands, CEO of Swedish Medtech The future of medical technology, the future of healthcare Uppsala Center for Medical Technology - about the collaboration between Uppsala University Hospital and the Faculties of Engineering and Science and Medicine and Pharmacy at Uppsala
- [European Medtech Week 2016](https://swedenbio.se/kalendarium/european-medtech-week-2016/) - Through various events organized by both medtech companies, academia and industry organizations, we want to provide a greater insight and understanding of what we as an industry contribute - for society and for the patient. During the week, several interesting seminars will be organized around Sweden.
- [Cross-border licensing - Licensing to "big pharma"](https://swedenbio.se/kalendarium/cross-border-licensing-licensing-to-big-pharma/) - In this session, we will cover a number of basic questions to prepare for and realize contacts with international licensees: Creating interest among global licensees - what does big pharma look for? How to succeed in a virtual negotiation? What factors influence the content of key contractual provisions? Are the contractual conditions different from licensing
- [The Future of Venture - from idea to patient](https://swedenbio.se/kalendarium/the-future-of-venture-from-idea-to-patient/) - From the program on 21 June: 09:00 ¦ PROGRAM FROM THE MAIN STAGE Ulf Stenerhag, CEO, Not for sale Ale AB Mats Gustafsson, Founder and CEO, Wednesday Relations AB 10:00 ¦ NETWORKING BREAK 10.30 ¦ Medicines The authorisation process for medicines Speaker: Marie Gårdmark, Director of Licensing, Medical Products Agency. Commercialization and life in an
- [Swedish life science industry - continued decline or revival?](https://swedenbio.se/kalendarium/swedish-life-science-industry-continued-decline-or-revival/) - The life science industry contributes to Swedish exports and provides many jobs for highly skilled people. At the same time, the industry has gone through some difficult years, such as AstraZeneca's high-profile closures. On behalf of Vinnova, the Swedish Agency for Growth Analysis has written the report Growth in the Swedish Life Science industry in
- [Biotechnology Days 2016](https://swedenbio.se/kalendarium/biotechnology-days-2016/) - As a partner, your company is made visible in various ways to Sweden's most committed biotechnology students, an occasion that only occurs every six years in Gothenburg. The structure of the Shortcut gives you a good insight into the competences of the students and the profiles of the different programs. At the same time, students
- [Climate-smart Healthcare](https://swedenbio.se/kalendarium/climate-smart-healthcare/) - Nordic Center for Sustainable Healthcare, together with partners, invites you to an exciting afternoon of climate-smart healthcare solutions. With climate-smart we mean everything from energy efficiency and smart biomaterials to good energy performance and logistics solutions within Medtech. Learning from each other is a great way to develop without having to make all the mistakes
- [Frontiers in Antibiotic Drug Discovery (FiADD)](https://swedenbio.se/kalendarium/frontiers-in-antibiotic-drug-discovery-fiadd/) - The symposium is organized jointly by the Medicinal Chemistry Section of the Swedish Pharmaceutical Society and ENABLE, one of the projects in the Innovative Medicines Initiative ND4BB, to showcase the future and opportunities for antibiotic drug discovery in a stimulating environment. It is also designed to provide plenty of opportunities to meet other delegates, renew
- [Public procurement breakfast meeting](https://swedenbio.se/kalendarium/public-procurement-breakfast-meeting/) - Welcome to a breakfast meeting on how social considerations in procurement contribute to skills supply, reduced exclusion and how we can all benefit from taking social considerations in business. If you are an entrepreneur interested in participating in a public procurement process and are curious or unsure how the new social clauses affect your business
- [Elementary my dear Watson](https://swedenbio.se/kalendarium/elementary-my-dear-watson/) - The goal of IBM Watson Health is to help healthcare professionals by analyzing large amounts of data such as medical literature, patient records, clinical trials and self-generated data to provide decision support that delivers clinically valuable insights and recommendations for personalized and evidence-based treatments. How does it change the patient-professional relationship and the experience during
- [SECOND EATRIS CONFERENCE: Building Bridges in Translational Medicine](https://swedenbio.se/kalendarium/second-eatris-conference-building-bridges-in-translational-medicine/) - EATRIS Conference Scope: Listen to SMEs and the biopharma industry about their needs from academic infrastructures; Discuss the opportunities and challenges that beset effective public-private collaboration in biomedical innovation; Learn more about crucial success factors for selection, design, and execution of sound translational research; and Discuss the major operational and technical translational research bottlenecks we
- [Drop in for personalized advice on Horizon 2020!](https://swedenbio.se/kalendarium/drop-in-for-personalized-advice-on-horizon-2020/) - On the morning of June 1, Tuulikki Lindmark and Håkan Sehlin from EUSMESupport will be at Medicon Village. One-to-one meetings on a drop-in basis give you advice and support on your application. Håkan Sehlin is also based in Lund, and sometimes at Medicon Village. A useful acquaintance! Take the opportunity to get started with advice
- [Is Horizon 2020 for your company?](https://swedenbio.se/kalendarium/is-horizon-2020-for-your-company/) - Does your company need a grant to run an innovative development project, or do you need funds to develop your products and services? We clarify the concepts and review your opportunities for funding from the EU's research and innovation programs Horizon 2020 and Eurostars. EUSMESupport2020 is a support office for small and medium-sized enterprises (SMEs),
- [New cancer drugs for personalized treatment](https://swedenbio.se/kalendarium/new-cancer-drugs-for-personalized-treatment/) - These developments represent a new era in cancer therapy. It offers hope for better treatment outcomes when these new drugs are combined with other anti-cancer medicines.The first immuno-oncology drugs have now been approved by the competent authorities for use in healthcare. - Have they been treated differently in terms of documentation requirements, investigation time, scope
- [BIO-Europe® 2016](https://swedenbio.se/kalendarium/bio-europe-2016/) - BIO-Europe® is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities, workshop and panel participation, a high profile exhibition, and private, prescheduled one-to-one meetings. Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage and
- [Biotechnology development process](https://swedenbio.se/kalendarium/biotechnology-development-process/) - Whether the ultimate goal is securing a partnership, selling your asset to a large biopharmaceutical company, or successfully navigating your way through the clinical drug development process on your way to achieving commercial success, this symposium is for you. Since 2006, close to 10 percent of the new drug approvals granted by the FDA have
- [Horizon 2020 - Open house at Vinnova](https://swedenbio.se/kalendarium/horizon-2020-open-house-at-vinnova/) - The Open House will provide an overview of Horizon 2020 opportunities, with focus on the Work Programme for 2016-2017. The day will start off with short presentations from National Contact Points and Support offices and after a light lunch there will be possibilities to network, interact and discuss with advisors. In addition to the calls
- [Breakfast with SwedenBIO in the BioVentureHub](https://swedenbio.se/kalendarium/breakfast-with-swedenbio-in-the-bioventurehub/) - Program: Jonas Ekstrand, CEO SwedenBIO: SwedenBIO - a national network that strengthens you and the industry. Politics and life sciences - what's going on? The world is coming to Sweden - find your business partner at NLSDays! Tuulikki Lindmark, Director EU Support Office, SwedenBIO: EU money - what can small businesses apply for in Horizon
- [Katalys- SwedenBIOS Future Day!](https://swedenbio.se/kalendarium/katalys-swedenbios-future-day/) - The seminar is free of charge for all employees of SwedenBIO member companies. After the seminar, we welcome you to SwedenBIO's big summer dinner with, among other things, the awarding of the SwedenBIO Award! READ MORE ABOUT THE PROGRAM HERE. From the program From start-up to billion dollar company - how we built a successful
- [Formulation Technology](https://swedenbio.se/kalendarium/formulation-technology/) - A new course in formulation technology for professionals and Ph.D students will be given at Lund University this fall. The course is given by researchers at Lund University, external speakers and in cooperation with Lund University Commissioned Education. Formulation is a key activity in many industries, such as pharmaceutics, nutraceutics and cosmetics. Successful formulation development
- [Are We on Track? A seminar on serialization in the pharmaceutical industry](https://swedenbio.se/kalendarium/are-we-on-track-a-seminar-on-serialization-in-the-pharmaceutical-industry/) - The purpose of the forum is to have an informal discussion with the pharmaceutical industry, pharmaceutical supply chain, pharmacies and NMVO. Based on the impact and the changes to be made, in order to accommodate all the provisions within the Delegated Act, it is important to have the articipation of the entire supply chain to
- [Bubble & Debate in Gothenburg](https://swedenbio.se/kalendarium/bubble-debate-in-gothenburg/) - Sweden is investing nationally in life sciences. What is being done in Region Västra Götaland? When? April 26. Debate at 16.00, mingle 17.00 Where? Biotech Center, Arvid Wallgrens Backe 20, Gothenburg. Cancellation should be made to info@swedenbio.se and non-cancelled places may be invoiced.
- [Conference on Clinical Trials](https://swedenbio.se/kalendarium/conference-on-clinical-trials/) - Most welcome to take part in a unique opportunity to meet representatives from the regulatory authorities and other experts within the field of clinical research. Listen to the latest news and currents trends, and network with professional colleagues from the Nordic countries. Who should attend? Professionals working with or interested in clinical trials in the
- [Introduction to Regulatory Affairs](https://swedenbio.se/kalendarium/introduction-to-regulatory-affairs/) - This is the training day for those who need an up-to-date overview of current regulations and how to ensure adequate regulatory documentation in all phases of a drug development project with a focus on early phase. The course will be held on four occasions in Umeå, Linköping, Lund and Stockholm in 2016. Target group The
- [Introduction to Regulatory Affairs](https://swedenbio.se/kalendarium/introduction-to-regulatory-affairs-3/) - This is the training day for those who need an up-to-date overview of current regulations and how to ensure adequate regulatory documentation in all phases of a drug development project with a focus on early phase. The course will be held on four occasions in Umeå, Linköping, Lund and Stockholm in 2016. Target group The
- [Introduction to Regulatory Affairs](https://swedenbio.se/kalendarium/introduction-to-regulatory-affairs-2/) - This is the training day for those who need an up-to-date overview of current regulations and how to ensure adequate regulatory documentation in all phases of a drug development project with a focus on early phase. The course will be held on four occasions in Umeå, Linköping, Lund and Stockholm in 2016. Target group The
- [New therapies for heart and lung diseases](https://swedenbio.se/kalendarium/new-therapies-for-heart-and-lung-diseases/) - The seminar. organized by IVA's division for Biotechnology, presents the latest developments in the project and the potential for future research by collaborations with major Swedish research infrastructures. PROGRAM Welcome Inger Andersson, Chairman of the Division for Biotechnology Introduction Staffan Josephson, Division for Biotechnology SCAPIS - Sweden's largest, most comprehensive study on cardiac and pulmonary
- [AIPPI day 2016](https://swedenbio.se/kalendarium/aippi-day-2016/) - Patents for second medical use have been granted by the EPO for a long time but experiences show that the regulatory system on generic substitution has a great impact on if, how and against who such patents can be enforced. After a brief outlook on recent developments in other EU countries there will be a
- [The regulatory pathway to market approval](https://swedenbio.se/kalendarium/the-regulatory-pathway-to-market-approval/) - Christina Jacobsson of Sofus talks about the results of the study she participated in at EMA, investigating the impact of early scientific advice on the applications submitted for new approvals. Johanna Henriksnäs (Consultant Regulatory Affairs) and Katarina Mercer (Consultant Regulatory Affairs) from Sofus talk about the development of biological medicines from a non-clinical and clinical
- [Stockholm Business Angels](https://swedenbio.se/kalendarium/stockholm-business-angels/) - One of STOAF's founders Lennart Ohlsson is a researcher in finance and venture capital. STOAF uses the best practice venture capital strategy and process in early stage investments, we emphasize "fair deal", syndication with other investors, transparency and long-term perspective. STOAF offers the value of selective international business angels network, both on the West Coast
- [International Forum on Quality & Safety in Healthcare](https://swedenbio.se/kalendarium/international-forum-on-quality-safety-in-healthcare/) - Now in its 21st year, the International Forum on Quality and Safety in Healthcare is one of the world's largest gatherings of healthcare professionals committed to improving patient care and their safety. The last International Forum in London in 2015 connected over 3,000 healthcare leaders and practitioners from 83 countries, providing an inspirational setting to
- [BioMalaysia & Asia Pacific Bioeconomy 2016](https://swedenbio.se/kalendarium/biomalaysia-asia-pacific-bioeconomy-2016/) - The Ministry of Science, Technology & Innovation (MOSTI) and Malaysian Biotechnology Corporation (BiotechCorp) are proud to be the host of BioMalaysia & Asia Pacific Bioeconomy 2016. BioMalaysia & Asia Pacific Bioeconomy has established itself as one of the key meeting points for industry professionals. Over the years, the event continues to increase its value as
- [The future of medical diagnostics](https://swedenbio.se/kalendarium/the-future-of-medical-diagnostics/) - Today, cancers diagnosed before tumors metastasize are often cured. And if feverish travelers could be tested between airport security and boarding, virus outbreaks like Ebola would be less threatening. More accurate diagnostics could slow down the spread of antibiotic resistance as antibiotics could be used only when they are effective. Several research breakthroughs have made
- [Biosimilars world 2016](https://swedenbio.se/kalendarium/biosimilars-world-2016/) - The competitive biosimilars landscape is rapidly evolving and creating significant revenue opportunities for companies that can successfully develop and market them. However, lower priced biosimilars are not enough to guarantee commercial success and maximize uptake: What steps need to be taken in order to successfully move the U.S biosimilars market forward: pricing strategies, physician engagement
- [National coordination of clinical studies](https://swedenbio.se/kalendarium/national-coordination-of-clinical-studies/) - In 2014, the Swedish government launched a comprehensive initiative to support and develop the conditions for clinical studies in Sweden.The activities have been launched during the past year and this is an inaugural event to celebrate that the work is underway. Welcome to the opening mingle in the new premises in Gothenburg. You will have
- [Money, politics and partnering - a lunch hour with SwedenBIO](https://swedenbio.se/kalendarium/money-politics-and-partnering-a-lunch-hour-with-swedenbio/) - Program: SwedenBIO - a national network that strengthens you and the industry. Jonas Ekstrand, CEO SwedenBIO Politics and life sciences - what's going on? Ingrid Heath, Deputy CEO and Head of Policy, SwedenBIO EU money - here it is! Tuulikki Lindmark, Director EU Support Office, SwedenBIO The world is coming to Sweden - find your
- [The SHEA health economics conference](https://swedenbio.se/kalendarium/the-shea-health-economics-conference/) - The keynote speaker is James Hammitt from Harvard, USA. His lecture addresses the current methodological, ethical and political challenges of health economic evaluations in health care. The keynote lecture on the second day of the conference will be given by Professor Martin Knapp from the London School of Economics & Political Science. SHEA usually brings
- [Politicians tasked with driving change](https://swedenbio.se/kalendarium/politicians-tasked-with-driving-change/) - Meet Innovation County Councillors Daniel Forslund (L), Stockholm County Council, and Robert Winroth (MP), Västerbotten County Council, who are responsible for a number of crucial issues for the future of the pharmaceutical industry - innovation development, collaboration and new healthcare information systems. 08.00-08.30 Breakfast is served 08.30-09.45 Speaker presentation, questions and discussion
- [Karolinska Institutet and the future of collaboration](https://swedenbio.se/kalendarium/karolinska-institutet-and-the-future-of-collaboration/) - Alexander von Gabain is Vice President for Innovation and Collaboration with Industry at Karolinska Institutet. How will he strengthen innovation at universities and establish a broader form of collaboration with industry? 08.00-08.30 Breakfast is served 08.30-09.45 Speaker presentation, questions and discussion
- [ChinaBio® Partnering Forum 2016](https://swedenbio.se/kalendarium/chinabio-partnering-forum-2016/) - ChinaBio® Partnering Forum 2015 had 858 delegates from 435 companies and 22 countries, making it the largest partnering conference in China. The 2016 edition promises to be even better with top notch attendance from pharma and biotech companies as well as leading researchers from China's top universities and institutes. The conference also features partneringONE®, enabling
- [Läkemedelsvärlden takes the pulse of: Anders Lönnberg](https://swedenbio.se/kalendarium/lakemedelsvarlden-takes-the-pulse-of-anders-lonnberg/) - The key questions are: How best to stimulate businesses in the sector? How to improve the uptake of innovation in healthcare? How can academia and industry move closer together? During an intense hour, Anders Lönnberg of Läkemedelsvärlden feels the pulse of what has actually been achieved. Has the work resulted in any concrete actions or
- [Technoport 2016](https://swedenbio.se/kalendarium/technoport-2016/) - Experience live equity crowdfunding, a pitching competition, hands-on workshops and inspiring talks from some of the world's greatest innovative minds. The Technoport conference is an annual international conference on innovation, entrepreneurship and commercialisation that aims to smash together the knowledge quality and mastery of complexity from the academic world with the rapid and agile workflow
- [Health 2.0 Europe 2016](https://swedenbio.se/kalendarium/health-2-0-europe-2016/) - Over 120 speakers and 600 attendees from around the world will reconvene to experience over 50 live product demos of innovative solutions that will shake up European health systems. Confirmed keynotes already include: Esther Dyson, Chairman, EDventure Holdings (USA) Dr. Rafael Grossmann, Practicing surgeon and digital health pioneer (USA) Damien Marmion, Global Head of Health,
- [Upgraded Life Festival](https://swedenbio.se/kalendarium/upgraded-life-festival/)
- [Digital Health Days 2016](https://swedenbio.se/kalendarium/digital-health-days-2016/)
- [Powder Technology in Pharma, Food and Chemistry](https://swedenbio.se/kalendarium/powder-technology-in-pharma-food-and-chemistry/) - There is a multitude of powders used in industry. The processing and handling of powder also involves a multitude of operations such as production, the size and type of particles, transportation, storage, redissolution, powder blending, etc. A clear understanding of the characteristics of powders is required in order to carry out these operations. The aim
- [New Updates in Drug Formulation & Bioavailability](https://swedenbio.se/kalendarium/new-updates-in-drug-formulation-bioavailability/) - Formulation and bioavailability are critical steps in the development process of new effective drugs. One reason for failure in clinical trials might be explained by poor formulation and bioavailability properties of the drug. Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about these topics at this meeting featuring about 100
- [Bubbel & Debatt Stockholm](https://swedenbio.se/kalendarium/bubbel-debatt-stockholm/) - Sweden is investing nationally in life sciences. What is being done in the Stockholm region? On the panel: Fredrik Piehl, Chief Physician Karolinska Institutet, Jakob Hellman, incoming Head of Innovation, Stockholm County Council, Maria Englund, Head of Operations Karolinska Trial Alliance, Bengt Gustavsson, Pharmacist and Doctor of Pathology, Norwegian Medical Director, Celgene. Moderator: Ingrid Helander,
- [The World Congress on Clinical Trials in Diabetes](https://swedenbio.se/kalendarium/the-world-congress-on-clinical-trials-in-diabetes/) - Our world renowned faculty will tackle these issues head on through a comprehensive scientific program which will focus on four key areas; Design the Best Study Improve Regulatory Process; Better Understanding of How to Collaborate with Regulatory Authorities Involvement of Digital Medicine Power Post-Marketing Surveillance We wish you a fruitful and insightful congress and an
- [Swedish Bio-Makers Conference](https://swedenbio.se/kalendarium/swedish-bio-makers-conference/) - This is an event by and for biomakers, biohackers and DIY biologists with the purpose of sharing inspirational stories and practical hacks and protocols from the greater biohacker movement. This is an event for people who want to be engaged in building the biomakers movement in Sweden and across the World. This event is for
- [BIO-PUB with Awapatent](https://swedenbio.se/kalendarium/bio-pub-with-awapatent/) - You will hear about surprising verdicts, drastic consequences and large sums of money, as we leave the details of the law behind and share our own and others' experiences in Sweden and abroad. Along the way you might pick up some patent law as well, but the focus of our presentation is on the stories
- [Market Access & Regulatory Affairs in Medical Devices](https://swedenbio.se/kalendarium/market-access-regulatory-affairs-in-medical-devices/) - The global economies are diverse and competitive and there is a need to establish a strategic approach to understand the variances and concentrate valuable resources on the most promising markets. The strategic approach to enter new markets will depend on local characteristics, regulations and the company's aspirations and ability to establish a position. The congress
- [Assistive devices & welfare technology](https://swedenbio.se/kalendarium/assistive-devices-welfare-technology/) - The purpose of this forum is to present new products, address current topics through seminars and thus increase the conditions for quality and accessible health and social care. It brings together assistive technology providers, policy makers, healthcare professionals, users and anyone with an interest in assistive technology.
- [The Future of Swedish & Danish Life Science](https://swedenbio.se/kalendarium/the-future-of-swedish-danish-life-science/) - How do we initialize cross-border partnerships between pharma, biobanking and healthcare? What roles will clinics and health organizations, academy and industry have in making this a reality? An inventory is needed to create a shared vision of how a triple-helix approach can be developed, leading to innovative processes and personalized solutions. How can we get
- [Social enterprises and social entrepreneurship - clarifying the terms](https://swedenbio.se/kalendarium/social-enterprises-and-social-entrepreneurship-clarifying-the-terms/) - Why is social entrepreneurship timely and what can it teach us? Can social entrepreneurship be sustainable and economically viable? Why does the City of Stockholm want social enterprises? What challenges does the city face? How can social enterprises develop? This morning we will discuss these issues and clarify the concepts of social entrepreneurship and social
- [BioAsia](https://swedenbio.se/kalendarium/bioasia/) - BioAsia seeks to enhance, enrich and encourage newer innovations, path-breaking discoveries and effective solutions in the industry by offering a vibrant global platform for convergence of the key stakeholders - Biotech & Biopharma Companies, research institutions, investors, service providers, policy makers, regulators and analysts.
- [Pharmacopoeia Day](https://swedenbio.se/kalendarium/pharmacopoeia-day/) - The conference is aimed at those who want to follow developments and changes in the European Pharmacopoeia.
- [Stockholm Corporate Finance Life Science/ Healthcare Day 2016](https://swedenbio.se/kalendarium/stockholm-corporate-finance-life-science-healthcare-day-2016/) - Staffan Lindstrand, Partner, will end the day by telling about the venture capital funds, HealthCap's business, which was founded in 1996 and invests focused in Life Science. HealthCap has raised more than EUR 1 billion in capital, invested in more than 100 companies, including over 30 IPOs around the world. The following companies, representing a
- [Healthcare Research Day 2016](https://swedenbio.se/kalendarium/healthcare-research-day-2016/) - A new research bill is on its way. The Alf agreement is in place. There is a major investment in treatment research and broad collaboration for more clinical studies. There is no shortage of money or infrastructure for clinical research in the health sector. The challenge now is to translate these investments into concrete results.
- [National conference on clinical research](https://swedenbio.se/kalendarium/national-conference-on-clinical-research/) - For the second year in a row, the conference will be organized by the Committee for National Coordination of Clinical Studies (KNSK) at the Swedish Research Council in collaboration with Forum Sydost, Forum Norr, FoU-centrum Skåne, Karolinska Trial Alliance, Gothia Forum and the Uppsala-Örebro region (regional host). UCR (Uppsala Clinical Research Center) is the local
- [Pharmaceutical Congress 2016](https://swedenbio.se/kalendarium/pharmaceutical-congress-2016/) - Two days with three tracks for those working in pharmacy, the pharmaceutical industry, government, healthcare or academia. In-depth lectures, hands-on knowledge, debates and research fronts. Take part in skills development in research & development, manufacturing & trade and use & patient safety. Professional networking and mingling. Plan now for two important days of top lectures
- [Nordic Life Science Days September 14-15](https://swedenbio.se/kalendarium/nordic-life-science-days-september-14-15/) - The Nordic region is proud to host some of the world's most innovative biotech, medtech and pharma companies. It also has the 12th strongest economy, making it the perfect place to invest. Set in the idyllic city of Stockholm, the conference offers conference sessions, panel discussions, company presentations, exhibition, face-to-face meetings and unique receptions, providing
- [SwedenBIO - Drug development course](https://swedenbio.se/kalendarium/swedenbio-drug-development-course/) - Target group The course is aimed at those who work in drug development (e.g. in small and medium-sized enterprises), and feel that they want a comprehensive view of the complex development chain. During the course you will gain insight into how to work in the different stages of development, what to consider and what pitfalls
- [Focus on: Cancer Collaboration](https://swedenbio.se/kalendarium/focus-on-cancer-collaboration/) - We are continuing last year's successful Dialogue Forum, with an inspirational lecture and exhibition. New this year is a different kind of speed-dating to find partnerships and joint funding. The meeting is a forum for cancer researchers, companies and clinicians regionally. Other interested parties from Lund University, Region Skåne and Medicon Village are also welcome.
- [10th Swiss-Scandinavian Bio-Business Seminar](https://swedenbio.se/kalendarium/10th-swiss-scandinavian-bio-business-seminar/) - During this high-level partnering and investor conference, Swiss and Nordic biotech, pharmaceutical and medtech companies as well as investors meet in one-to-one meetings and present themselves in plenum.
- [Lunch seminar on Competitive Intelligence](https://swedenbio.se/kalendarium/lunch-seminar-on-competitive-intelligence/) - "Make the best use of Competitive Intelligence: improve your business by identifying and monitoring your competitors" Lecturers: Eskil Söderlind and Göran Conradson from bulb INTELLIGENCE in Lund.
- [Biotech Umeå Investment Day](https://swedenbio.se/kalendarium/biotech-umea-investment-day/) - Welcome to an appreciated and successful partnering event. Biotech Umeå Investment Day offer a great opportunity for investors and partners looking for interesting companies and novel ideas, at early stages, within the categories Pharma, In vitro diagnostic/Medtech and Other This year we are proud to present 13 selected Umeå-based partnering and interesting "in the pipe
- [Park Annual](https://swedenbio.se/kalendarium/park-annual/) - Every year, about 400 people get together at Wallenberg´s Conference Center in Gothenburg, where the open climate Park Annual takes place. There are several short presentations from startup-companies and more recognized life science organizations in a three session seminar, where the business sector as well as clinical expertise always is set to be well represented.
- [Karolinska Institutet Science Park Day 2016](https://swedenbio.se/kalendarium/karolinska-institutet-science-park-day-2016/) - For program and registration see: http://sciencepark.ki.se/sv/event/karolinska-institutet-science-park-day-2016/
- [The investor's advice on how to build value in your company through orderliness.](https://swedenbio.se/kalendarium/the-investors-advice-on-how-to-build-value-in-your-company-through-orderliness/) - For one hour, John will share his experience of how professional board work and corporate governance can create value during the growth of companies and how companies with better organization often succeed in negotiating better terms with investors. When this is first brought to your attention before a negotiation, it is difficult to manage well
- [Intellectual property aspects in innovation...](https://swedenbio.se/kalendarium/intellectual-property-aspects-in-innovation/) - Patents are one of the most valuable and important business assets for a company. To be attractive to a licensing partner or a buyer of a project, there are certain things in relation to IP such as patents, that simply must be done correctly early on in a project. This seminar will focus on a
- [Toxicology in drug research and development](https://swedenbio.se/kalendarium/toxicology-in-drug-research-and-development/) - What are the rules and the order in which the different studies should be carried out? The lecture from Toxicology Knowledge Team Sweden AB (TKT) guides you through the basics of drug toxicology, from mechanistic targets and new chemical series to the design of toxicology studies. Founded in 2012 by eight toxicologists, TKT has extensive
- [Connect2Capital - A West Nordic venture capital forum 2016](https://swedenbio.se/kalendarium/connect2capital-a-west-nordic-venture-capital-forum-2016/) - There will be plenty of opportunities for meeting entrepreneurs that have passed our selection process. They will pitch on stage and you will be able to book matchmaking meetings. The program also contains a range of keynotes who present trends and success stories. More than 300 pre-booked one-to-one meetings between investors and entrepreneurs were conducted
- [Vitalis - The largest eHealth event in Scandinavia](https://swedenbio.se/kalendarium/vitalis-the-largest-ehealth-event-in-scandinavia/) - Vitalis has a unique integrated concept combining a strong conference program with a large and significant exhibition where the leading players from the eHealth sector present their products and services. Knowledge building, networking and important discussion regarding the future of health care and how visions can be transformed into reality. Come and be part of
- [Exploring the Human Protein Atlas](https://swedenbio.se/kalendarium/exploring-the-human-protein-atlas/) - Antibody-based methods have been used together with transcriptomic analysis to explore the human proteome. The data is released together with application-specific validation performed for each antibody. In the workshop different areas of the Protein Atlas will be explored, with a focus on the current version of the database. Practical questions will be given to the
- [Company mini-exhibition in Uppsala](https://swedenbio.se/kalendarium/company-mini-exhibition-in-uppsala/) - December 10, you will have the opportunity to meet with Fisher Scientific, Beckman Coulter AB and World Courier. Please contact Erika Erkstam, erika.erkstam@scilifelab.uu.se, if you have any questions about the mini exhibition.
- [Company mini-exhibition in Uppsala](https://swedenbio.se/kalendarium/company-mini-exhibition-in-uppsala-2/) - Nov 26, you will have the opportunity to meet with Science Imaging Scandinavia AB, IDT Intergrated DNA Technologies and Labvision AB. Please contact Erika Erkstam, erika.erkstam@scilifelab.uu.se, if you have any questions about the mini exhibition.
- [Lecture by Nobel prize winner Stefan W Hell](https://swedenbio.se/kalendarium/lecture-by-nobel-prize-winner-stefan-w-hell/) - In conjunction to this event he will give a lecture entitled "Optical microscopy: the resolution revolution" (abstract enclosed). The lecture will be followed by a panel discussion, where there will be opportunities to ask questions and discuss super-resolution microscopy and science in general with Stefan Hell. Time: November 20, 9:15-10:00 (Open lecture), 10:15-11:00 (Panel discussion)
- [Medeon Life Science Network](https://swedenbio.se/kalendarium/medeon-life-science-network-2/) - Andris Underdal Designer & Developer and co-founder of CRC Nordic. They help companies visualize and develop their ideas. He will talk about their innovation projects and how they can help everyone from start-ups to more established companies. http://www.crcnordic.com/kontakt/ Reza Kazemi He has extensive experience in 3D printing and was among the first to bring the
- [European Spallation Source (ESS)](https://swedenbio.se/kalendarium/european-spallation-source-ess/) - The facility will provide unprecedented neutron scattering capabilities, promising a great boost in science, technology and innovation within materials and biosystems. Constituting the host region, the Nordic countries are in a position to take maximum advantage of the scientific and industrial possibilities opening in relation to ESS. The conference invites representatives from the Nordic education
- [What challenges does your company face when going public?](https://swedenbio.se/kalendarium/what-challenges-does-your-company-face-when-going-public/) - The underlying positive stock market trend is influenced by several macroeconomic factors and trends at both national and global level, the question is how long the positive climate can continue? There are several different reasons why a company chooses to list on a stock exchange. This includes facilitating the raising of capital and providing exit
- [New horizons in bioprocessing](https://swedenbio.se/kalendarium/new-horizons-in-bioprocessing/) - This international educational forum will have an emphasis on change, developments, improvements, new directions, management and business areas of bio-processing with focus on technical rather than commercial achievements. Areas will include analytical techniques, cell culture and upstream processing, downstream processing and single-use systems. The event will feature about 140 delegates and 15 exhibitors. For updated
- [Bioscience 2015 - Research through innovative Technologies](https://swedenbio.se/kalendarium/bioscience-2015-research-through-innovative-technologies/) - Bioscience 2015 will include a series of interesting lectures focusing on new technologies and applications as well as the latest advances and results in research. Providing a platform for meetings and networking, the event is aimed at parties in both industry and academia. The seminar program comprises a series of brief, interesting presentations intended to
- [KBC DAYS 2015](https://swedenbio.se/kalendarium/kbc-days-2015/) - Keynote Speaker: Professor Kari Stefansson, MD Dr. med, President, CEO and Director of deCODE genetics Reykjavik, Iceland. From the program: Research news from KBC departments Techno-biological green Chemistry: Enzymes love Ionic liquids Panel discussion- Outreach activities at Umeå University The Midterm PhD-students at KBC present their poster Awardees and new faculty members Molecular Detection with
- [Network meeting on the theme - How do we get more clinical trials in Sweden?](https://swedenbio.se/kalendarium/network-meeting-on-the-theme-how-do-we-get-more-clinical-trials-in-sweden/) - October 21, 2015 at Läkemedelsverket, Uppsala Program The evening starts with light refreshments (sandwiches and drinks). Introduction Vera Franzén, Vera Franzén Consulting AB, Stockholm. New EU regulation for clinical trials - Key changes - Timetable - LV's work on clinical trials Gunilla Andrew-Nilsson Swedish Medical Products Agency, Uppsala Industry's perspective - Does the new regulation
- [CHaSE 2016, the career fair at Karolinska Institutet](https://swedenbio.se/kalendarium/chase-2016-the-career-fair-at-karolinska-institutet/) - CHaSE will be an interactive career fair at Karolinska institutet that will involve impressive talent pool with over 8500 students from Bachelor, Master, PhD students and Postdocs in life sciences and biotechnology, to medical and healthcare students like Nurses, Dentists, Doctors, Physiotherapists, Psychologists, etc; The goal of the event is to provide the students the
- [VINNOVA Annual Conference](https://swedenbio.se/kalendarium/vinnova-annual-conference/) - In recent years, VINNOVA has launched two major new initiatives: Challenge Driven Innovation (UDI) and Strategic Innovation Areas (SIO). Both programs are large and systemic to create lasting change in Sweden. With these initiatives, we also want to create conditions for international competitiveness and for sustainable solutions to global societal challenges. The idea is for
- [Bubble & Debate in Umeå](https://swedenbio.se/kalendarium/bubble-debate-in-umea/) - Much money is being invested in national life science environments in Sweden in order to strengthen the country as a whole in global competition. How should these national centers act to ensure that academia and businesses across the country can benefit from the expertise available? Debaters: Tomas Lundqvist, Life Sciences Director, MAX-IV Laboratory Håkan Billig,
- [Keys to increased attractiveness](https://swedenbio.se/kalendarium/keys-to-increased-attractiveness/) - Sweden's prosperity cannot be taken for granted. Other countries are increasing their competitiveness faster than we are. Globalization and digitalization affect us both internationally and domestically. At the same time, the demands of sustainable economic growth present major opportunities for Sweden. The report presents an eight-point program for the future. It is based on an
- [SwedenBIO CEO Summit](https://swedenbio.se/kalendarium/swedenbio-ceo-summit/) - At this year's SwedenBIO CEO Summit we have our sights set on the billion dollar deals. A good idea is a good start, but becoming an attractive business partner for the global players requires much more from a life science entrepreneur. In one afternoon, business leaders share how they got the deals everyone dreams of
- [MedTechEvening](https://swedenbio.se/kalendarium/medtechevening/) - The event aims to open doors to graduate work and recruitment, to create a link between students and you as a future employer. MedTechEvening provides a space for people from different academic backgrounds, but with similar prospects, to meet and exchange experiences. During the evening, we expect 200 people to attend, with most participants being
- [Breakfast seminar: Horizon 2020 - the EU Framework Programme for Research and Innovation.](https://swedenbio.se/kalendarium/breakfast-seminar-horizon-2020-the-eu-framework-programme-for-research-and-innovation/) - 2014 saw the launch of the EU's new framework program for research and innovation - Horizon 2020. Nearly €80 billion will be awarded to European researchers and innovators over a seven-year period. Horizon 2020 has simplified the rules, making it easier for e.g. small businesses - the EU wants to encourage small businesses to participate.
- [Biotech Showcase™ 2016](https://swedenbio.se/kalendarium/biotech-showcase-2016/) - The 2015 event showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. Now in its eighth year, Biotech Showcase 2016 is expected to feature presentations by close to 250 public and private companies and attract more than 2,100 attendees. The event
- [BIO-Europe Spring® 2016](https://swedenbio.se/kalendarium/bio-europe-spring-2016/) - The conference annually attracts the international "who's who" from biotech, pharma and finance for three days of high caliber networking. BIO-Europe Spring's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. Attend BIO-Europe
- [Pharma Outsourcing 2015](https://swedenbio.se/kalendarium/pharma-outsourcing-2015/) - Pharmaoutsourcing 2015 will be moderated by Pernille Hemmingsen, CMC Project Manager at Genmab, Denmark. One of the key items of the agenda is the interactive panel discussion about "Outsourcing "close to home" or "worldwide"?" moderated by Lucy Robertshaw, International Business Consultant at Lucy J Robertshaw that will allow you to submit questions and comments to
- [Antibiotics Forum](https://swedenbio.se/kalendarium/antibiotics-forum/) - In addition, a communication consultant gives a lesson on how to formulate messages according to the target audience. During the afternoon, everyone can also learn about good examples of completed projects. The day is organized in cooperation with the Swedish Board of Agriculture.
- [What financial communication is most successful in reaching potential investors?](https://swedenbio.se/kalendarium/what-financial-communication-is-most-successful-in-reaching-potential-investors/) - There is not only this "don't miss if you are interested in IR" opportunity but also a good breakfast at PR Newswire at Stureplan 2, on October 6, 08:30-10:00. Hurry to hanna.nilsson@prnewswire.se because places are very limited
- [Successful drug development](https://swedenbio.se/kalendarium/successful-drug-development-2/) - Developing new medicines is costly and time-consuming. Everyone involved is taking great risks. At the same time, new innovative medicines and treatments are essential for top-class healthcare. It is therefore essential that new medicines and products make it all the way to the market and are taken up by the healthcare system, both for the
- [SWElife Diabetes Innovation](https://swedenbio.se/kalendarium/swelife-diabetes-innovation/) - Connect with scientists in academia and industry, and the health care system, as well as with public and private investors in a highly interactive and informal environment. IDENTIFY NEEDS - DISCUSS SOLUTIONS - FIND PARTNERS
- [Pharmaceutical Industry Day 2016](https://swedenbio.se/kalendarium/pharmaceutical-industry-day-2016/) - Theme: Use of medicines in a borderless healthcare environment The Pharmaceutical Riksdag gives FOKUS points according to the Swedish Pharmacists' point system for competence development.
- [Boundary issues between regulatory frameworks](https://swedenbio.se/kalendarium/boundary-issues-between-regulatory-frameworks/) - The delineation and classification of new products presents both challenges and opportunities. There are similar products on the market classified under different regulations. The key to success is to ensure compliance with regulatory and official requirements. Getting it right from the start saves time and money. The aim of the day is to provide participants
- [Pharmaceutical Congress 2015](https://swedenbio.se/kalendarium/pharmaceutical-congress-2015/) - Two days with three tracks for those working in pharmacy, the pharmaceutical industry, government, healthcare or academia. In-depth lectures, hands-on knowledge, debates and research fronts. Take part in skills development in research & development, manufacturing & trade and use & patient safety. Professional networking and mingle after the program on 9 November. Plan now for
- [Sweden - attractive enough for corporate research facilities?](https://swedenbio.se/kalendarium/sweden-attractive-enough-for-corporate-research-facilities/) - The research facilities of large high-tech companies are important for Sweden as a knowledge nation. They also act as innovative hubs for regions and the country as a whole through their cooperation with businesses and universities. What determines the location of research and development facilities by multinational companies? How can we attract new facilities and
- [Biohacking and the connected body](https://swedenbio.se/kalendarium/biohacking-and-the-connected-body/) - The pace of change in both medical technology and smart wearables is dramatic and opens new perspectives on the body as a technology platform. Welcome to a seminar, organized by IVA's Department of Biotechnology, on what is happening at the cutting edge of research, subcultural trends and the visions of leading technology thinkers. Get a
- [Medeon Life Science Network](https://swedenbio.se/kalendarium/medeon-life-science-network/) - You will hear from Anders Murmark, Atrium Ljungberg, Lars Wannerberger, Galenica and Marie Klint, Kaichron. The free network is open to members of the life science industry.
- [Monitoring course for research nurses, BMA, etc.](https://swedenbio.se/kalendarium/monitoring-course-for-research-nurses-bma-etc/) - According to the regulatory framework for clinical trials, the sponsor is responsible for the quality control of each study by an independent monitor. This also applies to investigator-initiated studies, where the investigator is also the sponsor. During the course, we go through how you as a monitor prepare, start up, monitor and end an investigator-initiated
- [Basic course in clinical trials](https://swedenbio.se/kalendarium/basic-course-in-clinical-trials/) - According to the regulatory framework for clinical trials, the sponsor is responsible for the quality control of each study by an independent monitor. This also applies to investigator-initiated studies, where the investigator is also the sponsor. During the course, we go through how you as a monitor prepare, start up, monitor and end an investigator-initiated
- [Clinical evaluation of medical devices](https://swedenbio.se/kalendarium/clinical-evaluation-of-medical-devices/) - Content and structure - The regulatory framework for medical devices - Standards and European guidelines - Clinical evaluation - verification of safety and performance through clinical data - Clinical evaluation - methodological aspects - The regulatory framework for clinical evaluation and clinical trials of medical devices - Statistics - Risk management - analyzing, assessing and
- [Quality assurance of clinical trials](https://swedenbio.se/kalendarium/quality-assurance-of-clinical-trials/) - In-depth course for those who have overall responsibility for quality assurance work on clinical trials, whether you work in industry or at the trial site, with academic studies or industry-sponsored ones. This is a revised version of the course previously entitled "Site audits in clinical trials". As before, we address the quality assurance work around
- [Medicon Weekend](https://swedenbio.se/kalendarium/medicon-weekend/) - Medicon Weekend will take place on October 15-16 at Medicon Village in Lund, Sweden. Organizers are Medicon Village in collaboration with Region Skåne and Lund University. The Challenge - They only have 3 hours! Under the leadership of Susanna Dzamic, an unexpected combination of experts are challenged on issues related to life sciences and growth.
- [Vinge & Norén's patent seminar](https://swedenbio.se/kalendarium/vinge-norens-patent-seminar/) - The seminar will address the following issues - Examples of how patents create value; license, assignment, damages - The life cycle of a patent; a case study highlighting some interesting issues (patent application, DD, assignment) - A real-life infringement case - News - The Unitary Patent Court, new European patent and patent litigation procedure
- [The Scheele Symposium 2015](https://swedenbio.se/kalendarium/the-scheele-symposium-2015/) - This Symposium in honor of the 2015 Scheele Award Laureate is going to be mindblowing. Come and get inspired by Langer and fellow scientists. A Symposium with focus on innovation!
- [Innovation procurement - what have we learned from New Karolinska?](https://swedenbio.se/kalendarium/innovation-procurement-what-have-we-learned-from-new-karolinska/) - When equipping New Karolinska Solna, innovation procurement and innovation-friendly procurement are used to create more efficient care at lower cost - and faster development of tomorrow's healthcare solutions. Listen to Stockholm County Council, Karolinska University Hospital, involved suppliers, VINNOVA, the Swedish Public Procurement Agency and leading politicians talk about their experiences.
- [Trends in organic chemistry - How are drugs born?](https://swedenbio.se/kalendarium/trends-in-organic-chemistry-how-are-drugs-born/) - Access to safe and effective medicines affects the lives of millions of people. Science-based drug development has been around for over 100 years. While there have been many successes in the fairly linear journey, in recent decades linearity has been declining and it seems increasingly difficult to develop new medicines. What are the reasons for
- [Successful drug development](https://swedenbio.se/kalendarium/successful-drug-development/) - Developing new medicines is costly and time-consuming. Everyone involved is taking great risks. At the same time, new innovative medicines and treatments are essential for top-class healthcare. It is therefore essential that new medicines and products make it all the way to the market and are taken up by the healthcare system, both for the
- [Digital health days](https://swedenbio.se/kalendarium/digital-health-days/) - After two successful events we are glad to announce that the next Digital Health Days will be arranged 23-24th of September 2015. Two days of inspiring seminars, challenging discussions and hands-on workshops.
- [SwedenBIO Summit (closed)](https://swedenbio.se/kalendarium/swedenbio-summit-closed/) - Finding your fit among the variety of business models of the life science industry Life science companies have one thing in common: the need for money. When looking closer into the sources whereby money is attained, a variety of financing strategies unfolds. Which is the successful choice? They can be all, as long as you
- [Roundtable discussion: What do you need to be fundable in 2024?](https://swedenbio.se/kalendarium/roundtable-discussion-what-do-you-need-to-be-fundable-in-2024/) - With the evolving landscape and investor outlook and the challenges of developing new technologies and assets in the current biotech environment, this is an insightful and in-depth roundtable discussion with Syneos Health® and one of their strategic partners, TreeHill Partners, focusing on the key areas which should be considered by biotech companies to ensure they
- [Biologics Drug Development-3 day course](https://swedenbio.se/kalendarium/biologics-drug-development-3-day-course-2/) - Drug development of various types of biologic products is a complex and multidisciplinary process. The development integrates knowledge of the underlying disease, target identification, principles on biologics safety, planning strategy for toxicology and clinical studies incorporating the key aspects of manufacturing and controls. This three-day course provides insights into all parts that should be addressed
- [SwedenBIO i Göteborg/GoCo ](https://swedenbio.se/kalendarium/swedenbio-i-goteborg-goco/) - Vi välkomnar medlemmar och intresserade bolag för lite fredags-bubbel och något sött på Vigor & Joy's på GoCo mellan 13-14. Kom förbi och säg hej!!
- [Seminarium - så lyckas du med kapitalanskaffningen som onoterat life science-bolag](https://swedenbio.se/kalendarium/seminarium-sa-lyckas-du-med-kapitalanskaffningen-som-onoterat-life-science-bolag/) - Sciety brinner för innovationer, forskning och bolagsbyggande inom life science och digital hälsa. Därför bjuder vi in dig som forskar eller driver bolag till ett seminarium där vi delar med oss av våra bästa tips på hur du reser kapital. Vi kommer att prata om allt från hur man kommunicerar rätt till vad som är
- [Biotech Showcase™ 2024](https://swedenbio.se/kalendarium/biotech-showcase-2024/) - Biotech Showcase™ is an investor and networking conference devoted to providing private and micro-mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives. The event will be back in San Francisco, January 8–10, 2024, to continue to fulfil its mission of providing a forum for investors and biopharma innovators to
- [Vinnova seminarium: Kompetensförsörjning i life science-sektorn](https://swedenbio.se/kalendarium/seminarium-kompetensforsorjning-i-life-science-sektorn/) - Life science är en starkt växande sektor i Sverige, men kompetensåterväxten pekar i en annan riktning. Det visar Vinnovas första statistikrapport om de svenska life science-företagen. Välkommen på webbsänt seminarium där Vinnova tillsammans med gäster från branschen utforskar utmaningarna och hur vi bäst säkerställer kompetensförsörjningen för framtiden.Anmäl dig senast 15 september. Mer info och anmälan
- [<strong>BIO-Europe<sup>®</sup> 2023</strong> ](https://swedenbio.se/kalendarium/bio-europe-2023/) - Access the global biopharma community all under one roof at BIO-Europe­­®. After being delivered virtually for two years, the event returned face-to-face in 2022 breaking all records—becoming the biopharma reunion of the year. In 2023, BIO-Europe will continue to raise the bar with another record-breaking year. The 29th annual BIO-Europe will take place November 6–8,
- [Hesa-Fredrik AW på Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-pa-haymarket-4/) - Varje kvartal när Hesa Fredrik kallar* vill vi att du stänger av datorn, avslutar experimentet och signerar den där avvikelserapporten. För det är då dags att bege sig mot Life Science Stockholms nya vattenhål. Där får du möjlighet att knyta nya kontakter, bolla idéer och lösa knutar. Vi på SwedenBIO, i samarbete med våra medlemmar,
- [Hesa-Fredrik AW på Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-pa-haymarket/) - Varje kvartal när Hesa Fredrik kallar* vill vi att du stänger av datorn, avslutar experimentet och signerar den där avvikelserapporten. För det är då dags att bege sig mot Life Science Stockholms nya vattenhål. Där får du möjlighet att knyta nya kontakter, bolla idéer och lösa knutar. Vi på SwedenBIO, i samarbete med våra medlemmar, vill
- [Hesa-Fredrik AW på Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-pa-haymarket-2/) - Varje kvartal när Hesa Fredrik kallar* vill vi att du stänger av datorn, avslutar experimentet och signerar den där avvikelserapporten. För det är då dags att bege sig mot Life Science Stockholms nya vattenhål. Där får du möjlighet att knyta nya kontakter, bolla idéer och lösa knutar. Vi på SwedenBIO, i samarbete med våra medlemmar, vill
- [Hesa-Fredrik AW på Haymarket](https://swedenbio.se/kalendarium/hesa-fredrik-aw-pa-haymarket-3/) - Varje kvartal när Hesa Fredrik kallar* vill vi att du stänger av datorn, avslutar experimentet och signerar den där avvikelserapporten. För det är då dags att bege sig mot Life Science Stockholms nya vattenhål. Där får du möjlighet att knyta nya kontakter, bolla idéer och lösa knutar. Vi på SwedenBIO, i samarbete med våra medlemmar,
- [Stormöte för förtroendevalda inom SwedenBIO ](https://swedenbio.se/kalendarium/stormote-for-fortroendevalda-inom-swedenbio/) - Stormötet syftar till att identifiera glapp, överlapp och synergier mellan grupper samt utmana och finslipa SwedenBIOs fokusfrågor. Mer information kommer närmare mötet, men hör gärna av dig till vår Science Director Maja Neiman om du har frågor! Vi hoppas att vi ses där! SwedenBIO-kansliet
- [Almedalen – Paneldiskussion: Svensk life science i en konkurrensutsatt omvärld](https://swedenbio.se/kalendarium/almedalen-paneldiskussion-svensk-life-science-i-en-konkurrensutsatt-omvarld/) - På en världsmarknad där många industrier i många länder kämpar för att behålla fotfästet står sig Sveriges life science-industri väl. Vår innovationskraft inom läkemedelsutveckling överstiger den jämförelsevis modesta nivån av investeringar som görs i branschen, vi uppvisar goda resultat vad gäller att omvandla akademiska upptäckter till kommersiella produkter som gagnar patienter, och läkemedel är Sveriges
- [Almedalen – SwedenBIO:s trädgårdsmingel](https://swedenbio.se/kalendarium/almedalen-3/) - SwedenBIO kommer vara på plats i Almedalen även i år och bjuder in till det sedvanliga trädgårdsminglet i vårt hus på Visborgsgatan. Onsdagen den 28:e juni kl. 17:00 ser vi fram emot att mötas i sommarvärmen under årets mest späckade politikervecka för att umgås och utbyta tankar kring dagsfärska frågor på vårt trädgårdsmingel. Vi bjuder på god
- [Nordic Mixer at BIO](https://swedenbio.se/kalendarium/nordic-mixer-at-bio/) - To increase visibility of Swedish life science community and promote networking, SwedenBIO is organizing activities in Boston during BIO. Please save-the-dates - more information to come before the event. To ensure receiving all information, please let us know that you’re attending BIO, if you haven’t yet been in touch with Frida or Marjo. Location and more
- [Science for Breakfast with SwedenBIO](https://swedenbio.se/kalendarium/science-for-breakfast-with-swedenbio/) - SwedenBIO presents new CEO and pipeline-data over breakfast! Come enjoy breakfast while SwedenBIOs new CEO, Jessica Martinsson, presents highlights from the life science community and the 2023 pipeline report. On March 8, SwedenBIO launched the 2023 edition of the The Swedish Drug Discovery and Development Pipeline Report, containing a mapping of the pharmaceutical pipeline run by
- [BioStock Life Science Summit](https://swedenbio.se/kalendarium/biostock-life-science-summit/) - BioStock Life Science Spring Summit är en av Nordens viktigaste plattformar för privata och börsnoterade innovationsbolag att presentera sina projekt inför såväl svenska som internationella investerare, branschkollegor och potentiella samarbetspartners. Detta digitala event visar upp den stora bredd och innovationshöjd nordisk life science-sektor erbjuder, under två fullmatade programdagar som enkelt och bekvämt kan följas via valfri skärm. Detaljerad programinformation kommer att presenteras
- [Reflektionsseminarium och slutfest kring EU-ordförandeskapet](https://swedenbio.se/kalendarium/life-science-konferens-after-party/) - Direkt efter den officiella konferensen bjuder Kungl. Ingenjörsvetenskapsakademien IVA och SwedenBIO in till ett reflektionsseminarium om life science-konferensen och EU-ordförandeskapet. Därefter anordnas en life science-slutfest i Hagastaden för alla engagerade inom life science-ekosystemet, tillsammans med många andra aktörer. Mer information och anmälan finns här.
- [Workshop om RNA-LNP och icke-virala vektorer](https://swedenbio.se/kalendarium/workshop-om-rna-lnp-och-icke-virala-vektorer/) - Mer systematiska karakteriseringsinsatser och öppet utbyte av kunskap inom området krävs för att påskynda en effektiv och rationell strategi för LNP-utveckling. Under denna workshop kommer framstående forskare inom området att dela med sig av sina erfarenheter och engagera sig i diskussioner med ett bredare samhälle om karaktärisering och utveckling av LNP-vektorer för leverans av nukleinsyror.
- [Frukostseminarium: Kapital, kontakter och kommunikation: Så tar framgångsrika life-science bolag nästa steg i utvecklingsresan](https://swedenbio.se/kalendarium/frukostseminarium-kapital-kontakter-och-kommunikation-sa-tar-framgangsrika-life-science-bolag-nasta-steg-i-utvecklingsresan/) - Enligt SwedenBIOs färska pipeline-rapport upplever många life science-bolag just nu stora utmaningar. Bland dessa återfinns svårigheter att rekrytera personal med rätt kompetens, att attrahera tillväxtkapital och att skapa goda förutsättningar för en framgångsrik kommersialisering. För att kunna dela värdefulla insikter kring hur life science-bolag bäst kan hantera de utmaningar som bolagen ställs inför så har
- [Nordic Health Summit Japan](https://swedenbio.se/kalendarium/nordic-health-summit-japan/) - Nordic Health Summit Japan 2023 is a partnering and investor conference that connects Nordic healthcare innovations and Japanese investors and industry. We invite innovative Nordic health tech and life science companies to meet with Japanese stakeholders, including pharmaceutical companies, investors and medical device companies, who are eager to connect with the Nordics. This is a
- [Friends with benefits: How your life science company can benefit from MAX IV and ESS - Seminar](https://swedenbio.se/kalendarium/friends-with-benefits-how-your-life-science-company-can-benefit-from-max-iv-and-ess/) - Join us for a seminar on May 9th, 09:00–11:00, where Esko Oksanen (Instrument Scientist at ESS) and Marc Obiols-Rabasa (Industrial Relations Officer at MAX IV) will introduce you to the facilities and the possibilities they provide for researchers at life science companies. Per Brunmark from SmiLe Incubator will tell you more about how they guide
- [Biostock Investor Meeting 2023](https://swedenbio.se/kalendarium/biostock-investor-meeting-2023/) - BioStock Investor Meeting will be broadcasted online on this page and on our YouTube channel PROGRAM 10.00 Abliva10.20 Xbrane Biopharma10.40 Xintela11.00 Chordate Medical11.20 Aqilion – Expert insights11.40 QuiaPEG Pharmaceuticals12.00 WntResearch12.20 Arcede Pharma12.40 Closing remarks Additional companies may be added. EVENT DETAILS Where? The event will be broadcasted online on this page and on our YouTube channel. When? Thursday March
- [Bio€quity Europe 2023](https://swedenbio.se/kalendarium/bioequity-europe-2023/) - Join the discussion in Dublin or attend from home via a digital pass. Plus take advantage of two bonus days of digital one-to-one meetings. Now in our 23rd year, Bio€quity heads to Dublin, Ireland*, May 14-16, 2023, with a program focused on how to create a new playbook for biotech success in Europe. BioCentury and
- [Knowledge for Growth](https://swedenbio.se/kalendarium/knowledge-for-growth-3/) - The cream of the European life sciences community will be attending this business conference, attracting decision makers from biotech, pharma and MedTech as well as investors, universities, top-notch research institutes, policymakers, and competence providers. Join us and hundreds of life sciences professionals from about 500+ companies & organisations. The conference features an exciting programme, providing
- [Swiss Biotech Day 2023](https://swedenbio.se/kalendarium/swiss-biotech-day-2023/) - In 2022, the conference demonstrated the impressive growth of the Swiss biotech industry and presented an exciting program with ideal networking opportunities for over 1,100 participants across the globe. In 2023, the Swiss Biotech Day will again offer high-level experts from the life science industry the space to network, discuss and discover trends in R&D,
- [BIO International Convention in Boston 2023](https://swedenbio.se/kalendarium/bio-boston/) - BIO International Convention in Boston 2023 offers: One-on-One Partnering:The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Engaging ProgrammingInnovative programming around the current and future state of biotech. Including areas like therapeutic frontiers, the business of biotech, regulatory and policy outlooks,
- [SwedenBIO Annual Meeting and Executive Dinner 2023](https://swedenbio.se/kalendarium/swedenbios-arsmote-och-executive-dinner-2/) - Together with our main sponsor Erik Penser Bank, we’re happy to invite you to this years's Executive Dinner! Welcome to an evening full of networking with friends and colleagues from the industry - after feedback from the previous year food and drinks will be served in a nice mingle format. When: 10th of May at Färgfabriken, Stockholm
- [Anglo Nordic Life Science Conference 2023](https://swedenbio.se/kalendarium/anglo-nordic-life-science-conference-2023/) - 20th April 2023, the reception 19th April 2023 London, UK This year we are pleased to announce that the Swedish Ambassador to the UK, H.E. Ms Mikaela Kumlin Granit, invites registered Anglonordic Life Science Conference attendees to take part in drinks, canapes and networking at the Swedish Ambassador's Residence. Date & time: 19 April, 2023 |
- [Swiss Nordic Bio](https://swedenbio.se/kalendarium/swiss-nordic-bio-2/) - Swiss Nordic Bio carries 16 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners The conference has a broad focus within biotech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as
- [BIO-Europe spring 2023](https://swedenbio.se/kalendarium/bio-europe-spring-2023/) - BIO-Europe Spring attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts. Don't miss out! Read more here. As a SwedenBIO member you are offered a discount at BIO-Europe spring 2023. To receive the discount code please contact Marjo
- [Report launch: The Swedish Drug Discovery and Development Pipeline 2023](https://swedenbio.se/kalendarium/lansering-the-swedish-drug-discovery-and-development-pipeline-report/) - Tune in for key findings in the Swedish Drug Discovery and Development Pipeline Report 2023. We mark the release of the report by a live broadcast, Wednesday March 8th at 14.00, from the studio of our member and launch partner, DNB. You are welcome to submit questions during the broadcast. The report can be found
- [Nordic Life Science Days 2023](https://swedenbio.se/kalendarium/nordic-life-science-days-2023/) - This will be a unique opportunity to partner and network with the best of Nordic and International leaders in life sciences and celebrate together our 10th anniversary. Learn more and register as a delegate, exhibitor, investor, sponsor or company on nldays.com.
- [Läkemedelstillverkning för ett konkurrenskraftigt och friskare Sverige](https://swedenbio.se/kalendarium/lakemedelstillverkning-for-ett-konkurrenskraftigt-och-friskare-sverige/) - SwedenBIO arrangerar i samarbete med AstraZeneca, Pfizer, Novavax, Recipharm, APL, Valneva, NorthX Biologics, Phase2Phase Biopharma och Mpya Sci & Tech en halvdagskonferens med läkemedelstillverkning i fokus. Det här är ett möte som vänder sig till beslutsfattare och ett sätt för branschen att sträcka ut en hand för fördjupade samarbeten, nya perspektiv och ökad kunskap. Programmet
- [The Importance of Regulatory CMC Strategy During Early Development](https://swedenbio.se/kalendarium/the-importance-of-regulatory-cmc-strategy-during-early-development/) - Having the right Chemistry, Manufacturing, and Controls (CMC) documentation throughout drug development is essential for avoiding pitfalls, ensuring an efficient regulatory review process, and achieving the goals for your product. The key is an early development regulatory strategy that includes CMC. Join LINK Medical Research regulatory CMC webinar to strengthen your knowledge of how regulatory CMC
- [RESI Boston](https://swedenbio.se/kalendarium/resi-boston/) - More information about this RESI Conferences will come soon. As a SwedenBIO member you are offered a discount at RESI Boston. To receive the discount code please contact Frida Eriksson on frida.eriksson@swedenbio.se
- [Swedish Life Science Reception](https://swedenbio.se/kalendarium/swedish-life-science-reception/) - Have a drink and seize the opportunity to network and build stronger bonds within our booming business communities. Warmly welcome to Business Sweden’s office downtown, just two blocks from Union Square, on January 10th, from 5:30pm. Read more and register here.
- [RESI JPM San Francisco](https://swedenbio.se/kalendarium/resi-jpm-san-francisco/) - RESI San Francisco is an in-person conference with two days of dedicated to virtual-only partnering. Virtual attendees may attend for this option. The one day of in-person partnering also features expert panels, educational workshops, and the Innovator’s Pitch Challenge. Read more and register here. As a SwedenBIO member you are offered a 50% discount at
- [Nordic American Life Science Conference 2022](https://swedenbio.se/kalendarium/nordic-american-life-science-conference-2022/) - Welcome to the most comprehensive gathering of Nordic life science innovation in the US, covering key company developments and trends from Norway, Sweden, Denmark, Finland and Iceland. The only event of its kind in the US, providing the largest US-Nordic forum in the US for life sciences, while at the same time being an intimate
- [Park Annual 2022 by Sahlgrenska Science Park](https://swedenbio.se/kalendarium/park-annual-2022-by-sahlgrenska-science-park/) - Ett fysiskt event där det bjuds på tankeväckande presentationer och diskussioner, flera startups som pitchar sina idéer och Arvid Carlsson Award by Sahlgrenska Science Park som delas ut för 6:e året i rad. Läs mer och anmäl dig här.
- [Biotech Showcase 2023](https://swedenbio.se/kalendarium/biotech-showcase-2022/) - The conference offers 3 days in-person, 2 days virtually. Biotech Showcase ™ is an investor and partnering conference devoted to providing private and small and mid-cap biotechnology companies an opportunity to present and meet investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attract investors and biopharmaceuticals executives
- [J.P. Morgan Healthcare Conference](https://swedenbio.se/kalendarium/j-p-morgan-healthcare-conference/) - The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. Read more and register here.
- [Drug Development: 3 day course](https://swedenbio.se/kalendarium/drug-development-3-day-course-3/) - Drug development projects are often initiated by identifying treatment for a disease. The project usually contains a deep knowledge of the disease and the biological mechanism. However, in order to develop a drug for the disease, a broad knowledge of many different areas is required. This three-day course provides insights into all the parts that
- [BioStock Life Science Summit 2022](https://swedenbio.se/kalendarium/biostock-life-science-summit-2022/) - This year, we will meet in person, as more than 30 listed and private companies from a wide range of therapeutic areas present their innovations and business cases to invited investors. The programme also includes insights from professional investors and sector experts. Take the opportunity to listen to, mingle with and maybe even pitch to industry
- [SwedenBIO Summit 2022](https://swedenbio.se/kalendarium/swedenbio-summit-2022/) - This year we focus on the foundations necessary for building strong and resilient companies. We take inspiration from the pillars introduced by the international Worldview Ranking of health biotech sectors and translate them to intimate business stories. You will hear tales of success, and tales of hurdles and obstacles. You will also see a sneak peek of
- [Meet your regulator](https://swedenbio.se/kalendarium/meet-your-regulator-2/) - Anmäl i förväg vilket eller vilka områden du har frågor om. Vi svarar till exempel på frågor om: Protokoll för klinisk läkemedelsprövningTillverkning av läkemedel under utvecklingPreklinisk utvecklingVal av procedur för att få försäljningstillstånd i Sverige eller i EU. Det finns begränsat antal platser och det tas emot max två per företag. Det är först till
- [Meet your regulator](https://swedenbio.se/kalendarium/meet-your-regulator/) - Anmäl i förväg vilket eller vilka områden du har frågor om. Vi svarar till exempel på frågor om: Protokoll för klinisk läkemedelsprövningTillverkning av läkemedel under utvecklingPreklinisk utvecklingVal av procedur för att få försäljningstillstånd i Sverige eller i EU. Det finns begränsat antal platser och det tas emot max två per företag. Det är först till
- [Digital Health and AI: Benefits and Costs of Data Sharing in the EU ](https://swedenbio.se/kalendarium/digital-health-and-ai-benefits-and-costs-of-data-sharing-in-the-eu/) - The debate with expert policymakers, academics, industry and civil society representatives will provide the opportunity to exchange opinions on the impact and challenges of using new digital health technologies, and to identify areas of consensus and/or disagreement among experts. The event will also feature lessons learned from the COVID-19 pandemic and the need for better
- [Regulatoriska processer för prestandastudier (IVDR)](https://swedenbio.se/kalendarium/regulatoriska-processer-for-prestandastudier-ivdr/) - Presentation av det regulatoriska ramverk som reglerar prestandastudier av medicintekniska produkter för in vitro-diagnostik och vad som är aktuellt i Sverige. Regelverket (övergripande)Myndigheternas uppdrag och rollAnmälan och ansökan till Läkemedelsverket när flera regelverk behöver tillämpas samtidigt (till exempel CTR och IVDR). Föreläsare: Anna Skott, Regulatorisk utredare medicinteknik, Läkemedelsverket. Upplägget är cirka 45 minuter föreläsning och därefter
- [Klinisk prövning av läkemedel för avancerad terapi (ATMP)](https://swedenbio.se/kalendarium/klinisk-provning-av-lakemedel-for-avancerad-terapi-atmp/) - Tema: Regelverk och stöd vid utveckling Hur ser regelverket ut, vad omfattar det?Vad är viktigt att tänka på vid utveckling av ATMP?Ansökan om klinisk prövning av ATMP.Stöd och möjlighet till rådgivning. Föreläsare: Miriam Idar, Regulatorisk utredare avancerade terapier, Läkemedelsverket Upplägget är cirka 45 minuter föreläsning och därefter finns utrymme för frågor i cirka 15 minuter.
- [Register i klinisk forskning – en värdefull resurs](https://swedenbio.se/kalendarium/register-i-klinisk-forskning-en-vardefull-resurs/) - Innehåll: Genomgång av tillgängliga nationella register, hur de kan och får användas, olika möjliga projektupplägg med olika samverkanspartners. Kursen innehåller även övningar med praktiska handfasta råd för planering av en registerstudie. Nationella kvalitetsregisterSCB:s registerSocialstyrelsen:s registerMetadataverktyg för planering av registerforskningJuridiska möjligheter för registerforskningKvalitetssäkring av registerdataForskning på samkörda data från olika registerRandomiserade registerstudierPatientsamverkan och forskning på patientrapporterade
- [Välkommen till Oktoberfest hos EY!](https://swedenbio.se/kalendarium/valkommen-till-oktoberfest-hos-ey/) - Förutom traditionell mat, mingel med nya och gamla kontakter, har vi bett experterna på EY att dela med sig om ett par aktuella ämnen: Stipendier och Forskningsavdrag. Boosta ditt företags innovationsprofil och se till att du söker det du är berättigad till och som många företag missar.Hållbarhet med människan i fokus. Hur kan vi som arbetsgivare bäst
- [Webbinarium: Nationella piloten för repurposing](https://swedenbio.se/kalendarium/nationella-piloten-for-repurposing/) - Målsättningen är att ta fram en metod för att ge vetenskapligt och regulatoriskt stöd till akademiska forskare för att etablera nya indikationer för äldre läkemedel utanför patentskydd. Välkommen att höra mer om hur projektet fortskrider och få en möjlighet att ställa frågor till Läkemedelsverket. Det nationella pilotprojektet repurposing startades upp 2 februari 2022 av Läkemedelsverket i
- [Stockholm Life Science Conference](https://swedenbio.se/kalendarium/stockholm-life-science-conference/) - The COVID-19 pandemic is still not over. Yet now is the time to harness the momentum of the successes and the lessons learned. The collaborative effort leading to the rapid development of new vaccines and treatments is a true success story. But we have also seen what needs to be done better next time crisis
- [Så tar du fram och kommunicerar en strategisk forsknings- och innovationsagenda](https://swedenbio.se/kalendarium/sa-tar-du-fram-och-kommunicerar-en-strategisk-forsknings-och-innovationsagenda/) - Strategiska innovationsprogram har det senaste decenniet spelat en central roll i finansieringen av forskning och utveckling i Sverige. När ansvariga myndigheter nu förbereder nästa generations innovationsprogram, Impact Innovation, ges möjlighet för olika näringar att se över sitt strategiska arbete. Till grund för ett strategiskt innovationsprogram ligger en strategisk forsknings- och innovationsagenda. Trots att dokumentet har
- [FOKUS Patient Event 2022](https://swedenbio.se/kalendarium/fokus-patient-event-2022/) - Dagar och teman: 3/10 Patientsäkerhet i Sverige, Europa och världen - En heldag kring patientsäkerhet som berör alla patientgrupper, hälso- och sjukvården, life science-företag och offentliga verksamheter om hur patientsäkerhet kan se ut och arbetas med på olika sätt och ur olika perspektiv såväl i Sverige som i andra länder. 4/10 Forum för Kardiovaskulära sjukdomar -
- [BIO-Europe 2022](https://swedenbio.se/kalendarium/bio-europe-2022/) - BIO-Europe is finally back for life sciences partnering in person! This will be the first in-person BIO-Europe since its 2019 edition in Hamburg, Germany. It’s time to build real bridges with real people again. There’s no better place to do that than in lovely Leipzig, the city with more bridges than Venice, at BIO-Europe, the
- [Data Driven Collaboration: Blueprint for a Successful Life Science Nation](https://swedenbio.se/kalendarium/data-driven-collaboration-blueprint-for-a-successful-life-science-nation/) - Real world evidence (RWE) is fundamentally transforming the future of the life science sector in Sweden, at European level and globally. Unlike traditional research, RWE provides insights of what happens in the everyday clinical practice. This can deepen the understanding of how the individual patient and a heterogenous patient population will respond to a treatment,
- [Strategi- och affärsutveckling för life science-ledare](https://swedenbio.se/kalendarium/strategi-och-affarsutveckling-for-life-science-ledare/) - Utvärdering av tidigare kurs 100% av deltagarna skulle rekommendera kursen till en branschkollega.Citat från kursdeltagare: "Ger bredd och djup samtidigt samt möjlighet för interaktion och utbyte från kursdeltagare." Kursinnehåll I denna kurs ger erfarna och seniora experter inom life science dig en fördjupad förståelse för de mest affärskritiska skeendena i ett bolags utveckling: Att välja
- [Framtidens läkemedelsutveckling](https://swedenbio.se/kalendarium/framtidens-lakemedelsutveckling/) - Ur programmet Jenni Nordborg, Life Science-samordnare, Regeringskansliet Två block med efterföljande panelsamtal efter presentationer ifrån en bredd av företag och myndigheter med koppling till framtidens läkemedel Läs mer och anmäl dig här.
- [Health data and its potential for the future of Life Science](https://swedenbio.se/kalendarium/health-data-and-its-potential-for-the-future-of-life-science/) - The session contains two parts: Panel talk 15.30 - 16.30 The session will invite to a themed data panel talk presented by Devicia. The session will be held in English and the names of the panel partcipants will be released in August. After-Work 16.30 - 18.00Afterward, we round up an after-work and the opportunity to network. Read more
- [<strong>Health data and its potential</strong><br><strong>for the future of Life Science</strong>](https://swedenbio.se/kalendarium/health-data-and-its-potentialfor-the-future-of-life-science/) - Invitation August 30 at 15:30 -16:30 We need to collaborate to find new creative ways to accelerate Health Innovation. Together with GoCo, dNovo, Kickfile and Devicia we invite you to an afternoon session at GoCo Arena to meet in a new context to talk about challenges and opportunities with Health Data and its potential for the future of
- [SwedenBIO i Almedalen](https://swedenbio.se/kalendarium/swedenbio-i-almedalen/) - Välkommen att besöka oss i SwedenBIO-huset under Almedalsveckan. Vi finns på Visborgsgatan 5 i Visby under måndagen till onsdagen, med egna och medlemmars aktiviteter i vår mysiga trädgård. Almedalsveckan är fullspäckad med life science-event som vi och våra medlemsbolag organiserar! Vi har satt ihop hela listan över våra och våra medlemmars kommande sammankomster. Ta del
- [Karolinska Institutet Science Park DAY 2022](https://swedenbio.se/kalendarium/a-thriving-life-science-ecosystem-for-innovation-growth/) - Welcome to KI Science Park DAY 2022. The primary target group is life science companies, but also researchers and clinics are welcomed so the meeting breathes “triple helix”. Focus on innovation and collaboration. Read more and register here.
- [Get to know SwedenBIO over breakfast or drinks in Lund!](https://swedenbio.se/kalendarium/get-to-know-swedenbio-over-breakfast-or-drinks-in-lund/) - We want to show you how important the life science industry is for Sweden, how important Skåne is for the life science community, and what SwedenBIO does to support the community. Most of all, we want to get to know you! Sign up and tell a friend! Everyone is welcome but remember to register. Breakfast:
- [BioStock Life Science Spring Summit](https://swedenbio.se/kalendarium/biostock-life-science-spring-summit/) - BioStock Life Science Spring Summit offers an important platform for Nordic innovation companies, who get the chance to pitch their projects to Swedish and international investors, industry colleagues and potential partners. BioStock Life Science Spring Summit offers a broad line-up of Nordic innovation companies, that despite a relatively small local market, manage to attract industrial partnerships, research
- [Next generation commercialization for Life Science](https://swedenbio.se/kalendarium/next-generation-commercialization-for-life-science/) - EVERSANA welcome you to a breakfast program that examines best practices to expand into the U.S. market. The pharmaceutical pipeline is gaining momentum, led by many first-time launchers. But the reality is companies spend more than $200 million over three years leading up to launch, and 66% of drugs still don’t meet launch expectations. Session: Trends
- [JIM Symposium](https://swedenbio.se/kalendarium/jim-symposium/) - This symposium focuses on how precision medicine will change and improve diagnostics, treatment and prevention, as well as the potential for research and innovation within the precision medicine framework. Focus areas for the conference are cancer, rare diseases and complex diseases. Practice examples showcasing how precision medicine has been implemented in Europe will be presented
- [Klinisk prövning av läkemedel med genetiskt modifierade organismer](https://swedenbio.se/kalendarium/klinisk-provning-av-lakemedel-med-genetiskt-modifierade-organismer/) - Syftet med webbinarimet är att klargöra vad som gäller vid klinisk prövning av läkemedel som innehåller eller består av genetiskt modifierade (mikro-) organismer med fokus på: Regelverk och gränsdragning mellan myndigheternas ansvarsområdenAnsökan om avsiktlig utsättning respektive anmälan/ansökan om innesluten användning – och vad som ska skickas in till myndigheterna. Webbinariet riktar sig till personer inom
- [Dialogforum del 3](https://swedenbio.se/kalendarium/dialogforum-del-3/) - Regulatoriska processer del 3 – Regelverk för kliniska läkemedels­prövningar på människa. Syftet är att ge en översikt av det regulatoriska ramverk som reglerar kliniska läkemedelsprövningar. Seminariet kommer att täcka in: Myndigheternas uppdrag och rollRegelverket (övergripande)Tips och råd. Föreläsare: Gunilla Andrew-Nielsen, enhetschef för Kliniska prövningar och licenser, Läkemedelsverket. Upplägget är cirka 45 minuter föreläsning och därefter
- [Dialogforum del 2](https://swedenbio.se/kalendarium/dialogforum-strategiska-och-praktiska-aspekter-pa-lakemedelsgodkannande/) - Regulatoriska processer del 2 – Strategiska och praktiska aspekter på läkemedelsgodkännande. Syftet är att ge en översikt av regulatoriska aspekter för att få ut ett läkemedel på marknaden. Seminariet kommer att täcka in: Hur är en ansökan uppbyggdVal av godkännande procedur - strategiska utmaningarVilken hjälp kan man få? Regulatorisk och vetenskaplig rådgivning (nationell/central). Upplägget är
- [Dialogforum del 1](https://swedenbio.se/kalendarium/dialogforum-del-1-regulatoriska-processer/) - Den 24 maj är temat Regulatoriska processer del 1 – Regelverk för läkemedels­godkännande. Syftet är att ge en översikt av det regulatoriska ramverk som reglerar läkemedelsgodkännande (Försäljningsgodkännande). Seminariet kommer att täcka in: Dialogforum (Läkemedelsverket GD Björn Eriksson, Vice VD SwedenBIO Frida Lawenius)Myndigheternas uppdrag och rollRegelverket (övergripande)Olika typer av nyansökningar (legal grund). Upplägget är cirka 45
- [Dialogforum del 4](https://swedenbio.se/kalendarium/dialogforum-del-4/) - Regulatoriska processer del 4 – Kliniska prövningar av medicintekniska produkter. Syftet är att ge en översikt av regulatoriska ramverk som reglerar kliniska prövningar av medicintekniska produkter. Seminariet kommer att täcka in: Myndigheternas uppdrag och rollRegelverket (övergripande)Tips och råd. Föreläsare: Elin Karlberg, gruppchef för regulatoriska gruppen inom kliniska prövningar, Läkemedelsverket. Upplägget är cirka 45 minuter föreläsning
- [ChinaBio Partnering Forum 2022](https://swedenbio.se/kalendarium/chinabio-partnering-forum-2022/) - ChinaBio Partnering Forum returns to Beijing! 2 days in-person, 2 days virtually. This year's hybrid event enables you to identify, meet and network with leaders across the life science value chain. Read more and register here. As a SwedenBIO member you are offered a special discount at ChinaBio Partnering Forum 2022. To receive the discount code
- [Årsmöte och Executive Dinner (SwedenBIO 20 år!)](https://swedenbio.se/kalendarium/arsmote-och-executive-dinner/) - Välkommen att delta på SwedenBIO:s årsmöte med påföljande jubileumsmiddag. I guldglimrande inramning vill vi fira 20-årsjubileumet tillsammans med er. Som sig bör blir det en storslagen afton i gott sällskap och underhållning i världsklass!Observera redan nu att deadline för att skicka in motioner till årsmötet är 19/3. Passa på att göra din röst hörd så att
- [Seminarium om kapitalanskaffning](https://swedenbio.se/kalendarium/seminarium-om-kapitalanskaffning/) - Så lyckas du med kapitalanskaffning som onoterat life science-bolag Många som driver life science-bolag kan uppleva utmaningar kring finansiering. Det är ofta tidskrävande och väcker många frågor: Vilka investeringsaktörer finns det och vilken aktör passar bäst för vårt bolag? Vad är viktigt att tänka på när det gäller villkor och avtal? Hur kommunicerar vi potentialen
- [Opening the Ivory Tower Wide](https://swedenbio.se/kalendarium/opening-the-ivory-tower-wide/) - Sessions:I. Path from Scientific Research to Impact and Industry II. Freedom vs Impact? Role of Universities and FundersIII. Life Science Research for the Benefit of Patients and SocietyIV. Science Communication and Policy Advice The symposium is organized by the Swedish Collegium for Advanced Study (scas) and is an event of its Natural Sciences Programme (Measurable Human).
- [Tips to adapt to today’s auditing environment, an auditor’s perspective](https://swedenbio.se/kalendarium/tips-to-adapt-to-todays-auditing-environment-an-auditors-perspective/) - ProPharma Group offers a live webinar, free of charge, focusing on: Understand how we have adapted to hybrid auditingUnderstand how to overcome auditing challengesUnderstand how you can manage global vendor audit programs Click here for more info and registration.
- [Kvalitetsregister för forskning 5 maj 2022](https://swedenbio.se/kalendarium/kvalitetsregister-for-forskning-5-maj-2022/) - Lägre avgift till och med 31 mars! Konferensen kommer i år att livestreamas från Piperska Muren i Stockholm, du väljer om du deltar på plats i Stockholm eller online. Ta del av aktuella frågor om kvalitetsregisterforskning och få möjlighet att diskutera metoder över disciplin- och professionsgränser. Programmet innehåller såväl nationella exempel på hur kvalitetsregister används
- [Biocompatibility Matters 2022](https://swedenbio.se/kalendarium/biocompatibility-matters-2022/) - Program Advisor Committee Sherry Parker Senior Director of Regulatory Toxicology at WuXi AppTec Medical Device Testing – St. Paul, MN, USTed Heise Vice President, Regulatory and Clinical Services at MED Institute, USRon Brown Toxicologist at Risk Science Consortium, USArthur Brandwood Medtech Regulatory Expert with International Perspective, AustraliaLars-Magnus Bjursten Senior professor Bioimplant Research. Convener ISO 18562 series. Sweden.Philip Clay Director at Chorley
- [Biocom California's Global Life Science Partnering Conference](https://swedenbio.se/kalendarium/biocom-californias-global-life-science-partnering-conference/) - The partnering conference and the relationships you build promise to be fruitful for your business ventures this year and for many years to come. We are excited by the prospect of continuing an annual bio-pharma partnering conference that brings together leading deal makers and emerging biotechs from around the world, while providing a local San
- [Swiss Biotech Day 2022](https://swedenbio.se/kalendarium/swiss-biotech-day-2022/) - What to expect: Meet 850+ senior experts from the life science industry50+ exhibition from across EuropeDelegations from various regionsGeneral Assembly of the Swiss Biotech AssociationSwiss Biotech Success Stories AwardsInnovative biotech start-ups and medium-sized biotech companiesThematically focused panel discussionsPre-scheduled one-to-one partnering meetingsRead more and register here.
- [BIO 2022 San Diego (BIO International Convention)](https://swedenbio.se/kalendarium/bio-2022-san-diego-bio-international-convention/) - BIO is thrilled to be back in person for the 2022 International Convention happening in San Diego, CA June 13-16. The Convention theme ‘LIMITLESS’ is our commitment to unlocking possibilities for our members and attendees while paving the path to the future of our industry. The BIO International Convention attracts 15,000+ biotechnology and pharma leaders who come together for
- [Swiss Nordic Bio 2022](https://swedenbio.se/kalendarium/swiss-nordic-bio-2022/) - TIME AND PLACE When: 23 March 2022Where: Zürich Airport, Radisson Blu Hotel FOCUS The conference has a broad focus within biotech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as well as global, commercial corporations.The conference is open for biotech and pharma companies
- [BIO-Europe Spring 2022](https://swedenbio.se/kalendarium/bio-europe-spring-2022/) - BIO-EUROPE SPRING 2022 SHIFTS TO DIGITAL FORMAT Given recent renewals of corporate travel restrictions and the temporary suspension of large-scale events by the Kanton of Basel Stadt due to the spiking Omicron variant, we have regretfully decided to make BIO-Europe Spring a 100% digital event. Roche and Novartis will continue to fully endorse the digital
- [ATMP Sweden 2022](https://swedenbio.se/kalendarium/atmp-sweden-2022/) - Currently the 2022 conference is planned for Stockholm. The event is expected to be held at Aula, Solna campus Karolinska Institutet. The event is planned to coincide with the International Round Table on Nucleosides, Nucleotides and Nucleic acids, will be held august 28-31, 2022 in Stockholm, Sweden. IS3NA Society | IRT 2022 (irt2021.se) Registration and details
- [Virtual early development workshop](https://swedenbio.se/kalendarium/virtual-early-development-workshop-2/) - Advancing your drug or vaccine candidate from late-stage discovery into the clinic is one of the most critical steps in development. This is the phase when you make key decisions that will have long-term scientific and business impact, frequently under extreme time and cost pressure. Our protein design and optimization services help identify and mitigate
- [NLSDays 2022](https://swedenbio.se/kalendarium/nlsdays-2022/) - Registration includes All registrations are personal/individual, including access to all super sessions, fireside chats, exhibition, company presentations, One-on-One partnering including submission of up to 150 requests per company for onsite face-to-face meetings, coffee-breaks, lunches and receptions.SwedenBIO members receive 30% discount on their registration. Contact info@swedenbio.se for your discount code. Like a Nordic Saga, five small countries in
- [AI-Powered Medical Information Contact Centers](https://swedenbio.se/kalendarium/ai-powered-medical-information-contact-centers/) - AI can enable MI Contact Centers to transform the customer experience using digital avenues, thus helping create a truly scalable and global Medical Information capability. Participants will gain a better understanding of: Understand how to navigate the ever-changing MI landscape and scale-up MI servicesUnderstand how to create an AI-powered global MI capability to support HCPs,
- [Introducing the Innovative Health Initiative: Europe’s new partnership for health](https://swedenbio.se/kalendarium/introducing-the-innovative-health-initiative-europes-new-partnership-for-health/) - In the first session, IHI Executive Director Dr Pierre Meulien will present IHI and explain why we are launching a new European partnership for health. He will also describe what's new compared to the Innovative Medicines Initiative (IMI), and what will stay the same. IHI staff will then present opportunities for stakeholders to get involved
- [Biologics Drug Development: 3 day course](https://swedenbio.se/kalendarium/biologics-drug-development-3-day-course/) - Read more and register here.
- [Advanced Therapy Showcase in Tokyo#2 (ATST#2)](https://swedenbio.se/kalendarium/advanced-therapy-showcase-in-tokyo2-atst2/) - Now they are pleased to announce that the second edition of the series, the ATST#2, is going to be held on Friday, January 28, 2022. The ATST#2 features live-streaming company presentations and pre-arranged 1-on-1 business partnering meetings. The event will be fully virtual. Any entities or individuals engaged in the field of advanced therapy including
- [Biotech Showcase™ Digital 2022](https://swedenbio.se/kalendarium/biotech-showcase-digital-2022/) - What to expect: The event dates will remain the same, January 10–12, 2022 and January 17–19, 2022One-to-one meetings for January 10–12, 2022 will now be held virtually and expanded to a 24-hr timeframe to accommodate and facilitate meetings with delegates from around the worldAll event content, company presentations and program sessions will now be
- [SwedenBIO Summit 2021](https://swedenbio.se/kalendarium/swedenbio-summit-2/) - På årets SwedenBIO Summit vill vi vara med och skriva framgångssagor. Sagor som börjar i hårt slit, hjältemod, gemenskap och hälsoutmaningar och som nu ska betala sig; i genomslag på marknaden och äntligen nå fram till användaren. Att optimera bolagets resurser är ett sätt att säkra framgången. I life science-ekosystem cirkulerar erfarenheter, kontakter, investeringar och
- [Glögg Mingle – Digital Clinical Trials – Possibilities and Challenges](https://swedenbio.se/kalendarium/glogg-mingle-digital-clinical-trials-possibilities-and-challenges/) - Digital clinical trials are attracting a lot of attention right now. The pandemic has further raised questions and concerns on how we traditionally conduct clinical trials. There are many steps when conducting a clinical trial ranging from feasability, identification of potential subjects, eligibility assessment, efficacy assessment, safety assessment and subject retention to IMP handling, monitoring and other quality controls. So the
- [Making Clinical Trial Safety and Pharmacovigilance easy and affordable with HALOPV](https://swedenbio.se/kalendarium/making-clinical-trial-safety-and-pharmacovigilance-easy-and-affordable-with-halopv/) - Modules are available to cover all data and processes. You can start with the safety database modules and slowly add to your suite of modules, until you have a full pharmacovigilance system. You will hear from Martin Holm-Petersen CEO of Insife and also from the Safety Director Tina Elberling and Ewa Lyzell, Safety Group Manager for a full overview of how the
- [Partnering/licensering i läkemedelsindustrin – hur går det till i praktiken?](https://swedenbio.se/kalendarium/partnering-licensering-i-lakemedelsindustrin-hur-gar-det-till-i-praktiken/) - Seminarium arrangerat av Cirio Advokatbyrå tillsammans med Sprint Bioscience. Länk till anmälan.
- [How to successfully navigate the transition to the IVDR](https://swedenbio.se/kalendarium/how-to-successfully-navigate-the-transition-to-the-ivdr/) - Join us for breakfast Cirio law firm, Devicia, and Kickfile invite you to a complimentary breakfast seminar on 23 November 2021 in central Gothenburg. Join us in a conversation about the regulatory and legal aspects of an IVDR transition and take the opportunity to network with industry experts. Transition to the IVDR is required for
- [Back to Business: Expanding to the U.S](https://swedenbio.se/kalendarium/back-to-business-expanding-to-the-u-s/) - The Swedish-American Chamber of Commerce New England is excited to announce our event Back to Business: Expanding to the U.S, which will take place on the 27 of October at 9 AM on Zoom. Join this webinar to make sure that your company is ready to get back to business as restrictions are easing and the
- [Pop Up Talk - Optimize the Future of Pre-Clinical Studies With VivoLogica](https://swedenbio.se/kalendarium/pop-up-talk-optimize-the-future-of-pre-clinical-studies-with-vivologica/) - Advancements in scientific fields are moving at the speed of light, putting increasing pressure on developing new systems to log, analyze and ensure the integrity of data. Despite great scientific advancement, paper, pen and Excel are still the most frequently utilized tools to document critical pre-clinical studies. At VivoLogica we empower research through technology to bring research up
- [Executive dinner](https://swedenbio.se/kalendarium/executive-dinner/) - Den 14:e september rullar vi ut röda mattan för branschens egna stjärnor vid GuldBIO-galan, en filmfestival kantad av glitter & glamour ✨ 🎥Årets Executive Dinner är efterlängtad och efterfrågad av våra medlemsbolag. Då vi samlar ett stort antal människor till en sammankomst har vi förstås tänkt till kring hur eventet ska kunna genomföras i enlighet
- [New updates in Drug Formulation & Bioavailability](https://swedenbio.se/kalendarium/new-updates-in-drug-formulation-bioavailability-2/) - Moderator: Korbinian Löbmann,Associate Professor University of Copenhagen This event is a platform based on the concept of synergies between "science" and "business". Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about this exciting topic. The presented content and topics will focus on advancements in formulations and cutting edge technologies that
- [The Future of Swedish & Danish Life Science](https://swedenbio.se/kalendarium/the-future-of-swedish-danish-life-science-3/) - Hybrid event - Both physical and digitalThis year, The Future of Swedish & Danish Life Science is arranged as a hybrid event, i.e. event type that at the same time delivers the same experience and content to both a live and online audience. This years themes are: Reflections on the past decade, and looking to
- [BioPharm America 2021](https://swedenbio.se/kalendarium/biopharm-america-2021/) - Learn more and register here.
- [Bio-Europe Digital](https://swedenbio.se/kalendarium/bio-europe-digital/) - Learn more and register here.
- [Webbinarium - Implementering av klinisk prövningsförordning EU 536/2014](https://swedenbio.se/kalendarium/webbinarium-implementering-av-klinisk-provningsforordning-eu-536-2014/) - Webbinariet har temat "Implementering av klinisk prövningsförordning EU 536/2014” och är ett orienterande informationstillfälle om implementeringen och planerna för det fortsatta arbetet. Evenemanget kommer att hållas som ett så kallat Teams Live event. Det innebär obegränsat antal deltagare och ingen anmälan krävs för att delta. Med denna tekniska lösning är dock möjligheterna till interaktion i
- [Kurs i strategi- och affärsutveckling](https://swedenbio.se/kalendarium/affarsutvecklingskurs/) - Även om varje resa är unik finns det många utmaningar som är gemensamma för alla life science-bolag. Genom att tidigt skaffa dig en överblick över kommande strategiska beslut blir du bättre på att prioritera och använda dina resurser smart. Kursen hålls under fyra dagar den 20–22 oktober samt 25 november på Läkemedelsakademin i Stockholm. Begränsat
- [Park Annual 2021](https://swedenbio.se/kalendarium/park-annual-2021-2/) - Excited to meet you all on the Park Annual interactive platform allowing chat, one-to-one meetings and an inspiring exhibition in close connection to our live studio.Stay tuned for more info! Park Annual is free of charge.
- [Where Medical Device Regulation is Headed – Taking the Mystery out of Changes in the EU and US](https://swedenbio.se/kalendarium/where-medical-device-regulation-is-headed-taking-the-mystery-out-of-changes-in-the-eu-and-us/) - Interested in learning more? Register today and join us for a live webinar! Learning objectives of this Complimentary Live Webinar: · What will the new requirements look like in the EU and how should Sponsors adapt their regulatory strategy appropriately to obtain marketing approval for their device? · Explain the recent changes to FDA’s 510(k)
- [FDA Inspection Readiness: A Guide to Preparing for Success and Overcoming Remediation](https://swedenbio.se/kalendarium/fda-inspection-readiness-a-guide-to-preparing-for-success-and-overcoming-remediation/) - Interested in learning more? Register today and join us for a live webinar! Learning objectives of this Complimentary Live Webinar: · Help you manage inspections efficiently and effectively. · Best practices on how to avoid 483s and increased enforcement action(s). · The FDA’s approach to inspections, focus areas, and what documents they will be asking
- [HealthTech Innovation Days](https://swedenbio.se/kalendarium/healthtech-innovation-days/) - This event organized by HealthTech For Care, an endowment fund launched by France Biotech, and co-organised with EIT Health, and in collaboration with BIO Deutschland, BioWin , CEBR, Flanders.bio, LifeSci , SwissBiotech & Sweden Bio will accelerate patient access to healthcare solutions and contribute to building a stronger ecosystem. This event is open to many attendees of the healthcare ecosystem. Find more informations about our past editions and also
- [SwedenBIOs ordinarie föreningsstämma](https://swedenbio.se/kalendarium/swedenbios-ordinarie-foreningsstamma/) - Då stämman hålls digitalt genom Teams bjuder vi i år endast in en person per röstberättigat medlemsbolag. Föranmälan krävs och anmälan är personlig. Sista anmälningsdag är den 24:e maj. Bilagor Kallelse Ordinarie Föreningssammanträde Föreningen SwedenBIO 2021Årsredovisning föreningen SwedenBIO 2020Revisionsberättelse föreningen SwedenBIO 2020Valberedningens protokoll
- [Probiotics as invisible allies to promote our health and prevent diseases (BioGaia)](https://swedenbio.se/kalendarium/probiotics-as-invisible-allies-to-promote-our-health-and-prevent-diseases-biogaia/) - Do you know that antimicrobial resistance has been declared as one of the 10th public health threat for the coming years by WHO? Would you take care of your health before becoming ill? We will bring some answers to these questions and discuss the role of probiotics as health promoters in our day-to-day life.Click here
- [Brilliant Minds Studio Webinar – Gianfranco Grompone and guests (BioGaia)](https://swedenbio.se/kalendarium/brilliant-minds-studio-webinar-gianfranco-grompone-and-guests-biogaia/) - HOST Gianfranco Grompone, PhD Chief Scientific Officer, BioGaia GUEST Pedro Gutiérrez-Castrellón, MD, MSc, DSc Center for Translational Research on Mother-Child Health & Center for Research on Microbiota, Pre/Probiotics, Hospital General Dr Manuel Gea González, Ministry of Health, MexicoClick here to register.
- [Nordic AMPlify 2021 Launch Webinar: Accelerated U.S. Market Entry](https://swedenbio.se/kalendarium/nordic-amplify-2021-launch-webinar-accelerated-u-s-market-entry/) - WHY AMPLIFY? This initial workshop will give Nordic digital and MedTech companies a solid understanding of both the programme and the potential of the US market with US investors and healthcare leaders presenting an insider’s perspectives on current opportunities and essential knowledge on market entry. Webinar will cover: ✓ Introduction to Nordic AMPlify and Winston-Salem, North
- [Så blir life science-bolag ännu mer attraktiva för investerare](https://swedenbio.se/kalendarium/sa-blir-life-science-bolag-annu-mer-attraktiva-for-investerare/) - Life science-sektorn är unik och inte jämförbar med andra sektorer. Inte minst påverkas risknivån av osäkerheten kring bolagens kliniska utvecklingsprogram. För att underlätta investerarnas beslut och värderingen av bolagen har SwedenBIO tillsammans med marknadsplatserna Nasdaq och Spotlight nyligen arbetat fram en enhetlig standard för informationsgivning. Kommer trenden med den ökade investeringsviljan i life science att
- [Webbinarium - Avancerade terapier](https://swedenbio.se/kalendarium/webbinarium-avancerade-terapier/) - Läkemedelsverket bjuder in till en halvdag med temat avancerade terapier (ATMP). Webbinariet hålls på Teams, maximalt antal deltagare är 300 personer. Om fler än 300 personer anmäler sig kommer platser att prioriteras för avsedd målgrupp. Målgrupp Personer som är verksamma inom utveckling, tillverkning och klinisk läkemedelsprövning av läkemedel för avancerad terapi vid universitetssjukhus, akademi och
- [Life Science: Introduction to the UK and the NHS](https://swedenbio.se/kalendarium/life-science-introduction-to-the-uk-and-the-nhs/) - In partnership with Department for International Trade (DIT) Sweden and Embassy of Sweden, London, UK, the Swedish Chamber of Commerce for the UK invites Swedish Life Science, Medtech and Digital Health companies to learn about the opportunities and challenges businesses currently face entering the UK. Participants will have the chance to gain valuable insights into the
- [Surviving early biotech pitfalls – Overcoming challenges when moving from non-clinical to clinical](https://swedenbio.se/kalendarium/surviving-early-biotech-pitfalls-overcoming-challenges-when-moving-from-non-clinical-to-clinical/) - This event is designed to help biotech companies in early development however, the content will also be helpful for the full life cycle of a product. View the agenda below to learn more. Learn more and register here.
- [Medicintekniska produkter – grundkurs](https://swedenbio.se/kalendarium/medicintekniska-produkter-grundkurs/) - Utbildningsmål Efter kursen ska du ha fått: En överblick över CE-märkning och gällande regelverk för medicintekniska produkter inom EU, MDRKunskap om kvalitetssystem och teknisk dokumentationKunskap om involverade aktörer och myndigheterKunskap om riskledningssystem/risk management systemKunskap om tillämpliga regelverk, standarder och riktlinjer Kursens innehåll och upplägg Bakgrund till regelverket Berörda aktörerRegulatorisk strategiKvalificering och klassificering Standarder och vägledningsdokument Utvecklingsprocess Riskledningssystem, kvalitetssystem och
- [IVDR – en grundkurs](https://swedenbio.se/kalendarium/ivdr-en-grundkurs/) - Den nya lagstiftningen innebär stora förändringar för de flesta inom branschen med betydligt striktare krav på både verksamheten och dess produkter. Med en ny riskbaserad klassificering förväntas merparten av alla företag behöva ett anmält organ för bedömning av produkters överenstämmelse och CE-märkning. En annan stor förändring är de ökade kraven på klinisk evidens och ett
- [Building an Effective Cybersecurity Culture](https://swedenbio.se/kalendarium/building-an-effective-cybersecurity-culture/) - After registering, the link to attend this program will be sent before April 13, 2021.Click here for more information and registration.
- [Mpya Sci & Tech och Linus Jonkman – Digital frukostföreläsning](https://swedenbio.se/kalendarium/mpya-sci-tech-och-linus-jonkman-digital-frukostforelasning/)
- [Insider Talks - COVID-19 Vaccines & Treatments](https://swedenbio.se/kalendarium/insider-talks-covid-19-vaccines-treatments/) - Learning objectives of this Complimentary Live Webinar:Our panel of experts will discuss how to bring life-saving vaccines and treatments to market faster while ensuring patient health and safety – based on experience. Our team will share insights on: A strategic project management approach that ensures teams move quickly and adaptively to bring vaccines and treatments
- [Temadag – Medical Writing](https://swedenbio.se/kalendarium/temadag-medical-writing/) - Målgrupp Temadagen vänder sig till dig som skriver eller granskar regulatoriska dokument eller som är involverad i frågor rörande dokumentation; tex beställare av tjänster, statistiker eller medicinska experter. Lärandemål Efter dagen ska du som deltagare: Vara medveten om centrala regelverk och riktlinjer som är relevanta - hur man hittar dem, grundläggande kunskaper om hur man använder
- [Grow Your Nordic Life Science Business in the United States](https://swedenbio.se/kalendarium/grow-your-nordic-life-science-business-in-the-united-states/) - In lead-up to the SelectUSA Summit, The U.S. Department of Commerce and SelectUSA invite Nordic Life Science startups currently exploring business development opportunities in the United States, to an in-depth virtual seminar and networking session. Join us on April 13, 2021 to gain greater insight into working with the U.S. Food and Drug Administration, Investment
- [Life Science Bridge - Bridging the Gap](https://swedenbio.se/kalendarium/life-science-bridge-bridging-the-gap/) - With Sweden and the U.S. being at the top of the life science industry, we aim to build bridges between these nations to promote a healthy and innovative world. Bridging the Gap will be held 7-8th of April on Zoom. Day 1 is free of charge and the topics will be focused on The life science ecosystem in
- [EU-funding Café](https://swedenbio.se/kalendarium/eu-funding-cafe/) - För EU-funding Café behöver man inte registrera sig i förväg. Det kan dock vara bra att gå in och lägga in sitt foto och koppla sin LinkedIn-profil till sin användare.Klicka här för mer info.

## Medlemmar

- [Willuhn Consulting](https://swedenbio.se/medlemmar/willuhn-consulting/) - Willuhn Consulting supports companies and investors across the biotech and pharmaceutical landscape. Based in Stockholm and working globally, they combine scientific and technical expertise with practical industry know-how. Their work spans the full lifecycle, from early science and preclinical development to clinical supply, regulatory submissions, and commercial operations. They tailor each engagement to the client
- [Bondi Executive Search](https://swedenbio.se/medlemmar/bondi-executive-search/) - Recruitment & Interim of leaders and specialists in Life Science since 1998. www.bondi.se Bondi has an international network through their partnership with Kestria (the world’s largest executive search alliance). 90+ cities | 40+ countries | 6 continents This means they can help you expand globally and find top talent across the world. www.kestria.com
- [Mesenkia Therapeutics](https://swedenbio.se/medlemmar/mesenkia-therapeutics/) - Mesenkia Therapeutics is a Swedish-Japanese biotechnology company built on over three decades of collaborative research. Their modular KITAIbodies® is designed to develop first-in-class biologics for aggressive cancers with a high unmet medical need. Their lead program targets glioblastoma, while our KITAIbodies® are designed to enable future therapeutics across multiple indications and modalities. Through strategic collaborations
- [AOP Orphan Pharmaceuticals Sweden](https://swedenbio.se/medlemmar/aop-orphan-pharmaceuticals-sweden/) - AOP Orphan Pharmaceutical Sweden AB is a part of AOP Health Group. Since 1996, the AOP Health Group has been dedicated to developing innovative solutions to address unmet medical needs, particularly in the fields of rare diseases and intensive care medicine. The group has established itself internationally as a pioneer in integrated therapy solutions and
- [Veranex](https://swedenbio.se/medlemmar/veranex/) - Veranex is the world's first global Innovation Contract Research Organization (iCRO) providing integrated product development and contract research services for medical device and in-vitro diagnostic companies. Founded in 2021 but with a legacy over 20 years, Veranex combines design engineering, preclinical research, clinical trials, regulatory affairs, quality consulting, manufacturing, and market access services under one
- [Oxcia](https://swedenbio.se/medlemmar/oxcia-ab/) - The O2-DDR technology platform is versatile and different therapeutic effects can be achieved depending on which proteins are targeted and how they are modified. It enables addition of oxidative stress to cancer cells to kill them as well as blocking of oxidative stress to stop inflammation so that the body doesn’t overreact and cause patient
- [Bonsai Biotherapeutics](https://swedenbio.se/medlemmar/bonsai-biotherapeutics/) - Bonsai Biotherapeutics is a biopharmaceutical company developing disease-modifying therapies for autoimmune diseases. Its platform is based on tolerogens – biological drugs designed to restore immune tolerance to specific autoantigens. By targeting the disease process at its source, unlike current therapies that suppress or reduce immune function broadly, Bonsai aims to provide long-lasting therapeutic benefit while
- [AtrimusRx](https://swedenbio.se/medlemmar/atrimusrx/) - AtrimusRx AB is a pioneering Swedish life science company revolutionizing personalized medicine. As the first entity in Sweden to secure Medical Products Agency approval for commercial 3D-printed pharmaceuticals, the company has transitioned additive manufacturing from lab environments into active clinical practice. Operating at TRL 9, AtrimusRx delivers custom dosages tailored for pediatrics, adult care, and
- [Barncancerfonden](https://swedenbio.se/medlemmar/barncancerfonden/) - Barncancerfonden brings a child-centred, needs-driven perspective, grounded in families’ experiences and deep knowledge of paediatric oncology. The organisation’s work spans the full pathway – from early research to implementation in healthcare. In paediatric cancer, where patient populations are small and unmet needs remain high, collaboration across the life science ecosystem is essential. By engaging with
- [Cytely](https://swedenbio.se/medlemmar/cytely/) - Cytely is standardizing biological measurement. Today, the way life science teams measure what is happening inside cells depends on who runs the analysis or who manufactured the equipment, creating variability, slow turnaround, and results that are hard to reproduce. Cytely replaces that with a cloud platform that delivers consistent, traceable results from biological data, without
- [IKEM Innovations och kemiindustrierna i Sverige](https://swedenbio.se/medlemmar/ikem/) - IKEM is the industry and employers’ organisation for Sweden’s innovation and chemical companies. We negotiate collective agreements with the unions, provide expert advisory services, and advocate for policies that strengthen industrial competitiveness and enable the green transition. Representing some 1,200 companies with 70,000 employees, our members operate in chemicals, plastics, pharmaceuticals, refineries, biochemistry, bioengineering, and
- [Neurometa Therapeutics](https://swedenbio.se/medlemmar/neurometa-therapeutics/) - Neurometa Therapeutics’ experienced leadership team, with deep expertise in neuroscience and drug development, is advancing a differentiated platform targeting neurometabolism, with the potential to redefine treatment outcomes for patients with complex and currently underserved neurological disorders. Neuroscience remains one of the most promising areas of drug development, with significant unmet medical need. Neurometabolic modulation represents
- [MedEngine](https://swedenbio.se/medlemmar/medengine/) - MedEngine is a Nordic partner to the pharmaceutical industry, offering high-quality scientific expert services. MedEngine specializes in real-world evidence, market access, medical affairs, and commercial services. MedEngine is part of the Voisin Consulting Life Sciences group, which operates globally within the life sciences sector.
- [Macanda](https://swedenbio.se/medlemmar/macanda/) - The Macanda team has long backgrounds from the pharmaceutical industry, market access consulting, academia, and payer / HTA agencies in the Nordic countries and beyond. With a combined experience of more than 400 market access projects delivered, the team provides solutions to clients with complex market access demands in the biotech, pharmaceutical, and medtech industries.
- [Flemingsberg Science Foundation](https://swedenbio.se/medlemmar/flemingsberg-science-foundation/) - Through its Life Science Cluster initiative, the Foundation supports the growth of small and medium-sized companies, facilitates matchmaking with research infrastructure and core facilities, and creates high-impact meeting arenas for companies, investors, and public actors. By acting as a gateway to world-leading research, advanced infrastructure, and a collaborative ecosystem, the Foundation contributes to a strong,
- [NeoTargets AB](https://swedenbio.se/medlemmar/neotargets-ab/) - It combines in silico target identification with cancer-specific, biomarker-led validation in cancer cell lines, patient samples, translational toxicity models and in vivo studies to identify potent, safer and more selective targets early. Modality agnostic, NeoTargets advances programs in small molecules, cyclic peptides, RNAi and bifunctionals and works with partners to generate validated targets, lead compounds
- [AstraZeneca BioVentureHub AB](https://swedenbio.se/medlemmar/astrazeneca-bioventurehub-ab/) - By providing access to AstraZeneca’s scientific expertise, industry-grade facilities, collaboration opportunities, and a vibrant dare-to-share community, the hub offers a pragmatic bridge from university incubators to real-world industrial environments.The focus is on increase technology exploration that accelerates drug development and advances sustainability.Participation is strictly independent, and AstraZeneca holds no ownership or innovation rights. In return,
- [Collective Minds Radiology AB](https://swedenbio.se/medlemmar/collective-minds-radiology-ab/) - As the industry moves from fragmented, site-by-site trials towards centralised models, organisations increasingly rely on agile, secure platforms that provide robust data management, quality oversight, and expert imaging support. By embedding expert imaging intelligence at the core of trials, Collective Minds helps reduce operational risk, ensure compliance, and accelerate the generation of reliable evidence.
- [Aurevia](https://swedenbio.se/medlemmar/aurevia/) - The company was formed in 2025 when Scandinavian CRO, Artimed, P.R.I.S.M.A. CRO, Clinical Consulting, QAdvis, Kasve, Mectalent Medical Services, Lean Entries, and part of Labquality merged. Aurevia's services for the healthcare, pharmaceutical, and medical technology sectors cover quality assurance, regulatory affairs, clinical studies, training, and more. Their proven expertise and knowledge benefit medical device and
- [Ofichem Uppsala AB](https://swedenbio.se/medlemmar/ofichem-uppsala-ab/) - From purpose-built facilities at Uppsala Business Park, Ofichem Uppsala provide a full package of preclinical services, from medicinal chemistry and process development up to kg-scale, to (bio)analytical development and pre-formulation. The site has also long experience in impurity identification and synthesis and extractable and leachables analyses. The site is ISO9001 certified and experienced in new
- [Lonza Sweden](https://swedenbio.se/medlemmar/lonza/) - In Lonza Advanced Synthesis, they apply more than 125 years’ expertise in classic and complex chemistry to the manufacturing of small molecules, highly potent APIs, antibody-drug conjugates and bioconjugates.
- [MucoLife Therapeutics](https://swedenbio.se/medlemmar/mucolife-therapeutics/) - Its lead candidate is an inhaled peptide designed to dissolve airway-occluding mucus plugs and restore airway patency with high efficacy, potency, and safety. By addressing a shared underlying mechanism across multiple lung diseases, MucoLife Therapeutics aims to transform the treatment paradigm for mucus-mediated respiratory conditions.
- [Circio](https://swedenbio.se/medlemmar/circio/) - Circio has established a unique circular RNA (circRNA) vector expression technology for next generation RNA, DNA and viral therapeutics. The proprietary circVec platform is based on a modular genetic construct designed for efficient biogenesis of multifunctional circRNA inside target cells. The circVec platform has applications in multiple therapeutic settings, including genetic medicine, cell therapy and
- [Eurofins Professional Scientific Services](https://swedenbio.se/medlemmar/eurofins-professional-scientific-services/) - Eurofins PSS provides managed scientific services for GMP and GLP laboratory operations directly at the client’s site, using the client’s systems while fully managing its own teams and all related HR responsibilities. PSS support spans Quality, R&D, Manufacturing, and Operations, helping pharma scale lab operations quickly, maintain compliance, and reduce HR/admin load without adding headcount.
- [Cyclic Therapeutics](https://swedenbio.se/medlemmar/cyclic-therapeutics/) - Its proprietary platforms, EvoBind and RareFold, enable blind de novo design of linear and cyclic peptides directly from protein sequence, without requiring target structures, binding sites, or predefined peptide lengths. The models incorporate induced fit and directed evolution in silico and expand the design space beyond the 20 natural amino acids through non-canonical residues. The platform
- [The Park](https://swedenbio.se/medlemmar/the-park/) - Here, researchers, startups, advisors and large companies gather to promote innovation and collaboration within Life Science, technology and sustainability. The company offers flexible office solutions, from private rooms to open workspaces, as well as conference and event spaces for up to 500 people. As a member, you get access to an engaged community, regular seminars
- [Hammarskiöld](https://swedenbio.se/medlemmar/hammarskiold-co/) - For 25 years, Hammarskiöld has played a role in building one of the world's most vibrant business environments. With practical experience from the life sciences industry, Hammarskiöld has built a successful team focusing on legal issues in pharmaceuticals, medical devices and healthcare. The firm is proud of its diverse team and strong representation of female
- [DNB Carnegie](https://swedenbio.se/medlemmar/dnb-carnegie/) - DNB is the Nordic Healthcare Bank and a top 10 healthcare bank in the US. The company's client list include global pharma, biotech and medical device companies headquartered in the US and Europe. The company's clients are serviced by experienced bankers together with industry experts located in New York, Oslo and Stockholm.
- [IMariel ](https://swedenbio.se/medlemmar/imariel/) - The company provides strategic advice within IPR for Life Science companies. Supports in building up strong IP protection for pharmaceutical companies as well as before and during Due Dilligence processes and in investment processes. The company also support VC's in the evaluation of Life Science IP portfolios within pharmaceuticals and medical devices.
- [Swiss Business Hub Nordics](https://swedenbio.se/medlemmar/swiss-business-hub-nordics/) - The Swiss Business Hub (SBH) is part of the Embassy of Switzerland in Sweden. It supports SMEs from Switzerland and Liechtenstein in their business development in the Nordic countries – Denmark, Finland, Iceland, Norway and Sweden, and provide companies and the Nordic countries with information on Switzerland as a business location.The Swiss Business Hub also
- [Extem Pharma](https://swedenbio.se/medlemmar/extem-pharma/) - The unique services meet diverse pharmaceutical needs: * Advanced Formulation Development – Innovative solutions tailored to specific drug formulation requirements. * Contract Development and Manufacturing Organization (CDMO) – Small-batch manufacturing and formulation development for clinical trials. * Extemporaneous Manufacturing Custom-tailored medications for human and veterinary use, addressing unmet needs. With a focus on innovation and
- [Dicot Pharma](https://swedenbio.se/medlemmar/dicot-pharma/) - Dicot Pharma's most important product is Libiguin for the treatment of erectile dysfunction and premature ejaculation in men. The origin of Libiguin is a substance that comes from a plant of folk medicine against reduced sexual ability. Libiguin has effects in very low doses, giving a remarkable long lasting effect. The long-term effect does not
- [MultiHelix](https://swedenbio.se/medlemmar/multihelix/) - MultiHelix Think Tank is a network organized for interdisciplinary creation of new ideas supporting their mission. This international group consists of more than 50 highly professional member organisations including more than 100 professionals, from academy, industry, healthcare, patient organisations, investors as well as voluntary associations. A true MultiHelix formation. Twins’ International MultiHelix is facilitating partnering,
- [Apotekarsocieteten - The Swedish Pharmaceutical Society](https://swedenbio.se/medlemmar/apotekarsocieteten/) - The Swedish Pharmaceutical Society is an independent, non-profit organization for individuals working or studying within the pharmaceutical, medical technology, and broader life science fields. The Society provides a unique network that connects professionals, students, and researchers across the entire value chain — from discovery and development to use and patient benefit. Through its nationwide structure
- [Signum Life Science Sweden](https://swedenbio.se/medlemmar/signum-life-science-sweden/) - Owned by Lif Denmark, Signum provides data-driven insights and consulting expertise across all Nordic markets, helping life science companies optimize their commercial and medical strategies through advanced analytics and a deep understanding of healthcare professionals and market dynamics.
- [One-carbon Therapeutics](https://swedenbio.se/medlemmar/one-carbon-therapeutics/) - TH9619 is a first-in-class, potent, small-molecule, and a dual inhibitor of MTHFD1/2, highly overexpressed and cancer-specific enzymes within the one-carbon metabolic pathway. TH9619 kills cancer cells via a dual mechanism of action (1) inhibition of MTHFD1 traps folate leading to thymidine depletion (2) inhibition of nuclear MTHFD2 disrupts DNA damages response repair pathways. With its
- [Stockholms Handelskammare](https://swedenbio.se/medlemmar/stockholms-handelskammare/) - The company's vision is to make Stockholm Europe’s premier capital region—where city, business, and people thrive in a sustainable, innovative, and attractive environment. Since 1902, they have been a powerful meeting hub, bringing together leading companies and decision-makers to drive real impact. With global reach, their Arbitration Institute ranks among the world’s best, while their
- [59 North](https://swedenbio.se/medlemmar/let-em-know-ab/) - The company's network of journalists covers most of the leading, international trade press specializing in Pharma, Biotech and Medtech, as well as other media read by decision makers in the industry and in healthcare. They know key journalists personally, they understand how journalists work and what they are interested in - invaluable in gaining their
- [Corem Property Group](https://swedenbio.se/medlemmar/corem-property-group/) - The company works with proximity to tenants and strong commitment to each property. Their property portfolio is strategically located in metropolitan areas and growth areas. One of their most dynamic locations is Uppsala Business Park (UBP) – strategically located in the heart of Sweden's most expansive growth zone, Stockholm–Uppsala. Here there is a long history
- [Peter Asplund Consulting AB](https://swedenbio.se/medlemmar/peter-asplund-consulting-ab/) - Core expertise lies in senior advisory and operational support within complex, highly regulated environments. Across capabilities in strategy and business development, operational leadership and project management, clinical research, quality assurance, and digitalization and IT, focus is on transforming objectives into value-driven outcomes. Their approach ensures measurable impact while simultaneously strengthening a client’s own capabilities.
- [Cancerfonden](https://swedenbio.se/medlemmar/cancerfonden/) - The company is an independent, non-profit organization, without government support, and have been active since 1951. Thanks to the research they support, cancer survival has more than doubled over this period. In addition to fundraising and research financing, the company also inform and support everyone affected by cancer and have an important advocacy work.
- [Aspia](https://swedenbio.se/medlemmar/accountor-ekonomi-radgivning/) - The company believes in making the difficult simple, in efficiency, in change, knowledge and in being present where our customers are. They are a relationship-driven business partner, with the belief that people-to-people relationships are the foundation of all successful business.
- [Alvotech](https://swedenbio.se/medlemmar/alvotech/) - The company seeks to be a global leader in the biosimilar space by delivering high quality, cost-effective products and services, enabled by a fully integrated approach and broad in-house capabilities. Alvotech’s current pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer.
- [Digital Trial Consultants](https://swedenbio.se/medlemmar/digital-trial-consultants/) - Investments are most often syndicated with others, but direct investments are also possible depending on case and fit with the company's overall strategy. The service arm is primarily focusing on company strategies, roadmap strategies, go-to-market strategies, funding and M&A.
- [Novandi Chemistry AB](https://swedenbio.se/medlemmar/novandi-chemistry-ab/) - Services span route development, starting-material synthesis, long-term storage, QC, and third-party deliveries—ensuring high-quality compounds and streamlined logistics. The company runs a state-of-the-art radiosynthesis/radioanalytical lab; quality is verified by LC-MS, HPLC-radioflow/UV, TLC-radioscan, and NMR. Each project includes a full report and CoA. They can house radio compounds and provide on-demand third-party shipping. Novandi Chemistry also offer
- [ImmunoIVD](https://swedenbio.se/medlemmar/immunoivd/) - They specialize in qPCR assays purpose-built for newborn screening laboratories—easy to use, cost-effective, and optimized for high-throughput workflows. With a strong focus on quality and customer support, the company supply newborn screening programs across Europe, including Sweden, and internationally, reaching as far as New Zealand. ImmunoIVD is located in Nacka Strand and was founded in 2015.
- [Hamlet BioPharma](https://swedenbio.se/medlemmar/hamlet-biopharma-ab/) - The company is developing a cancer treatment called HAMLET (Human Alpha-lactalbumin Made LEthal to Tumor cells). It's a tumoricidal protein-lipid complex that acts through a broad attack on membrane constituents and multiple intracellular targets with conserved structural motifs.
- [BioLamina](https://swedenbio.se/medlemmar/biolamina/) - The company's mission is to support scientists in overcoming long-standing challenges in culturing embryonic stem cells, induced pluripotent stem cells, and other primary cells. With defined and reliable Biolaminin® substrates, they enable more efficient, consistent, and clinically relevant cell culture systems. Whether you're advancing basic research, developing cell therapies, or building disease models, BioLamina provides
- [Key2Brain](https://swedenbio.se/medlemmar/key2brain/) - Pairing their groundbreaking blood-brain barrier-crossing technology with cutting-edge drug discovery and development skills, Key2Brain enables access to the brain, unlocking the potential for treatments that were once out of reach.
- [Legado Bioresearch](https://swedenbio.se/medlemmar/legado-bioresearch/) - The company team combines expertise in study design with technical excellence in study execution to ensure the best service to both Swedish and international clients in the life science industry.
- [AlzeCure Pharma](https://swedenbio.se/medlemmar/alzecure-pharma-ab/) - AlzeCure Pharma AB is a Swedish clinical stage biotech company that develops new innovative drug therapies for the treatment of severe disorders that affect the central nervous system, such as Alzheimer’s disease and pain-indications for which currently available treatment is very limited. The company is listed on Nasdaq First North Premier Growth Market and is developing several
- [GoCo Health Innovation City](https://swedenbio.se/medlemmar/goco-health-innovation-city/) - GoCo Health Innovation City boasts a diverse set of companies, organizations, and individuals working to unlock new solutions to global health challenges. From their location in the booming region of Gothenburg, Sweden, they are pushing boundaries and expanding everyday. GoCo Health Innovation City brings different worlds, fields, and people together, facilitating a space for inspiring
- [STUNS Life science](https://swedenbio.se/medlemmar/stuns-life-science/) - STUNS Life science is an independent, not-for-profit actor that works to enhance the long-term competitiveness and growth of the life science sector. Their most important efforts are about turning up the flow of innovations, starting from defined needs in healthcare and society in general. Uppsala BIO does this together with companies, universities, healthcare, and public
- [Think Brand Direction](https://swedenbio.se/medlemmar/think-brand-direction/) - By focusing on bridging the gap between scientific advancements and commercial viability, the company thrives in translating complex research into actionable strategies that prioritize patient access and deliver measurable impact.The company does not have a website yet.Visit Åsa Magnusson's Linkedin / Head of Strategy at Think Brand Direction
- [Medicago PharmaTech](https://swedenbio.se/medlemmar/medicago-pharmatech/) - Medicago offers a wide range of modern, high-quality lab services at competitive prices. The services include freeze-drying, clean-room operation, bioprocessing and separation, stability studies, kit design and assembly. The company are continually available to customers in need of production resources, offering their professional support throughout projects and studies.
- [Ribocure](https://swedenbio.se/medlemmar/ribocure/) - Their mission is to establish a world-leading company in RNA R&D, ultimately making a positive impact on patients globally.
- [Vectura](https://swedenbio.se/medlemmar/vectura/) - In the properties, they want Sweden's leading players in the life science sector to be inspired by new ideas, feelings and solutions. With new ways of collaborating, new ways of building and new ways of thinking, the company create the conditions for fruitful meetings. For companies, municipalities and people who are committed to care, life
- [Chosa Oncology ](https://swedenbio.se/medlemmar/chosa-oncology/) - Chosa Oncology concept focuses on eliminating metastatic cancer cells that may escape treatment of the parent tumour via other methods. Because RhoC is not expressed in the parent tumour, the company goal is to use the developed product in combination with another therapy — specifically, treatment of the parent tumour by e.g. surgery, radiotherapy or
- [Zonda Partners](https://swedenbio.se/medlemmar/zonda-partners/) - The company has a long-standing experience, in-depth knowledge and networks in the life science industry. A partner of choice for companies seeking discreet, conflict-free and professional advice on all aspects of life science corporate finance.
- [Disruptive Pharma](https://swedenbio.se/medlemmar/disruptive-pharma/) - The MMC formulation technology is a precisely engineered solution for developing amorphous formulations of small molecules and peptides. An MMC drug formulation mitigates development risk and shortens development time, making it an ideal solution for enabling novel drugs to reach their full potential and for improvement of existing drug products. With the recent advancement of the
- [IRLAB Therapeutics](https://swedenbio.se/medlemmar/integrative-research-laboratories-sweden-ab-irl-ab/) - IRLAB Therapeutics is dedicated to the discovery and development of new drugs for treatment of Parkinson’s disease and other life-altering diseases that affect the central nervous system (CNS). IRLAB strives to transform the everyday life for patients who lack effective treatment options. Their purpose derives from the great medical need for safe and efficient treatments
- [Angelini Pharma Nordics](https://swedenbio.se/medlemmar/angelini-pharma-nordics/) - Angelini Pharma Nordics is a part of Angelini Industries, an Italian company. Established in early 2022 with its headquarters in Stockholm, Angelini Pharma Nordics has a dedicated team of 20 employees and focuses on treatments within Brain Health.
- [Umeå Biotech Incubator](https://swedenbio.se/medlemmar/umea-biotech-incubator/) - Umeå Biotech Incubator's mission is to create oppurtunities for growth in the region by supporting the development of Life Science business projects and companies. The company focuses on research organizations in the Umeå area, comprised of Umeå Universitet, Sveriges Lantbruksuniversitet (SLU), Norrlands Universitetssjukhus (NUS) and Försvarets forskningsinstitut (FOI). UBI may support researchers and innovations outside of
- [Croda](https://swedenbio.se/medlemmar/croda/) - Smart science to improve lives, is at the core of Croda's market strategy. They specialize in developing the highest quality and purest grades of pharmaceutical excipients, lipids and vaccine adjuvants to help formulate seamlessly and drive products to market.
- [Cereno Scientific](https://swedenbio.se/medlemmar/cereno-scientific-ab/) - Cereno Scientific is advancing a pipeline that includes an HDACi portfolio with two drug candidates in clinical phase – CS1 in pulmonary arterial hypertension and CS014 in idiopathic pulmonary fibrosis. The HDACi portfolio has an innovative disease-modifying approach to addressing the root mechanism of rare and fatal diseases, untapping the potential of epigenetic modulation in
- [PharmaRelations](https://swedenbio.se/medlemmar/pharma-relations/) - PharmaRelations is on a mission to grow people and companies in Life Science with the company's portfolio of Talent Services. PharmaRelations partners with clients in Nordic countries from their offices in Stockholm, Copenhagen, Helsinki and Oslo who can benefit from their comprehensive experience and network. PharmaRelations offers recruitments and customized interim services such as full-
- [Glycolink](https://swedenbio.se/medlemmar/glycolink/) - Glycolink is a biotech company developing next-generation biobased hydrogels for use across industries. By leveraging proprietary natural cross-linkers and sustainable ingredients, they enable the transition from fossil-based materials to eco-friendly alternatives. Starting with cosmetics, Glycolink's technology harnesses proteins from the pine forest to create high-performance, sustainable hydrogels.
- [SciLifeLab](https://swedenbio.se/medlemmar/scilifelab/) - SciLifeLab is a national resource of unique technologies and expertise available to life scientists, closely intertwined with their community of researchers in areas such as biomedicine, ecology and evolution. SciLifeLab brings scientists together across traditional boundaries and foster collaborations with industry, healthcare, public research organizations and international partners.
- [TFS HealthScience](https://swedenbio.se/medlemmar/tfs-healthscience/) - TFS specializes in key therapeutic areas for clinical development, including dermatology, internal medicine, neuroscience, oncology, and ophthalmology. Complementing this expertise, its strategic resourcing solutions—including functional outsourcing, strategic workforce solutions, expert recruitment, and insourcing services, offer flexible support tailored to client needs. Dedicated to empowering partners and enriching lives, TFS combines global reach with the agility
- [Immunovia](https://swedenbio.se/medlemmar/immunovia/) - Immunovia AB is a diagnostic company with a mission to improve survival rates for pancreatic cancer patients through early detection. Immunovia focuses on developing and commercializing simple blood-based tests to identify proteins and antibodies that indicate that a high-risk individual has developed pancreatic cancer. Immunovia's shares (IMMNOV) are listed on Nasdaq Stockholm.
- [Cellectricon](https://swedenbio.se/medlemmar/cellectricon/) - Cellectricon is a preclinical CRO specializing in neurobiology drug discovery. They have established service modules in the areas of Neuroinflammation, Peripheral Neuropathies, Neurodegeneration and Neuroplasticity. Cellectricon's mission is to create outstanding value for our Clients through highly customized in vitro neurobiology services, delivering scientific excellence, innovation, and quality of the highest of standards.
- [Ventri Labs](https://swedenbio.se/medlemmar/ventri-labs/) - VentriLabs is a medtech and biotech company offering safe and precise liquid pumping solutions. Their patented pump technology offers gentle handling of delicate media with complete flow control, in applications ranging from clinical systems to bioprocess operations. They specialize in optimizing liquid handling systems to maximize fluid protection by eliminating undesired mechanical and shearing effects
- [Christina Forselius AB](https://swedenbio.se/medlemmar/christina-forselius/) - Christina Forselius AB provides consultancy, interim management, and advisory services within the Life Science area, including project management, leadership, process optmisation and change management.
- [APNC Sweden](https://swedenbio.se/medlemmar/apnc-sweden/) - APNC Sweden is a statistical consulting company that specializes in offering statistical services within life science research. With nearly two decades of experience in the field, they have unique expertise in statistics and clinical research. Their focus is on registry-based studies of real-world data, epidemiological studies and randomized controlled trials. APNC Sweden's mission is to
- [Cencora Pharmalex](https://swedenbio.se/medlemmar/cencorapharmalex/) - PharmaLex adds to Cencora’s expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. They guide clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Their experts use technology-elevated solutions to support clients through the entire product lifecycle.
- [Scandinavian Regulatory Services](https://swedenbio.se/medlemmar/scandinavian-regulatory-services/) - Scandinavian Regulatory Services (SRS) provides expert regulatory and quality support to bring new and established medical devices, generic and established pharmaceuticals, and combination products to the market.
- [CTC Clinical Trial Consultants](https://swedenbio.se/medlemmar/ctc-clinical-trial-consultants-ab/) - CTC stands out by its in-house Site Network. It consists of six state-of-the-art research clinics across Sweden, including a FIH unit at Uppsala University Hospital, as well as a seventh clinic in Groningen, the Netherlands. They provide full-service management and conduct of Phase 0, FIH, Phase I and Phase II studies as well as medical
- [HOYA Consulting](https://swedenbio.se/medlemmar/hoya-consulting/) - HOYA Consulting is a strategic partner in drug development, with deep expertise in advanced therapies, ATMPs. Hoya helps stakeholders overcome complex preclinical and business challenges, from early research to market introduction.
- [ProsMedic Sweden](https://swedenbio.se/medlemmar/prosmedic-sweden/) - The mission of ProsMedic is to reduce prostate cancer mortality with a test suitable for screening and early detection.
- [SVF Vaccines](https://swedenbio.se/medlemmar/svenska-vaccinfabriken/) - SVF Vaccines develops vaccines and immunotherapies to prevent and treat life-threatening diseases. Their two principal projects are:- SVF-001: a therapeutic vaccine to cure Hepatitis B and D- A prophylactic vaccine targeting both the current COVID-19 pandemic and other coronavirus infections.
- [TikoMed](https://swedenbio.se/medlemmar/tikomed-ab/) - The company has a diversified drug portfolio within the field of pharmaceutical regenerative medicine. The portfolio contains three main products. TikoMeds business concept is to develop a drug portfolio up to a “Proof of Concept” stage in preclinical and up to early clinical studies. TikoMed will then use its board and management network and expertise to
- [Vicore Pharma Holding](https://swedenbio.se/medlemmar/vicore-pharma-holding-ab/) - Operations in Vicore Pharma Holding consist mainly of securing financing, management and operational expertise in portfolio companies. The company's key employees have many years of experience as inventors, founders and have had executive positions in several projects and companies.
- [Scandinavian Real Heart](https://swedenbio.se/medlemmar/scandinavian-real-heart-ab/) - Scandinavian Real Heart is developing a heart pump (TAH) that mimics the body's natural circulation and can be used as a transitional solution for patients waiting for a heart transplant. The heart pump's design and batteries should give the patient increased mobility and the opportunity for a higher quality of life.
- [iCoat Medical](https://swedenbio.se/medlemmar/icoat-medical-ab/) - iCoat Medical, headquartered in Stockholm and with operations in Uppsala and Lund, is a pharmaceutical company conducting clinical research to reduce ischemia-reperfusion injuries with a primary focus on kidney transplantation. iCoat Medical’s clinical drug candidate iCM012, based on 25 years of research and development in collaboration with leading academic institutes, is developed to improve the
- [MyCural Therapeutics](https://swedenbio.se/medlemmar/mycural-therapeutics-ab/) - MyCural is a biotech company developing a new cancer therapy for patients with aggressive tumors.
- [Indutrade](https://swedenbio.se/medlemmar/indutrade/) - Indutrade is an international technology and industrial group that develop and acquire companies that are characterised by high technical expertise and an ability to build enduring, close relationships with customers and suppliers. The company is a subsidiary of Indutrade AB and is part of the Life Science business unit.
- [Immuneed](https://swedenbio.se/medlemmar/immuneed-ab/) - Immuneed specializes in advanced ex vivo characterization of biotherapeutics to provide better understanding of first-in-man infusion reactions prior to clinical trial entry. Immuneed offers in-house services to address important questions related to the safety and function of biopharmaceuticals. With vast expertise in immunology and preclinical drug development, Immuneed assures high-quality immune assessments. All their services
- [Lanterna](https://swedenbio.se/medlemmar/lanterna/) - At Lanterna we specialize in and develop unique fluorescent nucleotide base analogues as well as fluorescent mRNA to aid pharmaceutical companies and researchers with accurately studying and validating nucleic acid therapeutics such as mRNA using fluorescence assays. Our team consist of leading expertise within fluorescence, chemical synthesis and molecule characterization, and are readily available to
- [Victri Advice](https://swedenbio.se/medlemmar/victri-advice/) - Victri Advice are executive strategic advisors within Public Affairs for life-science companies. Their focus is the Swedish market, with a Nordic outlook including some activities in Brussels.
- [Frans Schartaus Handelsinsitut](https://swedenbio.se/medlemmar/frans-schartaus-handelsinsitut/) - Frans Schartaus Handelsinstitut runs post-secondary YH programmes and upskill courses for professionals in a wide range of industries, including Life Science, training both leaders and specialists. YH-program Pharmaceutical technicians 1.5 years YH program Quality system in Life Science - upskilling for already working professionals
- [AAX Biotech](https://swedenbio.se/medlemmar/aax-biotech/) - The vision of AAX is to help improve cancer and autoimmune therapies.
- [2A Pharma](https://swedenbio.se/medlemmar/2a-pharma/) - 2A Pharma is a clinical stage biopharmaceutical company focused on discovering, developing and commercialising novel, cost effective prophylactic and therapeutic vaccines based on proprietary AAVLP platform technology. 2A Pharma’s vaccine platform is based on mutated parvoviral particles consisting essentially of one protein. The particles contain no viral genome and are replicative defective and non-pathogenic. Peptide sequences can
- [SallyQ](https://swedenbio.se/medlemmar/sallyq/) - SallyQ is a competence company where customer value and people are at the center. The company has extensive experience in recruitment and quality work within the Life Science industry. SallyQ's vision is to help innovative companies and people make as big a positive difference as possible in the world.
- [CCRM Nordic ](https://swedenbio.se/medlemmar/ccrm-nordic/) - CCRM Nordic is a leading organization dedicated to advancing research, development, and commercialization of advanced therapy medicinal products (ATMPs). With a focus on innovation and collaboration, CCRM Nordic strives to accelerate the translation of scientific discoveries into tangible therapies that address unmet medical needs.
- [Redeye](https://swedenbio.se/medlemmar/redeye-ab/) - At the heart of Redeye is their desire to help innovative and technology-rich businesses accelerate their growth. They keep eyes focused on technology-based businesses in the Nordic countries that compete in the global arena. These innovative companies provide people with a better standard of living by providing better information and allow more control over their living
- [Hemsö](https://swedenbio.se/medlemmar/hemso/) - Hemsö is Sweden's leading owner of public properties, managing and developing properties for nursing homes, education, healthcare and the judiciary system. Hemsö's operations are characterized by long-term thinking and sustainability.
- [Amrop](https://swedenbio.se/medlemmar/amrop/) - Amrop is one of the world’s largest retained executive search, board and leadership advisory partnerships with a strong commitment to the DEI agenda, advising organizations on identifying and developing Leaders For What’s Next. Amrop has strong presence in the Nordic market with 35 Partners and a global reach with 69 offices in 55 countries. With
- [4L Bioconsulting](https://swedenbio.se/medlemmar/4l-bioconsulting/) - 4L Bioconsulting offers consulting services in strategy, management, R&D and production. The company focuses on development of biotherapeutics or equipment/reagents/materials for the Life Science industry.
- [Insilico Medicine](https://swedenbio.se/medlemmar/insilico-medicine/) - The mission of Insilico Medicine is to extend healthy, productive longevity by transforming drug discovery and development with generative artificial intelligence, significantly reducing the time and cost of bringing life-saving medications to patients. The company integrates two business models: providing AI-powered drug discovery services and software through its Pharma.AI platform (www.insilico.com/platform/) and developing its own pipeline of
- [HepaPredict](https://swedenbio.se/medlemmar/hepapredict/) - HepaPredict is a CRO specializing in drug metabolism, toxicity, and drug development for liver disease. Using its well established long-term stable 3D spheroid model, the company offers in-house evaluations of drug metabolism, pharmacokinetic properties and safety, as well as drug target validations. HepaPredicts ambition is to commission its scientific experience and expertise to deliver highest-quality
- [Vivesto](https://swedenbio.se/medlemmar/vivesto/) - Vivesto develops drugs for difficult-to-treat cancer from early research to the clinic. The project portfolio consists of the cancer programs Cantrixil, Docetaxel micellar, and the veterinary oncology program Paccal Vet.
- [Scantox](https://swedenbio.se/medlemmar/scantox/) - Based on decades of experience, Scantox is a trusted partner for in-vivo preclinical research services for the pharmaceutical and medical device industries. The Scantox services enable clients to progress their drug or device development based on consistent, high-quality solid data to the highest technical and scientific standards.
- [Simsen Diagnostics](https://swedenbio.se/medlemmar/simsen-diagnostics/) - Simsen Diagnostics is a biotech startup focusing on transforming cancer care. The flagship solution, Simsen Personal, is a personalized cancer monitoring assay capable of detecting cancer years before standard-of-care tools. Situated in BioventureHub at AstraZeneca Gothenburg, the company is at the forefront of providing innovative and extremely sensitive solutions in cancer monitoring.
- [TuuLifeScience](https://swedenbio.se/medlemmar/tuulifescience-ab/) - TuuLifeScience provides support, project management and coordination of CMC activities: setting relevant time lines, focus on need-to-know activities, outsourcing of DS and DP development and production, compiling of CMC documentation for clinical trial applications, etc. Project lead in discovery phases: selecting the right compound and relevant assays, CD selection, formulation considerations, managing poorly soluble compounds.
- [Swedish StromaBio](https://swedenbio.se/medlemmar/swedish-stromabio/) - StromaBio is a clinical stage biopharma company developing Mesenchymal Stromal Cell (MSC) based cell therapies. Founded on more than two decades of world leading research, its aim is to bring new advanced therapies to patients with Respiratory Distress Syndrome (ARDS), and neurodegenerative Alzheimer’s Disease (AD)
- [CuraCell Holding](https://swedenbio.se/medlemmar/curacell-holding/) - Curacell develops cell based immunotherapies for cancer treatment focusing on TILs (Tumor Infiltrating Lymphocytes), an investigational therapy aimed at a durable cure for solid tumor cancers. The company is initiating its first clinical program targeting indications with high prevalence and the potential to make a significant impact on cancer patients worldwide.
- [Pila Pharma](https://swedenbio.se/medlemmar/pila-pharma/) - The candidate may also have both an appetite-suppressing and metabolic effect, and is thus expected to be used to reduce weight. In turn, improved weight control leads to fewer obesity-related sequelae such as diabetes and cardiovascular disease. By providing an effective obesity-regulating drug, Pila Pharma believes it has a good chance of becoming part of
- [Gesynta Pharma](https://swedenbio.se/medlemmar/gesynta-pharma-ab/) - Gesynta Pharma's most advanced drug candidate, vipoglanstat, is in clinical phase II development for the treatment of endometriosis – a painful, chronic inflammatory disease that affects about 10 percent of women of reproductive age. Endometriosis often leads to severely reduced quality of life and current drug treatments are inadequate for many patients. Gesynta Pharma aims to
- [ArgusEye](https://swedenbio.se/medlemmar/arguseye/) - The company’s patented sensor is based on nanoplasmonic sensing combined with fiber optics. By adding specific receptors, ArgusEye can offer flexible and sensitive sensing systems for a variety of targets.
- [Novocure](https://swedenbio.se/medlemmar/novocure/) - Novocure's commercial products have been approved in several countries for the treatment of adult patients with glioblastoma and malignant pleural mesothelioma. Novocure is conducting and has completed clinical trials of TTFields for the treatment of brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer.
- [Cell4Cure](https://swedenbio.se/medlemmar/cell4cure/) - The company’s proprietary technology platform is based on dendritic cells mediating antigen-specific tolerance for the prevention or cure of diseases where the immune system is the enemy.
- [Isofol Medical](https://swedenbio.se/medlemmar/isofol-medical/) - Isofol Medical AB (publ) is developing the drug candidate arfolitixorin with the aim of increasing the efficacy of current standard treatments for colorectal cancer and certain other tumor diseases. A Phase III study of arfolitixorin has been completed and the company is now evaluating opportunities to advance the drug candidate toward a marketing authorization application
- [Cytel](https://swedenbio.se/medlemmar/sds-life-science/) - Drug development requires teamwork. Cytel can help identify the strategic path forward for your specific product and offer experts to manage projects within all aspects of drug development. Cytel also gives expert advice on both strategic and operational levels, in development programs involving medical devices alone or in combination with drugs on the way to
- [Envue Technologies](https://swedenbio.se/medlemmar/envue-technologies-2/) - Envue Technologies, founded in 2020 as a spin-out from Chalmers University of Technology, specializes in the patented core innovation, Nanofluidic Scattering Microscopy (NSM). A platform technology offering real-time and label-free analysis of biological nanoobjects at the single-molecule level for a wide range of life science applications. NSM utilizes nanofluidic chips as miniature optical sensors in combination
- [BrainZell](https://swedenbio.se/medlemmar/brainzell/) - BrainZell is a Swedish start-up that specializes in the culture and use of stem cell-derived human brain organoids for early stages of drug discovery and toxicity studies. The company aims to improve the efficiency of the drug development by providing advanced human cell-based 3D test models to pharmaceutical and biotech companies, reducing the use of
- [Inossia](https://swedenbio.se/medlemmar/inossia/) - Inossia® develops medical device solutions with a strong focus on active ageing, better treatments and reduced healthcare costs for patients suffering from back pain. Inossia® has invented a softener for bone cement to better treat spinal fractures in osteoporotic patients.
- [Mannheimer Swartling](https://swedenbio.se/medlemmar/mannheimer-swartling-law-firm/) - What truly distinguishes Mannheimer Swartling in the Swedish legal market is the way the firm has built its full-service practice. It has specialist lawyers for all branches of business law, working in dedicated practice groups. All these groups are typically class-leading and they handle their own specialist projects independently – working at the forefront of
- [AdBIOPRO, Competence Centre for Advanced Bioproduction](https://swedenbio.se/medlemmar/adbiopro-competence-centre-for-advanced-bioproduction/) - This highly multi-disciplinary Centre gathers eight academic groups from KTH Royal Institute of Technology, Lund University, Karolinska Hospital, Karolinska Institutet and Linköping University, as well as 16 industrial partners. The industry partners are Alfa Laval, ArgusEye, AstraZeneca, BioInvent International, BioLamina, Cellcolabs, Cellevate, Cytiva, Erbi Biosystems, a company of Merck KGaA Darmstadt Germany, Magic Bioprocessing, Metenova, NorthX
- [Iscaff Pharma](https://swedenbio.se/medlemmar/iscaff-pharma/) - The cancer microenvironment influences malignant behaviors and treatment responses. Proprietary technology from Iscaffpharma can decode the microenvironment by focusing on patient-derived scaffolds, revealing important differences related to e.g. aggressiveness, age and subtypes of cancer. Iscaffpharma provides tools for drug discovery in the following areas: 1. drug screening 2. Target and drug discovery 3. Precision medicine
- [ANYO Labs](https://swedenbio.se/medlemmar/anyo-labs/) - The tools used by ANYO Labs are based on research at the University of Gothenburg and enable completely new possibilities when it comes to exploring new types of chemistry for further development.ANYO Labs has revolutionized the drug discovery process with i-TripleD, its revolutionary Machine Learning software, allowing screening of vast libraries of compounds in mere
- [Search4S](https://swedenbio.se/medlemmar/search4s-dustgoat/) - Search4S makes a difference by finding and evaluating the specialists & managers with the best skills for their clients. The company focuses on active search and networking to find hard-to-find candidates. Search4S works with customized recruitment in pharmaceuticals, biotech, medical technology, chemistry, food and environment.
- [Spago Nanomedical](https://swedenbio.se/medlemmar/spago-imaging-ab/) - Spago Nanomedical develops nanomedical products for cancer diagnostics and treatment. The company’s main activities are focused on developing SpagoPix, a nanomedical contrast agent for MRI, and the therapeutic development project Tumorad, for tumor selective radionuclide treatment.
- [Offspring Biosciences Sweden](https://swedenbio.se/medlemmar/offspring-biosciences-sweden/) - Offspring Biosciences applies integrated workflows for advanced analyses in tissues to assist project teams within the pharma industry to develop new therapeutic drugs in a more time and cost effective manner.
- [Statistikkonsulterna Väst](https://swedenbio.se/medlemmar/statistikkonsulterna-vast/) - Statistikkonsulterna is a CRO with specialists in statistics, mathematics and advanced programming in SAS and R. The company provides analysis services in planning, power estimation, SAP and analysis for the Life Science industry.
- [MERACCESS](https://swedenbio.se/medlemmar/meraccess/) - MERACCESS is a consulting company active in pharmaceuticals and life Science with a focus on contributing to patients' access to innovative drugs. The company offers services in Market Access.
- [Simplexia](https://swedenbio.se/medlemmar/simplexia/) - Simplexia is developing a vaccine against genital herpes caused herpes simplex virus, one of the most common sexually transmitted infection in the world. Simplexia's vaccine is based upon ground-breaking research from the University of Gothenburg. Based on the need for an effective treatment of Genital Herpes, a devastating disease with a number of feared complications,
- [Sangair ](https://swedenbio.se/medlemmar/sangair/) - The system can be attached to a patient and therefore slow down and control a sepsis infection by killing bacteria present in the blood. Another positive fact is that it also oxygenates the blood, which is beneficial due to the fact that oxygen levels usually are low in Sepsis patients.
- [Countagen](https://swedenbio.se/medlemmar/countagen/) - Countagen offers simple-to-use consumable reagent kits that allow users to analyze gene editing efficiency and specificity with the same high precision, but in a much more affordable way. The company's patent-pending technology offers a customized ‘plug-and-play’ solution that reduces the current time-consuming workflows from days to hours. It reliably counts and identifies gene edits with high
- [rAAVen Therapeutics](https://swedenbio.se/medlemmar/raaven-therapeutics/) - Using state of the art methodologies within cloning, virus variant production and sequencing, rAAVen builds novel viral vectors for precision targeting of defined cell populations or with desired properties.
- [Prolevi Bio](https://swedenbio.se/medlemmar/prolevi-bio/) - Prolevi is an international start-up with registered offices in Sweden. Prolevi’s platform patent technology focuses on women’s health with hypothyroidism as a first use case, due to huge unmet need. 750M patients suffer worldwide with 150M non respondent to current therapy. This is because current treatments are unable to follow healthy thyroid gland release cycles
- [Citeline](https://swedenbio.se/medlemmar/citeline/) - These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory related-decisions and create real-world opportunities for growth. Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D
- [ABB Pharmaceutical and Life Science](https://swedenbio.se/medlemmar/abb-pharmaceutical-and-life-science/) - Through enhanced synchronization of MES and DCS system, ABB ensure data integrity, enabling high-precision analysis and driving consistency of output for pharmaceutical and biotech companies to achieve operational excellence, reduce time to market and meet all industry standards and regulations. With thousands of installations worldwide, ABB is your partner of choice for innovative technological solutions,
- [Mendus](https://swedenbio.se/medlemmar/immunicum-ab/) - The results of a phase I / II study of INTUVAX® indicates that the vaccine can enhance the body’s immune system and thereby prolong survival in renal cancer. Additionally observed signs of synergistic effect with tyrosine kinase inhibitors – a different kind of drugs against tumor diseases. No confirmed vaccine-related adverse events were recorded.
- [Citizens Affairs](https://swedenbio.se/medlemmar/citizens-affairs/) - Citizens Affairs is behind the FOKUS Patient-project – a platform for knowledge sharing that caters to patients, healthcare workers, businesses and the public sector.
- [Arthur D. Little](https://swedenbio.se/medlemmar/arthur-d-little-ab/) - The company develops innovative solutions for their clients that continually reengineer existing business models. Their consultants always bring a little more in strategic planning, innovative thinking and technological expertise. Arthur D. Little works beyond the well-trodden paths and standardised concepts and instead deliver bespoke solutions suited to the economic reality of each of their clients.
- [Lantmännen Medical](https://swedenbio.se/medlemmar/lantmannen-as-faktor-ab/) - Lantmännen Medical is working with R&D of the Antisecretory Factor (AF), a protein endogenous to the human body which was discovered more than 20 years ago by the Swedish scientists Professors Stefan Lange and Ivar Lönnroth. AF has a fundamental role in secretory and inflammatory diseases, such as ulcerative colitis, Crohn's disease and Ménière's disease.
- [Bird & Bird Advokat](https://swedenbio.se/medlemmar/bird-bird-advokat-kb/) - Bird & Bird combines exceptional legal expertise with deep industry knowledge and refreshingly creative thinking, to help clients achieve their commercial goals. There are three key things that set them apart from their competitors: their deep industry knowledge, excellence in client service and international reach. These differentiators are all underpinned by their commitment to clarity, originality and passion.
- [Sciety](https://swedenbio.se/medlemmar/sciety-ab/) - Sciety is the leading investor syndicate in the Nordics with an exclusive focus on life science and health tech. We combine experience from life science and finance to select promising companies in the industry. Sciety invests own funds in all companies that pass our selection process and offer the network to co-invest on the same
- [Veltio Pharma](https://swedenbio.se/medlemmar/nvigorea-ab/) - VELTIO PHARMA is an innovative pharmaceutical company that aspires to transform problem poorly soluble drugs into bestselling products with high bioavailability. Through our proprietary nanotechnology platform, we aim to improve the solid oral dosage forms that make difference to the patients. Our special focus therapeutic areas include pain and inflammation, immune disorders, and cancer. We offer in-licensing opportunities and services in pre-clinical to Phase
- [Profundus](https://swedenbio.se/medlemmar/profundus/) - Profundus AB was founded on the results of research and development of a unique instrument for wide-field high-resolution adaptive optics retinal imaging, by the Adaptive Optics research team at the Department of Ophthalmology, University of Gothenburg. Profundus' aim is to provide researchers and clinicians with a tool that can visualize currently subclinical changes of retinal
- [Uppsala Universitet Invest](https://swedenbio.se/medlemmar/uppsala-universitet-invest/) - UU Invest is an early investor with a longer exit strategy than many other venture capital companies. UU Invest assists researchers and students in validating technology, markets and business models and also invests in projects before companies are formed. A collaboration with UU Invest means a long-term commitment and access to a broad network of
- [Waters Sverige](https://swedenbio.se/medlemmar/waters-sverige/) - Waters Corporation is the world's leading specialty measurement company focused on improving human health and well-being through the application of high-value analytical technologies and industry leading scientific expertise. Waters has continually pioneered chromatography, mass spectrometry, and thermal analysis innovations. Whether it’s discovering new pharmaceuticals, assuring the safety of the world’s food and water supplies, or
- [AnaCardio](https://swedenbio.se/medlemmar/anacardio/) - AnaCardio was founded based on ground-breaking research from Karolinska Institutet showing improved contractility of the heart muscle through a unique and differentiated mechanism. Its lead program AC01 is an oral ghrelin peptidomimetic small-molecule, which is being developed as a contractile agent in heart failure patients. You can find more information about AnaCardio at www.anacardio.com.
- [EIP Sweden](https://swedenbio.se/medlemmar/eip-sweden/) - Their patent drafting, prosecution and challenges practice obtains and defends high-value and complex patents for clients, and invalidates patents held by others during post-grant proceedings including oppositions at the European Patent Office (EPO).
- [MetaSafe Sweden](https://swedenbio.se/medlemmar/metasafe/) - In 2022 MetaSafe was reborn in the transfer of Admescope’s Swedish operation to the CTR group in Sweden. MetaSafe provides expertise in metabolite analysis in the ADME field and particularly in the field of Metabolites in Safety testing and radiolabel-assisted metabolite analysis.
- [Invest in Skåne](https://swedenbio.se/medlemmar/invest-in-skane/) - They provide professional advice and services to international companies considering Skåne for future investments and expansion and attract valuable talent to the region to secure a skilled, diverse and competent workforce in Skåne. Invest in Skåne is part of the department for Regional Development at Region Skåne.
- [Phase2Phase  Biopharma](https://swedenbio.se/medlemmar/phase2phase-biopharma/) - Phase2Phase Biopharma Consulting provides senior competence and services within CMC (Chemistry, Manufacturing & Control), Quality Assurance and thereto related services. Phase2Phase frequently supports its clients with CDMO Sourcing, Contract Negotiation, Due Diligence, CMC Strategies, Technology Transfer and Project Management. Phase2Phase Biopharma Manufacturing will provide GMP Drug Substance Manufacturing for biopharmaceutical companies at both clinical and
- [Redoxis](https://swedenbio.se/medlemmar/redoxis-ab/) - They provide a wide range of in vivo and in vitro models for evaluation of efficacy, mechanism of action, bench marking, PK/PD, initial safety and biomarker analysis of novel drugs. Redoxis routinely set up models on demand as a complement to their portfolio of validated models and performs tailor-made preclinical studies combining dedication, experience and
- [NorthX Biologics](https://swedenbio.se/medlemmar/cobra-biologics/) - NorthX Biologics is here to support your biologic program from start to finish, providing a complete solution where, in modern well-equipped labs, their skilled Scientists take care of your project. Each project and product is unique and they strive to partner with you to ensure that your special needs are catered for. They work in
- [Invest Stockholm Business Region](https://swedenbio.se/medlemmar/invest-stockholm-business-region/) - The company with its two subsidiaries; Visit Stockholm and Invest Stockholm, are responsible for promoting and developing Stockholm as a business and tourist destination under the brand Stockholm – The Capital of Scandinavia. Stockholm Business Region works closely with the business community, academic, and other institutions, as well as with various organizations in the city,
- [Fluicell](https://swedenbio.se/medlemmar/fluicell/) - Fluicell was founded in 2012 and provides easy-to-use research solutions in 3d single-cell bioprinting of biological tissues as well as single-cell biology and pharmacology. Fluicell is a world leader and pioneer in open-volume microfluidics for the life sciences, with customers in leading academic institutions and major pharmaceutical companies. Fluicell’s innovative technologies are supported by a
- [Eir Ventures Partners](https://swedenbio.se/medlemmar/eir-ventures-partners/) - Optimal and responsible value creation for companies and investors is obtained by working closely with their portfolio companies. Eir Ventures contribute with company building and management expertise, strategic thinking and extensive networks to drive healthcare innovation to the benefit of patients, healthcare systems, investors and society.
- [Modus Therapeutics Holding](https://swedenbio.se/medlemmar/modus-therapeutics-holding/) - Modus' largest owners are Karolinska Development (Nasdaq Stockholm: KDEV), KDev Investments AB, (jointly owned by Karolinska Development AB and Rosetta Capital) and John Öhd. The company has been listed on the Nasdaq First North Growth Market since July 2021.
- [Neola Medical](https://swedenbio.se/medlemmar/gpx-medical/) - NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for premature babies. Neola Medical was founded in 2016 and is headquartered in Lund, Sweden, and is based on a historical Swedish heritage of medical technology innovation and invaluable contributions to global healthcare.
- [Devyser Diagnostics](https://swedenbio.se/medlemmar/devyser-diagnostics/) - Devyser Diagnostics develop DNA tests with the end user in mind. Their focus is on eliminating tedious protocols and streamlining workflows to create tests that are simpler, faster and easier to use in routine diagnostics laboratories. And by simplifying the diagnostic process, they ensure you get cost-effective and reliable results. Devyser Diagnostics are based in
- [Birka BioStorage](https://swedenbio.se/medlemmar/birka-biostorage/) - Birka BioStorage is the main secure and safe storage facility in Scandinavia for biological and pharmaceutical samples. They offer on site storage services, shipping and shipment validation services, on-site storage enivironment mapping and validation. Their mission is to give their customers, the continuous off-site storage support they need, in order to be able to focus
- [Strike Pharma](https://swedenbio.se/medlemmar/strike-pharma/) - Today, Strike Pharma’s development program is focused on selection of novel, clinically-relevant candidates for use as immunotherapeutic vaccines in the treatment of solid tumors. Strike Pharma headquartered is in Uppsala, Sweden and they aim to use Adaptable Drug Affinity Conjugate (ADAC) technology to take precision medicine to a new level.
- [FINGERS Brain Health Institute](https://swedenbio.se/medlemmar/fingers-brain-health-institute/) - FINGERS Brain Health Institute’s (FBHI) journey began in 2009 from the ground-breaking FINGER study, leading to paradigm-shifting results on multidomain lifestyle interventions in 2015, which set the foundation for their present world-wide efforts for effective, holistic, and global solutions to dementia prevention and healthy brain aging. FINGERS Brain Health Institute mission is promoting healthy brain
- [QPS Netherlands B.V](https://swedenbio.se/medlemmar/qps-netherlands-b-v/) - Since 1995, QPS has grown from a tiny bioanalysis shop to a full-service CRO with 1,100+ employees in the US, Europe and Asia. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in neuropharmacology, DMPK, toxicology, bioanalysis, translational medicine and clinical development. QPS is an award-winning leader focused on bioanalytics and clinical trials,
- [Sound Bioventures Management](https://swedenbio.se/medlemmar/sound-bioventures-management/) - The fund has a geographic footprint on both sides of the Atlantic and will support the clinical development of novel medicines for diseases of high unmet medical need.
- [Merck Life Science](https://swedenbio.se/medlemmar/merck-life-science/) - Their tools, services and digital platforms empower scientists and engineers at every stage, helping deliver breakthrough therapies more quickly. With their three business units, they are a worldwide supplier of tools, high-grade chemicals, and equipment for academic labs, biotech, and biopharmaceutical manufacturers, as well as the industrial sector.
- [aera](https://swedenbio.se/medlemmar/aera/) - Founded in Copenhagen in January 2018, the firm now has patent attorneys in Stockholm, Oslo, Munich, Berlin and Madrid and has expanded its operations to cover all aspects of IP protection. The name aera is derived from the Latin word for ‘era’ (‘æra’ in Danish). The firm’s mission derives from its name – the firm
- [Alfa Laval](https://swedenbio.se/medlemmar/alfa-laval/) - Alfa Laval är en etablerad leverantör till biotillverkningsindustrin. Med produkter och system som är specifikt utformade och dokumenterade för biotekniska applikationer är de ett beprövat och testat varumärke. Mångfalden och kunskapen i deras globala nätverk med försäljnings- och servicerepresentanter möjliggör för att tillhandahålla anpassade och hållbara lösningar för att förbättra konkurrenskraften och säkerställa en enhetlig
- [NDA Group](https://swedenbio.se/medlemmar/nda-regulatory-service-ab/) - NDA Regulatory Service supports life science companies all over the world with the single aim to streamline the global development and commercialization process to accelerate patient access to important medical therapies. NDA comprises over 150 dedicated consultants with industry and regulatory agency backgrounds, supported by a network of over 1000 scientific, clinical, regulatory and drug development
- [Cytiva Sweden](https://swedenbio.se/medlemmar/cytiva-sweden/) - Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. They have a rich heritage tracing back hundreds of years, and a fresh beginning since 2020. Cytiva is a global life sciences leader dedicated to advancing and accelerating therapeutics. Cytiva is a trusted partner to customers
- [Thermo Fisher Scientific Phadia](https://swedenbio.se/medlemmar/thermo-fisher-scientific-phadia-ab/) - The mission is to enable the company's customers to make the world healthier, cleaner and safer. Thermo Fisher Scientific helps their customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through the company's premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services –
- [Biotage Sweden](https://swedenbio.se/medlemmar/biotage-sweden-ab/) - Biotage is built around the concept of HumanKind Unlimited. Their goal is to develop problem-solving solutions for society as a whole, helping to make the world a better place. Biotage does this through their technologies and their people – humankind unlimited. The company works in the fields of drug discovery, analytical chemistry and environmental and
- [HØIBERG](https://swedenbio.se/medlemmar/hoiberg/) - HØIBERG is a full service patent law firm providing services within the fields of Intellectual Property Rights (IPR), including Patents, Designs, Innovation Management, Technology Transfer and Business Development. They provide expert IPR knowledge in the fields ranging from biotech, foodtech, medtech, nanotech, chemistry and cleantech to hightech, software, electronics and mechanics.
- [Flerie Invest](https://swedenbio.se/medlemmar/flerie-invest/) - Flerie invests in venture and growth stage companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. They strive to be a long-term developer of companies with ambitious science and the ability to tackle major medical challenges
- [Prostatype Genomics](https://swedenbio.se/medlemmar/prostatype-genomics/) - Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By giving a comprehensive assessment of the aggressiveness of the prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Thus, the over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money
- [Omnio](https://swedenbio.se/medlemmar/omnio/) - Omnio AB is a biopharmaceutical company specialized in the development of new drug products based on the protein plasminogen’s immune regulatory effects. Omnio focuses on developing a novel biological drug for chronic wound healing where initial investigator-led treatments of patients with chronic wounds have shown great potential.
- [Elicera Therapeutics](https://swedenbio.se/medlemmar/elicera-therapeutics/) - Elicera Therapeutics AB is a clinical stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments.The company develops four drug candidates, two of which are in the field of oncolytic viruses and two in the field of CAR T-cell therapies, in addition to a platform technology called iTANK (ImmunoTherapies Activated with Nap for
- [Intelligent Implants Sweden](https://swedenbio.se/medlemmar/intelligent-implants-sweden/) - Intelligent Implants is developing electrotherapeutic devices to treat disease and aid recovery in bone and other tissues. They utilize data, engineering, and medicine to bring novel, active and connected medical devices to healthcare. Their integrated devices facilitate treatment for the patient as well as decision making for the healthcare professional.
- [Haeger & Carlsson](https://swedenbio.se/medlemmar/haeger-carlsson/) - Haeger & Carlsson's vision is to be the leading recruitment company within Life Science in the Nordic region. They believe that by bringing together individuals and organisations with similar values and objectives, they can provide the conditions needed for individuals to be successful and thus contribute to the company's success.
- [Bluefish Pharmaceuticals](https://swedenbio.se/medlemmar/bluefish-pharmaceuticals/) - Since their inception, Bluefish has developed the platform and know-how in order to participate in and to be an integral part of all major steps of the value chain in the offering of generic pharmaceuticals. Anchored in the vision of offering quality pharmaceuticals at prices affordable to all, Bluefish strives to be innovative and at
- [Hays Specialist Recruitment](https://swedenbio.se/medlemmar/hays-specialist-recruitment/) - Hays Sweden has since 2003 worked in following areas of expertise: life sciences, IT, technology & engineering and accountancy & finance. At Hays recruiting is the heart of their business. Hays are experts in recruiting qualified, professional and skilled people. Hays has a total of 10,000 employees in 240 offices in 33 countries in Europe, Australia, Asia, North and
- [Olink Proteomics](https://swedenbio.se/medlemmar/olink-promeotics/) - Olink Proteomics is a Swedish company dedicated to innovation, quality, rigor and transparency, providing products and services for human protein biomarker discovery. Their groundbreaking Olink panels for precision proteomics help scientists make research decisions more quickly and confidently through robust, multiplex biomarker analysis. Olink's high quality multiplex immunoassay panels help bring new insights into disease processes, improve
- [NEOGAP Therapeutics](https://swedenbio.se/medlemmar/neogap-ab/) - The company is located at Centre for Molecular Medicine at Karolinska Institutet, Stockholm, Sweden. NEOGAP Therapeutics strives to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system.
- [ClinStorage](https://swedenbio.se/medlemmar/clinstorage-ab/) - ClinStorage can act as a back-up storage solution when your samples are at risk i.e. power cuts or freezer break down. With ClinStorage's Rescue insurance agreement agreed volumes could be stored at ClinStorage while your storage equipment undergoes repairs and/or being replaced. The GMP standards are applicable for GLP and GCP samples and applied within Pharma
- [Fredersen Advokatbyrå](https://swedenbio.se/medlemmar/fredersen-advokatbyra/) - Fredersen is a law firm with offices in Malmö and Stockholm, and among their areas of expertise are life science and intellectual property rights. In life science, there are a number of specific types of agreements and with their experience and specialist knowledge, they have guided their clients through the various development phases. Many of them
- [Bergenstråhle & Partners](https://swedenbio.se/medlemmar/bergenstrahle-partners/)
- [Egetis Therapeutics](https://swedenbio.se/medlemmar/pledpharma-ab/) - The company’s most advanced project PledOx® reduces serious side effects associated with chemotherapy. The drug candidate Aladote™ is developed to reduce the risk of acute liver failure associated with acetaminophen poisoning. The project PP-099 aims to limit the reperfusion damage to the heart muscle following a heart attack. PledPharma’s drug candidates are based on rational development
- [Bulb Intelligence](https://swedenbio.se/medlemmar/bulb-intelligence/) - Bulb has long standing experience from identifying different competitive landscapes, to analyze different scenarios and defining key company strategies. Bulb guides you to improve your business by providing a structured understanding of both your competitive edge in the market place as well as your business challenges.
- [RegSmart Life Science](https://swedenbio.se/medlemmar/regsmart-life-science/) - With their long regulatory experience from senior positions at a regulatory agency and from small and big life science companies RegSmart Life Science facilitates your work by knowing “what to do, when and how”. The company provides fit for purpose advice and support in relation to European and US regulatory requirements, helping you to develop
- [OnDosis](https://swedenbio.se/medlemmar/ondosis/)
- [Alzinova](https://swedenbio.se/medlemmar/alzinova/) - Alzinova is a Swedish biopharma company specializing in the treatment of Alzheimer’s disease – one of the major health scourges, without effective treatment options. The Company’s proprietary AβCC peptide™ technology enables the development of disease-modifying therapies that with high precision could target the neurotoxic amyloid-β oligomers involved in the onset and progression of the disease.
- [Developeration](https://swedenbio.se/medlemmar/developeration/) - Developeration, founded in 2016, is a start-up company for innovative research and development of new operation methods. Their primary project is to develop a new operation method for treatment of hemorrhoids. They are developing a new innovative device which will make surgery possible without the necessity of narcosis, give less postoperative pain and decrease the treatment cost
- [FrostPharma](https://swedenbio.se/medlemmar/frostpharma/) - Since the start in 2017, FrostPharma has successfully commercialized a broad range of products across multiple disease areas, covering all Nordic countries and beyond. Key to success is the ability to match specific patient- and health care needs with relevant products in relation to their extensive in-house commercialization competence.
- [SmiLe Incubator](https://swedenbio.se/medlemmar/smile-incubator/) - SmiLe helps life science entrepreneurs of all maturity stages to commercialize their ideas and grow their business. That is realized by offering advanced coaching and development programs, well-equipped labs with state-of-the art instruments, a large international network of industry partners and investors, and a community of world-class life science innovators. SmiLe works on a no-equity,
- [Zelmic](https://swedenbio.se/medlemmar/zelmic/) - Zelmic’s have a strong track record of bringing topical products from idea to clinical testing. Zelmic has inhouse formulation, GMP analytical chemistry, and in vitro release capability to bring value to the drug development companies and can handle small molecules, peptides, and proteins. Moreover, Zelmic’s team members have been working with drug delivery technologies and
- [Zacco](https://swedenbio.se/medlemmar/zacco-ab/) - Through legal consulting, market analysis, IP portfolio construction and risk management, Zacco helps you turn passive intangible assets into sustainable business value. With more than 350 employees in all fields of intellectual property, including approximately 150 attorneys – of whom about 80 are experienced European Patent- , Trademark and/or Design Attorneys and 40 are Attorneys-at-Law
- [Xspray Pharma](https://swedenbio.se/medlemmar/xspray-pharma-ab/) - Xspray employs a patent-protected technology platform in order to create a pipeline of anti-cancer products with clinically relevant improvements or value enhanced generic versions for patients. Xspray primarly develops protein kinase inhibitors (PKI) for targeted cancer treatments. PKI’s are the second largest segment within cancer drugs.
- [Xintela](https://swedenbio.se/medlemmar/xintela-ab/) - Xintela’s operations are based on a patented technology platform, XINMARK™, from which the company makes use of specific markers to develop new treatments and diagnostics in regenerative medicine and cancer. The company is listed on Nasdaq First North Stockholm.
- [Xbrane Biopharma](https://swedenbio.se/medlemmar/xbrane-biopharma-ab/) - More than 60% of all pharmaceutical target proteins and the majority of all new pharmaceuticals and vaccines, are protein-based. In research and development, and production of these protein-based therapeutics, finding the optimal conditions for protein production is often a time-consuming and laborious process. Xbrane Biopharma has two tightly-controlled bacterial protein expression systems. They enable expression of host-toxic and challenging proteins,
- [Vironova](https://swedenbio.se/medlemmar/vironova-ab/) - Vironova is a Swedish biotechnology and software company providing comprehensive hardware, software, and services for the analysis of nanoparticles.Vironova revolutionizes access to transmission electron microscopy–based image analysis in biopharmaceutical development. The company's solution enables automated analyses for faster and better-informed decisions to secure robust bioprocessing and final product quality.
- [Viedoc Technologies](https://swedenbio.se/medlemmar/viedoc-technologies/) - Viedoc Technologies envisions a future where all researchers have access to the finest data entry technology available. By blending innovation with design, Viedoc aims to simplify the users' workday and help them run more efficient trials. The company understands how health-tech innovation has a major impact on global health, and are leading the progress towards the
- [Vicore Pharma](https://swedenbio.se/medlemmar/vicore-pharma-ab/) - The company's portfolio contains small molecules with potential indications including anti-inflammation, nerve generation and cardiovascular disease. Their vision is to lead the development of new molecules with agonistic action to the AT2 receptor into successful clinical drug entities. The AT2 receptor is expressed and activated in the fetus where it supports organ development and differention, and
- [VERIGRAFT](https://swedenbio.se/medlemmar/verigraft-ab/) - The company is a pioneer in the field of regenerative medicine, developing personalized human tissues for transplantation. The current focus area is the development of fully biological, personalized blood vessels that can be used to replace diseased or non-functioning blood vessels in patients.
- [Valneva Sweden](https://swedenbio.se/medlemmar/valneva-ab/) - Valneva’s portfolio includes two commercial vaccines for travelers: one for the prevention of Japanese encephalitis (IXIARO®) and the second (DUKORAL®) indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by LT-ETEC (Enterotoxigenic Escherichia coli). The Company has proprietary vaccines in development including candidates against Pseudomonas aeruginosa, Clostridium difficile and Lyme borreliosis.
- [Valea](https://swedenbio.se/medlemmar/valea-ab/) - Valea's employees include European patent, design and trademark attorneys and lawyers with expertise within intellectual property rights field. The partners have extensive experience and expertise in all areas of technology and related legal issues. Valea's expertise is combined with a natural business understanding of the commercial value that intellectual property assets represent for their clients.
- [Uppsala Innovation Centre (UIC)](https://swedenbio.se/medlemmar/uppsala-innovation-centre/) - Throughout their business development programs, UIC works closely with the private and public sector, with about twenty UIC partners. The partners contribute to the companies’ development through seminars, individual counseling and direct services to the companies. In addition, UIC has a broad network of hand-picked business coaches within all industrial sectors who share their expertice
- [Umecrine Cognition](https://swedenbio.se/medlemmar/umecrine-cognition-ab/) - Umecrine Cognition is developing pharmaceuticals against neurological disorders in the central nervous system, CNS that are caused by endogenous CNS-active steroids (GABA-steroids). The company is focused on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease, a growing area with high unmet medical need.
- [Truly Translational Sweden](https://swedenbio.se/medlemmar/truly-translational-sweden-ab/) - Truly Translational has solid experience in working with both small and large molecules. Their key therapeutic areas are inflammation, respiratory diseases, autoimmune diseases and oncology. As a member of the Medicon Valley Inhalation Consortium the company possesses access to unique competence and capabilities within inhalation, where Truly Translation offers pre-clinical in vivo inhalation pharmacology services.
- [Toxicology Knowledge Team Sweden](https://swedenbio.se/medlemmar/toxicology-knowledge-team-sweden-ab/) - The company was founded by a number of dedicated toxicologists at AstraZeneca who also are joint owners of the company – this guarantees a very high level of commitment among the consultants in all aspects of the company and its services. Toxicology Knowledge Team Sweden has gathered Sweden’s broadest commercially available expertise in toxicological risk
- [SynAct Pharma](https://swedenbio.se/medlemmar/synact-pharma-ab/) - The company has a platform technology based on a new class of drug candidates that target the acute exacerbations of chronic inflammatory diseases, with the primary aim to stimulate natural healing mechanisms. SynAct Pharma is focused on the development of novel and first in class agonists to target the melanocortin system. The melanocortin system is
- [SymCel Sverige](https://swedenbio.se/medlemmar/symcel-sverige-ab/) - The worldwide emergence of antibiotic resistance calls for effective exploitation of existing antibiotics. Antibiotic combinations with different modes of action can synergize for successful treatment. In the present study, SymCel used microcalorimetry screening to identify synergistic combination treatments against clinical MDR isolates. The synergistic effects were validated in a murine infection model.
- [Swedish Orphan Biovitrum](https://swedenbio.se/medlemmar/swedish-orphan-biovitrum-ab-publ/) - Sobi's research and product portfolio is primarily focused on haemophilia, inflammation and genetic and metabolic diseases. They have world-class capabilities in protein biochemistry and biologics manufacturing development - validated by leading industry partners. Their organisation spans 24 countries, delivering therapies to patients in 67 countries across the globe.
- [Sprint Bioscience](https://swedenbio.se/medlemmar/sprint-bioscience-ab/) - Since Sprint Bioscience's inception in 2009 the company have built a body of solid expertise and achieved a world leading position, thanks to their dedicated and skilled employees and their effective methodology. Sprint Bioscience works with a broad portfolio and quickly develop several parallel projects in the preclinical stage, up until the point when the
- [Spotlight Group](https://swedenbio.se/medlemmar/spotlight-group-ab/) - Established in 1997, the company today has helped approximately 170 companies to be listed on the Spotlight Stock Market, with hundreds of thousands of active investors. Sedermera Fondkommission and MCL have been two crucial operations in the Group’s development, with expertise in raising capital for growth companies, and capital markets and corporate law respectively.
- [Sixera Pharma](https://swedenbio.se/medlemmar/sixera-pharma/) - Sixera Pharma is a biopharmaceutical company based at the Karolinska Institute Science Park in Stockholm. The company was founded to develop basic research findings into treatments for skin diseases. The founders of Sixera Pharma has discovered key genes and the mechanisms regulating skin formation and barrier functions critical for the Netherton syndrome.
- [Sigrid Therapeutics](https://swedenbio.se/medlemmar/sigrid-therapeutics-ab/) - Sigrid Therapeutics is a clinical-stage biotechnology company pioneering a new class of therapies to prevent and treat lifestyle diseases. SiPore15™ is Sigrid Therapeutics’ lead product candidate in clinical development, originating from research at Stockholm University and Karolinska Institute. SiPore15™ is a breakthrough particle for the safe reduction of blood sugar levels in people at risk
- [Scandinavian Biopharma Holding](https://swedenbio.se/medlemmar/scandinavian-biopharma-holding-ab/) - Scandinavian Biopharma Holding develops together with the American global health non-profit organization, PATH Vaccine Solutions and researchers at the University of Gothenburg, a new travellers’ diarrhoea vaccine, an oral ETEC vaccine. The company has extensive experience in the field of vaccine and drug development, process development, commercial production and marketing & sales. The company offers contract research
- [Salipro Biotech](https://swedenbio.se/medlemmar/salipro-biotech-ab/) - The Salipro system of Salipro Biotech stabilises membrane proteins in a lipid environment and allows to work in detergent-free buffer systems. ​​ Various classes of membrane proteins can be incorporated into lipid Salipro nanoparticles: ​Human, bacterial, viral, GPCR, channels, transporters, receptors etc. The technology can be applied in structural biology, drug discovery, antibody development and vaccine development.
- [Sahlgrenska Science Park](https://swedenbio.se/medlemmar/sahlgrenska-science-park/) - Sahlgrenska Science Park is tasked by Business Region Göteborg, the Region Västra Götaland, the University of Gothenburg and Chalmers University of Technology with strengthening the innovation system in the life science field in the West of Sweden. Sahlgrenska Science Park's vision is to help the already successful medical sector of industry in the region to
- [Roche](https://swedenbio.se/medlemmar/roche-ab/) - Roche's research covers all stages of prevention, diagnosis and treatment of diseases to give people better health and quality of life. Roche AB, the pharmaceutical part of Roche in Sweden, currently works primarily with drugs in oncology, rheumatism, virology, inflammation, metabolism and CNS. Within these areas, we in Sweden also have extensive operations in clinical
- [RISE Research Institutes of Sweden](https://swedenbio.se/medlemmar/rise-research-institutes-sweden-ab/) - RISE Research Institutes of Sweden works closely with their customers to create value, delivering high-quality input in all parts of the innovation chain, and thus playing an important part in assisting the competitiveness of industry and its evolution towards sustainable development.
- [Renapharma](https://swedenbio.se/medlemmar/renapharma/) - Today Renapharma is a family-owned pharmaceutical company operated under the leadership of CEO Caroline Danielson and Kristin Danielson, who is currently researching iron metabolism at the Karolinska Institute. Through comprehensive scientific studies and trials, Renapharma is developing medications, dietary supplements and medical technology in order that the company benefits society through long-term improvements to people’s
- [RedHot Diagnostics](https://swedenbio.se/medlemmar/redhot-diagnostics-ab/) - RedHot captures product ideas from academic research and rapidly take them to the market. It is done in redhot’s streamlined processes, which includes everything from prototype to sales and marketing. The unique business structure, where a jointly owned company with the researchers contains all intellectual property while sales is done in redhot, creates a win-win situation
- [Randstad](https://swedenbio.se/medlemmar/randstad/) - Ranstad offers consulting staffing and recruitment of scientists and engineers. Randstad's consultant managers and recruitment consultants have a scientific or engineering education and work experience in the each field. Combined with great knowledge of personnel issues and extensive experience in recruiting, we understand our customers' need for flexibility and the right qualifications.
- [QureTech Bio](https://swedenbio.se/medlemmar/quretech-bio/) - We address a significant unmet medical need by developing a new class of antibacterial agents that target antimicrobial resistance. This is done either by a direct antimicrobial effect or by potentiating existing antibiotics. The compounds are new small molecule chemical entities from a well-developed chemical platform with excellent synthetic availability and desirable drug properties. QureTech
- [PwC](https://swedenbio.se/medlemmar/pwc-ab/) - PwC is among the leading professional services networks in the world. PwC helps organisations and individuals create the value they’re looking for, by delivering quality in assurance, tax and advisory services.
- [Potter Clarkson](https://swedenbio.se/medlemmar/potter-clarkson-ab/) - Great innovations have the potential to effect transformational change in all areas of our lives – providing lifesaving medical treatments, reducing energy, or simply making everyday tasks easier. But for these breakthrough ideas to become a reality, they need the very best patent protection. That is exactly what a Potter Clarkson patent attorney can deliver
- [PKxpert](https://swedenbio.se/medlemmar/pkxpert-ab/) - PKxpert has extensive experience from big pharma and biotech companies with small molecules; peptides, proteins and monoclonal antibodies; variety of nonclinical and clinical study designs; regulatory documentation; GLP (Good Laboratory Practice) including quality assurance, audits and SOP documentation.
- [Phosworks Digital Ideas](https://swedenbio.se/medlemmar/phosworks-digital-ideas/) - Phosworks is one of Sweden's leading digital agencies with 50 creative talents, who strives to make brands stand out in the crowd, and satisfying high demanding customers. Combining cutting edge competences in strategy, mobile media, design and technology, Phosworks creates business communication strategies and digital solutions for film and web that cross boundaries and make
- [PharmNovo](https://swedenbio.se/medlemmar/pharmnovo/) - The company combines smart chemistry and bioscience to discover new medicines to treat diseases of the nervous system. PharmNovo's aim has been to develop biased agonists of the delta opioid receptor (DOR). Unlike the mu opioid receptor which is the major target of conventional opioid drugs, activating the DOR does not provide good acute analgesia
- [Pharma Way](https://swedenbio.se/medlemmar/pharma-way/) - Pharma Way are building a portfolio of innovative, effective and safe products on the Scandinavian market. The Company's products are both developed inhouse or developed in close cooperation with global producers, all to meet the needs in areas where there are currently no good treatments. The company focuses primarily on personal health care products. Together
- [Pelago Bioscience](https://swedenbio.se/medlemmar/pelago-bioscience-ab/) - The company delivers in situ target engagement studies to accelerate preclinical and clinical drug discovery and diagnostics development. Using CETSA data and applications, drug discovery R&D companies are able to make better and more informed decisions at earlier stages in their projects. This reduces time and money spent on sub optimal compounds and allows faster development
- [Orexo](https://swedenbio.se/medlemmar/orexo-ab/) - The company is commercializing its proprietary product, Zubsolv® sublingual tablets, for treatment of opioid dependence, in the US. The Zubsolv sublingual tablet is an advanced formulation of buprenorphine and naloxone using Orexo’s extensive knowledge in sublingual technologies. Orexo has a portfolio of two approved and revenue generating products currently marketed under license in the US,
- [Oncorena](https://swedenbio.se/medlemmar/oncorena/) - Today, the prognosis for a patient with renal (kidney) cancer that has spread is very poor. Current treatment of metastasized kidney cancer only, on average, prolongs the life for the suffering patients with a few months, and often the therapy has severe side-effects. In experiments Oncorena has demonstrated that orellanine kills also kidney cancer cells and
- [Oncopeptides](https://swedenbio.se/medlemmar/oncopeptides/) - Oncopeptides has been granted a priority review by the U.S. Food and Drug Administration, for the New Drug Application of melflufen in combination with dexamethasone for the treatment of adult patients with multiple myeloma. Oncopeptides is a fully integrated global biotech company committed to bringing innovation to patients with an unmet medical need and improving
- [Novo Nordisk Scandinavia](https://swedenbio.se/medlemmar/novo-nordisk-scandinavia-ab/) - For almost 100 years, Novo Nordisk has been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems. The company's treatments today are helping millions of people living with diabetes, obesity, rare bleeding disorders, and growth hormone-related disorders. From their labs to their factory floors, Novo Nordisk is discovering and developing innovative biological
- [Novavax](https://swedenbio.se/medlemmar/novavax-ab/) - Novavax's recombinant nanoparticles and adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. The company's product pipeline targets a variety of infectious diseases with vaccine candidates currently in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza, and Ebola virus (EBOV). Novavax also has additional
- [Nordic BioAnalysis](https://swedenbio.se/medlemmar/nordic-bioanalysis-ab/) - The company's analysis follow GMP and are adapted to pharma, biotech, medical device and other healthcare industries. Nordic BioAnalysis seeks to provide accurate reliable and cost-effective analytical services to the healthcare industry, by building long- and short-term relationships with sponsors/customers who wish to promote patient well-being. Nordic BioAnalysis will take care of all your samples
- [NextCell Pharma](https://swedenbio.se/medlemmar/nextcell-pharma-ab/) - NextCell is focusing on research and development of novel stem cell therapies and is also running a tissue establishment and primary biobank, classified as healthcare provider. ProTrans is based on NextCell patent pending Selection Algorithm. Further, NextCell runs Cellaviva, Nordic's largest private stem cell bank, approved by IVO.
- [Nasdaq Stockholm](https://swedenbio.se/medlemmar/nasdaq-stockholm-ab/) - Innovation has always been--and will continue to be--part of our DNA. Today, the company is firmly established as a technology provider and strives to be the leading technology, trading, and intelligence provider to capital markets.
- [Nanexa](https://swedenbio.se/medlemmar/nanexa-ab/) - Since its founding in 2007, Nanexa has based its operations on a coating technique called Atomic Layer Deposition (ALD). Over the years, Nanexa has utilized the ALD technology in a variety of projects, ranging from detector technology for detecting nuclear explosions to coating on medical devices. Today, Nanexa benefits from its many years of experience
- [Mpya Sci & Tech](https://swedenbio.se/medlemmar/mpya-sci-tech/) - Mpya is devoted to questioning the conventional. The company believes that new ideas, new knowledge and new paths need to be an everyday vision. Mpya Sci & Tech has backgrounds and knowledge within science and technology. The company has added extensive experience from numerous science and technology recruitment processes, consultant assignments and organisational coaching. Today
- [Molecules of Man](https://swedenbio.se/medlemmar/molecules-of-man-ab/) - It is privately held and was founded in 2005 by Drs. Tobias Allander, Mats A A Persson, and Mr. Staffan Söderström. The company is focusing its efforts to develop human monoclonal antibodies for treatment or protection against hepatitis C, a liver disease caused by the hepatitis C virus (HCV) and estimated to affect 170 million
- [Milmed Unico](https://swedenbio.se/medlemmar/milmed-unico-ab/) - This balances and influences the connections between cells, which means that a number of rehabilitation processes are stimulated. The body's self-regulatory system is effectively rebuilt and the neuroendocrine systems are normalized and the body's immune system is raised.
- [Medivir](https://swedenbio.se/medlemmar/medivir-ab/) - Medivir has a leading competence within protease inhibitor design and nucleotide/nucleoside science and the company is dedicated to develop innovative pharmaceuticals that meet great unmet medical need. Medivir's commercial organization provides a growing portfolio of specialty care pharmaceuticals on the Nordic market. Medivir is listed on the Nasdaq Stockholm Mid Cap List.
- [Medicorent](https://swedenbio.se/medlemmar/medicorent/) - Through the alliance, Medicorent offers end to end clinical development services under one umbrella as well as strategic regulatory advice and supportive services including outsourcing & recruitments. The alliance offers flexible service models and long-term relations, fulfilling previously unmet multi-faceted need for start-ups and mid-size pharma-, biotech & medtech companies.
- [Medicon Village Innovation](https://swedenbio.se/medlemmar/medicon-village/) - At Medicon Village Innovation the entire value chain, from researchers to innovators and businessmen, work together under a single flag to create value for people’s health and wellbeing. Together with the medical research centres Biomedical Centre (BMC) in Lund and the Clinical Research Centre (CRC) in Malmö, as well as the developing research facilities ESS and
- [Medicon Valley Alliance](https://swedenbio.se/medlemmar/medicon-valley-alliance/) - Medicon Valley Alliance exists to make Medicon Valley an attractive destination for the best talent within life science. The organisation does this because talent is the single most important and valuable resource in a knowledge-intensive sector such as life science. They create value for our members by launching and driving initiatives that put Medicon Valley
- [Medeon](https://swedenbio.se/medlemmar/medeon-ab/) - Medeon's philosophy is that each and every growth industry has its unique needs. Medeon's focus is on knowledge-intensive companies in the life science field (pharmaceuticals, medical technology, biotechnology and healthcare). New hot spot in life science Medeon Science Park offers a 100 percent focus on life science with vast networking opportunities. Business services at the park
- [Lipum](https://swedenbio.se/medlemmar/lipum-ab/) - Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic inflammatory diseases. Lipum has a biological anti-inflammatory drug candidate developed against Rheumatoid Arthritis (RA) – an autoimmune disease characterized by chronic inflammation of the joints. It often causes disability and lowers the quality of life for millions.
- [Lipigon Pharmaceuticals](https://swedenbio.se/medlemmar/lipigon-pharmaceuticals-ab/) - Dyslipidemia characterized by high plasma triglycerides and low HDL-cholesterol is a key risk factor for cardiovascular disease. There are approximately 150 million people with this type of dyslipidemia in the G7 countries and 60 million of them are considered as high-risk patients. Lipigon Pharmaceuticals develops innovative first-in-class drugs aiming at treating these patients.
- [Link Medical Research](https://swedenbio.se/medlemmar/link-medical-research-ab/) - Our Scandinavian roots and culture provide a high-quality service delivery based on respect, work integrity and a strong focus on solutions. We are a pragmatic problem-solver, empowering our experienced specialists with modern technology that will change your expectations of a CRO partner. Our promise is to improve and accelerate your product development through transformative methods,
- [Lablytica Life Science](https://swedenbio.se/medlemmar/lablytica-life-science/) - Lablytica is a company specializing in bioanalytical services including sample analysis in plasma, tissue samples and urine. The research and development activities carried out at Lablytica's facility in Uppsala, Sweden, are fully compliant with Good Laboratory Practice (GLP) and relevant regulatory guidelines from the EMA and the FDA. The laboratory is also part of the
- [KLIFO](https://swedenbio.se/medlemmar/klifo/) - KLIFO offers multi-disciplinary consulting and operational solutions spanning all areas of regulatory affairs, clinical research, clinical trial supply, CMC development, pharmacovigilance, and the development of pharmaceutical and biotech products and medical devices. KLIFO's core ambition is to support their clients by avancing the progress of their client's drug development projects, and over the past decade, we have
- [Karolinska Institutet Science Park](https://swedenbio.se/medlemmar/karolinska-institutet-science-park-ab/) - Karolinska Institutet places great value on a dynamic interaction between the academic and the commercial sectors – for mutual benefits and general improvement for the whole society. To enable professional evaluation, development and commercialization of interesting innovations in Life Science and Medical Technology an overall innovation system has been created where KI Science Park plays an
- [Karolinska Institutet Innovations](https://swedenbio.se/medlemmar/karolinska-institutet-innovations-ab/) - KI Innovations AB is specialized in turning life science research into successful business. Their staff has the required skills and connections within the scientific and business communities. Karolinska Institutet Innovations AB transforms life science research into business. Through structured processes, researchers get support for commercializing their results. This applies to researchers at Karolinska Institutet and researchers
- [Karolinska Development](https://swedenbio.se/medlemmar/karolinska-development-ab/) - Karolinska Deverlopment's employees have extensive experience of research, development, financing and commercialisation of pharmaceutical and medtech projects. This expertise enables them to select attractive investment objects, to monitor the development of their portfolio companies, and to ensure that the companies have the right team composition and structure – both in order to progress the projects
- [Industrifonden](https://swedenbio.se/medlemmar/industrifonden/) - Industrifonden invests small and medium-sized Swedish growth companies. Industrifonden works on a commercial basis in partnership with entrepreneurs and other investors to generate a return. The company takes a long-term approach and reinvest all capital in new companies. In this way we also strengthen the Swedish venture capital market. Industrifonden wants to be an innovative
- [HealthCap](https://swedenbio.se/medlemmar/healthcap-ab/) - With more than EUR 900m raised since the start in 1996, HealthCap is one of the largest specialized providers of venture capital within life sciences in Europe. The investment objective of HealthCap is to achieve significant long-term capital appreciation. HealthCap diversify the portfolios by field of activity, geography and stage of company development.
- [Hansa Biopharma](https://swedenbio.se/medlemmar/hansa-medical-ab/) - Hansa Biopharma envisions organ transplantations made available to sensitized patients and for swift inhibition of attacks by the immune system to be brought to patients suffering from autoimmune conditions. The company's lead candidate drug, IdeS, is primarily developed as a single dose treatment to enable kidney transplantation for sensitized patients.
- [Hadean Ventures](https://swedenbio.se/medlemmar/hadean-ventures/) - The funds are backed by leading private and institutional investors. Hadean Ventures has offices in Oslo and Stockholm and collaborates with academic institutions and start-up hubs across the region.
- [GU Ventures](https://swedenbio.se/medlemmar/gu-ventures/) - GU Ventures build businesses out of groundbreaking ideas that help shape a better tomorrow. Their passionate team of company builders, financial experts, IP and legal talent ensure success for our companies. GU Ventures invest in disruptive ideas that aim to make the world a better place. Providing early stage funding is crucial for these ideas
- [Grifols Nordic](https://swedenbio.se/medlemmar/grifols-nordic-ab/) - Grifols is a leading global producer of plasma-derived protein therapies for patients who have rare, genetic diseases and potentially life-threatening infections. Grifols' diagnostic systems are composed of analyzers, instrumentation and reagents that satisfy the demands of clinical laboratory professionals who require precise results and a reliable diagnosis. Grifols can also offer high-quality contract manufacturing services.
- [Genovis](https://swedenbio.se/medlemmar/genovis-ab/) - The industry transition from small molecule drugs to large biopharmaceuticals require new tools for analytical workflows and detailed characterization of complex drugs such as monoclonal antibodies, antibody drug conjugates, Fc-fusion proteins etc. The SmartEnzymes developed and provided by Genovis are widely used throughout the biopharmaceutical industry to study critical drug quality attributes.
- [Gedea Biotech](https://swedenbio.se/medlemmar/gedea-biotech-ab/) - Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GDA001, is a natural substance that has always been part of our environment. It acts by lowering the pH as well as providing a physical barrier protection and inhibiting biofilm formation. The first
- [Galenica](https://swedenbio.se/medlemmar/galenica-ab/) - Galenica also manufactures commercially niched products for the market. Galenica is authorized and audited by the Swedish Medical Product Agency for the cGMP production of Clinical Trial Material. Galenica actively develops and launches pharmaceutical drugs to the market, utilizing our state-of-the-art expertise in drug formulation, manufacturing and quality control.
- [Gabather](https://swedenbio.se/medlemmar/gabather-ab/) - Gabather AB was founded in 2014, based on 10 years research at Lund University, to develop novel drug candidates for the treatment of several diseases originating in the central nervous system (CNS). Since there are several areas of unmet need as well as many medicines going off-patent, it is an opportune moment to develop new
- [Fujirebio Diagnostics](https://swedenbio.se/medlemmar/fujirebio-diagnostics-ab/) - Fujirebio Diagnostics specializes in the manufacturing of manual assay products, reagents and controls distributed throughout the U.S. and around the world, as well as custom-developed products for use through our worldwide network of distribution partner. Fujirebio Diagnostics' proven manufacturing process has made us a global partner of choice among leading diagnostic companies.
- [FHC Undeland](https://swedenbio.se/medlemmar/fhc-undeland-ab/) - Sven Undeland, has a broad commercial and clinical development experience from international pharmaceutical industry, based on leading positions in Pharmacia, AstraZeneca and Orexo. Sven’s strength is to give strategic commercial support in life science projects during development, to prepare the projects for successful licensing or launch.
- [EY](https://swedenbio.se/medlemmar/ernst-young-ab/) - At EY, they are committed to building a better working world — with increased trust and confidence in business, sustainable growth, development of talent in all its forms, and greater collaboration. EY wanta to build a better working world through their own actions and by engaging with like-minded organizations and individuals. This is EY's purpose — and
- [Empros Pharma](https://swedenbio.se/medlemmar/empros-pharma-ab/) - Empros Pharma develops pharmaceutical treatment against overweight and obesity. The EMP16 product is now in efficacy proof-of-concept clinical trials. The early phase safety and tolerability trials are finalized, demonstrating a best-in-class safety profile and improved blood glucose control.
- [Elypta](https://swedenbio.se/medlemmar/elypta/) - Elypta's approach is to measure a system of metabolic biomarkers - a profile of metabolites found to reflect an important process in cancer - in both blood and urine. Our learning algorithms then pin down the patterns specific to various forms of cancer using clinical data. Elypta proudly sponsors the clinical trial series AURORAX to
- [Dilafor](https://swedenbio.se/medlemmar/dilafor-ab/) - Dilafor is dedicated to the development of pharmaceutical products aimed at minimizing the risk for protracted labor and associated complications. Dilafor develops pharmaceutical products from heparin derivatives with low anticoagulant activity. The company has a balanced product portfolio representing some highly promising ideas and innovations in obstetrics.
- [Diamyd Medical](https://swedenbio.se/medlemmar/diamyd-medical-ab/) - The Company develops the diabetes vaccine Diamyd® with the active ingredient GAD, which has the potential to become a key piece of the puzzle of a future solution to prevent, treat or cure type 1 diabetes and other forms of diabetes.
- [Cytiva Testa Center](https://swedenbio.se/medlemmar/cytiva-testa-center-ab/) - Main objective for Testa Center is to bridge the gap from discovery to industrialization. It's an open non-GMP, production-like facility and test-bed for education, innovation and proof-of-concept experiments on production processes for biological products, e.g. monoclonal antibodies, peptides and proteins. You have access to both equipment and expertise to go from lab bench scale to
- [Cuviva](https://swedenbio.se/medlemmar/cuviva-ab/) - Cuviva is the only open, independent platform that fully focuses on improving the situation for both individuals and health care teams. The benefits with Cuviva: Individuals feel free and independent, family members feel involved, healthcare teams can work more efficiently and healthcare in general can save both time and money.
- [Curovir](https://swedenbio.se/medlemmar/curovir-ab/) - Curovir has offices at Karolinska Institutte Science Park and a small laboratory in Kalmar where some tests are performed, but most laboratory tests are performed elsewhere in collaboration with colleagues at universities, companies and hospitals around the world.
- [Cirio Advokatbyrå](https://swedenbio.se/medlemmar/cirio-advokatbyra/) - Cirio is a Swedish law firm based in Stockholm, serving local and international clients, navigating complex legal infrastructures and transactions, ultimately improving the way both business and society work. Cirio's high quality of service and their determination to deliver good results ensure they build long-term relationships with their clients, aiming to be not just an
- [Chiesi Pharma](https://swedenbio.se/medlemmar/chiesi-pharma-ab/) - An international company, with headquarter based in Parma, Italy. In short: four international research centres, three production facilities, 1 300 active patents, 42 ongoing projects in various phases of clinical development, and medicines available in more than 89 countries. The Swedish office is based in Stockholm.
- [Cantargia](https://swedenbio.se/medlemmar/cantargia/) - Cantargia AB's focus is on the development of a discovery made by Professor Thoas Fioretos and Dr Marcus Järås from Lund University. Their research showed that leukaemia stem cells express a protein on the surface called IL1RAP, which is not expressed to a large extent on normal cells. In collaboration with the founders, Cantargia has
- [Calliditas Therapeutics](https://swedenbio.se/medlemmar/calliditas-therapeutics-ab/) - Calliditas is a clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. Calliditas’ vision is to leverage its interdisciplinary expertise in pharmaceutical product development to identify, develop and commercialize novel treatments in orphan indications, with an
- [Buzzard Pharmaceuticals](https://swedenbio.se/medlemmar/buzzard-pharmaceuticals/) - Buzzard Pharmaceuticals AB is based at the Karolinska Institute Science Park in Stockholm and was founded in 2016 by Urban Paulsson and Maarten de Château. The company has acquired the rights to isunakinra from Eleven Biotherapeutics in 2017 with the intent to re-position isunakinra in cancer indications. Isunakinra is a chimeric protein binding to IL1R1
- [Business Region Göteborg](https://swedenbio.se/medlemmar/business-region-goteborg/) - The goal is to contribute to sustainable growth, a high level of employment and diversity in trade and industry in the region. Business Region Göteborg works closely together with municipal trade and industry leaders together with, and on behalf of, companies in the region.
- [Bristol-Myers Squibb](https://swedenbio.se/medlemmar/bristol-myers-squibb/) - The company commit to scientific excellence and investment in biopharmaceutical research and development to provide innovative, high-quality medicines that address the unmet medical needs of patients with serious diseases. Bristol-Myers Squibb applies scientific rigor to produce clinical and economic benefit through medicines that improve patients’ lives. The company strives to make information about our commercialized
- [BRANN](https://swedenbio.se/medlemmar/brann-ab/) - The business covers patents, trademarks, designs law and copyright as well as litigation and agreements and other matters concerning marketing and competition law. At Brann, specialists work either in the patent department or the legal department, which handles trademarks, design, commercial contracts and domain names. Both disciplines play a prominent role at all our offices as
- [BioStock](https://swedenbio.se/medlemmar/biostock-ab/) - Biostock's content target investors as well as representatives of companies and organizations in biotechnology, medical technology, diagnostics and drug development. Biostock's daily news updates are followed by a majority of decision-makers at management level in Nordic life science. By distributing BioStock's news, articles and interviews, and filmed investor events and capital market days parallel in a
- [BioReperia](https://swedenbio.se/medlemmar/bioreperia-ab/) - Many drugs fail at late stages of development due to efficacy or toxicity issues. BioReperia's services enable early identification of such issues, increasing the speed of pre-clinical development and success-rate of other candidates.
- [Biognos](https://swedenbio.se/medlemmar/biognos-ab/) - Biognos provides services in molecular modelling, particularly virtual screening. Biognos is offering these services primarily to pharmaceutical and biotech companies which do not have sufficient in-house modelling facilities. The company provide cost-efficient solutions with confidentiality. They also provide the services to academic groups working in the field of chemical biology.
- [BioArctic](https://swedenbio.se/medlemmar/bioarctic-neuroscience-ab/) - BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of disorders that affect the Central Nervous System. These types of treatments are commonly referred to as “disease modifiers”. They affect the underlying disease pathology and can hopefully stop or significantly delay disease progression. This is a large
- [Beactica](https://swedenbio.se/medlemmar/beactica-ab/) - As well as progressing its own drug discovery programmes in oncology and CNS, Beactica offers partnerships for fragment-based lead generation using its proprietary discovery platform and services in the area of SPR biosensor-based interaction analysis.
- [Awa Sweden](https://swedenbio.se/medlemmar/awapatent-ab/) - Awa Sweden likes to create winners and they do this by offering their clients a full scope of services that make the company a one-stop shop. Awa Sweden's philosophy is simple while their methods are robust. The company likes to acquire an overall strategic picture of the intellectual property assets of not only their clients
- [Attgeno](https://swedenbio.se/medlemmar/attgeno-ab/) - The development of Supernitro would not have been possible without the entrepreneurship of the Attgeno founders and their associates. The company has within its management, board of directors and scientific advisory associates not just researchers but also individuals with a history of building successful companies emerging from discoveries in nitric oxide and pulmonary hypertension research.
- [Atrogi](https://swedenbio.se/medlemmar/atrogi-ab/) - Atrogi was founded in 2013 by professor Tore Bengtsson with support from private investors. Professor Bengtsson has been conducting ground-breaking research on adrenergic signaling at Stockholm University for over 15 years and discovered how to selectively stimulate blood glucose uptake in skeletal muscle. This evidence is used to develop a treatment of T2D that produces
- [Atlas Antibodies](https://swedenbio.se/medlemmar/atlas-antibodies-ab/) - Building on their heritage with the Human Protein Atlas project, Atlas Antibodies provide highly validated reagents that enable leading research in biology, diagnostics and medicine for the purpose of understanding and improving human health.
- [AstraZeneca](https://swedenbio.se/medlemmar/astrazeneca-ab/) - The company focuses primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. Their expertise spans the entire life-cycle of a medicine and we have capabilities in both small molecules and biologics. This allows the company to search for solutions to unmet medical needs using both modalities, individually or in
- [Ascelia Pharma](https://swedenbio.se/medlemmar/cmc-contrast/) - Ascelia´s strategy is to develop and make available to patients a portfolio of differentiated, underappreciated and de-risked product candidates addressing unmet medical needs in cancer and cancer-related diseases. Ascelia is fully focused on two clinical-stage product candidates under development: Mangoral and Oncoral.
- [AQILION](https://swedenbio.se/medlemmar/aqilion-ab/) - AQILION explores novel scientific findings describing the biology behind the diseases and focus on developing new innovative treatments. Their mission is clear, the company identifies opportunities based on solid research resting on a firm biological foundation offering both clinical relevance and patient benefit.
- [Aptahem](https://swedenbio.se/medlemmar/aptahem-ab/) - The company’s primary pharmaceutical candidate, Apta-1, is being developed with the aim of preventing the high mortality rate caused by organ and tissue damage in sepsis patients, among others. The company holds patent protection in strategic target markets and actively seeks business development opportunities with potential collaborators.
- [APL – Apotek Produktion & Laboratorier](https://swedenbio.se/medlemmar/apl-apotek-produktion-laboratorier-ab/) - APL's social mission entails a responsibility to develop and provide a medically appropriate and quality-assured range of extemporaneous drugs and stock preparations. The purpose is for patients with special needs, who are unable to use the medicines available on the market, to be able to access the right treatment. This is done in close collaboration
- [Antaros Medical](https://swedenbio.se/medlemmar/antaros-medical-ab/) - Antaros Medical develops imaging methodologies and designs tailored imaging studies to answer questions in a precise way for key decisions in clinical stage drug development projects. The methodology mainly include immages from using Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET). Antaros Medical is specialized in cardio-metabolic conditions and in the field of oncology/immuno-oncology.
- [Annexin Pharmaceuticals](https://swedenbio.se/medlemmar/annexin-pharmaceuticals-ab/) - The company’s biological drug candidate ANXV – a human recombinant protein, Annexin A5 – is intended primarily for the acute treatment of patients with cardiovascular diseases with vascular damages and inflammation. The company also has a comprehensive patent portfolio for the treatment of diseases caused by vascular damage and inflammation. Annexin Pharmaceuticals has established and
- [Anchor Management Consulting](https://swedenbio.se/medlemmar/anchor-management-consulting-ab/) - Anchor Management Consulting has helped companies improve their business since 2007. The company consists of senior consultants with an average of 20 years experience from different roles in the workplace. This means that we are a relatively young company with a very deep expertise in the areas where we operate.
- [American Chamber of Commerce in Sweden](https://swedenbio.se/medlemmar/american-chamber-commerce-sweden/) - Since 1992, we have promoted U.S.-Swedish trade and investment and U.S. commercial interests in Sweden. The organisation promotes Swedish-American trade and investment, delivering critical business information to their member companies.
- [Almi Invest](https://swedenbio.se/medlemmar/almi-ab/) - This includes ideas with potential for growth in the early stages as well as existing companies that are investing in growth and expansion. Whatever new venture you are about to embark on – an international launch, developing a new product or service, entering a new market, buying or starting a business – you should get in
- [Albireo](https://swedenbio.se/medlemmar/albireo-ab/) - Albireo is focused on developing novel therapies that address unmet medical needs in the GI area. Specifically, they are concentrating on generating significant clinical data for their lead programme in chronic constipation, and on progressing our pre-clinical assets into the clinic. Their clinical pipeline includes product candidates that are designed to act locally to restore normal bile
- [Affibody](https://swedenbio.se/medlemmar/affibody-ab/) - Affibody is developing a portfolio of innovative drug projects and, in addition, offers the half-life extension technology, Albumod™, for outlicensing. Affibody has ongoing commercial relationships with several companies including Algeta, Amylin, Swedish Orphan Biovitrum, Daiichi-Sankyo, Daewoong, GE, and Thermo Fisher. Affibody was founded in 1998 by researchers from the Royal Institute of Technology and the Karolinska Institute
- [Advokatfirman Vinge](https://swedenbio.se/medlemmar/advokatfirman-vinge-kb/) - As business lawyers Vinge devote as much attention to the business aspects of our clients’ operations as the legal aspects. Vinge always work closely with clients and really get to prove their value and experience when they can roll up their sleeves and take an active role in the business. Based on Vinge's deep understanding of
- [Advokatfirman Lindahl](https://swedenbio.se/medlemmar/advokatfirman-lindahl-kb/) - Lindahl's legal experts can be found in six offices throughout Sweden, Stockholm, Göteborg, Malmö, Uppsala, Örebro and Helsingborg. They work to give their clients straight answers and clear advice, regardless of the complexity of the matter.
- [Adlersson Heath](https://swedenbio.se/medlemmar/adlersson-heath/) - Adlersson Heath AB are experts in dealing with the many complex situations that face the management of a life science company. The company understands the logic of the capital markets and the challenges that raising capital entails. The company understands the science that underpins innovation, and how it is best portrayed to different investor groups
- [AcuCort](https://swedenbio.se/medlemmar/acucort/) - AcuCort’s new, innovative drug candidate enables fast uptake of the active ingredient. ISICORT® is not a tablet that must be swallowed nor does it require access to water since it is a fast-dissolving oral film to be put on the tongue. It is based on a well-known version of cortisone – dexamethasone. Important benefits in
- [Active Biotech](https://swedenbio.se/medlemmar/active-biotech-ab/) - Treatments are currently under clinical development for Huntington’s disease (licensed to Teva Pharmaceutical Industries) and for solid cancer (licensed to NeoTX Therapeutics). In addition, activities are ongoing to find strategic and competent partners to secure the continued development of tasquinimod for the treatment of multiple myeloma, paquinimod for systemic sclerosis and the pre-clinical projects within the SILC
- [ABG Sundal Collier](https://swedenbio.se/medlemmar/abg-sundal-collier/) - The company was established in 2001 following a merger between Norwegian Sundal Collier and Swedish ABG and is today established adviser in Corporate Finance in the Nordic market. The business is managed on the basis of two business segments: Market and Investment Banking.
- [Abera Bioscience](https://swedenbio.se/medlemmar/abera-bioscience/) - Abera is a Swedish biotech company headquartered in Stockholm, Sweden. Abera is committed to becoming a world-leading company in innovative vaccine technologies. Abera has developed a unique vaccine platform based on Gram-negative bacteria and derived Outer Membrane Vesicles (OMVs) that can be decorated on the surface with multiple antigens of choice at a high density. Abera’s platforms
- [Celluminova](https://swedenbio.se/medlemmar/celluminova/) - Grown out from a collaboration between two Swedish Universities (Karolinska Institutet and Linköping University), Celluminova has been established to increase the visibility and distribute the products generated from the academic efforts.
- [Betagenon](https://swedenbio.se/medlemmar/betagenon/) - This biotechnology company is focused on the development of AMP-activated protein kinase (AMPK) activator compounds to treat chronic energy balance disorders diseases in metabolically challenged elderly and/or obese individuals. Drugs that activate AMPK are expected to have beneficial effects on metabolic and cardiorenal diseases.
- [SARomics Biostructures](https://swedenbio.se/medlemmar/saromics-biostructures/) - SARomics Biostructures provides a broad range of structural biology and drug discovery outsourcing services to the biotech industry and academic groups. It’s strategic location in close vicinity to the MAX IV synchrotron, one of the world’s best X-ray crystallography facilities, allows SARomics Biostructures to offer high quality and high resolution single-crystal X-ray diffraction data collection and
- [Business Sweden](https://swedenbio.se/medlemmar/business-sweden/) - Business Sweden is a global consultancy organization with approximately 500 colleagues working in 46 countries with the goal to creat maximum value for Sweden. Business Sweden’s purpose is to help Swedish companies grow global sales and international companies invest and expand in Sweden. Through it’s consultancy services they offer customers strategic advice and hands-on support

## Medlemmarnas inlägg

- [NorthX söker Process Development Scientist](https://swedenbio.se/anslagstavlan/northx-soker-process-development-scientist/) - Är du eller känner du en passionerad processutvecklare in om bakteriella bioprocesser? North söker just nu ytterligare en medlem till vårt utvecklings team. Tveka inte att höra av er! https://www.nxbio.com/peoplecareer/upstream-process-development-scientist
- [NorthX seeks Process Development Scientist](https://swedenbio.se/anslagstavlan/northx-soker-process-development-scientist/) - Are you or do you know a passionate process developer in the field of bacterial bioprocesses? North is currently looking for another member of our development team. Do not hesitate to contact us! https://www.nxbio.com/peoplecareer/upstream-process-development-scientist
- [NorthX seeks Process Development Scientist](https://swedenbio.se/anslagstavlan/northx-soker-process-development-scientist/) - Are you or do you know a passionate process developer in the field of bacterial bioprocesses? North is currently looking for another member of our development team. Do not hesitate to contact us! https://www.nxbio.com/peoplecareer/upstream-process-development-scientist
- [Skills needs in your organization? Haeger & Carlsson has consultants available!](https://swedenbio.se/anslagstavlan/kompetensbehov-i-din-organisation-haeger-carlsson-har-tillgangliga-konsulter/) - Skills needs in your organization? Haeger & Carlsson has consultants available! At Haeger & Carlsson, we have a large and established network of consultants in order to match each individual assignment with the right skills. Examples of roles in which the consultants have experience: Quality Assurance Manager Chief Medical Officer (CMO) Head of Medical Affairs
- [Traineeships sought for Pharmaceutical Technicians](https://swedenbio.se/anslagstavlan/praktikplatser-sokes-for-lakemedelstekniker/) - The purpose of the LIA is primarily to give the student an insight into how the work works at your workplace and is free of charge for the company. Are you able to host one or two trainees or have questions about what it means? If so, please contact Anna Lundin, Director of Education and
- [How do you manage expectations and communicate setbacks as a small, listed biotech company?](https://swedenbio.se/anslagstavlan/how-do-you-manage-expectations-and-communicate-setbacks-as-a-small-listed-biotech-company/) - In February 2021, Oncopeptides' drug candidate for relapsed or refractory multiple myeloma, Pepaxto®, was approved by the FDA for use in the USA. This marked an astonishing accomplishment for a small Swedish biotech company, but also the start of significant regulatory hurdles. In March the same year, Pepaxto was commercially available and the first patients
- [Need for consultants? Now or in the fall? Available skills - e.g. Head of QA, CMO, HR, Business Development, etc.](https://swedenbio.se/anslagstavlan/behov-av-konsulter-nu-eller-till-i-host-tillganglig-kompetens-exempelvis-head-of-qa-cmo-hr-business-development/) - Need for consultants? Now or in the fall? Available skills - e.g. Head of QA, CMO, HR, Business Development, etc. Is the budget for the fall set and is it time to fill the organization with valuable skills? Haeger & Carlsson has a large network of consultants and below you can read about some of
- [Haeger & Carlsson expands its recruitment and interim solutions team](https://swedenbio.se/anslagstavlan/haeger-carlsson-utokar-sitt-team-inom-rekrytering-och-interimslosningar/) - The demand for recruitment and interim solutions is increasing and thus we at Haeger & Carlsson have expanded our expertise in recruitment and interim. "It is with great pleasure that I want to convey that Lena Sörskog has joined us as Senior Recruitment Consultant. Lena has a solid competence and a broad network, including in
- [DNB Markets and Redeye form partnership to expand coverage in Equity Research](https://swedenbio.se/anslagstavlan/dnb-markets-and-redeye-form-partnership-to-expand-coverage-in-equity-research/) - The new partnership allows DNB to expand its extensive Nordic coverage and aims to leverage expertise in companies not covered by DNB through white labelled research that is made available to DNB's clients. Redeye is mainly focusing on Nordic growth companies with disruptive technologies. The Collaboration will also help growth companies to raise new equity,
- [Briefing on Europe's new partnership for health, the Innovative Health Initiative (IHI)](https://swedenbio.se/anslagstavlan/informationsmote-om-europas-nya-partnerskap-for-halsa-innovative-health-initia-tive-ihi/) - Vinnova is organizing a (hybrid) information meeting on IHI- Innovative Health Initiative on May 24 at 11-13 (at Vinnova in Stockholm or digitally via Teams). The program and future calls will be presented by Pierre Meulien, Executive Director IHI office, and two IMI (Innovative Medicine Initiative) projects with Swedish participation will share their experiences. Of
- [Road to FIH: a free webinar series offered by Lonza](https://swedenbio.se/anslagstavlan/road-to-fih-a-free-webinar-series-offered-by-lonza/) - In today's competitive environment, the gene to First In Human (FIH) journey is complicated and more challenging than ever. - Competitors are chasing the same indications as well as the finite funding available. - There is increased pressure to get the candidate into the clinic as fast as possible. - Amidst overwhelming uncertainty, companies must
- [Available consultants - e.g. Reg, QA, RP, CMO, Sustainability.](https://swedenbio.se/anslagstavlan/tillgangliga-konsulter-ex-reg-qa-rp-cmo-sustainability/) - Do you need consultants? Contact me if you need to hire a consultant! For example, we have the consultants mentioned below available. Get in touch if you want to hear more about any of these or if you have other needs. Consultant Reg RP - pharma, available immediately Solid experience in regulatory work in Pharma,
- [Curious to find out about clinical evidence for medical device software under the new EU regulations? Look no further than our brand new white paper.](https://swedenbio.se/anslagstavlan/curious-to-find-out-about-clinical-evidence-for-medical-device-software-under-the-new-eu-regulations-look-no-further-than-our-brand-new-white-paper/) - Read the white paper here.
- [PharmaRelations strengthens - new consultant manager in western Sweden](https://swedenbio.se/anslagstavlan/pharmarelations-forstarker-ny-konsultchef-i-vastsverige/) - To meet the increasing demand at PharmaRelations for consulting services in Life Science, we have recruited Aina Illiano as Consultant Manager Medical Interim with responsibility for the Gothenburg region. - I am very happy to welcome Aina Illiano to our great team. Recruiting another such experienced person is extremely important for our consulting services in
- [Life Science facilities to lease in Solna](https://swedenbio.se/anslagstavlan/life-science-facilities-to-lease-in-solna/) - SPACE TO LEASE A cozy office and functional laboratory space strategically located just outside of the city center. Suitable for companies looking for a place to perform their operations in proximity to Karolinska Institutet, Karolinska Hospital and many biotech companies in the area. Life Science Facility Solna
- [Offices and laboratories for rent in Solna](https://swedenbio.se/anslagstavlan/kontor-och-laboratorium-att-hyra-i-solna/) - A nice office with functional and fresh laboratories, in a central location in Stockholm. Well adapted for a company that wants well-adapted premises in the emerging biotech hub around Campus Solna, the New Karolinska Hospital and Karolinska Institutet. The premises are attractively located in Hagalund industrial area with just over 1.5 km to Stockholm Centrum
- [Funding available from Vinnova for projects in Testa Center](https://swedenbio.se/anslagstavlan/funding-available-from-vinnova-for-projects-in-testa-center/) - Maximum funding per project: 800 000 SEK. Required co-funding: 30% (for all entities, including universities). Open for SME and academic commercialization projects. Applications are welcome and will be evaluated continuously. Contact Malin.Wiederholm[at]stuns.se
- [Pharmiva seeks E-commerce Manager](https://swedenbio.se/anslagstavlan/pharmiva-soker-e-commerce-manager/) - Pharmiva is a forward-looking femtech life science company developing new innovative treatments for vaginal health. The company's first patented and CE-marked product Vernivia® is a vaginal mousse developed for the treatment of bacterial vaginosis, an infection that affects approximately one third of all women globally aged 14-49 years. For the first time, Vernivia® provides women
- [Welcome to a free European online recruitment fair!](https://swedenbio.se/anslagstavlan/valkommen-till-en-kostnadsfri-europeisk-online-rekryteringsmassa/) - Finland - Norway - Sweden Day is a great opportunity to meet candidates in the current situation! It is a recruitment fair for shortage sectors such as health, veterinary, tech/IT/industrial, mining, life sciences, education and chefs where Nordic employers meet candidates from different EU/EEA countries online.The online fair is part of the European Job Days
- [The Impact of Brexit](https://swedenbio.se/anslagstavlan/the-impact-of-brexit/) - The Impact of Brexit: How has your Business been Affected', A Medilink Midlands webinar, in partnership with the Office for Life Sciences, on how Life Sciences businesses are being affected by Brexit and the end of the Transition Period: https://attendee.gotowebinar.com/recording/8486255455998258188
- [Guide to Global Sustainable Goals](https://swedenbio.se/anslagstavlan/guide-to-global-sustainable-goals/) - Business Region Gothenburg has developed a report and two matrices that will serve as a guide for Life Science companies & organizations interested in knowing more about how their products and services contribute to the global sustainable goals as well as a guide to the European Green Deal. This information can be used for marketing purposes,
- [Validation engineer in life sciences](https://swedenbio.se/anslagstavlan/valideringsingenjor-inom-life-science/) - Do you have experience in methodological or instrument validation in the pharmaceutical industry? Are you curious as a person and interested in contribute to the the development of a company with strong corporate culture where participation, learning and curiosity are key components? Then read on! Right now we are looking at Mpya Sci & Tech is looking
- [Wanted: life science project managers](https://swedenbio.se/anslagstavlan/sokes-life-science-projektledare/) - We at Randstad Life Sciences are expanding and now we are looking for new colleagues. You have probably worked for a couple of years already, e.g. as a teacher. project manager, team leader or validation manager. We have a large customer portfolio, all over Mälardalen, with emphasis on the pharmaceutical industry. To be able to
- [Do you want to contribute new solutions to the needs of osteoarthritis care?](https://swedenbio.se/anslagstavlan/vill-ni-bidra-med-nya-losningar-pa-artrosvardens-behov/) - Osteoarthritis occurs in over a quarter of all individuals over the age of 40, with hip osteoarthritis being one of the most common forms. VGR as an innovation engine is currently working to find external solutions to needs based on the care journey of hip arthrosis patients. The project provides a process by which healthcare
- [Industrial Relations Officer for the InfraLife initiative](https://swedenbio.se/anslagstavlan/industrial-relations-officer-for-the-infralife-initiative/) - About the assignmentWe offer an inspiring job in a stimulating and international work environment. You will be part of a new team, building a new function integrated with the successful existing structures of the SciLifeLab External Relations Office, MAX IV Industrial Relations Team and ESS Host State Relations group. MAX IV and ESS are located
- [External Relations Officer](https://swedenbio.se/anslagstavlan/external-relations-officer/) - ABOUT THE ASSIGNMENT We offer an inspiring job in a stimulating and international working environment. You will be part of a new team, building a new function, developing this based on and integrated with the successful existing structures of the SciLifeLab External Relations Office, MAX IV Industrial Relations Team and ESS Host State Relations group.
- [Accelerating growth in your life science company](https://swedenbio.se/anslagstavlan/accelerating-growth-in-your-life-science-company/) - Join us in three online workshops starting Friday 29 January at 08.30-10.30 ! Learn more about sustainable growth and building trust from invention through internationalization. The purpose of the workshops is to give the entrepreneur in Life science companies an understanding of how the best conditions are created to come out stronger after the Corona
- [Do you want to help build the next Swedish success story in biopharmaceuticals?](https://swedenbio.se/anslagstavlan/vill-du-vara-med-och-bygga-nasta-svenska-successs-story-inom-biologiska-lakemedel/) - Do you have experience from the pharmaceutical industry and believe you can help us at Xbrane Biopharma achieve our vision, to provide biosimilars for critical diseases to enable global health equity and become a global leader in biosimilar development. Then you should apply for one of our vacancies on our website: Project Leader Head of
- [Software for quality management in the laboratory, with smart workflow management with XR technology.](https://swedenbio.se/anslagstavlan/programvara-for-kvalitetsstyrning-i-laboratoriet-med-smart-workflow-management-med-xr-teknologi/) - Hello! Sciar Company is a startup company from Helsinki, Finland. We have developed a tool for laboratories, where we want to reduce human error and create better data from work. The user creates work protocols, which are then displayed on a mobile or smart-glass device. The system recognizes what the user is doing and automatically
- [New facebook group for lab materials - buy and sell in Umeå](https://swedenbio.se/anslagstavlan/ny-facebookgrupp-for-labbmaterial-kop-och-salj-i-umea/) - It is now possible for companies in the Umeå region to buy and sell used laboratory equipment and access cheaper lab services. "Umeå University, the County Council and a number of food companies in Umeå often need a laboratory, but new equipment is expensive and requires a lot of knowledge to operate. This new Facebook
- [KI Science Park is growing! Available: great lab/office space.](https://swedenbio.se/anslagstavlan/ki-science-park-vaxer-finnes-toppenfina-lab-kontorslokaler/)
- [The Cobra family is growing! Do you want to work in Västernorrland with the forest as a neighbor and without traffic jams to work?](https://swedenbio.se/anslagstavlan/cobra-familjen-vaxer-vill-du-jobba-i/) - https://www.cobrabio.com/jobs
- [Ability to share senior and specialized skills](https://swedenbio.se/anslagstavlan/lorem-3/) - Member companies and their employees can contact Nordic Interim to make their services available to other member companies and member companies in need of senior and specialized skills can contact Nordic Interim for matching with available skills. Read more here: M2M offer from Nordic Interim
- [Digital platform makes researchers' lives easier](https://swedenbio.se/anslagstavlan/member-offer/) - The company has developed a user-friendly digital portal for researchers working with animal models. It handles everything from data collection, analysis, compliance and reporting. Most of it is currently handled manually with paper and pencil or in separate Excel files. It is time-consuming and prone to errors. Now the system keeps track of everything and
- [Kompetensbehov i din organisation?  Haeger & Carlsson har tillgängliga konsulter!](https://swedenbio.se/anslagstavlan/kompetensbehov-i-din-organisation-haeger-carlsson-har-tillgangliga-konsulter/) - Kompetensbehov i din organisation? Haeger & Carlsson har tillgängliga konsulter! Vi på Haeger & Carlsson har ett stort och etablerat kontaktnät av konsulter, detta för att kunna matcha varje enskilt uppdrag med rätt kompetens. Exempel på roller som konsulterna har erfarenhet av: Quality Assurance-Manager Chief Medical Officer (CMO) Head of Medical Affairs Qualified Person (QP) Business
- [Praktikplatser sökes för Läkemedelstekniker](https://swedenbio.se/anslagstavlan/praktikplatser-sokes-for-lakemedelstekniker/) - Syftet med LIA är primärt att den studerande ska få en inblick i hur arbetet fungerar just på er arbetsplats och är kostnadsfritt för företaget. Kan du ta emot en eller ett par praktikanter eller har frågor om vad det innebär? Hör i så fall av dig till utbildningsledare Anna Lundin. Telefon: 076-124 02 16Mejl: anna.2.lundin@edu.stockholm.se Det här
- [How do you manage expectations and communicate setbacks as a small, listed biotech company?](https://swedenbio.se/anslagstavlan/how-do-you-manage-expectations-and-communicate-setbacks-as-a-small-listed-biotech-company/) - In February 2021, Oncopeptides’ drug candidate for relapsed or refractory multiple myeloma, Pepaxto®, was approved by the FDA for use in the USA. This marked an astonishing accomplishment for a small Swedish biotech company, but also the start of significant regulatory hurdles. In March the same year, Pepaxto was commercially available and the first patients
- [Behov av konsulter? Nu eller till i höst?  Tillgänglig kompetens – exempelvis Head of QA, CMO, HR, Business Development](https://swedenbio.se/anslagstavlan/behov-av-konsulter-nu-eller-till-i-host-tillganglig-kompetens-exempelvis-head-of-qa-cmo-hr-business-development/) - Behov av konsulter? Nu eller till i höst? Tillgänglig kompetens – exempelvis Head of QA, CMO, HR, Business Development Är budgeten för hösten satt och är det dags att fylla på organisationen med värdefull kompetens? Haeger & Carlsson har ett stort kontaktnät av konsulter och nedan kan du läsa om några av dem. Vilket kompetensbehov
- [Haeger & Carlsson utökar sitt team inom rekrytering och interimslösningar](https://swedenbio.se/anslagstavlan/haeger-carlsson-utokar-sitt-team-inom-rekrytering-och-interimslosningar/) - Efterfrågan inom rekrytering och interimslösningar ökar och därmed har vi på Haeger & Carlsson utökat vår kompetens inom rekrytering och interim. "Det är med stor glädje jag vill förmedla att Lena Sörskog har börjat hos oss som Senior Recruitment Consultant. Lena har en gedigen kompetens och ett brett nätverk, bland annat inom klinisk läkemedelsutveckling och hon kommer
- [DNB Markets and Redeye form partnership to expand coverage in Equity Research](https://swedenbio.se/anslagstavlan/dnb-markets-and-redeye-form-partnership-to-expand-coverage-in-equity-research/) - The new partnership allows DNB to expand its extensive Nordic coverage and aims to leverage expertise in companies not covered by DNB through white labelled research that is made available to DNB’s clients. Redeye is mainly focusing on Nordic growth companies with disruptive technologies. The Collaboration will also help growth companies to raise new equity,
- [Informationsmöte om Europas nya partnerskap för hälsa, Innovative Health Initiative (IHI)](https://swedenbio.se/anslagstavlan/informationsmote-om-europas-nya-partnerskap-for-halsa-innovative-health-initia-tive-ihi/) - Vinnova anordnar ett (hybrid) informationsmöte om IHI- Innovative Health Initiative den 24 maj kl.11-13 (på Vinnova i Stockholm eller digitalt via Teams) Programmet samt kommande utlysningar kommer att presenteras av Pierre Meulien, Executive Director IHI office, och två IMI (Innovative Medicine Initiative) projekt med svenskt deltagande delar med sig av sina erfarenheter. Förstås avsätts även tid
- [Road to FIH: a free webinar series offered by Lonza](https://swedenbio.se/anslagstavlan/road-to-fih-a-free-webinar-series-offered-by-lonza/) - In today’s competitive environment, the gene to First In Human (FIH) journey is complicated and more challenging than ever. · Competitors are chasing the same indications as well as the finite funding available. · There is increased pressure to get the candidate into the clinic as fast as possible. · Amidst overwhelming uncertainty, companies must
- [Tillgängliga konsulter - ex Reg, QA, RP, CMO, Sustainability.](https://swedenbio.se/anslagstavlan/tillgangliga-konsulter-ex-reg-qa-rp-cmo-sustainability/) - Har du behov av konsulter? Kontakta mig om du har behov av att anlita en konsult! Som exempel har vi nedan nämnda konsulter tillgängliga. Återkom om du vill höra mer om någon av dessa eller om du har annat behov. Konsult Reg RP – pharma, tillgänglig omgående Gedigen erfarenhet av att arbeta regulatoriskt inom Pharma,
- [Curious to find out about clinical evidence for medical device software under the new EU regulations?  Look no further than our brand new white paper.](https://swedenbio.se/anslagstavlan/curious-to-find-out-about-clinical-evidence-for-medical-device-software-under-the-new-eu-regulations-look-no-further-than-our-brand-new-white-paper/) - Read the white paper here.
- [PharmaRelations förstärker - ny konsultchef i Västsverige](https://swedenbio.se/anslagstavlan/pharmarelations-forstarker-ny-konsultchef-i-vastsverige/) - För att möta ökande efterfrågan hos PharmaRelations på konsulttjänster inom Life Science har vi rekryterat Aina Illiano som konsultchef Medical Interim med ansvar för Göteborgsregionen. – Jag är väldigt glad att få välkomna Aina Illiano till vårt fantastiska team. Att rekrytera ännu en så erfaren person är oerhört viktigt för våra konsulttjänster inom Life Science
- [Funding available from Vinnova for projects in Testa Center](https://swedenbio.se/anslagstavlan/funding-available-from-vinnova-for-projects-in-testa-center/) - Maximum funding per project: 800 000 SEK. Required co-funding: 30% (for all entities, including universities). Open for SME and academic commercialization projects. Applications are welcome and will be evaluated continuously. Contact Malin.Wiederholm[at]stuns.se
- [Kontor och laboratorium att hyra i Solna](https://swedenbio.se/anslagstavlan/kontor-och-laboratorium-att-hyra-i-solna/) - Ett trevlig kontor med funktionella och fräscha laboratorier, med ett centralt läge i Stockholm. Väl anpassat för ett företag som vill ha välanpassade lokaler i den framväxande biotech-hubben kring Campus Solna, Nya karolinska sjukhuset samt Karolinska Institutet. LOKALERNA är attraktivt placerade i Hagalund industriområde med drygt 1,5 km till Stockholm Centrum samt samma avstånd till
- [Life Science facilities to lease in Solna](https://swedenbio.se/anslagstavlan/life-science-facilities-to-lease-in-solna/) - SPACE TO LEASE A cozy office and functional laboratory space strategically located just outside of the city center. Suitable for companies looking for a place to perform their operations in proximity to Karolinska Institutet, Karolinska Hospital and many biotech companies in the area. Life Science Facility Solna
- [Pharmiva söker E-commerce Manager](https://swedenbio.se/anslagstavlan/pharmiva-soker-e-commerce-manager/) - Pharmiva är ett framtidsinriktat femtech bolag inom Life Science och utvecklar nya innovativa behandlingar för vaginal hälsa. Bolagets första patenterade och CE-märkta produkt Vernivia® är en vaginal mousse framtagen för behandling av bakteriell vaginos, en infektion som drabbar cirka en tredjedel av alla kvinnor globalt i åldern 14–49 år. Med Vernivia® får kvinnor för första
- [Välkommen till en kostnadsfri europeisk online rekryteringsmässa!](https://swedenbio.se/anslagstavlan/valkommen-till-en-kostnadsfri-europeisk-online-rekryteringsmassa/) - Finland - Norway - Sweden Day är ett ypperligt tillfälle att träffa kandidater i rådande situation! Det är en rekryteringsmässa inom bristbranscher som hälsa, veterinärer, tech/IT/industri, gruvnäring, life science, pedagogik och kockar där nordiska arbetsgivare möter kandidater från olika EU/EES-länder online.Onlinemässan är en del av rekryteringsmässorna European Job Days som anordnas av olika europeiska länder.
- [The Impact of Brexit](https://swedenbio.se/anslagstavlan/the-impact-of-brexit/) - The Impact of Brexit: How has your Business been Affected’, A Medilink Midlands webinar, in partnership with the Office for Life Sciences, on how Life Sciences businesses are being affected by Brexit and the end of the Transition Period: https://attendee.gotowebinar.com/recording/8486255455998258188
- [Guide to Global Sustainable Goals](https://swedenbio.se/anslagstavlan/guide-to-global-sustainable-goals/) - Business Region Göteborg has developed a report and two matrices that will serve as a guide for Life Science companies & organisations interested in knowing more about how their products and services contribute to the global sustainable goals as well as a guide to the European Green Deal This information can be used for marketing purposes,
- [Sökes: life science-projektledare](https://swedenbio.se/anslagstavlan/sokes-life-science-projektledare/) - Vi på Randstad Life Sciences utökar och nu söker vi nya kollegor. Du har troligtvis jobbat ett par år redan som t.ex. projektledare, teamledare eller valideringsledare. Vi har en stor kundportfölj, över hela Mälardalen, med tyngd inom läkemedelsbranschen. För att kunna täcka upp för våra kunders olika behov söker vi nu dig som har gedigen
- [Valideringsingenjör inom Life Science](https://swedenbio.se/anslagstavlan/valideringsingenjor-inom-life-science/) - Har du erfarenhet av metod- eller instrumentvalidering inom läkemedelsindustrin? Är du nyfiken som person och intresserad av att bidra till utvecklingen av ett företag med stark företagskultur där delaktighet, lärande och nyfikenhet är viktiga komponenter? Då ska du läsa vidare! Just nu letar vi på Mpya Sci & Tech efter fler kollegor med erfarenhet av validering och processutveckling inom läkemedelstillverkning till konsultteamen Kvalitet och Kemisk analys i Stockholm. Vi letar efter dig
- [Vill ni bidra med nya lösningar på artrosvårdens behov?](https://swedenbio.se/anslagstavlan/vill-ni-bidra-med-nya-losningar-pa-artrosvardens-behov/) - Artros förekommer hos drygt en fjärdedel av alla individer över 40 år och höftartros är en av de vanligaste formerna. VGR som Innovationsmotor jobbar just nu med att söka externa lösningar på behov utifrån höftartrospatienters vårdresa. Projektet bidrar med en process genom vilken vårdens behov kan presenteras för externa aktörer, och utgör en bro för
- [External Relations Officer](https://swedenbio.se/anslagstavlan/external-relations-officer/) - ABOUT THE ASSIGNMENT We offer an inspiring job in a stimulating and international working environment. You will be part of a new team, building a new function, developing this based on and integrated with the successful existing structures of the SciLifeLab External Relations Office, MAX IV Industrial Relations Team and ESS Host State Relations group.
- [Industrial Relations Officer for the InfraLife initiative](https://swedenbio.se/anslagstavlan/industrial-relations-officer-for-the-infralife-initiative/) - About the assignmentWe offer an inspiring job in a stimulating and international work environment. You will be part of a new team, building a new function integrated with the successful existing structures of the SciLifeLab External Relations Office, MAX IV Industrial Relations Team and ESS Host State Relations group. MAX IV and ESS are located
- [Accelerating growth in your life science company](https://swedenbio.se/anslagstavlan/accelerating-growth-in-your-life-science-company/) - Join us in three online workshops starting Friday 29 January at 08.30-10.30 ! Learn more about sustainable growth and building trust from invention through internationalisation. The purpose of the workshops is to give the entrepreneur in Life science companies an understanding of how the best conditions are created to come out stronger after the Corona
- [Vill du vara med och bygga nästa svenska success story inom biologiska läkemedel?](https://swedenbio.se/anslagstavlan/vill-du-vara-med-och-bygga-nasta-svenska-successs-story-inom-biologiska-lakemedel/) - Har du erfarenhet från läkemedelsindustrin och tror att du kan hjälpa oss på Xbrane Biopharma att uppnå vår vision, att tillhandahålla biosimilarer till kritiska sjukdomar för att möjliggöra global hälsojämlikhet och bli en global ledare inom biosimilarutveckling. Då ska du söka någon av våra utlysta tjänster på vår hemsida: Project Leader Head of Non Clinical
- [Digital plattform förenklar forskarens vardag](https://swedenbio.se/anslagstavlan/member-offer/) - Bolaget har utvecklat en användarvänlig och digital portal för forskare som arbetar med djurmodeller. Den sköter allt från datainsamling, analys, compliance och rapportering. Det mesta hanteras idag manuellt med papper och penna eller i separata Excel-filer. Det är tidskrävande och innebär risk för felkällor. Nu håller systemet ordning på allt och guidar dig rätt, ser till att du följer detaljerade lagar och rapporterar
- [Ny facebookgrupp för labbmaterial – köp och sälj i Umeå](https://swedenbio.se/anslagstavlan/ny-facebookgrupp-for-labbmaterial-kop-och-salj-i-umea/) - Nu är det möjligt för företag i Umeå-regionen att köpa och sälja begagnad laboratorieutrustning samt få tillgång till billigare labbtjänster. ”Umeå universitet, landstinget och ett antal livsmedelsföretag i Umeå behöver ofta ett laboratorium, men ny utrustning är dyr och kräver mycket kunskap för att driva. Denna nya Facebook-grupp gör det möjligt för Umeå-företag att stödja
- [KI Science Park växer! Finnes: toppenfina lab/kontorslokaler.](https://swedenbio.se/anslagstavlan/ki-science-park-vaxer-finnes-toppenfina-lab-kontorslokaler/)
- [Möjlighet att dela senior och specialiserad kompetens](https://swedenbio.se/anslagstavlan/lorem-3/) - Medlemsföretag och deras anställda kan kontakta Nordic Interim för att ställa sina tjänster till förfogande för andra medlemsföretag och medlemsföretag med behov av senior och specialiserad kompetens kan höra av sig till Nordic Interim för matchning mot tillgänglig kompetens. Läs mer här: M2M-erbjudande från Nordic Interim
- [Cobra Familjen växer! Vill du jobba i Västernorrland med skogen som granne och utan bilköer till jobbet?](https://swedenbio.se/anslagstavlan/cobra-familjen-vaxer-vill-du-jobba-i/) - https://www.cobrabio.com/jobs
- [Programvara för kvalitetsstyrning i laboratoriet, med smart workflow management med XR-teknologi](https://swedenbio.se/anslagstavlan/programvara-for-kvalitetsstyrning-i-laboratoriet-med-smart-workflow-management-med-xr-teknologi/) - Hej! Sciar Company är ett startup företag från Helsingfors, Finland. Vi har utvecklat ett verktyg för laboratorier, var vi vill sänka mängden mänskliga misstag och skapa bättre data från arbetet. Användaren skapar arbetsprotokoll, vilka visas sedan på en mobil-, eller smart-glass apparat. Systemet känner igen vad användaren gör, och skapar automatiskt en dokumentation av arbetet,

## Medlemsförmåner

- [Discount on international partnering conferences](https://swedenbio.se/medlemsforman/rabatt-pa-internationella-partneringkonferenser/) - A selection is listed below: Nordic Life Science Days (SwedenBIO) BIO International Convention (BIO) Biotech Showcase (EBD Group) BIO Europe Spring (EBD Group) BIO Europe (EBD Group) Swiss Biotech Day Knowledge for Growth Swiss-Nordic Bio Anglonordic Life Science Conference Members of SwedenBIO receive a link to the page with all discount codes. Please contact us
- [Rabatt på internationella partneringkonferenser](https://swedenbio.se/medlemsforman/rabatt-pa-internationella-partneringkonferenser/) - Nedan listas ett urval: Nordic Life Science Days (SwedenBIO) BIO International Convention (BIO) Biotech Showcase (EBD Group) BIO Europe Spring (EBD Group) BIO Europe (EBD Group) Swiss Biotech Day Knowledge for Growth Swiss-Nordic Bio Anglonordic Life Science Conference Medlemmar i SwedenBIO erhåller en länk till sida med alla rabattkoder. Vänligen kontakta oss på info@swedenbio.se vid frågor
- [Discount on package solution at Cision](https://swedenbio.se/medlemsforman/syns-ditt-foretag-tillrackligt-berattar-du-nyheter-fran-ditt-bolag-for-omvarlden/) - Offer from Cision: Cision has developed a customized package solution for SwedenBIO's members that gives up to 20% discount for you as a new customer. For other selected services, such as listing, there is a 10% discount. If you are already a customer of Cision, you can contact your Account Manager to take advantage of
- [Discount on industry news](https://swedenbio.se/medlemsforman/branschnyheter/) - The Nordic Life Science News service, the business magazine Nordic Life Science and the news portal www.nordiclifescience.org bring the latest news, business, market trends, research and developments in pharmaceuticals, medical devices, biotechnology and diagnostics to over 40,000 readers worldwide. Read more about the offer here (remember your discount code: SWEDENBIO): https://nordiclifescience.org/swedenbio-subscription/It is also possible to
- [Discount on board training courses](https://swedenbio.se/medlemsforman/rabatt-pa-styrelseutbildningar/) - There is also a bank of candidates where companies can look for the right skills and experience for their board. At the national level, the Board Academy promotes good practices and sound principles for board work at a horizontal level. Read more about the current courses on boardacademy.com.
- [Discount on a three-day course in drug development](https://swedenbio.se/medlemsforman/rabatt-pa-tredagarskurs-i-lakemedelsutveckling/) - The course is held annually with two specializations - one on small molecules and one on biologics. The member's discount is given directly in the course registration form. Read more at https://www.lakemedelsakademin.se/utbildning-kurser/ Biologics Drug Development - 3 day courseDrug Development - 3 day course
- [Free meeting room in central Stockholm](https://swedenbio.se/medlemsforman/kostnadsfri-moteslokal-i-centrala-stockholm-for-mindre-moten/) - It can host meetings for up to 8 people, and you can also borrow a room for a few hours to sit and work. Please contact us a few days in advance to check availability.
- [Rabatt på paketlösning hos Cision](https://swedenbio.se/medlemsforman/syns-ditt-foretag-tillrackligt-berattar-du-nyheter-fran-ditt-bolag-for-omvarlden/) - Erbjudande från Cision: Cision har tagit fram en skräddarsydd paketlösning för SwedenBIOs medlemmar som ger upp till 20% rabatt för dig som ny kund. För övriga utvalda tjänster, vid exempelvis börsnotering, utgår 10% rabatt. Du som redan är kund hos Cision kan kontakta er Account Manager för att ta del av ytterligare erbjudanden kring tilläggstjänster,
- [Kostnadsfri möteslokal i centrala Stockholm](https://swedenbio.se/medlemsforman/kostnadsfri-moteslokal-i-centrala-stockholm-for-mindre-moten/) - Här kan man ha möten för upp till 8 personer, du kan också låna ett rum under ett par timmar där du kan sitta och arbeta. Kontakta oss helst ett par dagar i förväg för att kontrollera tillgänglighet.
- [Rabatt på branschnyheter](https://swedenbio.se/medlemsforman/branschnyheter/) - Genom nyhetstjänsten Nordic Life Science News, affärsmagasinet Nordic Life Science och nyhetsportalen www.nordiclifescience.org får över 40 000 läsare över hela världen ta del av de senaste nyheterna, affärerna, marknadstrenderna, forskningen och utvecklingen inom läkemedel, medicinteknik, bioteknik och diagnostik. Läs mer om erbjudandet här (kom ihåg din rabattkod: SWEDENBIO): https://nordiclifescience.org/swedenbio-subscription/Det är också möjligt att testa prenumerationen kostnadsfritt under två
- [Rabatt på styrelseutbildningar](https://swedenbio.se/medlemsforman/rabatt-pa-styrelseutbildningar/) - Här finns också en bank av kandidater där företag kan leta efter rätt kompetens och erfarenheter till sin styrelse. På nationell nivå driver StyrelseAkademien frågor på övergripande nivå för att främja god sed och sunda principer för styrelsearbete. Läs mer om aktuella kurser på styrelseakademien.se
- [Rabatt på tredagarskurs i läkemedelsutveckling](https://swedenbio.se/medlemsforman/rabatt-pa-tredagarskurs-i-lakemedelsutveckling/) - Kursen hålls årligen med två inriktningar – en mot små molekyler och en med fokus på biologiska läkemedel. Medlemsrabatten får du direkt i kursanmälan. Läs mer på https://www.lakemedelsakademin.se/utbildning-kurser/ Biologics Drug Development – 3 day courseDrug Development – 3 day course

## Medlemmar Erbjudanden

- [Free consultation on your company's graphic profile](https://swedenbio.se/erbjudande-fran-medlem/kostnadsfri-konsultation-om-ditt-foretags-grafiska-profil/) - Is it time for an updated identity? As companies evolve, the logo and graphic profile can fall behind and no longer reflect what the company wants to communicate. Have you thought about whether your logo represents what you want? A company's graphic profile is its public face - the first thing a potential customer sees.
- [Get three months free of charge for your sample storage service](https://swedenbio.se/erbjudande-fran-medlem/get-three-months-free-of-charge-for-your-sample-storage-service/) - As a member of SwedenBIO, you are entitled to get your first three months storage for free if you store your samples with us for a minimum of 12 months. The offer is valid for all samples shipped before the end of June 2023, and other fees except for the storage fee applies. To learn
- [Customized recruitment service for dedicated boards and senior advisors](https://swedenbio.se/erbjudande-fran-medlem/anpassad-rekryteringstjanst-for-dedikerade-styrelser-och-seniora-radgivare/) - K2 Search Life Science offers members of SwedenBio help to complete or compose a new board or advisory board. We identify and attract people with knowledge and experience in board or management positions in your specific field of activity. People who can join your board of directors or advisory board and can also contribute with
- [Fredersen Law Firm provides free training on contractual pitfalls](https://swedenbio.se/erbjudande-fran-medlem/fredersen-advokatbyra-ger-kostnadsfri-utbildning-i-fallgropar-i-avtal/) - A company enters into a variety of agreements from the launch of the idea until the drug is hopefully approved: transfer agreements, research agreements, CTAs, MTAs, license agreements, confidentiality agreements, consultancy agreements, etc. It is not uncommon for these agreements to be drafted in such a way that unnecessary problems can arise during licensing, takeovers,
- [Free GCP/GVP training as part of the contract](https://swedenbio.se/erbjudande-fran-medlem/kostnadsfri-gcp-gvp-utbildning-som-en-del-av-kontraktet/) - Contact tania.persson@a-plusscience.com to take advantage of this offer.
- [Free advice for your clinical trial](https://swedenbio.se/erbjudande-fran-medlem/kostnadsfri-radgivning-infor-din-kliniska-studie/) - Agenda - CTC Advisory board At your free consultation, you will have the opportunity to discuss in depth the potential design of your clinical trial and get feedback on important aspects for your study start from relevant key people at the CTC. You will meet a hand-picked team consisting of a selection of scientific, medical
- [Discount on consulting solutions, employer branding, etc.](https://swedenbio.se/erbjudande-fran-medlem/rabatt-pa-konsultlosningar-employer-branding-m-m/) - Offer Randstad Life Sciences & Engineering Members Sweden Bio.pptxDownload
- [Free and tailor-made IP workshop from a strategic and commercial perspective](https://swedenbio.se/erbjudande-fran-medlem/ip-workshop-ur-ett-strategiskt-och-kommersiellt-perspektiv/) - IP workshop from a strategic and commercial perspective, 60 minutes Objective: To identify, from a commercial IP perspective, relevant activities that can strengthen the company's competitiveness and expand its business. Agenda: Brief presentation of AWA's view on commercial IP strategy Current situation analysis: A comprehensive review of the company's offering, revenue streams, business situation and
- [Tailored offer: Communication due diligence and Equity story](https://swedenbio.se/erbjudande-fran-medlem/skraddarsytt-erbjudande-communication-due-diligence-och-equity-story/) - Hi Jonas Rodny, Head of Financial Communication at Paues Åberg, what does your membership offer consist of? - We have developed two solutions that give listed companies a solid foundation for continuous and active communication with the market. In Communication due diligence is a current analysis of your company's valuation compared to the industry index,
- [Save on laboratory essentials](https://swedenbio.se/erbjudande-fran-medlem/save-on-laboratory-essentials/) - More information here.
- [Discount on collaboration tools for board and management](https://swedenbio.se/erbjudande-fran-medlem/rabatt-pa-samarbetsverktyg-for-styrelse-och-ledning/) - The solution helps to streamline the workflow of meetings, from preparation to execution and follow-up. For more information visit www.nasdaq.com/se/boardvantage or contact: marcus.lindemann@nasdaq.com
- [Digital platform makes researchers' lives easier](https://swedenbio.se/erbjudande-fran-medlem/digital-plattform-forenklar-forskarens-vardag/) - Hi Kajsa Wiklund, Business Development Manager at Vivologica, what is your portal? - We have developed a user-friendly digital portal for researchers working with animal models. It handles everything from data collection, analysis, compliance and reporting. Most of it is currently handled manually with paper and pencil or in separate Excel files. It is time-consuming
- [Free communication consultation](https://swedenbio.se/erbjudande-fran-medlem/kostnadsfri-kommunikationskonsultation/) - Or are you facing an IPO and need to communicate the potential value of your company in a cost-effective way? Perhaps you have a good marketing budget and want to know where your investments have the best impact? Phosworks wants to contribute with its knowledge through an introductory offer to members of SwedenBIO and therefore
- [Ability to share senior and specialized skills](https://swedenbio.se/erbjudande-fran-medlem/mojlighet-att-dela-senior-och-specialiserad-kompetens/)
- [Rabatt på samarbetsverktyg för styrelse och ledning](https://swedenbio.se/erbjudande-fran-medlem/rabatt-pa-samarbetsverktyg-for-styrelse-och-ledning/) - Lösningen hjälper till att effektivisera arbetsflödet i samband med möten, från förberedelse till genomförande och uppföljning. För mer info besök www.nasdaq.com/se/boardvantage eller kontakta: marcus.lindemann@nasdaq.com
- [Kostnadsfri kommunikationskonsultation](https://swedenbio.se/erbjudande-fran-medlem/kostnadsfri-kommunikationskonsultation/) - Eller står ni inför en IPO och behöver förmedla ert företags potentiella värde på ett kostnadseffektivt sätt? Kanske har ni en bra marknadsbudget och vill veta var era investeringar ger bäst effekt? Phosworks vill bidra med sin kunskap genom ett introduktionserbjudande till medlemmar i SwedenBIO och ger er därför 4 timmar kostnadsfri konsultation. Läs mer om
- [Save on laboratory essentials](https://swedenbio.se/erbjudande-fran-medlem/save-on-laboratory-essentials/) - More information here.
- [Skräddarsytt erbjudande: Communication due diligence och Equity story](https://swedenbio.se/erbjudande-fran-medlem/skraddarsytt-erbjudande-communication-due-diligence-och-equity-story/) - Hej Jonas Rodny, ansvarig för Finansiell kommunikation på Paues Åberg, vad består ert medlemserbjudande av? – Vi har tagit fram två lösningar som ger noterade bolag en bra grund att stå på för att kunna skapa en kontinuerlig och aktiv kommunikation mot marknaden. En Communication due diligence är en nulägesanalys av ditt bolags värdering jämfört
- [Kostnadsfri och skräddarsydd IP-workshop ur ett strategiskt och kommersiellt perspektiv](https://swedenbio.se/erbjudande-fran-medlem/ip-workshop-ur-ett-strategiskt-och-kommersiellt-perspektiv/) - IP-workshop ur ett strategiskt och kommersiellt perspektiv, 60 minuter Syfte: Att utifrån ett kommersiellt IP-perspektiv identifiera relevanta aktiviteter som kan stärka företagets konkurrenskraft och expandera dess affär. Agenda: Kort presentation av AWA:s syn på kommersiell IP-strategi Nulägesanalys: Översiktlig genomgång av företagets erbjudande, intäktsströmmar, affärssituation och exploateringsstrategi. Kommersiella och interna ”pain points” Rekommendationer och nästa steg
- [Möjlighet att dela senior och specialiserad kompetens](https://swedenbio.se/erbjudande-fran-medlem/mojlighet-att-dela-senior-och-specialiserad-kompetens/)
- [Digital plattform förenklar forskarens vardag](https://swedenbio.se/erbjudande-fran-medlem/digital-plattform-forenklar-forskarens-vardag/) - Hej Kajsa Wiklund, affärsutvecklingsansvarig på Vivologica, vad innebär er portal? – Vi har utvecklat en användarvänlig och digital portal för forskare som arbetar med djurmodeller. Den sköter allt från datainsamling, analys, compliance och rapportering. Det mesta hanteras idag manuellt med papper och penna eller i separata Excel-filer. Det är tidskrävande och innebär risk för felkällor. Nu håller systemet ordning på
- [Rabatt på konsultlösningar, employer branding m.m.](https://swedenbio.se/erbjudande-fran-medlem/rabatt-pa-konsultlosningar-employer-branding-m-m/) - Erbjudande Randstad Life Sciences & Engineering Medlemmar Sweden Bio.pptxLadda ner
- [Kostnadsfri rådgivning inför din kliniska studie](https://swedenbio.se/erbjudande-fran-medlem/kostnadsfri-radgivning-infor-din-kliniska-studie/) - Agenda – CTC Advisory board På din kostnadsfria konsultation har du möjlighet att djupgående diskutera potentiell design för din kliniska studie och få feedback på viktiga aspekter inför din studiestart av relevanta nyckelpersoner på CTC. Du kommer att få träffa ett handplockat team bestående av ett urval av vetenskapliga, medicinska och regulatoriska rådgivare, farmakokinetiker, bioanalytiker,
- [Kostnadsfri GCP/GVP-utbildning som en del av kontraktet](https://swedenbio.se/erbjudande-fran-medlem/kostnadsfri-gcp-gvp-utbildning-som-en-del-av-kontraktet/) - Kontakta tania.persson@a-plusscience.com för att ta del av erbjudandet.
- [Fredersen Advokatbyrå ger kostnadsfri utbildning i fallgropar i avtal](https://swedenbio.se/erbjudande-fran-medlem/fredersen-advokatbyra-ger-kostnadsfri-utbildning-i-fallgropar-i-avtal/) - Ett bolag ingår en mängd olika avtal från det idén lanserades till läkemedlet förhoppningsvis blir godkänt; överlåtelseavtal, forskningsavtal, CTA, MTA, licensavtal, sekretessavtal, konsultavtal osv. Det är inte sällan dessa avtal har utformats på ett sådant sätt att det kan uppstå onödiga problem vid licensiering, uppköp, IPO eller vid kontakt med olika investerare. Att hantera avtal
- [Get three months free of charge for your sample storage service](https://swedenbio.se/erbjudande-fran-medlem/get-three-months-free-of-charge-for-your-sample-storage-service/) - As a member of SwedenBIO, you are entitled to get your first three months storage for free if you store your samples with us for a minimum of 12 months. The offer is valid for all samples shipped before the end of June 2023, and other fees except for the storage fee applies. To learn
- [Kostnadsfri konsultation om ditt företags grafiska profil](https://swedenbio.se/erbjudande-fran-medlem/kostnadsfri-konsultation-om-ditt-foretags-grafiska-profil/) - Är det dags för en uppdaterad identitet? I takt med att bolag utvecklas kan logotyp och grafisk profil halka efter, så att de inte längre motsvarar det som företaget vill kommunicera. Har du funderat över om er logotyp representerar det som ni vill? Ett företags grafiska profil är ansiktet utåt – det första som en
- [Anpassad rekryteringstjänst för dedikerade styrelser och seniora rådgivare](https://swedenbio.se/erbjudande-fran-medlem/anpassad-rekryteringstjanst-for-dedikerade-styrelser-och-seniora-radgivare/) - K2 Search Life Science erbjuder medlemmar i SwedenBio hjälp att komplettera eller komponera en ny styrelse eller advisory board. Vi identifierar och attraherar personer med kunskap och erfarenhet från styrelse- eller ledande befattningar inom ert specifika verksamhetsområde. Personer som kan gå in i er styrelse eller advisory board och kan dessutom bidra med sina utvecklade nätverk och operativa erfarenhet. Genom

## Kategorier

- [Okategoriserad](https://swedenbio.se/kategori/okategoriserad/)
- [Okategoriserad](https://swedenbio.se/kategori/okategoriserad/)
- [Påverkan](https://swedenbio.se/kategori/paverkan/) - Inbäddad på sidan “Vi ger branschen en starkare röst”
- [Nätverk](https://swedenbio.se/kategori/natverk/) - Inbäddad på sidan “Vi utökar ditt nätverk”
- [Branschnyheter](https://swedenbio.se/kategori/branschnyheter/)
- [Affär & Finans](https://swedenbio.se/kategori/affar-finans/)
- [Nätverk](https://swedenbio.se/kategori/natverk/) - Inbäddad på sidan “Vi utökar ditt nätverk”
- [Branschnyheter](https://swedenbio.se/kategori/branschnyheter/)
- [Affär & Finans](https://swedenbio.se/kategori/affar-finans/)
- [USA](https://swedenbio.se/kategori/usa/) - SwedenBIOs USA-orienterade arbete
- [Kliniska prövningar](https://swedenbio.se/kategori/kliniska-provningar/)
- [Finansiering](https://swedenbio.se/kategori/finansiering/) - Inbäddad på sidan för arbetsgruppen för finansiering
- [Public Affairs](https://swedenbio.se/kategori/public-affairs/) - Inbäddad på sidan för arbetsgruppen för Public Affairs
- [Forskning och utveckling](https://swedenbio.se/kategori/forskning-och-utveckling/) - Inbäddad på sidan för arbetsgruppen för forskning och utveckling
- [Produktion och processutveckling](https://swedenbio.se/kategori/produktion-och-processutveckling/) - Inbäddad på sidan för arbetsgruppen för produktion och processutveckling
- [Pandemic preparedness](https://swedenbio.se/kategori/pandemic-preparedness/) - Inbäddad på sidan för arbetsgruppen för pandemic preparedness
- [Kunskap](https://swedenbio.se/kategori/kunskap/) - Inbäddad på sidan “Vi bygger kunskap”
- [SwedenBIO nyheter](https://swedenbio.se/kategori/swedenbio-nyheter/)
- [USA](https://swedenbio.se/kategori/usa/) - SwedenBIOs USA-orienterade arbete
- [SwedenBIO nyheter](https://swedenbio.se/kategori/swedenbio-nyheter/)
- [Finansiering](https://swedenbio.se/kategori/finansiering/) - Inbäddad på sidan för arbetsgruppen för finansiering
- [Forskning och utveckling](https://swedenbio.se/kategori/forskning-och-utveckling/) - Inbäddad på sidan för arbetsgruppen för forskning och utveckling
- [Kunskap](https://swedenbio.se/kategori/kunskap/) - Inbäddad på sidan “Vi bygger kunskap”
- [Pandemic preparedness](https://swedenbio.se/kategori/pandemic-preparedness/) - Inbäddad på sidan för arbetsgruppen för pandemic preparedness
- [Public Affairs](https://swedenbio.se/kategori/public-affairs/) - Inbäddad på sidan för arbetsgruppen för Public Affairs
- [Produktion och processutveckling](https://swedenbio.se/kategori/produktion-och-processutveckling/) - Inbäddad på sidan för arbetsgruppen för produktion och processutveckling
- [Påverkan](https://swedenbio.se/kategori/paverkan/) - Inbäddad på sidan “Vi ger branschen en starkare röst”
- [Europa](https://swedenbio.se/kategori/europa/)
- [Intellectual Property](https://swedenbio.se/kategori/intellectual-property/) - Länkar till den dedikerade sidan för arbetsgruppen för IP
- [Intellectual Property](https://swedenbio.se/kategori/intellectual-property/) - Länkar till den dedikerade sidan för arbetsgruppen för IP
- [Almedalen](https://swedenbio.se/kategori/almedalen/)
- [Business Strategy](https://swedenbio.se/kategori/business-strategy/)
- [Medtech](https://swedenbio.se/kategori/medtech/)
- [Nordics](https://swedenbio.se/kategori/nordics/)
- [Asien](https://swedenbio.se/kategori/asien/)
- [Asien](https://swedenbio.se/kategori/asien/)
- [Nordics](https://swedenbio.se/kategori/nordics/)
- [Europa](https://swedenbio.se/kategori/europa/)
- [Akademi-industri samarbete](https://swedenbio.se/kategori/akademi-industri-samarbete/)
- [Akademi-industri samarbete](https://swedenbio.se/kategori/akademi-industri-samarbete/)
- [Expertnätverk](https://swedenbio.se/kategori/expertnatverk/)

## Etiketter

- [Gamla sidor](https://swedenbio.se/tag/gamla-sidor/) - Dessa inlägg var tidigare publicerade som egna sidor på hemsidan

## Företagskategorier

- [Medtech](https://swedenbio.se/foretagskategorier/medtech/)
- [Pharma](https://swedenbio.se/foretagskategorier/pharma/)
- [Biotech](https://swedenbio.se/foretagskategorier/biotech/)
- [Service Providers](https://swedenbio.se/foretagskategorier/service-providers/)
- [Diagnostics](https://swedenbio.se/foretagskategorier/diagnostics/)
- [Partner Organisations](https://swedenbio.se/foretagskategorier/partner-organisations/)
- [Investors & Finance](https://swedenbio.se/foretagskategorier/investerare-finance/)
- [Management consultants](https://swedenbio.se/foretagskategorier/management-consultants/)
- [Law](https://swedenbio.se/foretagskategorier/law/)
- [Other](https://swedenbio.se/foretagskategorier/other/)
- [Human Resources](https://swedenbio.se/foretagskategorier/human-resources/)
- [PR/Communication](https://swedenbio.se/foretagskategorier/pr-communication/)
- [Investment agency](https://swedenbio.se/foretagskategorier/investment-agency/)
- [Patents /IP Rights](https://swedenbio.se/foretagskategorier/patents-ip-rights/)
- [Incubator/Science Park](https://swedenbio.se/foretagskategorier/incubator-science-park/)
- [Life Science Companies](https://swedenbio.se/foretagskategorier/life-science-companies/)
- [Regulatory](https://swedenbio.se/foretagskategorier/regulatory/)
- [CRO/CDMO](https://swedenbio.se/foretagskategorier/cro-cdmo/)
- [Business Consultants](https://swedenbio.se/foretagskategorier/business-consultants/)
- [Other](https://swedenbio.se/foretagskategorier/other-partner-organisations/)
- [Other](https://swedenbio.se/foretagskategorier/other-life-science-companies/)
- [Healthtech](https://swedenbio.se/foretagskategorier/healthtech/)
- [Life Science Tools](https://swedenbio.se/foretagskategorier/life-science-tools/)